Citrus Sinensis ID: 011882
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 475 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.943 | 0.995 | 0.707 | 0.0 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.718 | 0.772 | 1e-144 | |
| Q9DC28 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.718 | 0.772 | 1e-144 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.627 | 0.718 | 0.769 | 1e-144 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.718 | 0.772 | 1e-144 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.627 | 0.718 | 0.772 | 1e-144 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.621 | 0.710 | 0.773 | 1e-144 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | no | no | 0.621 | 0.709 | 0.777 | 1e-144 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | no | no | 0.621 | 0.709 | 0.773 | 1e-144 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.621 | 0.732 | 0.777 | 1e-144 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 678 bits (1750), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/476 (70%), Positives = 388/476 (81%), Gaps = 28/476 (5%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF
Sbjct: 61 GG-TGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFF 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++ P+RA+ P G S+ +PP +N+DR +G EEGR + SRRR SG L NS N+
Sbjct: 300 LTAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNI 355
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 418
S Q + + ++D+M+ S +L +S+GSSRRV + GS+ R RT D
Sbjct: 356 SNQPTSSS-----ARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQRSRTGDV 410
Query: 419 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 474
S G + S G+ +G+ST +++ES ++GI++L ++ H
Sbjct: 411 SRGVIPRNSPGE--------------AGKSTR--RHYESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 231/299 (77%), Positives = 271/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 231/299 (77%), Positives = 271/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 512 bits (1318), Expect = e-144, Method: Compositional matrix adjust.
Identities = 230/299 (76%), Positives = 272/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I +EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1317), Expect = e-144, Method: Compositional matrix adjust.
Identities = 231/299 (77%), Positives = 271/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 511 bits (1317), Expect = e-144, Method: Compositional matrix adjust.
Identities = 231/299 (77%), Positives = 271/299 (90%), Gaps = 1/299 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1315), Expect = e-144, Method: Compositional matrix adjust.
Identities = 229/296 (77%), Positives = 270/296 (91%), Gaps = 1/296 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-144, Method: Compositional matrix adjust.
Identities = 230/296 (77%), Positives = 270/296 (91%), Gaps = 1/296 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKLE VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296
LC+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 240 LCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 510 bits (1314), Expect = e-144, Method: Compositional matrix adjust.
Identities = 229/296 (77%), Positives = 270/296 (91%), Gaps = 1/296 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296
LC+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 240 LCKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-144, Method: Compositional matrix adjust.
Identities = 230/296 (77%), Positives = 271/296 (91%), Gaps = 1/296 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I T EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GG-VGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 475 | ||||||
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.991 | 0.997 | 0.857 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.987 | 0.995 | 0.842 | 0.0 | |
| 357454569 | 475 | Casein kinase I isoform delta-like prote | 0.993 | 0.993 | 0.817 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.989 | 0.991 | 0.841 | 0.0 | |
| 363807148 | 471 | uncharacterized protein LOC100795570 [Gl | 0.991 | 1.0 | 0.812 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.991 | 0.995 | 0.813 | 0.0 | |
| 356550412 | 472 | PREDICTED: casein kinase I isoform delta | 0.991 | 0.997 | 0.804 | 0.0 | |
| 125527438 | 472 | hypothetical protein OsI_03457 [Oryza sa | 0.987 | 0.993 | 0.805 | 0.0 | |
| 224128674 | 470 | predicted protein [Populus trichocarpa] | 0.985 | 0.995 | 0.828 | 0.0 | |
| 20804657 | 472 | casein kinase I-like [Oryza sativa Japon | 0.989 | 0.995 | 0.800 | 0.0 |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2186), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/476 (85%), Positives = 440/476 (92%), Gaps = 5/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++ P RA+GPGAGPSSGMPP+ AN+DRQ G EEGR T W S DP+RRRNSGP+ +S N
Sbjct: 300 IANPPTRALGPGAGPSSGMPPSGANIDRQPGGEEGRPT-WPSMDPTRRRNSGPITSSVNF 358
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 419
SKQK P+AND SKDA +SS N LRSSG+SRR A+ +SR+AA+ G+++DP+ RTTDAS
Sbjct: 359 SKQKGPVANDLPLSKDAKLSSTNFLRSSGTSRRPAISSSRDAALTGNESDPTWSRTTDAS 418
Query: 420 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
P KIS GQRSSP+VS+E +H +SGR+T+NIK FESTLRGIESLHFNN+ERV +
Sbjct: 419 PAV--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTFESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/477 (84%), Positives = 440/477 (92%), Gaps = 8/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD++THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VS-TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
+S P+RA+GPGAGPS G+PPA AN+DRQSG E+GR +GWSSADPSRRR + P N +L
Sbjct: 300 ISGPPSRALGPGAGPSHGIPPAVANMDRQSGGEDGRPSGWSSADPSRRRTTVPALNLGSL 359
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 419
KQKSP+AND +KD++ ++ +R+SGSSRR AV +SR+A +VG ++DPSR R DAS
Sbjct: 360 -KQKSPVANDSTMAKDSLSAN---VRASGSSRRGAVSSSRDAVIVGGESDPSRSR-ADAS 414
Query: 420 PGAFQKISSGQRSSPVVSSENRHTTSGRST-SNIKNFESTLRGIESLHFNNNERVHH 475
PGA +KISSGQR SPV SSE++ +SGR+T SNIKNFESTL+GIESLHFNN ERV +
Sbjct: 415 PGALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKNFESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454569|ref|XP_003597565.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486613|gb|AES67816.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/478 (81%), Positives = 435/478 (91%), Gaps = 6/478 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPR+GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN+KTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRIGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYKVLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++
Sbjct: 61 GG-TGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIES 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++TP ARAIG GAGPSSG+PPA + +R SG E+GRH GWSS+DP+RRRNSGP+ N NL
Sbjct: 300 IATPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNL 359
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRV-AVPNSREAAVVGSDTDPSRPRTTDA 418
S+QK+P+ +D SK+ M+SS N R SGS+RRV AV NSR+ AVV S+ +PS P D
Sbjct: 360 SRQKAPVPSDSNGSKEVMLSSSNFFRPSGSTRRVGAVSNSRD-AVVSSEIEPSLPLARDG 418
Query: 419 SPGAFQKISSGQRSSPVVSSENRHTT-SGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
SPGA K S QR+SP+ SSE++ TT SGR+TSN+KNFEST+RGIESL+F N+E+V +
Sbjct: 419 SPGALLKTSGAQRNSPITSSEHKATTSSGRNTSNMKNFESTIRGIESLNF-NDEKVQY 475
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/479 (84%), Positives = 443/479 (92%), Gaps = 9/479 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEG+YNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDTATHQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VST-PARAIGPGAGPSSGM-PPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSAN 358
++T P+R +GPGAG SSG+ PPA AN DRQSG EEGR G SS DPSRRR S G+
Sbjct: 300 LATPPSRVLGPGAGTSSGLPPPAVANADRQSG-EEGRPAGLSSMDPSRRRIS---GDGGG 355
Query: 359 LSKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTD 417
LSKQKSP+A+D A SKDAM+SS + L RSSGSSRR AV +SR+AA++GS++DPSR TT+
Sbjct: 356 LSKQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVSSSRDAAIMGSESDPSRAHTTE 415
Query: 418 ASPG-AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
ASPG A ++ISSGQRSSPV SS+ + T+SGR+ +NIKN+EST+RGIE+L+F+N+ERVH+
Sbjct: 416 ASPGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKNYESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807148|ref|NP_001242599.1| uncharacterized protein LOC100795570 [Glycine max] gi|255641648|gb|ACU21096.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/475 (81%), Positives = 430/475 (90%), Gaps = 4/475 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRV NKFRLGRKIGSGS EIYLGTN QTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSSCEIYLGTNTQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFG+EGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+
Sbjct: 61 GG-TGIPNVRWFGIEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIES 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 360
++TP R I P AG SSG+PPA N DRQ+G RHTGWSS+DP+RRRNSGP+ N S
Sbjct: 300 IATPVRVIVPTAGQSSGLPPAVVNADRQTGGVNSRHTGWSSSDPARRRNSGPIANDGMSS 359
Query: 361 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 420
+QK+P+ +D SKD M+SS + RSSGS+RR AV +SR+AA VG++T+PS P T DASP
Sbjct: 360 RQKAPVPSDSTGSKDVMLSS-SNFRSSGSTRRGAVSSSRDAA-VGNETEPSHPLTMDASP 417
Query: 421 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
GA +KIS+ QRSSP++S E+ T+SGR+TSN+KN+ESTLRGIE+L+F N+ER+ +
Sbjct: 418 GALRKISNAQRSSPIMSFEHNRTSSGRNTSNMKNYESTLRGIETLNF-NDERLQY 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/476 (81%), Positives = 422/476 (88%), Gaps = 5/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRK SLKTVLMLADQMINR+EFV
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKFSLKTVLMLADQMINRIEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRDT THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDTTTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR++RDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++ P G GAG S+G+P P AN +R+ G EEGR G S+ D RRR SG L NS +L
Sbjct: 300 LAAPPARTGAGAGTSAGVPTPPVANPERKLGEEEGRAGGLSTGDGLRRRMSGSLLNSGSL 359
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 418
KQKSP+ANDP SKD +SS NL RSSG +R A+P+SREA G+++DPSR RT +A
Sbjct: 360 LKQKSPLANDPTVSKDPTLSSTNLTGRSSGFLKRAAIPSSREAVTGGNESDPSRSRTAEA 419
Query: 419 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 474
SP Q+ SSGQRSSPV SS+ + +SGR TS IKN+ESTL+GIESLHF ++ERVH
Sbjct: 420 SPSTMQRFSSGQRSSPVGSSDAKQQSSGRITS-IKNYESTLKGIESLHF-DDERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550412|ref|XP_003543581.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/476 (80%), Positives = 428/476 (89%), Gaps = 5/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRV NKFRLGRKIGSGSFGEIYLGTN QTNEEVA+KLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSFGEIYLGTNTQTNEEVAVKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK++RDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKHRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIES 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCR YP+EFASYFHYCRSL+FDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRSYPSEFASYFHYCRSLQFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++T PARAIGP AGPSSG+PPA N DRQ+G E RHTGWSS+DP+RRRNSGP+ N L
Sbjct: 300 IATPPARAIGPAAGPSSGLPPAVVNADRQTGGENSRHTGWSSSDPARRRNSGPIANDGML 359
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 419
S+QK+P +D SKD M+SS N S S+RR V +SR+ A VG++T+PS P T DAS
Sbjct: 360 SRQKAPFPSDSTRSKDVMLSSSNFRSSG-STRRGVVSSSRD-ATVGNETEPSHPLTVDAS 417
Query: 420 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
GA +KIS QRSSP++ E+ T+SGR+TSN+KN+EST+RGIE+L+F N+ER+ +
Sbjct: 418 QGALRKISGAQRSSPIMPFEHNRTSSGRNTSNMKNYESTIRGIETLNF-NDERLQY 472
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125527438|gb|EAY75552.1| hypothetical protein OsI_03457 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2026), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/478 (80%), Positives = 429/478 (89%), Gaps = 9/478 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEA
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 V-STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
+ S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L
Sbjct: 300 IASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTL 356
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDT-DPSRPRTTD 417
+KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ V+ +DT +PSR R TD
Sbjct: 357 AKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRD--VMPTDTSEPSRTRATD 414
Query: 418 ASPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
ASPGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 415 ASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128674|ref|XP_002329062.1| predicted protein [Populus trichocarpa] gi|222839733|gb|EEE78056.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/477 (82%), Positives = 423/477 (88%), Gaps = 9/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLG NIQTNEEVAIKLENVKT+HPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGANIQTNEEVAIKLENVKTRHPQLLYESKLYKMLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTP-ARAIGPGAGPSSGMPPAAA-NVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSAN 358
++ P RA GPGAGPSSG+PP A N DRQSG EEG S D +RRRNSGP+ NS N
Sbjct: 300 IANPTTRAHGPGAGPSSGIPPPGANNADRQSGGEEGGPGW-PSIDHARRRNSGPIVNSGN 358
Query: 359 LSKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 418
LSKQKSP+ ND + SKDA +SS N LRS SSR V +SR AA G+D+DPSRPRTTDA
Sbjct: 359 LSKQKSPVTNDLSLSKDATLSSSNFLRSIVSSRNPVVSSSRGAA-FGNDSDPSRPRTTDA 417
Query: 419 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
S F + +GQRSS +SSE +H++SGR+T NIK ESTL+GIESLH N R+HH
Sbjct: 418 S---FAVLQNGQRSSAALSSEQKHSSSGRNT-NIKTLESTLKGIESLHVNIEGRLHH 470
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|20804657|dbj|BAB92346.1| casein kinase I-like [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2024), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/477 (80%), Positives = 427/477 (89%), Gaps = 7/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEA
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 V-STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
+ S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L
Sbjct: 300 IASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTL 356
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 418
+KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ + + ++PSR R TDA
Sbjct: 357 AKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDT-SEPSRTRATDA 415
Query: 419 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
SPGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 416 SPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 475 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.974 | 0.995 | 0.701 | 8.6e-175 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.873 | 0.922 | 0.709 | 6.9e-158 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.783 | 0.855 | 0.756 | 1.3e-156 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.629 | 0.690 | 0.82 | 3e-142 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.877 | 0.876 | 0.603 | 9.8e-135 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.957 | 0.966 | 0.564 | 2e-134 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.964 | 0.989 | 0.550 | 4.5e-130 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.627 | 0.674 | 0.769 | 4.5e-130 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.964 | 0.989 | 0.548 | 4e-129 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.627 | 0.622 | 0.759 | 3.3e-127 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1698 (602.8 bits), Expect = 8.6e-175, P = 8.6e-175
Identities = 329/469 (70%), Positives = 374/469 (79%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+PN++W+GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFV
Sbjct: 61 GG-TGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD+ HQHIPYRENKNLTGTARY
Sbjct: 120 HQKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS-NHQHIPYRENKNLTGTARY 178
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
ASMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEA
Sbjct: 179 ASMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEA 238
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 239 LCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 298
Query: 301 VSTXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
+ST + +R SG +E R +GWSS P RRNSG + NS +L
Sbjct: 299 ISTPPPRHHGPVVGPSSALPPAITSAERPSGGDEARPSGWSSGIP--RRNSGQIFNSGSL 356
Query: 360 SKQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDAS 419
+KQK+P+++DPA SKD ++ AV +SREAAV+G+D++PS P+ +A
Sbjct: 357 AKQKAPVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSSREAAVLGTDSEPSNPQIVEAG 416
Query: 420 PGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNI-KNFESTLRGIESLHF 467
G+ KI N+ ++ R+T+++ KN+E+ L+GIESLHF
Sbjct: 417 SGSNSKIPVSRNSPIVSSEINKLSSPSRATTSVMKNYEANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1512 (537.3 bits), Expect = 6.9e-158, Sum P(2) = 6.9e-158
Identities = 303/427 (70%), Positives = 329/427 (77%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF
Sbjct: 61 GG-TGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFF 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEA
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
++ N+DR +G EEGR + SRRR SG L NS N+
Sbjct: 300 LTAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNI 355
Query: 360 SKQK-SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDA 418
S Q S A D ++ AV SR+ GS+ R RT D
Sbjct: 356 SNQPTSSSARDSMIPSSSLFAQSAGSSRRVT----AVSGSRDN-FPGSEELLQRSRTGDV 410
Query: 419 SPGAFQK 425
S G +
Sbjct: 411 SRGVIPR 417
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1480 (526.0 bits), Expect = 1.3e-156, Sum P(2) = 1.3e-156
Identities = 286/378 (75%), Positives = 312/378 (82%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+PN++WFGVEGDYN LV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+
Sbjct: 61 GG-TGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYF 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
ASMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+
Sbjct: 180 ASMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIES 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYP+EFASYFHYCRSLRFDDKPDY YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 VSTXXXXXXXXXXXXXXXXX--XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSAN 358
++ ++DR G EEG G D SRRR SG L NS N
Sbjct: 300 LTAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEG---GRPPMDSSRRRMSGALENSGN 356
Query: 359 LSKQKSPMANDPAFSKDA 376
LS + M + F++ A
Sbjct: 357 LSSRGPMMPSSSLFAQSA 374
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1354 (481.7 bits), Expect = 3.0e-142, Sum P(2) = 3.0e-142
Identities = 246/300 (82%), Positives = 278/300 (92%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKLE+VKT HPQL YE+++Y++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN++W+GVEGDYNVLV+DLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+
Sbjct: 61 GG-TGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAK+YRD++TH+HIPYRENK+L GT RY
Sbjct: 120 HSKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE
Sbjct: 180 ASLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIET 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRG+PTEFASYFHYCRSLRFDDKPDYAYLKRLFR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 240 LCRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQ 299
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
Identities = 259/429 (60%), Positives = 308/429 (71%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KLENVKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GGS GIPN++WFGVEGDY+V+VIDLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+
Sbjct: 61 GGS-GIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFM 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARY
Sbjct: 120 HTRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE
Sbjct: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LC+ P+EF SYFHYCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 240 LCKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG 299
Query: 301 VSTXXXXXXXXXXXXXXXXXXXXNVDRQS---GAEEGRHTGWSSADPSRRRNSGPLGNSA 357
S+ ++RQ G E R+ + + RR+ P S+
Sbjct: 300 -SSSGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRH--PTTTSS 356
Query: 358 NLSKQKSPMANDPAFSKDA-----MMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSR 412
+ +S ++D FSK VA +SR ++ G +
Sbjct: 357 PRDRSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTS 416
Query: 413 PRTTDASPG 421
R +S G
Sbjct: 417 SRLVSSSGG 425
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1317 (468.7 bits), Expect = 2.0e-134, P = 2.0e-134
Identities = 263/466 (56%), Positives = 313/466 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+PNL+W+GVEGDYNV+VIDLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+
Sbjct: 61 GG-TGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFM 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARY
Sbjct: 120 HTRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE
Sbjct: 180 ASVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LC+ P+EF SYF YCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 240 LCKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG 299
Query: 301 VSTXXXXXXXXXXXXXXXXXXXXNVDRQS--GAEEGRHTGWSSADP--SRRR--NSGPLG 354
S+ ++++Q +E R +S A SRR S
Sbjct: 300 SSSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTRD 359
Query: 355 NSANLSKQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPR 414
SA+ + P++ P + A+P+S + G +D
Sbjct: 360 RSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRR----AIPSSSRPSSAGGPSDSRSSS 415
Query: 415 TTDASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLR 460
S G + N TS S + E LR
Sbjct: 416 RLVTSTGGVGTVSNRASTSQRIQAGNESRTSSFSRAARNTREDPLR 461
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 262/476 (55%), Positives = 323/476 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++
Sbjct: 61 GG-TGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYM 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAK+YRD TH+HIPYRENKNLTGTARY
Sbjct: 120 HTRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E
Sbjct: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LC+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 240 LCKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSE 296
Query: 301 VSTXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 360
+ RQ + R +G + DP RR G+ +
Sbjct: 297 SNRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHT 352
Query: 361 KQK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTT 416
K + S +A A D + + +SR ++ G DP+R
Sbjct: 353 KHRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLI 409
Query: 417 DASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 472
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 410 PTSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 230/299 (76%), Positives = 265/299 (88%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KLE VKTKHPQL YE+K+Y +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TG+P+++WFGVEG+YN + IDLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++
Sbjct: 61 GG-TGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYM 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HS+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAK+YRD TH+HIPYRENKNLTGTARY
Sbjct: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+ YP+EF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 4.0e-129, P = 4.0e-129
Identities = 261/476 (54%), Positives = 322/476 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++
Sbjct: 61 GG-TGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYM 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H++ FLHRDIKPDNFLMGLGR+A+QVY+ID+ LAK+YRD TH+HIPYRENKNLTGTARY
Sbjct: 120 HTRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E
Sbjct: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LC+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 240 LCKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSE 296
Query: 301 VSTXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 360
+ RQ + R +G + DP RR G+ +
Sbjct: 297 SNRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHT 352
Query: 361 KQK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTT 416
K + S +A A D + + +SR ++ G DP+R
Sbjct: 353 KHRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLI 409
Query: 417 DASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 472
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 410 PTSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1249 (444.7 bits), Expect = 3.3e-127, P = 3.3e-127
Identities = 227/299 (75%), Positives = 261/299 (87%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIG GSFGE++L ++QT EE A+KLE KTKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GGS GIP+L+WFGV+GDYN +VIDLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++
Sbjct: 65 GGS-GIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYM 123
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HS+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK+YRD TH+HIPYRENKNLTGTARY
Sbjct: 124 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARY 183
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEA 240
AS+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE
Sbjct: 184 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEV 243
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299
LC+ YP EF SYF YCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 244 LCKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7079 | 0.9431 | 0.9955 | no | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7050 | 0.6189 | 0.6901 | yes | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7725 | 0.6273 | 0.7180 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7240 | 0.6463 | 0.9475 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7725 | 0.6273 | 0.7180 | yes | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7770 | 0.6210 | 0.7320 | yes | no |
| Q9DC28 | KC1D_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7725 | 0.6273 | 0.7180 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7658 | 0.6273 | 0.7180 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6644 | 0.6315 | 0.6072 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7645 | 0.6147 | 0.8 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7725 | 0.6273 | 0.7180 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7195 | 0.6210 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6870 | 0.6168 | 0.9071 | yes | no |
| Q20471 | KIN20_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7364 | 0.6189 | 0.5915 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7414 | 0.6168 | 0.8746 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7692 | 0.6273 | 0.7180 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034133001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (471 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 475 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 8e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.002 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 0.003 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 70/265 (26%), Positives = 110/265 (41%), Gaps = 32/265 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGST 64
+ L RK+GSGSFG +Y + T + VA+K+ +++ + E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH--- 57
Query: 65 GIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVE 118
PN + F + D+ LV++ DLF++ SR LS +A Q++ +E
Sbjct: 58 --PNIVRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLE 112
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
++HS +HRD+KP+N L+ V I DFGLAK+ GT
Sbjct: 113 YLHSNGIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTP 162
Query: 179 RYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237
Y + L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFD 222
Query: 238 IEALCRGYPTEFASYFHYCRSLRFD 262
G E C L D
Sbjct: 223 EPKWSSGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTGIPNLRW 71
+G G FG +YL + +T ++VAIK E+ + +L E ++ K L I L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN--HPNIVKLYG 58
Query: 72 FGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130
+ ++ LV++ G SL+DL KLS +L + Q++ +E++HS +HRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 131 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI- 189
KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 119 KPENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKG 169
Query: 190 EQSRRDDLESLGYVLMYFL 208
S + D+ SLG V++Y L
Sbjct: 170 YYSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 77/239 (32%), Positives = 118/239 (49%), Gaps = 12/239 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLQYEAKLYKILQGGSTG 65
+R+ RK+G GSFGE+YL + + + +A KLE+ + + E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP-N 59
Query: 66 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS 122
I L F + LV++ + G SLEDL R LS L + Q+++ +E++HS
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
K +HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y +
Sbjct: 120 KGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMA 176
Query: 183 MNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238
LG+ S D+ SLG L L G P++G K + + KI + + S+
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 22/232 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTG 65
+ + K+G GSFG++YL + +T + VAIK + +K ++ E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK--HPN 58
Query: 66 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
I L + D LV++ G L DL +LS Q+++ +E++HSK
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHSKG 117
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
+HRD+KP+N L+ V + DFGLA++ GT Y +
Sbjct: 118 IVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYMAPE 166
Query: 185 THLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 167 VLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK-HPQLQYEAKLYKILQGGS 63
+++ G KIG G+FG++Y N+ T E +A I++++ K ++ E K+ ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 TGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
PNL +++GVE + I + G +LE+L R L + + Q++ + +
Sbjct: 59 ---PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAY 114
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTA 178
+HS +HRDIKP N + + + DFG A + ++ T E ++L GT
Sbjct: 115 LHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTP 167
Query: 179 RYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 217
Y + G + R D+ SLG V++ G PW L
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ------ 60
+ F+ G+ IG GSF + L +TN+E AIK+ + + QL E K+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR----QLIKEKKVKYVKIEKEVLT 56
Query: 61 --GGSTGIPNLRWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
G GI L ++ + + N+ V++ G L+ + + S L K A +++
Sbjct: 57 RLNGHPGIIKL-YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILL 113
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------RYRDTAT 162
+E++HSK +HRD+KP+N L+ + + I DFG AK + +
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222
R + GTA Y S + DL +LG ++ L G P++G +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SNE 227
Query: 223 KQKYEKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 260
++KI + IE L P + L+
Sbjct: 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 78/300 (26%), Positives = 139/300 (46%), Gaps = 48/300 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIY---LGTNIQTNEEVAIKLENVKTKHPQLQ-------YE--- 52
G ++++ + IG G FG +Y ++ N + K+EN++ + ++ Y+
Sbjct: 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70
Query: 53 -AKLYKILQGGSTGIPNLRWFGV------EGDYNVLVIDLLGPSLEDLFN--FCSRKLSL 103
A I GIP +++G Y ++++ L + +++F C K +
Sbjct: 71 IALWKNIHNIDHLGIP--KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLI 128
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163
K ++ M+ +E++H H DIKP+N ++ R YIID+G+A +
Sbjct: 129 KNIMK---DMLTTLEYIHEHGISHGDIKPENIMVDGNNRG---YIIDYGIASHF--IIHG 180
Query: 164 QHIPY-RENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 221
+HI Y +E K+L GT YA ++ H G +RR DLESLGY ++ + LPW+G
Sbjct: 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240
Query: 222 ------KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS-LRFDDKPDYAYLKRLF 274
K +++ E K+ +F F C + L +++KPDY L ++F
Sbjct: 241 NLIHAAKCDFIKRLHEGKIKIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGS 63
++ G +G GSFG +YL + T E +A+K + L+ E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 TGIPNL-RWFGVEGDYNVLVIDLL-----GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 116
PN+ R++G E D +++ G SL L F KL + Q++
Sbjct: 59 ---PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEG 113
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
+ ++HS +HRDIK N L+ + DFG AKR D T + ++ G
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRG 165
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
T + + G E R D+ SLG ++ G PW
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 22/181 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGSTG 65
F + KIG G FGE+Y + +T +EVAIK+ K K ++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 IPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
PN ++++G ++ D +V++ G SL+DL ++ L+ + + +++ +E++H
Sbjct: 57 -PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
S +HRDIK N L+ +V +IDFGL+ + DT + + GT +
Sbjct: 116 SNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWM 164
Query: 182 S 182
+
Sbjct: 165 A 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGS 63
++++ +IG G+ G ++ + +T E VA+K ++ Q E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--H 58
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ L G VLV++ + L ++ R L V ++ V ++H+
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA----THQHIP--YRENKNLTGT 177
+HRD+KP N L+ + I DFGLA+ + + +HQ YR + L G
Sbjct: 119 GIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 178 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 211
+Y G+ DL ++G + L GS
Sbjct: 176 RKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 39/166 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT----------------KHPQL 49
+ K+G G++G +Y + +T E VA+K L+N + KHP +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 50 QYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 109
KL ++ L LV + L+ + LS + +
Sbjct: 61 ---VKLLDVI----HTERKL----------YLVFEYCDMDLKKYLDKRPGPLSPNLIKSI 103
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
Q++ + + HS LHRD+KP N L+ R + + DFGLA+
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 51/189 (26%), Positives = 82/189 (43%), Gaps = 47/189 (24%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLY 56
++ G+K+G G++ +Y + +T VAIK K K + E KL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56
Query: 57 KILQGGSTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD- 111
+ L+ PN L FG + + N LV + + LE + VL AD
Sbjct: 57 QELKH-----PNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADI 104
Query: 112 -----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY---RDTAT 162
+ +E++HS LHRD+KP+N L+ ++ + + DFGLA+ + T
Sbjct: 105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMT 160
Query: 163 HQHIP--YR 169
HQ + YR
Sbjct: 161 HQVVTRWYR 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLQYEAKLYKIL 59
+R G+ +G G+FG +YL ++ T E+A+K P L+ E +L K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGSTGIPNLRWFGVEGDYNVLVI---DLLGPSLED-------LFNFCSRKLSLKTVLML 109
Q ++++G D L I + G S++D L +RK +
Sbjct: 62 QHERI----VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------ 111
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
Q++ VE++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 112 --QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----T 162
Query: 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 66/250 (26%), Positives = 100/250 (40%), Gaps = 47/250 (18%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLQYEAKLYKILQ 60
+ I G+FG +YL T + AIK + NVK + + ++Q
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM--------MIQ 53
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
G S + L + DY LV++ L G L L +++ VE
Sbjct: 54 GESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVED 112
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+H + +HRDIKP+N L+ + + + DFGL++ ENK GT
Sbjct: 113 LHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPD 158
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------SE 231
Y + T LG+ + D SLG V+ FL G P+ A T ++ I E
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEE 215
Query: 232 KKVSTSIEAL 241
K S EA+
Sbjct: 216 VKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 40/167 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVK-----TKHPQL 49
+++ +++G G+FG +YL N +T E VAIK L VK +HP +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 50 QYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLM 108
KL ++ E D V + + +L L + + S +
Sbjct: 61 ---VKLKEVF--------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRS 103
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ Q++ + +H F HRD+KP+N L+ V I DFGLA+
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 8e-13
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 80/256 (31%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP---QLQY 51
+G GSFG++ L T + A+K +E+ T HP +L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 52 ----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLS 102
E KLY +L+ GG +LF+ S+ + S
Sbjct: 61 AFQTEEKLYLVLEYAPGG-----------------------------ELFSHLSKEGRFS 91
Query: 103 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR--YRDT 160
+ A +++ +E++HS ++RD+KP+N L L + + + DFGLAK +
Sbjct: 92 EERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGS 148
Query: 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 219
T+ GT Y + LG + D SLG VL+Y L G P+ A
Sbjct: 149 RTNT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---A 195
Query: 220 GTKKQKYEKISEKKVS 235
+K+ YEKI + +
Sbjct: 196 EDRKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 9e-13
Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKHPQLQY-----EAKLYKILQ 60
LG+K+G G+FGE+Y G EVA+K +K + Q EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLREARIMRKLD 59
Query: 61 GGSTGIPN-LRWFGV-EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINR 116
PN ++ GV + + ++ L KLSL +L A Q+
Sbjct: 60 H-----PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYR 169
+E++ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 31/155 (20%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGSTGIPN-LRW 71
KIG G+ GE+Y T+ T +EVAIK ++ ++ +L E + K + PN + +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-----PNIVDY 80
Query: 72 FG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFV 120
+ + GD +V++ + G SL D+ +++ + I V E++
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYL 132
Query: 121 HSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 154
HS++ +HRDIK DN L+ G V + DFG A
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 27/162 (16%)
Query: 9 FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQG 61
LG+K+G G+FGE+Y GT T +VA+K + + EA + K L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 62 GSTGIPNL-RWFGV--EGDYNVLVIDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQM 113
PN+ R GV +G+ +V + G DL +F KL+LK +L +A Q+
Sbjct: 61 -----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++ SK+F+HRD+ N L+ V I DFGL++
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 75/269 (27%), Positives = 112/269 (41%), Gaps = 51/269 (18%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGSTGIP 67
R IG G GE+YL + + VA+K L + EAK+ L GI
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI--HPGIV 65
Query: 68 NLRWFGVEGD---YNVLVIDLLGPSLEDLFNFCSRKLSL----------KTVLMLADQMI 114
+ +GD Y + I+ G +L+ L +K SL L + ++
Sbjct: 66 PVYSICSDGDPVYYTMPYIE--GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---RYRDTATHQHIPYREN 171
+E+VHSK LHRD+KPDN L+GL +V I+D+G A + + R
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 172 --KNLT------GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 223
++T GT Y + LG+ S D+ +LG +L L S P+ ++
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------RR 233
Query: 224 QKYEKISEKKVSTSIEALCRGYPTEFASY 252
+K KIS + V S P E A Y
Sbjct: 234 KKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 49/165 (29%), Positives = 69/165 (41%), Gaps = 24/165 (14%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY------EAKLYKILQGGSTGI 66
KIG G++G +Y + T E VAIK +K + E KL K L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNH----- 57
Query: 67 PN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
PN L F +GD LV + + L L R L + Q++ + F HS
Sbjct: 58 PNIIKLLDVFRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 164
LHRD+KP+N L+ + + DFGLA+ + TH
Sbjct: 117 HGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 23/163 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKILQGGS 63
++LG IG G+FG +Y G N++T + VAIK LE +K + + E L K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 TGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDL---FNFCSRKLSLKTVLMLADQMINR 116
PN+ ++ G + L I L SL + F L V Q++
Sbjct: 59 ---PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQG 111
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++H + +HRDIK N L + V + DFG+A + D
Sbjct: 112 LAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
F + K+G GS+G +Y + +T + VAIK+ V+ ++ E + K Q S I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK--QCDSPYI-- 60
Query: 69 LRWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
++++G D +++ S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 121 IHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH--PQLQYEAKLYKILQ 60
++R G +GSGSFG +Y G N+ + EV++ + + QL+ E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGSTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLF-NFCSRKLSLKTVLMLADQMIN 115
PN+ ++ G E + + L I L G SL L + S + + + Q++
Sbjct: 61 H-----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILL 113
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++H ++ +HRDIK N L+ V + DFG+AK
Sbjct: 114 GLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 50/189 (26%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQ-LQYEAKLYKILQGG 62
LG+K+G G+FGE+Y GT EVA+K E+ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 STGIPN-LRWFGV-EGDYNVLVI-------DLL---------GPSLEDLFNFCSRKLSLK 104
PN ++ GV + ++++ DLL SL DL +F
Sbjct: 61 ----PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA------- 109
Query: 105 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----T 160
L +A M E++ SK+F+HRD+ N L+G V I DFGL++ D
Sbjct: 110 --LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYK 160
Query: 161 ATHQHIPYR 169
+P R
Sbjct: 161 VKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 70/292 (23%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGGSTGIPN 68
+IG G++G++Y N +T E VA+K +EN K P E KL + L+ PN
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-----HPN 59
Query: 69 -LRWFGV---EGDYNVLVI------DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
+R + +G ++ ++ DL G L + K + + Q++ ++
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP----------Y 168
++HS LHRDIK N L+ + + DFGLA+ Y T ++ Y
Sbjct: 115 YLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPY----TKRNSADYTNRVITLWY 167
Query: 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228
R + L G RY + D+ S+G +L G +QG T+ ++ EK
Sbjct: 168 RPPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEK 213
Query: 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRLFRDLF 278
I E LC G PT+ + L + + KP Y KR R+ F
Sbjct: 214 IFE---------LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGGS 63
K+ + ++IG GSFG++YL + +K L N+ K E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 TGIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINR 116
PN+ +++ E +V++ G L + + +L Q+
Sbjct: 59 ---PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 117 VEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 160
++++HS+ LHRDIKP N FL V + DFG++K T
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSST 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 71/247 (28%), Positives = 105/247 (42%), Gaps = 56/247 (22%)
Query: 13 RKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQY-----EAKLYKILQGGST 64
+K+G G+FGE+Y G EVA+K +K + + EA++ K L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----- 53
Query: 65 GIPN-LRWFGV--EGDYNVLVI------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQ 112
G PN +R GV E + LV+ DLL S + LSLK +L A Q
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIP 167
+ +E++ SK F+HRD+ N L+G V I DFGL++ Y T +P
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 168 YR----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGT 221
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 171 IRWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEE 215
Query: 222 KKQKYEK 228
+ K
Sbjct: 216 VLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 67/282 (23%), Positives = 123/282 (43%), Gaps = 53/282 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGSTGI 66
F L RK+GSG FGE++ G + VAIK+ + K Q E + K L+
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL-- 64
Query: 67 PNLRWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
+ F V G+ ++ +L+ G L L + + L + +++ +A Q+ + ++
Sbjct: 65 --ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQHIPYRENKNLTGTAR 179
++ +HRD+ N L+G + DFGLA+ ++ ++ + IPY+ TA
Sbjct: 123 QNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAP 173
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237
A+ + S + D+ S G +L+Y F G +P+ G+ + Y++I+
Sbjct: 174 EAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT------- 218
Query: 238 IEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 271
GY P E C + +D+P + L+
Sbjct: 219 -----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
K+ KIG G+ G +Y ++ T +EVAIK N++ Q + E + +IL P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHP 76
Query: 68 N----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
N L + V + V++ L G SL D+ + + + + + +EF+HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 134
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153
+HRDIK DN L+G+ V + DFG
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 46/242 (19%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTK-----HPQLQYEAKLYK 57
I G++G ++L T + AIK ++ V T+ Q Y KLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 58 ILQGGSTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 113
QG NL + +E GD L ++ +G ED+ ++
Sbjct: 61 SFQGKK----NL-YLVMEYLPGGDLASL-LENVGSLDEDVARIYIA------------EI 102
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENK 172
+ +E++HS +HRD+KPDN L+ + + DFGL+K + + +E+K
Sbjct: 103 VLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 173 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
+ GT Y + LG S+ D SLG +L FL G P+ G T ++ ++ I
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNG 216
Query: 233 KV 234
K+
Sbjct: 217 KI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 32/238 (13%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLR- 70
G IGSGSFG +YLG N + E +A+K V+ + + +L + I L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVK--QVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 71 --------WFGVEGDYNVLVIDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVE 118
+ G D + L I L G S+ L N + + + +L V Q++ +
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKGLN 120
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----DTATHQHIPYRENKNL 174
++H++ +HRDIK N L+ + I DFG++K+ T T+ P +L
Sbjct: 121 YLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SL 172
Query: 175 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
G+ + + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGSTG 65
F L R IG G+FG++ + T + A+K N K K + + ILQ +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 66 -IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHS 122
+ NL + + + LV+DLL DL S+K+ V +++ +E++HS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-GTARYA 181
K +HRDIKPDN L+ V+I DF +A + T GT Y
Sbjct: 119 KGIIHRDIKPDNILLD---EQGHVHITDFNIAT---------KVTPDTLTTSTSGTPGYM 166
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 216
+ S D SLG V Y LRG P++G
Sbjct: 167 APEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 50/195 (25%), Positives = 78/195 (40%), Gaps = 38/195 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQGGST 64
+ + K+G G+FGE+Y I+T VA+K + N K P E K+ K L+ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 GIPNLRWFGVEGD---------YNVL---VIDLLG----PSLEDLFNFCSRKLSLKTVLM 108
+P + D Y V DL G PS++ K +
Sbjct: 70 -VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML---- 122
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P
Sbjct: 123 ---QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPN 171
Query: 169 RENKNLTGTARYASM 183
+ GT +Y ++
Sbjct: 172 PKGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 46/170 (27%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHPQLQYE 52
IG G++G +Y ++ T VA+K V +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI--- 63
Query: 53 AKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLE-DLFNFCSR----KLSLKTVL 107
+L + G T L + L+ ++ DL + S+ L +T+
Sbjct: 64 VRLLDVCHGPRT-------------DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
L Q++ V+F+HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 59/258 (22%), Positives = 97/258 (37%), Gaps = 39/258 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGG 62
+ F + + IG G+FGE++L + T + A+K+ +K +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA-DAD 59
Query: 63 STGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 120
S I L + + ++ LV++ + DL N RK +T +++ ++ V
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT-----------------H 163
H F+HRDIKPDN L+ + + DFGL K+
Sbjct: 118 HKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 164 QHIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGL 217
+ + GT Y + G D SLG V++Y L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---F 230
Query: 218 KAGTKKQKYEKISEKKVS 235
+ T ++ Y KI K S
Sbjct: 231 YSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL--QYEAKLYKILQGGS 63
K+ R +G G+FG ++L + V IK V+ TK +L Q E ++ K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58
Query: 64 TGIPN-LRWFGVEGDYNVLVIDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVE 118
PN + ++ + L+I + G +L + C+ L T+L Q++ +
Sbjct: 59 ---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--G 176
VH+K LHRD+K N L+ + V I DFG++K I ++K T G
Sbjct: 116 HVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVG 163
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVL 204
T Y S G +++ D+ +LG VL
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 25/167 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE 52
+K+ KIG G+FGE++ + +T + VA+K +EN K P L++E
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 53 --AKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 110
L +I + +T + G + LV + L L + + K +L + +
Sbjct: 72 NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
++N + ++H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 8e-10
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGSTG 65
+ +G GS G +Y + T + A+K +V QL E K L+ S
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLREL---KTLR--SCE 57
Query: 66 IPNL-RWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
P + + +G EG+ + +V++ + G SL DL K+ + +A Q++ ++++
Sbjct: 58 SPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115
Query: 121 HSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
H+K +HRDIKP N L+ +V I DFG++K +T + GT
Sbjct: 116 HTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVT 165
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 221
Y S G S D+ SLG L+ G P+ +
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGSTGIPNL 69
KIG G++G +Y + TNE +A I+LE P E L K +Q G+ +
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI----V 64
Query: 70 RWFGV-EGDYNV-LVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS 124
R V + + LV + L L+ + ++ L + Q++ + + HS
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSHR 122
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNLTGTAR 179
LHRD+KP N L + RR N + + DFGLA+ + T TH+ + YR + L G+
Sbjct: 123 VLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180
Query: 180 YAS 182
Y++
Sbjct: 181 YST 183
|
Length = 294 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 21/165 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
PR +L RK+G+G FGE+++GT N T +VA+K T P+ LQ EA++ K L
Sbjct: 4 PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ-EAQIMKKL 58
Query: 60 QGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMI 114
+ L + + V E + +V + + G L+ L + +KL L ++ +A Q+
Sbjct: 59 RH-----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++ S++++HRD+ N L+G I DFGLA+ D
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK---RYRDTATHQHIP 167
++ E++H++ ++RD+KP+N L+ G V ++DFG AK + T T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWT----- 151
Query: 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA------- 219
GT Y + L D SLG +L+Y L G P+
Sbjct: 152 ------FCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 220 ----GTKKQKYEKISEKKVSTSIEALCRGYPTE 248
G K ++ +K I+ L R P E
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 38/171 (22%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI---- 66
G +G G++G++ + T + VAIK K K ++ + + L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVG-MCGIHFTT 67
Query: 67 ------------PN---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL----KTVL 107
N L VEGD+ LV+D++ L+ + + RK+ L +
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCI 124
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 157
+L Q++N + +H F+HRD+ P N F+ G I DFGLA+RY
Sbjct: 125 LL--QILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 7e-09
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 49/174 (28%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTGI 66
++ L + IGSG++G + + +T +VAIK + NV AK +IL+ I
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLID---AK--RILRE----I 50
Query: 67 PNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD-------------- 111
LR E N++ ++D+L P + FN + + T LM D
Sbjct: 51 KLLRHLRHE---NIIGLLDILRPPSPEDFN----DVYIVTELMETDLHKVIKSPQPLTDD 103
Query: 112 -------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 155
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 104 HIQYFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 9e-09
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
K+ KIG G+ G ++ ++ T +EVAIK N++ K P+ E + +IL P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPK--KELIINEILVMKELKNP 76
Query: 68 NLRWF---GVEGDYNVLVIDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 122
N+ F + GD +V++ L G SL D+ C + + V + + +EF+H+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHA 133
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYA 181
+HRDIK DN L+G+ V + DFG Q P + ++ + GT +
Sbjct: 134 NQVIHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWM 182
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ + D+ SLG + + + G P+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 24/201 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGSTGIPN 68
R +G G+FGE L + + V K N+ + + E + +LQ PN
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-----PN 60
Query: 69 L-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSK 123
+ ++ D N L+I++ G +L D +L + VL Q+++ V ++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
LHRDIK N + +A + + DFG++K + + + GT Y S
Sbjct: 121 GILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSP 170
Query: 184 NTHLGIEQSRRDDLESLGYVL 204
G++ + + D+ +LG VL
Sbjct: 171 ELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
K+ KIG G+ G +Y ++ T +EVAI+ N++ Q + E + +IL P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77
Query: 68 N----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
N L + V + V++ L G SL D+ + + + + + +EF+HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 136 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 184
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ D+ SLG + + + G P+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 26/149 (17%), Positives = 60/149 (40%), Gaps = 17/149 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWF 72
+ + G +YL +E+ +K+ + K + E + ++L +P +
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 73 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 128
G ++ L+++ + G +L+ ++S + +A+Q+ + +H H
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 129 DIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
D+ P N L+ + IID+ A
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 42/231 (18%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKT---KHPQLQY--------EAKLYKIL 59
G IG G++G +YL N+ T E +A+K +E T +H Q E + K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 60 QGGSTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSR---KLSLKTVLMLADQ 112
N+ ++ G E L I L G S+ C R + + V +Q
Sbjct: 66 DH-----LNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQ 116
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
++ + ++HSK LHRD+K DN L+ I DFG++K+ D + +N
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNM 168
Query: 173 NLTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
++ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 21/212 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
K+ KIG G+ G +Y +I T +EVAIK N++ Q + E + +IL P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNP 76
Query: 68 N----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
N L + V + V++ L G SL D+ + + + + + ++F+HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 183
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ D+ SLG + + + G P+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
+RLG+ +G G+FG +YL + T E+A+K + P+ L+ E +L K L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 62 GSTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
++++G E ++ + + G S++D L+ Q++
Sbjct: 64 ERI----VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEG 118
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
V ++HS +HRDIK N L V + DFG +KR + + K++TG
Sbjct: 119 VSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTG 171
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
T + S G R+ D+ S+G ++ L PW +A
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKL-YKILQGGST 64
F L IG G++G++Y + +T + VAIK+ ++ + E K Y IL+ S
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSN 61
Query: 65 GIPNL-RWFGV--------EGDYNVLVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLAD 111
PN+ ++G D LV++L G S+ DL ++L + + +
Sbjct: 62 H-PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+ + + ++H +HRDIK N L L + A +V ++DFG++
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 43/182 (23%), Positives = 71/182 (39%), Gaps = 45/182 (24%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVK-----------TKHPQ- 48
+++ KIG G+F E+ + +T + AIK LE V + HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 49 LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 108
L+ L+ G LV +L+ +L +L R L K V
Sbjct: 61 LRLIEVLFDRKTGRLA----------------LVFELMDMNLYELIKGRKRPLPEKRVKS 104
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
Q++ ++ +H HRDIKP+N L+ + + + + DFG + + PY
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPY 155
Query: 169 RE 170
E
Sbjct: 156 TE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
+RLG+ +G G+FGE+YL + T E+A+K + + L+ E +L K L+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 62 GSTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
++++G E ++ V + G S++D L+ Q++
Sbjct: 64 DRI----VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQG 118
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
V ++HS +HRDIK N L A V + DFG +KR + + K++TG
Sbjct: 119 VSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGIKSVTG 171
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
T + S G R+ D+ S+ ++ L PW +A
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 35/199 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE 52
+KF + +IG G++G++Y + T E VA+K L+N K P QL +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 53 A--KLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
L +I+ Q + F + +Y + DL+G L +F S +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEY--MDHDLMGLLESGLVHF-----SEDHIK 119
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATH 163
Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y T+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTN 176
Query: 164 QHIP--YRENKNLTGTARY 180
+ I YR + L G RY
Sbjct: 177 KVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGS 63
F L IG GSFGE+Y + +TN+ VAIK LE + + +Q E + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57
Query: 64 TGIPNL-RWFG-VEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
P + +++G + +I G S DL KL + + +++ +E+
Sbjct: 58 --SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEY 113
Query: 120 VHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTAT 162
+H + +HRDIK N L+ G V + DFG++ + T +
Sbjct: 114 LHEEGKIHRDIKAANILLSEEG------DVKLADFGVSGQLTSTMS 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 55/192 (28%), Positives = 85/192 (44%), Gaps = 42/192 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGSTGIPNL 69
KIG G++G +Y G N +T + VA I+LE+ + P E L K LQ PN+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-----PNI 61
Query: 70 RWFGVEGDYNVLVIDLL--GPSLEDLFNFCS-------------RKLSLKTVLMLADQMI 114
V + D+L L +F F S + + + V Q++
Sbjct: 62 ----------VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YR 169
+ F HS+ LHRD+KP N L+ + + DFGLA+ + TH+ + YR
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168
Query: 170 ENKNLTGTARYA 181
+ L G+ RY+
Sbjct: 169 APEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ-YEAKLYKILQGGSTGIPNLRWF 72
+IG GSFGE+Y G + +T E VAIK+ +++ +++ + ++ + Q S I R++
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT--RYY 68
Query: 73 G--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
G ++G ++++ L G S DL L + + +++ ++++HS+ +HRD
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 189
IK N L+ V + DFG+A + DT ++ GT + + I
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---I 173
Query: 190 EQSRRD---DLESLGYVLMYFLRGSLPWQGL 217
+QS D D+ SLG + +G P L
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 38/153 (24%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 13 RKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LQYEAKLYKILQGGSTG 65
+++G G FG++ L T E+VA+K N + + E ++ + L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD--HEN 67
Query: 66 IPNLR-WFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
I + G ++ +I P SL D +++LK +L+ + Q+ ++++ S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 128 QRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 26/278 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR RL K+G G FGE+++GT T + VAIK T P+ EA++ K L+
Sbjct: 4 PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
+P E Y V G L+ L + L L ++ +A Q+ + + ++
Sbjct: 61 DKL-VPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
+++HRD++ N L+G N V I DFGLA+ D Y + ++
Sbjct: 120 RMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKW 169
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
+ L + + D+ S G +L + +G +P+ G+ ++ E +V
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYR 221
Query: 240 ALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276
C +G P C D++P + Y++ D
Sbjct: 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 51/264 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGST 64
F + +G+GSFG + L + + + A+K+ + VK K Q+++ +ILQ S
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQ--SI 58
Query: 65 GIPNL--RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
P L + + D N+ LV++ + G L + A Q++ +E++
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYL 117
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTAR 179
HS ++RD+KP+N L+ + I DFG AKR + T T L GT
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRTYT-----------LCGTPE 163
Query: 180 YAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVST 236
Y + + G ++ D +LG +L+Y L G P+ Q YEKI E KV
Sbjct: 164 YLAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKV-- 215
Query: 237 SIEALCRGYPTEFASYFHY-CRSL 259
F S+F + L
Sbjct: 216 -----------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 39/163 (23%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKT------------KHPQLQYEAK 54
KIG G++G ++ N +T+E VA+K E V + KH + +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI---VR 63
Query: 55 LYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
LY +L LV + L+ F+ C+ + + V Q++
Sbjct: 64 LYDVLHSDKK--------------LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL 109
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
+ F HS + LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQ 60
PR RL K+G G FGE+++GT T VAIK T P+ LQ EA++ K L+
Sbjct: 4 PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLR 59
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 117
++ + V + + ++ G L+ L + L L ++ +A Q+ + +
Sbjct: 60 HEKL----VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115
Query: 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
+V +++HRD++ N L+G N V + DFGLA+ D Y +
Sbjct: 116 AYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKF 165
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 235
++ + L + + D+ S G +L +G +P+ G+ ++V
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVL 213
Query: 236 TSIEALCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRLFRDLF 278
+E RGY P E H C +++P + YL+ D F
Sbjct: 214 DQVE---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 32/156 (20%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNL-R 70
IG G++G +Y G ++ T VA+K+ N+ T +Q E L L+ PN+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ--PPNITK 66
Query: 71 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR------------VE 118
++G L GP L + + S++T LM A + + ++
Sbjct: 67 YYGSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALK 115
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
++H +HRDIK N L+ V + DFG+A
Sbjct: 116 YIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQYEAKLYKILQGGSTGIPN-LR 70
+IG GSFG +Y TN TNE VA+K + K + + Q K K LQ PN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ--QLKHPNTIE 85
Query: 71 WFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 128
+ G ++ LV++ S DL + L + + + + ++HS + +HR
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 129 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
DIK N L+ QV + DFG A + + PY
Sbjct: 146 DIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGS 63
+L RK+G+G FGE++ G N T VA+K T P+ L EA++ K L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLA-EAQIMKKLRH-- 60
Query: 64 TGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
P L + + V + +V +L+ G LE L R L L ++ +A Q+ + +
Sbjct: 61 ---PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++ +++++HRD+ N L+G N + DFGLA+
Sbjct: 118 YLEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKL-------YKILQGGS 63
KIG GSFGE++ G + +T + VAIK LE + + +Q E + Y GS
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
W +E +DLL P D + + T+L +++ ++++HS+
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
+HRDIK N L+ +V + DFG+A + DT ++ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 184 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 213
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 27/162 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LQYEAKLYKILQGG 62
K+ +G GS+G + + +T + VAIK LE+ K + E ++ K L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-- 58
Query: 63 STGIPNL--------RWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQM 113
+ NL R + LV + + + L+DL + + L V Q+
Sbjct: 59 HENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQI 109
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ +EF HS + +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 110 LRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGSTGIPNL 69
KIG G++G +Y + T E VA I+LE P E L K L PN+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-----PNI 60
Query: 70 -RWFGV-EGDYNV-LVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 125
R V + + LV + L L+ + L + Q++ + + HS
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP--YRENKNLTGTAR 179
LHRD+KP N L+ R + + DFGLA+ + R T TH+ + YR + L G+ +
Sbjct: 121 LHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQ 176
Query: 180 YAS 182
Y++
Sbjct: 177 YST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 50/201 (24%), Positives = 75/201 (37%), Gaps = 59/201 (29%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKT------------KHPQL----- 49
KIG G++G +Y N T E VA+K E V + HP +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 50 --QYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTV 106
E KLY LV + L L+ + + L +
Sbjct: 67 VIHTENKLY------------------------LVFEFLHQDLKKFMDASPLSGIPLPLI 102
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATH 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH
Sbjct: 103 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTH 159
Query: 164 QHIP--YRENKNLTGTARYAS 182
+ + YR + L G Y++
Sbjct: 160 EVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTG 65
+ L ++IGSG++G++Y +I T E VAIK+ ++ +Q E +L+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEI---SMLKECRH- 59
Query: 66 IPNL-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
PN+ +FG + L I + G SL+D++ LS + + + + + ++H
Sbjct: 60 -PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+HRDIK N L+ V + DFG++
Sbjct: 119 ETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 25/157 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAK--------LYKI---LQGG 62
+I G++G +Y + +T E VA+K +L+ E + L +I L+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALK---------KLKMEKEKEGFPITSLREINILLKLQ 62
Query: 63 STGIPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
I ++ G D +V++ + L+ L + V L Q+++ V +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
H LHRD+K N L+ + I DFGLA+ Y
Sbjct: 123 HDNWILHRDLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
+R G+ +G G+FG +YL ++ T E+A K + P+ L+ E +L K LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLL-----GPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
++++G D + + G S++D L+ Q++
Sbjct: 64 ERI----VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEG 118
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
+ ++HS +HRDIK N L A V + DFG +KR + + +++TG
Sbjct: 119 MSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTG 171
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
T + S G R+ D+ SLG ++ L PW +A
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LQYEAKLYKILQGGS 63
F++ +KIG G F E+Y T + + VA+K E + K Q E L K L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFV 120
I L F + + N+++ L + + ++ L +TV Q+ + VE +
Sbjct: 64 V-IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 121 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
HS+ +HRDIKP N F+ G V + D GL + + T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVSTS 237
Y S + + D+ SLG +L P+ G K + QK E+ + T
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT- 230
Query: 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279
Y + C D +PD Y+ ++ + + +
Sbjct: 231 -----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 53/169 (31%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGSTGIPNL 69
IG G++G + N +TNE+VAIK +N L+ E KL L
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKL-------------L 58
Query: 70 RWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLAD----------------- 111
R E NV+ I D++ P + FN + + LM D
Sbjct: 59 RHLDHE---NVIAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQ 111
Query: 112 ----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 155
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ-YEAKLYKILQGGSTGIPNLRWF 72
+IG GSFGE++ G + +T + VAIK+ +++ +++ + ++ + Q S +
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 GVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130
++G ++++ L G +L+ L + + T+L +++ ++++HS+ +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 131 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 190
K N L+ V + DFG+A + DT + GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174
Query: 191 QSRRD---DLESLGYVLMYFLRGSLP 213
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L +K+G+G FGE+++G + +VAIK + P+ EA L K LQ
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 62 GSTGIPNL-RWFGVEGDYNVLVID--LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRV 117
P L R + V + +I + SL D KL++ ++ +A Q+ +
Sbjct: 61 -----PRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
F+ K+++HRD++ N L+ I DFGLA+ D
Sbjct: 116 AFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 23/160 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLQYEAKLYKIL 59
NK+ + +G G++G + N T E VAIK E+VK E K+ + L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57
Query: 60 QGGSTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
+ N F +G LV + + +L +L L V Q++
Sbjct: 58 RH-----ENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ + HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 112 AIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 42/156 (26%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
F L ++IGSG++G++Y N+ T E AIK+ ++ P + +I+ N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSN 67
Query: 69 L-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ +FG + L I + G SL+D+++ + LS + ++ + + + ++HSK
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRDIK N L+ V + DFG++ + T
Sbjct: 127 KMHRDIKGANILL---TDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 33/236 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-------KTKHPQLQYEAKLYKILQG 61
+ +G+G+FG ++L + + A+K+ + + +H + E ++ K +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVS- 59
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEF 119
I L W + ++ P E LF++ S + S T L A +++ +E+
Sbjct: 60 -HPFIIRLFW-TEHDQRFLYMLMEYVPGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTA 178
+HSK ++RD+KP+N L+ + + + DFG AK+ RD T T L GT
Sbjct: 117 LHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTP 162
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234
Y + ++ D +LG ++ L G P+ YEKI K+
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 10/161 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGSTGIPN-L 69
R+IG GSFG +Y +++TNE VAIK + K +++ K K LQ PN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ--RIKHPNSI 88
Query: 70 RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 127
+ G + LV++ S DL + L + + + + ++HS + +H
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 148
Query: 128 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
RDIK N L+ QV + DFG A + PY
Sbjct: 149 RDIKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGSTGIPNL 69
+IG G++G +Y + + VA+K V+T L E L K L+ PN+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH--PNI 64
Query: 70 -RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFV 120
R V D V + +DL + + L +T+ L Q + ++F+
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 125 HANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 49/237 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI----PN 68
KIG G+FG++Y G ++ N EVA+K ++ P K LQ PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKR----KFLQEAEILKQYDHPN 53
Query: 69 L-RWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK 123
+ + GV + ++ L P L F +K L++K +L ++ +E++ SK
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR----ENKNL 174
+ +HRD+ N L+G N + I DFG+++ Y + + IP + E N
Sbjct: 113 NCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN- 168
Query: 175 TGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 229
RY S + D+ S G +L++ F G P+ G+ + +Q E+I
Sbjct: 169 --YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
F++ +K+G GS+G +Y + N+ A+K ++ + Q + E + +I S PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPN 60
Query: 69 LRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEFV 120
+ + E D N L I + DL S++ + ++ + Q++ ++ +
Sbjct: 61 IISYK-EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
H + LHRD+K N L AN + I D G++K + K GT
Sbjct: 120 HEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTPH 166
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
Y + G S + D+ SLG +L + P++
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 44/287 (15%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L +K+G+G FGE+++GT N +VA+K T P+ EA++ K L+
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
++ + V + + ++ G L+ L + R L L ++ +A Q+ +
Sbjct: 61 DKL----VQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
++ +++HRD++ N L+G G I DFGLA+ D Y +
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPI 167
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTS 237
++ + L + + D+ S G +L + +G +P+ G+ + ++V
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQ 215
Query: 238 IEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276
+E RGY P C +++P + YL+ D
Sbjct: 216 VE---RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 45/151 (29%), Positives = 71/151 (47%), Gaps = 16/151 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTGIPNL 69
LG IG G FG++ LG ++VA+K L++ T EA + L+ PNL
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH-----PNL 62
Query: 70 -RWFGV--EGDYNVLVIDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS 124
+ GV +G+ +V + + SL D R ++L L A + +E++ K+
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
F+HRD+ N L+ + DFGLAK
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 11/98 (11%)
Query: 67 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 119
PN+ R++ +E D +V+DL+ G L + FN K + + + + QM+ + +
Sbjct: 69 PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128
Query: 120 VH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
+H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 129 LHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 29/166 (17%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLQYEAKLYKILQGGSTGIPNLR 70
+GSG++G + + + ++VA+K K P L + + Y+ L+ + +++
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRL----LKHMK 72
Query: 71 WFGVEGDYNV--------------LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
V G +V LV +L+G L ++ +KLS + V L Q++
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRG 130
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
++++HS +HRD+KP N + ++ I+DFGLA++ D T
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 38/173 (21%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE--A 53
+L R IG G++G +Y + + E VA+K ++N + P L++
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 54 KLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 113
+L +++ G D LV++ L L + S V L Q+
Sbjct: 70 ELKEVVVGKHL------------DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQL 117
Query: 114 INRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATH 163
+ ++++H +HRD+K N L+ G + I DFGLA+ Y A
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTYGLPAKP 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGSTGI 66
++LG IG+GSFG +Y I T+E+VAIK L++ + K+ +L L I I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI------NI 121
Query: 67 PNLR-WFGVE----GDYNV---LVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMIN 115
L+ ++ E + N+ +V++ + ++ +R L L V + + Q+
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++HSK HRD+KP N L + + + + DFG AK
Sbjct: 182 ALAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 13 RKIGSGSFGEI----YLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGSTG 65
R +G G FG++ Y N T E VA+K E + + E + K L +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI- 68
Query: 66 IPNLRWFGV---EGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVH 121
+++ G +G + +I P L L ++ + KL+L +L+ A Q+ + ++H
Sbjct: 69 ---VKYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
S+ ++HRD+ N L+ V I DFGLAK
Sbjct: 125 SQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 28/174 (16%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ------LQYEAKLYKILQGGST 64
K+G GSFG + G + + VA+K +K+ L+ A ++ +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDH---- 55
Query: 65 GIPNL-RWFGVEGDYNV-LVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
NL R +GV + + +V +L LG L+ L + T+ A Q+ N + ++
Sbjct: 56 --ENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
SK F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 114 ESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 31/212 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ--LQYEAKLYKILQ 60
F++ +KIG G F +Y + VA+K E + K Q L+ E L K L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLD 60
Query: 61 GGSTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQM 113
PN +++ + N L I L DL F R + +T+ Q+
Sbjct: 61 H-----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENK 172
+ +E +HSK +HRDIKP N + A V + D GL + + T H
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH------- 164
Query: 173 NLTGTARYASMNTHLGIEQSRRDDLESLGYVL 204
+L GT Y S + + D+ SLG +L
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
++ + +KIG GSFG+IYL +E IK ++ TK P + EA +++ P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHP 59
Query: 68 NL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEF 119
N+ +F + L I + DL +R+ + VL DQ+++ ++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKH 116
Query: 120 VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
+H + LHRDIK N FL G A + DFG+A++ D+ GT
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGTP 166
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
Y S + + D+ SLG VL P++G
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 34/172 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYK 57
PR N G+ +G+G+FG++ T +VA+K+ + + K
Sbjct: 33 PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 58 ILQ--GGSTGIPNLRWFGVEGDYNVLVIDLLGPSL--------EDLFNFCSRK----LSL 103
I+ G I NL G GP L DL NF RK L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ +L + Q+ + F+ SK+ +HRD+ N L+ G+ I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
FR+ +KIG G F E+Y T + VA+K L + K + ++ E L K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNH- 61
Query: 63 STGIPN-LRWFGVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMIN 115
PN ++++ + N L I L DL F R + KTV Q+ +
Sbjct: 62 ----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 116 RVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
+E +HS+ +HRDIKP N F+ G V + D GL + + T H +L
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SL 166
Query: 175 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 218
GT Y S + + D+ SLG +L P+ G K
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 18/214 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGS 63
F++ ++G G +G+++L T E VA+K + L + + S
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 64 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
+ L + + +Y L ++ + G L N LS +M V+ +H
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
++HRD+KP+NFL+ + + + DFGL+K A ++ G+ Y +
Sbjct: 120 LGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA----------NSVVGSPDYMA 166
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
G D SLG +L FL G P+ G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 92 DLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149
DLF+ KLS V + Q++ + +H + +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 150 DFGLAKR 156
D+GL K
Sbjct: 153 DYGLCKI 159
|
Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 31/157 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGSTGIPNL 69
KIG GS+G ++ N +T + VAIK P ++ E ++ K L+ PNL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-----PNL 62
Query: 70 RWFGVEGDYNVLVIDLLGPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVE 118
N++ + L +F +C R + + + Q + V
Sbjct: 63 --------VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
F H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 115 FCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 46/282 (16%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE---EVAIKL---ENVKTKHPQLQYEAKLYKILQGGSTGI 66
+++G G+FG + G + + EVA+K E++ + EA + L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----- 55
Query: 67 PNL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
P + R GV +G+ +LV++L LGP L+ L R++ + + LA Q+ + ++ S
Sbjct: 56 PCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLES 113
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------RYRDTATHQHIPYRENKNLTG 176
K F+HRD+ N L L R +Q I DFG+++ Y T P +
Sbjct: 114 KHFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK------- 163
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 234
YA + G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 164 --WYAPECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGE 215
Query: 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276
C P E S C R +D+P ++ L+ FR
Sbjct: 216 RLPRPEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 26/183 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGS 63
+ + L IG G+ +Y + NE+VAIK LE +T +L+ E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-- 58
Query: 64 TGIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMI 114
PN+ +++ V GD LV+ L G SL D+ + + TVL +++
Sbjct: 59 ---PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVL 112
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
+E++HS +HRDIK N L+G V I DFG++ D + K
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTF 166
Query: 175 TGT 177
GT
Sbjct: 167 VGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 56/288 (19%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGSTGIP 67
++GSG+FG + G ++ + VA+K+ P L+ EA + + L
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI--- 58
Query: 68 NLRWFGV-EGDYNVLVIDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 122
+R G+ E + +LV++L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 59 -VRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 174
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 114 TNFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----- 163
Query: 175 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKIS 230
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ----WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES-- 213
Query: 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
+++ + P E C + D++P +A ++ R+ +
Sbjct: 214 GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGSTGIPN-L 69
R+IG GSFG +Y +++ +E VAIK + K +++ K + LQ PN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ--KLRHPNTI 78
Query: 70 RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 127
++ G + LV++ S DL + L + + + + ++HS + +H
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 128 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
RD+K N L+ V + DFG A PY
Sbjct: 139 RDVKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGSTGIPNL-R 70
K+G G +GE+Y G + + VA+K E+ L+ EA + K ++ PNL +
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKH-----PNLVQ 66
Query: 71 WFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFL 126
GV E + ++ + +L D C+R+ ++ +L +A Q+ + +E++ K+F+
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-DTATHQ 164
HRD+ N L+G + V + DFGL++ DT T
Sbjct: 127 HRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGS 63
L R++G G+FG+++L N+ T +++ + ++ +K Q EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 64 TGIPNLRWFGV--EGDYNVLVIDLL------------GPSLEDLFNFCSRK----LSLKT 105
++++GV +GD ++V + + GP L + R+ L L
Sbjct: 69 I----VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 106 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165
+L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY 178
Query: 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 214
YR + R+ + + + + D+ S G +L F G PW
Sbjct: 179 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGGSTGIP 67
G+++G+G+F Y +++T +A+K + N ++ ++ EA +I P
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHP 63
Query: 68 NL-RWFGV---EGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 122
++ R G + +N+ V + G S+ L + + K ++ ++ +Q++ + ++H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121
Query: 123 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
+HRD+K N L+ G+R + I DFG A R T L GT +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ G + R D+ S+G V++ PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
+ L +++GSG++G++Y N+ T E A+K+ ++ + +++ + + I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI-- 68
Query: 69 LRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
+ +FG L I + G SL+D+++ + LS + + + + + ++HSK
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
+HRDIK N L+ V + DFG+A + TAT
Sbjct: 128 MHRDIKGANILL---TDNGDVKLADFGVAAKI--TAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLR 70
K+G G++ ++ G + T VA I+LE+ + E L K L+ + I L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN--IVTLH 70
Query: 71 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130
LV + L L+ + C +S+ V + Q++ + + H + LHRD+
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 131 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 182
KP N L+ ++ + DFGLA+ + T T+ + + YR L G++ Y++
Sbjct: 131 KPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 14/149 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGSTGIPNLR 70
R+IG GSFG +Y +++TNE VAIK + K +++ K + LQ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ--QLRHPNTI 78
Query: 71 WFGVEGDY-----NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
+ +G Y LV++ S D+ + L + + + + ++HS
Sbjct: 79 EY--KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+HRDIK N L+ V + DFG A
Sbjct: 137 IHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLQYEAKLYKILQGGST 64
+ +GSG+FG +Y G I E VAIK+ ++ + + L + S
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASV 66
Query: 65 GIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
P++ R G+ V +I L P L D + + +L Q+ + ++
Sbjct: 67 DHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
K +HRD+ N L+ + V I DFGLAK
Sbjct: 127 EKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRD 159
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLR 70
K+G G++ ++ G + T VA I+LE+ + E L K L+ I L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK--HANIVTLH 69
Query: 71 WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
+ + + LV + L L+ + C +S+ V + Q++ + + H + LHRD
Sbjct: 70 DI-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 182
+KP N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 129 LKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGS 63
F + +G G FGE+ + T + A+K+ + + +E + + S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 64 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
IP L++ + D LV++ G L L N + +++ + VH
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
++HRDIKP+N L+ R + + DFG A R
Sbjct: 121 MGYVHRDIKPENVLID---RTGHIKLADFGSAAR 151
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 57/192 (29%), Positives = 80/192 (41%), Gaps = 48/192 (25%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
+ IG G+FGE+ L + TN A+K +VK + L ++ KL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGSTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 111
Y Q NL +F ++ GD L+I L G EDL F +L+
Sbjct: 67 YYSFQDKD----NL-YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCA------- 113
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 -----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG 163
Query: 172 KNLTGTARYASM 183
R SM
Sbjct: 164 ----DHHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 36/161 (22%)
Query: 15 IGSGSFGEI----Y--LGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQ------ 60
+G G+FG + Y L N T E VA+K L++ +H + + E ++ K LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 61 ----GGSTGIPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 114
S G NLR LV++ L P SL D +L + +L+ A Q+
Sbjct: 70 YKGVCYSAGRRNLR----------LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++ SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 8/158 (5%)
Query: 297 QQSQVSTPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGP--- 352
S S+ + + G G GP + P P A + + E S+ P +S
Sbjct: 234 ASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 353 LGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSR 412
S + S S A + + SS R S SS + S A V PSR
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSS----RESSSSSTSSSSESSRGAAVSPGPSPSR 349
Query: 413 PRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTS 450
+ P S +R P + + ++GR T
Sbjct: 350 SPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTR 387
|
Length = 1352 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 13/177 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLR 70
K+G G++ +Y G + T+ VA I+LE+ + E L K L+ + I L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN--IVTLH 70
Query: 71 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130
LV + L L+ + C +++ V + Q++ + + H + LHRD+
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 131 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 182
KP N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 131 KPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGST 64
F +G +G+GSFG + + + T E AIK E +K K Q+Q+ A+ IL S
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK--QVQHVAQEKSILMELSH 77
Query: 65 G-IPN-LRWFGVEGDYNVLVIDLLGPSL-----------EDLFNFCSRKLSLKTVLMLAD 111
I N + F E L+ ++G L D+ F +L L
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------- 130
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRE 170
E++HSK ++RD+KP+N L L + + V + DFG AK+ D T T
Sbjct: 131 -----FEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT-------- 174
Query: 171 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230
L GT Y + + D ++G +L F+ G P+ T + YEKI
Sbjct: 175 ---LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKIL 228
Query: 231 EKKV 234
++
Sbjct: 229 AGRL 232
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 39/167 (23%), Positives = 79/167 (47%), Gaps = 28/167 (16%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
VG++++ IGSG++G + + ++ ++VAIK + L+ E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60
Query: 59 LQGGSTGIPN-------LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 111
+ N LR G + +V+DL+ L + + L+ + +
Sbjct: 61 FKH-----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLY 114
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAK 155
Q++ ++++HS + +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 53/201 (26%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTGIPNLRW 71
R IG G+FG ++ T+ + + VA+K + NV Q ++ + + L +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNV------FQNLVSCKRVFRE----LKMLCF 55
Query: 72 FGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------- 111
F + NVL +D+L P D F ++ + T LM +D
Sbjct: 56 FKHD---NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108
Query: 112 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIP- 167
Q++ ++++HS LHRDIKP N L+ +N + I DFGLA R + +H+
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLA-RVEEPDESKHMTQ 163
Query: 168 ------YRENKNLTGTARYAS 182
YR + L G+ Y S
Sbjct: 164 EVVTQYYRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQGGSTGIPNLRWF 72
+G G++G +Y ++ T +AIK + +++ Q L E L+ L+ + + L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-VQYLGSD 74
Query: 73 GVEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130
G + + + + G SL L + K + +T++ Q++ ++++H +HRDI
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 131 KPDNFLMGLGRRANQVYIIDFGLAKR 156
K DN L + + V I DFG +KR
Sbjct: 135 KGDNVL--VNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 11 LGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGST----G 65
LGR IG G FG++Y G + NE++A+ ++ K E K LQ
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE----KFLQEAYIMRQFD 65
Query: 66 IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVH 121
P++ + GV + V ++ L P L +L ++ L L ++++ + Q+ + ++
Sbjct: 66 HPHIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
SK F+HRDI N L+ + V + DFGL+ RY +
Sbjct: 125 SKRFVHRDIAARNVLVS---SPDCVKLGDFGLS-RYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 44/273 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKILQGGSTGIPNL 69
+G G+FGE++ GT ++ VA+K K PQ EA++ K PN+
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH-----PNI 54
Query: 70 -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSF 125
+ GV + I + D +F +K L K ++ A + ++ SK+
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYR-ENKNLTGTARY 180
+HRD+ N L+G N + I DFG++++ D ++ + IP + RY
Sbjct: 115 IHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
+S D+ S G +L F G P+ G+ T +Q E++ EK S
Sbjct: 172 SS-----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSCP 216
Query: 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272
C P + C + +++P ++ L++
Sbjct: 217 QKC---PDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 72/255 (28%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-----------------LENVKT- 44
+ LG+ +G G+FG++ + + VA+K +E +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 45 -KHPQL-------QYEAKLYKILQGGSTGIPNLRWF-----GVEGDYNVLVIDLLGPSLE 91
KH + E LY +++ + G NLR F +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHG--NLRDFLRARRPPGEYASPDDPRPPEE--- 127
Query: 92 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I DF
Sbjct: 128 --------TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADF 176
Query: 152 GLAKR------YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 205
GLA+ YR T T+ +P K + A + + TH QS D+ S G VL+
Sbjct: 177 GLARDIHHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG-VLL 224
Query: 206 Y--FLRGSLPWQGLK 218
+ F G P+ G+
Sbjct: 225 WEIFTLGGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK--HPQLQYEAKLYKILQGGS-TGIP 67
+ +G G+FG + + T + VAIK ++ T + E KL K L+ + +
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 68 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 127
++ +E Y V +LLG L L SR L + + Q++ +++VHS +H
Sbjct: 76 DIFISPLEDIY--FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVH 131
Query: 128 RDIKPDNFLMGLGRRANQVYIIDFGLAK 155
RD+KP N L+ + I DFGLA+
Sbjct: 132 RDLKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
NKF + +G G++G + + +T E VAIK EN + K L+ E K+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLK- 58
Query: 62 GSTGIPNLR-WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
I L+ F G LV + + ++ +L + + V Q+I + +
Sbjct: 59 -QENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
H +HRDIKP+N L+ N V + DFG A+ + + + Y T
Sbjct: 117 HKNDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRW 166
Query: 180 YASMNTHLGIEQSRRDDLESLGYVL 204
Y S LG + D+ S+G +L
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 54/282 (19%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
+++GSG FG ++LG + +VAIK+ E ++ ++ EAK+ L PN
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSH-----PN 60
Query: 69 L-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS 124
L + +GV + I + L N+ KL + +L + + +E++ S
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT---ARYA 181
F+HRD+ N L+G N V + DFGLA+ D + + GT ++A
Sbjct: 121 FIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDD---------QYTSSQGTKFPVKWA 168
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
S + D+ S G VLM+ F G +P YE+ S +V +E
Sbjct: 169 PPEVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV---VE 212
Query: 240 ALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRL 273
++ GY PTE + + C + +D+P + L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGSTGI 66
++G G+FG+++L N+ ++ VA+K E ++ Q EA+L +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-- 69
Query: 67 PNLRWFGV--EGDYNVLVIDLL------------GPS---LEDLFNFCSRKLSLKTVLML 109
+R++GV EG ++V + + GP L + +L+L +L +
Sbjct: 70 --VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
A Q+ + + ++ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YR 179
Query: 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 217
R+ + L + + D+ S G VL F G PW L
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 23/235 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLQYEAKLYKILQGGSTG 65
F + + IG G+FGE+ + ++ A+K+ N + + + + ++ G +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 66 IPNLRWFGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
I L + + + N+ LV+D +G L L + +L +M+ ++ VH
Sbjct: 63 ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
++HRDIKPDN LM + + + DFG + + T Q + GT Y S
Sbjct: 122 HYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISP 172
Query: 184 NTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233
+E + D SLG + L G P+ A + + Y KI K
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 30/157 (19%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK-LYKILQGGSTGIPNLRWF 72
+GSG++G + + +T E+VAIK K P Q + AK Y+ L T + +++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYREL----TLLKHMQHE 74
Query: 73 GVEGDYNVLVIDLLGPSLEDLFNF--------------CSRKLSLKTVLMLADQMINRVE 118
V G +V S ++ +F LS V L QM+ ++
Sbjct: 75 NVIGLLDVFTS---AVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++HS +HRD+KP N + ++ I+DFGLA+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 67/252 (26%), Positives = 106/252 (42%), Gaps = 49/252 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGST 64
K LG IG G FG + G T ++VA+K N+K T L+ A + K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHH---- 58
Query: 65 GIPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINR 116
NL R GV G Y +V++L+ S +L NF + +S+ +L + +
Sbjct: 59 --KNLVRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
+E++ SK +HRD+ N L+ + DFGLA+ + +P +
Sbjct: 113 MEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------W 163
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236
TA A + S + D+ S G +L W+ G + Y K+S K+V
Sbjct: 164 TAPEALKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKE 208
Query: 237 SIEALCRGYPTE 248
+E R P E
Sbjct: 209 CVEKGYRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K +++ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCK--------ENV-FG 149
Query: 170 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227
+N+ T GT Y + G++ + D S G +L L G P+ G + + +E
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFE 206
Query: 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF-RDLFIREGF--- 283
I +V T HY R + + K L++LF RD R G
Sbjct: 207 SI---RVDTP----------------HYPRWITKESKD---ILEKLFERDPTRRLGVVGN 244
Query: 284 ----QFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGR 335
F +WT L+ R + P P P +N DR+ +E+ R
Sbjct: 245 IRGHPFFKTINWTALE---------KRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGSTGI 66
+GSG++G++ + +T +VAIK ++ H + Y E +L K + + I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENV-I 77
Query: 67 PNLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L F +E +V LV L+G L ++ +KLS + L Q++ ++++H
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIH 135
Query: 122 SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 155
S +HRD+KP N + + ++ I+DFGLA+
Sbjct: 136 SAGIIHRDLKPSN----IAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 40/171 (23%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHP--------QLQYE 52
+G+++ R +G GS G ++ + ++ VA+K + KH +L ++
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62
Query: 53 --AKLYKILQGGSTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLM 108
K+Y++L G +G G + N + I + + L ++ LS + +
Sbjct: 63 NIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARL 118
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 155
Q++ ++++HS + LHRD+KP N + N + I DFGLA+
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 49/285 (17%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGSTGIPN 68
+L +K+G+G FGE+++G + +VA+K T Q EA L K LQ
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL---- 63
Query: 69 LRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+R + V E Y + G L+ L + K+ L ++ + Q+ + ++ K+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYAS 182
++HRD++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 124 YIHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAI 176
Query: 183 MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
I + D+ S G +L+Y G +P+ G+ S + A
Sbjct: 177 NFGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDVMSA 216
Query: 241 LCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
L RGY P E C + +++P + YL+ + D
Sbjct: 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI--PYR 169
QM+ ++ +HS +HRD+KP N ++ + + I+DFGLA+ TA + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR----TACTNFMMTPY- 182
Query: 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229
T Y + LG+ D+ S+G ++ ++GS+ +QG ++ K+
Sbjct: 183 -----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKV 234
Query: 230 SEKKVSTSIEALCRGYPT 247
E+ + S E + R PT
Sbjct: 235 IEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 32/144 (22%), Positives = 69/144 (47%), Gaps = 4/144 (2%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL-RWF 72
++G G+FG++Y N +T A K+ K++ Y ++ + I L F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 73 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 132
+G +++ G +++ + R L+ + ++ QM+ ++++HS +HRD+K
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 133 DNFLMGLGRRANQVYIIDFGLAKR 156
N L+ L + + DFG++ +
Sbjct: 139 GNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 117 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------RYRDTATH 163
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 26/219 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLQYEAKLYKILQGGSTG 65
F + + IG G+FGE+ + T A+K+ N + + + + ++ G
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 66 IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
I L + + +Y LV+D +G L L + +L +M+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
++HRDIKPDN L+ + + + DFG + T Q + GT Y S
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173
Query: 185 THLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 214
I Q+ D D SLG + L G P+
Sbjct: 174 ----ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 42/169 (24%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
+ +G G+FGE+ L + T A+K + +VK + L ++ +L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 56 YKILQGGSTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 111
Y Q NL +F ++ GD L+I + G EDL F
Sbjct: 67 YYSFQDKD----NL-YFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIA 108
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
++ VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 46/210 (21%), Positives = 93/210 (44%), Gaps = 25/210 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTGIPNL 69
++G+G+ G + + T + +A+K LE + Q+ E IL P +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE---LDILH--KCNSPYI 61
Query: 70 -RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-S 124
++G GD ++ + + G SL+ + ++ + + +A ++ + ++H K
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
+HRD+KP N L+ Q+ + DFG++ + ++ K GT+ Y +
Sbjct: 122 IIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPE 169
Query: 185 THLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
G + S + D+ SLG L+ G P+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 60/217 (27%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKI-LQGGSTG----IPN 68
IG G FGE+Y T + A+K L+ + K Q + A +I L STG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 126
+ + D ++DL+ DL S+ S + A ++I +E +H++ +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY-ASMNT 185
+RD+KP N L+ V I D GLA + H + GT Y A
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 186 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 39/173 (22%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG--- 61
V +++R +++GSG++G + + +T +VAIK KLY+ Q
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---------------KLYRPFQSELF 57
Query: 62 GSTGIPNLRWFGVEGDYNVL-VIDLLGP--SLEDLFNFC---------------SRKLSL 103
LR NV+ ++D+ P SL+ +F KLS
Sbjct: 58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE 117
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
+ L QM+ ++++H+ +HRD+KP N + ++ I+DFGLA++
Sbjct: 118 DRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 46/180 (25%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
++++ IG GS+G + + T E+VAIK E+V L+ E KL ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRH- 58
Query: 63 STGIPNLRWFGVEGDYNVLVIDLLGPS---LEDLF-NFCSRKLSLKTVLMLAD------- 111
P++ VE + I +L PS +D++ F + L V+ D
Sbjct: 59 ----PDI----VE----IKHI-MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH 105
Query: 112 -----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-RYRDTAT 162
Q++ ++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 39/169 (23%), Positives = 61/169 (36%), Gaps = 54/169 (31%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------ENVKTKHPQ 48
K+G G++ +Y G N T E VA+K EN+ H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 49 LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTV 106
+ E KL +LV + + L+ + L TV
Sbjct: 67 IHTENKL------------------------MLVFEYMDKDLKKYMDTHGVRGALDPNTV 102
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
Q++ + F H LHRD+KP N L+ + ++ + DFGLA+
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 62/288 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
++GSG+FG + G ++ VAIK+ EN K+ ++ EA++ L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI---- 57
Query: 69 LRWFGV-EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 122
+R GV E + +LV+++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 174
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 175 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 233 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
+A Q+++ + ++H + +HRDIKP N L+ + V I DFG+++ T P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225
Query: 169 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 213
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 26/169 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LENVKTKHPQLQYEAKLYKILQGGS 63
L R +G G+FGE+Y G + + VA+K L ++ + + L + L
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF---LMEALIMSK 65
Query: 64 TGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---------SRKLSLKTVLMLADQM 113
N+ R GV + I L + DL +F L++K +L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 114 INRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKR-YR 158
+++ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 44/193 (22%), Positives = 71/193 (36%), Gaps = 39/193 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWF 72
+++ G+ +YLG EVA+K+ + L+ EAK+ +IL G P + ++
Sbjct: 28 KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILA-GEGVTPEVYFY 84
Query: 73 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRD 129
G + + + + G L L RK L+ + L I E +
Sbjct: 85 GED---FIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV--- 138
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 189
+ D VYIIDF D+AT + P +N+T L
Sbjct: 139 LVND----------RDVYIIDF-------DSATFKKKP----RNVTQALSL------LFR 171
Query: 190 EQSRRDDLESLGY 202
E R + GY
Sbjct: 172 EGLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 70/277 (25%), Positives = 113/277 (40%), Gaps = 38/277 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
++ L ++IGSG FG ++LG +VAIK + EA++ L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH---- 58
Query: 66 IPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
P L + +GV E LV + + L D K S +T+L + + + ++
Sbjct: 59 -PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
S + +HRD+ N L+G NQV + DFG+ + D Y + ++
Sbjct: 118 SSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQ------YTSSTGTKFPVKW 167
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
+S + S + D+ S G VLM W+ G K YE S +V +I A
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFG-VLM--------WEVFSEG--KTPYENRSNSEVVETINA 216
Query: 241 LCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 272
R Y AS +C R +D+P ++ L
Sbjct: 217 GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 19/186 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEA-KLYKILQGGSTGIPNLRWF 72
KIG G++G++Y + T + VA+K ++ + A + +LQ S I +R
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 73 GVE------GDYNV-LVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVH 121
VE G ++ LV + L L+ + R L KT+ Q++ V H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNLTG 176
+HRD+KP N L + ++ + I D GL + + + TH+ + YR + L G
Sbjct: 128 KHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185
Query: 177 TARYAS 182
+ Y++
Sbjct: 186 STHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 140
LV L+G L ++ +KL+ V L Q++ ++++HS +HRD+KP N +
Sbjct: 99 LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-- 154
Query: 141 RRANQVYIIDFGLAKRYRDTAT 162
++ I+DFGLA+ D T
Sbjct: 155 -EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 34/213 (15%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHP----QLQYEAKLYKILQ 60
++ L +++G GSFG +YL + + E +K+ V +P Q EA+L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINR 116
I +E D ++ + G L+ + LS V Q++
Sbjct: 61 --HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIPYRENKN 173
V ++H + LHRD+K N + + N + I DFG+++ D AT
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------T 164
Query: 174 LTGTARYASMN--THLGIEQSRRDDLESLGYVL 204
TGT Y S H G + + D+ SLG +L
Sbjct: 165 FTGTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 48/169 (28%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------KHPQLQ--YEAKL 55
+G G+FG++Y + +T A K+ +++ KHP + YEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 56 YKILQGGSTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 111
Y+ L W +E G + ++++L E + R
Sbjct: 73 YE---------NKL-WILIEFCDGGALDSIMLELERGLTEPQIRYVCR------------ 110
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
QM+ + F+HS +HRD+K N L+ L V + DFG++ + + T
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 13/163 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYK-----ILQGG 62
F + + IG G+FGE+ + T + A+K+ N K L+ E ++ ++ G
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN---KWEMLKRAETACFREERDVLVNGD 59
Query: 63 STGIPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
I NL + + + LV+D +G L L + +L +M+ ++ VH
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164
++HRDIKPDN L+ + + + DFG R T Q
Sbjct: 120 QLGYVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 57/192 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLY------- 56
VG +++ IG G++G + T+ T +VAIK K P +E + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISP---FEHQTFCQRTLRE 53
Query: 57 -KILQGGSTGIPNLRWFGVEGDYNVLVI-DLLGPSLEDLFN----------------FCS 98
KIL R F E N++ I D++ P + FN +
Sbjct: 54 IKIL----------RRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT 100
Query: 99 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY 157
+ LS + Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+
Sbjct: 101 QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLAR-- 154
Query: 158 RDTATHQHIPYR 169
A +H
Sbjct: 155 --IADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 16/122 (13%)
Query: 98 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
S + A ++I ++F+H K ++RD+K DN L+ + + I DFG+ K
Sbjct: 90 SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK-- 144
Query: 158 RDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 214
+++ E K T GT Y + G + + D S G VL+Y L G P+
Sbjct: 145 ------ENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPF 196
Query: 215 QG 216
G
Sbjct: 197 HG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 50/286 (17%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQGGSTG 65
+L +K+G+G FGE+++ T N+ + ++ +K ++ EA + K LQ
Sbjct: 8 LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL- 63
Query: 66 IPNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
++ V + +I G L+ L + K L ++ + Q+ + F+
Sbjct: 64 ---VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARY 180
++++HRD++ N L+ + I DFGLA+ D RE + TA
Sbjct: 121 RNYIHRDLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPE 173
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
A I + D+ S G +LM + G +P+ G+ I
Sbjct: 174 AINFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIR 214
Query: 240 ALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
AL RGY P E + C R +++P + Y++ + D
Sbjct: 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 63/246 (25%), Positives = 95/246 (38%), Gaps = 61/246 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLENVK-TKHPQLQY--EA----- 53
K L R++G GSFG +Y G + E VAIK N + ++++ EA
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 54 -------KLYKILQGGSTGIPNL--RWFGVEGD---Y-------NVLVIDLLGPSLEDLF 94
+L ++ STG P L +GD Y L P+L+
Sbjct: 66 FNCHHVVRLLGVV---STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 95 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+ +AD M ++ +K F+HRD+ N ++ V I DFG+
Sbjct: 123 QMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT 166
Query: 155 KRYRDTATHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRGS 211
RD + YR K L A + G+ + + D+ S G VL M L
Sbjct: 167 ---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-AE 219
Query: 212 LPWQGL 217
P+QGL
Sbjct: 220 QPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 47/203 (23%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGSTGIPNLRW 71
KIG GS G + + + +VA+K+ +++ + + L E + + Q + + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV-VEMYKS 86
Query: 72 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 131
+ V + VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 132 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 191
D+ L+ L R V + DFG + + +P R K+L GT + +
Sbjct: 145 SDSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPY 194
Query: 192 SRRDDLESLGYVLMYFLRGSLPW 214
D+ SLG +++ + G P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 35/147 (23%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN----L 69
++G G+FG++Y N +T A K+ + K++ Y ++ IL S PN L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEI-DIL--ASCDHPNIVKLL 68
Query: 70 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
F E + +L+ G +++ + R L+ + ++ Q + + ++H +HRD
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKR 156
+K N L L + + DFG++ +
Sbjct: 129 LKAGNILFTLD---GDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 2 EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKT-KHPQLQYEA 53
EP+ NK F R +G+GSFG + L T + VAIK E K K Q+ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 54 KLYKILQG-GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--MLA 110
KIL NL + Y LV++ + + F F R + A
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFYA 137
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 170
Q++ E++ S + ++RD+KP+N L+ + + + DFG AK DT T+
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAK-VVDTRTY------- 186
Query: 171 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
L GT Y + L + + D +LG + L G P+
Sbjct: 187 --TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG 61
P + + + IG G++G+++ N + + A+K L+ + +++ E Y IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKA 70
Query: 62 GSTGIPNLRWFG-------VEGDYNVLVIDLL-GPSLEDLFN-FCSR--KLSLKTVLMLA 110
S ++++G GD LV++L G S+ DL F R ++ + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+ + ++ +H +HRD+K +N L+ V ++DFG++ + T
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 47/175 (26%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LENVKTKHPQLQYEAKLYKILQ--GGS 63
+ L +++G G++G + N +T+EE VAIK + NV +K + + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------ 111
I L D+ + +F +L L LM AD
Sbjct: 62 KNITCL-------------YDM-----DIVFPGNFNELYLYEELMEADLHQIIRSGQPLT 103
Query: 112 ---------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
Q++ ++++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 104 DAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 23/219 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKI-LQGGSTG----IPN 68
IG G FGE+Y T + A+K L+ + K Q + A +I L STG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 126
+ + D ++DL+ DL S+ S K + A ++I +E +H++ +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT- 185
+RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 186 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 224
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 52/228 (22%), Positives = 95/228 (41%), Gaps = 49/228 (21%)
Query: 12 GRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT---KHPQLQYEAKLYKILQGGST 64
G +G G++G +Y G Q ++V + NV ++ +LQ E L K L+ +
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 65 GIPNLRWFGVEGDYNVL--------------VIDLLGPSLEDLFNFCSRKLSLKTVLMLA 110
+++ G D N + +++ GP E +F ++
Sbjct: 65 ----VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK----------- 109
Query: 111 DQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY---RDTATHQHI 166
Q+++ V ++H+ +HRDIK +N LM G + +IDFG A+R TH ++
Sbjct: 110 -QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
K++ GT + + R+ D+ S+G + G P
Sbjct: 165 L----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 37/169 (21%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYK---------- 57
F L +G+G++G++Y G +++T + AIK+ +V + +++ E + K
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 58 ----ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 111
++ G+ + W LV++ G S+ DL N L + + +
Sbjct: 68 YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+++ + +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 47/205 (22%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL-RWF 72
KIG GS G + + T+ T +VA+K +++ Q + E +++ PN+ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 73 G--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
+ GD +V++ L G +L D+ +++ + + + ++ + F+H++ +HRD
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHRD 140
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI 189
IK D+ L+ +V + DFG + + +P R K+L GT + + +
Sbjct: 141 IKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISRL 190
Query: 190 EQSRRDDLESLGYVLMYFLRGSLPW 214
D+ SLG +++ + G P+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGSTGIPNL 69
K+G GS+ +Y G + + VA+K+ E T ++ EA L K L+ + I L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHAN--IVLL 68
Query: 70 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
+ LV + + L + L + V + Q++ + ++H + LHRD
Sbjct: 69 HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRD 128
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG- 188
+KP N L+ ++ + DFGLA+ + +P N T Y + LG
Sbjct: 129 LKPQNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 189 IEQSRRDDLESLGYVLMYFLRGSLPWQGLK 218
E S D+ +G + + ++G + G+K
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 33/117 (28%), Positives = 46/117 (39%), Gaps = 19/117 (16%)
Query: 122 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNLTGTA 178
+ LHRD+KP N FL N V + DFGLAK + ++ GT
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
Y S + + D+ SLG ++ S P+ A + Q KI E K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 10/153 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGSTGIPNL 69
+ +G G+FGE+ L + T+ A+K ++V ++ +A+ + + + + L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 70 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--MLADQMINRVEFVHSKSFLH 127
+ + D V+D + D+ + R VL ++ +E VH F+H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGG--DMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124
Query: 128 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
RDIKPDN L+ L + + DFGL +R T
Sbjct: 125 RDIKPDNILIDLD---GHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 213
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
Q++ ++F+HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 23/192 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGSTGIP 67
IG G+FGE+ L T A+K LE + H + + + +++ S +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI----LVEADSLWVV 64
Query: 68 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKS 124
+ ++ + N+ +I P D+ +K +L +T +A+ ++ ++ +H
Sbjct: 65 KM-FYSFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLG 121
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLTGTARYASM 183
F+HRDIKPDN L+ V + DFGL + H+ YR N +L + +M
Sbjct: 122 FIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK--AHRTEFYRNLNHSLPSDFTFQNM 176
Query: 184 NTHLGIEQSRRD 195
N+ E +R+
Sbjct: 177 NSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 10/117 (8%)
Query: 100 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
K L A ++I ++F+HSK ++RD+K DN L+ + I DFG+ K
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCK---- 144
Query: 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ + GT Y + LG + + D S G +L L G P+ G
Sbjct: 145 ---ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 208
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 42/202 (20%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFG 73
KIG GS G + + T T ++VA+K +++ + + ++ + + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 132
+ GD +V++ L G +L D+ +++ + + + ++ + ++H++ +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 133 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 192
D+ L+ R + + DFG + + +P R K+L GT + + +
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 193 RRDDLESLGYVLMYFLRGSLPW 214
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 38/172 (22%), Positives = 77/172 (44%), Gaps = 35/172 (20%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYK---------- 57
F L +G+G++G++Y G +++T + AIK+ +V + + +++ E + K
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 58 ----ILQGGSTGIPNLRWFGVE----GDYNVLVIDLLGPSL-EDLFNFCSRKLSLKTVLM 108
++ G + W +E G LV + G +L ED + R
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR--------- 128
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+++ + +H+ +HRDIK N L+ +V ++DFG++ + T
Sbjct: 129 ---EILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 65/270 (24%), Positives = 110/270 (40%), Gaps = 42/270 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGSTGIPNL 69
+IG G+FGE++ G N VA+K +T P L+ EA++ K PN+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILK-----QYSHPNI 55
Query: 70 -RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
R GV + +V++L+ G +L +K ++ + + +E++ SK
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR-ENKNLTGTAR 179
+HRD+ N L+ N + I DFG+++ Y T + IP + R
Sbjct: 116 IHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238
Y+S D+ S G +L F G++P+ L + +Q E I E+ V
Sbjct: 173 YSS-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPC 217
Query: 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYA 268
LC P C +P ++
Sbjct: 218 PELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 39/232 (16%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGS 63
L R++G G+FG+++L E L VKT EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 64 TGIPNLRWFGV--EGDYNVLVIDLLGPSLEDLFNFCS---------------RKLSLKTV 106
++++GV EGD ++V + + DL F +L+ +
Sbjct: 69 I----VKFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166
L +A Q+ + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY- 175
Query: 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 217
YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 176 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+ +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 10/153 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGG-S 63
F + IG G+FGE+ L T + A+K L++ K QL + +L S
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 64 TGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
+ +L + + Y L+++ L G + L + S + + +E VH
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH 118
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
F+HRDIKPDN L+ R + + DFGL+
Sbjct: 119 KLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 29/164 (17%)
Query: 13 RKIGSGSFGEIYL------GTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
R +G G FG++ L G N T E+VA+K ++ + K +IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILR------ 61
Query: 67 PNL------RWFGV---EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
NL ++ G+ +G + L+++ L SL++ K++LK L A Q+
Sbjct: 62 -NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 37/150 (24%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGST 64
+ + + IG G+FGE+ L + T + A+KL E +K +E + I+ ++
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER--DIMAFANS 102
Query: 65 GIPNLRWFGVEGD-YNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS 122
++ + D Y +V++ + DL N S + K +++ ++ +HS
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHS 160
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152
F+HRD+KPDN L+ ++ + + DFG
Sbjct: 161 MGFIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 172 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231
K GT + + G E D +LG L + P+ + + EK+
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--------RARGEKVEN 206
Query: 232 KKVSTSIEALCRGYPTEF-ASYFHYCRSLRFDDKPDYAYLKRL-FRD 276
K++ I YP +F + +C +L P+ KRL FRD
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 38/158 (24%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFG 73
IG G++G++Y TN + A+K L+ + +++ E Y ILQ ++++G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE---YNILQSLPNHPNVVKFYG 86
Query: 74 V--EGDYNV-----LVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 122
+ + D V LV++L G S+ +L C ++L + + + ++ +H+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRD+K +N L+ V ++DFG++ + T
Sbjct: 147 NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 298 QSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADP------SRRRNSG 351
+ + P G + P+S PP AA A T + D SR
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 352 PLGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSG----SSR-RVAVPNSREAAVVGS 406
A ++ +P A PA ++ ++LR++G S R A ++ AA +
Sbjct: 524 AAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA 583
Query: 407 DTDPSRPR 414
P+ PR
Sbjct: 584 APKPAAPR 591
|
Length = 830 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
++ +HS ++RD+KP+N L+ + + DFGL+K D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 177 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 216
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 55/242 (22%), Positives = 96/242 (39%), Gaps = 26/242 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKIL--QGGSTGIPNLRW 71
+G G FGE+ T + A K L+ + K + + A K + + S I +L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 72 FGVEGDYNVLVIDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 129
D LV+ L+ G L+ ++N + A Q+I +E +H + ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 130 IKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARYASMNTHLG 188
+KP+N L+ V I D GLA + GT Y + G
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKKIKGRA---------GTPGYMAPEVLQG 168
Query: 189 IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248
D +LG L + G P++ Q+ EK+ ++++ + YP +
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFR--------QRKEKVEKEELKRRTLEMAVEYPDK 220
Query: 249 FA 250
F+
Sbjct: 221 FS 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 92 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 137
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 18/226 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYK-ILQG-GSTG 65
FR R +G G FGE+ T + A K LE + K + + A K IL+ S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 66 IPNLRWFGVEGDYNVLVIDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ NL + D LV+ ++ G L+ ++N + + L A +++ +E +H +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTARYAS 182
+ ++RD+KP+N L+ + I D GLA + IP E+ + GT Y +
Sbjct: 122 NTVYRDLKPENILLD---DYGHIRISDLGLAVK---------IPEGESIRGRVGTVGYMA 169
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228
+ D LG ++ + G P++G K K+++ ++
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL- 69
+GSG+FG +Y G + E VAIK+ N +T P+ E + + L S P+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEF-MDEALIMASMDHPHLV 72
Query: 70 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFLH 127
R GV + ++ L P L K ++ + L+L Q+ + ++ + +H
Sbjct: 73 RLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVH 132
Query: 128 RDIKPDNFLMGLGRRANQVYIIDFGLAK 155
RD+ N L+ + N V I DFGLA+
Sbjct: 133 RDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 157
Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 21/59 (35%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 100 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 157
+L V L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGSTGI 66
+ IGSG+ G + + T + VAIK +NV H + Y E L K++ + I
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKLVNHKNI-I 78
Query: 67 PNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L F + LV++L+ +L + L + + L QM+ ++ +H
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLH 135
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
S +HRD+KP N ++ + + I+DFGLA+
Sbjct: 136 SAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 170
++++ +E++HS+ ++RDIK +N ++ + + I DFGL K D AT
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM------- 152
Query: 171 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
K GT Y + + R D LG V+ + G LP+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 475 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.52 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.92 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.9 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.96 | |
| PLN02236 | 344 | choline kinase | 96.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.67 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.43 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.3 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.13 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.48 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.0 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.65 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.85 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.66 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-60 Score=432.90 Aligned_cols=294 Identities=71% Similarity=1.246 Sum_probs=287.7
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+++++|+++++||+|+||.+|+|....+|+.||||+++....++++.+|.++++.|++. ..||.+.+|+.+..++++|
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g-~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGG-VGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccC-CCCchhhhhccccccceee
Confidence 468899999999999999999999999999999999999999999999999999999998 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||++|++|+++++.|.+.|+.+++++++.||+..|+|+|.+++|||||||+|+|++.+.....+.|+|||+|+.+.+..+
T Consensus 90 MdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 99999999999999999999999999999999999999999999999999999999888889999999999999999999
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
..|+||++....+||.+|++-..+.|.++++++|+.|+|++|+++..|.+||++.++.++.|++++|.+++..++++.+|
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
+++|.||.-++.+|..+.+++.|++..|.++|+-+|...+.+.|+.|||+.++.+
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-58 Score=437.78 Aligned_cols=291 Identities=61% Similarity=1.044 Sum_probs=282.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|+-.|+++++||+|+||++|+|++..+++.||||++..+...+++..|.+.+++|.+. ++||.++.|+.++.++.|||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~-~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGT-EGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCC-CCCCceeeeccccchhhhhh
Confidence 57889999999999999999999999999999999999999999999999999999976 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC--CCCCcEEEeecCCcccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|++|+||+|+++.|+++|+.+++++|+.||+..++|+|++.+|.|||||+|+||+.. .+.+.|.|+|||+|+.+.++.
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 999999999999999999999999999999999999999999999999999999863 345679999999999999999
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
+.+|+||++.+.+.||.+||+.+.++|.++++++|+.|||-|++++|.|.+||+|+++.+.+++|++|.+++..++++.+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
|.++|.+|..++.+...+++++-|+|+.+..+|.++|.+.|...|+.|||..+.
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 999999999999999999999999999999999999999999999999999865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=384.26 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=219.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-EEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-YNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-~~~lv 82 (475)
.+.+.++.||+|..|+||++.++.|++.+|+|++..... ..++.+|.++++.+++ ++|+.+++.+..+. ...|+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~s--pyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQS--PYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC--CCeeeEeEEEEeCCceEEee
Confidence 367888999999999999999999999999999854433 3578999999998855 99999999999888 59999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||| ||||++++... +++++..+..|+.+|++||.|||+ ++||||||||+|||| +..|.|||||||.++.+.+.
T Consensus 157 mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence 9999 99999999854 679999999999999999999995 999999999999999 68999999999999988775
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHhhccccccH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~ 238 (475)
. .++++||..|||||.+.|..|+.++||||||++|+||++|++||... ......+.+..|.....+.
T Consensus 233 ~---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-- 301 (364)
T KOG0581|consen 233 I---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-- 301 (364)
T ss_pred h---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC--
Confidence 2 36789999999999999999999999999999999999999999763 2345566666666544332
Q ss_pred HHHhcC-ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 239 EALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 239 ~~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
++.+ ++++|++|+..||.+||.+||++.+| +++-|.+.
T Consensus 302 --lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL---l~Hpfi~~ 340 (364)
T KOG0581|consen 302 --LPEGEFSPEFRSFVSCCLRKDPSERPSAKQL---LQHPFIKK 340 (364)
T ss_pred --CCcccCCHHHHHHHHHHhcCCcccCCCHHHH---hcCHHHhh
Confidence 3444 89999999999999999999998877 56666553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=388.96 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=218.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
.+.+.|.+.+.||+|+||.|-+|..+.||+.||||+++... ......+|+++|+.|+| |+|++++.+++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H--P~IV~~~d~f~ 246 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH--PNIVRIKDFFE 246 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC--CCEEEEeeeee
Confidence 35678999999999999999999999999999999987542 22346799999999988 99999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
..++.||||||+ ||.|.+.+- .++.+.+....-++.||+.||.|||++||+||||||+|||+..+.++..+||+|||+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999 999999886 355789999999999999999999999999999999999998766778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~---~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|+...... ...++|||+.|.|||++.+.. +..++|||||||+||-+++|.+||.+.... ....+.|.
T Consensus 326 AK~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~ 395 (475)
T KOG0615|consen 326 AKVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQIL 395 (475)
T ss_pred hhccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHh
Confidence 99775322 246789999999999998765 345889999999999999999999875332 22445565
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
..++.. .+..+..++++..+||.+||..||++||+++++ |++-+.
T Consensus 396 ~G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea---L~hpW~ 440 (475)
T KOG0615|consen 396 KGRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEA---LNHPWF 440 (475)
T ss_pred cCcccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH---hcChhh
Confidence 555543 233456789999999999999999999998876 555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=398.39 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=226.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.+|+.++.||+|||+.||.+++..+|+.||+|++... ...+.+..|++|.+.|+| +||+.++.++++.++.||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H--pnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH--PNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC--CcEEeeeeEeecCCceEE
Confidence 5699999999999999999999999999999998653 234568899999999988 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|+|+| .++|..+++ ..+.+++.+++.++.||+.||.|||+++|||||||..|+|| +++.+|||+|||||..+..+
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCc
Confidence 99999 889999998 56789999999999999999999999999999999999999 58889999999999988755
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ...++|||+.|.|||++.....+..+||||+|||||-||.|++||+. .+..+.|.+|.......
T Consensus 172 ~E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~---- 237 (592)
T KOG0575|consen 172 GE-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSM---- 237 (592)
T ss_pred cc-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccc----
Confidence 33 24678999999999999999999999999999999999999999976 45677777777665543
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~ 286 (475)
+..++.+.++||.++|..||.+||++++| |++-|...|+..+
T Consensus 238 -P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 238 -PSHLSAEAKDLIRKLLRPNPSERPSLDEV---LDHPFFKSGFTPA 279 (592)
T ss_pred -ccccCHHHHHHHHHHhcCCcccCCCHHHH---hcCHhhhCCCcCC
Confidence 34678999999999999999999998877 6666667766543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=377.28 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=210.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
...++|.+.++||.|+||+||+|+++.++..||||.+..+.- .+-+..|+++++.++| +||+.++++....++.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H--~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH--PNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC--cceeeEEEEEecCCeE
Confidence 356789999999999999999999999999999998876642 2346789999999996 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC---CcEEEeecCCcc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAK 155 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~---~~vkL~DFGlA~ 155 (475)
||||||| ||+|.+++.. .+.+++.++..++.||+.||++||+++||||||||+||||+..... -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999 8999999984 4579999999999999999999999999999999999999864223 579999999999
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.+.... ...+++|++.|||||++..+.|+.|+|+||+|+|||+|++|+.||.... ..+.+..+....
T Consensus 164 ~L~~~~--------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t---~~eL~~~~~k~~-- 230 (429)
T KOG0595|consen 164 FLQPGS--------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET---PKELLLYIKKGN-- 230 (429)
T ss_pred hCCchh--------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC---HHHHHHHHhccc--
Confidence 887543 2357899999999999999999999999999999999999999997643 344443333222
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
..++.+...+...+.+++...+..++.+|-++.+.
T Consensus 231 ~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 231 EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred cccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 22222333455667789999999999999886543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=383.37 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=225.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|++++.||+|+|++||+|+++.+++.||||++.+. .+.+-+.+|..+|..|.+ |+.|++|+.-+.++...
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~-hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSG-HPGIVKLYFTFQDEESL 149 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhC-CCCeEEEEEEeecccce
Confidence 357899999999999999999999999999999986543 345567889999999975 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+|+||+ +|+|.++|++. +.|++..+..++.||+.||+|||++|||||||||+|||| +.++.+||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence 9999999 99999999854 679999999999999999999999999999999999999 689999999999999987
Q ss_pred cccccccc----cccc--CCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 159 DTATHQHI----PYRE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 159 ~~~~~~~~----~~~~--~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
.......- .+.. ...++||..|.+||++.....+..+|||+||||||+|+.|..||.+.+. ...+++|...
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQAL 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHh
Confidence 65432111 1111 2569999999999999999999999999999999999999999988554 3444555444
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
.+. +..++|+.+.+||.++|..||.+|++.++|.+ + .|...+||.-+-
T Consensus 303 ~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~---H-------pFF~~Vdw~nlw 350 (604)
T KOG0592|consen 303 DYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA---H-------PFFEGVDWENLW 350 (604)
T ss_pred ccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhh---C-------cccccCChhhhh
Confidence 332 45788999999999999999999999866643 2 344556676543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=372.70 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=224.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|+++++||+|+||+||+++.+.|++.+|+|++++.. .......|..|+..+.| |.|+.+...+.+.+..
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h--PFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH--PFIVKLIYSFQTEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC--CcEeeeEEecccCCeE
Confidence 3578999999999999999999999999999999887653 23457789999988665 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+|+||+ ||.|...++ ..+.|++..+..++.+|+.||.|||++|||||||||+|||| +..|+|+|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcc
Confidence 9999999 889999988 45689999999999999999999999999999999999999 689999999999999655
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ...+++||+.|||||++.+..|+..+|+||||++||||++|..||.+ .+..+.+++|...+...
T Consensus 177 ~~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~-- 244 (357)
T KOG0598|consen 177 KDGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL-- 244 (357)
T ss_pred cCCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC--
Confidence 4433 23568999999999999999999999999999999999999999987 45567777777766322
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPD----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 300 (475)
....++.+.++++..+|..||++|.. +.+| ....+....+|+.+.....+
T Consensus 245 --~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 245 --PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred --CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCcccccCCHHHHHhcCCC
Confidence 12337889999999999999999963 2221 22355667899987655443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=358.48 Aligned_cols=243 Identities=25% Similarity=0.333 Sum_probs=206.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEE--eeEeCCEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRW--FGVEGDYNV 80 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~--~~~~~~~~~ 80 (475)
.+|+|.++||.|.||+||++.++.+|..||.|.++..... ..+..|+.+++.|+| +||+.++. +..+....+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~H--pNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNH--PNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCC--chHHHHHHHhhhccchhhH
Confidence 4699999999999999999999999999999987654332 357889999999988 99998865 444555689
Q ss_pred EEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 81 LVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~--~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
|||||| +|+|..+++.. ++.+++.++++++.|++.||..+|. .. |+||||||.||+| +.+|.|||+|||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfG 173 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFG 173 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccch
Confidence 999999 99999998743 4569999999999999999999999 44 9999999999999 588999999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
|++.+....+. ..+++|||.||+||.+.+..|+.++||||+||++|||+.-+.||.+. ...+...+|.+.
T Consensus 174 L~r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qg 243 (375)
T KOG0591|consen 174 LGRFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQG 243 (375)
T ss_pred hHhHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcC
Confidence 99998876553 35679999999999999999999999999999999999999999985 444555566665
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
..+.... ..++.++..||..|+..|++.||+.
T Consensus 244 d~~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 244 DYPPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 5433221 3467899999999999999999984
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=354.39 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=212.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+.+.++|+|+||+||+|+++.||+.||||.+....+.+ -..+|+++++.|+| +|++.+..++......+||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH--~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH--ENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc--chHHHHHHHHHhcceeEEE
Confidence 57999999999999999999999999999999876554433 35789999999987 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
+|||..++.+.++.....++.+.+..++.|++.|+.|+|+++||||||||+||||+ ..+.+||||||+|+.+..+..
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc
Confidence 99999988888887777899999999999999999999999999999999999995 789999999999998875332
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 231 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 231 (475)
.-+.++.|.+|.|||.+.| .+|+..+||||+||++.||++|...|.+..+.+....+.+...
T Consensus 157 -------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 157 -------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred -------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 1245688999999999998 6799999999999999999999999998655443333333221
Q ss_pred -------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 -------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 -------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..-..+++.-..+++.-+.+|++.||..||++|++.++++
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1112223333344556789999999999999999988875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=369.46 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=214.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeE-EEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-EEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-YNV 80 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~-vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-~~~ 80 (475)
.+..+.+.||.|+||+||+|.+. |.. ||||++...... ..+..|+.++..++| +||+.+++++.+.. ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~H--pNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRH--PNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCC--CCeeeEEEEEcCCCCceE
Confidence 44567778999999999999974 555 999998765422 368899999999877 99999999999887 789
Q ss_pred EEEEcC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEeeCCCCC-cEEEeecCCccc
Q 011882 81 LVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~ 156 (475)
|||||+ +|+|.+++.. .+..+++..++.|+.||+.||.|||+++ ||||||||+|||| +... ++||+|||+++.
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCcccee
Confidence 999999 9999999986 3678999999999999999999999999 9999999999999 4665 999999999987
Q ss_pred ccccccccccccccCCCCccCcccccccccc--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
...... ......||+.|||||++. ...|+.|+||||||++||||+||..||.+... .+....+.....
T Consensus 194 ~~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~ 263 (362)
T KOG0192|consen 194 KVISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGL 263 (362)
T ss_pred eccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCC
Confidence 654321 123368999999999999 55899999999999999999999999998654 333333333333
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.. .+...+|+.+..++..||..||+.||++.+|...|+.+.....
T Consensus 264 Rp---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 RP---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CC---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 22 2334589999999999999999999999999999998876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=372.03 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=217.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hH--HHHHHHHHHHHhCCCCCcCeeEEeeEeCC-EE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQ--LQYEAKLYKILQGGSTGIPNLRWFGVEGD-YN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~--~~~E~~il~~l~~~~~~i~~l~~~~~~~~-~~ 79 (475)
.+-++|.++++||.|.||.||+|+.+.+|+.||||.++.+-.. ++ -.+|++.++.|.. |+||+.+.....+.+ ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~-hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNP-HPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCC-CCcchhhHHHhhccCceE
Confidence 3567899999999999999999999999999999987655432 22 3568888887773 399999988888877 99
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|+|||||.++|+++++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||+. ....|||+|||+|+....
T Consensus 86 ~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 86 YFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRS 162 (538)
T ss_pred eeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEeccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999994 578999999999998765
Q ss_pred cccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------ 232 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 232 (475)
.. || +.++.|.+|.|||+++. .-|+.+.||||+|||++|+.+-+..|.|....+...++-.+...
T Consensus 163 kp-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 163 KP-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred CC-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 43 23 45789999999999875 45899999999999999999999999986554443333333211
Q ss_pred ----------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 233 ----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 233 ----------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.....+..+...++.++.++|.+|+.+||++|||+.++ |+..|.+.+
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a---l~~pffq~~ 297 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA---LQHPFFQVG 297 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH---hcCcccccc
Confidence 12334555666778999999999999999999999887 445554444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=368.39 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=218.9
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeC--
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEG-- 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~-- 76 (475)
|+..+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+ ...+|+.||+.|.| +||+.+.....+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~H--pNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDH--PNIIKLEEIVTSKLS 190 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCC--CcccceeeEEEecCC
Confidence 345577999999999999999999999999999999887766443 36789999999988 9999998887766
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...|||+|||..+|.-++....-+|++.++..++.||+.||+|||++||+|||||.+|||| |..|.+||+|||||+.
T Consensus 191 ~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 191 GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARF 267 (560)
T ss_pred ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceee
Confidence 7899999999999999998666689999999999999999999999999999999999999 6899999999999998
Q ss_pred ccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 232 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 232 (475)
+....... .+..+-|.+|.+||.++|.. |+.++|+||.||||.||+.|+..|++.+.....+++.++...
T Consensus 268 y~~~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e 341 (560)
T KOG0600|consen 268 YTPSGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE 341 (560)
T ss_pred ccCCCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence 87654322 24567899999999999975 999999999999999999999999996655555544443211
Q ss_pred ------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+.+.+..+|....+|+..+|.+||++|.|+.+.+
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 112223444677889999999999999999999988774
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=364.90 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=212.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-------CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-------~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
...++|++++.||+|+||.|++|.+..+++.||||+++.. .....+.+|+.+++.+.++ +||++++.+....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~H-pnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSH-PNIIRLLEVFATP 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccC-CCEeEEEEEEecC
Confidence 3467899999999999999999999999999999987764 2344677899999999843 8999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC-CcEEEeecCCc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLA 154 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGlA 154 (475)
...|+||||+ ||+|.+.+.. .+++.+.++..++.||+.|++|||++||+||||||+|||++ .+ +.+||+|||++
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLS 168 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEeccccc
Confidence 9999999999 7899999986 77899999999999999999999999999999999999994 55 89999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCC-C-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-Q-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
....... ....+.+||+.|+|||++.+.. | +.++||||+||+||.|++|..||... +....+.+|...
T Consensus 169 ~~~~~~~-------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 169 AISPGED-------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKG 238 (370)
T ss_pred cccCCCC-------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcC
Confidence 8773111 1245789999999999999988 8 48999999999999999999999873 334455555554
Q ss_pred cccccHHHHhcCC-hHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 KVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+. ++..+ ++++..|+.+||..||..|+++.+|+
T Consensus 239 ~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Ccc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 443 23445 89999999999999999999988875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=342.90 Aligned_cols=269 Identities=21% Similarity=0.296 Sum_probs=228.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|++++.||.|+||.|.+++.+.+|..+|+|+++..... +....|..+++.+.+ |.++++.+.+.+..+.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~--PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH--PFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC--ceeEEEEEeeccCCeE
Confidence 457899999999999999999999999999999998765422 346779999998885 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||. ||-|..++..+ ++|++..++.++.||+.||+|||+++|++|||||+|||| |..|.+||+|||+|+...
T Consensus 120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEec
Confidence 9999999 99999999854 579999999999999999999999999999999999999 689999999999999876
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
... -+.|||+.|+|||++....|+.++|.|||||++|||+.|..||.... ..+.|++|.+.++..
T Consensus 196 ~rT----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~---~~~iY~KI~~~~v~f-- 260 (355)
T KOG0616|consen 196 GRT----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN---PIQIYEKILEGKVKF-- 260 (355)
T ss_pred CcE----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC---hHHHHHHHHhCcccC--
Confidence 542 36799999999999999999999999999999999999999998743 478889998887653
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccC
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 302 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 302 (475)
+..++.++++|+..+|+.|-.+| +..+..-.+++. +-++....+|.....+..+.+
T Consensus 261 ---P~~fs~~~kdLl~~LL~vD~t~R--~gnlknG~~dIk---~H~wF~~v~W~~i~~r~ie~P 316 (355)
T KOG0616|consen 261 ---PSYFSSDAKDLLKKLLQVDLTKR--FGNLKNGVEDIK---NHPWFKGVDWEAILQRKIEPP 316 (355)
T ss_pred ---CcccCHHHHHHHHHHHhhhhHhh--hcCcCCCccccc---cCcccccccHHHHhhccccCC
Confidence 46678999999999999999998 222222222322 234556789998766655443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.82 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=210.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--EEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--YNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--~~~lv 82 (475)
.+|..++.||+|+||.||++.+.++|+.+|||.+..... ...+.+|+.++..|+ |++|+++++...... ..++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~--~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN--HPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC--CCCEEeeCCccccccCeeeEee
Confidence 458899999999999999999999999999998765521 345899999999999 499999988744333 78999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-CCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++...+.+|++..+..++.||++||+|||++|||||||||+||||. . ++.+||+|||+++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccccccccc
Confidence 9999 9999999987666899999999999999999999999999999999999994 5 689999999999877641
Q ss_pred ccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......+.||+.|||||++.. ....+++|||||||++.||+||+.||.+. ......+..+.... ..+
T Consensus 172 ~~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P 242 (313)
T KOG0198|consen 172 GTK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLP 242 (313)
T ss_pred ccc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---CCC
Confidence 111 112345789999999999995 33456999999999999999999999874 22233333443333 222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.++..++.+.++++..|+..||++|||+.+| |++.|...
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL---L~hpf~~~ 281 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL---LEHPFLKQ 281 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHH---hhChhhhc
Confidence 5667789999999999999999999998887 56666544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=368.66 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=214.4
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
++++++||+|.||+||+|.+. ....||+|.++..... ..+..|+.+++.|+| ++++++++++..++..|||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H--~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRH--EKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcc--cCeEEEEEEEecCCceEEEEEecc
Confidence 567899999999999999973 4458999998886554 678899999999998 89999999999999999999999
Q ss_pred CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
.|+|.+++.. .+..+...+.+.++.|||+||+||+++++|||||-..|||| +++..|||+|||||+...++...
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~-- 359 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYT-- 359 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCcee--
Confidence 9999999986 45679999999999999999999999999999999999999 57889999999999955544331
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......-...|.|||.+....++.+||||||||+||||+| |+.||.++.. .+.++.+....... .+.+
T Consensus 360 ----~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~le~GyRlp----~P~~ 428 (468)
T KOG0197|consen 360 ----ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLELLERGYRLP----RPEG 428 (468)
T ss_pred ----ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHHHhccCcCC----CCCC
Confidence 1222234567999999999999999999999999999999 9999988654 34444443332221 2367
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
||+++.+++..||..+|++||||+.+...|++++..
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 999999999999999999999999999999998754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=364.11 Aligned_cols=272 Identities=21% Similarity=0.315 Sum_probs=216.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||.||+|+-+.||+.+|+|++++.... ..+..|..+|..... +.+++++..+.+.++.|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds--~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDS--PWVVKLYYSFQDKEYLY 217 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCC--CcEEEEEEEecCCCeeE
Confidence 47899999999999999999999999999999998765432 346778888887443 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||||+ ||++..++. ..+.|++..+..++.+++.||+.||+.|||||||||+|+|| |..|++||+||||++.+..
T Consensus 218 LiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhh
Confidence 999999 999999997 45689999999999999999999999999999999999999 6999999999999975532
Q ss_pred cccc------------------ccccc----c------------------cCCCCccCccccccccccCCCCCCchhHHH
Q 011882 160 TATH------------------QHIPY----R------------------ENKNLTGTARYASMNTHLGIEQSRRDDLES 199 (475)
Q Consensus 160 ~~~~------------------~~~~~----~------------------~~~~~~GT~~Y~APE~~~g~~~s~ksDIwS 199 (475)
.... ...+. + .....+|||.|||||++++..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 1100 00010 0 123468999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 200 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 200 lG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
|||||||||.|..||.+.+ ..+.+.+|..-+..-..+. ...++++.++||.+|+. ||++|....-+.++-.
T Consensus 374 LG~ImyEmLvGyPPF~s~t---p~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~---- 444 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSET---PQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK---- 444 (550)
T ss_pred HHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc----
Confidence 9999999999999998854 4555555554331111110 12456899999999999 9999986333333222
Q ss_pred HcCCCCCCcccccccc
Q 011882 280 REGFQFDYVFDWTILK 295 (475)
Q Consensus 280 ~~~~~~~~~~dw~~~~ 295 (475)
.++...++|+-..
T Consensus 445 ---HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 445 ---HPFFKGVDWDHLR 457 (550)
T ss_pred ---CCccccCCcchhh
Confidence 3556678898654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=368.23 Aligned_cols=271 Identities=21% Similarity=0.281 Sum_probs=225.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|.++++||+|+||+|+++..+.+++.+|||++++.. ..+.+..|..|+.... .||.+.+++..+...++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccCCeE
Confidence 3578999999999999999999999999999999988754 3356888999999887 569999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ ||++..+. ..+.|++..+..++..|+.||.|||++|||+||||.+|||| |..|.+||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence 9999999 77743333 34679999999999999999999999999999999999999 689999999999999754
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .+.+++||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+. +..+.+..|....+..
T Consensus 520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~~~y-- 587 (694)
T KOG0694|consen 520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDEVRY-- 587 (694)
T ss_pred CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCC--
Confidence 3222 346899999999999999999999999999999999999999999984 4456666666555443
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccccccCC
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 303 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 303 (475)
+..++.+..+|++++|..+|++|..+. +.-++..+ ++....||+.+...+.+++-
T Consensus 588 ---P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h-------pFFr~i~w~~L~~r~i~PPf 644 (694)
T KOG0694|consen 588 ---PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH-------PFFRSIDWDDLLNRRIKPPF 644 (694)
T ss_pred ---CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC-------CccccCCHHHHhhccCCCCC
Confidence 356789999999999999999998752 11111222 34455789998877666544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=363.25 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=220.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.+-|++++-||.|+.|.|-+|++..||+.+|||++..... ...+.+|+-+|+++.| +|+..+++.++...+.|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~H--pnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEH--PNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcC--CCeeeeeeeeccCceEE
Confidence 4679999999999999999999999999999999876633 2358899999999988 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+|.||+ ||-|.+++- .++++++.++.+++.||+.|+.|+|..+|+||||||+|+|| +..+.|||+|||+|..-..
T Consensus 89 lvlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EEEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccC
Confidence 999999 888988886 36789999999999999999999999999999999999999 5667799999999976443
Q ss_pred cccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.. ...+.||++.|+|||++.|.+| +.++||||+|||||.||+|++||++ ......+.++..+.+..
T Consensus 165 gk--------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~M-- 231 (786)
T KOG0588|consen 165 GK--------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEM-- 231 (786)
T ss_pred Cc--------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccC--
Confidence 22 2356799999999999999998 7999999999999999999999985 45677777877777653
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
+..++.+.++||.+|+..||..|.+.++| |++.|....
T Consensus 232 ---Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI---~kHP~l~g~ 269 (786)
T KOG0588|consen 232 ---PSNISSEAQDLLRRMLDVDPSTRITTEEI---LKHPFLSGY 269 (786)
T ss_pred ---CCcCCHHHHHHHHHHhccCccccccHHHH---hhCchhhcC
Confidence 47889999999999999999999997777 666665543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=353.12 Aligned_cols=261 Identities=18% Similarity=0.307 Sum_probs=205.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE- 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~- 75 (475)
-.++|++.++||+|+||.||+|.+. .+++.||||++...... ..+..|..++..+.+ |+||+.+++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~ 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN-HLNVVNLLGACTKP 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhcc-CcceeeEEeEecCC
Confidence 3578999999999999999999753 34568999998654322 347789999888843 3899999887664
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC--------------------------------------------------------
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS-------------------------------------------------------- 98 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~-------------------------------------------------------- 98 (475)
....+++|||+ +++|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 45689999999 899999886431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCC
Q 011882 99 -----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173 (475)
Q Consensus 99 -----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~ 173 (475)
..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+...... .....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hcccC
Confidence 247888999999999999999999999999999999999 46789999999999865432211 11233
Q ss_pred CccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHH
Q 011882 174 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY 252 (475)
Q Consensus 174 ~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~l 252 (475)
..++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+..... ......+++++.++
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~l 309 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR----MRAPENATPEIYRI 309 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----CCCCCCCCHHHHHH
Confidence 456788999999999999999999999999999997 999998754321 11222222111 11235678999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 253 FHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 253 i~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+..||..||++||++.+|++.|++++.+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.58 Aligned_cols=253 Identities=20% Similarity=0.228 Sum_probs=212.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+|..+++||+|.||.||+|++..||+.||||.++..... -...+|++.++.++| +||+.+.+.+...+...||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h--~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH--PNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC--cchhhhhhhccCCCceEEE
Confidence 4789999999999999999999999999999998776443 357899999999986 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
+||+..+|+..++.....|+..++..++.++++||+|||++.|+||||||.|+||+ .++.+||+|||+|+.+.....
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCc
Confidence 99999999999997777899999999999999999999999999999999999994 889999999999999876544
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
.. ..-+-|.+|.|||.+.|.. |+..+||||.|||+.||+.|..-|.|..+-+...++..+.....
T Consensus 157 ~~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 157 IQ-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred cc-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 22 1226799999999999865 89999999999999999999988888655444333333221111
Q ss_pred -------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+....+.+..+|+..||.+||.+|.++.+.+
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 1112224445567889999999999999999988774
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=362.19 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=216.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.+.+.+...||+|.||+||+|.|- -.||||+++.+...+ .|+.|+.+|+.-+| .||+.+.+++....+ .|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH--~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRH--ENILLFMGACMNPPL-AI 464 (678)
T ss_pred HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcch--hhheeeehhhcCCce-ee
Confidence 456788999999999999999984 469999999876543 47889999987776 889999999988888 88
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|.-+| |.+|+.++.-...+|.+.+.+.|+.||++|+.|||.++|||||||..||+| .+++.|||+||||+..-..-
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeee
Confidence 88999 889999998777789999999999999999999999999999999999999 46699999999999754332
Q ss_pred ccccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...+ ......|...|||||+++.. +|+..+||||||||+|||++|.+||.. ....+.+..+..+.....
T Consensus 542 ~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 542 SGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred cccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEecccccCcc
Confidence 1111 11345788999999999744 589999999999999999999999984 334455666666655566
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...+..++|.++++|+..||.+++++||.+.+|+..|++++.
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 667778899999999999999999999999999998888764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.52 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=203.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.++||.|+||.||+|.+..+++.||||+++... ....+.+|+.+++.++| ++++.++.+.......++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH--ANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC--CCEeeEEEEEcCCCeEEEEE
Confidence 67999999999999999999999999999999876432 23357789999998876 89999999998899999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc-
Confidence 999889999987666678999999999999999999999999999999999999 4778999999999976433211
Q ss_pred cccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 234 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 234 (475)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+........
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1133478999999999876 4589999999999999999999999987543222221211111000
Q ss_pred --------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........++.++.+||..||.+||.+|||+.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0011112235678899999999999999999988885
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.36 Aligned_cols=265 Identities=20% Similarity=0.307 Sum_probs=217.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.-.++|++...||.|.-++||+|..+.+++.||||+++.+... +.+.+|+..+..+.| |||+.++..+..+...|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H--PNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH--PNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC--CCcceEEEEEEecceeE
Confidence 4467899999999999999999999999999999998766433 568899999998887 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 81 LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+||.|| +||+.+++... ...|++..+..|+++++.||.|||.+|.||||||+.|||| +.+|.|||+|||.+-.+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeec
Confidence 999999 99999998743 4459999999999999999999999999999999999999 589999999999987776
Q ss_pred ccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc-
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS- 235 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 235 (475)
+..... .++. ++++||++|||||+++. ..|+.|+||||||++..||++|..||...... +..+.++.. ..+
T Consensus 178 ~~G~R~--~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLqn-~pp~ 251 (516)
T KOG0582|consen 178 DSGDRQ--VTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQN-DPPT 251 (516)
T ss_pred ccCcee--eEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhcC-CCCC
Confidence 654322 2333 78899999999999543 35999999999999999999999999875442 222233322 222
Q ss_pred ----ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 236 ----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 236 ----~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
..-....+.++..|++++..||..||.+||+++++ |+..|.+..
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL---lkh~FFk~~ 299 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL---LKHAFFKKA 299 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH---hccHHHhhc
Confidence 11112235577899999999999999999999887 555555444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.42 Aligned_cols=243 Identities=19% Similarity=0.250 Sum_probs=198.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.+ ++++.+..++.+.+..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~--~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS--RFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCC--CcEEEEEEEEccCCeEEEE
Confidence 48999999999999999999999999999998764321 1245678888888866 8899998888889999999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ ++++.+||+|||++..+...
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCC
Confidence 9999 88998877543 3468999999999999999999999999999999999999 57789999999999865432
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. .....||..|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+..... .....
T Consensus 156 ~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~ 223 (285)
T cd05631 156 ET--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEE 223 (285)
T ss_pred Ce--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----ccccc
Confidence 21 1235789999999999999999999999999999999999999987544322222222111 11122
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
+...++.++.+|+.+||..||++||++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 345678999999999999999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=335.03 Aligned_cols=256 Identities=19% Similarity=0.221 Sum_probs=209.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEee--EeCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFG--VEGD 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~--~~~~ 77 (475)
+-.+.|+.+.+|++|+||.||+|+++.|++.||+|.++.+.... .-.+|+.++..++ |+||+.+..+. ..-+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~--H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR--HPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC--CCCeeeeEEEEeccccc
Confidence 34567999999999999999999999999999999988765433 3567888877766 49999996554 4567
Q ss_pred EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 78 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
..|||||||..+|..+++..+.+|...++..++.|++.||+|||.+.|+||||||+|+|+ .+.|.+||+|||+|+.+
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhh
Confidence 799999999999999999888899999999999999999999999999999999999999 58899999999999998
Q ss_pred cccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 234 (475)
..+.. ..+..+-|.+|.|||.++|.. |+...|+||+|||+.||++++.-|.|....+...++.++....-
T Consensus 228 gsp~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 228 GSPLK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cCCcc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 77532 224567899999999999876 89999999999999999999999998665544444444321110
Q ss_pred -----------------cccHHHH---hc--CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 -----------------STSIEAL---CR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 -----------------~~~~~~l---~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+...+ +. ++++.-.+|+..+|.+||.+|.|+.+.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 0000011 11 1346778999999999999999988763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=357.25 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=210.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..|...++||+|+.|.||.|..+.+++.||||.++.... .+-+..|+.+++.++| +||+++...+...+..|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H--~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHH--PNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccc--hHHHHHHHHhcccceeEEEEe
Confidence 468889999999999999999999999999998766543 3457788888887776 899998777777799999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ |++|.+++.. ..+++.++..|+++++.||+|||.+||+|||||.+|||++ .++.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC-
Confidence 99 9999999973 3599999999999999999999999999999999999995 778899999999998876554
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
...+++||+.|||||+.....|++++||||||+|++||+.|+.||-..+. .+.+..|.....+. -....
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~P~--lk~~~ 493 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTPK--LKNPE 493 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCCCC--cCCcc
Confidence 23678999999999999999999999999999999999999999976333 22222222211111 11235
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.++++|++|+.+||..|+++|+++.+| |++-|.+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eL---L~HpFl~ 527 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKEL---LEHPFLK 527 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHH---hcChhhh
Confidence 678999999999999999999998887 5565543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.14 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=216.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+....+ .+.+|++|++.|+| +||+.++..++.....|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkH--pniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKH--PNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCC--cchhhHHHhhcccceEEEE
Confidence 57999999999999999999999999999999886554332 48899999999988 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
.||+-|+|..++.+ ..+++++.+..|+.|++.||.|||+.+|+|||+||.|||+ +..+.+|+||||+|+.+.....
T Consensus 80 te~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence 99997799999984 5689999999999999999999999999999999999999 5889999999999998765322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......||+.|||||...+.+|+..+|+||||||+|||+.|+.||.. ....+.+..|.......+
T Consensus 156 -------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p----- 220 (808)
T KOG0597|consen 156 -------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPP----- 220 (808)
T ss_pred -------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCc-----
Confidence 12456899999999999999999999999999999999999999965 445566666665554433
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
...+..|..+++..|.+||..|.+..++ +.+.|.+.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~L---l~HpF~k~ 256 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDL---LGHPFWKG 256 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHH---hcChHHhh
Confidence 3567899999999999999999997766 55555443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=345.96 Aligned_cols=238 Identities=21% Similarity=0.311 Sum_probs=202.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|+.++..+..++..|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH--PFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC--CCCCcEEEEEEcCCEEE
Confidence 478999999999999999999999999999999876432 22357789999888865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence 999999 8899998874 4578999999999999999999999999999999999999 5788999999999986643
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.. ....||+.|+|||++.+..++.++|||||||+||||++|..||.+. ...+.+..+......
T Consensus 171 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~---- 233 (329)
T PTZ00263 171 RT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIYEKILAGRLK---- 233 (329)
T ss_pred Cc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCcC----
Confidence 21 2357999999999999999999999999999999999999999763 334444555443322
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
+...++..+.+|+.+||..||.+||+.
T Consensus 234 -~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 -FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 234578899999999999999999973
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.45 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=200.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|..+++.+.| ++|+.++++..+....++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH--PFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC--CcHhhhHhhhccCCeEEE
Confidence 47999999999999999999999999999999876432 12346778888888876 999999998889999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.+...
T Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 79 LMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC
Confidence 99999 8899999874 4579999999999999999999999999999999999999 47789999999999866432
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 155 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~----- 216 (291)
T cd05612 155 T----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKLE----- 216 (291)
T ss_pred c----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcC-----
Confidence 1 23579999999999999999999999999999999999999997743 33444444433321
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
+...++..+.++|.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 23456889999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=338.12 Aligned_cols=254 Identities=20% Similarity=0.226 Sum_probs=201.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+|+.+++.++| ++++.+..++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ--ENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC--ccccchhhhEecCCEEEEE
Confidence 579999999999999999999999999999998765432 2356788888888876 8999998888889999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc
Confidence 9999666656665455679999999999999999999999999999999999999 4778999999999987643221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 234 (475)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+.....
T Consensus 156 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 156 A------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred c------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 1 11245789999999999998999999999999999999999999987433222211111110000
Q ss_pred ----------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........++.++.+|+.+||..||++||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000111223678899999999999999999998775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.44 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=202.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||.||+|.+..+++.||||+++... ....+..|.+++..+.+ ++|+.++.++...+..|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS--EWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC--CCCccEEEEEEcCCEEEE
Confidence 57999999999999999999999999999999986432 22346678888887764 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.....
T Consensus 79 v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY 154 (333)
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc
Confidence 99999 8999999974 4579999999999999999999999999999999999999 57889999999999865431
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---ccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---STS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~ 237 (475)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+... .+.+..+..... ...
T Consensus 155 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 221 (333)
T cd05600 155 ----------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPV 221 (333)
T ss_pred ----------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCC
Confidence 2345799999999999999999999999999999999999999987433 222333222111 000
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......++.++.+++.+||..+|++||++.+|+
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 0000124688999999999999999999977664
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=338.55 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=201.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||+|+||.||+|.+..+++.||||++..... .....+|+.+++.+.| ++++.++.+....+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH--ANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC--CCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 2356789999988876 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc
Confidence 9999999999887666679999999999999999999999999999999999999 5778999999999975432211
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......||+.|+|||++.+. .++.++|||||||+||||++|..||.+... ....+..+.....
T Consensus 159 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 159 -------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred -------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhc
Confidence 11335789999999998764 589999999999999999999999987533 1222222111000
Q ss_pred ------------------cccHHHHh--cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ------------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ------------------~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+.... ..+++++.+|+..||+.||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00001111 12457889999999999999999988774
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=340.99 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=202.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEcc----------------CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTG 65 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~----------------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~ 65 (475)
..++|++.++||+|+||.||+|.+.. ++..||||++...... ..+.+|++++..+.| ++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD--PN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC--CC
Confidence 35789999999999999999998532 3457999998754322 357789999888865 89
Q ss_pred cCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 011882 66 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFL 126 (475)
Q Consensus 66 i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIv 126 (475)
|+.+++++...+..+++|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999889999999999 889999886421 2367889999999999999999999999
Q ss_pred ecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHH
Q 011882 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY 206 (475)
Q Consensus 127 HrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~e 206 (475)
||||||+|||+ +..+.+||+|||+++.+..... +.......++..|+|||++.+..++.++|||||||++||
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 4678999999999986543221 111233456889999999998899999999999999999
Q ss_pred HHc--CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 207 FLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 207 llt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
|++ +..||.+............................+|..+.+++.+||..||++||++.+|.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 986 678887754322222111111111001111122457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=350.98 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=214.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch---HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~---~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
...|...+.||.|.||.||+|.+..+++.||||++..+.... +++.|+.++..+.. ++|..+++.+..+...+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~--~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS--PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc--chHHhhhhheeecccHHHH
Confidence 456888899999999999999999999999999998776544 57788888887776 8899999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||| ||++.++++ .+..+.+..+..|+.+++.||.|||.++.+|||||+.||||. ..+.|||+|||++-.+....
T Consensus 90 Mey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 999999998 344568999999999999999999999999999999999996 55999999999998776644
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ...+++||+.|||||++.+..|+.|+||||||++.|||++|..||.......... +. .....+.+
T Consensus 166 ~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----lI---pk~~PP~L 231 (467)
T KOG0201|consen 166 K-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----LI---PKSAPPRL 231 (467)
T ss_pred h-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----ec---cCCCCCcc
Confidence 3 2368899999999999998899999999999999999999999998876622111 11 11222334
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
...+++.|++|+..||.+||+.||++.+| |++-|.+..
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~L---LKh~FIk~a 269 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKEL---LKHKFIKRA 269 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHH---hhhHHHHhc
Confidence 45788999999999999999999999887 555555553
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.27 Aligned_cols=259 Identities=26% Similarity=0.496 Sum_probs=195.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCchHHHHHH------------HHHHHH-hCCCCCcC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQLQYEA------------KLYKIL-QGGSTGIP 67 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~~~~~~E~------------~il~~l-~~~~~~i~ 67 (475)
+.+++|++.++||+|+||.||+|.+..+ +..+|+|+....... +..|. ..+..+ ...|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~--~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET--IVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc--hhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 4678999999999999999999998777 678888875443321 11111 111122 22458888
Q ss_pred eeEEeeEeCC----EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 68 NLRWFGVEGD----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 68 ~l~~~~~~~~----~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.+++.+.... +.+++|+++..++.+++... ..+++..++.|+.||+.||.|||+++|+||||||+|||+ +..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence 8887665443 56889999988998888743 346888999999999999999999999999999999999 467
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 223 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~ 223 (475)
+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 88999999999877543221111111223457999999999999999999999999999999999999999876432221
Q ss_pred HH------HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 224 QK------YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 224 ~~------~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.. +..+...+ .....+|.++.+++..||..+|++||++++|++.|
T Consensus 243 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11 11111111 12356789999999999999999999999999876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.71 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=200.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEcc-CCeEEEEEEeccCCC----chHHHHHHHHHHHHhC-CCCCcCeeEEeeE-----e
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----HPQLQYEAKLYKILQG-GSTGIPNLRWFGV-----E 75 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~-~~~~i~~l~~~~~-----~ 75 (475)
++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+|..+++.+.. .|++|+.+++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899998765432 2346678888877753 4699999987764 3
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....++||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 45689999999989999987543 458999999999999999999999999999999999999 47789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 232 (475)
+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+...
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG 226 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhC
Confidence 8654321 123457899999999999989999999999999999999999999875432 222222211
Q ss_pred --------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....++.+...++..+.+++.+||+.||++||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 111223344456788999999999999999999988885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.15 Aligned_cols=254 Identities=19% Similarity=0.267 Sum_probs=198.7
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----CE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG-----DY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-----~~ 78 (475)
+|++.++||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.++| ++|+.++.+.... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH--PDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCC--CCEeeecceEeccCCCCCce
Confidence 5999999999999999999999999999999876432 22357789999988875 8999887766432 35
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.|+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence 799999999999998874 4469999999999999999999999999999999999999 578899999999998654
Q ss_pred ccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH--------
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK-------- 228 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~-------- 228 (475)
...... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus 155 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 155 NDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 322111 01134579999999999876 5789999999999999999999999976432111111111
Q ss_pred ----H-----------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 229 ----I-----------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 229 ----i-----------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+ ...............+++++.+++.+||..||++||++.+++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 0 011111222333356788999999999999999999988774
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=355.81 Aligned_cols=206 Identities=25% Similarity=0.344 Sum_probs=179.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhC----CCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQG----GSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~----~~~~i~~l~~~~~~~~~~ 79 (475)
+.-+|+|++.||+|.||+|.+|.+..|++.||||+++.+. ...+...|+.+|..|+. ..-|++++++++...++.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3458999999999999999999999999999999987654 34677889999999982 336788999999999999
Q ss_pred EEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|||+|++..+|.++++..+ ..|+...+..|+.||+.||.+||+.||||+||||+||||..- ....|||+|||.|....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccC
Confidence 9999999999999998654 349999999999999999999999999999999999999643 34489999999998655
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 221 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~ 221 (475)
+... +++-+..|.|||+++|.+|+.+.||||||||+.||++|...|.|....+
T Consensus 343 q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 343 QRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred Ccce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 4322 4577889999999999999999999999999999999988888754433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=345.73 Aligned_cols=237 Identities=19% Similarity=0.272 Sum_probs=195.5
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||+++... ....+..|..++..+.| ++|+.+..++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH--PFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC--CCCCCEEEEEEcCCEEEEEEeCCC
Confidence 47999999999999999999999999886432 12345678888887765 89999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~---- 150 (323)
T cd05571 79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC----
Confidence 8899888874 4579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....+||+.|+|||++.+..++.++|||||||+||||++|..||.... ....+..+..... .+...++
T Consensus 151 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~ 219 (323)
T cd05571 151 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLS 219 (323)
T ss_pred ---cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCC
Confidence 1234579999999999999999999999999999999999999997632 2333333333222 2335678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKP-----DYAYL 270 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RP-----t~~~l 270 (475)
+++.++|..||..||++|| ++.++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l 248 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEI 248 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence 9999999999999999999 66655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.32 Aligned_cols=240 Identities=21% Similarity=0.257 Sum_probs=198.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+|++++.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+. ++++.++.++...+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP-PFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCC-CceeeeEEEEEcCCEEEEE
Confidence 5899999999999999999999999999999886432 223456777887777653 6788888888888999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 80 MEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCC
Confidence 9999 8899988864 4568999999999999999999999999999999999999 467899999999987532211
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+...... +
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~-----~ 220 (324)
T cd05587 156 K-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVS-----Y 220 (324)
T ss_pred C-------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----C
Confidence 1 1234579999999999999999999999999999999999999997643 33444444433221 2
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
...++.++.+++.+||..||.+|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 35678999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=353.19 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=196.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe--------C
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE--------G 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--------~ 76 (475)
..++|+++++||+|+||.||+|.+..+++.||||.+... .....+|+.+++.+.| ++++.+..++.. .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h--~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNH--INIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--cchHHHHHHHHHhcCC--CCCcceeeeEeecccccCCCc
Confidence 356899999999999999999999999999999987543 2345678999988876 889888665432 2
Q ss_pred CEEEEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 DYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.+.++||||++++|.+++.. ....+++..++.++.||+.||.|||++|||||||||+||||+ ...+.+||+|||+
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGl 217 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGS 217 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeecccc
Confidence 35779999998899887753 245699999999999999999999999999999999999994 2345799999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
|+.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+.........+..+...
T Consensus 218 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 218 AKNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred chhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 987643221 1245789999999998875 5899999999999999999999999875432222111111100
Q ss_pred c---------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 K---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~---------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .......++...|.++.+||.+||..||.+||++.+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 00011122345678999999999999999999998874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=330.71 Aligned_cols=254 Identities=14% Similarity=0.229 Sum_probs=204.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.+.||+|+||.||+|.+. ..+..||+|+++..... ..+..|+.++..++ |++++.+.+++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD--HSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC--CCCcCeEEEEEecCCCc
Confidence 457999999999999999999875 34678999988765332 24566777777665 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence 9999999 779999987655679999999999999999999999999999999999999 467899999999876532
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... ...+..+......
T Consensus 159 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~-- 227 (266)
T cd05064 159 SEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVEDGFRL-- 227 (266)
T ss_pred ccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCCC--
Confidence 2111 01122345778999999999999999999999999999775 9999987543 2223333322211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.....+|..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 228 --~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12356889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.06 Aligned_cols=250 Identities=16% Similarity=0.189 Sum_probs=199.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.++|+++++||+|+||.||+|.+..+++.||||... ...+.+|+.+++.++| ++|+.++.++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINH--PSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCC--CCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999999999999999753 2457889999999876 9999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 86 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 86 ~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
++++|..++.. ...+++.+++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+........
T Consensus 165 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~-- 238 (391)
T PHA03212 165 YKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN-- 238 (391)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc--
Confidence 99999888864 4569999999999999999999999999999999999999 47789999999999754332111
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----CHHHHHHHHhhcc--------
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKK-------- 233 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~----~~~~~~~~i~~~~-------- 233 (475)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+....
T Consensus 239 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 239 ----KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ----ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 123457999999999999999999999999999999999999887542211 0011111111000
Q ss_pred ------------------c----cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 ------------------V----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ------------------~----~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. ..........+|.++.+||.+||++||.+||++.+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 0000011124577899999999999999999998875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.35 Aligned_cols=257 Identities=21% Similarity=0.342 Sum_probs=204.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC-----eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|++.+.||+|+||.||+|.+..++ +.||||+++..... ..+..|+.+++.+.. |++|+.+++.+...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~-h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQ-HKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhcc-CCceeeEeeEecCCCC
Confidence 46999999999999999999875443 57999998754332 346789999988843 3999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------- 98 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~----------------------------------------------------------- 98 (475)
.++||||+ +++|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 899999885321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 99 ----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 99 ----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
..+++..++.|+.||+.||.|||++||+||||||+|||++ +++.+||+|||+++.+......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcce-----
Confidence 2478889999999999999999999999999999999994 6788999999999865433211
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... .+.......... .....+|+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~ 342 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAPP 342 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCCH
Confidence 11123345678999999999899999999999999999997 999997754321 122222111111 11234689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
++.+++.+||+.||++||++.+|.++|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=337.21 Aligned_cols=237 Identities=20% Similarity=0.286 Sum_probs=194.2
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||++.+..+|+.||+|++.... ....+..|..+++.+.| ++++.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH--PFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC--CCCcceeeEEecCCEEEEEEeCCC
Confidence 47999999999999999999999999886432 12345678888887765 89999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 150 (323)
T cd05595 79 GGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC----
Confidence 8899888863 4579999999999999999999999999999999999999 5778999999999875432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||+.|+|||++.+..++.++|||||||+||||++|..||.... ....+..+...... +...++
T Consensus 151 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~~~~~~~-----~p~~~~ 219 (323)
T cd05595 151 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR-----FPRTLS 219 (323)
T ss_pred ---ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCC
Confidence 1134579999999999999999999999999999999999999997643 23333333322221 235678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKP-----DYAYL 270 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RP-----t~~~l 270 (475)
+++.++|..||..||++|| ++.++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~ 248 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEV 248 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHH
Confidence 9999999999999999998 55554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=342.46 Aligned_cols=243 Identities=20% Similarity=0.276 Sum_probs=200.8
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||+|+||.||+|.+..+++.||||+++... ....+..|..++..+.| ++|+.+..++...+..|+||||+ ++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC--PFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999999999999999876432 12346678888887765 99999998888999999999999 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 79 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 79 ELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC------
Confidence 99998874 4579999999999999999999999999999999999999 5778999999999985433221
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...++++
T Consensus 149 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~ 219 (312)
T cd05585 149 -KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRD 219 (312)
T ss_pred -ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHH
Confidence 1234579999999999999999999999999999999999999997643 3344444443322 233567899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 249 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
+.+++.+||..||.+||++..+.++|.+.+
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 999999999999999998766666676644
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=338.46 Aligned_cols=240 Identities=21% Similarity=0.268 Sum_probs=197.5
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHh-CCCCCcCeeEEeeEeCCEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ-GGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~-~~~~~i~~l~~~~~~~~~~~lv 82 (475)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+..|.+++..+. ..|++|+.++.++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999986432 2234667777766554 2469999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 889988775 4579999999999999999999999999999999999999 577899999999987543221
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+...... +
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~-----~ 220 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEVR-----Y 220 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----C
Confidence 1 1235679999999999999999999999999999999999999997643 23333333332221 2
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
...++.++.++|.+||..||.+||+..
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 345789999999999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=340.28 Aligned_cols=271 Identities=18% Similarity=0.272 Sum_probs=211.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..++|++.++||+|+||.||+|.+..++..||+|++...... ..+.+|+++++.++| ++|+.+++++...+..++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS--PYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC--CcccceeEEEEECCEEEE
Confidence 467899999999999999999999999999999987765332 357789999998875 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +..+.+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence 99999 8899999874 44689999999999999999999985 79999999999999 4678899999999976543
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH------------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE------------ 227 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~------------ 227 (475)
.. .....||..|+|||++.+..++.++|||||||++|||++|..||...........+.
T Consensus 157 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 21 134578999999999999899999999999999999999999997533211110000
Q ss_pred -------------------------HHhhccccccHHHHh-cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 228 -------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 228 -------------------------~i~~~~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+.........+.+. ..++.++.+|+.+||..||++||++.+|+ .+.|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell---~h~~~~~ 304 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM---VHAFIKR 304 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh---hCHHHhc
Confidence 000000000000011 13578899999999999999999988884 4444443
Q ss_pred C-CCCCCcccccc
Q 011882 282 G-FQFDYVFDWTI 293 (475)
Q Consensus 282 ~-~~~~~~~dw~~ 293 (475)
. .+....+.|..
T Consensus 305 ~~~~~~~~~~~~~ 317 (333)
T cd06650 305 SEAEEVDFAGWLC 317 (333)
T ss_pred CccccccHHHHHH
Confidence 3 44455667753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=333.72 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=203.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||+|+||.||+|.+..+++.||||.++.... ...+.+|+.+++.++| ++++.++.++..++..++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--ANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC--CCcceEEEEEeeCCeEEEE
Confidence 4679999999999999999999999999999998764432 2356788998888875 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc
Confidence 9999889999887666678999999999999999999999999999999999999 4778999999999976433221
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......+|..|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+........
T Consensus 160 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 160 -------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred -------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 1123467999999999876 4589999999999999999999999987544322222222111100
Q ss_pred ---------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........++.++.++|.+||..||.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 0011112235688999999999999999999988874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=328.58 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=200.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhC-CCCCcCeeEEeeEe-----CC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQG-GSTGIPNLRWFGVE-----GD 77 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~-----~~ 77 (475)
+|++.+.||+|+||.||+|.++.+++.||||.++.... .....+|..+++.+.. .|++|+.++.++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999998865432 2346678888887753 46999998877653 35
Q ss_pred EEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+++||++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 679999999889999887543 348999999999999999999999999999999999999 4778999999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 232 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 232 (475)
+..... .....||..|+|||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 643221 12357899999999999989999999999999999999999999764332222222211100
Q ss_pred ---------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+...++.++.+++.+||+.||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001122334456788999999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=345.95 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=204.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||+|.+..+++.||||+++... ....+..|.+++..+.+ ++++.++.++.+++..|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS--PWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC--CCccchhhheecCCeEEE
Confidence 57999999999999999999999999999999986432 22346778888887765 999999988999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCccc
Confidence 99999 88999998754 679999999999999999999999999999999999999 57889999999999876543
Q ss_pred cccc----------------------ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 011882 161 ATHQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 218 (475)
Q Consensus 161 ~~~~----------------------~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~ 218 (475)
.... ...........||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3000 000011234579999999999999999999999999999999999999998744
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCC-HHHHHH
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKR 272 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~ 272 (475)
....+.++.........+. ...+++++.++|..||. ||.+||+ +.++++
T Consensus 235 ---~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 ---LQETYNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---HHHHHHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 2333333333111111111 12368999999999997 9999999 888743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.65 Aligned_cols=245 Identities=19% Similarity=0.266 Sum_probs=195.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+|+++++||+|+||.||++++. .+++.||+|++.... ....+..|..++..+.+ |++++.++.++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ-SPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccC-CCCcccEEEEEecCCE
Confidence 5999999999999999999864 478999999875421 12346678888888764 3899999988888999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccc
Confidence 99999999 8899998863 4569999999999999999999999999999999999999 46789999999999865
Q ss_pred cccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhcccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVS 235 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~ 235 (475)
...... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||......... .....+.....
T Consensus 156 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 228 (332)
T cd05614 156 LSEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP- 228 (332)
T ss_pred cccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC-
Confidence 433221 112457999999999998764 789999999999999999999999754332222 22222222111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
.+...++..+.+++.+||..||++||++.
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 229 ----PFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 12345789999999999999999999544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=343.75 Aligned_cols=268 Identities=19% Similarity=0.298 Sum_probs=205.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++++.||+|+||+||+|.+..+++.||||++.... ....+..|..++..+++ ++|+.++..+.+....|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~--~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS--LWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC--CCcceEEEEEecCCeEEE
Confidence 57999999999999999999999999999999986432 12346678888887765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 79 IMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred EEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCccccccc
Confidence 99999 8899999874 4579999999999999999999999999999999999999 46789999999999865432
Q ss_pred cccc-------ccc---------------------cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 011882 161 ATHQ-------HIP---------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 212 (475)
Q Consensus 161 ~~~~-------~~~---------------------~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~ 212 (475)
.... ..+ .......+||+.|+|||++.+..++.++|||||||+||||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1100 000 001124589999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCCcc
Q 011882 213 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRLFRDLFIREGFQFDYVF 289 (475)
Q Consensus 213 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~---~RPt~~~l~~~L~~l~~~~~~~~~~~~ 289 (475)
||.+.. ..+.+.++........++. ...+++++.++|.+++. ++. .||++++|+ ++ ++-...
T Consensus 235 Pf~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~---~h-------p~f~~~ 299 (363)
T cd05628 235 PFCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK---TN-------PFFEGV 299 (363)
T ss_pred CCCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh---CC-------CCCCCC
Confidence 997643 3344444443221111111 12357889999998664 444 457776663 22 333456
Q ss_pred cccccc
Q 011882 290 DWTILK 295 (475)
Q Consensus 290 dw~~~~ 295 (475)
+|....
T Consensus 300 ~~~~~~ 305 (363)
T cd05628 300 DWEHIR 305 (363)
T ss_pred CHHHHH
Confidence 777553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=338.32 Aligned_cols=240 Identities=20% Similarity=0.260 Sum_probs=197.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+|++.+.||+|+||.||+|.+..+++.||||++..... ......|..++..+.+ |++++.+..++...+..|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK-PPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCeEeeEEEEEecCCEEEEE
Confidence 58999999999999999999999999999998865421 1234556666665544 48888898888899999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCC
Confidence 9999 8899988864 4569999999999999999999999999999999999999 577899999999997543221
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+...... +
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~-----~ 220 (323)
T cd05616 156 V-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVA-----Y 220 (323)
T ss_pred C-------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----C
Confidence 1 1234679999999999999999999999999999999999999998743 33444444443321 2
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
+..++.++.+++.+||..+|++|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 35678999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=329.39 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=210.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEecc----CCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----- 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~----~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----- 75 (475)
+...|..++.||.|+||.|+.+.++.+|+.||||.+.. .....+..+|+++++.++| +||+.+.+....
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~H--eNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRH--ENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcC--CCcceEEeecccccccc
Confidence 45677888999999999999999999999999997652 2233567889999999985 888888766543
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
-...|+|+|+|+.+|..+++ .+..++.+.+..++.||+.||.|+|+.+|+||||||.|+|+ +.++.+||||||+|+
T Consensus 98 f~DvYiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEecccccee
Confidence 45689999999999999998 34459999999999999999999999999999999999999 588889999999999
Q ss_pred cccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH------
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK------ 228 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~------ 228 (475)
......... ..+.++-|.+|.|||++.. ..|+.+.||||+||||.||++|+.-|.|.+.....+.+..
T Consensus 174 ~~~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 174 YLDKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred eccccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 876431111 1245788999999998864 5699999999999999999999999988543322222211
Q ss_pred ------Hh-----------hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 229 ------IS-----------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 229 ------i~-----------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
+. ......+...+.++.++...+|+++||.+||.+|+|+++. |++.+.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA---L~hPYl 313 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA---LAHPYL 313 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH---hcChhh
Confidence 11 1223344566667888999999999999999999997766 555543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=354.29 Aligned_cols=255 Identities=17% Similarity=0.220 Sum_probs=192.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCC----CCCcCeeEEeeE-eCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGG----STGIPNLRWFGV-EGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~----~~~i~~l~~~~~-~~~~~ 79 (475)
.++|+++++||+|+||.||+|.+..+++.||||+++... .......|+.+++.+.+. +.+++.+..++. .....
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999986432 233467788888887652 234566655554 44678
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCC-------------CCCc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR-------------RANQ 145 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~-------------~~~~ 145 (475)
|+||+++|++|.+++.. ...+++..+..|+.||+.||+|||+ .|||||||||+||||..++ +...
T Consensus 208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99999999999998874 3579999999999999999999998 5999999999999996322 1125
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 225 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~ 225 (475)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.........
T Consensus 287 vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999988643221 2346899999999999999999999999999999999999999987543222222
Q ss_pred HHHHhhcccc---------------------------ccHHHHh-------cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 226 YEKISEKKVS---------------------------TSIEALC-------RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 226 ~~~i~~~~~~---------------------------~~~~~l~-------~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+.++...... ..+..+. ....+.+.+||..||.+||++||++.+++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 2211100000 0000000 00135678999999999999999988884
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=323.54 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=219.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
++.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.+. ..+++.+|+.|.+.|+| |+|+.+.....+..+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH--P~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEESFH 85 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC--CcEeehhhhhccccee
Confidence 57788999999999999999999999999999999887653 45679999999999998 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|||+|++ |+.|..-+-. ..-+++..+-.+++||+++|.|+|.+||||||+||.|+|+...+..--+||+|||+|..+.
T Consensus 86 ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999 7777544431 2358999999999999999999999999999999999999877777789999999999887
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
+.. ....+.||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+ .+....|+.|....+..+-
T Consensus 165 ~g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred Ccc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCC
Confidence 322 23467999999999999999999999999999999999999999988 3456677888777765544
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
+. +..+.++.++|+.+||..||.+|.|+.|.
T Consensus 234 ~~-w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 234 PE-WDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred cc-cCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 33 36788999999999999999999997765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.47 Aligned_cols=260 Identities=19% Similarity=0.285 Sum_probs=203.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++|+.++.++..++..|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN--PWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CCCcceEEEEEcCCeEEE
Confidence 57999999999999999999999999999999986432 12346678899888864 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 79 v~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 79 IMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred EECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceecccc
Confidence 99999 8899999874 4569999999999999999999999999999999999999 57889999999999865432
Q ss_pred cccccc-----------------c---------c-----ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc
Q 011882 161 ATHQHI-----------------P---------Y-----RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR 209 (475)
Q Consensus 161 ~~~~~~-----------------~---------~-----~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt 209 (475)
...... + + ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 110000 0 0 00113479999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 210 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 210 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
|..||.+.. ..+.+..+.........+. ...+++++.++|.+|+. +|.+|++...+.++|.+.
T Consensus 235 G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDN---PQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCC---HHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 999997643 2333333332211111110 12468899999999996 999999843344445443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=336.70 Aligned_cols=259 Identities=18% Similarity=0.291 Sum_probs=205.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..++|+++++||+|+||.||++.+..++..||+|++..... ...+.+|+++++.++| ++++.++.++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS--PYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC--CCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999876532 2357889999988875 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99999 8899999874 34689999999999999999999986 69999999999999 4678899999999986543
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH-----------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----------- 228 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~----------- 228 (475)
.. .....||..|+|||++.+..++.++|||||||+||||++|+.||...........+..
T Consensus 157 ~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred cc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 22 1345799999999999999999999999999999999999999965332111000000
Q ss_pred ----------------------------HhhccccccHHHH-hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 229 ----------------------------ISEKKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 229 ----------------------------i~~~~~~~~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
..........+.. ...+++++.+||.+||.+||++||++.+| |++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h~~~ 304 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNHTFI 304 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcChHH
Confidence 0000000000000 12367899999999999999999999888 445554
Q ss_pred Hc
Q 011882 280 RE 281 (475)
Q Consensus 280 ~~ 281 (475)
+.
T Consensus 305 ~~ 306 (331)
T cd06649 305 KR 306 (331)
T ss_pred hh
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=339.96 Aligned_cols=242 Identities=21% Similarity=0.295 Sum_probs=201.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCC-eEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..++|++.++||+|+||.||+|.+..++ ..||||++.... ....+..|..++..+.| ++|+.++.++.....
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH--PFCVNLYGSFKDESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC--CCCcceEEEEEeCCE
Confidence 3467999999999999999999876655 689999875321 23456779999888875 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999 8899999874 4579999999999999999999999999999999999999 57889999999999865
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 182 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~-- 246 (340)
T PTZ00426 182 DTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGIIY-- 246 (340)
T ss_pred CCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCC--
Confidence 432 124579999999999999889999999999999999999999998643 33344444433221
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYL 270 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l 270 (475)
+...+++++.+++.+||+.||++|+ +++++
T Consensus 247 ---~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 281 (340)
T PTZ00426 247 ---FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281 (340)
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence 2355788999999999999999996 55554
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=334.31 Aligned_cols=236 Identities=21% Similarity=0.271 Sum_probs=192.4
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||+++... .......|..++..+. .|++|+.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999886432 1223455666655443 4599999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 80 GGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC----
Confidence 8899988874 4579999999999999999999999999999999999999 5778999999999976433221
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~~ 220 (316)
T cd05592 152 ---KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRP-----HFPRWIS 220 (316)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC-----CCCCCCC
Confidence 12346799999999999999999999999999999999999999987432 333333332221 1234578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~ 268 (475)
.++.+++..||..||++||++.
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCCh
Confidence 8999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=338.69 Aligned_cols=238 Identities=19% Similarity=0.284 Sum_probs=195.1
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||++.+..+++.||||++.... ....+..|..+++.+.| ++++.+..++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH--PFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CCCcceEEEEEcCCEEEEEEeCCC
Confidence 47999999999999999999999999986532 12346678888877765 89999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||| +..+.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 150 (328)
T cd05593 79 GGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA---- 150 (328)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc----
Confidence 8899888763 4579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+..... .+...++
T Consensus 151 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~ 219 (328)
T cd05593 151 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEDI-----KFPRTLS 219 (328)
T ss_pred ---ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHhccCCc-----cCCCCCC
Confidence 1134579999999999999999999999999999999999999997643 2233333322221 2345678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKP-----DYAYLK 271 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RP-----t~~~l~ 271 (475)
.++.++|.+||..||++|+ ++.+++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 9999999999999999997 666653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=343.58 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=203.2
Q ss_pred CceEEeeeEeeeCceeEEEEEE-----ccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|++.++||+|+||.||+|.+ ..++..||||+++.... ...+.+|+.++..+.. |+||+.+++++...+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~-HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-HINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcC-CcceeeeeeeeccCCc
Confidence 4799999999999999999974 34567899999865432 2357789999988843 4999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------- 98 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~----------------------------------------------------------- 98 (475)
.++||||+ +++|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999 899998886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 99 ---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 99 ---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
..+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcccc
Confidence 1478889999999999999999999999999999999994 6778999999999866443211
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
.......++..|+|||++.+..++.++|||||||+||||++ |..||....... ..+..+... ... ...
T Consensus 271 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~ 339 (375)
T cd05104 271 -----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-YRM---LSP 339 (375)
T ss_pred -----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-ccC---CCC
Confidence 11223345678999999999999999999999999999997 899997653321 112222211 111 112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
...|.++.+|+.+||..||++||++.+|++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 34678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=337.63 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=203.7
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------------hHHHHHHHHHHHHhCCCCCc
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------PQLQYEAKLYKILQGGSTGI 66 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------------~~~~~E~~il~~l~~~~~~i 66 (475)
....|+|++++.||+|.||.|-+|.+..+++.||||++.+.... +...+|+.+++.|.| +||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H--~nV 170 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH--PNV 170 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC--cCe
Confidence 35678999999999999999999999999999999998654321 357889999999987 999
Q ss_pred CeeEEeeE--eCCEEEEEEEcC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 67 PNLRWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 67 ~~l~~~~~--~~~~~~lvme~~-g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
++++.+-. ..+..|||+||| .|.+...- +... +++.+++.|+.+++.||+|||.+|||||||||+|+||+ .
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---S 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---C
Confidence 99988866 447889999999 44443221 2344 99999999999999999999999999999999999995 7
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLK 218 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----~s~ksDIwSlG~iL~elltG~~Pf~~~~ 218 (475)
.++|||+|||.+..+......... .......||+.|+|||...+.. .+.+.||||+||+||.|+.|++||.+
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-- 321 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-- 321 (576)
T ss_pred CCcEEeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc--
Confidence 799999999999876332111100 0112358999999999988733 36889999999999999999999977
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
....+.+.+|....+..+.. ..+.+.+++||.++|.+||+.|.+..+|.
T Consensus 322 -~~~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 322 -DFELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred -chHHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 45567777877766543221 23568899999999999999999977664
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.32 Aligned_cols=246 Identities=20% Similarity=0.258 Sum_probs=196.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.++| ++|+.++.++...+..++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH--PNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC--CCcceeeeEeccCCeEEEE
Confidence 35789999999999999999999999999999998654322 357789999988875 8999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+. ..+.+..+..|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+....
T Consensus 151 ~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 151 LEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc
Confidence 9999 7787542 235678889999999999999999999999999999999 477899999999998764322
Q ss_pred cccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
. ......||..|+|||++.. ...+.++|||||||+||||++|+.||......+.......+.....
T Consensus 223 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 293 (353)
T PLN00034 223 D-------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-- 293 (353)
T ss_pred c-------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC--
Confidence 1 1234579999999998743 2346799999999999999999999975433332222222221111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
......++.++.+||.+||..||++||++.+|++
T Consensus 294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1123467899999999999999999999887743
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=340.21 Aligned_cols=252 Identities=20% Similarity=0.224 Sum_probs=195.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++|+.++.++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH--KNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCC--CCEeeeeeeeccCCCc
Confidence 35689999999999999999999999999999999886432 22346678888887765 8999987776533
Q ss_pred ---CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 ---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ---~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...|+||||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence 3579999999888887764 358999999999999999999999999999999999999 5788999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~- 232 (475)
++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 170 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 170 ARTACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred ccccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 975433211 13457899999999999999999999999999999999999999875332111111100000
Q ss_pred ------------------c--c-cccHHH------------HhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ------------------K--V-STSIEA------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ------------------~--~-~~~~~~------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. . ...... .....+.++.+||.+||..||++||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0 0 000000 0112357789999999999999999988774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.67 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=202.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+..|+++++||+||.+.||++.. .+.+.||+|.+...... ..+..|+.+|..|++. ..|+.+++|...+++.||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~-~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH-DKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC-ceEEEEeeeeccCceEEE
Confidence 56699999999999999999985 44566777754443332 3478999999999987 889999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||||-..+|..+++........-.+..+..||+.|+.++|.+||||.||||.|||| -.|.+||+|||+|..+....
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccc
Confidence 99999999999998766666656889999999999999999999999999999999 47899999999999887655
Q ss_pred cccccccccCCCCccCccccccccccCCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-----------~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
+.. ....-+||+.||+||.+.... .++++||||||||||+|+.|+.||.... ....++..|.
T Consensus 514 TsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~ 586 (677)
T KOG0596|consen 514 TSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT 586 (677)
T ss_pred cce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc
Confidence 432 123458999999999987543 4689999999999999999999997642 2334455555
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+.+.. +.++.++++.||.+||++||++.+|+
T Consensus 587 ~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 587 DPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 4433333333322 23499999999999999999987773
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=344.05 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=216.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE-EE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDY-NV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~-~~ 80 (475)
.++|.++++||.|+||.+++++++..++.||+|.++...... ....|..++..++| |+|+.+...+++++. .+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~h--P~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLH--PNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccC--CCeeeeccchhcCCceEE
Confidence 468999999999999999999999999999999987765332 46789999998776 999999888877766 99
Q ss_pred EEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|||+|| ||+|.+++...+ ..|+++.++.|+.||+.||.|||+++|+|||||+.||+++ +++.|||.|||+|+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcC
Confidence 999999 999999998665 5599999999999999999999999999999999999995 77888999999999887
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ...++.||+.||+||.+.+.+|+.|+|||||||++|||++-+.+|... +....+.+|.....
T Consensus 158 ~~~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~---- 223 (426)
T KOG0589|consen 158 PEDS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLY---- 223 (426)
T ss_pred Cchh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccC----
Confidence 6542 235679999999999999999999999999999999999999999774 44555555555443
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
..+...++.+++.+|..|+..+|+.||++.+|+..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23456788999999999999999999999998654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.52 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=200.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||+|.+..+++.||||+++.... ...+..|..++..+.+ ++++.+..++...+..|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~--~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS--PWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CCCcceeeEEecCCeEEE
Confidence 479999999999999999999999999999999875422 2346677777776654 899999988888999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||| +..+.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCC
Confidence 99999 899999998766789999999999999999999999999999999999999 57889999999999876543
Q ss_pred ccccccccccCCCCccCcccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~------g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
... ......||+.|+|||++. +..++.++|||||||+||||++|..||..... ...+..+.....
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~ 226 (330)
T cd05601 156 KMV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQR 226 (330)
T ss_pred Cce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCC
Confidence 221 112347899999999987 45678999999999999999999999976432 333344332211
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
....+ ....++.++.+|+..||. +|.+||++.++
T Consensus 227 ~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l 260 (330)
T cd05601 227 FLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260 (330)
T ss_pred ccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHH
Confidence 11111 013468899999999998 99999998766
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=330.73 Aligned_cols=269 Identities=22% Similarity=0.338 Sum_probs=219.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.|+++++||.|.-|+||+|+...++..+|+|++.... +..+.+.|.+||..+.| |.++.++...+..++.|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH--PFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH--PFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC--CccchhhheeeccceeEE
Confidence 56899999999999999999999999999999987543 23457789999999987 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||||| ||+|..+++... +.|++..+..++.+|+.||+|||-.|||.|||||+|||| .++|+|.|+||.|+.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence 99999 999999998654 459999999999999999999999999999999999999 6899999999999875421
Q ss_pred cccc-------------------------------cc-----------------cc-cccCCCCccCccccccccccCCC
Q 011882 160 TATH-------------------------------QH-----------------IP-YRENKNLTGTARYASMNTHLGIE 190 (475)
Q Consensus 160 ~~~~-------------------------------~~-----------------~~-~~~~~~~~GT~~Y~APE~~~g~~ 190 (475)
..+. .. .| -.....++||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 00 00 01235688999999999999999
Q ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCC----
Q 011882 191 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---- 266 (475)
Q Consensus 191 ~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt---- 266 (475)
.+.++|+|+||++||||+.|..||.|.. ..+.+.+|....+..+-. ..++...++||+++|.+||.+|..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~---~~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSN---NKETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCC---chhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccc
Confidence 9999999999999999999999999853 456666666554432111 245689999999999999999987
Q ss_pred HHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011882 267 YAYLKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 267 ~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
++||.+ -.|..-++|.....
T Consensus 386 A~eIK~----------HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 386 AAEIKR----------HPFFEGVNWALIRC 405 (459)
T ss_pred hHHhhc----------CccccCCChhheec
Confidence 444432 24556678986544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=344.95 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=198.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||.||+|++..+++.||||++.... ....+..|++++..+.| ++|+.++..+.+++..|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN--EWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC--CCcceEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999875421 23457789999988876 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+|..+...
T Consensus 79 v~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 79 VMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCcccccc
Confidence 99999 8999999874 4568999999999999999999999999999999999999 57789999999998644211
Q ss_pred ccccc------------------------------------cccccCCCCccCccccccccccCCCCCCchhHHHHHHHH
Q 011882 161 ATHQH------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL 204 (475)
Q Consensus 161 ~~~~~------------------------------------~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL 204 (475)
..... ........++||+.|+|||++.+..++.++|||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00000 000011245799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011882 205 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 270 (475)
Q Consensus 205 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 270 (475)
|||++|..||.+... ......+.........+ ....+++++.++|.+|+ .+|.+|+ ++.++
T Consensus 235 yell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 235 YEMLVGQPPFLADTP---AETQLKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eehhhCCCCCCCCCH---HHHHHHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999987432 22222222211111110 11357889999999977 5999999 65555
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.34 Aligned_cols=255 Identities=21% Similarity=0.245 Sum_probs=198.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..|+++++||+|+||+||+|.+..+++.||||++..... ...+..|..+++.+.+ ++|+.++.++.+.+..|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN--EWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC--CCeeeeEEEEecCCEEEE
Confidence 369999999999999999999999999999999865321 2346778888888765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 79 VMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccc
Confidence 99999 8899999874 4569999999999999999999999999999999999999 47789999999998754211
Q ss_pred cccccc----------------------------------------ccccCCCCccCccccccccccCCCCCCchhHHHH
Q 011882 161 ATHQHI----------------------------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 200 (475)
Q Consensus 161 ~~~~~~----------------------------------------~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSl 200 (475)
...... .......++||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 100000 0001134679999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHh--cCCCCCCCCHHHHH
Q 011882 201 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLK 271 (475)
Q Consensus 201 G~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl--~~dp~~RPt~~~l~ 271 (475)
||+||||++|..||..... .+....+........++ ....+++++.++|.+|+ ..++..||++.+|+
T Consensus 235 G~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999999976432 22222222111111111 01246889999999954 45555699988774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=344.96 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=197.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|.+++..+.| ++|+.++.++.+..+.|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS--PWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC--CCcceEEEEEEcCCeeEE
Confidence 57999999999999999999999999999999875432 12346778888887765 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 79 IMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 99999 8999999874 4579999999999999999999999999999999999999 47789999999999754321
Q ss_pred cccccc-------cc---------------------------------ccCCCCccCccccccccccCCCCCCchhHHHH
Q 011882 161 ATHQHI-------PY---------------------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESL 200 (475)
Q Consensus 161 ~~~~~~-------~~---------------------------------~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSl 200 (475)
...... .. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 100000 00 00113579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011882 201 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 270 (475)
Q Consensus 201 G~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 270 (475)
||+||||++|..||.+... ...+..+.........+. ...++.++.++|.+|+. +|.+|+ ++.++
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999999976432 333333332111111100 12467899999999997 777765 66555
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.57 Aligned_cols=241 Identities=20% Similarity=0.262 Sum_probs=198.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+ +++++.+..++...+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-PPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCchhheeeEEecCCEEEEE
Confidence 4889999999999999999999999999999886432 11235667777766654 47888888888888999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ |++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 80 MEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCC
Confidence 9999 8899998864 4569999999999999999999999999999999999999 577899999999997543221
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+...... +
T Consensus 156 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~-----~ 220 (323)
T cd05615 156 V-------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVS-----Y 220 (323)
T ss_pred c-------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----C
Confidence 1 1234579999999999999999999999999999999999999998743 33444444443322 2
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
...++.++.+++.+||..+|.+|++..
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 346788999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=336.33 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=199.5
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHH-HHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAK-LYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~-il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
+.||+|+||.||+|++..+++.||+|++..... ...+..|.. +++.+ .|++|+.++.++...+..|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~--~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV--KHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC--CCCCCCceeEEEEcCCeEEEEEeCC
Confidence 479999999999999999999999999864321 112333333 23334 4499999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~--- 151 (325)
T cd05602 79 NGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG--- 151 (325)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC---
Confidence 8899998874 4568999999999999999999999999999999999999 5778999999999975433221
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... +...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~ 219 (325)
T cd05602 152 ----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQ-----LKPNI 219 (325)
T ss_pred ----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCcC-----CCCCC
Confidence 1234679999999999999999999999999999999999999997643 33444444433221 23467
Q ss_pred hHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 246 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
+.++.+++.+||+.||.+||++.+.. .++.. ..+...++|+...
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~---~~i~~---~~~~~~~~~~~~~ 263 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDF---MEIKN---HIFFSPINWDDLI 263 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCH---HHHhc---CcccCCCCHHHHH
Confidence 89999999999999999999976432 22221 2234557787654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.24 Aligned_cols=242 Identities=20% Similarity=0.237 Sum_probs=197.1
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.|++.++||+|+||.||++.+..+++.||||++..... ...+..|+.+++.+++ ++++.+...+..++..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS--RFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC--CCEeeeeeeecCCCeEEEE
Confidence 48999999999999999999999999999998764321 1235678888888865 8999999888888999999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+|||+ ++.+.++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCC
Confidence 9999 88999887643 3469999999999999999999999999999999999999 46789999999999865432
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+...... ....
T Consensus 156 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~ 223 (285)
T cd05605 156 ET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEE 223 (285)
T ss_pred Cc--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----cccc
Confidence 21 12347899999999999989999999999999999999999999875432222222221111 1112
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
+...++..+.+|+.+||..||++||+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLG 249 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcC
Confidence 33457899999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.88 Aligned_cols=255 Identities=20% Similarity=0.349 Sum_probs=209.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..+|.+.++||+|+||.||+|.+..+++.||+|++..... ...+..|+++++.+.| ++++.++.++......+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH--PNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC--CChhheEEEEcCCCCcEEEEE
Confidence 4569999999999999999999999999999998765432 2457789999998865 899999999988999999999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ ++.+.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCcccccccccee
Confidence 99 889999987543 358999999999999999999999999999999999999 4778999999999987654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+....+... .. ...
T Consensus 160 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~-~~---~~~ 226 (263)
T cd05052 160 T------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKG-YR---MER 226 (263)
T ss_pred e------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC-CC---CCC
Confidence 1 1122344678999999999999999999999999999998 9999976432 2222222221 11 123
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
...+|.++.+++.+||..+|++||++.++.+.|+.+|
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 4568899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.30 Aligned_cols=236 Identities=20% Similarity=0.262 Sum_probs=191.9
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
++||+|+||.||+|.++.+++.||||+++... .......|..++..+. .|++++.++.++...+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-ENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCCccCeeEEEEeCCEEEEEECCCC
Confidence 47999999999999999999999999886532 2234556666665443 3499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05620 80 GGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN---- 151 (316)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC----
Confidence 8899988874 4579999999999999999999999999999999999999 5778999999999875322111
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~~~~-----~~~~~~~ 220 (316)
T cd05620 152 ---RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRVDTP-----HYPRWIT 220 (316)
T ss_pred ---ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCCCCC
Confidence 1234679999999999999999999999999999999999999997643 2333333322211 1234578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~ 268 (475)
.++.+++.+||..||++||++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCCh
Confidence 8999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=327.56 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=206.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC-----eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+...... ..+..|+.++..+.| ++++.+..++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h--~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH--PNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC--cccceEEEEEcCCC
Confidence 467999999999999999999976554 68999987654322 346778888888765 89999999988888
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---G 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---c
Confidence 999999999 889999987532 458899999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 220 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~ 220 (475)
+++.+||+|||+++....... +.......++..|+|||.+.+..++.++|||||||+||||++ |..||.+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~- 232 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN- 232 (283)
T ss_pred CCCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 678899999999986543221 111233467889999999998899999999999999999998 9999987543
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.+.+..+...... .....+|.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 233 --~~~~~~i~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 --QEVIEMIRSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2333333332221 2345789999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=331.79 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=215.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch-----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~-----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+..+|++.+.||+|.||.|-+|.....|+.||||.++.+.... .+.+|++|+..|+| |||+.++.+++..+..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH--PhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH--PHIIQIYEVFENKDKI 128 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC--CceeehhhhhcCCceE
Confidence 4568999999999999999999998999999999877654332 47889999999987 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+|||||. +|.|++++..+ +.+++.++..|++||..|+.|+|.++++|||||.+|||| |.++++||+||||+..|.
T Consensus 129 vivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhc
Confidence 9999999 99999999864 579999999999999999999999999999999999999 689999999999998887
Q ss_pred ccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
+... ..+|||++.|++||++.|.+| ++.+|-||||++||-|+.|.+||+|. +.+..+.+|....+..
T Consensus 205 ~~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE- 272 (668)
T KOG0611|consen 205 DKKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE- 272 (668)
T ss_pred cccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC-
Confidence 6543 357899999999999999998 79999999999999999999999984 4455566666555433
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..-|....-||..||..+|+.|.|+.+|..
T Consensus 273 -----P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 273 -----PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 345778899999999999999999887753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=328.73 Aligned_cols=289 Identities=43% Similarity=0.701 Sum_probs=243.2
Q ss_pred ccCC-ceEEeeeEeeeCceeEEEEEEccCC-eEEEEEEeccCCCc--hHHHHHHHHHHHHhC--CCCCcCeeEEee-EeC
Q 011882 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTKH--PQLQYEAKLYKILQG--GSTGIPNLRWFG-VEG 76 (475)
Q Consensus 4 ~i~~-~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAvKi~~~~~~~--~~~~~E~~il~~l~~--~~~~i~~l~~~~-~~~ 76 (475)
.... +|++.++||+|+||.||+|.+..++ ..+|+|++...... ..+..|..++..+.. ...+++.+.+.+ ...
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 3445 8999999999999999999987774 68999998765333 379999999999984 347899999999 588
Q ss_pred CEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC--CCCcEEEeecCC
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGL 153 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGl 153 (475)
.+.|+||+++|.+|.++..... +.|+..+++.|+.|++.+|++||+.|+|||||||+|++++... ....++|+|||+
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 8999999999999999997555 7899999999999999999999999999999999999998543 226799999999
Q ss_pred cc--ccccccccccccccc-CCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 154 AK--RYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 154 A~--~~~~~~~~~~~~~~~-~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|+ .+.......+.+.+. ...+.||..|++++++.+.+.++++|+|||++++.||+.|.+||.+.........+.+..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 444333322344444 346779999999999999999999999999999999999999998877665555555554
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
....... .+...|.++..++..+-..++.++|++..+..+|++.+.+.+...+.++||+...
T Consensus 254 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~ 315 (322)
T KOG1164|consen 254 RKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL 315 (322)
T ss_pred hhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence 4443332 4455688999999999999999999999999999999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.99 Aligned_cols=250 Identities=22% Similarity=0.264 Sum_probs=197.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++++.||+|+||.||++.+..+++.||||+++... ....+..|..++..+.+ ++|+.++.++..++..|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR--RWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC--CCCCceEEEEecCCeEEE
Confidence 57999999999999999999999999999999986421 22346677777776654 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCC
Confidence 99999 999999998666779999999999999999999999999999999999999 47789999999999765443
Q ss_pred ccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.. ..+.+..+......
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~ 226 (331)
T cd05597 156 GTV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEH 226 (331)
T ss_pred CCc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCc
Confidence 221 1123469999999999874 347889999999999999999999997632 33444444332221
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 270 (475)
..++.....++.++.+++.+|+..+++. |+++.++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF 263 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 2222223457899999999988753332 5665444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.71 Aligned_cols=262 Identities=19% Similarity=0.273 Sum_probs=206.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEE-eeE-----e-CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRW-FGV-----E-GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~-~~~-----~-~~ 77 (475)
.+++|.+.|.+|||+.||+|.+...+..||+|.+-..... ..+.+|+.+++.|.++ +||+.+++ ... . ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh-~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGH-KNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCC-CceeeEeccccccccCCCcee
Confidence 4688999999999999999999888899999976544322 3578999999999975 99999877 222 1 24
Q ss_pred EEEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
..+|.|||| |++|-++++.. ...|++.++++|+.|+++|+.+||... |||||||-+||||+ .++.+||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence 568999999 68999999743 455999999999999999999999988 99999999999994 788999999999
Q ss_pred cccccccc-ccccccc-ccCCCCccCccccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 154 AKRYRDTA-THQHIPY-RENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 154 A~~~~~~~-~~~~~~~-~~~~~~~GT~~Y~APE~~---~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
|....... ....+.+ ........|+.|.|||++ .|.+++.|+|||+|||+||.|+....||.+... ..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------ee
Confidence 97543322 1111111 111223569999999987 477899999999999999999999999987422 12
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
|...++..+. ...++..|++||..||+.||++||++.+++..+.++..+..
T Consensus 266 Ilng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 266 ILNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred EEeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 3333332221 14678999999999999999999999999888877765544
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.33 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=206.4
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
|+.+..++|+++++||+|+||+||+|.+..+++ .||||+++..... ..+..|..++..+.+ ++++.+.+++
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~ 78 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS--PYVCRLLGIC 78 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCC--CCCceEEEEE
Confidence 677788999999999999999999999877776 4899987654332 345667777776654 8898888877
Q ss_pred EeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 74 ~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
... ..+++|+|+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ +.+.+||+|||
T Consensus 79 ~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG 154 (279)
T cd05109 79 LTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFG 154 (279)
T ss_pred cCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCC
Confidence 654 467888888 8899999876566799999999999999999999999999999999999994 67789999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+++.+........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+..
T Consensus 155 ~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~ 226 (279)
T cd05109 155 LARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK 226 (279)
T ss_pred ceeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC
Confidence 9987654322111 112245678999999999899999999999999999998 999997643322 1222222
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.... . ....++.++.+++.+||..||++||++.++++.|+++..
T Consensus 227 ~~~~-~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 GERL-P---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCcC-C---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 1 124578899999999999999999999999988887754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.82 Aligned_cols=237 Identities=18% Similarity=0.239 Sum_probs=194.0
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|+++.+++.||||++.... ....+..|..++..+. .|++++.++.++...+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-CCCchhceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 1233556667766554 3499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 80 GGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred CchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC----
Confidence 8899988874 4579999999999999999999999999999999999999 5778999999999875432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (320)
T cd05590 152 ---TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVV-----YPTWLS 220 (320)
T ss_pred ---cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCC
Confidence 1234579999999999999999999999999999999999999998643 33444444433221 224578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~ 269 (475)
.++.+++..||..||++||++.+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCCC
Confidence 99999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=329.55 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=202.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----CEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG-----DYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-----~~~~lv 82 (475)
.|.-.+++|.|+||.||.|....+++.||||..-.+. ....+|..+++.+.| +||+.+..++... -+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~--r~knrEl~im~~l~H--pNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK--RYKNRELQIMRKLDH--PNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC--CcCcHHHHHHHhcCC--cCeeeEEEEEEecCCCchhHHHHH
Confidence 5888999999999999999999999999999653322 244679999997776 9999987665522 256799
Q ss_pred EEcCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 83 IDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 83 me~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||+..+|.+.++.. +..++...+.-+..||++||.|||+.||+||||||+|+|++ .+.+.+||||||.|+.+..
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeecc
Confidence 999999999998743 56799999999999999999999999999999999999996 5679999999999998876
Q ss_pred cccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
... +..+..|..|.|||.+.|.. |+.+.||||.|||+.||+.|+.-|.|....+....+.++....-...+
T Consensus 179 ~ep--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 179 GEP--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred CCC--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 554 34568899999999999864 999999999999999999999999996554433333332211111111
Q ss_pred ---------------------HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 ---------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ---------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+....+++..+|+.++|.++|.+|.++.+++
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 113345689999999999999999999987774
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.11 Aligned_cols=235 Identities=20% Similarity=0.247 Sum_probs=192.7
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
++||+|+||.||+|++..+++.||||++.... ....+..|.+++..+.+ |++|+.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-HPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccC-CCCccceeeEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999886532 11235567777766543 499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 80 GGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc----
Confidence 8899988864 4579999999999999999999999999999999999999 5788999999999975433221
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~ 220 (321)
T cd05591 152 ---TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLS 220 (321)
T ss_pred ---cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCC
Confidence 1234579999999999999999999999999999999999999998643 33444444433321 123468
Q ss_pred HHHHHHHHHHhcCCCCCCCCH
Q 011882 247 TEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~ 267 (475)
.++.+++..||..||++||+.
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCC
Confidence 999999999999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=332.83 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=190.8
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHH-HHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKL-YKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~i-l~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
+.||+|+||+||+|.+..+++.||||++..... ...+..|..+ ++.+. |++++.++..+...+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~--hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC--CCCCCCeeEEEEeCCEEEEEEcCC
Confidence 479999999999999999999999999764321 1223334333 33343 499999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 151 (323)
T cd05575 79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK--- 151 (323)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC---
Confidence 8899988874 4579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
......||+.|+|||++.+..++.++|||||||+||||++|..||... +..+.+..+...... +...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~-----~~~~~ 219 (323)
T cd05575 152 ----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYDNILNKPLR-----LKPNI 219 (323)
T ss_pred ----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHHHHHcCCCC-----CCCCC
Confidence 123457999999999999999999999999999999999999999764 334444444443321 23467
Q ss_pred hHHHHHHHHHHhcCCCCCCCCHH
Q 011882 246 PTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
+.++.++|.+||+.||.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 89999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.93 Aligned_cols=242 Identities=21% Similarity=0.218 Sum_probs=199.4
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCEEEEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDYNVLVI 83 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~~~lvm 83 (475)
..||+|++|.||+|.+ +|+.||||.++..... ..+.+|+.++..++| +||+.+++++.+ ..+.++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDS--NNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCC--CCEEEEeeeEEecccCCCceEEEE
Confidence 6789999999999985 7999999988654322 345689999998876 899999888766 45789999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.. ...+++...+.++.|++.||.|||+ .+++||||||+|||+ ++++.+||+|||+++.+....
T Consensus 102 Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 102 EYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc
Confidence 999 8899999974 4579999999999999999999998 499999999999999 477899999999998654322
Q ss_pred cccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
....||..|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+........
T Consensus 178 ----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~-- 242 (283)
T PHA02988 178 ----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLK-- 242 (283)
T ss_pred ----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCC--
Confidence 13468899999999976 678999999999999999999999998743 2333444432222211
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
+...+|+++.+++.+||+.||++||++.+|++.|+.+.
T Consensus 243 -~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 -LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 22357899999999999999999999999999998764
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=337.24 Aligned_cols=238 Identities=20% Similarity=0.278 Sum_probs=193.2
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||++.... ....+..|.+++..+.| ++|+.+..++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h--p~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH--PFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CCCCceEEEEEcCCEEEEEEeCCC
Confidence 47999999999999999999999999986532 11335567777776654 89999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|..++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~--- 151 (325)
T cd05594 79 GGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA--- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc---
Confidence 8899888763 4579999999999999999999997 899999999999999 5778999999999975432221
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+... ...+..+...... +...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~~-----~p~~~ 219 (325)
T cd05594 152 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIR-----FPRTL 219 (325)
T ss_pred ----ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCCC-----CCCCC
Confidence 11345799999999999999999999999999999999999999976432 2333333222211 23567
Q ss_pred hHHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011882 246 PTEFASYFHYCRSLRFDDKP-----DYAYLK 271 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RP-----t~~~l~ 271 (475)
++++.+++.+||+.||++|+ ++.+++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 89999999999999999997 666653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=349.71 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=199.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
..+++|++.++||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+. |++++.++......
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~--h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD--FFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC--CCcEEEeecceeccccc
Confidence 3568999999999999999999999999999999998665332 23455666655544 47777765443321
Q ss_pred -----CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 77 -----DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 77 -----~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
...++||||+ +++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||| +.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEE
Confidence 1468999999 88999988643 3468999999999999999999999999999999999999 4678999
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
|+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+.
T Consensus 184 L~DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~ 255 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMH 255 (496)
T ss_pred EEecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHH
Confidence 99999998765432111 1235689999999999999999999999999999999999999997643 233333
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+...... .+...+++++.+++..||..||++||++.++++
T Consensus 256 ~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 33332221 234678899999999999999999999998865
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=323.05 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=205.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC------
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD------ 77 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~------ 77 (475)
.|+.+++||+|+||+||+|+++.+|+.||+|.+...... ....+|+.+++.|++. ++|+.+.++.....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~-~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHA-NHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCC-cceEEEEeeeeecccccccc
Confidence 477788999999999999999999999999998776542 3578999999999985 33999988887766
Q ss_pred EEEEEEEcCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 YNVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..++|+||+..+|..++.... ..++...+..++.||+.||+|||+++|+||||||+|||| ++.+.+||+|||+|
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchH
Confidence 889999999999999999776 358889999999999999999999999999999999999 47899999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+.+.-+. +.....++|.+|.|||++.|. .|+...||||+|||++||++++.-|.+..+.+....+.++....
T Consensus 168 ra~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 9665322 223456899999999999998 59999999999999999999999999865533333333322111
Q ss_pred c----------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 V----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ~----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ...+....+...+...+++.+|++.+|.+|.++...++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 0 01111111223357899999999999999999887643
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.43 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=200.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++.++||+|+||.||+|.+..+++.||||+++... ....+..|+.+++.+.+ ++++.++.++..+...|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h--~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS--EWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC--CCcceEEEEEecCCEEE
Confidence 467999999999999999999999999999999986421 22335678888887765 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 999999 8999999863 468999999999999999999999999999999999999 5788999999999986543
Q ss_pred cccccccccccCCCCccCccccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~----~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.. ....+.++......
T Consensus 195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMDHKNS 265 (370)
T ss_pred CCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCc
Confidence 2210 12345799999999998754 37899999999999999999999998743 23444444432211
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 270 (475)
...+. ...++.++.++|..||..+|++ |+++.++
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 11111 1246899999999999998987 9997776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.90 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=218.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+...|++.+.||.|.||.||+|+.+.+|+.+|+|++...... ..+.+|+.+++.+.. |++++.++..++.....
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-HPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-CCCEEEEEEEEEcCCeE
Confidence 556899999999999999999999999999999998765432 478999999999985 39999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-CCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGlA~~~ 157 (475)
++|||++ |+.|.+.+... .+++.++..++.||+.++.|||+.||+||||||+|||+...+. .+.+|++|||+|..+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 89999988755 3999999999999999999999999999999999999975433 358999999999987
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... .....+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.. ......++....+...
T Consensus 190 ~~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~---~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 190 KPGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET---EFEIFLAILRGDFDFT 258 (382)
T ss_pred cCCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC---hhHHHHHHHcCCCCCC
Confidence 6621 1245699999999999999999999999999999999999999998854 3444556666655332
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+..++..+++++..|+..||..|+++.++++
T Consensus 259 -~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 259 -SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2334677899999999999999999999988865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.02 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=195.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.| ++|+.++..+...+..|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h--~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN--EWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC--CcCCeEEEEEEeCCEEEE
Confidence 36999999999999999999999999999999876432 12356778888888765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.+...
T Consensus 79 v~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 79 VMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCcccccc
Confidence 99999 8899998874 3568999999999999999999999999999999999999 57889999999998644211
Q ss_pred ccccc----------------------------------------cccccCCCCccCccccccccccCCCCCCchhHHHH
Q 011882 161 ATHQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 200 (475)
Q Consensus 161 ~~~~~----------------------------------------~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSl 200 (475)
..... .........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 10000 00001124579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 201 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 201 G~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
||+||||++|..||.+... .+...++.........+ ....+++++.++|.+|+ .+|.+|++
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 9999999999999987432 23333332211111111 11346789999998876 59999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=332.04 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=201.2
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||+|+++.... ...+..|..++..+.. |++|+.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~-hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCC-CCcCCceeeEEEeCCEEEEEEeCCC
Confidence 479999999999999999999999999875421 1235567777665533 499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|..++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 80 GGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC----
Confidence 8899888763 4579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC------CHHHHHHHHhhccccccHHH
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~ 240 (475)
......||..|+|||++.+..++.++|||||||++|||++|..||...... ........+..... .
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~ 223 (329)
T cd05618 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----R 223 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----C
Confidence 123467999999999999999999999999999999999999999642211 11122222322222 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
++..++.++.+++.+||..||++||++.... .+.+++ ..++-..++|......
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i~---~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADIQ---GHPFFRNVDWDLMEQK 276 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHHh---cCCCCCCCCHHHHHcC
Confidence 3356788999999999999999999853110 011221 1234445678765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=340.21 Aligned_cols=255 Identities=16% Similarity=0.192 Sum_probs=203.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.+..+|+++++||+|+||.||+|... .+++.||||.+... ....+|+++++.++| ++|+.++.++......|+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h--~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH--RAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC--CCccceeeeEeeCCEEEE
Confidence 34567999999999999999999754 35678999987543 345689999998876 899999988888999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
+||+++++|.+++. ....+++.+++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+++.+....
T Consensus 164 v~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCccc
Confidence 99999999999885 45679999999999999999999999999999999999999 577899999999998665432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
.. .......||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+..+.....
T Consensus 240 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 240 DT-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cc-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 21 112346799999999999999999999999999999999999999987654433333332221100
Q ss_pred --------------------cccHHHH--hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 235 --------------------STSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 235 --------------------~~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.. ...++.++.++|.+||..||++||++.+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000111 1245678999999999999999999988843
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.74 Aligned_cols=244 Identities=22% Similarity=0.276 Sum_probs=194.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||++++..+++.||||++.... ....+..|..++..+.+ ++|+.++.++...++.|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC--QWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEcCCEEEE
Confidence 57999999999999999999999999999999876421 11235566777665544 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.+...
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCC
Confidence 99999 999999998666789999999999999999999999999999999999999 47788999999999876443
Q ss_pred ccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||.... ..+.+.++......
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~ 226 (331)
T cd05624 156 GTV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEER 226 (331)
T ss_pred Cce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCc
Confidence 221 1123579999999999876 457899999999999999999999997643 33444444432221
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCC
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKP 265 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RP 265 (475)
...+.....++.++.+++.+|+..++ +|+
T Consensus 227 ~~~p~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 227 FQFPSHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred ccCCCccccCCHHHHHHHHHHccCch-hhc
Confidence 22222234578999999999998654 444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=337.72 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=221.4
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
...-.+||-|.||.||.|.|++....||||.++.+... .+|..|+.+++.+.| +|++++.++|..+..+||+.|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikH--pNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH--PNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcC--ccHHHHhhhhccCCCeEEEEeccc
Confidence 34567999999999999999999999999998877654 579999999999987 99999999999999999999999
Q ss_pred CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
.|+|.+++..|++. ++...++.++.||..||+||..+++|||||-..|+|++ ++..|||+||||++.+..+....|
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceecc
Confidence 99999999988765 77888899999999999999999999999999999995 788999999999999877655333
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
. ...-...|.|||-+.-..++.|+|||+|||+|||+.| |..||.+.+.......+++...+. -+.+
T Consensus 424 A------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~-------~PeG 490 (1157)
T KOG4278|consen 424 A------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD-------GPEG 490 (1157)
T ss_pred c------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc-------CCCC
Confidence 2 2233567999999999999999999999999999998 999999865433333333332222 2478
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
||+.+.+|+..||++.|.+||+|+++.+.|+.+|....+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999999999976654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.84 Aligned_cols=264 Identities=20% Similarity=0.268 Sum_probs=203.7
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.+ |++++.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-NPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcC-CCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 479999999999999999999999999875422 1236678888877754 389999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|..++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 80 GGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC----
Confidence 8899888863 4579999999999999999999999999999999999999 4778899999999975332211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----CHHHHHHHHhhccccccHHHHh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
.....+||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+..... .+.
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p 223 (327)
T cd05617 152 ---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIP 223 (327)
T ss_pred ---ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCC
Confidence 123467999999999999999999999999999999999999999653221 11222222222221 133
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
..++.++.+++.+||..||.+|+++.... .++++. ..++....+|+.....
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~-~~~~i~---~h~~f~~~~~~~~~~~ 274 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQPQT-GFSDIK---SHTFFRSIDWDLLEKK 274 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCC-CHHHHH---cCCCCCCCCHHHHHhC
Confidence 55788999999999999999999854211 122222 2234455678765433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.37 Aligned_cols=239 Identities=18% Similarity=0.254 Sum_probs=193.4
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||+++.... ...+..|..++..+.+ |++|+.++.++......|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~-hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN-HPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccC-CCCCCceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999875321 1236678888877754 499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
|++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 80 ~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (329)
T cd05588 80 GGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD---- 151 (329)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC----
Confidence 8899888763 4579999999999999999999999999999999999999 5778999999999975322111
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHHHHHhhccccccHHH
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~ 240 (475)
......||..|+|||++.+..++.++|||||||++|||++|..||....... ....+..+..... .
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 223 (329)
T cd05588 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----R 223 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----C
Confidence 1234689999999999999999999999999999999999999996432111 1112222322222 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
+...++.++.+++.+||..||.+|+++.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 3356788999999999999999999843
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=330.16 Aligned_cols=236 Identities=22% Similarity=0.284 Sum_probs=192.1
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||+||+|.+..+++.||||+++... .......|..++..+. .|++++.++.++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 47999999999999999999999999886532 2234556666665542 3599999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 80 GGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC----
Confidence 8899999874 3569999999999999999999999999999999999999 4778999999999975432211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......||..|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~ 220 (316)
T cd05619 152 ---KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRMDNP-----CYPRWLT 220 (316)
T ss_pred ---ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCccCC
Confidence 1234579999999999999999999999999999999999999997643 2333333332221 1223567
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~ 268 (475)
.++.+++.+||..||++||++.
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCCh
Confidence 8999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=334.03 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=198.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||++.+..+++.||+|++.... ....+..|..++..+. |++++.++.++...+..|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--NQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC--CCCEeeEEEEEecCCEEEE
Confidence 57999999999999999999999999999999875321 1123556777766554 4899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++......+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccC
Confidence 99999 899999998666779999999999999999999999999999999999999 57789999999999765432
Q ss_pred ccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||... ...+.+.++......
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~ 226 (332)
T cd05623 156 GTV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKER 226 (332)
T ss_pred Ccc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCcc
Confidence 221 1123579999999999863 45789999999999999999999999764 334445555443322
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 270 (475)
...+..+..++.++.+++.+|+..+++. |+++.++
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~ 263 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDF 263 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHH
Confidence 2223334567899999999999765443 5665555
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=317.41 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=207.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||+|++..+++.||||.+..... ...+..|+++++.++| ++++.+..++...+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH--PNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC--cceeeeeeeEEECCeEEE
Confidence 689999999999999999999999999999997654221 1246778888888865 899999999888999999
Q ss_pred EEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 82 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ ..+.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceec
Confidence 99999 77999888642 34589999999999999999999999999999999999994 6788999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... ........+........
T Consensus 157 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 228 (267)
T cd08228 157 SSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPL 228 (267)
T ss_pred cchhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCC
Confidence 54321 11234688999999999988899999999999999999999999976432 22222333322222111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
....++..+.+++.+||..+|++||++.+|++.|+.+
T Consensus 229 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 ---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234678999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.97 Aligned_cols=271 Identities=19% Similarity=0.272 Sum_probs=208.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++++.||+|+||.||+|.+..+++.||||+++... ....+..|..++..+.+ ++++.++..+...+..|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG--AWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC--CCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999999999999999986421 22346678888877765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+++.+...
T Consensus 79 v~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 79 IMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCcccccc
Confidence 99999 8899999874 4569999999999999999999999999999999999999 57889999999999765322
Q ss_pred cccccc----------------------------ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 011882 161 ATHQHI----------------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 212 (475)
Q Consensus 161 ~~~~~~----------------------------~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~ 212 (475)
...... ........+||+.|+|||++.+..++.++|||||||+||||++|..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 110000 0001124579999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011882 213 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 292 (475)
Q Consensus 213 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 292 (475)
||.+... ...+.++.........+. ...++.++.++|.+|+ .||.+|++...+.+++.+. +-..++|.
T Consensus 235 Pf~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp-------~f~~~~~~ 302 (360)
T cd05627 235 PFCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP-------FFEGVDWG 302 (360)
T ss_pred CCCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC-------CCCCCCHH
Confidence 9977433 333444432211111110 1236789999999976 5999999754444445443 33446787
Q ss_pred ccc
Q 011882 293 ILK 295 (475)
Q Consensus 293 ~~~ 295 (475)
...
T Consensus 303 ~~~ 305 (360)
T cd05627 303 HIR 305 (360)
T ss_pred HHh
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.71 Aligned_cols=236 Identities=19% Similarity=0.243 Sum_probs=190.5
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.+.+ ++++.+..++......|+||||+ ++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS--RFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC--CcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 6999999999999999999999998764322 1345678888888855 89999988888889999999999 88
Q ss_pred CHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 89 SLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 89 sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..+.....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~--- 152 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS--- 152 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc---
Confidence 99887743 23459999999999999999999999999999999999999 4678899999999986644322
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+.... ..+...
T Consensus 153 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 223 (280)
T cd05608 153 ----KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDK 223 (280)
T ss_pred ----cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCccc
Confidence 123457999999999999999999999999999999999999999764332211 1122221111 122346
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
++.++.+++.+||+.||++||++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCC
Confidence 78999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=337.56 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=200.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-----E
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-----Y 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-----~ 78 (475)
+|+++++||+|+||.||+|.+..+++.||||.+..... ...+.+|+++++.++| +||+.++.+....+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKH--DNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCC--CCcCCHhheecCCCccccce
Confidence 58899999999999999999999999999998754321 2357788888888875 89999888777665 7
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.|+||||++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecc
Confidence 89999999989988876 34579999999999999999999999999999999999999 577899999999998654
Q ss_pred ccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 232 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 232 (475)
..... ......+|..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+......
T Consensus 155 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 155 PDESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred cCccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 32211 112346899999999998754 799999999999999999999999875432222222111000
Q ss_pred ---------------c-ccccHH---HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 233 ---------------K-VSTSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 233 ---------------~-~~~~~~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
. ...... .+....++++.+||.+||..||++||++.++ |++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 291 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPYL 291 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH---hcCHhh
Confidence 0 000111 1223457889999999999999999998877 444443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=335.69 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=197.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe----
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE---- 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~---- 75 (475)
.+.++|++++.||.|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++|+.++.+...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKH--ENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCC--Cchhhhhhhhcccccc
Confidence 356889999999999999999999999999999998765322 2346678999988876 888887665432
Q ss_pred --CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 --GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 --~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
....|++|++++++|.+++. ...+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence 24569999999999998886 3569999999999999999999999999999999999999 4778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
++...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 165 ~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 165 ARQADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred ceecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 98654321 24578999999999987 46899999999999999999999999764322111111111000
Q ss_pred c-----------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 K-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~-----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .......+..++++.+.+|+.+||..||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0 00111223345667889999999999999999988774
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.64 Aligned_cols=236 Identities=19% Similarity=0.343 Sum_probs=198.4
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCH
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSL 90 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL 90 (475)
++.||+|+.|.||+|+ -.++.||||.++. ...-+++-|+.|+| +||+.+.++|.....+||+|||| .|-|
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~e-----lkETdIKHLRkLkH--~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRE-----LKETDIKHLRKLKH--PNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhh-----hhhhhHHHHHhccC--cceeeEeeeecCCceeEEeeeccccccH
Confidence 5789999999999998 4688999996532 22345666777776 99999999999999999999999 8899
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccccc
Q 011882 91 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 170 (475)
Q Consensus 91 ~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~ 170 (475)
..+++ .+++++...+..|..+|+.||.|||.+.|||||||.-||||+ .+..|||+|||-++...+..+.
T Consensus 200 ~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk------- 268 (904)
T KOG4721|consen 200 YEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK------- 268 (904)
T ss_pred HHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh-------
Confidence 99998 467899999999999999999999999999999999999996 6678999999999988776442
Q ss_pred CCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHH
Q 011882 171 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 250 (475)
Q Consensus 171 ~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 250 (475)
-.|+||..|||||++.+.+.+.|+|||||||||||||||..||.+.+.. ..+..+....+.- .++..||+.|+
T Consensus 269 -MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~L---pvPstcP~Gfk 341 (904)
T KOG4721|consen 269 -MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHL---PVPSTCPDGFK 341 (904)
T ss_pred -hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccc---cCcccCchHHH
Confidence 3579999999999999999999999999999999999999999875432 1122222222222 23467899999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 251 SYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 251 ~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
-||++||+..|..||+|.+|+.-|
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999987655
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=330.32 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=194.2
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..+++.||||++.... ....+..|.+++..+. .|++++.++.++...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999886432 2234567777777665 3599999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
|++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 80 GGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC----
Confidence 8899988874 4579999999999999999999999999999999999999 5778999999999975322211
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....+||..|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+...... +...++
T Consensus 152 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (318)
T cd05570 152 ---TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVR-----YPRWLS 220 (318)
T ss_pred ---cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCcCC
Confidence 1234579999999999999999999999999999999999999997643 33334444333221 234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCH
Q 011882 247 TEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~ 267 (475)
.++.++|.+||..||++||++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=331.06 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=194.4
Q ss_pred eeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+++||+|+||.||++++. .+++.||||+++... ....+..|..+++.++| ++|+.++.++..++..|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~~~~~~~~~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH--PFIVDLIYAFQTGGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC--CchhceeeEEecCCeEEEE
Confidence 368999999999999864 468899999876431 12345678888888875 9999999888899999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 79 LEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred EeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCC
Confidence 9999 8899998874 4568999999999999999999999999999999999999 577899999999997543322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+..... .+
T Consensus 155 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~-----~~ 219 (323)
T cd05584 155 T-------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKL-----NL 219 (323)
T ss_pred C-------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC-----CC
Confidence 1 1234579999999999999899999999999999999999999997643 2333444433322 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYL 270 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l 270 (475)
...+++++.++|.+||..+|++|| ++.++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 356789999999999999999999 65555
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.01 Aligned_cols=248 Identities=20% Similarity=0.251 Sum_probs=194.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE----- 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----- 75 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|..+++.+.| ++++.+..+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH--KNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCC--CCccccceeeccccccc
Confidence 56899999999999999999999999999999998865322 2356778888888765 888888665432
Q ss_pred -CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 -GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 -~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....|+||||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCc
Confidence 24579999999889988775 358899999999999999999999999999999999999 47789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+....... .....||..|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+.++.....
T Consensus 174 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~ 242 (364)
T cd07875 174 RTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLG 242 (364)
T ss_pred cccCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 86543211 13457899999999999999999999999999999999999999774332 22222211000
Q ss_pred cc-------------------------cHHHH------------hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ST-------------------------SIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ~~-------------------------~~~~l------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. ....+ ....+.++.+||.+||..||.+||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 00000 011245789999999999999999988773
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=328.36 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=204.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.-..+|++.+.||+|+||.||+|.+..+++ .||||+++.... ...+..|+.+++.+.| +|++.+++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN--PHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEcCC
Confidence 345789999999999999999999876665 489998764432 2356778888887765 8999998888765
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
. .+++++|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157 (316)
T ss_pred C-ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence 4 56788887 889999998666679999999999999999999999999999999999999 467889999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+.... + +..+.....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-ISSILEKGE 228 (316)
T ss_pred cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H-HHHHHhCCC
Confidence 765432211 0122345678999999999999999999999999999997 99999764322 2 222222221
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
... ....++.++.+++.+||..+|++||++.+|+..|.++..
T Consensus 229 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111 124567899999999999999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.77 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=205.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|+++++||+|+||.||+|++... +..||||++...... ..+..|++++..+.. |+||+.+++++....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~-HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGP-HLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCC-CCCeeeEEEEEccCC
Confidence 45688999999999999999987433 357999998654332 357789999988863 399999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC----------------------------------------------------------
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------- 98 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~---------------------------------------------------------- 98 (475)
..||||||+ +++|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999 899998876421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 99 -------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 99 -------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..+++.+++.++.||+.||.|||+++|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--- 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--- 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---
Confidence 2378888999999999999999999999999999999994
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 220 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~ 220 (475)
.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||+||||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 6788999999999866432211 11233467788999999999899999999999999999997 99999764322
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
. ..+..+..... . .....+|.++.+++.+||..+|++||++.+|.+.|++++
T Consensus 347 ~--~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 S--TFYNKIKSGYR-M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--HHHHHHhcCCC-C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 11222222111 1 123467899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.82 Aligned_cols=255 Identities=19% Similarity=0.257 Sum_probs=203.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||.|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++| ++|+.++.++...+..++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--ANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC--CCcceEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999998764432 2356779999988876 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++........
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC
Confidence 9999889999987666679999999999999999999999999999999999999 4778999999999975433211
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......++..|+|||++.+. .++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 160 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 160 -------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred -------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 11234678999999998764 478999999999999999999999987543221111111110000
Q ss_pred ---------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 235 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 235 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..........+++++.+||.+||..||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112233457889999999999999999999887753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=318.93 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=205.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.++||+|+||.||+|.+ .++..||+|.+..... ...+..|..+++.++| ++++.+..........+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH--DKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCC--CCeeeEEEEEcCCCCcEEEEe
Confidence 46899999999999999999986 4667899998765432 3567889999998875 899999888888899999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+++||||||+||++ +..+.+||+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCce
Confidence 99 88999998643 3568999999999999999999999999999999999999 4778999999999987654221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+...... ..
T Consensus 159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 225 (261)
T cd05072 159 T------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRM----PR 225 (261)
T ss_pred e------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 1 1123346778999999998889999999999999999998 9999976432 2222333222111 11
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
...+|.++.+++.+||..+|++||+++++.++|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 24578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.66 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=198.7
Q ss_pred eeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
++.||+|+||.||++.+. .+++.||||++.... ....+..|++++..+.| ++|+.++.++..++..|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH--PFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC--CCcccEEEEEEcCCEEEEEEc
Confidence 367999999999999863 578999999886432 12345678888887765 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 79 FLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC-
Confidence 99 8899998863 4569999999999999999999999999999999999999 4778999999999986543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+...... +..
T Consensus 154 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i~~~~~~-----~p~ 219 (318)
T cd05582 154 ------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLG-----MPQ 219 (318)
T ss_pred ------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHHHcCCCC-----CCC
Confidence 123457999999999999988999999999999999999999999764 233444444333321 234
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRD 276 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~ 276 (475)
.+++++.+++.+||+.||++||++.+ +.+++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 57899999999999999999999776 4444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=333.54 Aligned_cols=252 Identities=19% Similarity=0.204 Sum_probs=194.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|..+++.+.| ++++.++.++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH--KNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCC--Cchhceeeeeeccccc
Confidence 356899999999999999999999999999999998865422 2346678888888875 8898887765432
Q ss_pred ---CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 ---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ---~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...|+||||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence 3579999999888888775 358999999999999999999999999999999999999 4778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++....... .....||..|+|||++.+..++.++|||||||+||+|++|..||.+.................
T Consensus 166 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 166 ARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred cccCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 986543211 134578999999999999999999999999999999999999998643211111100000000
Q ss_pred c-------cc---------------cHH------------HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 V-------ST---------------SIE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ~-------~~---------------~~~------------~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .. ... ......+.++.++|.+||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 0 00 000 00112346789999999999999999988874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.67 Aligned_cols=240 Identities=20% Similarity=0.241 Sum_probs=193.3
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||+|+||.||++.+..+|+.||+|.+.... ....+..|.++++.+.+ ++++.+..++..+...|+||||+ |+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS--PFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC--CcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999999999999999875422 12335568889888865 89999988888899999999999 88
Q ss_pred CHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 89 SLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 89 sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~----- 150 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT----- 150 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce-----
Confidence 9988875433 358999999999999999999999999999999999999 4778899999999986643221
Q ss_pred cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccccHHHHhcCCh
Q 011882 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....||..|+|||++.+..++.++|||||||++|||++|..||........ .+........... .....++
T Consensus 151 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 223 (277)
T cd05607 151 ---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK----FEHQNFT 223 (277)
T ss_pred ---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc----cccccCC
Confidence 1234689999999999999999999999999999999999999976433211 1222222221111 1124578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.++.+++.+||+.||++||++.++.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccch
Confidence 9999999999999999999997764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.33 Aligned_cols=255 Identities=16% Similarity=0.270 Sum_probs=207.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.+.||+|+||.||+|.+..+ ...||||+++..... ..+..|..++..+++ ++++.+..+....+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH--PNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC--CCcceEeEEEecCCce
Confidence 36799999999999999999998654 458999987654332 346678888888765 8999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+++|||+ +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.++|+|||+++.+.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence 9999999 889999998666679999999999999999999999999999999999999 477889999999999775
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+....+.......
T Consensus 158 ~~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~- 228 (266)
T cd05033 158 DSEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVEDGYRLP- 228 (266)
T ss_pred ccccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCCC-
Confidence 222110 0112345678999999999899999999999999999998 999997643 233333333221111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1245789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=337.78 Aligned_cols=250 Identities=20% Similarity=0.269 Sum_probs=198.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|++.++||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.| ++++.++.++..+...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h--p~iv~~~~~~~~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS--PWVVQLFCAFQDDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC--CCEeeEEEEEEcCCEE
Confidence 3578999999999999999999999999999999875421 12346678888887765 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||| +..+.+||+|||+|+.+.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecc
Confidence 9999999 8999999863 468999999999999999999999999999999999999 578899999999998764
Q ss_pred ccccccccccccCCCCccCccccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.+.. ....+.++.....
T Consensus 194 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKN 264 (370)
T ss_pred cCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCc
Confidence 3221 1123567999999999997653 7899999999999999999999997643 3344444443222
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 271 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~ 271 (475)
....+. ...++..+++++..|+..++.. |+++.+++
T Consensus 265 ~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 265 SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 111111 1246788999999999754433 77876663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=331.07 Aligned_cols=260 Identities=19% Similarity=0.312 Sum_probs=203.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE-eC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV-EG 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~ 76 (475)
.++|++.+.||+|+||.||+|.+.. +++.||+|+++..... ..+..|+.++..+.. |++|+.+++++. .+
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~-h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH-HLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhcc-CcchhheeeeEecCC
Confidence 4689999999999999999997543 4578999998754332 346678888888843 388998887665 45
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC---------------------------------------------------------
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS--------------------------------------------------------- 98 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~--------------------------------------------------------- 98 (475)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6788999999 889999885321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCc
Q 011882 99 ---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175 (475)
Q Consensus 99 ---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~ 175 (475)
..+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+++.+...... .......
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~ 236 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VRKGDAR 236 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcch-----hhccCCC
Confidence 2578999999999999999999999999999999999994 6788999999999876432211 1123345
Q ss_pred cCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHH
Q 011882 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 254 (475)
Q Consensus 176 GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~ 254 (475)
++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .+.......... .....+++++.+++.
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~l~~ 310 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRM---RAPEYATPEIYSIML 310 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCC---CCCccCCHHHHHHHH
Confidence 6788999999999999999999999999999997 999997743321 111111111111 112456789999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 255 YCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 255 ~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+||+.+|++||++.+|++.|++++..
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.35 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=203.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
++|++.+.||+|+||.||++.+. .+..||+|.+..... ...+..|+.+++.+.+ ++++.+++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH--PKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC--CCceeEEEEEccCCCEEEEEEc
Confidence 57999999999999999999874 556899998765433 3567889999998875 8999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee-
Confidence 9 889999987555568999999999999999999999999999999999999 46788999999999865432211
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ..+.+..+....... ...
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~~~----~~~ 224 (256)
T cd05114 157 -----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFRLY----RPK 224 (256)
T ss_pred -----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCCCC----CCC
Confidence 1123345678999999998889999999999999999999 999997643 233344443322111 123
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
..+.++.+++.+||..+|++||++++|++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 4578899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.15 Aligned_cols=249 Identities=18% Similarity=0.216 Sum_probs=204.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-CeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..|.+.+.||.|+||.||+|.+..+ ++.||+|.+...... ..+..|+.++..+.| ++|+.++.++...+..||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH--FGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC--CCEeEEEEEEEECCEEEEEE
Confidence 4499999999999999999998877 788999976544322 245678888887765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 84 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||+ |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||| +..+.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 999 89999887532 3458999999999999999999999999999999999999 4778999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......
T Consensus 222 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~~--- 290 (478)
T PTZ00267 222 SVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYDP--- 290 (478)
T ss_pred cccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC---
Confidence 3211 12245679999999999999999999999999999999999999997633 333344443332221
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...++.++.++|..||..||++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 22457889999999999999999999998853
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=322.13 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=203.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEc----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.+|++.++||+|+||.||+|.+. .+++.||+|.+...... ..+..|+.+++.+.| ++++.+.++.......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH--PNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC--CCeeeEEEEEecCCce
Confidence 57999999999999999999853 35578999988643332 347789899888865 9999999998889999
Q ss_pred EEEEEcC-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 80 VLVIDLL-GPSLEDLFNFC----------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~----------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
|++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cC
Confidence 9999999 78999988532 1247889999999999999999999999999999999999 46
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 221 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~ 221 (475)
.+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 788999999999876433211 11233456788999999998889999999999999999998 9999977432
Q ss_pred HHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 222 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 222 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
......+..... ...+..++.++.+++.+||..||++||++.+|.+.|+.
T Consensus 233 -~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 -QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222222222221 12345688999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=322.07 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=206.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|.+.+.||+|+||.||+|.+.. +++.||||+++..... ..+.+|+++++.+.+ ++++.++.++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH--ENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC--CCchheeeEEecCC
Confidence 4679999999999999999998743 3578999998755433 467889999998875 89999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
..++||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence 999999999 899999987432 347889999999999999999999999999999999999 477
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 222 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~ 222 (475)
+.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--- 230 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--- 230 (280)
T ss_pred CeEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999765332211 11223356789999999999999999999999999999998 9999976433
Q ss_pred HHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 223 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
...+..+....... ....++.++.+++.+||..||++||++.+|++.|+
T Consensus 231 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EEVIECITQGRLLQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 23333333322211 22467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.60 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=219.9
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
|-.|.+=|.+.+.||+|.|.+|-+|++.-||+.||||++...... ..+..|++.+++++| +||++++.+-..+.
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH--pNiVRLYEViDTQT 90 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH--PNIVRLYEVIDTQT 90 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC--cCeeeeeehhcccc
Confidence 346778899999999999999999999999999999998765432 468899999999998 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..||++|+- +|+|.++|-+....+.+..+.+++.||+.|+.|+|+..+|||||||+||++- .+-|.|||+|||++..
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK 168 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence 999999999 8899999987777899999999999999999999999999999999999986 5789999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s-~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
|.... ...+.||+..|-|||+++|..|+ +++||||||||||-|++|+.||+..++ .+.+-.|...++.
T Consensus 169 f~PG~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYt 237 (864)
T KOG4717|consen 169 FQPGK--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYT 237 (864)
T ss_pred CCCcc--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhccccc
Confidence 76543 23578999999999999999985 689999999999999999999987544 4555666666654
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. +..++.+.++||..||..||.+|.+.++|.
T Consensus 238 v-----PshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 238 V-----PSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred C-----chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 3 345678999999999999999999988764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=320.11 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=204.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|++.+.||+|+||.||+|.+.. ++..||+|........ ..+..|..+++.+.+ ++++.+.+++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH--QNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEccCC
Confidence 5679999999999999999999877 7789999987644322 346778888888765 89999999888888
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
..++||||+ |++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+........+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 899999999 899999987543 2489999999999999999999999999999999999996443445799999
Q ss_pred cCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011882 151 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 151 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i 229 (475)
||+++.+...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+... ......+
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~ 234 (277)
T cd05036 163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV 234 (277)
T ss_pred CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 9999876332210 11122234578999999999899999999999999999997 9999986433 2222222
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
..... ......+|.++.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22111 1123567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.79 Aligned_cols=243 Identities=20% Similarity=0.263 Sum_probs=197.1
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.|++.+.||+|+||+||+|.+..+++.||+|++..... ...+..|+.+++.+++ ++++.+.+.+..++..+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~--~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS--QFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCC--cCceeEEEEEecCCEEEEE
Confidence 48899999999999999999999999999998764321 1235678899988866 8899998888889999999
Q ss_pred EEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ ++.+.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCC
Confidence 9999 789988876433 469999999999999999999999999999999999999 46788999999999765332
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+.... ......
T Consensus 156 ~~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~----~~~~~~ 223 (285)
T cd05632 156 ES--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV----LETEEV 223 (285)
T ss_pred Cc--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh----hccccc
Confidence 11 123578999999999999899999999999999999999999998643321111211111 111122
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
+...++.++.+|+..||..||++||+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 345678999999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.81 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=203.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|++.++||+|+||.||+|.+..+ ..||||+++.... ...+..|+.+++.+.+ ++++.++.+.. ....++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH--EKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCC--CCcceEEEEEC-CCCcEEEE
Confidence 357899999999999999999997655 4699998875433 3467889999998865 88988877654 45679999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||+++ +++.+||+|||+++.+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeeccccc
Confidence 999 78999999743 34589999999999999999999999999999999999994 67889999999998664332
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ......++..|+|||+..+..++.++|||||||++|||++ |..||.+... .+.+..+..... . .
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 223 (262)
T cd05071 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-M---P 223 (262)
T ss_pred cc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCC-C---C
Confidence 11 1123356778999999998899999999999999999999 8899976432 233333322111 1 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
....+|..+.+++.+||+.+|++||++.++.++|++.|
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 12457899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.43 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=209.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|.+.+.||+|+||.||++.+. .++..||+|.+..... ...+..|+.++..++| ++++.+..++...+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH--EHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEecCCc
Confidence 467999999999999999999853 3456799998765432 2357789888888865 899999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ ++.+.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCc
Confidence 99999999 889999986432 248999999999999999999999999999999999999 47789
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 159 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~ 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NE 230 (288)
T ss_pred EEeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 999999999865432211 11223456788999999999889999999999999999998 9999976432 33
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+..+...... .....++.++.+++.+||+.||.+||++.++.+.|+++...
T Consensus 231 ~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 VIECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 33444333221 12345789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.65 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=197.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|..+++.+.| ++++.++..+..+.+.|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h--p~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS--PWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEcCCEEE
Confidence 578999999999999999999999999999999875422 12235677788777655 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 120 lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCc
Confidence 999999 8899999873 458999999999999999999999999999999999999 4778999999999987643
Q ss_pred cccccccccccCCCCccCccccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||.+. +....+.++......
T Consensus 195 ~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~ 265 (371)
T cd05622 195 EGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNS 265 (371)
T ss_pred CCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCc
Confidence 2211 123467999999999997643 789999999999999999999999763 334445555433221
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCC---CCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~---RPt~~~l 270 (475)
...+. ...++.++.++|..|+. ++.. |+++.+|
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei 301 (371)
T cd05622 266 LTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEI 301 (371)
T ss_pred ccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHH
Confidence 11111 13578999999999998 5555 5565555
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=318.06 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=201.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
...++|++.++||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..+.| ++++.+.+++...+..++
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h--~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH--CNIVAYFGSYLSREKLWI 83 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCC--CCeeeeeEEEEeCCEEEE
Confidence 345679999999999999999999999999999999865432 2346678888877765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence 99999 7899998864 4578999999999999999999999999999999999999 46788999999999866432
Q ss_pred ccccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|..||...... .....+........
T Consensus 160 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 229 (267)
T cd06646 160 IA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMSKSNFQPP 229 (267)
T ss_pred cc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---hhheeeecCCCCCC
Confidence 21 123457899999999885 344788999999999999999999999654321 11111111111111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.......++.++.+++.+||..+|++||++++|++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 11112356889999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=316.12 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=201.7
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH----HHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~----~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
|++++.||+|+||.||++.+..+++.||+|++........ ...|..+++.+.+ ++|+.+..+.......+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH--PNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB--TTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc--ccccccccccccccccccccc
Confidence 8999999999999999999999999999999887654332 2448889999954 999999999999999999999
Q ss_pred cCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~g~-sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
++.+ +|.+++. ....+++..++.++.||+.||.+||++||+|+||||+|||+ +.++.++|+|||++..+.....
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~- 153 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE- 153 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS-
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc-
Confidence 9955 9999997 44679999999999999999999999999999999999999 5789999999999986421111
Q ss_pred cccccccCCCCccCcccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~-g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......++..|+|||++. +..++.++||||||+++|+|++|..||...........+.+........... ..
T Consensus 154 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 226 (260)
T PF00069_consen 154 ------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QS 226 (260)
T ss_dssp ------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SH
T ss_pred ------ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-cc
Confidence 123457899999999998 7889999999999999999999999998752222233333222211111000 00
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+.++.+++..||+.||++||++.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122489999999999999999999888753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.60 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=196.6
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|+.+++.+++ ++++.+...+...+..|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~--~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS--RFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCC--CCeeeeeEEEecCCEEEEE
Confidence 488999999999999999999999999999987643221 235678888888865 8898888888888999999
Q ss_pred EEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ |++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +..+.++|+|||++......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCC
Confidence 9999 889998886433 359999999999999999999999999999999999999 46788999999999754332
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. .....||..|+|||++.+..++.++|||||||++|||++|..||.................. ....
T Consensus 156 ~~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~ 223 (285)
T cd05630 156 QT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEE 223 (285)
T ss_pred cc--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhh
Confidence 11 12347899999999999999999999999999999999999999875432222222222111 1112
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
+...+++++.+|+.+||+.||++||+
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccC
Confidence 33567899999999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.18 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=219.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.+.++.+.||+|+||+||+|+-.. ....||||.++.+... .+|++|++++..|+| +||+++++.+.+++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H--~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH--PNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC--CCeEEEEEEEccCCe
Confidence 456788999999999999998542 3357999998877654 469999999999998 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS---------RK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 144 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~---------~~----ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 144 (475)
.|+|+||| .|+|.+++.... .. ++..+.+.|+.|||.||+||-++.+|||||-..|+||+ +..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cce
Confidence 99999999 999999997442 12 88999999999999999999999999999999999995 788
Q ss_pred cEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011882 145 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 223 (475)
Q Consensus 145 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~ 223 (475)
.|||+||||++..-..+. |+-...-.-..+||+||.++..+|+.+||||||||+|||+++ |..||.++.. .
T Consensus 641 ~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~ 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---Q 712 (774)
T ss_pred EEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---H
Confidence 999999999997655443 222222334679999999999999999999999999999998 9999999654 4
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+.++.|....+ -..+.+||.++++|+..||+.+|.+||+|.+|...|++.....
T Consensus 713 EVIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 713 EVIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 55555555544 2345789999999999999999999999999999999886543
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.66 Aligned_cols=235 Identities=23% Similarity=0.281 Sum_probs=189.4
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHH-HHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAK-LYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~-il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||.||+|++..+++.||||++..... ...+..|.. +++.+. |++|+.++.++...+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK--HPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC--CCCccceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999998764321 122333433 344444 499999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|...+.. ...+++..+..|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 151 (321)
T cd05603 79 NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE--- 151 (321)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC---
Confidence 8899887763 4568999999999999999999999999999999999999 5778999999999975432211
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... +....
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~ 219 (321)
T cd05603 152 ----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQ-----LPGGK 219 (321)
T ss_pred ----ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCC
Confidence 1234579999999999999899999999999999999999999997743 33444444433221 23457
Q ss_pred hHHHHHHHHHHhcCCCCCCCCHH
Q 011882 246 PTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
+.++.+++..||+.||.+||+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 88999999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=319.96 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=202.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
+..++|++.+.||+|+||.||+|.+.. ++..||||+++.... ...+..|+.+++.+.+ ++++.+..++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~--~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC--HHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEcC
Confidence 456889999999999999999998642 356899998754332 2246678888887765 899999999888
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
....++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+|||++ .++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCC
Confidence 89999999999 889999986432 2357888999999999999999999999999999999994 6788
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
++|+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .+
T Consensus 158 ~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~ 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQ 229 (277)
T ss_pred EEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence 999999999865432221 11122356788999999999899999999999999999999 7899976432 22
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.+..+...... .+...++..+.+++.+||+.+|++||++.++++.|+
T Consensus 230 ~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 23323222211 223567899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.67 Aligned_cols=255 Identities=18% Similarity=0.234 Sum_probs=192.4
Q ss_pred eeeEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE--eCCEEEEEEEcCC
Q 011882 12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV--EGDYNVLVIDLLG 87 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~~~~~lvme~~g 87 (475)
+++||+|+||.||+|.++ .+++.||||.+..........+|+.+++.+.| ++|+.+..++. .....|++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKH--PNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCC--CCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999965 46789999998766666678899999999876 89998877664 3567899999999
Q ss_pred CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCccccc
Q 011882 88 PSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 88 ~sL~~ll~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~~~~ 158 (475)
++|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+|||+... +..+.+||+|||+|+.+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 99999876431 248999999999999999999999999999999999999532 345789999999998764
Q ss_pred ccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH------HHHHHHHhh
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISE 231 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~------~~~~~~i~~ 231 (475)
.... +........||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...+..+..
T Consensus 164 ~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 164 SPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred CCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 4321 11122356789999999999875 589999999999999999999999975332100 011111110
Q ss_pred c---c----------cc--------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 K---K----------VS--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~---~----------~~--------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. . .. ...+......+.++.+||.+||..||.+|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0 00 0000001123457889999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.85 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=200.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.+..|.+.++||+|+||.||+|.+..+++.||||... ...+.+|+.+++.++| +||+.++.++..+...++||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H--pnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH--PAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC--CCCCcEEEEEEECCEEEEEEE
Confidence 4668999999999999999999999999999999632 2346789999999876 999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 85 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 85 ~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
++.++|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+++.+......
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccccc-
Confidence 99889999887655679999999999999999999999999999999999999 46788999999999876432211
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----CHHHHHHHHhhcccc----
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVS---- 235 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~---- 235 (475)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+......
T Consensus 317 ----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 317 ----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 0122457999999999999999999999999999999999987765432211 111222221111100
Q ss_pred -c-------------------------cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 -T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 -~-------------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ....+ ..++.++.+||.+||..||.+||++.+|++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 00001 134568999999999999999999988854
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.30 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=209.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+...... ..+.+|+.++..+.+ ++++.+.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH--EHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC--CCcceEEEEEccCCc
Confidence 4679999999999999999998543 4567999987654432 357788888888765 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
.++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence 99999999 899999986432 348999999999999999999999999999999999999 47
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 221 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~ 221 (475)
++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 231 (291)
T ss_pred CCcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 789999999999865432211 11233467889999999999999999999999999999998 9999976433
Q ss_pred HHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 222 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 222 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
...+..+...... .....+|..+.+++.+||..+|++||++.+|++.|+++...
T Consensus 232 -~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 232 -TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2333333332221 12345789999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.20 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=209.6
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPS 89 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~s 89 (475)
-+||+|.||+||-|+|..|...+|||-+..+.. ..-+..|+.+...|+| .||+++.+.+.++++.-|.||-. ||+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrH--kNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRH--KNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhh--HhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 369999999999999999999999997655433 2448899999999988 89999999998999999999998 999
Q ss_pred HHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 90 LEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 90 L~~ll~~~~~~l--s~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
|.+++...-+++ ++.++-.+..||++||.|||++.|||||||-+||||. .-.|.+||+|||-++.+-.-..
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP----- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP----- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-----
Confidence 999998777777 8899999999999999999999999999999999996 4578999999999987654322
Q ss_pred cccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 168 YRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
...+++||..|||||++..++ |+.++|||||||++.||.||++||..+... ...+.++..-+..++++ ..+
T Consensus 732 --~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~iP---eel 804 (1226)
T KOG4279|consen 732 --CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPIP---EEL 804 (1226)
T ss_pred --cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCCc---HHH
Confidence 346789999999999998665 899999999999999999999999876542 22333444434444333 445
Q ss_pred hHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 246 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
+.+.+.+|.+|+..||.+||++.+| |.+.|.+-+
T Consensus 805 saeak~FilrcFepd~~~R~sA~~L---L~DpFlq~~ 838 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDL---LQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHh---ccCcccccC
Confidence 7889999999999999999998877 666665443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.48 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=199.5
Q ss_pred Cce-EEeeeEeeeCceeEEEEEE----ccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEe--C
Q 011882 7 NKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVE--G 76 (475)
Q Consensus 7 ~~y-~l~~~LG~G~fG~Vy~a~~----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~ 76 (475)
++| ++.+.||+|+||+||++.. ..+++.||+|++..... ...+.+|+++++.+.| ++++.+..++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH--ENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCC
Confidence 455 9999999999999988653 35678999999875432 2456789899888865 899998877654 3
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...+++|||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence 5689999999 8899999874 469999999999999999999999999999999999999 467889999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH-----------H
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----------Q 224 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~-----------~ 224 (475)
.+...... +.......++..|+|||++.+..++.++|||||||++|||++|..||......... .
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05080 156 AVPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231 (283)
T ss_pred ccCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence 76542211 11112234667799999999888999999999999999999999998653221000 0
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.+.......... .....+|.++.+++.+||+.+|++||++++|++.|+++.
T Consensus 232 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000000000 112457899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.13 Aligned_cols=256 Identities=17% Similarity=0.309 Sum_probs=204.6
Q ss_pred ceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+|++.+.||+|+||.||+|.+.. ....|++|++...... ..+..|+.++..+.| ++++.+.+.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH--PHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC--CCEeeEEEEEecCCCc
Confidence 58899999999999999998753 2357999987654432 357778888888865 8999999999989999
Q ss_pred EEEEEcC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 011882 80 VLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 135 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 135 (475)
+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999 789999886421 2478999999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 214 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf 214 (475)
|+ ++++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 159 ll---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 159 LV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred EE---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99 46789999999999865433221 11123356778999999998889999999999999999998 99999
Q ss_pred CCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 215 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 215 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+... .+ +........... ....++.++.+++..||+.+|++||++.++++.|++++.+
T Consensus 231 ~~~~~---~~-~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 231 PGIAP---ER-LFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCH---HH-HHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 76432 22 222222111111 2346789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.57 Aligned_cols=257 Identities=19% Similarity=0.272 Sum_probs=205.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCe--EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ...+..|+.++..+.+ |++++.++.++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH-HPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcC-CCchhheEEEEccCCcceE
Confidence 579999999999999999999877765 478887764322 2356778888888753 4999999999988899999
Q ss_pred EEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 82 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
+|||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCe
Confidence 99999 789999986432 248899999999999999999999999999999999999 46788
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ..
T Consensus 158 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~ 226 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AE 226 (297)
T ss_pred EEECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence 99999999864321111 111233567999999999889999999999999999997 9999976433 22
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.+..+..... ......++.++.+|+.+||..+|.+||+++++++.|..++....
T Consensus 227 ~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 227 LYEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 2333322111 11224578999999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=316.46 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=200.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.| ++++.++++...+...|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH--PNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC--CCEeeeEEEEeeCCeEEEEE
Confidence 58999999999999999999988999999998764322 2457788889888875 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCc
Confidence 999889988886433 468999999999999999999999999999999999999 477899999999997653321
Q ss_pred cccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH-----------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----------- 229 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i----------- 229 (475)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||.+.............
T Consensus 156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 156 R-------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred c-------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 1 11233678899999998765 4789999999999999999999999764321111111000
Q ss_pred ----------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 230 ----------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 230 ----------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...............+++++.++|.+||..||++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011112223457899999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=329.93 Aligned_cols=236 Identities=21% Similarity=0.260 Sum_probs=189.8
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHH-HHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKL-YKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~i-l~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
+.||+|+||+||+|.+..+|+.||||++..... ...+..|..+ ++.+. |++|+.++..+...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~--hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK--HPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC--CCCCccEEEEEecCCEEEEEEcCC
Confidence 479999999999999999999999998864321 1223344433 33333 499999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 79 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~--- 151 (325)
T cd05604 79 NGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD--- 151 (325)
T ss_pred CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC---
Confidence 8899888763 5579999999999999999999999999999999999999 5778999999999975432211
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
......||..|+|||++.+..++.++|||||||+||||++|..||.... ..+.+..+..... .+...+
T Consensus 152 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~ 219 (325)
T cd05604 152 ----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPL-----VLRPGA 219 (325)
T ss_pred ----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCc-----cCCCCC
Confidence 1234579999999999999999999999999999999999999997643 3334444433322 123457
Q ss_pred hHHHHHHHHHHhcCCCCCCCCHHH
Q 011882 246 PTEFASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~~~ 269 (475)
+.++.+++..|+..+|.+||++.+
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCC
Confidence 889999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=320.46 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=204.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.+|++.++||+|+||.||+|.+..+ ++.||||+++..... ..+..|..++..++| ++|+.++.+......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH--PNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC--CCcCeEEEEEcCCCc
Confidence 4688999999999999999987543 578999998755432 346678878777765 899999999998899
Q ss_pred EEEEEEcC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
.++++||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ ++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence 99999999 78999988521 2348889999999999999999999999999999999999 46
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 221 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~ 221 (475)
++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 232 (283)
T ss_pred CCceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 788999999999865432211 11223456789999999998889999999999999999998 8899977432
Q ss_pred HHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 222 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 222 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.+.+..+...... .+...+|.++.+++.+||+.+|++||++.+|+..|+.
T Consensus 233 -~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3344444443322 2345789999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.93 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=196.9
Q ss_pred eEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-C
Q 011882 14 KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-G 87 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g 87 (475)
.||+|+||.||+|.+. .++..||||++...... ..+.+|+.+++.+.| ++++.+..++. ....++||||+ +
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h--~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN--PYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCC--CCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999865 44567999988655332 347789999998865 88999887764 45679999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 88 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 88 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~--- 152 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYY--- 152 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccce---
Confidence 89999987656679999999999999999999999999999999999999 467889999999998654332110
Q ss_pred cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .....+..... ..+...++
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~ 224 (257)
T cd05115 153 -KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR----LDCPAECP 224 (257)
T ss_pred -eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC----CCCCCCCC
Confidence 11112234678999999998889999999999999999996 99999875432 22222222211 11234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
+++.+++.+||..+|++||++.+|.+.|+.++
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.78 Aligned_cols=256 Identities=16% Similarity=0.268 Sum_probs=206.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.+.||+|+||.||+|.+..++. .||+|.++..... ..+..|..++..++| +++++++.++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH--PNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEecCCcc
Confidence 4689999999999999999999865543 7999987654322 356778888887764 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+++|||+ +++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999 789999998666679999999999999999999999999999999999999 467899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... .......++..|++||++.+..++.++|||||||++||+++ |..||.+... .+.+..+..... .
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~-~- 228 (267)
T cd05066 158 DDPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYR-L- 228 (267)
T ss_pred ccccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCc-C-
Confidence 432211 01112234678999999999899999999999999999886 9999977543 222333332211 1
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.....+|..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11245789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.47 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=206.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.+.||+|+||.||+|.+ .+++.||||.++.... ..++..|+.+++.++| ++++.++.++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH--PKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCC--CCccceeEEEecCCCeeeeee
Confidence 46799999999999999999996 4567899998865433 3467889999998875 899999999998999999999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||+++.+.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCcc
Confidence 99 999999987543 468999999999999999999999999999999999999 4678899999999987753221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... .+.+..+..... .. .
T Consensus 159 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~~---~ 225 (261)
T cd05068 159 E------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYR-MP---C 225 (261)
T ss_pred c------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-CC---C
Confidence 1 1112233568999999999899999999999999999999 9999977432 223333322211 11 1
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
...++..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 245789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=321.40 Aligned_cols=261 Identities=19% Similarity=0.314 Sum_probs=207.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.++|.+.+.||+|+||.||+|.+.. +...||+|++...... ..+..|..++..+.. |++++.+..++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEec
Confidence 4789999999999999999998643 2357999998754322 246678888887743 3899999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
.+..|+||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-- 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--
Confidence 99999999999 789999997532 248899999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
+.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 174 -~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 -TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred -cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 467899999999997654321100 1112234578999999999889999999999999999998 899997633
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
. .+....+..... ......++.++.+++.+||..+|++||++.+|++.|++++...+
T Consensus 248 ~---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 V---EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred H---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 2 222223222211 11234578999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=313.10 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=197.0
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++||+|+||.||+|.+..+++.||+|....... ...+..|.++++.+.| ++++.+.+++......++||||+ ++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH--PNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEcCCCCeEEEEeeccCC
Confidence 479999999999999999999999998654322 2357889888888865 99999999999999999999999 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~---- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS---- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc----
Confidence 9999987555568999999999999999999999999999999999999 467889999999997644321100
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+.. .... .....++.
T Consensus 152 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~-~~~~---~~~~~~~~ 223 (252)
T cd05084 152 -TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQ-GVRL---PCPELCPD 223 (252)
T ss_pred -cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHc-CCCC---CCcccCCH
Confidence 0011123567999999999889999999999999999997 99999764321 11222211 1111 12345689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
++.+++.+||..+|++||++.+|.+.|+
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 9999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.17 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=200.5
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeE--eC
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGV--EG 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~ 76 (475)
+...++|+++++||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..|.| ++|+.++.++. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~H--PNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH--KNIVRYIDRFLNKAN 86 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCC--CCcCeEEEEEEecCC
Confidence 3456899999999999999999999999999999998865432 2357789999998876 88999877654 34
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEeeC-----
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG----- 140 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~-------gIvHrDIKP~NILl~~~----- 140 (475)
...||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||..+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 6789999999 88999998743 34699999999999999999999984 49999999999999632
Q ss_pred ---------CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHc
Q 011882 141 ---------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 209 (475)
Q Consensus 141 ---------~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~ellt 209 (475)
+....+||+|||+++.+..... .....||+.|+|||++.+ ..++.++||||||||||||++
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 1234599999999986543221 134579999999999865 348899999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 210 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 210 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
|..||..... ..+.+..+.... .. ....++.++.+||..||..+|.+||++.+++.
T Consensus 239 Gk~PF~~~~~--~~qli~~lk~~p-~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 239 GKTPFHKANN--FSQLISELKRGP-DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCCcCCc--HHHHHHHHhcCC-CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999976432 223333222211 11 12456899999999999999999999888753
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.27 Aligned_cols=249 Identities=18% Similarity=0.240 Sum_probs=195.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++| ++|+.++.++......++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNH--PSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCC--CCCcChhheEEeCCeeEEEEEc
Confidence 45799999999999999999999999999999975332 34568888888876 8999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 86 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 86 ~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++.......
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~--- 212 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA--- 212 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc---
Confidence 9999999887666779999999999999999999999999999999999999 5778899999999975332111
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH-------HHHHHHhhc-c----
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K---- 233 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~-------~~~~~i~~~-~---- 233 (475)
.....||..|+|||++.+..++.++|||||||+||||+++..|+......... ..+..+... .
T Consensus 213 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 213 -----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred -----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 12457999999999999999999999999999999999865554332211100 011111100 0
Q ss_pred -cc-----ccHH-----------------HH-hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 -VS-----TSIE-----------------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 -~~-----~~~~-----------------~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. .... .+ ...++.++.+||.+||..||.+||++.+|+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 00 0000 00 124567788899999999999999998874
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.76 Aligned_cols=252 Identities=19% Similarity=0.364 Sum_probs=200.8
Q ss_pred eEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE---
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY--- 78 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~--- 78 (475)
|++.+.||+|+||.||+|.+..+ +..||||+++..... ..+..|.++++.+.| ++++.++.+......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH--PNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCC--CCeeeEEeeeccCCcccc
Confidence 67899999999999999987654 478999988754332 346778888887765 889998877655443
Q ss_pred ---EEEEEEcC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 79 ---NVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 79 ---~~lvme~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
.+++|||+ +++|..++... ...+++..++.++.||+.||.|||+++|+||||||+||++ ++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence 79999999 88999887532 2358999999999999999999999999999999999999 577899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~ 228 (475)
|||+++.+...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+..
T Consensus 156 dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~ 227 (273)
T cd05035 156 DFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY 227 (273)
T ss_pred Cccceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 99999876543221 11122345778999999998889999999999999999999 9999976432 233333
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+...... .....++.++.+++.+||..||++||++.+|++.|+++
T Consensus 228 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3322211 12356789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=312.06 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=205.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
++|++.+.||.|+||.||+|.+..+++.|++|++..... ...+..|..+++.++| ++++.++++.......|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH--PNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC--CChhceEEEEEeCCEEEEEEe
Confidence 689999999999999999999988999999998875432 3457888888888765 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++......+++.++..++.|++.||.|||++||+|+||||+||++ ++.+.+||+|||++..+.....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence 99 779999987655689999999999999999999999999999999999999 4778899999999986654221
Q ss_pred cccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
......++..|+|||.+.+. .++.++|||||||++|||++|..||..... .+....+...........
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 12345789999999999877 789999999999999999999999976432 222222222211111111
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....++.++.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346788999999999999999999988853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=311.43 Aligned_cols=246 Identities=21% Similarity=0.265 Sum_probs=203.1
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+|++.++||.|+||.||++.+..+++.||+|.++.... ...+..|..+++.++| ++++.+...+...+..|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH--PNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC--CCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999998764332 2456778888887765 899999999999999999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ ++.+.++|+|||++..+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc
Confidence 99 88999988643 3458999999999999999999999999999999999999 5778999999999976644321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.... ....+..+...... .+.
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~ 221 (255)
T cd08219 156 -------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYK----PLP 221 (255)
T ss_pred -------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCC----CCC
Confidence 1234578999999999999889999999999999999999999997632 22333333322221 123
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++..+.+++.+||+.||++||++.+|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 456789999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.16 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=208.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+..|+++++.+.+ ++++.++.++...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~--~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH--PNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCeeeeeeeeecCCeEEE
Confidence 68999999999999999999998899999999875322 13457788888888865 889999988888999999
Q ss_pred EEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 82 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+|||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeec
Confidence 99999 78999988643 3458999999999999999999999999999999999999 46788999999999765
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+........
T Consensus 157 ~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 157 SSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPL 228 (267)
T ss_pred cCCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCC
Confidence 43221 11234688999999999998899999999999999999999999976432 22222222222222111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+ ...++.++.+++.+||..+|++||++.+|++.|+++
T Consensus 229 -~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 -P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 125678999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.95 Aligned_cols=257 Identities=19% Similarity=0.294 Sum_probs=203.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC----------------eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGI 66 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~----------------~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i 66 (475)
.++|+++++||+|+||.||+|.+..++ ..||+|++...... ..+..|+.++..+.+ +++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD--PNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC--CCE
Confidence 468999999999999999999876544 56899988755432 356778999998875 899
Q ss_pred CeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 011882 67 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 135 (475)
Q Consensus 67 ~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 135 (475)
+.+..++..+...+++||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999998889999999999 889999987543 2689999999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc--CCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLP 213 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt--G~~P 213 (475)
+++ ..+.++|+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LVG---KNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred eec---CCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 994 6689999999999865433211 11223456789999999998889999999999999999998 7788
Q ss_pred CCCCCCCCHHHHHHHHhhc---cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 214 WQGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 214 f~~~~~~~~~~~~~~i~~~---~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
|..... .+.+..+... ............+|.++.+++.+||+.||++||++.+|.+.|+
T Consensus 234 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 876432 2222222221 0000001112456789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.60 Aligned_cols=249 Identities=18% Similarity=0.269 Sum_probs=202.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
++|++.+.||+|+||.||+|.+. .+..||||.+..... ...+..|..+++.+.| ++++.+++++......+++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH--EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCC--CCeeeEEEEEccCCCcEEEEEc
Confidence 57999999999999999999864 445699998765432 3467889888888865 9999999999888899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence 9 789999997655579999999999999999999999999999999999999 4678999999999986543221
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.......++..|++||++.+..++.++|||||||++|||++ |..||..... ......+....... ...
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLY----RPH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCC----CCC
Confidence 11123346778999999998889999999999999999998 9999976443 22233333322111 123
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
..+.++.+++.+||..+|++||++.+|++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=313.86 Aligned_cols=246 Identities=21% Similarity=0.327 Sum_probs=200.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE-eCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV-EGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~~~~~lvme~ 85 (475)
.+|++.+.||+|+||.||++.. .+..||+|.++.......+..|+.+++.+.+ ++++.+.++.. .....+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH--SNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCC--CCeeeEEEEEEcCCCceEEEEEC
Confidence 5799999999999999999975 5888999998766555678889999998875 88888877654 55678999999
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 86 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||++ ++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC--
Confidence 9 7899999875433 48999999999999999999999999999999999999 477899999999997654322
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....+.... . ..+.
T Consensus 157 --------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~ 221 (256)
T cd05082 157 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY-K---MDAP 221 (256)
T ss_pred --------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC-C---CCCC
Confidence 12345678999999999889999999999999999997 9999976322 22222222211 1 1123
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
..+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 5678999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=313.50 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=204.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+..++|+++++||+|+||.||+|.+ .+++.||+|.+..... ...+..|..+++.+++ ++++.+..+. ..+..+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH--PRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCC--cCeeeEEEEE-ccCCcEEE
Confidence 3467899999999999999999985 5678899998775443 3467889999998875 8888888775 44568999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+||++ ++++.++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9999 88999988643 3468999999999999999999999999999999999999 47789999999999876532
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+... ......+..... .
T Consensus 156 ~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~-~--- 222 (260)
T cd05067 156 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYR-M--- 222 (260)
T ss_pred Ccc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCC-C---
Confidence 211 1123356788999999998889999999999999999998 9999986443 222222222211 1
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.....+|.++.+++.+||..+|++||++++|..+|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1234578899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=310.28 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=204.3
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+++++.++| ++++.+..++...+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS--SYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC--CCeehheeeeccCCEEEEEE
Confidence 5899999999999999999999999999999876432 22346678888887765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||+++.+....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCcc
Confidence 999 88999998754 45699999999999999999999999999999999999994 67899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.... .......+....... +
T Consensus 156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~ 221 (256)
T cd08529 156 N-------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPP----V 221 (256)
T ss_pred c-------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----C
Confidence 2 1234578899999999999999999999999999999999999997643 233333333322221 2
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.+++.+||+.+|++||++.+|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 2357899999999999999999999988854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.43 Aligned_cols=247 Identities=20% Similarity=0.331 Sum_probs=196.0
Q ss_pred eeEeeeCceeEEEEEE--ccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~--~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||.||+|.+ ..+++.||||+++..... ..+..|+.++..+.+ ++++.+.+++. .+..++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN--PYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC--CCcceEEEEEc-CCCcEEEEecC
Confidence 3689999999999965 457789999998755433 346778888888765 89999887765 45668999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.|||+ +.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~- 152 (257)
T cd05116 78 ELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY- 152 (257)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee-
Confidence 7899999874 4569999999999999999999999999999999999999 467889999999998764432211
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... .+...
T Consensus 153 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~ 222 (257)
T cd05116 153 ---KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERM----ECPQR 222 (257)
T ss_pred ---eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCC
Confidence 11122345678999999988889999999999999999998 9999976433 2233333322211 13356
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+++++.++|.+||..||++||++++|.+.|+..
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=313.21 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=202.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.+|++.+.||+|+||.||+|.+. ++..+|||++..... ...+..|+++++.+.+ ++++.+++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH--PNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC--CCEEEEEEEEcCCCceEEEEec
Confidence 56999999999999999999875 567899998765433 3457789999888865 8999999998888999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...+....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc-
Confidence 9 889999987655679999999999999999999999999999999999999 47788999999999865432211
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+..... . ....
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~~ 224 (256)
T cd05059 157 -----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR-L---YRPK 224 (256)
T ss_pred -----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc-C---CCCC
Confidence 1112234568999999999899999999999999999999 8999976433 233333322211 1 1224
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.+|.++.+++.+||..+|++||++.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=315.03 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=209.7
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
|......+|++.++||+|+||.||+|.++.+++ .||+|.+...... ..+.+|+.++..+.| ++++.+..++
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~ 78 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH--PHVVRLLGIC 78 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCC--CCcceEEEEE
Confidence 445667899999999999999999999877665 6899987655432 346678888887765 8999998887
Q ss_pred EeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 74 ~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.. ...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||
T Consensus 79 ~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg 154 (279)
T cd05057 79 LS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFG 154 (279)
T ss_pred ec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCc
Confidence 76 7789999999 889999998666679999999999999999999999999999999999999 467889999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+++.+....... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... +....+..
T Consensus 155 ~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~ 226 (279)
T cd05057 155 LAKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEK 226 (279)
T ss_pred ccccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhC
Confidence 998765322211 0112234678999999988889999999999999999998 99999875432 22222222
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
... . .....++..+.+++.+||..+|.+||++.+|++.|.+++.+
T Consensus 227 ~~~-~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GER-L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCC-C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111 1 11234678899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.30 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=211.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||.|-||.||+|+.++++-.||+|++-.. ....++.+|++|...|+| |||.+++.++.+....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h--pnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH--PNILRLYGYFHDSKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC--ccHHhhhhheeccceeE
Confidence 57899999999999999999999999999999986433 234568899999888887 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 81 LVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|++||. +|.|...+.. ...+|++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||.+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecC
Confidence 999999 7777777763 345699999999999999999999999999999999999995 78899999999986543
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.. ...++|||..|.+||+..+..++..+|+|++|++.|||+.|..||.... ..+.|.+|.......+
T Consensus 176 ~~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p- 242 (281)
T KOG0580|consen 176 SN---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP- 242 (281)
T ss_pred CC---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC-
Confidence 21 2367899999999999999999999999999999999999999997743 5667777766655432
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..++.+..++|.+|+..+|.+|....+++
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHh
Confidence 67889999999999999999999976663
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=321.36 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=204.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeE--EEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
-++|++.+.||+|+||.||+|.+..++.. +|+|.++.... ...+.+|++++..+.+ |++++.+++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~-h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcC-CCCcceEEEEECCCCCce
Confidence 36899999999999999999998877764 56766543221 2346778888888843 399999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC
Q 011882 81 LVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 144 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 144 (475)
+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCC
Confidence 999999 889999986432 257899999999999999999999999999999999999 4678
Q ss_pred cEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011882 145 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 223 (475)
Q Consensus 145 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~ 223 (475)
.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 162 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 230 (303)
T cd05088 162 VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 230 (303)
T ss_pred cEEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---
Confidence 99999999986432110 1112234678999999988889999999999999999998 99999764432
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
+.+..+..... ......++.++.+++.+||..+|++||++.+++..|..++....
T Consensus 231 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 231 ELYEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHHhcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 22222221110 11223468899999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=314.66 Aligned_cols=252 Identities=19% Similarity=0.347 Sum_probs=198.1
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCe--EEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe------C
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE------G 76 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~--~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~ 76 (475)
|.+.++||+|+||.||+|.+..++. .||||.++.... ...+..|..+++.++| ++++.++.++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH--PNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEccCCcccCC
Confidence 4578999999999999999877765 699998765422 2346778888888765 899998776532 2
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
...+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECC
Confidence 3468999999 78998887432 2348999999999999999999999999999999999999 4778999999
Q ss_pred cCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 011882 151 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 151 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i 229 (475)
||+++.+..... +.......++..|++||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+
T Consensus 156 fg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~ 227 (272)
T cd05075 156 FGLSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYL 227 (272)
T ss_pred CCcccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 999987644321 111223356778999999999999999999999999999999 8999976432 3333333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
...... .....++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 228 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 332211 12346789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.44 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=200.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC--------------eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCee
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN--------------EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNL 69 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~--------------~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l 69 (475)
++|++.++||+|+||.||+|.+..++ ..||||+++..... ..+.+|++++..+++ ++++.+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h--~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN--PNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CCcCeE
Confidence 58999999999999999999875432 35899988654322 347789999998876 899999
Q ss_pred EEeeEeCCEEEEEEEcC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 011882 70 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 137 (475)
Q Consensus 70 ~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 137 (475)
++++......++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999 889999886431 136888999999999999999999999999999999999
Q ss_pred eeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCC
Q 011882 138 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQ 215 (475)
Q Consensus 138 ~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt--G~~Pf~ 215 (475)
+ +++.+||+|||++..+..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 163 G---NHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred c---CCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 4 677899999999986543221 111223456789999999998899999999999999999988 678887
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 216 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
............+................+|..+.+|+.+||..+|++||++.+|++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 643322111111111100000001122456899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.43 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=207.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|..+++.+.| ++++.++.++...+..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH--PNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC--CchhhhhheeEeCCeEEE
Confidence 579999999999999999999999999999997654321 1356678888888765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 82 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhcc
Confidence 99999 78999988642 3458999999999999999999999999999999999999 46788999999999866
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.+.... .......+........
T Consensus 157 ~~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 228 (267)
T cd08229 157 SSKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPL 228 (267)
T ss_pred ccCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCCCCC
Confidence 443221 12357899999999999988999999999999999999999999764321 1222222222111111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
....++.++.+++.+||..+|++||++.+|++.++++
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134678999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=314.46 Aligned_cols=258 Identities=15% Similarity=0.254 Sum_probs=205.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.+.||+|+||.||+|.+..+++ .||||++..... ...+..|+.+++.+.| ++++.+..+...+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH--PNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC--cCcceEEEEECCCCce
Confidence 4679999999999999999999877664 699999865432 2357778888888765 8999999999888999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++.+++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCccccccc
Confidence 9999999 779999998666679999999999999999999999999999999999999 467899999999998654
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... .+........+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+.... ..+
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~-~~~ 231 (269)
T cd05065 158 DDTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDY-RLP 231 (269)
T ss_pred cCcccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCC-cCC
Confidence 322111 1111111123567999999999999999999999999999886 9999976432 22233332211 111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
....+|..+.+++.+||..+|++||++.+|+..|+.+
T Consensus 232 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1245789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.33 Aligned_cols=260 Identities=18% Similarity=0.268 Sum_probs=200.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc----------------CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGI 66 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~----------------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i 66 (475)
.++|++.++||+|+||.||++.+.. ++..||||++...... ..+..|+.+++.+.+ +++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD--PNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCc
Confidence 4679999999999999999986432 3457999998754322 357789999888865 899
Q ss_pred CeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 011882 67 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 135 (475)
Q Consensus 67 ~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~----------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 135 (475)
+.++.++...+..+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999 789999987532 2377889999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc--CCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLP 213 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt--G~~P 213 (475)
|++ .++.++|+|||+++.+...... .......++..|++||...+..++.++|||||||++|||++ |..|
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 162 LVG---KNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred EEc---CCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 994 6788999999999865432211 11122345678999999988889999999999999999998 7899
Q ss_pred CCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 214 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 214 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
|..............................++..+.+++.+||..||++||++.+|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 97643322111111111000000000112457899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.48 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=200.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.++||+|+||.||+|.+..+|+.||+|.+..... ...+..|+++++.++| ++++.+..+..+....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH--KNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC--CCeeeHHHHhccCCceEEEE
Confidence 59999999999999999999999999999998765432 2356789999988865 89999988888899999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.+.....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC-
Confidence 999889998887656679999999999999999999999999999999999999 4678999999999986543221
Q ss_pred cccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc---------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 233 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 233 (475)
......++..|+|||++.+.. ++.++|||||||++|||++|..||..... ....+..+....
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhH
Confidence 112346789999999988754 78999999999999999999988643221 122222211100
Q ss_pred ---------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ---------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...........+++++.+++.+||..||.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000011223456789999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=313.57 Aligned_cols=257 Identities=16% Similarity=0.236 Sum_probs=205.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..++|+..+.||+|+||.||+|.+..+++ .||||.+..... ...+..|++++..+.+ ++++.+..++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSH--HNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC--CCeeEEEEEEccCCC
Confidence 34689999999999999999999876654 799998765432 2346778888877765 899999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++..++.++.|++.||+|||+.||+||||||+||++ +.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 99999999 789999997666679999999999999999999999999999999999999 46788999999999866
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
........ .......+..|++||++.+..++.++|||||||++|||++ |..||..... ......+.......
T Consensus 158 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~~ 230 (268)
T cd05063 158 EDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRLP 230 (268)
T ss_pred ccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCCC
Confidence 43322110 0111233567999999998889999999999999999997 9999976432 23333332221111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
....++.++.+++.+||..+|++||++.+|++.|+++
T Consensus 231 ----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1235789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=314.41 Aligned_cols=256 Identities=18% Similarity=0.216 Sum_probs=198.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCCch---HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHP---QLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~~~---~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|++.+.||+|+||+||+|.+..+++ .|++|.+....... .+..|..++..+ .|++++.+++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l--~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL--DHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC--CCCCcceEEEEECC-Cc
Confidence 4689999999999999999999887776 47777765432222 233344444444 45899999887754 45
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++++||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence 67788888 899999998666779999999999999999999999999999999999999 47789999999999866
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
....... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+.... .+..+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~ 230 (279)
T cd05111 160 YPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERL 230 (279)
T ss_pred cCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcC
Confidence 4322111 1123467788999999998899999999999999999998 99999875332 222222222111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
. ....++..+.+++..||..+|++||++.++.+.|..+..
T Consensus 231 ~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 A---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 123467889999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=318.79 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=205.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|.+.+.||+|+||.||+|.+. .++..||||+++..... ..+..|..+++.+.. |++++.++.++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~ 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN-HENIVNLLGACTIG 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccC-CCCcceEEEEEecC
Confidence 3468999999999999999999853 34568999987654322 347789999988843 39999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
+..+++|||+ +++|.+++..... .+++.+++.|+.||+.||.|||+++|+|+||||+|||+ +..+.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 9999999999 7899999875332 38999999999999999999999999999999999999 46788999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....... .+.+.....
T Consensus 189 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~ 260 (302)
T cd05055 189 RDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEG 260 (302)
T ss_pred ccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcC
Confidence 866443211 01123456788999999999999999999999999999998 999998754321 121221111
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
... ......+.++.+++.+||..+|++||++.+|++.|+++
T Consensus 261 ~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 11235688999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.75 Aligned_cols=251 Identities=21% Similarity=0.342 Sum_probs=207.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..+|++.++||.|+||.||+|.+.. ++.||+|++..... ...+..|..+++.+++ ++++.+..++...+..++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH--KHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC--cchhheeeeEecCCCeEEEE
Confidence 4679999999999999999999866 88999999876543 3567788888888865 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence 999 78999998753 3458999999999999999999999999999999999999 477899999999998764322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. ......++..|++||++.+..++.++|||||||++|+|++ |..||.+.. ..+.+..+..... . .
T Consensus 159 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~-~---~ 224 (261)
T cd05148 159 Y-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR-M---P 224 (261)
T ss_pred c-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc-C---C
Confidence 1 1123356778999999998889999999999999999998 899997643 2333333332211 1 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
....++.++.+++.+||..+|++||++.+|.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=315.79 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=200.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.++||+|+||.||+|.+..+++.||||+++..... ..+..|..+++.++| ++++.+.......+..+++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h--~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH--SNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC--CCeeeEEEEEEeCCEEEEEE
Confidence 36899999999999999999999999999999998755432 346678888887765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. .+.+++.+++.++.||+.||.|||++||+|+||||+||++ +..+.+||+|||++..+.....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence 999 7899998874 4579999999999999999999999999999999999999 4778899999999976543211
Q ss_pred ccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
......|+..|+|||++. ...++.++|||||||++|||++|..||....... .+.............
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~ 231 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKL 231 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCcc
Confidence 123457999999999974 4458899999999999999999999996543211 111111111111110
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.-...++..+.+++.+||..+|++||++++|++
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111246788999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=316.34 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=196.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.++||+|+||.||+|.+..+++.||||++...... ..+..|.+++..+.| ++++.+++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS--PYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999988654322 346778888887765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 79 EFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred ecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-
Confidence 999 7777543 257889999999999999999999999999999999999 478899999999998654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH----HHHHHHHhhccccccH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKKVSTSI 238 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~ 238 (475)
.....||..|+|||++.+..++.++|||||||++|+|++|..||........ ......+.......
T Consensus 150 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 219 (279)
T cd06619 150 --------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-- 219 (279)
T ss_pred --------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--
Confidence 1345799999999999999999999999999999999999999975432211 11111111111110
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.....+++++.+++.+||..+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 -LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred -CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 011346789999999999999999999888753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.18 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=205.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|++.+.||+|+||.||++.+... ...||+|++...... ..+..|+.+++.+.. |++++.+..++....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEcCCC
Confidence 47899999999999999999997644 378999987654332 246678888888743 399999999988888
Q ss_pred EEEEEEEcC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---T 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---c
Confidence 999999999 88999998632 3458999999999999999999999999999999999999 4
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 220 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~ 220 (475)
+++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 240 (293)
T ss_pred CCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence 6789999999999876543211 11122345678999999998889999999999999999997 9999976432
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.+.+..+...... .....++.++.+++.+||..+|++||++.+|++.|++++
T Consensus 241 --~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 --EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2223322222111 122456889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=316.14 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=203.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.++||+|+||.||+|.++. .+..||+|+++..... ..+..|..+++.+.+ ++++.++.++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC--HHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEcCC
Confidence 45789999999999999999997642 3458999987644322 235667788887765 8999999988888
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcE
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 146 (475)
...|+||||+ +++|.+++.... ..++...++.++.||+.||.|||+++|+||||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence 8999999999 899999997432 2356788999999999999999999999999999999994 67899
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 225 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~ 225 (475)
+|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 159 ~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQV 230 (288)
T ss_pred EECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 9999999986543221 111223355778999999999899999999999999999998 7899976432 222
Q ss_pred HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 226 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
+..+...... .....++..+.+++.+||+.+|++||++.++++.|++.+
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 2222222111 123456899999999999999999999999998888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=314.16 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=206.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEcc----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-C
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE-G 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~ 76 (475)
-.++|++.+.||+|+||.||+|.+.. ++..|++|++...... ..+..|..+++.+.| ++++.+++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH--QNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEecCC
Confidence 45789999999999999999999876 3588999987644322 346678888887754 999999887665 5
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~-------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
...+++++|+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ +.+.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEE
Confidence 7789999998 789999987542 3589999999999999999999999999999999999994 6789999
Q ss_pred eecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~ 227 (475)
+|||+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |..||..... .....
T Consensus 159 ~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~ 230 (280)
T cd05043 159 TDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA 230 (280)
T ss_pred CCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH
Confidence 9999998765432211 1123356778999999999889999999999999999998 9999976433 22222
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+... .... ....+|+++.+++.+||..+|++||++.++++.|+++..+
T Consensus 231 ~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 YLKDG-YRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHcC-CCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22221 1111 1234689999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=317.82 Aligned_cols=260 Identities=17% Similarity=0.304 Sum_probs=207.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-------cCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-------~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
..++|.+.+.||+|+||.||+|.+. .++..||+|++..... ...+..|+.++..+.. |++++.+..++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhcc-CCCchheeEEEe
Confidence 4578999999999999999999753 2345799998764322 2457788888888843 399999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 138 (475)
.....+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili- 170 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV- 170 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence 899999999999 789999987532 247888999999999999999999999999999999999
Q ss_pred eCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 011882 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 217 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~ 217 (475)
+.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 171 --~~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 171 --TENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred --cCCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 467899999999998764432211 1123356778999999999889999999999999999998 88898764
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
. ..+.+..+...... .....++.++.+++.+||..+|++||++.+|++.|++++.-
T Consensus 244 ~---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 P---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred C---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 3 23333333322211 12246789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=324.81 Aligned_cols=260 Identities=20% Similarity=0.316 Sum_probs=202.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE-eC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV-EG 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~ 76 (475)
.++|++.++||+|+||.||+|.+. .+++.||||+++..... ..+..|+.++..+.++ ++++.++.++. .+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH-LNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCC-ccHhhhcceeecCC
Confidence 368999999999999999999853 46789999998764433 3467799998888653 88888876654 45
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC---------------------------------------------------------
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS--------------------------------------------------------- 98 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~--------------------------------------------------------- 98 (475)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 6789999999 889999886421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccc
Q 011882 99 ---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169 (475)
Q Consensus 99 ---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~ 169 (475)
..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..... +.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YV 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcc-----hh
Confidence 236788899999999999999999999999999999999 4678999999999986543221 11
Q ss_pred cCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 170 ~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+..... . .....++++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~-~---~~~~~~~~~ 310 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR-M---RAPDYTTPE 310 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCC-C---CCCCCCCHH
Confidence 1223356778999999999899999999999999999996 99999764332 111122211111 1 112346789
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 249 FASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+.+++..||..+|++||++.+|++.|+.+++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=310.87 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=202.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.+ ++++.++.++...+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH--ERIVQYYGCLRDDETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC--CCeeeeEEEEccCCeE
Confidence 579999999999999999999999999999998754321 1346678888887765 8999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+++|||+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+|||+++.+.
T Consensus 80 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecc
Confidence 9999999 8899998874 3468999999999999999999999999999999999999 467889999999997654
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+......
T Consensus 156 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--- 225 (263)
T cd06625 156 TICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN--- 225 (263)
T ss_pred cccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCCC---
Confidence 321110 001235688999999999999999999999999999999999999976422 2222222221111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+...++.++.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 2234567899999999999999999999888864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=350.08 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=206.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|++++..++| ++++.++.++.+.+..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H--PNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH--PGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC--cCcCeEEEEEeeCCEEEE
Confidence 689999999999999999999999999999998865322 2357788999888876 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 82 VIDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~----------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
+|||+ |++|.+++... ...++...++.|+.||+.||+|||++||+||||||+|||+ +..+.+||+|
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiD 156 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILD 156 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEe
Confidence 99999 89999988642 1235677889999999999999999999999999999999 4778899999
Q ss_pred cCCccccccccccc-----------ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 011882 151 FGLAKRYRDTATHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219 (475)
Q Consensus 151 FGlA~~~~~~~~~~-----------~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~ 219 (475)
||+++......... ...........||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 99998762211100 0001112345799999999999999999999999999999999999999976332
Q ss_pred CCHHHHHHHHhhccccccHH-HHhcCChHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011882 220 GTKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 280 (475)
Q Consensus 220 ~~~~~~~~~i~~~~~~~~~~-~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 280 (475)
.... .... ...+.. .....+|+.+.+++.+||..||++|| +++++.+.|+..+..
T Consensus 237 ~ki~--~~~~----i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 237 RKIS--YRDV----ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh--hhhh----ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 1110 001100 01246789999999999999999996 567777777777653
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=331.21 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=204.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|.++++||+|+||.||+|.+. .+++.||||+++..... ..+..|++++..+.. |+|++.+++++.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~-H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGP-HLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCC-CCCeEEEEEEEccCCC
Confidence 46888999999999999999863 35578999998755333 257789999988863 3999999999998889
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------- 98 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~----------------------------------------------------------- 98 (475)
.++||||+ +++|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999 899999986432
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC
Q 011882 99 --------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 140 (475)
Q Consensus 99 --------------------------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 140 (475)
..+++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~-- 273 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC-- 273 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe--
Confidence 1367778899999999999999999999999999999994
Q ss_pred CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 011882 141 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 219 (475)
Q Consensus 141 ~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~ 219 (475)
+.+.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 274 -~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 274 -EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred -CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 6788999999999865432210 11223467889999999999889999999999999999998 8999976432
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 220 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 220 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
. +.+.......... .....++.++.+|+.+||..+|.+||++.+|++.|++++
T Consensus 348 ~---~~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 N---EQFYNAIKRGYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred h---HHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 2 1121211111111 122456899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=328.50 Aligned_cols=235 Identities=21% Similarity=0.241 Sum_probs=186.9
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHh-CCCCCcCeeEEeeEeCCEEEEEEEcC-C
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQ-GGSTGIPNLRWFGVEGDYNVLVIDLL-G 87 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~-~~~~~i~~l~~~~~~~~~~~lvme~~-g 87 (475)
||+|+||+||+|++..+++.||||++..... ......|..++..+. ..|++++.++..+......|+||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999998754321 112334555554432 24699999999999999999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 88 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 88 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 899888864 4579999999999999999999999999999999999999 4778999999999975432221
Q ss_pred cccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 168 YRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....+||..|+|||++.+. .++.++|||||||+||||++|..||.+.. ..+.+..+........ ...++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence 12346799999999999865 48999999999999999999999997632 3344444443322211 12468
Q ss_pred HHHHHHHHHHhcCCCCCCCCH
Q 011882 247 TEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~ 267 (475)
.++.+++..||..||++||++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCC
Confidence 899999999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.52 Aligned_cols=262 Identities=18% Similarity=0.305 Sum_probs=207.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC-------CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~-------~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
...+|++++.||+|+||.||+|.+... ...||+|+++..... ..+..|+.++..+.. |++|+.++.++.
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~ 88 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK-HKNIINLLGACT 88 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcC-CCCeeeeeEEEc
Confidence 345799999999999999999986432 237999987754332 357788888888843 389999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 138 (475)
..+..+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 889999999999 889999986421 2478899999999999999999999999999999999994
Q ss_pred eCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 011882 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 217 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~ 217 (475)
.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 169 ---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 ---EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ---CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 6788999999999865432211 11122345678999999999999999999999999999998 89999764
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.. ...+..+...... .....++.++.+++.+||..+|++||++.+|++.|+.++....
T Consensus 241 ~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 241 PV---EELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CH---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 32 2333333222111 1234578899999999999999999999999999999886554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=313.49 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=203.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.+.||+|+||.||+|.+... +..||+|.+...... ..+..|+.++..+.+ ++++.+++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC--HHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC--CceeEEEEEEcCC
Confidence 457899999999999999999998644 378999997644322 246678888877754 8999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcE
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 146 (475)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 9999999999 789999986422 236888999999999999999999999999999999999 477899
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 225 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~ 225 (475)
||+|||+++.+..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 159 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEV 230 (277)
T ss_pred EECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHH
Confidence 9999999986544321 111234467889999999998889999999999999999998 9999976432 333
Q ss_pred HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 226 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
...+..... ..+...++.++.+++.+||..+|++||++.+|++.|+
T Consensus 231 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 333332211 1123457899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=327.13 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=203.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-EEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-YNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-~~~lv 82 (475)
.++|.-..+||+|+||.||+|.- .++..||||.++.... ..++..|++++..++| +|++.+.+||.+.+ ..+||
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H--~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRH--PNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCC--cCcccEEEEEecCCceEEEE
Confidence 35677788999999999999984 5668999998877655 4679999999998885 99999999999998 59999
Q ss_pred EEcC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 83 IDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+||+ .|+|++.+..... .++|...++|+.++|.||+|||+.. ||||||||+|||| |.+..+||+|||+|+..
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccC
Confidence 9999 7899999975555 8999999999999999999999843 9999999999999 68999999999999655
Q ss_pred cc-cccccccccccCCCC-ccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---CHHHHH-HHHhh
Q 011882 158 RD-TATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---TKKQKY-EKISE 231 (475)
Q Consensus 158 ~~-~~~~~~~~~~~~~~~-~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~---~~~~~~-~~i~~ 231 (475)
.. ... . ... .||..|++||++..+..+.|+||||||++|+||++|+.|.+..... ...... ..+..
T Consensus 228 ~~~~~~---~-----~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 228 PEGDTS---V-----STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred Cccccc---e-----eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 43 111 0 112 7999999999999889999999999999999999999888754311 111111 11111
Q ss_pred ccccccHHH-Hh-cCCh-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 232 KKVSTSIEA-LC-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 232 ~~~~~~~~~-l~-~~~p-----~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
......++. +. ..++ ..+..+...|+..+|.+||++.+|.+.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111111111 11 1222 23677888999999999999999988886553
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.00 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=199.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++| ++++.+..++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH--PNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC--CCEeeeeeEEeeCCEEEEE
Confidence 579999999999999999999998999999998754322 2346778888888875 8999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ ++.|..++. ....+++..++.++.||+.||.|||+.||+||||||+||++ +.++.++|+|||++..+....
T Consensus 79 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 79 FEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EeccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCc
Confidence 9999 545555443 44569999999999999999999999999999999999999 467899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------- 232 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 232 (475)
. ......++..|+|||++.+ ..++.++|||||||++|||++|..||.+.........+......
T Consensus 155 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 155 D-------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred c-------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 1 1123467889999999886 45789999999999999999999999875432222211111000
Q ss_pred ---------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
............++..+.+|+.+||..+|++||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 001112233456788999999999999999999998775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=310.90 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=202.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+..|+.+++.+.+ ++++.++.+.. ....+++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH--DKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCC--CceEEEEeEEC-CCCcEEE
Confidence 34578999999999999999999864 667799998865433 3467889999998876 88888877764 4557899
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++ +++.++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCc
Confidence 9999 78999998753 34589999999999999999999999999999999999994 6788999999999866442
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+.... ..
T Consensus 156 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~~--- 222 (260)
T cd05070 156 EYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGY-RM--- 222 (260)
T ss_pred ccc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC-CC---
Confidence 211 1122345678999999998889999999999999999999 8999976433 22233332211 11
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.....++.++.+++.+||..+|++||++.++.++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1234678899999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=311.76 Aligned_cols=251 Identities=20% Similarity=0.348 Sum_probs=198.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEe------CC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVE------GD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~~ 77 (475)
..+.|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.+ |++++.+..++.. ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-HRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcC-CCCeeeEeeEEeecCCCCCCc
Confidence 35779999999999999999999999999999999865433 2457788888887753 3899998877654 34
Q ss_pred EEEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..|++|||+ +++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||++ ++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCce
Confidence 689999999 77999998753 3468999999999999999999999999999999999999 477889999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
....... ......|+..|+|||++.+ ..++.++|||||||++|||++|..||..... ......+.
T Consensus 160 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~---~~~~~~~~ 229 (272)
T cd06637 160 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 229 (272)
T ss_pred ecccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHh
Confidence 6543221 1234578999999999863 3578899999999999999999999975432 22222221
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..... ......++.++.+++.+||..+|.+||++.++++
T Consensus 230 ~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 1112356889999999999999999999888753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.40 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=200.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|++.++||+|+||.||+|.+..+ ..||+|.+..... ...+..|+.+++.+.| ++++.++.+.. .+..+++|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRH--DKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCC--CCeeeEEEEEc-CCCcEEEE
Confidence 347799999999999999999987544 4699998765433 2457789999988875 78888776654 45678999
Q ss_pred EcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||+ ++++.++|+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 999 679999987533 348999999999999999999999999999999999999 477889999999997654322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ......+.... .. .
T Consensus 157 ~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-~~---~ 223 (260)
T cd05069 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGY-RM---P 223 (260)
T ss_pred c------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-CC---C
Confidence 1 11123356778999999998889999999999999999999 9999987433 22233332221 11 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
....+|..+.+++.+||..||++||++++|.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 234578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=315.91 Aligned_cols=250 Identities=19% Similarity=0.288 Sum_probs=200.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
..+.|+++++||.|+||.||+|.+..+++.||+|++...... ..+..|+.+++.+.| ++++.+...+..+...++|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH--PYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC--CcEeeeEEEEEeCCeEEEE
Confidence 457799999999999999999999999999999998655322 346678888887775 8999999988888999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|..++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence 9999 788888876556679999999999999999999999999999999999999 467899999999987543321
Q ss_pred cccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
. ......++..|+|||++.+ ..++.++|||||||++|||++|..||..... .+.+.++......
T Consensus 165 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~- 233 (292)
T cd06644 165 Q-------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPP- 233 (292)
T ss_pred c-------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCc-
Confidence 1 1134568899999999853 3468899999999999999999999976432 2223333222111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......++.++.+++.+||..+|++||++.+++
T Consensus 234 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 234 -TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred -cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1112245678999999999999999999988774
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.19 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=203.7
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----------hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----------~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... ..+..|+.++..+.| ++++.+.+++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH--ENIVQYLGSSLDA 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC
Confidence 588999999999999999999889999999987543321 246678888888865 8999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
++.+++|||+ +++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||++ ++.+.++|+|||+++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~ 154 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISK 154 (267)
T ss_pred CccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCc
Confidence 9999999999 8899999974 3568999999999999999999999999999999999999 477899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.+....... ..........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... ...+..+....
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~-- 228 (267)
T cd06628 155 KLEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENA-- 228 (267)
T ss_pred ccccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhccC--
Confidence 775322111 011112345689999999999998899999999999999999999999986432 22333322211
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+.+...++.++.++|.+||+.||++||++.+|++
T Consensus 229 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 --SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 12233567899999999999999999999988854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=305.16 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=203.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeE-----eCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGV-----EGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~-----~~~~ 78 (475)
+++|++.++||+|||+.||++++..+++.||+|.+.... ..+...+|++..+++++ +++..+..+.. ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s--~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNS--PNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCC--cchHHHHHHHHHhhccCcee
Confidence 567999999999999999999999999999999876654 23457889999999988 88888765544 3345
Q ss_pred EEEEEEcC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.||+++|. .|+|.+.++... ..+++.+++.|+.+|++||++||+.. +.||||||.|||++ +.+.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEecc
Confidence 89999998 889999987653 35999999999999999999999998 99999999999995 57899999999
Q ss_pred Cccccccccc--ccccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 153 LAKRYRDTAT--HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 153 lA~~~~~~~~--~~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
.++...-... .+.....+...-.+|..|.|||.+.- ...+.++|||||||+||+|+.|..||...-... .....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSlaL 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLAL 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEEE
Confidence 9986543221 11111112233467999999999864 346899999999999999999999996421100 00000
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.+....+..+ . ...+++.+.++|+.|++.||.+||++.+|+..++++.
T Consensus 254 Av~n~q~s~P--~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIP--N-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccC--C-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111111111 0 1237899999999999999999999999999888764
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=309.40 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=207.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+..++|++.++||+|+||.||+|.+. .++.||||.+..... ...+..|+.+++.+++ ++++.++.++......+++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH--DKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC--CCEeeeeeeeecCCceEEE
Confidence 55788999999999999999999964 567899998875433 3568889999988875 8999999998888899999
Q ss_pred EEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||++ ++++.+||+|||+++.+...
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccch
Confidence 9999 889999987533 469999999999999999999999999999999999999 46789999999999876532
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.. .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+... ...+..+..... .
T Consensus 157 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~-~--- 223 (261)
T cd05034 157 EY------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR-M--- 223 (261)
T ss_pred hh------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-C---
Confidence 11 11122345678999999999889999999999999999998 9999976432 333333332211 1
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.....+|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1124568899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=312.75 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=196.6
Q ss_pred EEeeeEeeeCceeEEEEEEc----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++.+.||.|.||.||+|.+. ..+..|+||+++..... ..+..|.+.+..++| ++|+.+++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH--PNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB--TTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc--ccccccccccccccccccc
Confidence 57899999999999999987 34678999999654332 467888898888855 9999999999988889999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||+++|+|+||+++|||++ .++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 9999 78999999866 56799999999999999999999999999999999999994 6889999999999876322
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+.. ..+....+......
T Consensus 157 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~~~~~---- 224 (259)
T PF07714_consen 157 SKY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQGQRL---- 224 (259)
T ss_dssp SSE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHTTEET----
T ss_pred ccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc----
Confidence 111 11233457789999999998889999999999999999999 789997753 33334444333221
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.....+|..+.+++..||..+|++||++.+|++.|
T Consensus 225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12356899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=319.17 Aligned_cols=254 Identities=18% Similarity=0.230 Sum_probs=190.3
Q ss_pred eeeEeeeCceeEEEEEEcc--CCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE--eCCEEEEEEEcCC
Q 011882 12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV--EGDYNVLVIDLLG 87 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~--~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~~~~~lvme~~g 87 (475)
+.+||+|+||.||+|.+.. ++..||+|.+........+.+|+.+++.++| ++++.+..++. .....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKH--PNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCC--CCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999653 5689999998766656678899999998876 88988877664 4567899999999
Q ss_pred CCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCccccc
Q 011882 88 PSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 88 ~sL~~ll~~~--------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~~~~ 158 (475)
++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 9999887532 1248899999999999999999999999999999999999432 356789999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH------HHHHHHHhh
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISE 231 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~------~~~~~~i~~ 231 (475)
..... ........||..|+|||++.+. .++.++|||||||++|||++|..||........ ...+..+..
T Consensus 164 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 164 SPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred CCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 43211 1122345789999999999874 479999999999999999999999975322100 000000000
Q ss_pred c---c-------------cc-------------cc----HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 K---K-------------VS-------------TS----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~---~-------------~~-------------~~----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. . .. .. .+......+..+.+|+.+||..||.+|||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 0 0 00 00 0000112345688999999999999999998875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.26 Aligned_cols=260 Identities=19% Similarity=0.314 Sum_probs=206.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.++|.+.++||+|+||.||+|.+.. ....||+|+++..... ..+..|+.+++.+.. |++++.++.++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK-HKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccC-CCCeeeEEEEEcc
Confidence 4689999999999999999998632 3457999987654332 246678888887743 3999999999888
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
....+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-- 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV-- 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE--
Confidence 88999999999 889999986532 348899999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 168 -~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 168 -TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred -cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 467889999999998664322111 1112234568999999999889999999999999999999 899997643
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
. ...+..+...... .....++.++.+++.+||..+|++||++.++++.|+++....
T Consensus 242 ~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 242 V---EELFKLLREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred H---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 2 2333333322211 123467889999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=314.01 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=203.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..+|++.++||+|+||.||+|... .++..||+|.+..... ...+..|++++..+++ ++++.+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH--QHIVRFYGVCTEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC--CCCceEEEEEecCCc
Confidence 467999999999999999999743 3466899998764432 2457788888888865 899999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~--------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---CC
Confidence 99999999 889999987532 2488999999999999999999999999999999999994 67
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 222 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~ 222 (475)
+.+||+|||+++....... +.......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 230 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--- 230 (280)
T ss_pred CCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---
Confidence 8999999999976543211 111233456788999999999999999999999999999998 9999976433
Q ss_pred HHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 223 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
...+..+...... .....+|+.+.+++.+||..||.+||++.+|++.|+
T Consensus 231 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 TEAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2233333222111 122467899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=309.29 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=206.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.++|++.++||+|+||.||+|.+..+++.|++|.+........+..|.++++.+.+ ++++.+.+++......|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS--PYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC--CcEeeeeeeeecCCcEEEEEec
Confidence 36899999999999999999999888999999998766556678899999998854 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||++ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc--
Confidence 9 789999998667789999999999999999999999999999999999999 4678899999999987654321
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... .. ......
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~-~~~~~~ 224 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPP-PT-LSDPEK 224 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh---hhhhhhccCCC-CC-CCchhh
Confidence 122346889999999999999999999999999999999999999764332 11111111111 00 111234
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
++.++.+++..||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 6789999999999999999999988753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.87 Aligned_cols=258 Identities=19% Similarity=0.277 Sum_probs=219.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
-|.++.+||+|+||.||+|.++.+|+.||||.+.++....++..|+.+++.+.. ++++++++.+......|||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S--~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKS--KYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCC--chhhhhhhhhccCCceEeehhhcC
Confidence 377889999999999999999999999999999999999999999999998877 88999988888888899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
.|++.+++...++++++.++..++...+.||+|||...-||||||..|||| +.+|..||+|||.|-.+.+.-.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA---- 184 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA---- 184 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH----
Confidence 789999999888899999999999999999999999999999999999999 6889999999999988776543
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
..+++.||+.|||||++....|+.++||||||++..||..|+.||.+.... ..+..|..+..++.. -+...+
T Consensus 185 ---KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~--KPE~WS 256 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFK--KPEEWS 256 (502)
T ss_pred ---hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCC--ChHhhh
Confidence 236789999999999999999999999999999999999999999876542 112222222222111 112357
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 285 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 285 (475)
.+|.++++.||.++|++|-++-+| +++-|.++....
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L---~~H~FiknA~g~ 292 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRL---CEHTFIKNAPGC 292 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHH---hhhhhhcCCCcc
Confidence 899999999999999999886544 677777665443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.06 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=204.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.+.||.|+||.||+|.+ .++.||||.+..... ..++..|..++..+++ ++++.++++.......++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH--PNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCC--cceeeeEEEEcCCCCeEEEEE
Confidence 56899999999999999999985 488999999876654 4567889999988875 889999988888899999999
Q ss_pred cC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccccc
Confidence 99 6899999875432 58999999999999999999999999999999999999 4778999999999987633221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
...++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+..... ...
T Consensus 158 ----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 220 (256)
T cd05039 158 ----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEA 220 (256)
T ss_pred ----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCC
Confidence 2245678999999998889999999999999999997 9999976432 222222222111 112
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
...+|+++.+++.+||..+|++||++.+|++.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 34678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.45 Aligned_cols=249 Identities=18% Similarity=0.336 Sum_probs=195.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.+.||+|+||.||+|.+..+|+.||||.++..... .++..|..++.... .|++++.+..++......|++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHc-CCCCeeeeeEEEecCCcEEEEh
Confidence 4799999999999999999999999999999988654322 23444555433333 3499999999999899999999
Q ss_pred EcCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 84 DLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||+.++|.+++... +..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..+..
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 99999998888642 34589999999999999999999997 99999999999999 5778999999999986543
Q ss_pred cccccccccccCCCCccCccccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
... .....|+..|+|||++.+ ..++.++|||||||++|||++|..||..... ..+.+..+......
T Consensus 157 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~ 226 (283)
T cd06617 157 SVA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSP 226 (283)
T ss_pred ccc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCC
Confidence 211 122468899999999865 4468999999999999999999999965322 12222222221111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. + ....+|.++.+++.+||..+|++||++.+|++
T Consensus 227 ~-~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 Q-L--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C-C--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1 01347899999999999999999999988854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=314.17 Aligned_cols=248 Identities=18% Similarity=0.280 Sum_probs=200.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ...+.+|..+++.+.+ ++++.++..+...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS--PYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC--CcHHhhhhheecCCeEEEEE
Confidence 479999999999999999999988999999998765432 2357788888888765 89999999888899999999
Q ss_pred EcC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 84 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||+ +++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ ..+.+||+|||++..+..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccC
Confidence 999 88998888743 2369999999999999999999997 5999999999999994 678899999999976543
Q ss_pred cccccccccccCCCCccCccccccccccCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~------~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
... ....|+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+..+....
T Consensus 156 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd06622 156 SLA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD 226 (286)
T ss_pred Ccc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC
Confidence 221 2346888999999986543 5889999999999999999999997643322223333333222
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. .+...++.++.+++.+||..+|++||++.++++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 21 223457899999999999999999999988854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.29 Aligned_cols=247 Identities=19% Similarity=0.295 Sum_probs=199.1
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.|++.+.||+|+||.||+|.+..++..|++|.+..... ...+..|+++++.+.| ++++.+..++......++||||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h--~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH--PNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC--CCeeeEEEEEeeCCEEEEEEEe
Confidence 47899999999999999999999999999998765432 2346678888888765 8999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|..++......+++..+..++.||+.||.|||+.||+||||||+|||+ +..+.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc--
Confidence 9 788888876555679999999999999999999999999999999999999 4678899999999976543221
Q ss_pred ccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 165 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
......|+..|+|||++. +..++.++|||||||++|||++|..||..... .+.+..+....... .
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~ 228 (282)
T cd06643 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--L 228 (282)
T ss_pred -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--C
Confidence 123457899999999984 44578899999999999999999999976432 23333332221111 1
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....++.++.++|.+||..+|++||++.+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 12245788999999999999999999987763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.30 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=197.4
Q ss_pred eeEeeeCceeEEEEEEccCC---eEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||.||+|.+..++ ..||+|.+..... ...+..|..+++.+.| ++++.+..++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH--PCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876655 7899998775543 2357778888888765 88999887765 45679999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~-- 151 (257)
T cd05060 78 PLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY-- 151 (257)
T ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc--
Confidence 78999999743 379999999999999999999999999999999999999 47789999999999876443221
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
+.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+...... .....
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 222 (257)
T cd05060 152 --YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL----PRPEE 222 (257)
T ss_pred --cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC----CCCCC
Confidence 111122335678999999999899999999999999999998 9999976432 2233333222211 12356
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=308.61 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=200.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.++|++.+.||+|+||.||++. .+++.||+|++........+..|+.++..+++ ++++.+..++... ..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHH--KNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCC--CCcCeEEEEEcCC-CcEEEEEC
Confidence 4679999999999999999987 57889999998766555678889998888765 8899988777654 46899999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 86 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 86 ~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccC--
Confidence 9 789999987543 358999999999999999999999999999999999999 467899999999997643321
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
.....+..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+...... ...
T Consensus 155 --------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 219 (254)
T cd05083 155 --------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRM----EPP 219 (254)
T ss_pred --------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCC----CCC
Confidence 12234568999999998899999999999999999997 9999976433 2222222221111 123
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
..+|.++.+++.+||..+|++||++++|++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 5678999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=311.23 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=199.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.++| ++++.+..++...+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH--ANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC--cceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999988999999998765432 2346679999998875 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc
Confidence 9999889999987666679999999999999999999999999999999999999 5778899999999875432111
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---cc-----
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---KK----- 233 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---~~----- 233 (475)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .+.+..+.. ..
T Consensus 159 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 159 -------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred -------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhh
Confidence 1122356889999999876 45899999999999999999999999764321 111111110 00
Q ss_pred -----------------ccccHHHHhcCCh--HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 -----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 -----------------~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+......+. .++.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011111122334 78899999999999999999888753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=306.64 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=203.9
Q ss_pred eeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||.||+|.+... +..|+||++...... ..+..|++++..+. |++++.++.++......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG--HPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC--CCChheeeeeecCCCceEEEEEec
Confidence 4799999999999998766 889999998766543 46778999998887 499999998888899999999999
Q ss_pred -CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 87 -GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 87 -g~sL~~ll~~~--------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEccccccccc
Confidence 99999999865 4679999999999999999999999999999999999999 46789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+......
T Consensus 156 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~- 226 (262)
T cd00192 156 YDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYRL- 226 (262)
T ss_pred ccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC-
Confidence 54321 112234567899999999998889999999999999999999 6999987532 3333333322111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.....++.++.+++.+||..+|++||++.++++.|
T Consensus 227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 227 ---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred ---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12345689999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=303.52 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=199.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeE-eCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGV-EGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~~~~~lv 82 (475)
.|++.+.||.|+||.||++.+..+++.||||.+...... ..+..|.++++.+++ ++++.+..... .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH--PNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCC--CCeeeeeeeecCCCCEEEEE
Confidence 499999999999999999999999999999988654322 346678888887765 78888766554 45578999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+||++ +..+.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEeccc
Confidence 9999 78999988753 3458999999999999999999999999999999999999 46789999999999876432
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||.... .......+...... .
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~----~ 221 (257)
T cd08223 156 CD-------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKLP----P 221 (257)
T ss_pred CC-------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCC----C
Confidence 21 1234578999999999999999999999999999999999999997533 22222233222221 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...+++++.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 23467899999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=309.56 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=203.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.+ ++++.+..+...+...++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH--PYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC--CCCcceeeEEecCCeeEEEe
Confidence 59999999999999999999999999999998875442 2457788889888874 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||++++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC-
Confidence 999999999997666779999999999999999999999999999999999999 4678899999999987654321
Q ss_pred cccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 232 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 232 (475)
.......|+..|+|||++.+.. ++.++|||||||++|||++|..||.+................
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 1122347899999999987654 689999999999999999998888664321111111110000
Q ss_pred ------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 ------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........+....+.++.+++.+||..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0011123334567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=310.94 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=197.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE----
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY---- 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~---- 78 (475)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..+.++ ++++.++.++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES-IYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCC-CCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999998765432 24577899999988653 889998887776554
Q ss_pred -EEEEEEcCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 79 -NVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 79 -~~lvme~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.|++|||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ...+.+||+|||+
T Consensus 80 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~ 157 (295)
T cd07837 80 SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGL 157 (295)
T ss_pred eEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeeccc
Confidence 8999999988999887643 23589999999999999999999999999999999999995 2378999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
++.+..... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.... ..+.++...
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~ 227 (295)
T cd07837 158 GRAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKL 227 (295)
T ss_pred ceecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHH
Confidence 986543211 11223568899999988764 4799999999999999999999999764322 222211110
Q ss_pred c-----------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 K-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~-----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. ....+......++.++.++|.+||..||.+||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 0 01111222345789999999999999999999988774
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.22 Aligned_cols=255 Identities=17% Similarity=0.219 Sum_probs=193.9
Q ss_pred EEeeeEeee--CceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 10 RLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 10 ~l~~~LG~G--~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+++++||+| +|++||++.+..+|+.||||.++..... ..+..|..+++.++| ++|+.++.++..++..++||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--pniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH--PNIVPYRATFIADNELWVVT 78 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEECCEEEEEE
Confidence 367889999 7899999999999999999998754322 346678888888765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+||+.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccc
Confidence 999 88999998643 3459999999999999999999999999999999999999 467889999998765443221
Q ss_pred cccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc----
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---- 235 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 235 (475)
..............++..|+|||++.+ ..++.++|||||||++|||++|..||....... .+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 232 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLD 232 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCcccccc
Confidence 111000011123457888999999986 358999999999999999999999997643211 11111110000
Q ss_pred -------------------------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 -------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 -------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.........+++++.+++.+||+.||++||++++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000111235678999999999999999999988853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=315.28 Aligned_cols=259 Identities=19% Similarity=0.272 Sum_probs=204.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+-.++|++.+.||+|+||.||+|.+..+++ .||+|++...... ..+..|..++..+.| ++++.+++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH--PHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCcccEEEEEcCC
Confidence 456789999999999999999999887776 5789987654332 246678888777765 9999998877654
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..+++++|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLAR 157 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccc
Confidence 457888888 789999987666679999999999999999999999999999999999999 467789999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... ......++..|++||++.+..++.++|||||||++|||++ |..||.+.... .+..+.....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~ 228 (303)
T cd05110 158 LLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDLLEKGE 228 (303)
T ss_pred cccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHCCC
Confidence 764322110 1123346778999999999999999999999999999997 99999764321 1222222211
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
... ....++..+.+++..||..+|++||++.+|++.|+++...
T Consensus 229 ~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 RLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111 1244678999999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=314.95 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=200.6
Q ss_pred ceEEeeeEeeeCceeEEEEEE----ccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~ 78 (475)
-|+++++||+|+||.||+|.+ ..+++.||+|.++.... ...+.+|+.+++.+.+ ++++.+.+++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH--ENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCC--CCeeeeeeEEecCCCCc
Confidence 479999999999999999974 45688999998764432 2357789999888865 8899888877654 67
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ |++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||+++.+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCcccccc
Confidence 89999999 8999999875555689999999999999999999999999999999999994 6788999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-----------C-CHHHH
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------G-TKKQK 225 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~-----------~-~~~~~ 225 (475)
...... ........++..|+|||++.+..++.++|||||||++|||+++..|+..... . .....
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 543221 1112345678889999999988899999999999999999998766532110 0 00011
Q ss_pred HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 226 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
...+..... ......++.++.+|+.+||+.+|++||++.++++.|+++
T Consensus 236 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKR----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCcc----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111111 112345789999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.94 Aligned_cols=250 Identities=20% Similarity=0.353 Sum_probs=198.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeE------eCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGV------EGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~------~~~~ 78 (475)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|..++..+.. |++++.+.+++. ....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH-HRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcC-CCcEEEEeeehhcccccCCCCE
Confidence 478999999999999999999999999999999876543 23457778888888754 489998887764 3467
Q ss_pred EEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.|++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++ ++.+.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence 89999999 67999998753 3458899999999999999999999999999999999999 4678899999999886
Q ss_pred ccccccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
...... ......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+..
T Consensus 171 ~~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~ 240 (282)
T cd06636 171 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPR 240 (282)
T ss_pred hhcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhh
Confidence 543221 123457899999999986 34578899999999999999999999976432 222222222
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.... ......++.++.++|.+||..||.+||++.+|++
T Consensus 241 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NPPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1111 1122457899999999999999999999988853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=313.95 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=201.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.++||+|+||.||++.+..++..||+|.+...... .++..|++++..++| ++++.++.++..++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS--PYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEeeCCEEEEEe
Confidence 4799999999999999999999999999999988654332 346789999888865 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCcccccccc
Confidence 999 88999998753 579999999999999999999998 6999999999999994 67889999999987653321
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 231 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 231 (475)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 155 ---------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 155 ---------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225 (308)
T ss_pred ---------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence 1345789999999999988899999999999999999999999965332111111100000
Q ss_pred -------------------ccccccHHHHh-cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 232 -------------------KKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 232 -------------------~~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.......+.++ ..++.++.+++.+||..+|++||++.+| +++.+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l---l~~~~~~ 291 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL---TKHPFIK 291 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH---hcChhhh
Confidence 00000000000 1357789999999999999999998877 4444433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.60 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=201.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|..+++.+.| ++++.+..++..+...|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h--~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN--PNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC--CCEeeEEEEEEeCCEEEEee
Confidence 4689999999999999999999999999999998765433 2456778888877655 89999998888899999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++. ...+++.+++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc
Confidence 999 889999986 3468999999999999999999999999999999999999 4678899999999886543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...+........ . ....
T Consensus 172 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~~~--~-~~~~ 239 (296)
T cd06654 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTP--E-LQNP 239 (296)
T ss_pred -------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCCCC--C-CCCc
Confidence 112347899999999999888999999999999999999999999764321 111111111110 0 0112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++..+.+++.+||..+|++||++.+|++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 457789999999999999999999888854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=309.52 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=198.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++++.+.+++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH--ANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC--CCEeEEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999987654322 256788888888875 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+.+......+.+..+..++.||+.||.|||++||+|+||||+|||+ +..+.+||+|||+++.......
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 82 FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC
Confidence 9999888888776555568899999999999999999999999999999999999 4678999999999976433221
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 232 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 232 (475)
......++..|+|||++.+. .++.++|||||||++|||++|..||.+... ..+.+.++...
T Consensus 159 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 159 -------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred -------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhh
Confidence 11234678999999998764 478999999999999999999999976432 12222221110
Q ss_pred ----------------cccccHHHHhc--CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ----------------KVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ----------------~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+.. ..+.++.+++.+|+..||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 00001111111 1257899999999999999999988874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.70 Aligned_cols=261 Identities=18% Similarity=0.247 Sum_probs=206.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||++.+..+++.||||.+..... ...+..|+.+++.+.+ ++++.+++.+..+++.++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN--PFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC--CCeeeeEEEEecCCEEEE
Confidence 479999999999999999999999999999998765432 2346678888887765 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +..+.+||+|||+++.....
T Consensus 79 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 79 VMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcC
Confidence 99999 8899999974 3569999999999999999999999999999999999999 47789999999998742211
Q ss_pred ccccc--------cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 161 ATHQH--------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 161 ~~~~~--------~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
..... ..........|+..|+|||.+.+..++.++|||||||++|||++|..||.+.. ..+.+..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~ 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISD 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 11000 00001123468889999999998889999999999999999999999997643 23333333222
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
....+. ....+|.++.+++.+||+.+|++||+..++.++|++.+
T Consensus 232 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 232 DIEWPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ccCCCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 211111 11257899999999999999999999887877777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=302.58 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=206.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||.|+||.||.+++..+++.|++|.+..... ...+..|+.+++.++| ++++.+..++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH--PNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC--CCeeEEEeEEecCCeEEEEE
Confidence 59999999999999999999999999999998765432 2357789999998865 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEccccc
Confidence 999 88999998754 34689999999999999999999999999999999999994 67889999999998764433
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......|+..|+|||++.+..++.++|||||||++|||++|..||... ...+.+..+....... .
T Consensus 156 ~-------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~ 221 (256)
T cd08221 156 S-------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTP----V 221 (256)
T ss_pred c-------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCC----C
Confidence 2 123457899999999999988999999999999999999999999763 3334444444433322 1
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.+++.+||..+|++||++.++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 2567899999999999999999999988865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.30 Aligned_cols=252 Identities=20% Similarity=0.226 Sum_probs=199.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~ 78 (475)
-.++|++.++||+|+||.||+|.+..+|+.||+|++...... .....|+.+++.++| ++++.+..+.... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH--PNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCC--CCCcceEEEEecCCCCe
Confidence 457899999999999999999999999999999987654322 245678899988876 8888888776544 56
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.++||||++++|.+++......+++.+++.++.||+.||.|||++||+||||||+||++ +..+.+||+|||++..+.
T Consensus 83 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence 89999999889999988666779999999999999999999999999999999999999 477899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 234 (475)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+... .+.+..+.....
T Consensus 160 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~ 229 (309)
T cd07845 160 LPAK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPN 229 (309)
T ss_pred CccC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence 4321 1122345788999999876 4579999999999999999999999976433 222222221100
Q ss_pred ----------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........+++++.++|.+||..||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0011111233578899999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.59 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=203.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+..|+.++..+.| ++++.+.+++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h--~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH--PNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC--CchheEEEEEcCCC
Confidence 4679999999999999999998743 678999998865433 2347778888888865 89999999998888
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 135 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~---------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 135 (475)
..+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||+++|+||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999 789999986422 2478889999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 214 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf 214 (475)
|+ +.++.++|+|||++..+..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 162 l~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 162 LV---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred Ee---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99 4778999999999976543221 111122345678999999999899999999999999999997 88899
Q ss_pred CCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 215 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 215 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.+... .+.+..+...... .....++.++.+++.+||..+|++||++.+|.+.|+
T Consensus 234 ~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 76432 2333333322221 123467899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=309.57 Aligned_cols=253 Identities=19% Similarity=0.313 Sum_probs=198.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeE-----eCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGV-----EGD 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~-----~~~ 77 (475)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.. |++++.++.++. .++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-HPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhc-CCCeeeeeeeeeecccCCCC
Confidence 356899999999999999999999999999999998764332 3457789898888853 389999887763 446
Q ss_pred EEEEEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
..++||||+ +++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~ 170 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGV 170 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCc
Confidence 789999999 8899988753 234689999999999999999999999999999999999994 677899999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
++.+..... ......|+..|+|||++.+ ..++.++|||||||++|||++|..||...... ..+..
T Consensus 171 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~ 240 (286)
T cd06638 171 SAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFK 240 (286)
T ss_pred eeecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhh
Confidence 986643221 1123468999999999853 34788999999999999999999999764331 22222
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...... .......++.++.+++.+||+.+|++||++.+|++
T Consensus 241 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 241 IPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2111111 11112346788999999999999999999988864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=311.47 Aligned_cols=253 Identities=19% Similarity=0.218 Sum_probs=199.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-------hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-------~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|+++++.++| ++++.++.++...+..+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH--PNIIGLLDVFGHKSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC--CCChhhhheeecCCEEE
Confidence 589999999999999999999889999999988655432 235678888888875 89999999999899999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||+++.+...
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence 999999999999997544469999999999999999999999999999999999999 46789999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-------
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 232 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 232 (475)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.+........+.......
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 156 NR-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred Cc-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 21 1122356888999999865 45789999999999999999998888764332211111111000
Q ss_pred -------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 -------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........+....+.++.+++..||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0011122233456788999999999999999999888854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.18 Aligned_cols=260 Identities=22% Similarity=0.250 Sum_probs=199.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEE----ccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeE--eCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGV--EGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~~ 77 (475)
.++|++.+.||+|+||.||+|.. ..+++.||||.+...... ..+..|++++..++| ++++.+.+++. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH--DNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC--CCeeEEEEEEccCCCC
Confidence 46899999999999999999973 457889999987654332 357789999888865 89999877654 345
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccc
Confidence 689999999 899999997655679999999999999999999999999999999999999 4678899999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH------------HH
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------------KQ 224 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~------------~~ 224 (475)
+....... .......++..|+|||++.+..++.++|||||||++|||++|..|+........ ..
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 64432210 011122345679999999998999999999999999999998877643221100 00
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.+..+...... ......++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000 011245788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=307.56 Aligned_cols=251 Identities=21% Similarity=0.224 Sum_probs=195.9
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DYNVLVI 83 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~~~lvm 83 (475)
|++.++||+|+||.||+|.+..+++.||||.++..... .....|..++..+.. |++++.++.++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP-HPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCC-CCCccceEEEEecCCCCcEEEEE
Confidence 78999999999999999999999999999987654222 223456666666653 48999998888877 8899999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||+.++|.+.+......+++.+++.++.||+.||.|||++||+||||||+||+++ . +.+||+|||+++.+.....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCC-
Confidence 9998899888875556799999999999999999999999999999999999994 4 8999999999986643221
Q ss_pred cccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 232 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 232 (475)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.........+......
T Consensus 155 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 155 -------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred -------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 123468899999997654 45789999999999999999999999764332111111111100
Q ss_pred -----------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 -----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.....+..+...++.++.++|.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0011123334567899999999999999999999888753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=331.84 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=210.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe---E-EEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---E-VAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~-vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.++..+.++||+|+||+||+|..+..+. . ||||..+... ...++..|+++++.++| +||+.++++....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H--~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH--PNVVRFYGVAVLE 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEcCC
Confidence 3455667999999999999999765432 3 8999877522 22458889999999887 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...+||||+| ||+|.+++......++..+.+.++.+.+.||+|||++++|||||-..|+|++ ..+.+||+|||+++
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSR 310 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCcccccc
Confidence 9999999999 9999999997776799999999999999999999999999999999999995 66778999999987
Q ss_pred cccccccccccccccCC-CCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 156 RYRDTATHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
.-..-. ... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+..... ...+|....
T Consensus 311 ~~~~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~~~~ 379 (474)
T KOG0194|consen 311 AGSQYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIVKNG 379 (474)
T ss_pred CCccee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHHhcC
Confidence 543111 111 1124578999999999999999999999999999999 899999976543 333332222
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.... .....|.++..++.+||..+|++||++.++.+.|+.+....
T Consensus 380 ~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 380 YRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 2221 12367899999999999999999999999999999987543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.20 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=203.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| ++++.+..++..+...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS--PYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC--CCeeeeeEEEEECCeEEEEE
Confidence 579999999999999999999999999999998865532 2356778888888875 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++... .+++..++.++.|++.||.|||+++|+||||+|+||++ ++++.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence 999 88999998743 79999999999999999999999999999999999999 5788999999999987754321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|+..|+|||.+.+..++.++|||||||++|||++|..||..... ......+....... +.
T Consensus 154 -------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~----~~ 219 (274)
T cd06609 154 -------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPS----LE 219 (274)
T ss_pred -------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCC----Cc
Confidence 12345788999999999998899999999999999999999999976432 22222222221111 11
Q ss_pred cC-ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. ++.++.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22 7889999999999999999999888843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=304.90 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=212.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
-++|.-.+.||.|..+.|-++.++.+++++|+|++...... +....|+.|++.+.++ |+|+.+.++++.
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GH-P~II~l~D~yes 94 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGH-PYIIDLQDVYES 94 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCC-CcEEEeeeeccC
Confidence 35678889999999999999999999999999987654321 1246788999998875 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
+.+.++|+|+| .|-|.|++.. .-.++++....|+.|++.|++|||.++||||||||+|||+ +++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 99999999999 8899999873 4569999999999999999999999999999999999999 68899999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~------~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
+.+..... ....|||+.|+|||.+... .|+..+|+|++|||||.|+.|..||... .....+..
T Consensus 171 ~~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~ 239 (411)
T KOG0599|consen 171 CQLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRM 239 (411)
T ss_pred eccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHH
Confidence 98765432 2457999999999988643 4889999999999999999999999752 33455667
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
|.++++...-++ +.+++...++||.+||+.||.+|.|+++++
T Consensus 240 ImeGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 240 IMEGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HHhcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 777776554443 367889999999999999999999988874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=313.01 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=203.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.++||.|+||.||+|.+..+++.||+|++...... ..+..|+++++.++| ++++.+..++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH--PNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC--CceeEEEEEEecCCeEEEEe
Confidence 35799999999999999999999889999999998654322 356778889888874 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc
Confidence 999 889999988666779999999999999999999999999999999999999 5778999999999876543221
Q ss_pred ccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
......|+..|++||.+. +..++.++|||||||++|||++|..||..... .+.+..+.......
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~- 227 (280)
T cd06611 159 -------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT- 227 (280)
T ss_pred -------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC-
Confidence 113457899999999975 34478899999999999999999999976432 23333333221111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......++.++.+++..||..+|++||++.+++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 -LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred -cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 011245788999999999999999999988773
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=311.18 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=202.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..+|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|..+++.++| ++++.+..+....+..++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKN--PNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCC--CceeeeeeeEecCceEEEEE
Confidence 3579999999999999999999999999999998765432 3456778888888865 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++. ...+++.+++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 96 e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 96 EYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc
Confidence 999 889999886 3468999999999999999999999999999999999999 4678999999999886543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... ......+...... .....
T Consensus 171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~~~~~~~--~~~~~ 238 (296)
T cd06655 171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTP--ELQNP 238 (296)
T ss_pred -------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCc--ccCCc
Confidence 11235789999999999988899999999999999999999999976432 2222222211110 11123
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+++.+.++|.+||..||++||++.+|+
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 45788999999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=307.98 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=203.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+|+..+.||+|+||.||+|.+..+++.||||++..... ...+..|+++++.++| ++++.+.+++.+.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH--PHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC--CceehhhceeccCCeE
Confidence 58899999999999999999999999999998865431 2457789999998876 8999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++. .....+||+|||++..+.
T Consensus 79 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccccccccc
Confidence 9999999 8899999874 45789999999999999999999999999999999999994 233469999999998775
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..............+......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 229 (268)
T cd06630 156 AKGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--- 229 (268)
T ss_pred cccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---
Confidence 43221110 123457899999999999888999999999999999999999999754433323322222211111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+...+++++.+++.+||..+|++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 122345678999999999999999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.85 Aligned_cols=257 Identities=19% Similarity=0.216 Sum_probs=198.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG----- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----- 76 (475)
++++|++.++||+|+||.||+|.+..+++.||||+++.... ...+..|+.+++.+++ ++++.++.+....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH--ENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCC--CCcCchhheeeccccccc
Confidence 67899999999999999999999999999999998764322 2346678888888875 8898887665433
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...|++|||++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.
T Consensus 81 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceee
Confidence 3579999999889988875 4579999999999999999999999999999999999999 5778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 231 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---- 231 (475)
......... ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+..
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 156 ADPEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred ccccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 644322111 1234578999999998765 4589999999999999999999999976332111111110000
Q ss_pred -------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 -------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 -------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.........+...++.++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011122233456788999999999999999999887744
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=307.69 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|.+.++||+|+||.||+|.+... ...||||....... ...+..|+.+++.+.| ++++.++.++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--PHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCC--CchhceeEEEcC-CCc
Confidence 45799999999999999999997544 34799998765432 2357778888888865 889998887765 456
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.++.||+.||.|||++|++||||||+|||++ ..+.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeecc
Confidence 8999999 8899999986555699999999999999999999999999999999999994 67899999999998665
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+....+......
T Consensus 159 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~-- 227 (270)
T cd05056 159 DESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERL-- 227 (270)
T ss_pred cccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcC--
Confidence 43211 1112345568999999988889999999999999999886 9999977543 2223333222211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.....+|.++.+++.+||..+|++||++.++++.|+++..+
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12356789999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.89 Aligned_cols=258 Identities=20% Similarity=0.295 Sum_probs=212.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC-----eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++.+.||+|.||.||.|...... ..||||.++..... .++.+|..++..+.| +||+.+.+++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~H--pNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDH--PNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCC--cceeeEEEeecCCCC
Confidence 45788999999999999999975432 24899987766443 458889999998887 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 79 NVLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
.+|++||| ||+|..++... ...++..+++.|+.|||+|+.||+++++|||||-..|+||+ ....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEccc
Confidence 99999999 99999999977 55699999999999999999999999999999999999994 6799999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|+|+.+.+... |+......-...|||||.+....++.|+|||||||+|||+++ |..||.+.........+....
T Consensus 847 GlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 847 GLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred chhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 99994433322 222222233568999999999999999999999999999999 999998755432222222221
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+. .+..||..+.++|.+||+.+|++||+|..|++.+..++...
T Consensus 922 --RL~-----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 --RLD-----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred --ccC-----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 221 23689999999999999999999999999999888877544
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=305.02 Aligned_cols=253 Identities=20% Similarity=0.360 Sum_probs=202.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+..++|++.++||+|+||.||+|.+ ..+..||+|.+..... ...+.+|+.+++.+++ ++++.+..+... ...+++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH--DKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCC--CCcceEEEEEcC-CCeEEE
Confidence 3568899999999999999999985 4566799998765432 2457789999988865 889888777766 678999
Q ss_pred EEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++||||||+||++ +..+.+||+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence 9999 78999998753 3458889999999999999999999999999999999999 47789999999999865432
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......++..|+|||++.+..++.++|||||||++|++++ |..||.+.... .....+......
T Consensus 156 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~---- 222 (260)
T cd05073 156 EYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYRM---- 222 (260)
T ss_pred Ccc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC----
Confidence 211 1122346678999999998889999999999999999998 99999764332 222222221111
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.....++.++.+++.+||..+|++||++.+|.++|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1224678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.58 Aligned_cols=249 Identities=17% Similarity=0.295 Sum_probs=201.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||+|+||+||++.+..+++.||+|++..... ...+..|++++..+.| ++++.+..++......++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS--PYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC--CCcceEeeeEecCCEEEEE
Confidence 3679999999999999999999999999999998765432 2457788888888865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ ++|+||||||+||++ ++.+.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9999 8899988874 4569999999999999999999997 699999999999999 47789999999998755332
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC-----H---HHHHHHHhhc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----K---KQKYEKISEK 232 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~-----~---~~~~~~i~~~ 232 (475)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... . ...+..+...
T Consensus 158 ~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 IA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred cc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 21 23578999999999998889999999999999999999999998643310 0 1111111111
Q ss_pred cccccHHHHh-cCChHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 233 KVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 233 ~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
. ...+. ..++.++.+++.+||..||++||++.++++.
T Consensus 229 ~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 P----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred c----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 11111 1267899999999999999999999888653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=311.08 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=204.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc----CCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEe--C
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVE--G 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~ 76 (475)
..+|++.+.||+|+||.||+|.+.. +++.||||++..... ...+..|+++++.+.+ ++++.+..++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~--~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH--ENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC--CChheEEeeeecCCC
Confidence 3578999999999999999998643 478999999876554 3467888888888865 889998888776 6
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence 6889999999 889999998655569999999999999999999999999999999999999 467899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-----------HH
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQ 224 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-----------~~ 224 (475)
........ +.......++..|++||.+.+..++.++|||||||++|||++|..||........ ..
T Consensus 158 ~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 76532211 1111223456679999999988999999999999999999999999865322110 11
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.+.......... .....+|.++.+++.+||..+|++||++.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111 11235678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=304.86 Aligned_cols=252 Identities=19% Similarity=0.279 Sum_probs=194.1
Q ss_pred eeEeeeCceeEEEEEEcc---CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE-eCCEEEEEEEc
Q 011882 13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV-EGDYNVLVIDL 85 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~---~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~~~~~lvme~ 85 (475)
+.||+|+||.||+|.+.. .+..||||.+...... ..+..|..+++.+.| ++++.++.++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSH--PNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCC--CCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 3457999987543322 356678888877765 88998887654 45678999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||+ +..+.+||+|||+++.+......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~- 154 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY- 154 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce-
Confidence 9 889999997655667888899999999999999999999999999999999 46788999999999865432210
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.........++..|+|||.+.+..++.++|||||||++|||++| ..||..... ......+...... ....
T Consensus 155 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~ 225 (262)
T cd05058 155 --SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRL----LQPE 225 (262)
T ss_pred --eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCC----CCCC
Confidence 01112234567889999999988999999999999999999995 566755322 2222222221111 1123
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+|..+.+++.+||..+|++||++.+|++.|++++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 468899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=309.77 Aligned_cols=265 Identities=19% Similarity=0.275 Sum_probs=216.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
--++|..+++||+|.||.|-+++.+.+++.||||+++.+... ..-.-|.++++..+| |.+..+...+...+..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H--PFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH--PFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC--cHHHHhhhhhccCceE
Confidence 347899999999999999999999999999999998765322 234568888887766 8888888888899999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||. ||.|.-.+.. .+.|++.....+...|+.||.|||+++||.||||.+|.|+ |++|++||+|||+++.-.
T Consensus 244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcc
Confidence 9999999 8888777763 4579999999999999999999999999999999999999 799999999999998644
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ..+++|||+.|+|||++....|++++|+|.+||+||||++|++||...+. ...++-|....+
T Consensus 320 ~~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~---- 385 (516)
T KOG0690|consen 320 KYGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDL---- 385 (516)
T ss_pred cccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhc----
Confidence 3322 24689999999999999999999999999999999999999999987443 223333332222
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCC--HHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPD--YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt--~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
.++..++++.+.|+..+|..||.+|.. .++..++.++-|. ..++|+..-.+
T Consensus 386 -kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF-------~~v~W~~~~~K 438 (516)
T KOG0690|consen 386 -KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF-------ASVDWEATYRK 438 (516)
T ss_pred -cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh-------ccCCHHHHHHh
Confidence 234678899999999999999999963 3556666665543 34688865443
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=308.25 Aligned_cols=247 Identities=20% Similarity=0.274 Sum_probs=195.8
Q ss_pred eeEeeeCceeEEEEEEccCCe--EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~--~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+..++. .+++|.++.... ...+..|++++..+.+ |++++.+++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhcc-CCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999888775 468887764322 2356778888888854 389999999999999999999999
Q ss_pred CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 87 GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 87 g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
+++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCC
Confidence 889999986432 247899999999999999999999999999999999999 47789999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+.
T Consensus 157 gl~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~ 225 (270)
T cd05047 157 GLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 225 (270)
T ss_pred CCccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHh
Confidence 9986322111 0112234667999999998889999999999999999997 9999976432 22233322
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
..... .....++.++.+++.+||..+|.+||++.+++..|++++
T Consensus 226 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 21111 122356789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=312.69 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=200.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|.+++..+.+ ++++.+++.+......|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH--PFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC--CCchhheeeeecCCEEEE
Confidence 4799999999999999999999889999999988755322 346778888888875 899999999999999999
Q ss_pred EEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+|||+ |++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+|+ .++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhcccc
Confidence 99999 88999998753 35699999999999999999999999999999999999994 678999999999876543
Q ss_pred ccccccc----------------------ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 011882 160 TATHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 217 (475)
Q Consensus 160 ~~~~~~~----------------------~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~ 217 (475)
....... .......+.||..|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2211000 000123457899999999999988999999999999999999999999764
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
.. ...+..+........ ....++.++.+++.+||..+|++||+
T Consensus 236 ~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 236 NR---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred ch---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 32 233333333222111 01226899999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=301.23 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=202.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+++ ++++.++......+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH--PNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC--CchhheeeeEecCCEEEEEE
Confidence 59999999999999999999999999999998865432 2357778888888865 89999988888889999999
Q ss_pred EcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++ ++.+.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence 999 88999999754 34589999999999999999999999999999999999995 345678999999998764432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+... ......+...... .+
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----~~ 221 (256)
T cd08220 157 K--------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFA----PI 221 (256)
T ss_pred c--------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCC----CC
Confidence 1 1235789999999999988899999999999999999999999976432 2223333222211 23
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.+++.+||..+|++||++.+++.
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 3567899999999999999999999988853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=331.57 Aligned_cols=241 Identities=22% Similarity=0.315 Sum_probs=207.0
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
|.-++.||.|+||.||-|.+..+.+.||||.++...+ ..++..|+.+++.+.| ||++.+.+++..+...||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H--PntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH--PNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC--CCcccccceeeccchHHHHH
Confidence 6667889999999999999999999999998765543 3468899999999987 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|||-||-.|++.-.++++.+.++..|..+.+.||.|||+++.||||||..||||+ +.+.|||+|||.|.....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc----
Confidence 9999999999988888999999999999999999999999999999999999995 889999999999976543
Q ss_pred cccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.+.|+||+.|||||+++. +.|+-++||||||++..||...++|+..+++... +..|.+...++..
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIAQNesPtLq-- 246 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPTLQ-- 246 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHHhcCCCCCC--
Confidence 356899999999999874 4699999999999999999999999988765332 2233333322211
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...++..|..|+..||.+-|.+||+.++++
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 134678999999999999999999988774
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=303.79 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=205.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.+.||.|+||+||+|.+..++..||+|++..... ...+..|+++++.+.+ ++++.+.......+..+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH--PNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC--CCEEEEEEEEeeCCEEEEEE
Confidence 579999999999999999999988999999999865432 3457788888888765 89999998889999999999
Q ss_pred EcC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 84 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 84 e~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++ ++++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccC
Confidence 999 88999998753 2468999999999999999999999999999999999999 46788999999999877654
Q ss_pred ccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.... ........|+..|++||++... .++.++|||||||++|+|++|..||...... +.+.+........ ..
T Consensus 156 ~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~ 228 (267)
T cd06610 156 GDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPS-LE 228 (267)
T ss_pred cccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCC-cC
Confidence 3321 0122445789999999998877 6899999999999999999999999764332 2222222221111 11
Q ss_pred HH--hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 AL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. ...+++++.+++..||..||++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 1357889999999999999999999888754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=301.59 Aligned_cols=244 Identities=20% Similarity=0.304 Sum_probs=195.7
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++||+|+||.||+|.. .++..||+|+++..... ..+..|+.+++.+.| ++++.+..++......++||||+ ++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH--PNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC--CCcCeEEEEEecCCccEEEEECCCCC
Confidence 4789999999999985 57889999987654322 246678888888754 99999999999999999999999 89
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++......+++..++.++.|++.||.|||++|++||||||+||++ +..+.+||+|||++.........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~----- 149 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS----- 149 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc-----
Confidence 9999887555668999999999999999999999999999999999999 46788999999999754332110
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
......++..|+|||++.+..++.++|||||||++|++++ |..||.+.... .....+..... . .....++.
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~-~---~~~~~~~~ 221 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYR-M---SCPQKCPD 221 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCC-C---CCCCCCCH
Confidence 1112344678999999998889999999999999999998 99999775332 22222222111 1 12345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.+.+++.+||..+|++||++.++.+.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=302.71 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=197.5
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++||.|+||.||+|.+.. ++.||+|++...... ..+..|+.+++.+.+ ++++.+..++......++||||+ ++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH--PNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999876 999999987655432 357788888888875 89999999999999999999999 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||++..........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~---- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV---- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee----
Confidence 9999987655678999999999999999999999999999999999999 577899999999998654221100
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
......++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+... ... .....+|.
T Consensus 151 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~~~~-~~~---~~~~~~~~ 222 (251)
T cd05041 151 -SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERIESG-YRM---PAPQLCPE 222 (251)
T ss_pred -ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHHhcC-CCC---CCCccCCH
Confidence 0112234677999999998889999999999999999998 89999775432222 222111 111 11245789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
++.+++.+||..+|++||++.+|++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.01 Aligned_cols=249 Identities=19% Similarity=0.324 Sum_probs=207.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH---HHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~---~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++.+++..||.|.-|+||+++.+.+|..+|||.+......++ +.....++.. .+.++.|+..++++..+...+|+|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~-s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhh-ccCCCeeeeeeeEEeeCchHHHHH
Confidence 456678899999999999999999999999999877655443 3334444433 344599999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+|...++.++....+++++..+-++...++.||.||-+ +|||||||||+|||+ |..|+|||||||++-.+.+...
T Consensus 171 elMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 171 ELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence 999999999999888899999999999999999999997 689999999999999 6899999999999988877654
Q ss_pred ccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
+ ....|.+.|||||.+.-. .|+.++||||||++|+||+||+.||.+.+ +..+.+.++..... +.++
T Consensus 248 h--------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~eP-P~L~ 316 (391)
T KOG0983|consen 248 H--------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEP-PLLP 316 (391)
T ss_pred c--------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCC-CCCC
Confidence 3 345899999999998643 58999999999999999999999998854 34555666655333 2222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. ..++++.|.+++..||.+|+.+||.|.+|+
T Consensus 317 ~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 317 G-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred c-ccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 1 245899999999999999999999998874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=308.21 Aligned_cols=235 Identities=23% Similarity=0.325 Sum_probs=199.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||++.+..+++.||||++.... ....+..|+++++.+.| ++++.++.++..+...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH--PFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC--CCccceeeEEEcCCeEEE
Confidence 57999999999999999999999999999999876432 22457778899888874 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+|||+ +++|.+++... ..+++..+..++.||+.||.|||++||+|+||||.|||| +.++.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC
Confidence 99999 99999998753 579999999999999999999999999999999999999 46789999999999876443
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+..... .
T Consensus 155 ----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~ 216 (290)
T cd05580 155 ----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----R 216 (290)
T ss_pred ----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----c
Confidence 124578999999999998889999999999999999999999997643 2333333332221 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKP 265 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RP 265 (475)
+...++..+.+++.+||..+|.+|+
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHcc
Confidence 2345689999999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.05 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=200.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+|++.++||.|++|.||+|++..+++.||||.++.... ...+..|+.+++.++| ++++.+..++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH--ENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC--CCEeeeeeeEeeCCcEEEEEe
Confidence 59999999999999999999999999999998765432 3456789999998865 899999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ ++++.++|+|||++........
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc
Confidence 99889999886543 458999999999999999999999999999999999999 4778999999999976543211
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......++..|++||++.+. .++.++|||||||++|+|++|..||.+.........+........
T Consensus 156 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 156 -------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred -------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHH
Confidence 11234578899999998764 478999999999999999999999987543222111111100000
Q ss_pred --------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 235 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 235 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
......+...++.++.+++..||+.||.+||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01112223456788999999999999999999888753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.59 Aligned_cols=252 Identities=16% Similarity=0.270 Sum_probs=197.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.+|+..++||+|+||.||++.+..+++.||||.+...... ..+..|..++..+.. |++++.+++++......+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~-~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD-CPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcC-CCCEeeeeeEEecCCcEEEEE
Confidence 4677889999999999999999999999999987654322 346677777776653 389999999888888999999
Q ss_pred EcCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 84 DLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 84 e~~g~sL~~ll~~----~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||++.+|.++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +..+.+||+|||+++.+.
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhc
Confidence 9998888776542 23569999999999999999999997 599999999999999 467889999999998654
Q ss_pred ccccccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.... .....|+..|+|||++.+. .++.++|||||||++|||++|..||.... ...+.+.++......
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~ 229 (288)
T cd06616 160 DSIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP 229 (288)
T ss_pred cCCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC
Confidence 4321 1233688999999999876 68999999999999999999999997643 122222222221111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.........++.++.+|+.+||..+|++||++.+|+.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111112347889999999999999999999988753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=309.15 Aligned_cols=246 Identities=21% Similarity=0.344 Sum_probs=201.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
...|+..++||.|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++++.+.+++......++|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEECCEEEEE
Confidence 35688999999999999999999889999999987754322 346678888887765 8999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++. ..++++..+..++.|++.||.|||+.+|+|+||+|+||++ +..+.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 81 MEYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCc
Confidence 9999 889999886 3568999999999999999999999999999999999999 467889999999997664322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......++..|+|||++.+..++.++|||||||++|||++|..||...... .....+..... +.+
T Consensus 156 ~-------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~----~~~ 221 (277)
T cd06640 156 I-------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNNP----PTL 221 (277)
T ss_pred c-------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCCC----CCC
Confidence 1 112346888999999999988999999999999999999999999764332 11222211111 122
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++..+.+++.+||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 3456789999999999999999999998843
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=306.74 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=200.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++++.||.|+||.||+|.+..+++.||||.+...... ..+..|+++++.++| ++++.+..++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH--PNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC--CCCcchhhhcccCCcEEEEe
Confidence 589999999999999999999999999999987654322 357789999998876 89999999999999999999
Q ss_pred EcCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+.++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||++ +.++.+||+|||++..+.....
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc
Confidence 99988998888653 3468999999999999999999999999999999999999 5778999999999976543211
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 232 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 232 (475)
......++..|+|||++.+.. ++.++|||||||++|||++|..||.+.........+......
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 156 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred -------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 112335788999999987755 588999999999999999999999764322111111110000
Q ss_pred ------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 ------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........+...++.++.++|.+||..||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0011122233456789999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.04 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=201.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|++.++||+|+||.||+|.+..+++.||||.++... ....+..|+++++.+.+ ++++.+.+++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH--ENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC--CCeeehhheEEECCEEEEE
Confidence 47999999999999999999999999999999876432 23467889999998885 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||+++++.+.+......+++.++..++.||+.||.|||+++|+|+||||+||++ ++.+.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc
Confidence 9999666655554455669999999999999999999999999999999999999 4688999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 231 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 231 (475)
. ......++..|+|||++.+. .++.++||||||+++|+|++|..||.+............+..
T Consensus 156 ~------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 156 S------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 11345788999999999988 789999999999999999999999976432211111111000
Q ss_pred -------------ccccccHHH-HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 -------------KKVSTSIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 -------------~~~~~~~~~-l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.......+. ....++.++.+++.+||..+|++||++++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000001111 12234889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.02 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=195.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+++ ++++.+..++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH--KNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCC--CCCcceeeeeccCCCc
Confidence 46788999999999999999999999999999999875432 12346678888888876 8888887765432
Q ss_pred ---CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 ---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ---~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...|+||||++++|.+.+.. .++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence 35799999998899988763 38999999999999999999999999999999999999 5778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..+.++....
T Consensus 165 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~ 233 (353)
T cd07850 165 ARTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQL 233 (353)
T ss_pred ceeCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhc
Confidence 986543211 12346889999999999999999999999999999999999999764321 1111111100
Q ss_pred cc-------------------------ccHHHH-------------hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 VS-------------------------TSIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ~~-------------------------~~~~~l-------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. .....+ ....+.++.++|.+||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 000010 113466789999999999999999988874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.30 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=199.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.| ++++.++.++......|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH--GNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC--CCEeeEEEEEecCCeEEEE
Confidence 679999999999999999999999999999998765422 2457789999998865 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||++++|.+.+..... .+++..+..++.||+.||+|||+++|+||||||+||+++ ...+.+||+|||++.......
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCc
Confidence 99998899888764332 368889999999999999999999999999999999995 345679999999997653321
Q ss_pred cccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 233 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 233 (475)
. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus 158 ~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 R-------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred c-------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 1 11234678999999998764 47899999999999999999999997643221111111100000
Q ss_pred --------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 --------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...........+++++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112223457889999999999999999999888854
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.09 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=201.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.+|++.+.||+|+||.||+|.+. .+..+|||++..... ...+..|+++++.+.+ ++++.++.++......+++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSH--PKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCC--CCeeeEEEEEccCCceEEEEEc
Confidence 57999999999999999999874 467899998765433 3568889999998865 8899999888888899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.++.|++.||.|||+++|+||||||+||++ +.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCccc-
Confidence 9 889999987656678999999999999999999999999999999999999 46788999999999765432111
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+..+...... . ...
T Consensus 157 -----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~-~---~~~ 224 (256)
T cd05112 157 -----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL-Y---KPR 224 (256)
T ss_pred -----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC-C---CCC
Confidence 1122345678999999998889999999999999999998 9999976332 2233333221110 0 123
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
..+.++.+++.+||..+|++||++.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=304.10 Aligned_cols=252 Identities=20% Similarity=0.332 Sum_probs=201.3
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--------hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--------~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+|++.+.||.|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.+.+ ++++.+.+++.+.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH--VNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC--CCEeeEeeEeecCCeE
Confidence 589999999999999999986 57889999987654321 346778888888875 8999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+|+|+||||+||++ +..+.++|+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 78 SIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhh
Confidence 9999999 8899999874 3468999999999999999999999999999999999999 577899999999998653
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
....... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... ....
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~ 227 (265)
T cd06631 154 WVGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAH--RGLM 227 (265)
T ss_pred hcccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhc--cCCC
Confidence 3211110 001123457899999999999988999999999999999999999999764321 111111111 1112
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+.+...++.++.+++.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2344678899999999999999999999988753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.89 Aligned_cols=259 Identities=21% Similarity=0.241 Sum_probs=200.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEcc--CCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~--~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~ 78 (475)
+|++.++||+|+||.||+|.+.. +++.||||++... .....+..|+.++..++| ++++.++.++... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH--ENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC--CCccceEEEEeCCCCce
Confidence 58999999999999999999988 8999999988762 234567789999888876 8999999888877 88
Q ss_pred EEEEEEcCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee-CCCCCcEEEeecCC
Q 011882 79 NVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL 153 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~-~~~~~~vkL~DFGl 153 (475)
.++||||++++|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||+
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 79 VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99999999889988876432 25899999999999999999999999999999999999953 11278999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHH
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY 226 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------~~~~~ 226 (475)
++.+...... ........++..|+|||++.+. .++.++|||||||+||+|++|..||.+..... ....+
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 159 ARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred ccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9876443221 1122345789999999998774 47999999999999999999999998654322 00011
Q ss_pred HHHhhc----------------------------ccc-ccHHH-Hh--cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 227 EKISEK----------------------------KVS-TSIEA-LC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 227 ~~i~~~----------------------------~~~-~~~~~-l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+... ... ..... +. ...+.++.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111000 000 00111 11 145678999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=302.74 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=197.7
Q ss_pred eeEeeeCceeEEEEEEcc-CC--eEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~-~~--~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+..|..++..++| ++++.++.+... ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH--ENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCC--CCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 3699998876544 2357778888888865 889999888777 8899999999
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 87 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 87 -g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc-
Confidence 889999987544 4689999999999999999999999999999999999994 6689999999999876543221
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
+.......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.+..+...... .....
T Consensus 154 ---~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~ 224 (257)
T cd05040 154 ---YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGER---LERPE 224 (257)
T ss_pred ---eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCc---CCCCc
Confidence 111223467889999999999899999999999999999998 9999976433 2333333221111 11224
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.+|..+.+++..||..+|++||++.+|++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 57899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=307.08 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=198.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|++.++||+|+||.||+|.+..+++.||+|++..... ...+..|++++..+.| ++++.+..++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH--ENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC--cchhhHHHhcccCCeEEEE
Confidence 579999999999999999999988999999998654332 2356778888888765 8999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|..+.. ....+++..++.++.||+.||.|||+.||+|+||+|+||++ ++++.++|+|||++..+....
T Consensus 79 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 79 FEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCc
Confidence 9999 556666554 34469999999999999999999999999999999999999 477899999999998654432
Q ss_pred cccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--------- 231 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~--------- 231 (475)
. ......++..|+|||++.+. .++.++|||||||++|||++|..||...........+..+..
T Consensus 155 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 E-------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred c-------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 1 11235688999999998764 478899999999999999999999976432111111111000
Q ss_pred --------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 --------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 --------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
............+++..+.+++.+||..+|++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00011122234567899999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=309.65 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=200.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..+|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|..+++.+.| ++++.+.+++..++..++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN--PNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCEEEEee
Confidence 47899999999999999999999999999999988654332 346667777776655 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc
Confidence 999 8899998863 468999999999999999999999999999999999999 4778999999999976543321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+...... ...+..... ......
T Consensus 171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~~~~~~~--~~~~~~ 238 (297)
T cd06656 171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNGT--PELQNP 238 (297)
T ss_pred -------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eeeeccCCC--CCCCCc
Confidence 11234789999999999998899999999999999999999999976432111 111111000 000112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++..+.+++.+||..+|++||++.+|++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 456788999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=303.89 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=200.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEe------C
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVE------G 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~ 76 (475)
.-.++|++.+.||+|+||.||+|.+..+++.|++|++..... ...+..|..+++.+.. |++++.++.++.. .
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN-HPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcC-CCChheEEEEEEecCCCCcc
Confidence 446899999999999999999999988999999999876543 3457788888888854 3999999888765 3
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
...++||||+ +++|.+++... +..+++..+..++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECCCc
Confidence 4589999999 78999988653 35799999999999999999999999999999999999994 67889999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-----~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
++........ ......|+..|+|||++.+. .++.++|||||||+||+|++|..||..... ...+.
T Consensus 159 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~ 228 (275)
T cd06608 159 VSAQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALF 228 (275)
T ss_pred cceecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHH
Confidence 9976543222 11335689999999988643 367899999999999999999999975432 22222
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+......... ....++.++.+++.+||..||++||++.+|++
T Consensus 229 ~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhhccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22222111110 11236789999999999999999999988854
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=309.73 Aligned_cols=263 Identities=22% Similarity=0.245 Sum_probs=200.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe----
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE---- 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~---- 75 (475)
...++|++.++||+|+||.||+|.+..+++.||||++..... .....+|+++++.++| ++++.+..+..+
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH--PNVVPLIDMAVERPDK 82 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCC--CCccchhhheeccccc
Confidence 346899999999999999999999999999999998754432 2356789999998876 888888766543
Q ss_pred ----CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 76 ----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 76 ----~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
....++||+|++.+|...+......+++..+..++.||+.||.|||++||+|+||||+|||+ ++++.++|+||
T Consensus 83 ~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~df 159 (311)
T cd07866 83 SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADF 159 (311)
T ss_pred ccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcC
Confidence 33579999999889988887555679999999999999999999999999999999999999 57889999999
Q ss_pred CCccccccccccccc----ccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011882 152 GLAKRYRDTATHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226 (475)
Q Consensus 152 GlA~~~~~~~~~~~~----~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~ 226 (475)
|+++........... .........|+..|+|||.+.+. .++.++|||||||++|||++|..||.+.......+.+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999876543221110 01112345678999999988764 4789999999999999999999999764432222222
Q ss_pred HHHhh----------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 227 EKISE----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 227 ~~i~~----------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..... .............+...+.+++.+||..||++||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 11110 0011111222234557899999999999999999988774
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.08 Aligned_cols=239 Identities=23% Similarity=0.309 Sum_probs=187.6
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHh-CCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQ-GGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~-~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
.||+|+||.||++.+..+++.||||.+...... .....|..+++.+. ..|++++.+..+...++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999987643221 12344555555543 24588888888888888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++.. ...+++..+..|+.||+.||.|||+++|+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 8899988864 4569999999999999999999999999999999999999 5778999999999975543211
Q ss_pred ccccCCCCccCcccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 167 PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~-g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
....||..|+|||.+. +..++.++|||||||++|||++|..||......... .+...... ....++..+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~----~~~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLT----VNVELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhc----CCcCCcccc
Confidence 2346899999999987 456899999999999999999999999865433322 22221111 111234567
Q ss_pred hHHHHHHHHHHhcCCCCCCC-----CHHHH
Q 011882 246 PTEFASYFHYCRSLRFDDKP-----DYAYL 270 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RP-----t~~~l 270 (475)
+.++.++|.+||..||.+|| +++++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~ 252 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 89999999999999999999 46655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.45 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=197.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC---
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--- 77 (475)
..++|++.++||+|+||.||+|.+..+++.||||.+...... .....|+.+++.+.| ++++.++.++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH--ENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCC--CCccceEEEEecccccc
Confidence 346799999999999999999999999999999987543322 235678888888865 88998887765443
Q ss_pred -----EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 78 -----YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 78 -----~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
..++||||++++|.+++......+++.+++.++.||+.||.|||++||+|+||||+|||+ +..+.+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg 164 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFG 164 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCC
Confidence 459999999989999887655579999999999999999999999999999999999999 477899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
++..+....... ........++..|+|||.+.+.. ++.++||||||+++|||++|..||.+.........+..+..
T Consensus 165 ~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred CcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 998765432211 01123346789999999987654 78999999999999999999999976443222222222110
Q ss_pred ccc------------------ccc-----HHHHh-cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 KKV------------------STS-----IEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~~~------------------~~~-----~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
... ... ...+. ...+..+.++|.+||..||.+||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 000 000 00000 01246678999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=303.13 Aligned_cols=239 Identities=18% Similarity=0.224 Sum_probs=188.5
Q ss_pred eeEeeeCceeEEEEEEccCC----------eEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~----------~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.||+|+||.||+|.+..++ ..|++|++..... ...+.+|..+++.+.| ++++.+.+++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH--KHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCC--cchhheeeEEec-CCcEE
Confidence 47899999999999987766 4588887665443 4567788888888765 899999888877 77899
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC----CCCcEEEeecCCccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLAKR 156 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~----~~~~vkL~DFGlA~~ 156 (475)
||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999 8899999876555799999999999999999999999999999999999996322 112799999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~--~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
.... ....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+. ...
T Consensus 158 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~ 223 (259)
T cd05037 158 VLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQH 223 (259)
T ss_pred cccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCC
Confidence 5431 123567789999999887 78999999999999999999 688887754322222211 110
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
. +.......+.+++.+||..+|++||++.+|++.|
T Consensus 224 ~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 R------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred C------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0111237899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=304.37 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=190.5
Q ss_pred eeEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.+. .++..+|+|.++..... ..+..|+.+++.++| ++++.+.+++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH--SNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCC--CCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 34568999987654432 246678888888865 89999998888888899999999
Q ss_pred CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 87 GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 87 g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
+++|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcce
Confidence 789999986432 2467778899999999999999999999999999999994 678899999999975432211
Q ss_pred ccccccccCCCCccCccccccccccCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-------~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+.......|+..|+|||++.+. .++.++|||||||++|||++ |..||......... ...+.....
T Consensus 156 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~ 228 (269)
T cd05087 156 -----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQL 228 (269)
T ss_pred -----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccC
Confidence 1112335678899999998643 35789999999999999996 99999765432111 111222222
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
....+.+...++..+.+++..|| .+|++||++++|...|+
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222333457789999999999 68999999999987764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=308.66 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=201.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEG--DY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~ 78 (475)
..++|++.+.||.|+||.||+|.+..+++.||||.++...... .+..|+.++..+.| ++++.+..+.... ..
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH--PNIVTVKEVVVGSNLDK 80 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC--CCEEEEEEEEEecCCCc
Confidence 3468999999999999999999999899999999886543322 35678888888874 9999998887766 89
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.|+||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +..+.+||+|||++..+.
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYG 157 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeecc
Confidence 99999999889999988666679999999999999999999999999999999999999 477899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc---
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 234 (475)
.... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||..........++........
T Consensus 158 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 158 SPLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred CCcc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 4321 112346788999999987654 68999999999999999999999976443222221111100000
Q ss_pred -------------------cccHHHHhcC--ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 235 -------------------STSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 235 -------------------~~~~~~l~~~--~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+...... +++.+.++|.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000111111 4788999999999999999999888854
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.07 Aligned_cols=256 Identities=20% Similarity=0.245 Sum_probs=188.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCC-eEEEEE------------------EeccC-CCchHHHHHHHHHHHHhCCCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LENVK-TKHPQLQYEAKLYKILQGGST 64 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAvK------------------i~~~~-~~~~~~~~E~~il~~l~~~~~ 64 (475)
+.++|+++++||+|+||+||+|..+... ..+++| .+... .....+.+|+.++..++| +
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H--p 223 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH--E 223 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC--C
Confidence 4578999999999999999998764322 222222 11111 112346788888888876 9
Q ss_pred CcCeeEEeeEeCCEEEEEEEcCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 140 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 140 (475)
||+.++.++...+..|++|++++++|.+++... ........++.|+.||+.||.|||++|||||||||+||||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--- 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--- 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 999999999999999999999988888877532 1224567788999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 141 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 141 ~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
+..+.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..++.+....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 47789999999999876543221 123467999999999999999999999999999999999987654332222
Q ss_pred CHHHHHHHHhhc------cc-------------------cccHHHHh--cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 221 TKKQKYEKISEK------KV-------------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 221 ~~~~~~~~i~~~------~~-------------------~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+.++... .+ ...+..+. ..++..+.++|.+||..||.+||++.+++
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 222222211110 00 00111111 24577889999999999999999999884
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.93 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=196.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-------hHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLQYEAKLYKILQGGSTGIPNLRWFGVE--GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-------~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~ 77 (475)
.+|++.++||+|+||.||+|.+..+++.||||.+...... ..+..|+.+++.+.| ++++.+.+++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH--ERIVQYYGCLRDPMER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCC--CCeeeEEeEeccCCCc
Confidence 5799999999999999999999999999999987543211 246678888888865 899998887655 35
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+++|||+ +++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+|||+ +..+.++|+|||+++.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKR 155 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccc
Confidence 788999999 88999998743 468999999999999999999999999999999999999 4778999999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
+...... ........|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+......
T Consensus 156 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~- 227 (265)
T cd06652 156 LQTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN- 227 (265)
T ss_pred ccccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCC-
Confidence 5432110 0112335689999999999998899999999999999999999999976422 2222222221111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+...++..+.+++..|| .+|++||++++|++
T Consensus 228 --~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 228 --PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred --CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 1122345678999999999 49999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.19 Aligned_cols=252 Identities=18% Similarity=0.315 Sum_probs=203.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|+++++||.|+||.||+|+++.+ .+.|++|.+...... ..+..|+++++.+.| ++++.++.++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH--KNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC--cceeeeEEEECCCCc
Confidence 6799999999999999999997543 467999987654433 457889999998865 899999999988899
Q ss_pred EEEEEEcC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
.++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEEc
Confidence 99999999 789999987433 1589999999999999999999999999999999999994 67889999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~ 228 (475)
|||+++....... .......++..|++||.+.+..++.++|||||||++|+|++ |..||..... ...+..
T Consensus 160 ~~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR 230 (275)
T ss_pred ccccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH
Confidence 9999875432211 11233466788999999998889999999999999999998 8899976432 233333
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
+........ ....+|..+.+++.+||..+|++||++.+++..|.
T Consensus 231 ~~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 332222111 12467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=299.11 Aligned_cols=246 Identities=21% Similarity=0.245 Sum_probs=203.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.++||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.+++ ++++.+..+....+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH--PNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC--CCeeeeEeeecCCCeEEEEE
Confidence 5999999999999999999999999999999876432 22357788888888876 88999999999999999999
Q ss_pred EcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+|||+ +.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence 999 889999887533 358999999999999999999999999999999999999 467889999999998664432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||... .....+..+...... ..
T Consensus 156 ~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~----~~ 221 (256)
T cd08218 156 EL-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYP----PV 221 (256)
T ss_pred hh-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCC----CC
Confidence 11 12346889999999999988999999999999999999999999753 233334443333222 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.++|.+||+.+|++||++.+|++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 3467899999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.41 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=198.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----CE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG-----DY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-----~~ 78 (475)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|..+++.+.. |++++.++.++... ..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~-h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN-HPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcC-CCCeEEEEEEEEeccccCCCe
Confidence 35789999999999999999999999999999998865432 3456778888887743 48999988877643 36
Q ss_pred EEEEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.++++. ....+++..++.++.|++.||.|||++||+||||||+||++ +..+.+||+|||++
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~ 175 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVS 175 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccc
Confidence 89999999 8899998863 34568999999999999999999999999999999999999 46788999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCC-----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i 229 (475)
..+...... .....|+..|+|||.+.... ++.++|||||||++|||++|..||..... ...+..+
T Consensus 176 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~ 245 (291)
T cd06639 176 AQLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKI 245 (291)
T ss_pred hhccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHH
Confidence 865432211 12346899999999986543 68999999999999999999999976432 2223333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........ .....++..+.+++.+||..+|++||++.+|++
T Consensus 246 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 246 PRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22211110 012345678999999999999999999888754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.29 Aligned_cols=249 Identities=18% Similarity=0.265 Sum_probs=189.0
Q ss_pred eeEeeeCceeEEEEEEcc--CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~--~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|.... ....||+|.+...... ..+..|+.+++.+.| ++|+.+++.+......++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h--~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH--PNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC--CCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999997533 3457889976543322 245678888887754 99999999988889999999999
Q ss_pred CCCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 87 GPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 87 g~sL~~ll~~~~~----~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh
Confidence 8899999875432 25678889999999999999999999999999999999 5778999999999875432211
Q ss_pred ccccccccCCCCccCccccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH-Hhhcc
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKK 233 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g-------~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~ 233 (475)
+.......++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+.. +....
T Consensus 156 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~ 227 (269)
T cd05042 156 -----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVREQD 227 (269)
T ss_pred -----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhhccC
Confidence 001123356778999998743 356889999999999999998 8899976432 222222 22222
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.....+.+...++..+.+++..|| .||++||++++|.++|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222223345568899999999999 59999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.60 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=195.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~ 77 (475)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ...+..|+.+++.++| ++++.+..+... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH--ERIVQYYGCLRDRAEK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCC--CCeeeEEEEEEcCCCC
Confidence 479999999999999999999999999999998764321 1246678888888865 889888877654 46
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||++ +.++.+||+|||+++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccc
Confidence 789999999 7899999874 3468999999999999999999999999999999999999 5678899999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
+....... .......++..|+|||++.+..++.++|||||||++|||++|..||..... .+.+........
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~-- 226 (266)
T cd06651 156 LQTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPT-- 226 (266)
T ss_pred cccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCC--
Confidence 54321100 011234689999999999998899999999999999999999999976432 222222221111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+.+...++..+.+++ .||..+|++||++++|+
T Consensus 227 -~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 227 -NPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred -CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 1122334678888988 68889999999988884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=299.59 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=208.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.+.||.|++|.||+|.+..+++.|+||++..... ...+..|...+..+++ ++++.+..++......+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES--PYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC--CCeeeEEEEEccCCeEEEEE
Confidence 479999999999999999999999999999998876643 3567788888888874 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ..+++..++.++.||+.||.|||+ .|++||||+|+||++ +.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 79 EYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCC
Confidence 999 79999999753 679999999999999999999999 999999999999999 578899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........+....+..... ..+
T Consensus 155 ~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 223 (264)
T cd06623 155 DQ-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSL 223 (264)
T ss_pred Cc-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCC
Confidence 21 1234688999999999998899999999999999999999999987643233444444432222 122
Q ss_pred hcC-ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... ++..+.+++..||..+|++||++.++++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 344 7899999999999999999999988854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=303.84 Aligned_cols=247 Identities=19% Similarity=0.329 Sum_probs=202.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .++.+|+++++.+. |++++.+..++......+++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN--SPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC--CCchhhhheeeecCCEEEEEE
Confidence 4789999999999999999999999999999987665332 35677888888877 489999998888889999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++......+++..+..++.||+.||.|||+ .||+|+||||+||+++ ..+.++|+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHH
Confidence 999 689999998655789999999999999999999999 9999999999999994 67889999999997664322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CCHHHHHHHHhhccccccHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~ 239 (475)
. ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..+.......
T Consensus 156 ~---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (265)
T cd06605 156 A---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR--- 223 (265)
T ss_pred h---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC---
Confidence 1 125788999999999999999999999999999999999999976421 11222222222222111
Q ss_pred HHhcC-ChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+... ++.++.++|.+||..+|++||++.+++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 224 -LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred -CChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 1122 688999999999999999999988874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=302.46 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=200.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC------------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~------------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
+|.+.+.||.|+||.||+|.+..+++.||||.++.... .+.+..|+.++..+.+ ++++.+++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH--LNIVQYLGFETT 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC--CCcceEEEEecc
Confidence 58999999999999999999988999999997653211 1235678888887765 899999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.+..++||||+ +++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||++ +.++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~ 155 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGIS 155 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccc
Confidence 99999999999 88999998754 579999999999999999999999999999999999999 47889999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
+......... ......|+..|+|||.+.+.. ++.++||||||+++|||++|..||..... .+.+..+...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNK 227 (272)
T ss_pred cccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhcc
Confidence 7654321111 123456899999999988755 78999999999999999999999965322 2222222211
Q ss_pred c-ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 K-VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ~-~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ...........++.++.+++.+||..+|++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1 111122334567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=314.66 Aligned_cols=258 Identities=18% Similarity=0.247 Sum_probs=201.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeE----eC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGV----EG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~----~~ 76 (475)
++++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.| ++++.+..++. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH--DNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC--CCccCHHHhccccCCCC
Confidence 5689999999999999999999999999999999876542 22356778899988875 88888766543 34
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...++||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEeccccccee
Confidence 57899999998899998863 4569999999999999999999999999999999999999 4788999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH------
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------ 229 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i------ 229 (475)
........ ........|+..|+|||.+.+ ..++.++|||||||++|||++|..||.+.........+...
T Consensus 157 ~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 64432211 011234578999999999866 45899999999999999999999999764322111111110
Q ss_pred -----------------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 230 -----------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 230 -----------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...........+...++.++.++|.+||+.+|++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 011111222334466789999999999999999999988764
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.07 Aligned_cols=240 Identities=19% Similarity=0.223 Sum_probs=186.9
Q ss_pred eeEeeeCceeEEEEEEccCCe-------EEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~-------~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+.||.|+||.||+|.+..++. .||+|++..... ...+..|..+++.+.| ++++.++.++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h--~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH--KHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC--CChhheeeEEEeCCCcEEEE
Confidence 469999999999999865543 488888654332 2346678888877765 99999999998888999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-----CCcEEEeecCCcccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKRY 157 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-----~~~vkL~DFGlA~~~ 157 (475)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. ...++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999 88999999866667899999999999999999999999999999999999963221 124799999998754
Q ss_pred cccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHhhcccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
... ....++..|+|||++.+. .++.++|||||||++|||++|. .||...... .. .......
T Consensus 159 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---~~-~~~~~~~-- 221 (258)
T cd05078 159 LPK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---KK-LQFYEDR-- 221 (258)
T ss_pred CCc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---HH-HHHHHcc--
Confidence 321 234688899999999874 4799999999999999999984 666543221 11 1111111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
..+....+.++.+++.+||+.+|++||++++|++.|
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ---HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112234567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=305.21 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=195.6
Q ss_pred eeEeeeCceeEEEEEEccCC------eEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~------~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+.||+|+||.||+|++.... +.||||.+.... ....+..|+.+++.+.| ++|+.+..++...+..+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH--PNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC--CCeeeEeeeecCCCCeEEEE
Confidence 36899999999999976544 689999875543 23457788888888865 89999999988889999999
Q ss_pred EcC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC--CCCcEEEeecCCc
Q 011882 84 DLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLA 154 (475)
Q Consensus 84 e~~-g~sL~~ll~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGlA 154 (475)
||+ +++|.+++... ...+++.+++.++.||+.||.|||+++|+|+||||+|||++.++ ....++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999 88999988642 13478999999999999999999999999999999999996322 2238999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+....
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~ 230 (269)
T cd05044 159 RDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGG 230 (269)
T ss_pred ccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCC
Confidence 865433211 11223356788999999999899999999999999999998 9999976432 22222222211
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.. .....+|..+.+++.+||..+|++||++.+|++.|+
T Consensus 231 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 122457899999999999999999999999988876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=308.37 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=200.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++++.+..++...+..++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC--CccHhhhcccccCCceEEEE
Confidence 4588889999999999999999889999999987644322 346778888887764 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++. ...+++..+..++.||+.||.|||++||+|+||+|+||+++ +++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcch
Confidence 999 789998886 45789999999999999999999999999999999999994 678899999999986654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+..... ..+.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~----~~~~ 222 (277)
T cd06642 157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIPKNSP----PTLE 222 (277)
T ss_pred -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---HhhhhcCCC----CCCC
Confidence 11234688999999999998999999999999999999999999976433221 111111111 1223
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++.++.+++.+||..+|++||++.+|+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 456889999999999999999999999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.69 Aligned_cols=255 Identities=20% Similarity=0.225 Sum_probs=198.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++| ++++.+.++....
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH--ENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCC--CCccchHHheecccccc
Confidence 5789999999999999999999999999999999875431 22356678888888865 8898887665433
Q ss_pred -CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 -~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...|++|||++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence 35799999999999998874 4579999999999999999999999999999999999999 467899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 231 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~--- 231 (475)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 157 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 157 TTSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred ccCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 6644321 1134568899999998875 4589999999999999999999999976422111111111000
Q ss_pred --------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 --------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.............++.++.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00111122334567899999999999999999999887743
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=298.66 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=202.3
Q ss_pred eEEeeeEeeeCceeEEEEEEccCC----eEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+++.+.||.|+||.||+|.+...+ ..||+|++..... ...+..|+.++..+.+ ++++.++.++......++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH--PNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC--CchheEEEEEcCCCeeEE
Confidence 467899999999999999988766 8999999876543 3467788899888844 899999999988899999
Q ss_pred EEEcC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||++ +++|.+++...... +++..+..++.||+.||.|||+.||+|+||||+||++ +..+.++|+|||+++....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceeccc
Confidence 99999 88999998754434 9999999999999999999999999999999999999 4677999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
..... .....++..|++||.+.+..++.++|||||||++|+|++ |..||.... ....+..+.......
T Consensus 156 ~~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~-- 224 (258)
T smart00219 156 DDYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLKKGYRLP-- 224 (258)
T ss_pred ccccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCCCCC--
Confidence 32211 112237789999999988889999999999999999998 889987632 233333333332221
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
....++.++.+++.+||..+|++||++.++++.|
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2244789999999999999999999999987653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=303.72 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=200.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.|++.+.||+|+||.||+|.+..+++.||||+++.... ..++..|+.+++.+.. .|++++.+..++..+...|+|
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 358899999999999999999999999999998865432 2457788889888862 348999999888899999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++ ..+.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCc
Confidence 9999 8899998863 4799999999999999999999999999999999999994 67899999999998765433
Q ss_pred cccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... .....+..... +.
T Consensus 156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~----~~ 221 (277)
T cd06917 156 S-------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLIPKSKP----PR 221 (277)
T ss_pred c-------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhccccCCC----CC
Confidence 1 1123478999999999875 44789999999999999999999999764321 11111111111 11
Q ss_pred Hhc-CChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 241 LCR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 241 l~~-~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+.. .++.++.+++..||..||++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 222 37889999999999999999999888854
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.28 Aligned_cols=252 Identities=20% Similarity=0.235 Sum_probs=199.4
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
|++.++||.|++|.||+|.+..+|..||||++..... ...+..|+++++.+++ ++++.+..++..++..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH--PNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC--CCccCHhheeccCCeEEEEEe
Confidence 7889999999999999999999999999998765432 2357789999888875 899999999999999999999
Q ss_pred cCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|++++|.+++.... ..+++..++.++.||+.||.|||+++++||||+|+||+++ .++.++|+|||++..+.....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc-
Confidence 99889999887543 3689999999999999999999999999999999999994 678999999999976533211
Q ss_pred cccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH-------------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------- 229 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i------------- 229 (475)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+...
T Consensus 155 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 155 ------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred ------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 11223568899999988764 4789999999999999999999999764321111111100
Q ss_pred --------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 230 --------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 230 --------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...............++.++.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000011222334567889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=307.01 Aligned_cols=245 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
...|++.++||+|+||.||+|.+..+++.||+|++...... ..+..|+++++.++| ++++.+.+++...+..+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH--PNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEEeCCeEE
Confidence 45699999999999999999999889999999987643321 346778888888865 99999999999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||+.++|.+++......+++..+..++.||+.||.|||+.||+||||+|+||++ ++++.++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCCC
Confidence 999999889988887666779999999999999999999999999999999999999 47789999999998754321
Q ss_pred ccccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
....|+..|+|||++. ...++.++||||||+++|||++|..||.+... ......+........
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTL 234 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCC
Confidence 2356888999999885 34578999999999999999999999976432 122222221111111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ...++.++.+++.+||..+|++||++.+|+.
T Consensus 235 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 S---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred C---chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 1236789999999999999999999888854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.43 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=201.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeE--eCCEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGV--EGDYNVL 81 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~~~~~l 81 (475)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.+ ++++.+..+.. .....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH--PNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCC--CccceeeeeeecCCCCEEEE
Confidence 58999999999999999999999999999998865432 2346678888888876 88988877654 4467899
Q ss_pred EEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 82 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH-----~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
+|||+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ ..+.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccc
Confidence 99999 88999998754 457999999999999999999999 89999999999999994 67899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
++..+..... ......|+..|++||++.+..++.++||||||+++|+|++|..||.... .......+...
T Consensus 156 ~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~ 225 (265)
T cd08217 156 LAKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEG 225 (265)
T ss_pred ccccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcC
Confidence 9987654321 0123478999999999999889999999999999999999999998643 22333333322
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. ..+...++.++.+++.+||..+|++||++.+|++
T Consensus 226 ~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 22 1233567899999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.02 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=201.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+|+..+.||+|+||.||+|.+..+++.|+||.+.... ....+..|+.+++.+.| ++++.+.+++......+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH--PNIVQYLGTEREEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC--CCchheeeeEecCCeEE
Confidence 5888999999999999999998899999999876543 22357778888888765 89999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
++|||+ +++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||++ +..+.+||+|||++.....
T Consensus 79 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 79 IFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccc
Confidence 999999 78999998743 468999999999999999999999999999999999999 4678999999999986544
Q ss_pred cccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.. ......|+..|++||.+.... ++.++|+|||||++|+|++|..||.... .......+.... ..
T Consensus 155 ~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~---~~ 220 (258)
T cd06632 155 FS--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSK---EL 220 (258)
T ss_pred cc--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHHHHHHhcc---cC
Confidence 32 123457899999999998776 8999999999999999999999997643 222222222211 11
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+...++.++.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2234567899999999999999999999888753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.84 Aligned_cols=240 Identities=17% Similarity=0.191 Sum_probs=184.2
Q ss_pred eeEeeeCceeEEEEEEcc------------CCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~------------~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+.||+|+||.||+|.... ....|++|++...... ..+..|..++..+.| ++++.+++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h--p~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH--KHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCC
Confidence 468999999999998532 2236899987554322 245666777777765 999999999998889
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC----CCcEEEeecCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR----ANQVYIIDFGL 153 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~----~~~vkL~DFGl 153 (475)
.+++|||+ +++|..++......+++..++.|+.||+.||.|||++||+||||||+||||..+.. ...++|+|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999 77888887755567999999999999999999999999999999999999963211 12389999999
Q ss_pred cccccccccccccccccCCCCccCcccccccccc-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHhh
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-g~~~s~ksDIwSlG~iL~ell-tG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+..+... ....++..|+|||.+. +..++.++|||||||+||||+ .|..||........ .....
T Consensus 159 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~ 223 (262)
T cd05077 159 PITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYE 223 (262)
T ss_pred CccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHh
Confidence 8754321 2346788999999887 466899999999999999998 58999876432211 11111
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.... +....+.++.+|+.+||+.||++||++.+|++.|
T Consensus 224 ~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 GQCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cCcc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 1223467899999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.17 Aligned_cols=263 Identities=18% Similarity=0.244 Sum_probs=204.1
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC----CCchHHHHHHHHHHHH-hCCCCCcCeeEEeeEe
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKIL-QGGSTGIPNLRWFGVE 75 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l-~~~~~~i~~l~~~~~~ 75 (475)
+++.+.++|++.+.||+|+||.||+|.+..+++.||||.+... .....+..|+.++..+ +| ++++.+++++..
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~ni~~~~~~~~~ 78 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH--PNIVKLLNVIKA 78 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCC--CCccceeeeecc
Confidence 4678899999999999999999999999889999999976432 1223466788888888 54 899999887654
Q ss_pred --CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 --GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 --~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
....|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~ 153 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGL 153 (337)
T ss_pred CCCceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccc
Confidence 346899999998899988863 378999999999999999999999999999999999999 5788999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh--
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS-- 230 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~-- 230 (475)
++.+....... .......+.||..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.........+....
T Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 154 ARSLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred hhccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 98765432211 00122345789999999988654 57899999999999999999999997643322111111110
Q ss_pred ---------------------hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 231 ---------------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 231 ---------------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..........+...++.++.+++..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 001111223344557899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=315.34 Aligned_cols=249 Identities=22% Similarity=0.261 Sum_probs=209.8
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.|+-.+.|+.-++||+||||+||-+.-..||+.||+|.+..+. ...-...|..++..+.. +.|+.+...++..
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s--~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS--PFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc--CcEEEEeeeecCC
Confidence 3556788999999999999999999999999999999765432 22336778889988877 7899998888999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
+..|+||.+| ||+|.-.|...+ ..|++..++.++.+|+.||++||..+||.|||||+|||| |+.|+|.|+|+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLA 334 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLA 334 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceE
Confidence 9999999999 999987776544 359999999999999999999999999999999999999 78999999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
..+...... ...+||..|||||++.+..|+...|+|||||+||||+.|+.||...+.....+.+.+. .
T Consensus 335 vei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----~ 402 (591)
T KOG0986|consen 335 VEIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----T 402 (591)
T ss_pred EecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH----H
Confidence 988765432 2448999999999999999999999999999999999999999875544333333222 2
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
....+++...++++.++|++..|..||.+|...
T Consensus 403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 233445667889999999999999999999764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.01 Aligned_cols=239 Identities=17% Similarity=0.227 Sum_probs=184.3
Q ss_pred eEeeeCceeEEEEEEccC------------------------CeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcC
Q 011882 14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIP 67 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~------------------------~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~ 67 (475)
+||+|+||.||+|....+ ...||+|++..... ...+..|+.++..+.| +|++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h--~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH--IHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC--CCee
Confidence 699999999999985322 13588998754322 1245567777776665 9999
Q ss_pred eeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC----CC
Q 011882 68 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RR 142 (475)
Q Consensus 68 ~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----~~ 142 (475)
.+++++......++||||+ +++|..++......+++..++.|+.||+.||+|||++||+||||||+|||++.. ..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999 889988887656679999999999999999999999999999999999999632 11
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 220 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~ell-tG~~Pf~~~~~~ 220 (475)
...+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......
T Consensus 160 ~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 235899999998654321 12357888999998876 56899999999999999985 699999765432
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 274 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 274 (475)
.....+ ..... +....+.++.+++.+||+.+|++||++.+|++.|
T Consensus 229 ~~~~~~----~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKERFY----EKKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH----HhccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 211111 11111 1123457899999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.31 Aligned_cols=265 Identities=20% Similarity=0.266 Sum_probs=204.7
Q ss_pred CCCccCCceEE-eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----------------HHHHHHHHHHHHhCCC
Q 011882 1 MEPRVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------------QLQYEAKLYKILQGGS 63 (475)
Q Consensus 1 m~~~i~~~y~l-~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----------------~~~~E~~il~~l~~~~ 63 (475)
|..-+.++|.. .+.||.|+||.||+|.+..+++.||||++....... .+..|++++..+.|
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-- 79 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-- 79 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC--
Confidence 67778899975 577999999999999999999999999876443221 46678888888875
Q ss_pred CCcCeeEEeeEeCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 64 ~~i~~l~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
++++.+..++...++.+++|||+.++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++ +..
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~ 155 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSK 155 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCC
Confidence 899999999999999999999998899999873 4569999999999999999999999999999999999999 477
Q ss_pred CcEEEeecCCcccccccccccc-------cccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCC
Q 011882 144 NQVYIIDFGLAKRYRDTATHQH-------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQ 215 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~-------~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~ 215 (475)
+.++|+|||++..+........ ..........++..|+|||.+.+.. ++.++|||||||++|||++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 8999999999987652211000 0000112335788999999998754 6899999999999999999999998
Q ss_pred CCCCCCHHHHHHHHhhcc--------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 216 GLKAGTKKQKYEKISEKK--------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 216 ~~~~~~~~~~~~~i~~~~--------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+.........+....... ...........++.++.+++..||..+|++||++++++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 754322111111111000 01112223345678999999999999999999988875
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.89 Aligned_cols=269 Identities=19% Similarity=0.310 Sum_probs=206.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
-.++|++.+.||+|+||.||+|.+..+++.||||.++..... ..+..|..++..+. .|++++.+++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-CCCchHhhheeeecCCeEEE
Confidence 357899999999999999999999888999999998754332 23445665554443 35999999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+|||++++|.+++......+++..+..++.||+.||.|||+ .||+||||||+||++ ++++.+||+|||++..+...
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCC
Confidence 99999889999887666789999999999999999999997 699999999999999 47789999999999766443
Q ss_pred ccccccccccCCCCccCccccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
... ....++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ..+.+..+.......
T Consensus 169 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS 238 (296)
T ss_pred Ccc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC
Confidence 221 1235788999999997654 78999999999999999999999965321 122233332222111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 291 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw 291 (475)
.+ ....++.++.+++.+||..||++||++.++++. .++.......+.+.+|
T Consensus 239 -~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~--~~~~~~~~~~~~~~~~ 289 (296)
T cd06618 239 -LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH--PFIRRYETAEVDVAGW 289 (296)
T ss_pred -CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC--hhhhccchhHHHHHHH
Confidence 11 112468899999999999999999999888543 3333333333333444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=301.44 Aligned_cols=252 Identities=19% Similarity=0.255 Sum_probs=197.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~~~~l 81 (475)
++|+..++||.|++|.||+|.+..+++.||+|.+..... ...+.+|++++..+.| ++|+.++.++.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS--PYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC--CCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999998875433 2457788888888765 899998876653 447899
Q ss_pred EEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 82 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 82 vme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
||||+ +++|.+++.. ....+++..+..|+.||+.||.|||+.||+|+||+|+||++ +..+.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccc
Confidence 99999 8899988753 23458999999999999999999999999999999999999 46778999999998765
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CCHHHHHHHHhhcccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVS 235 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~ 235 (475)
..... ....++..|++||.+.+..++.++|||||||++|+|++|..||..... ....+....+......
T Consensus 156 ~~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 156 VNSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226 (287)
T ss_pred ccccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence 43221 234678899999999998999999999999999999999999986532 1222222222221111
Q ss_pred ccHHHHh--cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....... ..+++++.+++.+||..+|.+||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1000000 134678999999999999999999887743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=299.95 Aligned_cols=249 Identities=22% Similarity=0.283 Sum_probs=198.8
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCE-----
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDY----- 78 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~----- 78 (475)
|++.+.||+|+||.||+|++..+++.||||.+...... ..+..|..+++.+.. .|++++.+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999998754332 245568778777753 46999999988887776
Q ss_pred EEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.+++||+++++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcceec
Confidence 89999999889999887543 3599999999999999999999999999999999999994 6689999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 232 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 232 (475)
..... .....++..|+|||++.+..++.++|||||||++|||++|..||.+.... +.+.++...
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 226 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPS 226 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCC
Confidence 44321 12235788999999999999999999999999999999999999874432 222222110
Q ss_pred -----------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 -----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 -----------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
............++.++.+++.+||..||++||++.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 011111222334568889999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=316.57 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=213.0
Q ss_pred EEeeeEeeeCceeEEEEEEccC--C--eEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQT--N--EEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~--~--~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+.++||+|.||.||.|..... | -.||||..+.+.. .+.+..|+-+++.+.| +||+++++++.+. ..|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdH--phIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDH--PHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCC--cchhheeeeeecc-ceeEE
Confidence 3457899999999999986532 2 3689998776543 3458889999998887 9999999998766 46999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||++ -|-|..+++..+..++..++..++.||+.||.|||++.+|||||-..|||++ ...+|||+|||+++.+.+..
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccc
Confidence 9999 8899999998888899999999999999999999999999999999999995 77899999999999887755
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. |.. ....-...|||||.+.-..++.++|||-|||++||++. |..||++.+..+....+++... ..
T Consensus 546 y-----Yka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------lP 612 (974)
T KOG4257|consen 546 Y-----YKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------LP 612 (974)
T ss_pred h-----hhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-------CC
Confidence 3 221 12233567999999999999999999999999999987 9999999877654443333222 22
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
++.+||+.+..|+.+||+++|.+||++.+|...|.++++....
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 4478999999999999999999999999999999999985543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=297.45 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||.|+||.||+|.+..++..||+|.+... .....+..|+.+++.+++ ++++.+.+.+......++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH--PNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC--CChhhhhheeccCCeEEEEE
Confidence 589999999999999999999999999999987654 233457789998888875 89999998888999999999
Q ss_pred EcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ ++...+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCc
Confidence 999 889999887533 3589999999999999999999999999999999999995 333567999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.. .....|+..|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+...... .+
T Consensus 157 ~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~ 222 (257)
T cd08225 157 EL-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQGYFA----PI 222 (257)
T ss_pred cc-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhcccCC----CC
Confidence 21 123468999999999998889999999999999999999999997532 22333333222221 22
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.+++.+||..+|++||++.+|++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3457889999999999999999999888853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.76 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=201.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-- 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-- 77 (475)
+..++|++.+.||+|+||.||+|.+..+++.||||+++.... ...+..|..+++.++| ++++.++.++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h--~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH--RNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCC--CCeeeeeheecCcchh
Confidence 345789999999999999999999999999999999865432 2346678888888865 89999877766544
Q ss_pred --------EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 78 --------YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 78 --------~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
..+++|||++++|.+++......+++..++.|+.||+.||.|||+.||+||||||+||++ ++.+.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 789999999888888887555579999999999999999999999999999999999999 577899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
|||++..+...... ......++..|++||++.+. .++.++|||||||++|||++|+.||...........+..
T Consensus 159 dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999876543220 11223568889999988754 468999999999999999999999976433222222222
Q ss_pred Hhhcccc----------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 229 ISEKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 229 i~~~~~~----------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....... ......+..+|..+.+++..||..+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111100 0111223457899999999999999999999988753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.91 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=216.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+|++.||.|+||.|.+++++.+++.||+|+++.. .....|..|..++..-.. .-|+.++..+.++.+.|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns--~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS--EWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc--HHHHHHHHHhcCccceE
Confidence 46899999999999999999999999999999998762 233457778888775543 77888988999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ ||+|-.++.... +++++.+..++..|+.||.-||+.|+|||||||+|||| |..|+|||+|||.|-.+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCC
Confidence 999999 999999998766 89999999999999999999999999999999999999 6899999999999988875
Q ss_pred cccccccccccCCCCccCcccccccccc----C-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~----g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+.... ....+|||.|.|||++. + +.|++.+|+||+||++|||+.|..||.. ....+.|.+|...+-
T Consensus 228 dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 228 DGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKE 298 (1317)
T ss_pred CCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhh
Confidence 54322 34569999999999986 3 4689999999999999999999999976 456777888877644
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
.-.++.. ..++.+.++||...+. +|+.|..-.-+-++-.+ +|..-.+|+..+
T Consensus 299 ~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H-------pFF~g~~W~~iR 350 (1317)
T KOG0612|consen 299 SLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH-------PFFEGIDWDNIR 350 (1317)
T ss_pred hcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC-------ccccCCChhhhh
Confidence 3333321 2378999999999875 68888772222222222 344567896543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=299.80 Aligned_cols=248 Identities=21% Similarity=0.279 Sum_probs=196.1
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
+.....||+|+||.||+|.+..++..||+|.+..... ...+..|+.+++.++| ++++.+.+++..++..+++|||+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH--RNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC--CCeeeeeeeeccCCEEEEEEecC
Confidence 4445689999999999999988999999998765433 2357788898888865 89999999999999999999999
Q ss_pred -CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 87 -GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 87 -g~sL~~ll~~~~~~l--s~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+++|.+++......+ ++..++.++.||+.||.|||++||+||||||+||+++ ...+.++|+|||++..+.....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC-
Confidence 889999987544455 8889999999999999999999999999999999995 3357899999999976543221
Q ss_pred cccccccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
......|+..|+|||++.+.. ++.++||||||+++|+|++|..||....... ......... .....+
T Consensus 165 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~---~~~~~~ 233 (268)
T cd06624 165 ------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMF---KIHPEI 233 (268)
T ss_pred ------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhh---ccCCCC
Confidence 112346899999999987654 7899999999999999999999997643211 111111100 111123
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+++++.+++.+||..+|++||++.+|++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3567889999999999999999999988753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=300.37 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=197.1
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||.|+||.||+|.+..+++.||||++...... ..+..|..++.. ...|++++.++.++...+..|++|||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-QGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh-cCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 6799999999999999899999999987643221 123334333332 334599999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++... ..+++..+..++.||+.||.|||+.+|+||||+|+||++ +..+.++|+|||+++....
T Consensus 81 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 81 GGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc-------
Confidence 88999999743 468999999999999999999999999999999999999 4678899999999875432
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....|+..|++||.+.+..++.++||||||+++|||++|..||..... .+.+..+....... .......++
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~ 221 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCS 221 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCC
Confidence 1234688999999999998899999999999999999999999976432 33333333222211 112234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.++.+++.+||..+|++||++..+.++|.+.+.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 999999999999999999998888887777655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=301.03 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=201.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+-|++.++||.|+||.||+|.+..+++.||||+...... ...+..|..++..+.| ++++.++.++..++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC--CCEeEEEEEEEeCCeEEEEE
Confidence 348889999999999999999988999999998764432 2346678888887765 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++. ...+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++..+.....
T Consensus 82 e~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 82 EYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence 999 779998886 3568999999999999999999999999999999999999 4678899999999976543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..... +.+.
T Consensus 157 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 222 (277)
T cd06641 157 -------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNP----PTLE 222 (277)
T ss_pred -------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCC----CCCC
Confidence 11234688999999999988899999999999999999999999976432 222222222111 1233
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++.++.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 457899999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=301.42 Aligned_cols=240 Identities=22% Similarity=0.262 Sum_probs=189.4
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
.||+|+||.||+|.+..+++.||||++...... .....|..+++.+.. .|++++.+.+++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999899999999987653211 123445555555542 4588988888888899999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
|++|.+++.. ...+++..++.|+.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence 8899988863 4579999999999999999999999999999999999999 467889999999997654321
Q ss_pred ccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 167 PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
.....|+..|+|||++.+. .++.++|||||||++|||++|..||.+............+.... ..+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 222 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-----VELPDSF 222 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC-----CCCCCcC
Confidence 1245789999999999754 68999999999999999999999998753322222221111111 1123456
Q ss_pred hHHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011882 246 PTEFASYFHYCRSLRFDDKP-----DYAYLK 271 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RP-----t~~~l~ 271 (475)
+.++.+++.+||..+|.+|| ++.+++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 89999999999999999999 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.65 Aligned_cols=242 Identities=25% Similarity=0.303 Sum_probs=200.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.+.| ++++.++.++......++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH--PFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC--CChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999998899999999886532 22457778888888765 8999998888889999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ |++|.+++... ..+++..+..|+.||+.||.|||++||+|+||||+||++ ++++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCc
Confidence 9999 88999998754 579999999999999999999999999999999999999 577899999999998664432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.........+....... .....
T Consensus 155 ~--------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~ 221 (258)
T cd05578 155 L--------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLY 221 (258)
T ss_pred c--------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccC
Confidence 1 1235688999999999988899999999999999999999999987544322222222111 11223
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
...+|.++.++|.+||..||.+||++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCcc
Confidence 356789999999999999999999984
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.57 Aligned_cols=257 Identities=19% Similarity=0.223 Sum_probs=197.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-------
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVE------- 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~------- 75 (475)
++++|++.+.||.|+||.||+|.+..+++.||||.+...... ..+..|+++++.+++ ++++.++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h--~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH--DNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCC--CcchhhHhhhccccccccc
Confidence 468999999999999999999999999999999987654432 357789999988865 888887654332
Q ss_pred -------CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 76 -------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 76 -------~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
....|+||||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEE
Confidence 24679999999889988886 34699999999999999999999999999999999999995 34567999
Q ss_pred eecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
+|||+++.+....... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+...........
T Consensus 157 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 157 GDFGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred CCcccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999998654322111 01122367889999998764 457899999999999999999999997643221111111
Q ss_pred HH----------------------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 228 KI----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 228 ~i----------------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. ...........+...++.++.+++.+||..||++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 00 001111222333456788999999999999999999988874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.84 Aligned_cols=247 Identities=18% Similarity=0.309 Sum_probs=198.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.|.....||+|+||.||++.+..++..||||.+..... ...+..|..+++.++| ++++.+...+..+++.++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH--ENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC--CcHHHHHHheecCCeEEEEEe
Confidence 456667889999999999999988999999998754332 2346778888887765 899999888888999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++. ...+++.+++.++.||+.||.|||++||+||||||+||++ ++++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 100 FLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc-
Confidence 99 789988875 3468999999999999999999999999999999999999 4678999999999976543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......|+..|+|||.+.+..++.++|||||||++|||++|..||.+... ...+..+... ..... ....
T Consensus 174 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~-~~~~ 242 (292)
T cd06658 174 ------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDN-LPPRV-KDSH 242 (292)
T ss_pred ------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCCcc-cccc
Confidence 12345789999999999988899999999999999999999999976432 2222222111 11111 1123
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.++..+.+++..||..||.+||++.++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 46789999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=298.89 Aligned_cols=242 Identities=19% Similarity=0.258 Sum_probs=192.2
Q ss_pred CCceEEeeeE--eeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~L--G~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.+.+ |+|+||.||++.++.+++.+|+|++....... .|..+...+. .|++++.++..+...+..|+||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~-~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhh-cCCCEEEEEEEEecCCeeEEEE
Confidence 3567787777 99999999999999999999999976542221 2333333333 4599999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC-cEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+||++. ..+ .++|+|||+++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 89 DYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC-
Confidence 999 89999999754 4799999999999999999999999999999999999995 445 8999999999765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~ 240 (475)
....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+...... ...
T Consensus 164 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~ 228 (267)
T PHA03390 164 ----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLP 228 (267)
T ss_pred ----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----cCC
Confidence 234689999999999998999999999999999999999999985432211 1111111111 112
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 271 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~ 271 (475)
..+.+++.+.++|.+||+.+|.+||+ +++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 23467899999999999999999995 57664
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=305.89 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=199.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..|+..+.||+|+||.||+|.+..+++.||||.+...... ..+..|+.+++.++| ++++.+..++...+..++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH--PNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC--CCEEEEEEEEeeCCeEEE
Confidence 4588999999999999999999999999999987643221 246678888887765 899999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc-
Confidence 99999889988887666779999999999999999999999999999999999999 46789999999998754321
Q ss_pred cccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
....|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+........
T Consensus 179 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~- 244 (317)
T cd06635 179 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL- 244 (317)
T ss_pred ----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCC-
Confidence 2346889999999974 34688999999999999999999999976422 222222222211111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+++.+.+++.+||..+|.+||++.+|++
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 12346788999999999999999999988854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=301.34 Aligned_cols=249 Identities=22% Similarity=0.254 Sum_probs=202.2
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
|++.+.||.|++|.||+|.+..+++.|++|.+...... ..+..|..+++.+.+ ++++.++.+...+...+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH--PNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC--CCcchHHHhhccCCCEEEEEe
Confidence 67889999999999999999889999999987654332 457778888888874 899999988888899999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 85 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 85 ~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
|++++|.+++......+++..++.++.||+.||.|||+++|+|+||||+||++ +.++.++|+|||.+..+.....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc--
Confidence 99889999887666689999999999999999999999999999999999999 4678999999999987654321
Q ss_pred ccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----------
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 232 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 232 (475)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... ..+..+...
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhccc
Confidence 11234678899999999877 6899999999999999999999999764321 111111110
Q ss_pred --------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 --------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........+...++.++.++|.+||..||.+||++.+|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0011122334457889999999999999999999988753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=306.18 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=196.3
Q ss_pred ceEEeeeEeeeCceeEEEEEEccC--CeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GD 77 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~--~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~ 77 (475)
+|++.+.||+|+||.||+|.+..+ +..||||.+..... ...+..|+.+++.+.+ |++++.+..++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG-HKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCChheeeeeeeeccccCC
Confidence 589999999999999999999887 88999998764321 2356778888888754 3889988776432 25
Q ss_pred EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 78 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
..+++|++++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 80 ~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence 6789999999999998863 4579999999999999999999999999999999999999 46789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH---------
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE--------- 227 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~--------- 227 (475)
....... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 156 SENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred ccccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 5432211 011234578999999998876 458999999999999999999999997643211111100
Q ss_pred ---HHhh-----------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 228 ---KISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 228 ---~i~~-----------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+.. .........+...++.++.+++.+||..||.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000 0011122333445678999999999999999999988763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.77 Aligned_cols=247 Identities=17% Similarity=0.292 Sum_probs=200.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..|+...+||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++++.+..++..++..+++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--p~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH--QNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC--CchhhhhhheeeCCeEEEEEe
Confidence 446667789999999999999988999999999765432 2456678877777764 899999998889999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 99 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 99 FLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred cCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc-
Confidence 99 789998875 3568999999999999999999999999999999999999 5778999999999976543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......|+..|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+...... ......
T Consensus 173 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~--~~~~~~ 241 (297)
T cd06659 173 ------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPP--KLKNAH 241 (297)
T ss_pred ------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCC--CccccC
Confidence 1134578999999999999899999999999999999999999997533 22333333222111 111234
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.++.++.+++.+||..+|++||++.+|++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 57889999999999999999999888855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=297.14 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=212.5
Q ss_pred eEE-eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 9 FRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 9 y~l-~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
|++ .+.||+|+|+.|--+..+.++.+||||++.+...+ .++.+|++++..++++ +||+.+..|++++..+|||||-
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh-~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGH-KNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCC-ccHHHHHHHhcccceEEEEEec
Confidence 444 36899999999999999999999999998876554 4588999999999885 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
| ||+|...|.+ ...|++.++..+..+|+.||.|||.+||.||||||+|||....+.-.-||||||.|+.-+.......
T Consensus 158 m~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 158 MRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred ccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9 8898888874 4569999999999999999999999999999999999999755555679999999986544332222
Q ss_pred ccccccCCCCccCcccccccccc---CC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------------HHHHHH
Q 011882 165 HIPYRENKNLTGTARYASMNTHL---GI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYE 227 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~---g~--~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------------~~~~~~ 227 (475)
.+......+.+|+..|||||+.. +. .|+.+.|+||||||||-||.|..||.|.-..+ ....++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 22222345668999999999764 32 48999999999999999999999998753221 345567
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.|++.++..+-. -+..++.+.++++..++..|+.+|.++..++
T Consensus 317 sIQEGkYeFPdk-dWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 317 SIQEGKYEFPDK-DWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHhccCCcCChh-hhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 788877755433 3467889999999999999999998876653
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.44 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=199.6
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DYNVLV 82 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~~~lv 82 (475)
|++.++||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.+ ++++.+..+.... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH--PNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC--CCeeeheeeEecCCCCcEEEE
Confidence 789999999999999999999899999999987653 22346778889988875 8999998888877 899999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||+ ++++.+||+|||++........
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 79 FEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred eccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCc
Confidence 9999889999987554579999999999999999999999999999999999999 4788999999999987655432
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh----------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 231 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 231 (475)
. ......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+.....
T Consensus 156 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 156 A------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred c------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 1 11233568889999988764 578999999999999999999999976443211111111100
Q ss_pred ------------ccccccHHHHhcC-ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 ------------KKVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ------------~~~~~~~~~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
......+...... ++.++.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000111122233 3889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=291.80 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=203.6
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
+|.+.+.||+|++|.||++.+..+++.|++|++.... ....+..|.++++.+.+ ++++.+..++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH--PNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC--CCEeEEEEEEecCCeEEEEEec
Confidence 5899999999999999999998899999999987665 34568889998888874 8999999999888999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++ +.+.++|+|||++........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc--
Confidence 9 6999999986556799999999999999999999999999999999999994 678999999999987654321
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
.....|+..|++||.+.+..++.++||||||+++|+|++|..||..... ................ ....
T Consensus 154 ------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~~~~ 222 (253)
T cd05122 154 ------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLR--NPEK 222 (253)
T ss_pred ------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhcCCCCcC--cccc
Confidence 1345789999999999988899999999999999999999999976432 2222222211111100 0112
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
++.++.+++.+||..||++||++.++++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4789999999999999999999988754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.96 Aligned_cols=254 Identities=16% Similarity=0.190 Sum_probs=207.0
Q ss_pred ccCCceEEe-eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE----eCCE
Q 011882 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV----EGDY 78 (475)
Q Consensus 4 ~i~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~----~~~~ 78 (475)
.|.++|++- ++||-|-.|.|-.+.++.|++.+|+|++. +.+...+|+++...... |+||+.+.++++ ....
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~-h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASG-HPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcC-CCceEEeehhhhhhccCcee
Confidence 366788874 78999999999999999999999999875 44667889988776655 499999877654 3456
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+|||+| ||.|...++..+ ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|......+..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 78999999 999999887654 3599999999999999999999999999999999999998777778899999999996
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 235 (475)
-..... ..+.+-|+.|+|||++-...|+...|+||+||++|-|++|..||........ ...-.+|....+.
T Consensus 214 t~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 214 TQEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cCCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 543222 2345789999999999988999999999999999999999999986543221 1222344444443
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
.+-++ +..+++..+++|+.+|..+|.+|.|+.++
T Consensus 286 FP~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 286 FPEPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred CCChh-HhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 33333 35678899999999999999999997766
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.59 Aligned_cols=250 Identities=22% Similarity=0.247 Sum_probs=198.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE-GDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~~~ 79 (475)
+.++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|++++..+.| ++++.+..++.. ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH--ENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCC--CCeeeEeeeEecCCCcE
Confidence 5788999999999999999999999999999999764322 23457789999888875 899998887654 5678
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+++|||++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++.....
T Consensus 86 ~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence 9999999999998886 3468899999999999999999999999999999999999 4778999999999975432
Q ss_pred cccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH---------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------- 229 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i--------- 229 (475)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+.
T Consensus 161 ~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 161 Q----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred C----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 1 123467889999999876 56899999999999999999999999764321111111110
Q ss_pred --------------hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 230 --------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 230 --------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......+....+..++.++.++|.+||+.+|++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000111223344456789999999999999999999988773
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=298.78 Aligned_cols=252 Identities=18% Similarity=0.320 Sum_probs=195.9
Q ss_pred eEEeeeEeeeCceeEEEEEEcc---CCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD---- 77 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~---- 77 (475)
|++.+.||+|+||.||+|.+.. +++.||||++..+... .++..|+.+++.+.| ++++.+++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH--PNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC--CCcceEEEEEccCCCCCc
Confidence 6788999999999999998653 5789999988654332 246778888888865 89999988775432
Q ss_pred --EEEEEEEcC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 78 --YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 78 --~~~lvme~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
..+++++|+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence 347888888 88998876422 1247899999999999999999999999999999999999 467889999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~ 228 (475)
|||+++.+..... +.......++..|++||.+.+..++.++|||||||++|||++ |..||.+... ...+..
T Consensus 156 dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~ 227 (273)
T cd05074 156 DFGLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNY 227 (273)
T ss_pred cccccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHH
Confidence 9999986543221 111223356678999999998889999999999999999999 8999976432 222222
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+...... .....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 228 ~~~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221111 11235678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=296.62 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=197.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~ 77 (475)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+..|+++++.+++ ++++.+.++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h--~~i~~~~~~~~~~~~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH--DRIVQYYGCLRDPEEK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCC--CCcceEEEEEEcCCCC
Confidence 579999999999999999999999999999998753211 1246778889988875 889988877654 35
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||+++.
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccc
Confidence 688999999 7899998874 3458999999999999999999999999999999999999 4678899999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ...+.++... .
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---~ 225 (264)
T cd06653 156 IQTICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQ---P 225 (264)
T ss_pred cccccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcC---C
Confidence 54321100 011245689999999999998899999999999999999999999976432 2222222211 1
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+.++..+++++.+++.+||. ++..||++.+++
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 1223456788999999999999 579999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=308.98 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=194.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
.+.++|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.| ++++.+..++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~ 89 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQH--ENVIGLLDVFTSAVSG 89 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCC--CCccchhheecccccC
Confidence 356899999999999999999999999999999998764321 2346788898888865 8898887776543
Q ss_pred ---CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 ---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ---~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...++||+|+..+|..++ ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~ 163 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGL 163 (342)
T ss_pred CCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCC
Confidence 346899999988887765 3469999999999999999999999999999999999999 4778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+...
T Consensus 164 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~ 230 (342)
T cd07879 164 ARHADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKV 230 (342)
T ss_pred CcCCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh
Confidence 9754321 123467899999999876 45899999999999999999999999864321 111111110
Q ss_pred --------------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 --------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 --------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+...++.++.++|.+||+.||++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 001112222345678899999999999999999998885
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=298.24 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=197.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEcc-CCeEEEEEEeccCCC---------c---hHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK---------H---PQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAvKi~~~~~~---------~---~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
.|++.+.||+|+||.||+|.+.. +++.||||.+..... . .++..|..++... ..|++++.+..++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-LRHPNIVRYYKTFL 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-CCCCCeeeEEeeEc
Confidence 48899999999999999999877 678999998654321 1 1244455554432 23499999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
..+..+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .+|+|+||||+|||+ +..+.+||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEe
Confidence 999999999999 7899988753 24468999999999999999999996 789999999999999 477899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i 229 (475)
|||++........ .....|+..|++||++.+..++.++||||||+++|||++|..||..... ......+
T Consensus 157 dfg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKI 225 (269)
T ss_pred cccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHH
Confidence 9999986544321 1345789999999999998899999999999999999999999975332 2222333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
........ ....++.++.+++.+||..||++||++.++...+.
T Consensus 226 ~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 32222111 11356789999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=307.78 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=201.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-----E
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-----Y 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-----~ 78 (475)
+|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.+ ++++.+.++..... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH--ENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC--cchhhhhhhhcccCcccccc
Confidence 5999999999999999999998889999999876533 23467889999998874 88998887776654 7
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.|++|+|++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence 899999998899988863 4479999999999999999999999999999999999999 467899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-----
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 232 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 232 (475)
...... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.+.... +.+..+...
T Consensus 155 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~ 227 (330)
T cd07834 155 PDEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPS 227 (330)
T ss_pred cccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCC
Confidence 542110 112345689999999999988 7899999999999999999999999775432 112221110
Q ss_pred ---------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+...++.++.+++.+||+.+|++||++.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 001112223345788999999999999999999988875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.88 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=198.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.+.|...++||+|+||.||+|.+..+++.|+||++...... ..+..|..+++.++| ++++.+..++.+....|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH--PNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC--CCCccEEEEEEeCCEEE
Confidence 34577788999999999999999999999999987643321 346678888888865 99999999999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||+.++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++.....
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC-
Confidence 999999889999887666779999999999999999999999999999999999999 4678899999999864321
Q ss_pred ccccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.....|+..|+|||++. +..++.++|||||||++|||++|..||...... .....+.......
T Consensus 174 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~- 239 (313)
T cd06633 174 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSPT- 239 (313)
T ss_pred ----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC-
Confidence 13457899999999985 356889999999999999999999999764332 2222222211111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....++..+.+++.+||+.+|.+||++.+++
T Consensus 240 --~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 240 --LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11234678899999999999999999988875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.14 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=197.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC---
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--- 77 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.| ++++.+..++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH--ENVIGLLDVFTPDLSLD 90 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCC--CCccceeeeecCCcccc
Confidence 67889999999999999999999999999999998754322 2346789999988876 88888877665432
Q ss_pred ---EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 ---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ---~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..++||+|++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++ ..+.++|+|||++
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccc
Confidence 468999999999998886 35799999999999999999999999999999999999994 6788999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~- 232 (475)
....... ....++..|++||++.+ ..++.++|||||||++|+|++|..||.+.........+.++...
T Consensus 166 ~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 166 RQTDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred cccccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 7653321 23467899999999876 35789999999999999999999999864332111111111000
Q ss_pred ----------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+..+...++.++.++|.+|+..||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000112233356788899999999999999999988875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.71 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=212.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
|.-+|.-..+||.|.||.||-|.+..+|+..|+|-++... ..+.+..|..++..+.| +|++.++++.+..+..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH--pNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH--PNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC--ccccccCceeecHHHHH
Confidence 4457888899999999999999999999999999655432 33568899999999988 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|.|||| ||+|.+++. .++..++.....+..|++.||.|||++|||||||||+||+| +.++.+|++|||.|..+..
T Consensus 1311 IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecC
Confidence 999999 999999998 45567777788899999999999999999999999999999 5788999999999998766
Q ss_pred cccccccccccCCCCccCccccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~---~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
.. +.++ .+.+.+.||+.|||||++.|.. -..++||||||||+.||+||+.||..++.. .+.+.++..+..+
T Consensus 1387 ~~--~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~P- 1460 (1509)
T KOG4645|consen 1387 NA--QTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKP- 1460 (1509)
T ss_pred ch--hcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCC-
Confidence 52 1222 3445679999999999998654 578999999999999999999999886542 3333333333222
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.++..++.+-.++|.+||..||+.|.++.+| |+..|-+.
T Consensus 1461 ---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ql---le~~f~~~ 1499 (1509)
T KOG4645|consen 1461 ---QIPERLSSEGRDFLEHCLEQDPKMRWTASQL---LEHAFGKS 1499 (1509)
T ss_pred ---CCchhhhHhHHHHHHHHHhcCchhhhHHHHH---HHhhcccc
Confidence 2334478999999999999999999886654 55555443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.76 Aligned_cols=246 Identities=23% Similarity=0.299 Sum_probs=205.3
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ...+..|.++++.+++ ++++.+..........+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH--PNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC--CChhheEEEEecCCEEEEEE
Confidence 58999999999999999999998999999999876533 2457788888888874 89999988888889999999
Q ss_pred EcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 84 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+||++ +..+.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence 999 78999998764 3679999999999999999999999999999999999999 4678999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+......... ..
T Consensus 156 ~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~ 221 (258)
T cd08215 156 TVD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YP 221 (258)
T ss_pred Ccc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CC
Confidence 321 1233578999999999999889999999999999999999999997643 233333332222 12
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+...++.++.+++.+||..+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 233467899999999999999999999988854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=292.78 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=201.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|+||.||+|.+..+++.||||+++..... ..+..|..+++.+.+ ++++.+..+....+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH--PNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC--CChhheeeeEecCCEEEEEE
Confidence 599999999999999999999889999999998765442 357788888888865 89999999988999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. ...+++..+..|+.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 79 EYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred ecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCC
Confidence 999 8899999874 34589999999999999999999999999999999999994 678999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~---~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.... ......++..|++||++.+.. ++.++|||||||++||+++|..||..... .......+.... ...++
T Consensus 155 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~-~~~~~ 228 (264)
T cd06626 155 TMGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGH-KPPIP 228 (264)
T ss_pred cccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCC-CCCCC
Confidence 1100 012357889999999998776 88999999999999999999999976432 112222222211 11111
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. ...++..+.+++..||..+|++||++.+++
T Consensus 229 ~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 229 D-SLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred c-ccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1 123588999999999999999999988875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.91 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=205.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..+.|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|.++++.+.+ ++++.++.++......++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH--PNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC--CCeeEEEEEEEECCEEEEEE
Confidence 35679999999999999999999988899999999876543 4467788888888865 89999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh
Confidence 999 699999998654479999999999999999999999999999999999999 4678999999999876543321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......++..|++||++.+..++.++|||||||++|+|++|..||..... ......+....... .. ..
T Consensus 172 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~-~~ 239 (286)
T cd06614 172 -------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPP-LK-NP 239 (286)
T ss_pred -------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCC-Cc-ch
Confidence 11234678899999999988899999999999999999999999976432 22222222222111 11 11
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..++.++.++|.+||+.+|.+||++.+|+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 34789999999999999999999998884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=302.59 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=199.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ...+..|..+++.+.| ++++.++.++...+..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--p~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH--PNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC--CCeeehhheeeeCCcEEEEE
Confidence 4689999999999999999999988999999998764432 2356778888887764 89999999988899999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||++..+.....
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc
Confidence 999 8899998863 468899999999999999999999999999999999999 4678899999999876544322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......|++.|++||.+.+..++.++|||||||++|++++|..||....... .+..+....... ....
T Consensus 171 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~~~~~~~--~~~~ 238 (293)
T cd06647 171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGTPE--LQNP 238 (293)
T ss_pred -------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehhcCCCCC--CCCc
Confidence 1133578999999999998889999999999999999999999997643211 111111111000 0112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..++..+.+++.+||..+|++||++.+++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 34678899999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.31 Aligned_cols=248 Identities=19% Similarity=0.314 Sum_probs=208.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.|.|+..||.|+||.||+|.++.++-..|-|++..+... .++.-|++||..+.| |+|+.++..+..++..+|.+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH--P~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH--PVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC--hHHHHHHHHHhccCceEEEEe
Confidence 4588999999999999999999999988999988665433 457778999888875 999999888888889999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|| ||-...++-..++.+++.++.-+++|++.||.|||+++|||||||..|||++ -+|.|+|+|||.+........
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHh-
Confidence 99 7777777777888999999999999999999999999999999999999996 678999999999865443222
Q ss_pred cccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
....|.||++|||||+..+ .+|+.++||||||++|.||..+.+|...+.. ...+.+|.....++.+
T Consensus 186 ------kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 186 ------KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLL 256 (1187)
T ss_pred ------hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCccc
Confidence 2357899999999998764 5799999999999999999999999877544 4445555544443322
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
-+..++..|.+|+..||..||..||++++|+
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2345778999999999999999999998875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.38 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=209.3
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
....+.|.+.+.||+|.|+.|.+|.+..++..||||++....... .+.+|+++++.|.| |||++++.+.+....
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H--PnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH--PNIVKLFSVIETEAT 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC--cceeeeeeeeeecce
Confidence 345578999999999999999999999999999999987655432 36789999998887 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ ++.+.+++...+ ...+.++..++.|++.|++|||+++|||||||.+|||| +.+..+||+|||++..+
T Consensus 130 lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFF 205 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceee
Confidence 99999999 999999998554 56669999999999999999999999999999999999 57788999999999988
Q ss_pred cccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
..... ..+++|++.|+|||++.|.+| ++.+|+||+|++||-|+.|.+||.+.... ..-..+...++..
T Consensus 206 ~~~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rvl~gk~rI 274 (596)
T KOG0586|consen 206 DYGLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRVLRGKYRI 274 (596)
T ss_pred ccccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchheeeeecc
Confidence 75432 357899999999999999987 78999999999999999999999874332 2222333333322
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.-.++.+..++|.++|.++|.+|++.+++.
T Consensus 275 -----p~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 275 -----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred -----cceeechhHHHHHHhhccCccccCCHHHhh
Confidence 233567899999999999999999988764
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.66 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=190.9
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||+|+||.||+|.+..+++.||+|++.... ....+..|.++++.+++ ++++.+.......+..|+||||+ ++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS--RFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC--CCEeeeeeEEecCCeEEEEEecCCCC
Confidence 689999999999999999999999876432 12235678888888864 99999988888889999999999 78
Q ss_pred CHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 89 SLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 89 sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
+|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~----- 150 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK----- 150 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc-----
Confidence 9999887543 369999999999999999999999999999999999999 4778999999999976543211
Q ss_pred cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
.....++..|++||++.+..++.++|||||||++|+|++|..||...........+.... . .....+...+++
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~ 223 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT---L-EMAVEYPDKFSP 223 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc---c-cccccCCccCCH
Confidence 123467889999999998889999999999999999999999997654322222222111 1 111123345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~ 269 (475)
++.++|.+||..+|.+||++.+
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHccCChhHccCCCc
Confidence 9999999999999999995443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.60 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=194.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.++..++| ++|+.+..+....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH--ENVIGLLDVFTPARSLE 92 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCC--Ccccceeeeeeeccccc
Confidence 56889999999999999999999999999999998764321 2346678888888865 8898887665432
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+++++++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccc
Confidence 3478999999999998886 3469999999999999999999999999999999999999 46788999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~- 232 (475)
+..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|..||...........+......
T Consensus 168 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 168 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred cccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 754321 123578899999999877 46889999999999999999999999764322111111111000
Q ss_pred ----------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.............++++.++|..||..||.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 000011112234578899999999999999999987764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=322.86 Aligned_cols=271 Identities=23% Similarity=0.313 Sum_probs=210.3
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC---CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~---~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
+-....|...+.||+|+||.||+|+++.+|+.||||.++.. ...+...+|++++++|+| +||+.+.+..++.
T Consensus 9 ~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh--~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 9 SGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH--PNIVKLFDIEETKFLG 86 (732)
T ss_pred cCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc--hhhhhhcccCCccccC
Confidence 34456788999999999999999999999999999988763 334567889999999994 9999987776543
Q ss_pred ---CEEEEEEEcC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC-CCCcEEEe
Q 011882 77 ---DYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYII 149 (475)
Q Consensus 77 ---~~~~lvme~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~ 149 (475)
...++||||| ||||...++... ..+++.+++.++..++.||.|||++|||||||||.||++-.+. .....||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 3568999999 999999998543 2499999999999999999999999999999999999996543 33357999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC-HHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYE 227 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~-~~~~~~ 227 (475)
|||.|+.+.+... ...+.||..|.+||++.. ..|+..+|.|||||++|+++||.+||-...... ..+...
T Consensus 167 DfG~Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 167 DFGAARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred cccccccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 9999999887653 356899999999999994 789999999999999999999999997543321 122222
Q ss_pred HHhhccccc-----------------cH---HHHhcCChHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCC
Q 011882 228 KISEKKVST-----------------SI---EALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 228 ~i~~~~~~~-----------------~~---~~l~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~l~~~~~~ 283 (475)
.+..++... .+ ..++.++-..+...+..+|..+|.+|- .+.+....+.+++...-.
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv 316 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV 316 (732)
T ss_pred hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence 222111100 00 111122223466778888899999998 777777778888766543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.69 Aligned_cols=256 Identities=18% Similarity=0.271 Sum_probs=202.1
Q ss_pred ceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+|++.+.||+|+||.||++.+. .+++.||||+++... ....+..|..++..+.++ ++++.+......+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~-~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC-PFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCC-cchhhhheeeecCCE
Confidence 4899999999999999999864 467899999876432 123466788888888654 899999888888899
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||.||++ +.++.++|+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECcccccc
Confidence 99999999 7899988863 3568999999999999999999999999999999999999 46788999999999865
Q ss_pred cccccccccccccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKV 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~ 234 (475)
...... ......|+..|++||.+.+.. .+.++||||||+++|||++|..||...........+ ..+....
T Consensus 156 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 228 (288)
T cd05583 156 LAEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK- 228 (288)
T ss_pred cccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC-
Confidence 443211 122356899999999988765 788999999999999999999999653222111111 1111111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
......++.++.+++.+||+.+|++||++.++.++|+..+.
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 229 ----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 11234568899999999999999999999999888887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.96 Aligned_cols=245 Identities=21% Similarity=0.308 Sum_probs=198.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
...|+..+.||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.++| ++++.+..++......+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH--PNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCC--CCcccEEEEEEcCCeeE
Confidence 3458888999999999999999999999999998754321 1246678888888765 88999999988999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||+.++|.+++......+++.+++.++.|++.||.|||+++|+||||||+|||+ +.++.++|+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc
Confidence 999999889988887666679999999999999999999999999999999999999 46789999999998765332
Q ss_pred ccccccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~- 233 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPA- 233 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHhhcCCCC-
Confidence 23468899999999853 45788999999999999999999999764322 1222222211111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.....++..+.++|.+||..+|++||++.++++
T Consensus 234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112357789999999999999999999988754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.65 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=198.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.|.-.++||+|++|.||++.+..+++.|+||.+..... ...+.+|+.+++.+.+ ++++.+..++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h--~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH--PNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC--CChheEEEEEEcCCeEEEEEec
Confidence 56677899999999999999988999999998764432 2346778888887765 8999999998899999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc--
Confidence 9 8899999874 579999999999999999999999999999999999999 4778999999999875543211
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+....... .. ....
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~-~~-~~~~ 240 (285)
T cd06648 171 -----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPK-LK-NLHK 240 (285)
T ss_pred -----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCC-Cc-cccc
Confidence 11235689999999999988899999999999999999999999976332 23333333221111 11 1133
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
++..+.+++.+||..+|++||++.+++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 678999999999999999999988775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=288.94 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=206.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DYNVL 81 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~~~l 81 (475)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ...+..|.++++.+.+ ++++.+....... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH--PNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC--CCEeeEEEEEecCCCCeEEE
Confidence 58899999999999999999988999999999876543 3567888888888875 8999998888887 89999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||++ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++. ..+.++|+|||.+......
T Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEecccc
Confidence 99999 999999987544 899999999999999999999999999999999999994 6789999999999877654
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
... .......++..|++||.+.+..++.++||||||+++|+|++|..||.... ........+.... ....
T Consensus 155 ~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~---~~~~ 224 (260)
T cd06606 155 ETG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSG---EPPE 224 (260)
T ss_pred ccc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccC---CCcC
Confidence 321 01134578999999999998889999999999999999999999998754 2222222222211 1122
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...++.++.+++.+||..+|++||++.+++.
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 33556899999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=308.69 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=196.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC---
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--- 77 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+ ++++.+..+....+
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH--ENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccC--CCHHHHHHHhhcccccc
Confidence 5788999999999999999999999999999999876432 12346678888888865 88887766554443
Q ss_pred ---EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 ---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ---~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..++|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccc
Confidence 3899999999999999873 579999999999999999999999999999999999999 46788999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
...... .....++..|+|||.+.+. .++.++|||||||++|||++|..||.+... ...+..+....
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~ 232 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLV 232 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhc
Confidence 865432 1234688899999998753 578999999999999999999999976432 22222221110
Q ss_pred --------------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 --------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 --------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......+...++.++.++|.+||..+|++||++.+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 01112223345688999999999999999999988874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=293.78 Aligned_cols=249 Identities=18% Similarity=0.264 Sum_probs=186.9
Q ss_pred eeEeeeCceeEEEEEEccC--CeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~--~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
+.||+|+||.||+|..... ...+++|.++.... ...+..|+.++..++| ++++.+...+......|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH--PNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC--cchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23567776654432 2457778888887765 99999999999889999999999
Q ss_pred CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 87 GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 87 g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+++|.+++.... ..+....++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh-
Confidence 789999987532 346777889999999999999999999999999999999 4678899999999864322110
Q ss_pred cccccccCCCCccCccccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhc-cc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KV 234 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g-------~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~ 234 (475)
........|+..|+|||++.+ ..++.++|||||||++|||++ |..||..... ...+..+... ..
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~ 227 (268)
T cd05086 155 ----IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQV 227 (268)
T ss_pred ----hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhccc
Confidence 011234578899999998753 245789999999999999996 5778865432 2333332221 11
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
....+.+...+++.+.+++..|| .+|++||++++|++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11122334457889999999999 67999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=293.47 Aligned_cols=234 Identities=18% Similarity=0.244 Sum_probs=192.0
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++++.+..+...+...+++|||+ ++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH--PFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC--CCEeeeeeeEEcCCccEEEEecCCCC
Confidence 6999999999999988899999998765332 2457788888888865 89999999989999999999998 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||+++.......
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~------ 148 (262)
T cd05572 79 ELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK------ 148 (262)
T ss_pred cHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc------
Confidence 99999874 3468999999999999999999999999999999999999 4678999999999987654321
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
.....|+..|++||.+.+..++.++||||||+++|+|++|..||..... +..+.+..+........ ....++.+
T Consensus 149 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~ 222 (262)
T cd05572 149 --TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLE---FPNYIDKA 222 (262)
T ss_pred --cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCC---CCcccCHH
Confidence 1234688999999999988899999999999999999999999987542 22333333332111111 12344789
Q ss_pred HHHHHHHHhcCCCCCCCC
Q 011882 249 FASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt 266 (475)
+.+++.+||..+|++||+
T Consensus 223 ~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 223 AKDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHHccCChhhCcC
Confidence 999999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=288.47 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=203.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.+.||+|++|.||++.+..+++.|+||.+..... ...+..|++++..+.+ ++++.+..+.......+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH--PNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC--CCccEEEEEEEeCCEEEEEE
Confidence 58999999999999999999988999999998866543 2357788888888865 88999998888889999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ ..+.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 79 EYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred ecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCcc
Confidence 999 77999998744 5799999999999999999999999999999999999994 578999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
. .....++..|++||.+.+..++.++||||||+++|+|++|..||..... ............ ..+.
T Consensus 155 ~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 220 (254)
T cd06627 155 D-------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDH----PPLP 220 (254)
T ss_pred c-------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCC----CCCC
Confidence 1 2345789999999999888889999999999999999999999976432 222222222211 1233
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..++.++.+++.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 567899999999999999999999888753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.60 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=200.8
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
|++.++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.+ ++++.+..++......++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--PNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC--CCHHHHHhhhhcCCceEEEec
Confidence 678899999999999999999999999999887643 23456778888888874 999999998888899999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 85 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 85 ~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+++++|.+++......+++..++.++.|++.||.|||++||+||||+|+||++ ++++.++|+|||+++.......
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc--
Confidence 99889999998655579999999999999999999999999999999999999 4678999999999986644321
Q ss_pred ccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh------------
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------------ 231 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~------------ 231 (475)
......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+.....
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 11233567889999999877 789999999999999999999999976432211111111100
Q ss_pred ---------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 ---------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ---------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.............++.++.+++..||..+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011111223345789999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.18 Aligned_cols=251 Identities=15% Similarity=0.206 Sum_probs=188.5
Q ss_pred eeEeee--CceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G--~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
..||.| +||+||++.+..+++.||||++...... ..+..|+.+++.++| ++|+.++.++..++..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h--~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH--PNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCcceEeeeEecCCceEEEEecc
Confidence 456666 9999999999999999999998754432 346677777776665 89999999999999999999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 87 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 87 -g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+. ..+.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccc
Confidence 78999988754 34589999999999999999999999999999999999994 67889999998765443322111
Q ss_pred ccccccCCCCccCccccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc-------
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 235 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~--~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 235 (475)
...+.......++..|+|||++.+. .++.++|||||||++|||++|..||.+.... +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCccccc
Confidence 1111112223467789999999874 4789999999999999999999999764321 111111100000
Q ss_pred -----------------------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 236 -----------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 236 -----------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.........++.++.+|+.+||..||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000011123567899999999999999999999884
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=289.34 Aligned_cols=244 Identities=18% Similarity=0.288 Sum_probs=201.5
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+|++.++||+|+||.||++.+..+++.||||.+..... ...+..|.++++.+++ ++++.+..++......++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH--PNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC--CCchhhhhhhccCCEEEEEe
Confidence 58999999999999999999999999999998765432 2346678888888874 89999988888889999999
Q ss_pred EcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 84 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++ ..+.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhcc
Confidence 999 88999988642 34689999999999999999999999999999999999995 578899999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ....|+..|++||.+.+..++.++|+||||+++|||++|..||..... ......+......
T Consensus 156 ~~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~---- 219 (256)
T cd08530 156 NMA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYP---- 219 (256)
T ss_pred CCc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC----
Confidence 311 234688999999999998899999999999999999999999976432 2222223222222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+...++.++.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 223457889999999999999999999988854
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.05 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=209.6
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEE---EEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--EEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--YNV 80 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vA---vKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--~~~ 80 (475)
.+...+||+|+|-+||+|.|..+|.+|| ||+-+.... .+.+..|+++|+.|+| +||++++.++.+.. ...
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H--~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKH--PNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCC--CceeeeeeheecCCCceee
Confidence 4567899999999999999999999987 554333322 2468889999999988 99999987776554 478
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+|.|++ .|+|..++++. ++++.+.+..|++||+.||.|||++. |||||||-+||+|+ ...|.|||+|+|||+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHh
Confidence 899999 99999999854 57999999999999999999999985 99999999999997 67899999999999988
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... +...|||.|||||++. ..|+..+||||||++|+||+|+..||.... ...+.|.++..+..+..
T Consensus 197 r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 197 RKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHH
Confidence 76543 3468999999999998 679999999999999999999999998875 46788999888777655
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+..+ -.+++++||.+|+.. ..+||++.+| |.+.|..
T Consensus 265 l~kV---~dPevr~fIekCl~~-~~~R~sa~eL---L~d~Ff~ 300 (632)
T KOG0584|consen 265 LSKV---KDPEVREFIEKCLAT-KSERLSAKEL---LKDPFFD 300 (632)
T ss_pred hhcc---CCHHHHHHHHHHhcC-chhccCHHHH---hhChhhc
Confidence 5443 368999999999999 9999997776 5555543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.68 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=202.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|.+++..+. .|++++.++.++...+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-cCCCchhHHHHhcCCceEEE
Confidence 57999999999999999999999999999999876532 1235677888888776 24999999888888899999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||++ +++|.+++... ..+++..++.|+.||+.||.|||++|++|+||||+||++ +.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 80 VLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCc
Confidence 99999 99999999743 479999999999999999999999999999999999999 46788999999999876543
Q ss_pred ccccc-------------cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 161 ATHQH-------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 161 ~~~~~-------------~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
..... ........+.|+..|++||++.+..++.++||||||+++|++++|..||.... ..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~ 232 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQ 232 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHH
Confidence 32110 01122345678999999999998889999999999999999999999998643 233333
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
.+..... .+...+++.+.+++..||..+|++||++
T Consensus 233 ~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 233 KILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 3332221 1234568899999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.67 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=195.9
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
|++.+.||+|+||.||+|.+..+++.||||.+...... ....+|...+..+.. |++++.++.++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-HPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccC-CCCchhHHHHhhcCCcEEEEEec
Confidence 78999999999999999999888999999987654321 223457777766652 48999998888889999999999
Q ss_pred CCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
++++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||||+||++ +..+.++|+|||+++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC--
Confidence 9999999887543 468999999999999999999999999999999999999 4788999999999986544221
Q ss_pred ccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc----------
Q 011882 165 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 233 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 233 (475)
.....++..|+|||++.+ ..++.++||||||+++|||++|..||......+.......+....
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 123468899999998864 457899999999999999999999997653322221111111000
Q ss_pred ------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
............+..+.+++..||..+|++||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112222334688999999999999999999888753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=302.38 Aligned_cols=257 Identities=19% Similarity=0.266 Sum_probs=202.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-CCchHHHHHHHHHHHHhCCCCC----cCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGSTG----IPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~~----i~~l~~~~~~~~~ 78 (475)
.+.++|++.++||+|.||.|-.+.+..++..||||+++.- ...+....|+++++.+....|+ ++++..++...+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3578999999999999999999999999999999987643 3445567899999999664433 4455666777888
Q ss_pred EEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC----------------
Q 011882 79 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR---------------- 141 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~---------------- 141 (475)
.|||+|++|.|+.+++...+ .+|+...+..++.|++++++|||+.+++|-||||+|||+...+
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 99999999999999997533 4599999999999999999999999999999999999996321
Q ss_pred -CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 142 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 142 -~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
+...|+|+|||.|+.-.+.. ...+.|..|.|||+++|..++..+||||+||||+|+++|...|+.-.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13368999999998543322 3568899999999999999999999999999999999999999986544
Q ss_pred CHHHHHHHHhhccccccHHHH----------------------------hcC----------ChHHHHHHHHHHhcCCCC
Q 011882 221 TKKQKYEKISEKKVSTSIEAL----------------------------CRG----------YPTEFASYFHYCRSLRFD 262 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l----------------------------~~~----------~p~~l~~li~~cl~~dp~ 262 (475)
.....++.|........+..- |+- --.+|.+|++.||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 434444444432111111111 100 013589999999999999
Q ss_pred CCCCHHHH
Q 011882 263 DKPDYAYL 270 (475)
Q Consensus 263 ~RPt~~~l 270 (475)
+|+|+.|+
T Consensus 396 ~RiTl~EA 403 (415)
T KOG0671|consen 396 RRITLREA 403 (415)
T ss_pred ccccHHHH
Confidence 99997776
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.30 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=205.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
++.++.++||+|.||.|+.|.|...+ ..||||.+..... ..+|.+|+.++..|+| +|++++|++..+ ....
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H--~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH--PHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC--cceeEEeeeecc-chhh
Confidence 45778899999999999999997543 4799999876653 3679999999999988 899999888776 6678
Q ss_pred EEEEcC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 81 LVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||++ .|+|.+.+.. ....|-...+..++.||+.||.||.++++|||||-..|+||. ....||||||||.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccC
Confidence 999999 8999998876 345588899999999999999999999999999999999994 68899999999999887
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... |.......-...|+|||.+....++.++|||+|||+||||++ |..||.|.... +.+++|..+....
T Consensus 264 ~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL~~iD~~erLp- 335 (1039)
T KOG0199|consen 264 ENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QILKNIDAGERLP- 335 (1039)
T ss_pred CCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHHHhccccccCC-
Confidence 65431 111122233567999999999999999999999999999998 89999997653 4444444322211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
-.+.||+.+++++..||..+|.+||+|..|.+
T Consensus 336 ---RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 ---RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ---CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23678999999999999999999999999963
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=311.62 Aligned_cols=242 Identities=20% Similarity=0.323 Sum_probs=203.4
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcCC
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLG 87 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~g 87 (475)
.+.||+|.||+||-|++.++|+.||||++.+.. ...++..|+.|++.+.| |.|+.+...++..+..++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H--PGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH--PGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC--CCeeEEEEeecCCceEEEEehhhc
Confidence 478999999999999999999999999986542 34578899999998876 999999999999999999999997
Q ss_pred CCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 88 PSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 88 ~sL~~ll-~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
|++.++| ...++++++.....++.||+.||.|||.++|+|+||||+|||+...+.-.++||||||+|+.+.+...
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---- 722 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---- 722 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh----
Confidence 6666554 55577899999999999999999999999999999999999998776677999999999998876543
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
....+||+.|+|||+++.+.|.+.-|+||.|||+|--+.|.+||.... +..+.++.....-.+.+ ++.++
T Consensus 723 ----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P----W~eis 792 (888)
T KOG4236|consen 723 ----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP----WSEIS 792 (888)
T ss_pred ----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc----hhhcC
Confidence 246799999999999999999999999999999999999999997632 23333333333222222 35567
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~ 269 (475)
.+..+||..+|+..-.+|-+.+.
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHh
Confidence 89999999999999999977543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.97 Aligned_cols=243 Identities=17% Similarity=0.284 Sum_probs=192.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.... ....+..|+.++..+.++ ++|+.++..+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS-PFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccC-CChhceeeEeecCCe
Confidence 5899999999999999999874 478999999876432 123467788888888653 899999888888899
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 80 LHLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceec
Confidence 99999999 7899998874 4568999999999999999999999999999999999999 46789999999999865
Q ss_pred cccccccccccccCCCCccCccccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKV 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~--~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~ 234 (475)
...... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+ ..+.....
T Consensus 156 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (290)
T cd05613 156 HEDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229 (290)
T ss_pred cccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC
Confidence 432211 11235689999999998764 3678999999999999999999999753322222222 11111111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
.+...+++.+.+++.+||..+|++||+
T Consensus 230 -----~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 230 -----PYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred -----CCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 123457889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.03 Aligned_cols=145 Identities=23% Similarity=0.419 Sum_probs=128.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+++++||+|+||.||+|.+..+++.||||+++..... ..+..|..++..+++ ++|+.++.++....+.|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS--PFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC--CCcCeEEEEEEECCEEE
Confidence 37899999999999999999999999999999998654321 456778888887765 89999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
|||||+ |++|.+++.. ...+++..++.|+.||+.||.|||.+|||||||||+|||| +..+.+||+|||+++.
T Consensus 81 lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~~ 153 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSKV 153 (669)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCcc
Confidence 999999 8999999874 3468999999999999999999999999999999999999 4678999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=291.35 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=199.6
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||.|+||.||+|++..+++.|+||++..... ...+..|..+++.+.| ++++.+..........|++|||+ ++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS--PYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC--cchhHHHHheecCcEEEEEEecCCCC
Confidence 6899999999999988899999998865432 2356777888887764 89999988888899999999999 78
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc-ccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-HIP 167 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~-~~~ 167 (475)
+|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||++ +.++.++|+|||++.......... ...
T Consensus 79 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 79 DLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccc
Confidence 9999997543 79999999999999999999999999999999999999 577899999999987654321100 000
Q ss_pred cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChH
Q 011882 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 247 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 247 (475)
........++..|++||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+........ .. ..++.
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~--~~-~~~~~ 228 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWP--ED-VEVSD 228 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCC--cc-ccCCH
Confidence 011234568889999999998889999999999999999999999997643 3333333333222111 11 12489
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.+.+++.+||+.+|++||++..+.++|++-+
T Consensus 229 ~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 9999999999999999999987777777554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=308.53 Aligned_cols=260 Identities=17% Similarity=0.275 Sum_probs=215.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
....+.++||+|-||+|.+|+ ...+..||||+++..... ..+..|+++|..|++ |||+.+.+.|..++..++++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh--PNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH--PNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCC--CCeeEEEeeeecCCchHHHH
Confidence 456789999999999999998 355689999998776533 468899999999865 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ .|+|.+++.....+ +..+....|+.||+.||+||.+.+||||||.+.|+|+ +.++++||+|||+++.+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCC
Confidence 999 99999999865433 4666778899999999999999999999999999999 589999999999999665443
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
. |+.....+-..+|||+|.+..++++.++|||+||++|||+++ ...||..+.+....+...............
T Consensus 692 y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 692 Y-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred c-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 3 233344566789999999999999999999999999999865 789998876654444444443333333333
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
..+.-||.++.+++..||..|-.+||+|++|...|++.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 34466899999999999999999999999999888765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.55 Aligned_cols=245 Identities=23% Similarity=0.294 Sum_probs=195.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+|.+.++||+|+||.||++.+..++..+++|+.+... ...+...|..+++.++| ++++.++.++.+....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH--PAIVKFHASFLERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC--CcHHHHHHHHhcCCceE
Confidence 5999999999999999999998877777777654321 12235567777777765 89999988888888899
Q ss_pred EEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 81 LVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
+||||+ +++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||++. .+.++|+|||+++.
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~ 154 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRL 154 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceee
Confidence 999999 8899988864 235699999999999999999999999999999999999994 35699999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
+..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+......
T Consensus 155 ~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~- 223 (260)
T cd08222 155 LMGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPTP- 223 (260)
T ss_pred cCCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCCC-
Confidence 644322 1234568899999999988889999999999999999999999996532 22333333222211
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+...++.++.+++.+||..+|++||++.++++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 223467889999999999999999999888853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.63 Aligned_cols=244 Identities=18% Similarity=0.287 Sum_probs=196.0
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
....+||+|+||.||++.+..+++.||||.+..... ...+..|+.+++.+.+ ++++.+..++...+..+++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH--ENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC--cchhheeeEEEeCCEEEEEEecCC
Confidence 334679999999999999999999999998754332 2346778888887765 89999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+++|.+++. ...+++..++.++.|++.||+|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~---- 171 (292)
T cd06657 101 GGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP---- 171 (292)
T ss_pred CCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc----
Confidence 779988775 3468999999999999999999999999999999999999 4678899999999876543221
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
......|+..|++||.+.+..++.++|||||||++|+|++|..||.+... .+.+..+... ....... ...++
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~~-~~~~~ 243 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLKN-LHKVS 243 (292)
T ss_pred ---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccCC-cccCC
Confidence 11335789999999999888899999999999999999999999976332 2222222211 1111111 24568
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 247 TEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 247 ~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+.+++.+||..+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 89999999999999999999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=306.41 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=205.0
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---------chHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---------~~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
|.++++|-++.+||.|||++||+|.|....+.||||+-..... +....+|..|.+.|.| +.|+++++|+
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDH--pRIVKlYDyf 536 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDH--PRIVKLYDYF 536 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCc--ceeeeeeeee
Confidence 5678899999999999999999999999999999998544332 2335678888888877 7888887776
Q ss_pred E-eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 74 V-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 74 ~-~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
. +.+.+|.|+||| |.+|.-+++ ..+-++++++..|+.||+.||.||.+. .|||-||||.||||-.+...|.+||+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 5 678899999999 778877776 455699999999999999999999986 59999999999999877778899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 225 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~----~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~ 225 (475)
||||++.+.+..............+.||.+|++||+|.-. ..+.++||||+|||+|.++.|+.||.......+.-.
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 9999999988766544444456678999999999998643 368999999999999999999999965322111111
Q ss_pred HHHHhhc-cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 226 YEKISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 226 ~~~i~~~-~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
...|... .+..+ .-+.++.+.+.+|.+||++.-++|.+..+|
T Consensus 696 eNTIlkAtEVqFP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 696 ENTILKATEVQFP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhchhcceeccCC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 1111110 00000 013457899999999999999999775444
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=310.86 Aligned_cols=269 Identities=19% Similarity=0.265 Sum_probs=218.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..+++++..||-||||.|-++........+|+|++++... .+.+..|..|+..+.. +.|++++--+.+..+.|
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s--~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS--DFIVRLYRTFRDSKYVY 496 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc--hHHHHHHHHhccchhhh
Confidence 3567888999999999999998654444589998775432 2336678888887764 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+.||-| ||.|+.++.. .+.|+..+...++..+++|++|||.+|||.|||||+|.|| +.+|-+||.|||+|+.+..
T Consensus 497 mLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhcc
Confidence 999999 9999999974 5679999999999999999999999999999999999999 6899999999999998876
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... +-+++||+.|.|||+++++..+.++|.||||+++|||++|..||.+.+. ...|..|....- .-
T Consensus 573 g~K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid---~i 638 (732)
T KOG0614|consen 573 GRK--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGID---KI 638 (732)
T ss_pred CCc--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhh---hh
Confidence 432 3468999999999999999999999999999999999999999998554 444444443221 12
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 301 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 301 (475)
.+++.++....+||.++...+|.+|..+ ..|.++-++ .|..-|||+.++..+.++
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH-------~Wf~gfdweglr~~~L~p 695 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH-------RWFEGFDWEGLRSRTLPP 695 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh-------hhhhcCChhhhhhccCCC
Confidence 3446778889999999999999999763 233333333 344568999987765443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=299.32 Aligned_cols=274 Identities=21% Similarity=0.253 Sum_probs=221.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-..+|.++.+||+|+||.|.+|..+.+.+.+|||+++.+.. .+--..|.++|.+... .+.++.++..+..-+..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~k-ppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-PPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCC-CchHHHHHHHhhhhhhe
Confidence 34679999999999999999999999999999999876532 2234567777765544 48888888888899999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ ||+|--.++.. ++|.+..+..++.+|+-||-+||++|||.||||.+|||| +..+.|||+|||+++.-.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccc
Confidence 9999999 99998888754 579999999999999999999999999999999999999 689999999999998643
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
-... ...+++||+.|+|||++.-.+|+..+|+||+||+||||+.|+.||.+. +..+.+..|.+....
T Consensus 502 ~~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvs--- 568 (683)
T KOG0696|consen 502 FDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVS--- 568 (683)
T ss_pred cCCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCc---
Confidence 3222 246789999999999999999999999999999999999999999984 445667777776654
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCC
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 303 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 303 (475)
.++.++.+..+++...|.+.|.+|....---+ +++ .. -.+..-.||+.....+++++-
T Consensus 569 --yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge--~di-~~--H~FFR~iDWek~E~~eiqPPf 626 (683)
T KOG0696|consen 569 --YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGE--RDI-RE--HPFFRRIDWEKLERREIQPPF 626 (683)
T ss_pred --CcccccHHHHHHHHHHhhcCCccccCCCCccc--cch-hh--CcchhhccHHHHhhccCCCCC
Confidence 24678899999999999999999964321100 111 01 133345799988887777654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=290.60 Aligned_cols=251 Identities=18% Similarity=0.284 Sum_probs=204.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.+-+..||.|+||+|++..++.+|+..|||.+..... ..++..|.+....-... ++|+++++....++..||+||
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~c-p~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNC-PNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCC-cHHHHHhhhhhcCCceeeeHH
Confidence 44556789999999999999999999999998876554 34577777777666555 999999988888888899999
Q ss_pred cCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 85 LLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 85 ~~g~sL~~ll~~~----~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+|.-||..+.++. +..+++..+-.|....+.||.||-. ..||||||||+|||| +..|.|||||||++-.+.+
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence 9999998887532 4569999999999999999999996 689999999999999 6899999999999987766
Q ss_pred cccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
+... +.-.|...|||||.+.. ..|+.++||||||++|||++||.+||.+... ..+.+..+..+..+..
T Consensus 221 SiAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 221 SIAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL 290 (361)
T ss_pred HHHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence 5432 23378899999999864 3489999999999999999999999987543 4444555554444332
Q ss_pred H-HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 I-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~-~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ..-+-.++..+..+|..|+.+|-.+||.|.+|++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2 1223457889999999999999999999998864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.04 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=188.0
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
|.+++.+|.| |.||.+++..+++.||||+++... ....+..|+.++..++| ++++.++.++...+..+++||
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h--~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH--PNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC--cchhhhhheeecCCeEEEEEe
Confidence 3344444444 555666666799999999986542 12357888999988875 899999888888999999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||.+..+.....
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccc
Confidence 99 78999998753 34689999999999999999999999999999999999994 678999999999986644322
Q ss_pred ccccccccCCCCccCccccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 233 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~--~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 233 (475)
.............++..|+|||++.+. .++.++|||||||++|||++|..||...... .....++....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccC
Confidence 111111122345678899999998763 4789999999999999999999999864321 11111111000
Q ss_pred --------c-------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 --------V-------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 --------~-------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ..........++.++.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 00000111233568899999999999999999887743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=284.11 Aligned_cols=265 Identities=19% Similarity=0.230 Sum_probs=201.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC----eEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-C
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE-G 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~ 76 (475)
...|+++++||+|.||.||+|..++++ +.+|||.++... ......+|+.+++.++| +|++.+..++.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h--~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKH--PNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcC--CcchhHHHHHhccC
Confidence 357999999999999999999766554 378999887663 34568899999999998 788877555444 8
Q ss_pred CEEEEEEEcCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee-CCCCCcEEEeec
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDF 151 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~-~~~~~~vkL~DF 151 (475)
...++++||...+|.++|+... +.++...+..|+.||+.|+.|||++=|+||||||.||||.- +...|.|||+||
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 8899999999999999998653 34899999999999999999999999999999999999952 234589999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------C
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------T 221 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~---------~ 221 (475)
|+|+.+.++-. |......++-|.+|.|||.++|.. |+.+.|||++|||+.||++-+.-|.+.... +
T Consensus 181 GlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 181 GLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred cHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999876543 333445667899999999999875 899999999999999999988888763221 1
Q ss_pred HHHHHHHHhhcc----------ccc---cHHHH----------------hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 222 KKQKYEKISEKK----------VST---SIEAL----------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 222 ~~~~~~~i~~~~----------~~~---~~~~l----------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.... ++. .+..+ .+.-++...+|+.++|..||-+|.|+.+.
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA-- 334 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA-- 334 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH--
Confidence 111222211100 000 00000 01124457899999999999999998766
Q ss_pred HHHHHHH
Q 011882 273 LFRDLFI 279 (475)
Q Consensus 273 ~L~~l~~ 279 (475)
|++.+.
T Consensus 335 -leh~yF 340 (438)
T KOG0666|consen 335 -LEHPYF 340 (438)
T ss_pred -hccccc
Confidence 555443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.13 Aligned_cols=257 Identities=16% Similarity=0.257 Sum_probs=215.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
...+|.++||.|.||+||+|+-+..+ ..||||.++..... .+|..|+.|+-++.| |||+++.++........
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH--PNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH--PNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC--CcEEEEEEEEecCceeE
Confidence 45789999999999999999987666 47999999876543 358889999988776 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|+.||| .++|+.++....+.|+..++.-+++.|+.||.||-+.++|||||-..|||| +.+-.+|++||||++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence 999999 999999999888889999999999999999999999999999999999999 6888999999999998766
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
+.... | ......=..+|.|||.+.-..++.++||||||++|||.+. |..||.++.. .+.+..|.+.-..++
T Consensus 784 d~~~~---y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaIe~gyRLPp- 855 (996)
T KOG0196|consen 784 DPEAA---Y-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAIEQGYRLPP- 855 (996)
T ss_pred CCCcc---c-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHHHHhccCCCC-
Confidence 54211 1 1111112478999999999999999999999999999887 9999988654 333344433222111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
+-+||..|..|+..||++|-.+||.|.+|+..|++++.
T Consensus 856 ---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 856 ---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 25789999999999999999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=261.52 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=208.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+|.-.++||+|.||+||+|++..+++.||+|.+..+... ....+|+-+++.++| .||++++.....+....+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh--knivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH--KNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh--cceeehhhhhccCceeEEe
Confidence 3577789999999999999999999999999988766543 357899999999998 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
+|||..+|..++..+++.++.+.+..++.|++.||.|+|+++++||||||+|.|| +.++.+||+|||+|+.+.-+.
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce-
Confidence 9999999999999999999999999999999999999999999999999999999 689999999999999775432
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc-----
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS----- 235 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~----- 235 (475)
+.-...+-|.+|.+|.++.|.. |+...|+||.|||+.|+.. |...|.+.+..+...++.+.......
T Consensus 156 ------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred ------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 2334456799999999999877 7999999999999999997 77888886554444444443321111
Q ss_pred ----------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 236 ----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 236 ----------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
.....+...+...=++++++.+.-+|..|.++++.
T Consensus 230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaa 280 (292)
T KOG0662|consen 230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAA 280 (292)
T ss_pred cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHH
Confidence 11112222334455789999999999999997765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=305.60 Aligned_cols=241 Identities=20% Similarity=0.243 Sum_probs=200.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..+.|++...||.|+|+.|-.+.+..+++..++|++... ..+...|..++..... |++++.+...+.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~-h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRD-HPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcC-CCcceeecceecCCceeeeeeh
Confidence 457899999999999999999999999999999998765 3455667777766655 4999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
++ |+-|.+.+.. .+....++..|+.||+.|+.|||++|||||||||+|||+. ++.++++|+|||.++.....-
T Consensus 397 ~l~g~ell~ri~~--~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~-- 470 (612)
T KOG0603|consen 397 LLDGGELLRRIRS--KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC-- 470 (612)
T ss_pred hccccHHHHHHHh--cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh--
Confidence 99 5555554432 2333378888999999999999999999999999999994 478899999999998776541
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.+-+=|..|.|||+....+|+.++||||||++||+||+|+.||..-... .+.+..+...+.. .
T Consensus 471 --------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~ 533 (612)
T KOG0603|consen 471 --------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------E 533 (612)
T ss_pred --------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------c
Confidence 1235688999999999999999999999999999999999999874433 4455555544433 5
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.++.+.++|+.+||+.||.+||++.++.
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 6789999999999999999999998874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.30 Aligned_cols=234 Identities=23% Similarity=0.299 Sum_probs=194.0
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
||.|+||.||++.+..+++.||+|++..... ...+..|+.+++.+.+ ++++.++..+..+...+++||++ ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH--PFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC--CcHHHHHHHeecCCeeEEEEecCCCC
Confidence 6999999999999988899999998765432 2357788888888874 89999988888999999999999 99
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~ 168 (475)
+|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||++ +..+.++|+|||++........
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC------
Confidence 999998743 468999999999999999999999999999999999999 4678899999999987644321
Q ss_pred ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 169 ~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
......++..|++||.+.+...+.++|+||||+++|+|++|..||.... ..+.+..+..... .+...++.+
T Consensus 149 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~~~~~~~~ 219 (250)
T cd05123 149 -RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED---RKEIYEKILKDPL-----RFPEFLSPE 219 (250)
T ss_pred -cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCCHH
Confidence 1234578999999999998888999999999999999999999996532 2333333333221 233456899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH
Q 011882 249 FASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt~~~ 269 (475)
+.+++.+||..||++||++.+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 999999999999999999855
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.41 Aligned_cols=249 Identities=18% Similarity=0.191 Sum_probs=167.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC----CeEEEEEEeccCCCchHHHHHHHHHHHHhCCC-CCcCe-eEE----e-eE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKTKHPQLQYEAKLYKILQGGS-TGIPN-LRW----F-GV 74 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~----~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~-~~i~~-l~~----~-~~ 74 (475)
.++|++.++||+|+||.||+|.+..+ +..||||.+...... |..+...+.+.. ..+.. +.. . ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNERVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence 46899999999999999999999888 899999986543221 111222222110 11111 111 1 24
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRK-------------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 134 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~-------------------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 134 (475)
.....++||||+ +++|.+++...... .....+..|+.||+.||+|||+++||||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 566789999999 78999988643211 1234567899999999999999999999999999
Q ss_pred EEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCC----------------------CC
Q 011882 135 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----------------------QS 192 (475)
Q Consensus 135 ILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----------------------~s 192 (475)
|||+ ++.+.+||+|||+|+.+...... ....+.||+.|+|||++.... ++
T Consensus 286 ILl~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 286 IIFS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred EEEe--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9995 34578999999999865433221 124568899999999764322 34
Q ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-------------ccccHH---HHhcCChHHHHHHHHHH
Q 011882 193 RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------VSTSIE---ALCRGYPTEFASYFHYC 256 (475)
Q Consensus 193 ~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------~~~~~~---~l~~~~p~~l~~li~~c 256 (475)
.++|||||||+||||+++.+|+... ..+....+.... ...... .+........++||.+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 5679999999999999988776431 111111111100 000000 00111233456899999
Q ss_pred hcCCCCCCCCHHHHH
Q 011882 257 RSLRFDDKPDYAYLK 271 (475)
Q Consensus 257 l~~dp~~RPt~~~l~ 271 (475)
|..||++||++.+++
T Consensus 434 L~~dP~kR~ta~e~L 448 (566)
T PLN03225 434 MRFKGRQRISAKAAL 448 (566)
T ss_pred ccCCcccCCCHHHHh
Confidence 999999999988774
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.53 Aligned_cols=251 Identities=20% Similarity=0.357 Sum_probs=208.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeE-----eCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGV-----EGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~-----~~~~ 78 (475)
-.+.|+|++.||.|.+|.||+++++.+++.+||||...... .++++.|..+++.+.++ +|++.+++++. .++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~h-pnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHH-PNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCC-CCcceEEEEEEEecCCCCCe
Confidence 35679999999999999999999999999999999876654 45688888899888775 89998887775 4578
Q ss_pred EEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.||||||| |||.-|+++.. +.++.+..+..|+..++.||.+||...+||||||-.|||++ .++.|||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeee
Confidence 99999999 89999999754 45699999999999999999999999999999999999995 789999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCC-----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+..... ...+++||+.|||||++...+ |+.++|+||||++..||..|.+|+.++... ..+..|..
T Consensus 173 ldsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpR 242 (953)
T KOG0587|consen 173 LDSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 242 (953)
T ss_pred eecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCC
Confidence 766443 346789999999999997654 688999999999999999999999886542 23333333
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+.. .-++....+|.++|..||.+|++.||+..+++
T Consensus 243 NPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll 280 (953)
T KOG0587|consen 243 NPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELL 280 (953)
T ss_pred CCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhc
Confidence 222221 11345678999999999999999999976653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.99 Aligned_cols=256 Identities=21% Similarity=0.236 Sum_probs=187.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeE-------
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGV------- 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~------- 74 (475)
..++|+.++.||+||||.||+++++-+|+.||||.+..... ...+.+|++++..|+| +|++.++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnH--pNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNH--PNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCC--cceeeeehhhhccCCccc
Confidence 45789999999999999999999999999999998876642 2347889999999987 77765531100
Q ss_pred --------------------------------------------------------------------------------
Q 011882 75 -------------------------------------------------------------------------------- 74 (475)
Q Consensus 75 -------------------------------------------------------------------------------- 74 (475)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------eC-------CEEEEEEEcCCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHH
Q 011882 75 -------------------------EG-------DYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVH 121 (475)
Q Consensus 75 -------------------------~~-------~~~~lvme~~g~sL~~ll~~~~~~l-s~~~~~~i~~qi~~aL~yLH 121 (475)
+. .+.||-||||..+|...+...+... .....+++++||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 2458999999555544443233222 47789999999999999999
Q ss_pred hCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc---cc-------ccccc-cccccCCCCccCccccccccccCCC
Q 011882 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DT-------ATHQH-IPYRENKNLTGTARYASMNTHLGIE 190 (475)
Q Consensus 122 ~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~---~~-------~~~~~-~~~~~~~~~~GT~~Y~APE~~~g~~ 190 (475)
++|||||||||.||+| +..+.|||+|||+|+... .. .+... ...-..+..+||..|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999 588999999999998722 00 00000 1111235678999999999998765
Q ss_pred ---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 191 ---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 191 ---~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
|+.|+|+||||+||+||+. ||.. .......+..+.....+.+ +.+...--+.-..+|+.|++.||.+||++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCH
Confidence 9999999999999999985 5643 1222333333333333332 22222223456789999999999999999
Q ss_pred HHHH
Q 011882 268 AYLK 271 (475)
Q Consensus 268 ~~l~ 271 (475)
.+|+
T Consensus 866 ~eLL 869 (1351)
T KOG1035|consen 866 TELL 869 (1351)
T ss_pred HHHh
Confidence 8875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=281.88 Aligned_cols=273 Identities=20% Similarity=0.282 Sum_probs=217.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|.++++||.|+|..|.+++.++|.+.||+|+++++- .-+-.+.|..+.....+. |.++-++.++..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~-pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNN-PFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCC-CeEEehhhhhcccceEE
Confidence 478999999999999999999999999999999876543 223467788888776654 88888888888999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+|.||. |++|--.++ ..++++++.+..+...|+.||.|||++|||.||||.+|+|| +..+.+||+|+|+++.-..
T Consensus 328 fvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCC
Confidence 999999 888876666 45689999999999999999999999999999999999999 6899999999999986544
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----CCCHHHHHHHHhhccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYEKISEKKV 234 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~-----~~~~~~~~~~i~~~~~ 234 (475)
+.. ...+++||+.|.|||++.|.+|+..+|+|+|||+|+||+.|+.||.-.. ..+....++.|.++..
T Consensus 404 ~gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 404 PGD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 333 3467999999999999999999999999999999999999999997432 2233444555666554
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 299 (475)
. ++..++-....+++.-|.+||.+|....- .--|.++ .+.++..-.||+.+..+|.
T Consensus 477 r-----iprslsvkas~vlkgflnkdp~erlgc~~-~~g~~di---k~h~ffr~idwd~leqk~v 532 (593)
T KOG0695|consen 477 R-----IPRSLSVKASHVLKGFLNKDPKERLGCRP-QTGFSDI---KSHAFFRSIDWDLLEQKQV 532 (593)
T ss_pred c-----ccceeehhhHHHHHHhhcCCcHHhcCCCc-ccchhhh---hcchhhhhCCHHHHhhccc
Confidence 3 23556677788999999999999854221 0022222 2234444679998765543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.80 Aligned_cols=220 Identities=17% Similarity=0.178 Sum_probs=176.9
Q ss_pred eCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHH
Q 011882 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF 96 (475)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~ 96 (475)
|.||.||++.+..+++.||+|.+..... ...|... .+...+++++.++.++...+..+++|||+ |++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~--~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLT--IIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHH--HHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999999999999998865432 2333332 33445699999999999999999999999 7899998864
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCcc
Q 011882 97 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176 (475)
Q Consensus 97 ~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~G 176 (475)
. ..+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++..+.... ....+
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~ 144 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAV 144 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCc
Confidence 3 469999999999999999999999999999999999999 467889999999887654321 12356
Q ss_pred CccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHH
Q 011882 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYC 256 (475)
Q Consensus 177 T~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~c 256 (475)
+..|+|||.+.+..++.++|||||||++|||++|..||...... +.. ... ..+...++..+.++|.+|
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~-~~~---~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INT-HTT---LNIPEWVSEEARSLLQQL 212 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccc-ccc---cCCcccCCHHHHHHHHHH
Confidence 77899999998888999999999999999999999887542211 000 000 012345788999999999
Q ss_pred hcCCCCCCCCHH
Q 011882 257 RSLRFDDKPDYA 268 (475)
Q Consensus 257 l~~dp~~RPt~~ 268 (475)
|+.||++||++.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999963
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=286.00 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=203.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----EEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----YNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----~~~lv 82 (475)
...++.++||+|.||.||+|. -+++.||||++... ....++.|..|+....-.|+||+.+........ ..+||
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 346788999999999999998 56799999998755 456789999999998888899999988877555 78999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~---------~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
++|. .|+|.++++ ...+++....+|+..|++||+|||+ ..|+|||||..|||| ..+.++.|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9999 999999998 4579999999999999999999996 259999999999999 588999999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCC-CC-----CchhHHHHHHHHHHHHcCC------------CCC
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRGS------------LPW 214 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s-----~ksDIwSlG~iL~elltG~------------~Pf 214 (475)
||..+...... .....-+||.+|||||++.|.- +. .+.||||+|.|||||++.. +||
T Consensus 362 LAl~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 99988743321 1223468999999999998753 22 4689999999999999752 333
Q ss_pred CC-C-CCCCHHHHHHHHhhccccccHHHHhc--CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 215 QG-L-KAGTKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 215 ~~-~-~~~~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
+. . ...+..+....+..++..+.++.... ....-+.+.++.||..|++.|.|+.-+.+.+.++.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 31 0 11122333333444444444333332 23567999999999999999999999988888774
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=280.81 Aligned_cols=265 Identities=22% Similarity=0.306 Sum_probs=210.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----CEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG----DYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----~~~ 79 (475)
.|..+..+.+.||+|.||+||+|.| .|+.||||++... +.....+|.+|++-.--.|+||..+......+ ...
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEeccc-chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4678899999999999999999997 5899999998754 55678899999998777779998887766533 357
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
+||.+|. .|||.|+++. ..++.+..++++..++.||++||.. .|.|||||..|||| .+++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEee
Confidence 9999999 9999999984 6799999999999999999999952 49999999999999 6899999999
Q ss_pred cCCcccccccccccccccccCCCCccCccccccccccCCC------CCCchhHHHHHHHHHHHHcC----------CCCC
Q 011882 151 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPW 214 (475)
Q Consensus 151 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~------~s~ksDIwSlG~iL~elltG----------~~Pf 214 (475)
+|||...........++ .+..+||.+|||||++...- .-..+||||||.||||++.. ++||
T Consensus 360 LGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred ceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99998877654433332 35679999999999986432 13478999999999999852 6899
Q ss_pred CCCCCCC--HHHHHHHHhhccccccHHHHhcCCh--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 215 QGLKAGT--KKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 215 ~~~~~~~--~~~~~~~i~~~~~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+.-+.+ ..+..+-+--.+..+.++..+...| ..+.++++.||..+|.-|-++--|.+.|.++.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 8764433 2222222223344444444444443 468899999999999999999999999888863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=275.44 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=199.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeE------
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGV------ 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~------ 74 (475)
..+.|+-..+||+|.||+||+|+.+.+|+.||+|++-.+ .......+|++++..|+| ++++.+...+.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkH--env~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKH--ENVVNLIEICRTKATPT 92 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcc--hhHHHHHHHHhhccCCc
Confidence 456788899999999999999999999999999854322 123457889999999988 77777654432
Q ss_pred --eCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 75 --EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 75 --~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
+....|+||++|..+|..++.....+|+..++.+++.+++.||.|+|...|+|||+||+|+|| +.++.+||+|||
T Consensus 93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFG 169 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFG 169 (376)
T ss_pred ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccc
Confidence 233479999999999999998777789999999999999999999999999999999999999 578999999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+|+.+........-.| .+.+-|.+|.+||.++|. +|+++.|||..||||.||++|++-+++.........+..+..
T Consensus 170 lar~fs~~~n~~kpry---tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRY---TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred cccceecccccCCCCc---ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 9998876544322211 344669999999999986 589999999999999999999999988543222222211110
Q ss_pred ---cccccc----------------------HHHHhc--CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ---KKVSTS----------------------IEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ---~~~~~~----------------------~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+...+. ++...+ .-.++..+|+.+++.+||.+|+++++++
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 000000 000111 1134678999999999999999998874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.62 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=206.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
+.++.+.||+|.||.|++|.-.. ....||||.++..... ..+..|.++++.+..+ +|++.+.+.+....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H-~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKH-PNIVNLLGACTQDG 375 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCC-cchhhheeeeccCC
Confidence 44677799999999999997431 1457999988765544 5688899999988764 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..++|+||+ .|+|.+++..++ ..++..+++.++.||+.|++||+++.+|||||-..|||++
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~--- 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT--- 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---
Confidence 999999999 899999998665 2489999999999999999999999999999999999995
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCcc--CccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG--TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
.+..+||+|||+|+....... |. .....| ...|||||.+....|+.++||||||++|||+++ |..||.+..
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred CCCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 678999999999986444322 11 111122 345999999999999999999999999999998 999998743
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.. ...++.+..+.. ...+..|+.++.+++..||..+|++||++.++.+.|..++..
T Consensus 527 ~~--~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 PT--EELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred cH--HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 21 222333332222 122356789999999999999999999999999999997654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=290.47 Aligned_cols=274 Identities=22% Similarity=0.262 Sum_probs=205.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.-|..++.||-|+||+|.++....|...||+|.+.+.+.. .....|..||..... +-+++|++.+.+.+..|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn--~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN--EWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC--cceEEEEEEeccCCceEE
Confidence 3488999999999999999998889999999987654321 235668888876665 788999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ ||++-.|+-. -+-|.+..+..++.++..|+++.|..|+|||||||+|||| |.+|.|||+|||||+-+.-.
T Consensus 707 VMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceec
Confidence 99999 9999998874 3579999999999999999999999999999999999999 68999999999999866422
Q ss_pred cccc------cc------c---------------c--------ccCCCCccCccccccccccCCCCCCchhHHHHHHHHH
Q 011882 161 ATHQ------HI------P---------------Y--------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 205 (475)
Q Consensus 161 ~~~~------~~------~---------------~--------~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ 205 (475)
.... |. + . .....++||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1100 00 0 0 0123468999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 011882 206 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 285 (475)
Q Consensus 206 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 285 (475)
||+.|+.||-.........++...... +. -..|.+++.+..++|.++. -++++|..-. ..+.+ ..-.|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~-l~---~~~~~~ls~e~~~li~kLc-~sad~RLGkn-g~d~v------KaHpf 930 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNF-LH---IPYQGNLSKEALDLIQKLC-CSADSRLGKN-GADQV------KAHPF 930 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhc-cc---cccccccCHHHHHHHHHHh-cChhhhhccc-chhhh------hcCcc
Confidence 999999999876554433332221110 00 1124667888888888754 3577775421 11111 12345
Q ss_pred CCccccccccccc
Q 011882 286 DYVFDWTILKYQQ 298 (475)
Q Consensus 286 ~~~~dw~~~~~~~ 298 (475)
....||..+..+.
T Consensus 931 FkgIDfsslRkq~ 943 (1034)
T KOG0608|consen 931 FKGIDFSSLRKQR 943 (1034)
T ss_pred ccccchHhhhhcc
Confidence 5667888754443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=319.47 Aligned_cols=249 Identities=15% Similarity=0.172 Sum_probs=189.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL- 86 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~- 86 (475)
.|...+.||+|+||.||+|.+..++..||||.++.... ....|+++++.++| ++|+.+++++...+..|+||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H--pnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH--PNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC--CCcceEEEEEEcCCCCEEEEeCCC
Confidence 45667889999999999999989999999998764332 23456777777754 99999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+++|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||++ +..+..++. ||.+......
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC---
Confidence 899999986 4899999999999999999999 6799999999999999 455566654 6665433211
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--CHHHHHHHHhhc-cc----cc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEK-KV----ST 236 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~--~~~~~~~~i~~~-~~----~~ 236 (475)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+........ .. ..
T Consensus 836 --------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 836 --------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred --------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCc
Confidence 1236889999999999999999999999999999999999999643211 111111100000 00 00
Q ss_pred cHH---HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 237 SIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 237 ~~~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+. ........++.+++.+||+.||++||++.++++.|+++..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 000 0000112467889999999999999999999999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=274.81 Aligned_cols=136 Identities=25% Similarity=0.428 Sum_probs=115.7
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCC------CCcCeeEEeeE-
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGS------TGIPNLRWFGV- 74 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~------~~i~~l~~~~~- 74 (475)
+..+++|.+.++||.|.|++||+|.|..+.+.||+|+.+... ..+....|+++|+.+.... .+|+++++.+.
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 445689999999999999999999999999999999986543 3355788999999987654 34566655543
Q ss_pred ---eCCEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEe
Q 011882 75 ---EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMG 138 (475)
Q Consensus 75 ---~~~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~ 138 (475)
.+...|||+|++|.+|..+|.+.. +.++...+..|++||+.||.|||. .||||-||||+||||.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 567899999999999999998765 349999999999999999999996 7999999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.21 Aligned_cols=206 Identities=23% Similarity=0.295 Sum_probs=177.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-CCchHHHHHHHHHHHHhCCC----CCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGS----TGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~----~~i~~l~~~~~~~~~ 78 (475)
.+.++|.+....|+|-|++|..|.+..-|+.|||||+... .++..=..|++||+.|+... .|++.++-.+...+.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 5788999999999999999999999999999999998654 34566788999999998632 345666666777889
Q ss_pred EEEEEEcCCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~--ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.|||+|.+..+|.++++..+.. |....+..++.|+..||..|-.+||+|.||||+||||. .....+||||||.|..
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASF 586 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccccc
Confidence 9999999999999999877655 78899999999999999999999999999999999996 4567899999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
..+... .| +.-+..|.|||+++|.+|+...|+||+||+||||.||+..|.|.+..
T Consensus 587 ~~enei---tP------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 587 ASENEI---TP------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cccccc---cH------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 655332 22 34567899999999999999999999999999999999999885543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.59 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=211.0
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.+..++||+|+||+||+|.|...|+ +||||++..... ..++..|+-++..+.| +|++++.+++.... .-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldH--pnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDH--PNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCC--chHHHHhhhcccch-HHH
Confidence 4567899999999999999987665 689998765443 3567888888887776 99999998887666 678
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|.+|+ +|+|.++++..+.++-.+..+.|..||++||.|||++++|||||-..|||| .....+||.|||+|+.+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence 88898 999999999888899999999999999999999999999999999999999 58889999999999987765
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
...-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..||++....+....+++... +
T Consensus 852 ~~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--L----- 919 (1177)
T KOG1025|consen 852 EKEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--L----- 919 (1177)
T ss_pred cccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--C-----
Confidence 442221 11223567999999999999999999999999999998 9999999766554444433222 1
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..+..++.+++-++.+||..|++.||+|+++...|.++...-
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 122457889999999999999999999999999998876443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=256.77 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=191.2
Q ss_pred CceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHH
Q 011882 19 SFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLF 94 (475)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll 94 (475)
+||.||+|.+..+++.||+|++..... ...+..|.+.++.+++ ++++.+..++......+++||++ +++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH--PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC--CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988899999999876554 4578889998888844 89999999988889999999999 44999998
Q ss_pred HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCC
Q 011882 95 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174 (475)
Q Consensus 95 ~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~ 174 (475)
.... .++...++.++.+++.+|.|||+.+|+|+||+|.||+++ ..+.++|+|||++........ ....
T Consensus 79 ~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~--------~~~~ 146 (244)
T smart00220 79 KKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGL--------LTTF 146 (244)
T ss_pred Hhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccc--------cccc
Confidence 7533 389999999999999999999999999999999999994 668999999999987654321 2345
Q ss_pred ccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHH
Q 011882 175 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 254 (475)
Q Consensus 175 ~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~ 254 (475)
.++..|++||.+.+..++.++||||||+++|+|++|..||..... ....+..+....... ......++.++.+++.
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIR 222 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHH
Confidence 788899999999988899999999999999999999999976321 122222222222111 1111117889999999
Q ss_pred HHhcCCCCCCCCHHHHHH
Q 011882 255 YCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 255 ~cl~~dp~~RPt~~~l~~ 272 (475)
+||..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999988864
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.74 Aligned_cols=246 Identities=20% Similarity=0.229 Sum_probs=189.5
Q ss_pred EeeeEeeeCce-eEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcCCCC
Q 011882 11 LGRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPS 89 (475)
Q Consensus 11 l~~~LG~G~fG-~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~g~s 89 (475)
-.+.+|.|+.| .||+|. ..|+.||||.+-. ......++|+.+++.... |+||+++++...+..+.||+.|+|.++
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-e~~~~A~rEi~lL~eSD~-H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLLE-EFFDFAQREIQLLQESDE-HPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHhh-HhHHHHHHHHHHHHhccC-CCceEEEEeeccCCceEEEEehHhhhh
Confidence 34678899988 679998 5789999996532 234567889999987765 499999988888999999999999999
Q ss_pred HHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC--CCCcEEEeecCCccccccccccc
Q 011882 90 LEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 90 L~~ll~~~~~~---ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
|+++++..... ......+.++.|++.||++||+.+||||||||+||||...+ ....++|+|||+++.+.....
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s-- 666 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS-- 666 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc--
Confidence 99999853111 11245678899999999999999999999999999997542 335789999999998865433
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.++...+..||-.|+|||++.....+.++|||||||++|+.++| .+||... .+.-..|......- ..+..
T Consensus 667 --S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-----~~R~~NIl~~~~~L--~~L~~ 737 (903)
T KOG1027|consen 667 --SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-----LERQANILTGNYTL--VHLEP 737 (903)
T ss_pred --hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-----HHhhhhhhcCccce--eeecc
Confidence 22335678899999999999998889999999999999999995 9999653 22222232222111 01111
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
....+..+||.+|+..+|..||++.+|+
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 1112889999999999999999998884
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-33 Score=247.83 Aligned_cols=212 Identities=21% Similarity=0.276 Sum_probs=171.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch---HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~---~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+..-+..||+|++|.|-+.++..+|...|+|-+......+ ++.+|..+......+ |.++.+++........+|+||
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~C-Pf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDC-PFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCC-CeEEEeehhhhccccEEEeHH
Confidence 3445678999999999999999999999999876554432 344555555444433 777777777777888999999
Q ss_pred cCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 85 LLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 85 ~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
.|..||..+... .+..+++..+-+|+..++.||.|||++ .|||||+||+|||| +..|+||+||||++-.+.++
T Consensus 126 ~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred HhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhh
Confidence 999999888653 356799999999999999999999985 89999999999999 68999999999999887765
Q ss_pred ccccccccccCCCCccCccccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~----~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
... +.-.|...|||||.+... .|+.++||||||+++.||.++++||... .+..+.+.++.+..
T Consensus 203 iAk--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 203 IAK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEP 269 (282)
T ss_pred hHH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCC
Confidence 431 124788999999988643 5899999999999999999999999764 34566666665543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=249.34 Aligned_cols=250 Identities=19% Similarity=0.310 Sum_probs=193.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~~~lvm 83 (475)
.++|++.+++|.|-|++||.|.+..+++.++||+++.- +...+.+|++|++.|.++ +||+.+.....+. ....|++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg-~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGG-PNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCC-CCeeehhhhhcCccccCchhHh
Confidence 46799999999999999999999999999999998754 456799999999999976 9999987776644 4567899
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+. ..+...+.. +++..++..++.|++.||.|+|+.||+|||+||.|++|+ .....++|+|+|+|..+.....
T Consensus 115 E~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce
Confidence 998 556665553 688899999999999999999999999999999999996 4567899999999988765432
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCC-CCCCHHHHHHHHhh---------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL-KAGTKKQKYEKISE--------- 231 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~-~~~~~~~~~~~i~~--------- 231 (475)
-+..+.+..|--||.+..-+ |+..-|+|||||+|..|+..+.||..- ...+..-++.++..
T Consensus 189 --------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 189 --------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred --------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 12335667788899988754 789999999999999999999998532 22222222222110
Q ss_pred ---ccccccHHHHh----------------cC-ChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ---KKVSTSIEALC----------------RG-YPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ---~~~~~~~~~l~----------------~~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+.+....+. .. .+++..+|+.++|..|.++|+|+.|..
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 11111111110 11 258899999999999999999998774
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=273.52 Aligned_cols=254 Identities=19% Similarity=0.196 Sum_probs=172.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc----------------cCCeEEEEEEeccCCCc----------------hHHHHHH
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLENVKTKH----------------PQLQYEA 53 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~----------------~~~~~vAvKi~~~~~~~----------------~~~~~E~ 53 (475)
.++|++.++||+|+||.||+|.+. ..++.||||.++..... .....|.
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 23467999987643211 1122345
Q ss_pred HHHHHHhCCC---CCcCeeEEeeE--------eCCEEEEEEEcC-CCCHHHHHHHcC-----------------------
Q 011882 54 KLYKILQGGS---TGIPNLRWFGV--------EGDYNVLVIDLL-GPSLEDLFNFCS----------------------- 98 (475)
Q Consensus 54 ~il~~l~~~~---~~i~~l~~~~~--------~~~~~~lvme~~-g~sL~~ll~~~~----------------------- 98 (475)
.++..+++.. .+++.+..++. .....+|||||+ +++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 5555555421 11233333332 234679999999 889999886321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCc
Q 011882 99 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178 (475)
Q Consensus 99 ~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~ 178 (475)
..+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.+...... ......+|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~~tp 374 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGMLDP 374 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccCCCc
Confidence 124667889999999999999999999999999999999 46788999999999755332110 011224588
Q ss_pred cccccccccCCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCCCCCCCH--------HHHHH
Q 011882 179 RYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTK--------KQKYE 227 (475)
Q Consensus 179 ~Y~APE~~~g~~~----------------------s~ksDIwSlG~iL~elltG~~-Pf~~~~~~~~--------~~~~~ 227 (475)
.|+|||++..... ..+.||||+|||||+|++|.+ ||.+...... ...+.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 9999999864321 134699999999999999986 7764321111 11111
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCC---CCCCCHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLK 271 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp---~~RPt~~~l~ 271 (475)
.+...... .. .....++..++|+.+||..++ .+|+++++++
T Consensus 455 ~~~~~~~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 11111111 11 234567899999999999866 6899988774
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=274.15 Aligned_cols=197 Identities=23% Similarity=0.359 Sum_probs=173.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----------CchHHHHHHHHHHHHh-CCCCCcCeeEEeeEe
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQ-GGSTGIPNLRWFGVE 75 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~-~~~~~i~~l~~~~~~ 75 (475)
.+|..++.||+|+||.|++|.++.+..+|+||.+.+.. +-..+-.|+.||..|+ +.|+||+++..|+++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45999999999999999999999999999999875432 2234677999999987 567999999999999
Q ss_pred CCEEEEEEEcC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 GDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 ~~~~~lvme~~--g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
++++||+||-- |-+|.++|+ .+..+++.++.-|+.||+.|+++||+.||||||||-+|+++ +.+|.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccc
Confidence 99999999998 668888887 45679999999999999999999999999999999999999 6899999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 216 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~ 216 (475)
|....... ...++||..|+|||++.|..| +..-|||+||++||.++....||.+
T Consensus 717 aa~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 87544322 246899999999999999887 7888999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=252.28 Aligned_cols=264 Identities=20% Similarity=0.308 Sum_probs=200.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-CCchHHHHHHHHHHHHhCCCCCcCe-eEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGSTGIPN-LRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~~i~~-l~~~~~~~~~~~lv 82 (475)
+.+.|.|.+.||+|-||.+-+|+++.++..+|+|.+... ....++.+|...--.|.++ .||+. +...+...++.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H-~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPH-QHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccc-hhhhHHHHHHhhcCceEEEe
Confidence 467899999999999999999999999999999976543 3445677777765556554 44443 44455677899999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ .++|..-+. ...+-+.....++.|+++||.|||++++||||||.+||||-.. +...|||||||+.+......
T Consensus 101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCcee
Confidence 9999 788877665 2458889999999999999999999999999999999999533 44589999999998654322
Q ss_pred cccccccccCCCCccCccccccccccCCC-----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhcccc
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 235 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 235 (475)
. ...-+..|.+||...... ..+.+|||.||+++|.+++|.+||+.....+. ...+.+....+.
T Consensus 178 ~----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~- 246 (378)
T KOG1345|consen 178 K----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN- 246 (378)
T ss_pred h----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-
Confidence 1 123456789999765432 36789999999999999999999984322221 222333333333
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
...+.....+++.+..++++-|..++++|=-..+..+....++.+..+
T Consensus 247 ~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 247 PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 344555677889999999999999999997777777777777766554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=260.29 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=186.2
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG-- 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-- 76 (475)
|....+.+-.+.||-|+||+||.++|..+|+.||+|.+..- .....+.+|.+++..++| .|+....++-...
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkH--dNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRH--DNVLSLLDILQPANP 126 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhcc--ccHHHHHHhcCCCCc
Confidence 34455667788999999999999999999999999965321 123457788888888887 5555443332222
Q ss_pred ---CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 ---DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ---~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...|++.|+|..+|..++- ....++.+.+.-++.||+.||.|||+.+|+||||||.|.|+ +.+..+||||||+
T Consensus 127 dfFqEiYV~TELmQSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGL 202 (449)
T KOG0664|consen 127 SFFQELYVLTELMQSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGL 202 (449)
T ss_pred hHHHHHHHHHHHHHhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEeccccc
Confidence 1247788888888888775 35579999999999999999999999999999999999999 6889999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
|+....... .++ +..+-|..|.|||.++|.. |+.+.||||.|||+.||+..+..|+........+.+..+...
T Consensus 203 ARvee~d~~-~hM-----TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 203 ARTWDQRDR-LNM-----THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred ccccchhhh-hhh-----HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 997654332 111 2235688999999999865 899999999999999999999999875543333333322211
Q ss_pred cccccHHHHhcC--------------------------ChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 233 KVSTSIEALCRG--------------------------YPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 233 ~~~~~~~~l~~~--------------------------~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
.-...+.--|.+ -.-+...++..++..||++|.+..+.
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 111111111111 12345677788888888888775443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=256.21 Aligned_cols=258 Identities=19% Similarity=0.274 Sum_probs=198.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCchH---HHHHHHHHHHHhCCCCCcCeeEEeeEe-CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQ---LQYEAKLYKILQGGSTGIPNLRWFGVE-GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~~~---~~~E~~il~~l~~~~~~i~~l~~~~~~-~~ 77 (475)
.++++...+-+|.||.||.|.|+.. .+.|.+|.++.....-+ +..|.-++..+ .|+|+..+.+...+ ..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~--sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA--SHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC--cCCCccceeEEEeeccC
Confidence 4688888999999999999977642 34567776654443322 33344444433 35888888776654 45
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
..++++.++ -++|..++..|+ +.++..++..++.|++.|++|||.+||||.||...|++| ++.-+|||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEec
Confidence 667777788 679999998553 347888899999999999999999999999999999999 577899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~ 228 (475)
|=.+++.+.....+. -..+......|||||.+.+..|+.++||||||++||||++ |+.||...++......+.+
T Consensus 439 DsaLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred cchhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999876655432 1122344678999999999999999999999999999998 9999987655333322222
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.... +.+-+||+++..++..||...|++||+++++...|.++..+.
T Consensus 514 GyRl-------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 514 GYRL-------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ccee-------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 2111 123579999999999999999999999999999999987554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=233.75 Aligned_cols=208 Identities=28% Similarity=0.428 Sum_probs=182.1
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCH
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSL 90 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL 90 (475)
||+|++|.||++.+..+++.++||+....... ..+.+|..+++.+.+ ++++.+..++......+++||++ +++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH--PNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC--CCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 68999999999998778999999998877653 678899999999877 89999999999889999999999 5999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-CCcEEEeecCCcccccccccccccccc
Q 011882 91 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTATHQHIPYR 169 (475)
Q Consensus 91 ~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGlA~~~~~~~~~~~~~~~ 169 (475)
.+++......++...+..++.+++.+|.+||++|++|+||+|.||++. . .+.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------
Confidence 999985545689999999999999999999999999999999999995 4 68999999999987654321
Q ss_pred cCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 170 ENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 170 ~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
......+...|++||.+... ..+.+.|+|+||+++|+| ..
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~ 189 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PE 189 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HH
Confidence 11234678899999999887 788999999999999999 56
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 249 FASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
+.+++..|+..+|++||++.++++.
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhC
Confidence 8899999999999999999888653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=258.21 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=201.0
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEcc---CCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
|.+.+.|.++++||+|.|+.||++.+.. ..+.||+|.+........+..|.+++..+.+. .+|..+..+...++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~-~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGS-DNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccc-hhhhcchhhhccCCee
Confidence 4567889999999999999999999887 78899999998888888999999999999886 8888999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ .....+++. .++..++..++..++.||.++|.+|||||||||.|||.+ ...+.-.|+|||+|..+.
T Consensus 111 ~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHH
Confidence 9999999 566666664 578999999999999999999999999999999999997 556677899999998322
Q ss_pred ccc------c----------ccc---------------------cccccCCCCccCccccccccccCCC-CCCchhHHHH
Q 011882 159 DTA------T----------HQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESL 200 (475)
Q Consensus 159 ~~~------~----------~~~---------------------~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSl 200 (475)
... . ... ..........||++|.|||++...+ ++.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 110 0 000 0011223457999999999998765 7999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCH--HHH--------HHHH--hhcc------------------cc--------------c
Q 011882 201 GYVLMYFLRGSLPWQGLKAGTK--KQK--------YEKI--SEKK------------------VS--------------T 236 (475)
Q Consensus 201 G~iL~elltG~~Pf~~~~~~~~--~~~--------~~~i--~~~~------------------~~--------------~ 236 (475)
|+|++-++++.+||....+... .+. +.+. .... +. .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999954322110 000 0000 0000 00 0
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+.....+|..+.+++.+|++.||.+|.++++.+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 01111122456889999999999999999998763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=243.99 Aligned_cols=255 Identities=20% Similarity=0.223 Sum_probs=193.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+..+|.-++.+|.|.- .|..+.|..+++.||+|..... ...+...+|..++..+.+ .|++.++.++...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~--~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNH--KNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcc--cceeeeeeccCccccHH
Confidence 4467888899999998 8888889999999999975433 233567889999988887 7888887776533
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+|||+|..+|.+.+. -.++-+++..|+.|++.|+.|||+.||+||||||+||++ +..+.+||+|||+|
T Consensus 92 ~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhh
Confidence 3469999999999999887 357888999999999999999999999999999999999 68899999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 231 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~--- 231 (475)
+..... .. .+.++.|..|.|||++.|..|...+||||+||++.||++|...|.|...-+...++.....
T Consensus 166 r~e~~~--~~------mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDTD--FM------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCcc--cc------cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 854332 12 2345889999999999999999999999999999999999999987432221111111000
Q ss_pred -------------------ccccccHHHHhcC------------ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 232 -------------------KKVSTSIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 232 -------------------~~~~~~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
........++.+. -.....+++.+||..+|++|-+++++ |++.+.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da---L~HPY~ 313 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA---LRHPYI 313 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH---hcCCee
Confidence 0000111111110 12457899999999999999996655 555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=267.28 Aligned_cols=264 Identities=18% Similarity=0.256 Sum_probs=209.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++++++|+|.||.||+++++.+++..|+|+++.... ..-++.|+-+++.++| +||+.+++-....+..+++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h--~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRH--PNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCC--cChHHHHhhhhhhcCcEEEE
Confidence 3689999999999999999999999999999999876643 3457778888777766 99999988888899999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||| |++|+++.. ..+.+++.++....+..+.||+|||++|-+|||||-.|||++ +.+.+||.|||.+-.+.....
T Consensus 92 EycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred EecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh
Confidence 999 889998875 456899999999999999999999999999999999999995 789999999999987654433
Q ss_pred ccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
..+.+.||+.|||||+.. ...|...+|||++|++..|+..-+.|-...... +.+.......+..+..
T Consensus 168 -------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 168 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTL 237 (829)
T ss_pred -------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCcc
Confidence 236789999999999763 456899999999999999999888886554332 2221111111111111
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH-----------HHHHHHHHHcCCCC
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK-----------RLFRDLFIREGFQF 285 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~-----------~~L~~l~~~~~~~~ 285 (475)
+-.....+.|.+|++.|+..+|++||+++.++ .+..+++.+.+...
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 11133568899999999999999999987653 34556666665444
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=226.63 Aligned_cols=197 Identities=30% Similarity=0.451 Sum_probs=168.2
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
|.+.+.||+|++|.||+|.+..+++.||||.+.... ....+..|.+.++.+.+ ++++.+..+.......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~--~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH--PNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC--CChhhheeeeecCCceEEEEec
Confidence 678899999999999999998889999999987654 23567788888888854 8899999888888999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..+..++.|++.+|.+||+++++|+||+|.||+++ ..+.++|+|||++..+......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc-
Confidence 9 5599999975433389999999999999999999999999999999999994 5689999999999877554210
Q ss_pred ccccccCCCCccCccccccccc-cCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 011882 165 HIPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~-~g~~~s~ksDIwSlG~iL~elltG~~Pf~~ 216 (475)
......++..|++||.+ ....++.++|||+||+++|||++|+.||..
T Consensus 155 -----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11345678899999998 666788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=218.98 Aligned_cols=167 Identities=17% Similarity=0.181 Sum_probs=128.3
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccc
Q 011882 88 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167 (475)
Q Consensus 88 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~ 167 (475)
|+|.+++...+..+++.+++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc------
Confidence 6899999866667999999999999999999999998 9999999 47788888 99998654321
Q ss_pred cccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH--HHhcCC
Q 011882 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 245 (475)
Q Consensus 168 ~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 245 (475)
..||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 26899999999999999999999999999999999999999764321 12222222111111000 001122
Q ss_pred hH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 246 PT--EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 246 p~--~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
+. ++.+++..||..+|++||++.+|++.+..+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 69999999999999999999999887765543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=271.99 Aligned_cols=188 Identities=14% Similarity=0.170 Sum_probs=135.6
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee----------------
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL---------------- 139 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~---------------- 139 (475)
....+++||+++.+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3457888999999999999755567999999999999999999999999999999999999942
Q ss_pred CCCCCcEEEeecCCccccccccc--------cccccc-ccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTAT--------HQHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 210 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~--------~~~~~~-~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG 210 (475)
.+..+.+||+|||+++....... ....+. .......||+.|||||++.+..++.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 12345677777777764321100 000000 001224689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 211 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 211 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..|+.... ..+..+....... ..... ..+...++.+||..+|.+||++.+|++
T Consensus 212 ~~~~~~~~-----~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 212 VSSREEKS-----RTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCchhhHH-----HHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88875321 1122221111111 11111 345678899999999999999998853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-24 Score=207.89 Aligned_cols=257 Identities=30% Similarity=0.407 Sum_probs=193.3
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
|.+.+.||.|+||.||++.+. ..+++|.+...... ..+.+|..++..+.+. ++++.+..+.......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-PNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-cceeeEEEEEecCCEEEEEE
Confidence 789999999999999999976 78999987665443 3477888888888774 36888888887777789999
Q ss_pred EcC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC-cEEEeecCCcccccc
Q 011882 84 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRD 159 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~~~~ 159 (475)
+++ +++|.+++.... ..+....+..++.|++.+|.|+|+.+++||||||+|||+. ... .++++|||+++.+..
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCC
Confidence 999 788887776433 2699999999999999999999999999999999999994 555 799999999986554
Q ss_pred cccccccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHHHHHHhhcccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVS 235 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~ 235 (475)
........ .......||..|++||.+.+ ..++...|+||+|++++++++|..||...... ...+....+......
T Consensus 155 ~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 155 PGSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCcccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 33211000 12356789999999999998 57899999999999999999999998765431 112222222222211
Q ss_pred ccHHHHhcCC----hHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 236 TSIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 236 ~~~~~l~~~~----p~~l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
.......... ...+.+++..|+..+|..|.+.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011111111 2578999999999999999987766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=224.45 Aligned_cols=180 Identities=19% Similarity=0.213 Sum_probs=133.6
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEcc-CCeEEEEEEeccCC-------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
+.+.++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+|+++++.+.+. ..++.++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~-~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGI-GVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCC-CCCcEEEEc--
Confidence 4577899999999999999999999876 67888999864321 123478999999999873 334455543
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEeeCCCCCcEEEeecC
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI-KP~NILl~~~~~~~~vkL~DFG 152 (475)
...||||||+ |++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||++ .++.+||+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECc
Confidence 3479999999 778863 21 111 1467899999999999999999999 99999994 56789999999
Q ss_pred Cccccccccccccc-ccccCCCCccCccccccccccCCC------CCCchhHH
Q 011882 153 LAKRYRDTATHQHI-PYRENKNLTGTARYASMNTHLGIE------QSRRDDLE 198 (475)
Q Consensus 153 lA~~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~g~~------~s~ksDIw 198 (475)
+|+.+........+ .+..-.+..+++.|+|||.+...+ .+...|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99987664432222 112224678899999999987543 23446666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=229.41 Aligned_cols=253 Identities=20% Similarity=0.242 Sum_probs=180.6
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC---CCchH-----HHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQ-----LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~---~~~~~-----~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.....+|.|++|.|+.+......+.++.|..... ..... +..|..+-..| .|++++.......+.....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l--~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL--SHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc--cCCchhhhHHHHhhcccchh
Confidence 5678899999999998887766666666654321 11111 11122222222 33555443333333333333
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
+||||..+|..++.. ...++..++..++.|++.||.|||+.||.||||||+|+|+. ..+.+||+|||.+..+.-..
T Consensus 399 ~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCc
Confidence 499995599888873 34799999999999999999999999999999999999994 77899999999998776543
Q ss_pred cccccccccCCCCccCccccccccccCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCCCCHHH-HHHHHhhccccccHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVSTSIE 239 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~-ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~~ 239 (475)
... .......+|+..|+|||++.+.+|.+ ..||||.|++++.|++|+.||......+... ...............
T Consensus 475 e~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 475 EKN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred chh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 321 11345679999999999999999964 6899999999999999999998654433221 111112222333445
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+...+|.+-+.+|.+||+.+|.+|-++++|+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 56677899999999999999999999987773
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=189.78 Aligned_cols=138 Identities=23% Similarity=0.264 Sum_probs=103.7
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----------chH-----------------HHHHHHHHHHHhCC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQ-----------------LQYEAKLYKILQGG 62 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----------~~~-----------------~~~E~~il~~l~~~ 62 (475)
+.+.||+|+||.||+|.+. +|+.||||+++.... ... ...|.+++..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999986 899999999865421 011 23488889988763
Q ss_pred CCCcCeeEEeeEeCCEEEEEEEcCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEeeC
Q 011882 63 STGIPNLRWFGVEGDYNVLVIDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLG 140 (475)
Q Consensus 63 ~~~i~~l~~~~~~~~~~~lvme~~g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~gIvHrDIKP~NILl~~~ 140 (475)
+++....+... ..+|||||++ ++|...+. ....++..+++.++.||+.+|.|| |+.||+||||||+|||++
T Consensus 80 --~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-- 152 (190)
T cd05147 80 --GIPCPEPILLK--SHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-- 152 (190)
T ss_pred --CCCCCcEEEec--CCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE--
Confidence 33222222222 2389999995 44444322 245799999999999999999999 799999999999999994
Q ss_pred CCCCcEEEeecCCccccc
Q 011882 141 RRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 141 ~~~~~vkL~DFGlA~~~~ 158 (475)
.+.++|+|||+|....
T Consensus 153 --~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 --DGKLYIIDVSQSVEHD 168 (190)
T ss_pred --CCcEEEEEccccccCC
Confidence 3679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=196.11 Aligned_cols=232 Identities=23% Similarity=0.277 Sum_probs=147.7
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch-----HHHHHHHHHHHHhC---------CCCCcCeeEEe-
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQG---------GSTGIPNLRWF- 72 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~-----~~~~E~~il~~l~~---------~~~~i~~l~~~- 72 (475)
.+...+.||.|+|+.||.+++..||+++|||+........ ++.+|.-....+.+ ....++.+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4667899999999999999999999999999876544322 23333322222111 00001111100
Q ss_pred -------eEeC---C-----EEEEEEEcCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 011882 73 -------GVEG---D-----YNVLVIDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 131 (475)
Q Consensus 73 -------~~~~---~-----~~~lvme~~g~sL~~ll~~~---~~~---ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIK 131 (475)
.... . ..+++|+.+-++|.+++... ... +.....+.+..|++..+++||..||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 1 23678888899999987532 221 2334446677999999999999999999999
Q ss_pred CCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccC--------CCCCCchhHHHHHHH
Q 011882 132 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV 203 (475)
Q Consensus 132 P~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--------~~~s~ksDIwSlG~i 203 (475)
|+||++ +.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYRC----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEEG----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceeec----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 58899999999887755432210 133577899997643 247889999999999
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCC
Q 011882 204 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 264 (475)
Q Consensus 204 L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R 264 (475)
+|.|++|.+||........... .-..|.++|+.++.||..+|+.+|++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986433211110 122466889999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=193.74 Aligned_cols=171 Identities=15% Similarity=0.225 Sum_probs=129.4
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH-----------HHHHHHHHHHHhCCCCCcCeeE
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LQYEAKLYKILQGGSTGIPNLR 70 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~-----------~~~E~~il~~l~~~~~~i~~l~ 70 (475)
+..+.++|++++.||.|+||.||++.+ ++..+|||++.......+ +.+|+..+..+.+ ++++.+.
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~--~GI~~~~ 101 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS--EGLASLN 101 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH--CCCCcce
Confidence 346789999999999999999999764 577899999865432222 4677778888866 7888887
Q ss_pred EeeEeC--------CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 71 WFGVEG--------DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 71 ~~~~~~--------~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
.++... ...+|+|||+ |.+|.++.. +++ ....+|+.+|..||+.||+||||||+|||++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 775533 3578999999 678987742 333 2456999999999999999999999999995
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHH
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 208 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ell 208 (475)
.++ ++|+|||..+....... .-..++...|+.++|||+|||+|..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 455 99999998876533211 011344455778999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=215.12 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=183.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~~lvm 83 (475)
-+..|.|.+.||+|+||.||+|.+.. |+.||||+.+.....+ +..-.+++.+|+. .-+.|..+.......+.-+||+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 36679999999999999999999755 9999999987665433 1112223333330 0033444444455667778999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC----CCCCcEEEeecCCccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----~~~~~vkL~DFGlA~~~~ 158 (475)
+|. .|+|.++++ ..+.+++..+..|+.||+.-++.||..+|||+||||+|+||... .+...++|+|||.+--+.
T Consensus 774 ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999 999999998 56679999999999999999999999999999999999999642 234569999999986543
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
--.... ..+..++|-.+-.+|+..|.+++...|.|.|..+++-||.|+.-= ...+. .......+
T Consensus 853 lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~---------~~~~~~~~ 916 (974)
T KOG1166|consen 853 LFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGS---------SWMVKTNF 916 (974)
T ss_pred EcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCc---------ceeccccc
Confidence 322211 123457899999999999999999999999999999999985321 00000 00001111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..+.. -.-..+++..+|..|-..=|...+|+..|++.+.+.
T Consensus 917 ~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 917 PRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred hhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11111 023456777788877777888899988888887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=181.97 Aligned_cols=138 Identities=21% Similarity=0.288 Sum_probs=105.3
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------------------------hHHHHHHHHHHHHhCC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------PQLQYEAKLYKILQGG 62 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------------------------~~~~~E~~il~~l~~~ 62 (475)
+.+.||+|+||.||+|.+. +|+.||||+++..... ..+..|...+..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999998754211 1135678888888763
Q ss_pred CCCcCeeEEeeEeCCEEEEEEEcCCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEee
Q 011882 63 STGIPNLRWFGVEGDYNVLVIDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 63 ~~~i~~l~~~~~~~~~~~lvme~~g~-sL~-~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~ 139 (475)
...++....+ .. .||||||+++ ++. ..+. ...++..++..++.|++.+|.+||+ +||+||||||+|||++
T Consensus 80 ~i~~p~~~~~--~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 80 GVPVPEPILL--KK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCCceEEEe--cC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 2223333332 22 4899999944 333 3333 3468889999999999999999999 9999999999999994
Q ss_pred CCCCCcEEEeecCCcccccc
Q 011882 140 GRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~ 159 (475)
++.++|+|||+|+....
T Consensus 153 ---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 ---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ---CCCEEEEEcccceecCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=181.00 Aligned_cols=193 Identities=17% Similarity=0.108 Sum_probs=139.9
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch------HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~------~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.+...|++|+||+||++.. .+..++.+-+....... .+.+|+++++.|.+. ++++.++.+ +..+++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~-~~vP~ll~~----~~~~lv 76 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGL-PRTPRLLHW----DGRHLD 76 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCC-CCCCEEEEE----cCEEEE
Confidence 44678899999999998873 77888877665544322 367899999999775 888888765 346899
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI-KP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|+|+ |.+|.+.+.. ....++.|++.+|.+||++||+|||| ||+|||++ .++.++|+|||+|......
T Consensus 77 meyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 77 RSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred EeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCc
Confidence 9998 7788654321 12457889999999999999999999 79999994 6678999999999854432
Q ss_pred ccccc-cccc-----cCCCCccCccccccccccCC-CCC-CchhHHHHHHHHHHHHcCCCCCCCCCC
Q 011882 161 ATHQH-IPYR-----ENKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLKA 219 (475)
Q Consensus 161 ~~~~~-~~~~-----~~~~~~GT~~Y~APE~~~g~-~~s-~ksDIwSlG~iL~elltG~~Pf~~~~~ 219 (475)
..... ..++ .......++.|++|+...-. ..+ .+.++++.|+.+|.++|+.+++.+...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 21000 0000 00011357788888866543 233 567888999999999999999876544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-22 Score=214.79 Aligned_cols=218 Identities=22% Similarity=0.352 Sum_probs=153.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
-.+|..++.|-.|+||.||+++++.+.+.+|+|+-+ +.. |++. |. ...+..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l---------ilRn-------il------t~a~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL---------ILRN-------IL------TFAGNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cch---------hhhc-------cc------cccCCccee---
Confidence 468999999999999999999999999999997522 111 1110 00 011111222
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc-
Q 011882 86 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ- 164 (475)
Q Consensus 86 ~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~- 164 (475)
++-..+++. -++++.. ++.+++|||+.||+|||+||+|.||+ .-|.+|++|||+.+.........
T Consensus 136 --gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchh
Confidence 333344442 2234332 37899999999999999999999995 78999999999998643221110
Q ss_pred ---cc----ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 165 ---HI----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 165 ---~~----~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
++ .....+.++||+.|.|||++.-..|+..+|+|++|+|+||++.|..||.+.+. .+.+..+...... .
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~-w 277 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIE-W 277 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhcc-c
Confidence 11 01123567999999999999999999999999999999999999999998544 3333333222211 1
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYA 268 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~ 268 (475)
.+. -..++++.++++.++|..+|.+|--..
T Consensus 278 pE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 278 PEE-DEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ccc-CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111 245789999999999999999996433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=214.44 Aligned_cols=251 Identities=14% Similarity=0.100 Sum_probs=175.9
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+|...+.||++.|=.|.+|++ ..|. |+||++-..... ..+.++.+-.+..-..++|+..+....+.+...|||=+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 688899999999999999986 3444 999987544321 22333333233333344888877766777778888989
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc-
Q 011882 85 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH- 163 (475)
Q Consensus 85 ~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~- 163 (475)
|...+|.|.+. ...-+...+...|+.||+.||..+|..||+|+|||.+||||+ .-+-+.|+||..-+..--+.+.
T Consensus 102 yvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCCCc
Confidence 99999999886 233378889999999999999999999999999999999995 6677999999877653222111
Q ss_pred cccccccCCCCccCccccccccccCC----------C-CCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~----------~-~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
..+.|.. .+..--.+|.|||.|... . .+++.||||+||++.||++ |+.||.- ...-.|....
T Consensus 178 adf~fFF-DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~- 251 (1431)
T KOG1240|consen 178 ADFTFFF-DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGN- 251 (1431)
T ss_pred ccceEEE-ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccC-
Confidence 1111110 111234579999988641 2 5789999999999999998 7888842 1111122211
Q ss_pred ccccccHHHHhcCC-hHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 232 KKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 232 ~~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
....+.+...+ ...+++++..|++.||.+|.++++.++.
T Consensus 252 ---~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ---ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 12222222222 2468999999999999999999988665
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-22 Score=206.32 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=191.1
Q ss_pred eEeeeCceeEEEEEEc---cCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 14 KIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
.+|+|.||.|+++.-. ..+.-+|+|+.+..... .....|..++..++.. +.++.++.........++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~-~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNT-PFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCC-CceeeeeeeeccccchhHhhhhc
Confidence 3799999999998632 34567899987654322 1345677777777644 88889988888888999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
|+.|...+. ....+++..+..+...++.+++++|+.+|+|||+|++||++ +..|.+++.|||+++...+...
T Consensus 80 rgg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 80 RGGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred ccchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh---
Confidence 767766654 34568889999999999999999999999999999999999 6889999999999997765332
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 245 (475)
.+||..|||||++. ....++|.||||++++||++|..||.+ +....|...+... +..+
T Consensus 153 --------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~-----p~~l 210 (612)
T KOG0603|consen 153 --------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEM-----PREL 210 (612)
T ss_pred --------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCC-----chhh
Confidence 28999999999999 457899999999999999999999987 2233333323222 1334
Q ss_pred hHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011882 246 PTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300 (475)
Q Consensus 246 p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 300 (475)
..+..+++.+++..+|..|--. .-+.+..++. +-...||.....++.+
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~-------f~~~i~~~~l~~r~~~ 260 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE-------FFQSIDWNELEARSRP 260 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc-------hheeeeHhhHhhcCCC
Confidence 5778899999999999999765 3344444433 3455788876655443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=185.64 Aligned_cols=192 Identities=18% Similarity=0.229 Sum_probs=144.4
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC-CcEEEeecCCc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGlA 154 (475)
+...|+||.-...+|.+++. .+..+......|+.|+++|+.|||.+||.|||+|.+||||..+++. ..+.|+|||.+
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 44579999999999999986 4567888899999999999999999999999999999999776433 46789999988
Q ss_pred ccccccccccccccccC-CCCccCccccccccccCCCC------CCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHH
Q 011882 155 KRYRDTATHQHIPYREN-KNLTGTARYASMNTHLGIEQ------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKY 226 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~-~~~~GT~~Y~APE~~~g~~~------s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~ 226 (475)
-.- ....-..||... -...|....||||+....+- -.++|.|+.|.+.||++....||........ ...|
T Consensus 393 LAd--~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 393 LAD--DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eec--cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 532 222233444322 23467889999999875431 2489999999999999999999987322111 1112
Q ss_pred HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 227 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
++ ..++.+...+|+.+++++..+|+.||.+|++..-..+.|+=.+
T Consensus 471 qe-------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 471 QE-------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSL 515 (598)
T ss_pred hh-------hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHH
Confidence 21 2234556788999999999999999999999776555555333
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=176.97 Aligned_cols=142 Identities=19% Similarity=0.214 Sum_probs=110.6
Q ss_pred ceEEeeeEeeeCceeEEEEE-EccCCeEEEEEEeccCCCc--------------------------hHHHHHHHHHHHHh
Q 011882 8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKH--------------------------PQLQYEAKLYKILQ 60 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~-~~~~~~~vAvKi~~~~~~~--------------------------~~~~~E~~il~~l~ 60 (475)
-|++.+.||+|+||.||+|. +..+|+.||||++...... ..+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6789999999987653210 12467999999997
Q ss_pred CCCCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEe
Q 011882 61 GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMG 138 (475)
Q Consensus 61 ~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g-IvHrDIKP~NILl~ 138 (475)
.....++.++.+. ..++||||+ |.+|..+.. ....+...++..++.||+.+|.+||++| |+||||||+|||+.
T Consensus 109 ~~~i~~p~~~~~~----~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAWR----RNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEec----CceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 6334455554432 248999999 446655432 2345667778899999999999999999 99999999999994
Q ss_pred eCCCCCcEEEeecCCccccc
Q 011882 139 LGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~ 158 (475)
.+.++|+|||+|....
T Consensus 184 ----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 ----DGKVVIIDVSQSVELD 199 (237)
T ss_pred ----CCCEEEEEChhhhccC
Confidence 5789999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=167.70 Aligned_cols=137 Identities=16% Similarity=0.220 Sum_probs=107.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhC---CCCCcCeeEEeeEeCC---E-EEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQG---GSTGIPNLRWFGVEGD---Y-NVLV 82 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~---~~~~i~~l~~~~~~~~---~-~~lv 82 (475)
.+.||+|+||.||. ++.++.. +||++.... ....+.+|+.+++.+.+ .|++|+.++++...+. + ..+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 57899999999995 6677666 699876532 23568999999999965 5699999998888763 4 3478
Q ss_pred EEcCC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEeeCC-CCCcEEEeecCCcc
Q 011882 83 IDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 155 (475)
Q Consensus 83 me~~g---~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL-~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGlA~ 155 (475)
|||+| ++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+.+.
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99965 899999974 346655 46688888888 999999999999999999997533 34589999955443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-20 Score=174.47 Aligned_cols=243 Identities=13% Similarity=0.158 Sum_probs=183.6
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
...++-+|.+...|+.|+|+|. |..+++|+++..... .++..|.--++.+.| |||..+.+.+.......++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifsh--pnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSH--PNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecC--CchhhhhhhccCCCCceEee
Confidence 3456778999999999999985 446778888765433 346667777777776 99999999999888889999
Q ss_pred EcC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEE--eecCCcccc
Q 011882 84 DLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYI--IDFGLAKRY 157 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL--~DFGlA~~~ 157 (475)
.|| .++|..++..... .++..++.+++.+|+.|+.|||+.. |.---|....++| |++.+.+| +|--++...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec
Confidence 999 8899999975432 2678899999999999999999864 3334578888999 45554443 343322110
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s---~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
....-.+.||+||.+...+-+ +++|+|||.++||||.|...||.+........ +|. +
T Consensus 344 --------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kia---l 403 (448)
T KOG0195|consen 344 --------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIA---L 403 (448)
T ss_pred --------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhh---h
Confidence 112346889999999877643 57899999999999999999998865533222 222 2
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
......++.+++..+..|+..|+..||.+||.|+.|+-+|+++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2233345678889999999999999999999999999988875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-18 Score=161.24 Aligned_cols=132 Identities=27% Similarity=0.417 Sum_probs=105.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++.||+|++|.||+|.+ .+..|+||+....... ..+.+|..++..+.+ ++++....++......++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK--AGVNVPAVYFVDPENFII 76 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH--CCCCCCeEEEEeCCCCEE
Confidence 36799999999999986 7788999976543221 236678888888876 445444444455667789
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
+|||+ |.+|.+++.... . ....++.+|+.+|.+||+.||+|||++|.|||+. .+.++|+|||+++.
T Consensus 77 v~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999 889999986422 2 8889999999999999999999999999999994 57899999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=159.18 Aligned_cols=127 Identities=25% Similarity=0.410 Sum_probs=99.9
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEeccCCC----------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.||+|+||.||+|. .++..|++|+...... ..++.+|.+++..+.+....++.+ ++......+++|
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~--~~~~~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVV--YDVDPDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEE--EEEECCCCEEEE
Confidence 48999999999998 4678899998543321 134567999999988743344444 444566678999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
||+ |++|.+++.... . .++.|++.+|.+||+.||+|+|+||.|||+. .+.++|+|||+++.
T Consensus 77 e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 999 889998876321 1 8899999999999999999999999999994 67899999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=178.67 Aligned_cols=209 Identities=16% Similarity=0.228 Sum_probs=162.5
Q ss_pred CCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcEEEeeC
Q 011882 63 STGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFLMGLG 140 (475)
Q Consensus 63 ~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gI-vHrDIKP~NILl~~~ 140 (475)
|.|+..+.+.+..+...++|.+|| .++|.+.+......+++.-...++.+|+.||.|||...| .|+.|+..|+++
T Consensus 6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--- 82 (484)
T KOG1023|consen 6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--- 82 (484)
T ss_pred hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee---
Confidence 488999999999999999999999 899999998766778888999999999999999998766 999999999999
Q ss_pred CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCC-------CCCchhHHHHHHHHHHHHcCCCC
Q 011882 141 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLRGSLP 213 (475)
Q Consensus 141 ~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-------~s~ksDIwSlG~iL~elltG~~P 213 (475)
+....+||+|||+.......... .......-...|.|||.+.+.. .+.+.||||||++++|+++.+.|
T Consensus 83 d~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 83 DSRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 68899999999998776431100 0111123456799999998742 36779999999999999999999
Q ss_pred CCCCCCCC-HHHHHHHHhh---ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 214 WQGLKAGT-KKQKYEKISE---KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 214 f~~~~~~~-~~~~~~~i~~---~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
|....... ..+.+..+.. ....+.+.... .+++++..++..||..+|++||++..+...++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 98643222 2333333333 22233333222 5677899999999999999999999998888877653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=159.51 Aligned_cols=137 Identities=20% Similarity=0.288 Sum_probs=105.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC------------------------chHHHHHHHHHHHHhCCC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------HPQLQYEAKLYKILQGGS 63 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~------------------------~~~~~~E~~il~~l~~~~ 63 (475)
.|.+.+.||+|+||.||+|.+ .+|+.||||++..... ......|..++..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488999999999999999986 4899999998654320 012456777787776632
Q ss_pred CCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 64 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 64 ~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
..++.... ....++||||+ |++|..+.. ......++.+|+.++.++|+.||+||||||+||++ +.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 23444433 23458999999 778766532 13466889999999999999999999999999999 46
Q ss_pred CCcEEEeecCCcccccc
Q 011882 143 ANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~ 159 (475)
++.++|+|||++..+..
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-19 Score=181.51 Aligned_cols=174 Identities=25% Similarity=0.348 Sum_probs=130.6
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.+.||.|++| ..+|.+++... ...-++...+.++.|++.|++| +|.+|||+||.||++. .+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 4689999999 88999999632 2347788999999999999999 9999999999999995 566899999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
........+ ..-++.......||..||+||++.|..|+.++||||||+||+|++. -..+|.... .+..+...
T Consensus 403 ~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------TLTDIRDG 475 (516)
T ss_pred eeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------hhhhhhcC
Confidence 987765541 1112223455689999999999999999999999999999999997 344443211 12222222
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 267 (475)
.++ +.+...+| +-..|+++++...|.+||++
T Consensus 476 ~ip---~~~~~d~p-~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 476 IIP---PEFLQDYP-EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred CCC---hHHhhcCc-HHHHHHHHhcCCCcccCchH
Confidence 222 12223333 44689999999999999943
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=177.83 Aligned_cols=133 Identities=25% Similarity=0.441 Sum_probs=104.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-C---------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-K---------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~---------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..|...++||+|+||.||+|.+. +..+++|+...+. . ...+.+|.+++..+++ ++++....++...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~p~~~~~~~ 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR--AGVPTPVIYDVDP 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc--cCCCeeEEEEEeC
Confidence 44567899999999999999864 3344444321111 1 1346789999999876 6666666666666
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||+ |++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ +.+.++|+|||+++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~ 475 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCcccc
Confidence 7789999999 889998875 356799999999999999999999999999999 35689999999997
Q ss_pred c
Q 011882 156 R 156 (475)
Q Consensus 156 ~ 156 (475)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6e-17 Score=149.27 Aligned_cols=137 Identities=24% Similarity=0.348 Sum_probs=96.9
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hH----------------------HHHHHHHHHHHhCCCC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQ----------------------LQYEAKLYKILQGGST 64 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~----------------------~~~E~~il~~l~~~~~ 64 (475)
+.+.||+|+||.||+|.+. +++.||||++...... .. ...|...+..+.....
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999975 8999999987653211 00 1345555555554323
Q ss_pred CcCeeEEeeEeCCEEEEEEEcCCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCC
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~g~-sL~-~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~ 141 (475)
.++....+ ...++||||+.+ .+. ..+.... . ...+..++.+++.++.++|. +||+||||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 34444433 235899999943 221 1222111 1 16788999999999999999 9999999999999994
Q ss_pred CCCcEEEeecCCcccccc
Q 011882 142 RANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~ 159 (475)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 67899999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-15 Score=145.93 Aligned_cols=133 Identities=17% Similarity=0.216 Sum_probs=99.6
Q ss_pred eeEe-eeCceeEEEEEEccCCeEEEEEEeccCC---------------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-
Q 011882 13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE- 75 (475)
Q Consensus 13 ~~LG-~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---------------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~- 75 (475)
..|| .||.|+||.+.. .+..++||.+.... ......+|..++..|.+....++....+...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999874 47789999764311 1235678999999998754445666555432
Q ss_pred CCE---EEEEEEcC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 76 GDY---NVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 76 ~~~---~~lvme~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
... .++|||++ | .+|.+++.. ..++... +.||+.+|.+||++||+||||||.|||++ .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 35999999 4 589988863 3455543 57899999999999999999999999994 556899999
Q ss_pred cCCccc
Q 011882 151 FGLAKR 156 (475)
Q Consensus 151 FGlA~~ 156 (475)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.5e-16 Score=134.54 Aligned_cols=133 Identities=20% Similarity=0.333 Sum_probs=109.2
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPS 89 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~s 89 (475)
+++.||.|.++.||++... +..++||..........+..|..++..+.+....++.+..+....+..+++|||+ |..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4678999999999999963 3789999876544345788999999999874467888888777778899999999 555
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 90 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 90 L~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
+..+ +......++.+++.+|.+||.. +++|+||||+|||+. +.+.++|+|||.++.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 5433 5567778899999999999984 799999999999995 468899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.2e-17 Score=175.11 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=188.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC-CeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
...|.+.+.||+|+|+.|-+.....+ ...+|+|.+...... .....|..+-+.+.. |.++..+........+.+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~-h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK-HSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc-cccccccCCccCCCcccc
Confidence 45799999999999999999886433 346777766554311 223346666666654 588999999999999999
Q ss_pred EEEEcC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeeCCCCC-cEEEeecCCccc
Q 011882 81 LVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~-g~sL~~ll-~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~ 156 (475)
+.+++. |+++.+.+ .......+...+-.++.|+..+|.|+| ..++.||||||+|.++. ..+ .+++.|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhcc
Confidence 999998 88888777 322225777888899999999999999 99999999999999994 556 899999999998
Q ss_pred ccc-cccccccccccCCCCcc-CccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 157 YRD-TATHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 157 ~~~-~~~~~~~~~~~~~~~~G-T~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+.. ..... .....+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||....... ..+......+
T Consensus 175 ~~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~ 247 (601)
T KOG0590|consen 175 YRNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK 247 (601)
T ss_pred ccccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc
Confidence 877 32211 1233467 99999999999854 4788999999999999999999997643322 1122222211
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
.. .....+..+.....+++.+++..+|..|.+..++
T Consensus 248 ~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 248 GR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred cc-cccCccccCChhhhhcccccccCCchhccccccc
Confidence 11 0112235677889999999999999999996655
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-13 Score=142.00 Aligned_cols=140 Identities=20% Similarity=0.310 Sum_probs=96.0
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc------------------------------------------hHHH
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------------PQLQ 50 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~------------------------------------------~~~~ 50 (475)
+.||+|++|+||+|+. .+|+.||||+.+..... -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 68999999987543210 0133
Q ss_pred HHHHHHHHHhCC---CCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 011882 51 YEAKLYKILQGG---STGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKSF 125 (475)
Q Consensus 51 ~E~~il~~l~~~---~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~-aL~yLH~~gI 125 (475)
+|+..+..+... ++.+..-..+.......+|||||+ |.+|.++.......+. ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 455545554321 122222222333344579999999 8888887653222232 3456666666 4788999999
Q ss_pred eecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 126 vHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+|+|+||.||++ ..++.++|+|||++..+..
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 999999999999 4678999999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-15 Score=153.16 Aligned_cols=254 Identities=17% Similarity=0.167 Sum_probs=188.6
Q ss_pred cCCceEEeeeEee--eCceeEEEEEE--ccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~--G~fG~Vy~a~~--~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+.+.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ...-.+|..-.+.+. .|.+.+..+......
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~-~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID-SHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC-ccccccccCcccccC
Confidence 3456778899999 99999999988 78889999996322211 122334444443333 346666667777888
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEeeCCCC-CcEEEeec
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDF 151 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~----aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DF 151 (475)
+..++-.|+|+.+|..+......-++...++.++.+... ||..+|+.+|+|-|+||+||++. .+ ..++++||
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDF 267 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCc
Confidence 999999999999999988765555888899999999999 99999999999999999999995 44 78999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
|+...+.+...... +.......|...|++||...+ -++..+|||+||.++.+..++..+...-......+ +.
T Consensus 268 ~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r---- 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LR---- 339 (524)
T ss_pred ceeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cc----
Confidence 99998876543221 111223367888999999887 46889999999999999999877765432111111 11
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
......++|.+...++...+..++..++-.|++.+.+..
T Consensus 340 --~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 --QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111234567777888888999999999999988776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-13 Score=124.59 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=101.4
Q ss_pred eeeEeeeCceeEEEEEEcc------CCeEEEEEEeccCC------------C------------chH----HHHHHHHHH
Q 011882 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT------------K------------HPQ----LQYEAKLYK 57 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAvKi~~~~~------------~------------~~~----~~~E~~il~ 57 (475)
...||.|--+.||.|.... .+..+|||+.+... . ... ..+|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 25799999754211 0 001 237888898
Q ss_pred HHhCCCCCcCeeEEeeEeCCEEEEEEEcCCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCc
Q 011882 58 ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPS-LE-DLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN 134 (475)
Q Consensus 58 ~l~~~~~~i~~l~~~~~~~~~~~lvme~~g~s-L~-~ll~~~~~~ls~~~~~~i~~qi~~aL~yL-H~~gIvHrDIKP~N 134 (475)
.+......+|..+.+ ...+|||||++++ +. ..+. ...++..++..+..|++.+|..| |..||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 887755667777754 4578999999653 21 1222 22456667788899999999999 89999999999999
Q ss_pred EEEeeCCCCCcEEEeecCCccccc
Q 011882 135 FLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 135 ILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||+. ++.++|+|||.|....
T Consensus 156 IL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE----CCcEEEEECCCceeCC
Confidence 9994 4679999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=3e-12 Score=135.41 Aligned_cols=145 Identities=18% Similarity=0.267 Sum_probs=92.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------------------------------------
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------------------------- 46 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---------------------------------------- 46 (475)
..|+. +.||+|++|+||+|+.+.+|+.||||+.......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 7899999999999998777999999997643100
Q ss_pred --hHHHHHHHHHHHHhCC---CCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHH
Q 011882 47 --PQLQYEAKLYKILQGG---STGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMIN 115 (475)
Q Consensus 47 --~~~~~E~~il~~l~~~---~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~-----ls~~~~~~i~~qi~~ 115 (475)
-++.+|......+... .+.+..-..|.......+|||||+ |..|.++-...... +....+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 0134455444444321 111111122333355678999999 88887753211222 3333333344444
Q ss_pred HHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCcccccc
Q 011882 116 RVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 116 aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~~~~~ 159 (475)
+..|++|+|+||.||++..+ ...+.++++|||++..+..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 46999999999999999522 1123899999999987644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-13 Score=120.26 Aligned_cols=126 Identities=20% Similarity=0.286 Sum_probs=95.4
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCC
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPS 89 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~s 89 (475)
++.|+.|.++.||++.. .++.|+||+..... .......|..+++.+... ..++.++.+.. ...++|||++ |.+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~-~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEA-GIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHh-CCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46789999999999985 47889999875543 234578899999998764 44666666543 3357999999 656
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 90 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 90 L~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gI-----vHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+.+. . .....++.+++.+|..||..++ +|+|++|.|||++ .+.++|+|||.+.
T Consensus 78 l~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred cccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 5432 0 1123467899999999999885 9999999999994 4579999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-11 Score=110.64 Aligned_cols=142 Identities=18% Similarity=0.242 Sum_probs=105.6
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEecc-CCCch---------HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHP---------QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~-~~~~~---------~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.+..|-+|+-+.|+++.+ .|+.++||.--. .-.++ +...|++++..+..--...|.+ +..+....+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l--~~~D~~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL--IFIDTYGGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE--EEEecCCCe
Confidence 677889999999999984 788889995222 22222 3567899988887632334444 445555667
Q ss_pred EEEEcCCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 81 LVIDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~g~--sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
|+|||+.+ ++.+++...-.. ........++.+|-+.|.-||..+|||+||..+||+|..++....+.|+|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999965 888887644333 33334478889999999999999999999999999997655566679999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-11 Score=111.05 Aligned_cols=128 Identities=24% Similarity=0.397 Sum_probs=94.8
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCC-Cch---------HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHP---------QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~---------~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
..|++|+-+.||.+.+ -|..+++|.--.+. .++ ...+|++++..+.. ..++.-..+..+.+...|+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~--~GV~~P~v~dvD~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE--AGVPVPIVYDVDPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH--cCCCCCeEEEEcCCCCEEE
Confidence 4678999999999975 45568888533222 222 35678899888877 3454445566667777899
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
|||. |..|.+++... ...++..+-.-+.-||..||||+||.++||+++ .+.++++||||+..
T Consensus 78 me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence 9999 66777788743 245566666677889999999999999999994 44599999999973
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.8e-12 Score=139.36 Aligned_cols=271 Identities=19% Similarity=0.172 Sum_probs=186.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEe---eEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWF---GVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~---~~~~~ 77 (475)
.+.+.+++-+-+|.++.++.+.-..+|...++|+.....+- .....+..++ .++..+.+..+ .....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~-----i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL-----ITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc-----ccCCCCceecccCCCCCCC
Confidence 45688888999999999999987677766666654332211 0111111110 00222333222 23456
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+|+|+|+ +++|...+.. ....+.+-....+..+..+++|||...++|||+||.|+|+ ...+..++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccc
Confidence 678999999 7788888773 3357777778888899999999999999999999999999 4788999999984443
Q ss_pred cccc---ccc---------------------cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 011882 157 YRDT---ATH---------------------QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 212 (475)
Q Consensus 157 ~~~~---~~~---------------------~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~ 212 (475)
...- ... .....+......||+.|.+||...+......+|+|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2110 000 0001123445689999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011882 213 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 292 (475)
Q Consensus 213 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 292 (475)
||... +..+.++.+.......+ ......+.+.++++...+..++.+|-.+.-- ....+-.+....+|+
T Consensus 1034 p~na~---tpq~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNAE---TPQQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCCc---chhhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCcc
Confidence 99764 34455555555444322 1223356889999999999999999775422 223445666778998
Q ss_pred ccccc
Q 011882 293 ILKYQ 297 (475)
Q Consensus 293 ~~~~~ 297 (475)
.+..+
T Consensus 1102 ~l~~q 1106 (1205)
T KOG0606|consen 1102 NLALQ 1106 (1205)
T ss_pred ccccc
Confidence 77544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1e-10 Score=110.05 Aligned_cols=139 Identities=19% Similarity=0.279 Sum_probs=103.5
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---CEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---DYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---~~~~lvme~~ 86 (475)
+.|+.|.++.||++.. .+|+.++||+...... ...+..|.+++..+......++.+..+.... +..+++||++
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999985 3368899998765432 4578999999999987545577777776653 2568999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------- 122 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~------------------------------------------- 122 (475)
|.+|.+.+. ...++......++.+++..|..||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 666665442 1346677777777788888877773
Q ss_pred -------------CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 -------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 -------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..++|+|++|.|||++.+ ..+.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236899999999999521 14568999999885
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-11 Score=127.98 Aligned_cols=241 Identities=19% Similarity=0.142 Sum_probs=166.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-cCCeEEEEEEeccCCCc--hH--HHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKH--PQ--LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~vAvKi~~~~~~~--~~--~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..+|.++.+||.|.|+.|+.+... .++..|++|-+...... .+ -..|+-+...+..+ .+++.+...+......|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~-~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSH-LPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcc-cccCCCCCCcccccccc
Confidence 467899999999999999998744 57788999954332211 11 23455555566554 55666444444555556
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+-.||| ++++...+ .....+++...+.+..|++.++.++|+..++|+|+||+||++. ++.+..++.|||.++.+.-
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhccccccccccce
Confidence 899999 66665544 3455688999999999999999999999999999999999996 2227789999999975322
Q ss_pred cccccccccccCCCCccCcccc--ccccccCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHhhccccc
Q 011882 160 TATHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~--APE~~~g~~~s~ksDIwSlG~iL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
.. ..+.+..+++ +++......+..+.|++|||..+.+.+++. +++.+... ..+....
T Consensus 420 ~~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~~~--- 479 (524)
T KOG0601|consen 420 SS----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------LTIRSGD--- 479 (524)
T ss_pred ec----------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------eeeeccc---
Confidence 11 1223344444 555556667899999999999999999985 44443211 1111111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+ ...+...++..+.+.+...++..||.+.++..
T Consensus 480 -~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 480 -TP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -cc-CCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 11 11333477888899999999999998776643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.4e-09 Score=105.97 Aligned_cols=135 Identities=19% Similarity=0.131 Sum_probs=98.4
Q ss_pred CceeEEEEEEccCCeEEEEEEeccCCC-----------ch--HHHHHHHHHHHHhCCCCCcCeeEEeeEe-----CCEEE
Q 011882 19 SFGEIYLGTNIQTNEEVAIKLENVKTK-----------HP--QLQYEAKLYKILQGGSTGIPNLRWFGVE-----GDYNV 80 (475)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----------~~--~~~~E~~il~~l~~~~~~i~~l~~~~~~-----~~~~~ 80 (475)
....|+.+. -.|+.|.||....... .+ ...+|...+..|.......|....+++. ....+
T Consensus 34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 334466654 3678899996533221 11 3678999888886643555666666653 23578
Q ss_pred EEEEcCCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC----CCCCcEEEeecCC
Q 011882 81 LVIDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRANQVYIIDFGL 153 (475)
Q Consensus 81 lvme~~g~--sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----~~~~~vkL~DFGl 153 (475)
||||++++ +|.+++... ....+......++.+|+..+.-||..||+|+|+++.||||..+ +....+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99999954 799998632 3446677888999999999999999999999999999999631 2356899999998
Q ss_pred cc
Q 011882 154 AK 155 (475)
Q Consensus 154 A~ 155 (475)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 85
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-10 Score=117.35 Aligned_cols=183 Identities=17% Similarity=0.162 Sum_probs=131.9
Q ss_pred eEEeeeEeeeCceeEE-EEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 9 FRLGRKIGSGSFGEIY-LGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy-~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
|.| ...+-++.+ || .|..+.++.+|.|...+.... .....+-++-++.++| |+|..++...+..+..|||.|-
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRH--P~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRH--PNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccC--chhhhhhhhhcccCceEEEeec
Confidence 555 333334443 44 466678899999998876655 3445666677777776 9999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+-+ |...++. +....+...+.||+.||.||| +++++|++|.-+-|+| +..|..||++|-++..........
T Consensus 91 V~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 91 VRP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred ccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCccc
Confidence 843 5556653 336777888999999999998 6789999999999999 588999999999886544322100
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 212 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~ 212 (475)
....---.|..|+.+.... -..|.|-|||+++|++.|.+
T Consensus 163 -------~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 163 -------KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -------ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 0111122355565543222 35699999999999999933
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.4e-11 Score=113.49 Aligned_cols=203 Identities=11% Similarity=0.128 Sum_probs=131.0
Q ss_pred HHHHHHHHhCCCCCcCeeEEeeEeCC-----EEEEEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 011882 52 EAKLYKILQGGSTGIPNLRWFGVEGD-----YNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS 122 (475)
Q Consensus 52 E~~il~~l~~~~~~i~~l~~~~~~~~-----~~~lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~ 122 (475)
+.-+-.+++..|.+++.++.|..+.. ...++.||+ -++|..++++ +...+..+...+|+.||+.||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 33344444544567888766665443 467888999 8899998864 34558899999999999999999998
Q ss_pred CC--ceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHH
Q 011882 123 KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 200 (475)
Q Consensus 123 ~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSl 200 (475)
.. |+|+++..+-|++ ..++.||+.---... ..... ......+...-.+-+.|.+||.=.....+.++|||+|
T Consensus 195 ~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s-~h~s~--~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDS-THPSV--NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred cCCccccCCcchhheee---cCCceEEecccCccc-cchhh--hhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 74 9999999999999 466766653211100 00000 0000112223356788999998776667889999999
Q ss_pred HHHHHHHHcCCCCCC-CCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 201 GYVLMYFLRGSLPWQ-GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 201 G~iL~elltG~~Pf~-~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
|+..+||..+..--. ........+.+..... .+. ..--+.++..|++-.|..||++.+++
T Consensus 269 gmcAlemailEiq~tnseS~~~~ee~ia~~i~--------~le---n~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESKVEVEENIANVII--------GLE---NGLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred hHHHHHHHHheeccCCCcceeehhhhhhhhee--------ecc---CccccCcCcccccCCCCCCcchhhhh
Confidence 999999998765321 1111111111111100 000 12235688999999999999988763
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-09 Score=108.15 Aligned_cols=256 Identities=13% Similarity=0.176 Sum_probs=157.4
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCe-e------EEeeEeCCEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN-L------RWFGVEGDYNVL 81 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~-l------~~~~~~~~~~~l 81 (475)
..+.+.||+|+-+.+|-.-. -+ ..+-|+.....-..+.+ ..+.+...- .++.+.. + .+-...+....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~aq-k~a~la~~p-~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQAQ-KVAELAATP-DAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecch--hh-chhheeecCCCchHHHH-HHHHhccCC-CCcchhhhhcccHHHhhCCCccceeEE
Confidence 34578899999999997542 12 23457654332221111 111111111 1111111 1 111233444778
Q ss_pred EEEcC-CC-CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 82 VIDLL-GP-SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 82 vme~~-g~-sL~~ll~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.|..+ |. .+..++.-. -..+.+..+++.++.|+.+.+.||+.|.+-+|+.++|||++ +++.|.|+|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccce
Confidence 88887 33 333333211 12378999999999999999999999999999999999995 6788888885433
Q ss_pred ccccccccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCC----HHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT----KKQ 224 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~~~----~~~ 224 (475)
....+... ...-+|...|.+||.-. |.+-+...|.|.||+++++++.| .+||.|..... ..+
T Consensus 165 qi~~ng~~--------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 165 QINANGTL--------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred eeccCCce--------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 32211111 12347899999999754 44567889999999999999986 99998753211 111
Q ss_pred -HHHH--------HhhccccccHHHHhcCChHHHHHHHHHHhcCC--CCCCCCHHHHHHHHHHHHHH
Q 011882 225 -KYEK--------ISEKKVSTSIEALCRGYPTEFASYFHYCRSLR--FDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 225 -~~~~--------i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~d--p~~RPt~~~l~~~L~~l~~~ 280 (475)
.+.. -.....+.+.+.-+.-+|+.+..|+.+|+..- +.-||+++..+..|..+-.+
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0100 00011111111112346899999999999643 56899998887777766543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.3e-10 Score=103.05 Aligned_cols=125 Identities=26% Similarity=0.395 Sum_probs=80.5
Q ss_pred eEEEEEEccCCeEEEEEEeccCC--------------C---------c-----hHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 22 EIYLGTNIQTNEEVAIKLENVKT--------------K---------H-----PQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 22 ~Vy~a~~~~~~~~vAvKi~~~~~--------------~---------~-----~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
.||.|.. ..|..||||+..... . . ....+|.+.|..+....-++|.++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899985 678899999754311 0 0 125678888988877545677776543
Q ss_pred EeCCEEEEEEEcCC--C-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 74 VEGDYNVLVIDLLG--P-SLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 74 ~~~~~~~lvme~~g--~-sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y-LH~~gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
..+|||||++ + .+..+.. . .++......++.+++..+.. +|..||||+||.+.|||++ .+.++|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~-~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKD-V--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHH-C--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE-
T ss_pred ----CCEEEEEecCCCccchhhHHh-c--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEE
Confidence 3579999996 5 3333332 1 22245567788888886655 5799999999999999995 3489999
Q ss_pred ecCCccccc
Q 011882 150 DFGLAKRYR 158 (475)
Q Consensus 150 DFGlA~~~~ 158 (475)
|||.|....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.1e-08 Score=93.04 Aligned_cols=111 Identities=19% Similarity=0.280 Sum_probs=87.2
Q ss_pred chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----CEEEEEEEcC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 011882 46 HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG----DYNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119 (475)
Q Consensus 46 ~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----~~~~lvme~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~y 119 (475)
.....+|...+..|.......|....+++.. ...+|++|++ + .+|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3467889998888876546667777776653 2458899998 4 379999874332 6777888999999999999
Q ss_pred HHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 120 LH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
||++||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999964443458999999988743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-09 Score=114.88 Aligned_cols=154 Identities=12% Similarity=0.198 Sum_probs=105.1
Q ss_pred HHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccccccc--CCCCccCccccccccc
Q 011882 110 ADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE--NKNLTGTARYASMNTH 186 (475)
Q Consensus 110 ~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~--~~~~~GT~~Y~APE~~ 186 (475)
+.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+++........-....|.. .....-...|.|||++
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3455699999996 689999999999999 688999999999987654432211111111 1122346679999999
Q ss_pred cCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCC
Q 011882 187 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP 265 (475)
Q Consensus 187 ~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP 265 (475)
.+...+.++|+|||||.+|.+.. |+.-+..... ........ ............++|+++.+-+.+++..+..-||
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~---~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSR---NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhh---cccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 99888999999999999999985 4444433211 11111111 1111111112257899999999999999999999
Q ss_pred CHHHH
Q 011882 266 DYAYL 270 (475)
Q Consensus 266 t~~~l 270 (475)
++.++
T Consensus 258 ~~~~l 262 (700)
T KOG2137|consen 258 TLDLL 262 (700)
T ss_pred chhhh
Confidence 76554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.1e-07 Score=84.78 Aligned_cols=138 Identities=12% Similarity=0.086 Sum_probs=101.4
Q ss_pred eeeCceeEEEEEEccCCeEEEEEEecc--------CCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCEEEEEE
Q 011882 16 GSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDYNVLVI 83 (475)
Q Consensus 16 G~G~fG~Vy~a~~~~~~~~vAvKi~~~--------~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~~~lvm 83 (475)
|.||.+-|+.... .|+.+=||.-.. ....+.+.+|...+..|......++.+..+... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5689999998763 444677884321 123457999999999998754556666644332 22358899
Q ss_pred EcCC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 84 DLLG--PSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 84 e~~g--~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
|-++ .+|.+++.... .+.+......++.+|+..|.-||+.|+.|+|+-+.|||+..+ ....|+++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 9886 69999875321 246777888999999999999999999999999999999422 123499999987764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.7e-07 Score=90.61 Aligned_cols=210 Identities=18% Similarity=0.210 Sum_probs=145.0
Q ss_pred ceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeE----eCCEEEEEEEcC--CCCHH
Q 011882 20 FGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGV----EGDYNVLVIDLL--GPSLE 91 (475)
Q Consensus 20 fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~----~~~~~~lvme~~--g~sL~ 91 (475)
-.+.|++....+|..|++|.+..... ......-++.++.+.| .+++.+..++. .+...++|++|. .++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h--~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCH--TNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhcc--CceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 35789999999999999998743221 1123445667777776 88888765544 445679999998 56888
Q ss_pred HHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 92 DLFNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 92 ~ll~~~--------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
++.-.. +.+.++..++.++.|+..||.++|+.|+.-+-|.|.+||+. ....++|.--|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeee
Confidence 765211 23477899999999999999999999999999999999994 4447888777766544
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
..+.. |.+.+ -.+-|.=.||.+++.|.+|..- |.. +. .+. .
T Consensus 444 ~~d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~--d~--~~~----------s 485 (655)
T KOG3741|consen 444 QEDPT---------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRT--DS--TQS----------S 485 (655)
T ss_pred cCCCC---------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccc--cc--hHH----------H
Confidence 33210 11111 2367999999999999998543 221 11 111 1
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 273 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 273 (475)
.+..+...++.++++++.+....++++ -++.+++..
T Consensus 486 ~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 486 HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 123344567788899999999888886 455555433
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-07 Score=88.08 Aligned_cols=138 Identities=18% Similarity=0.271 Sum_probs=91.8
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH-----------HHHHHHHHHHHhC-CCCCcCeeE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LQYEAKLYKILQG-GSTGIPNLR 70 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~-----------~~~E~~il~~l~~-~~~~i~~l~ 70 (475)
..+.++|++.+.+-......|.+.. .+|+.+++|.........+ ..++......+.. +......++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 3567899999999998888888876 5788999997655432211 2223333333322 112222212
Q ss_pred EeeE-----eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC
Q 011882 71 WFGV-----EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 144 (475)
Q Consensus 71 ~~~~-----~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 144 (475)
...+ .....+|+|||+ |..|.++.. +++ .++..|.++|.-||+.|++|+|+.|.||++. ++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CC
Confidence 2211 234457899999 767766543 222 3556778889999999999999999999994 45
Q ss_pred cEEEeecCCcc
Q 011882 145 QVYIIDFGLAK 155 (475)
Q Consensus 145 ~vkL~DFGlA~ 155 (475)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 69999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.3e-07 Score=85.42 Aligned_cols=72 Identities=18% Similarity=0.146 Sum_probs=57.6
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcCCC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGP 88 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~g~ 88 (475)
.+||+|..+.||+. .+..+++|+.........+.+|.+++..+......++.++.++...+...++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2456889987765555678999999999986434578888888888888999999944
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.2e-07 Score=83.36 Aligned_cols=128 Identities=26% Similarity=0.414 Sum_probs=97.4
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++.+.|++|.+|.||+|.+ .|..+|+|+-..+.....+..|++++..++.. ..-+.++.|+.+. +.|||. |.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~-~~~p~vy~yg~~~----i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGE-GVTPEVYFYGEDF----IRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhc-CCCceEEEechhh----hhhhhhcCc
Confidence 3467899999999999996 56799999998888888999999999999986 6778888887654 449999 66
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC--CcEEEeeCCCCCcEEEeecCCccc
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP--DNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP--~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.|.++... .+.+.++. +++.---|-..||-|..|.- .||++ .++.+.|+||..|+.
T Consensus 98 ~L~~~~~~----~~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIG----GDRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhc----ccHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 88887652 13333333 34443445567899988864 46666 445899999999974
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.7e-07 Score=88.15 Aligned_cols=134 Identities=20% Similarity=0.349 Sum_probs=96.1
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----------------Cc--------hHHHHHHHHHHHHhCCCC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------KH--------PQLQYEAKLYKILQGGST 64 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----------------~~--------~~~~~E~~il~~l~~~~~ 64 (475)
+.++.+||.|--+.||.|.+ ..|.++|||+-+... .+ ...++|.++|..|...--
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45788999999999999996 478899999632110 00 125678888888876323
Q ss_pred CcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.+|... ..+..++|||+. |.-|..+ +++.+..-.|+..|+.-+.-+-..||||+|+.+=|||++ ++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence 455432 345678999999 4444322 224455566666777777766789999999999999994 78
Q ss_pred CcEEEeecCCccc
Q 011882 144 NQVYIIDFGLAKR 156 (475)
Q Consensus 144 ~~vkL~DFGlA~~ 156 (475)
|.++++||=-+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 8999999977654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.5e-07 Score=97.70 Aligned_cols=141 Identities=20% Similarity=0.306 Sum_probs=94.0
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc------------------------------------------hHHH
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------------PQLQ 50 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~------------------------------------------~~~~ 50 (475)
..|+.++-|+||.|+. .+|+.||||+....-.. -++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999995 66999999985432110 0134
Q ss_pred HHHHHHHHHhC---CCCCcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 011882 51 YEAKLYKILQG---GSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 126 (475)
Q Consensus 51 ~E~~il~~l~~---~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIv 126 (475)
+|+..+..+.. ..+.+..-..|.+-....+|+|||+ |-.+.++.......++.+.+...+.++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 55555555543 1222222233444456678999999 7688777433334566555544444333 3444458999
Q ss_pred ecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 127 HrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|.|..|.||++ +.++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 5779999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.6e-07 Score=85.16 Aligned_cols=134 Identities=22% Similarity=0.276 Sum_probs=92.0
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---------------------h-----HHHHHHHHHHHHhCCCCCcC
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------P-----QLQYEAKLYKILQGGSTGIP 67 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---------------------~-----~~~~E~~il~~l~~~~~~i~ 67 (475)
.|..|--+.||+|.. .++..||||+.+..... . -...|..-|..+....-.+|
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 455566669999984 67889999986543211 0 13456666666655334444
Q ss_pred eeEEeeEeCCEEEEEEEcCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCC
Q 011882 68 NLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN 144 (475)
Q Consensus 68 ~l~~~~~~~~~~~lvme~~g~sL~--~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~ 144 (475)
.-+.+ ..++|||||+|.... -.++ .-.+...+...+..++++.+.-|-. .++||+||..=|||+. .+
T Consensus 134 ~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~ 203 (268)
T COG1718 134 EPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DG 203 (268)
T ss_pred Cceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CC
Confidence 43332 246899999966511 0111 1124444788889999999998887 9999999999999993 68
Q ss_pred cEEEeecCCccccc
Q 011882 145 QVYIIDFGLAKRYR 158 (475)
Q Consensus 145 ~vkL~DFGlA~~~~ 158 (475)
.++|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 89999999997554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.5e-06 Score=82.12 Aligned_cols=140 Identities=18% Similarity=0.274 Sum_probs=82.7
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE---eCCEEEEEEEcC-C
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV---EGDYNVLVIDLL-G 87 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~---~~~~~~lvme~~-g 87 (475)
++.|+.|..+.||++.... ..++||+.........+..|..+++.+......++.++.++. .....+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999998533 589999865543345788999999999764334677776443 445678999998 6
Q ss_pred CCHHH----------------HHH---HcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 011882 88 PSLED----------------LFN---FCS---RKLSLKT---------VLML------------ADQMIN-RVEFVHS- 122 (475)
Q Consensus 88 ~sL~~----------------ll~---~~~---~~ls~~~---------~~~i------------~~qi~~-aL~yLH~- 122 (475)
..+.. .+. ... ..+.... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 66665 111 110 0111000 0000 111222 2333332
Q ss_pred ------CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 ------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 ------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..++|+|+.|.|||++ ..++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 4599999999999995 355666899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.7e-06 Score=80.85 Aligned_cols=75 Identities=19% Similarity=0.280 Sum_probs=56.1
Q ss_pred EeeeCc-eeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCHHH
Q 011882 15 IGSGSF-GEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLED 92 (475)
Q Consensus 15 LG~G~f-G~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~~ 92 (475)
|-.|.. ..||+... .+..++||+..... ...+..|+++++.+... ..+|.++.++...+..++||+++ |.+|..
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~-~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGK-LPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhc-CCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 78999874 34688999865543 45688999999999876 66888888887777789999998 666654
Q ss_pred H
Q 011882 93 L 93 (475)
Q Consensus 93 l 93 (475)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-05 Score=73.28 Aligned_cols=130 Identities=22% Similarity=0.308 Sum_probs=96.1
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCC------------------CchHHHHHHHHHHHHh-C---CCCCcCee
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------------KHPQLQYEAKLYKILQ-G---GSTGIPNL 69 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~------------------~~~~~~~E~~il~~l~-~---~~~~i~~l 69 (475)
...||+|+.-.||.- ..+...+||+..... ...+..+|...+..+. . ...+|+.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999999973 345567899877654 2356778888887777 3 23667888
Q ss_pred EEeeEeCCEEEEEEEcC-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 70 RWFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 70 ~~~~~~~~~~~lvme~~-------g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
+++.+.+.-..+|+|.. ..+|.+++. ...++. .+...+. .-..||-+.+|+.+||+|.||++...++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 88888888889999977 447888885 334655 3333333 3446788999999999999999987655
Q ss_pred CC-cEEEee
Q 011882 143 AN-QVYIID 150 (475)
Q Consensus 143 ~~-~vkL~D 150 (475)
.. .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 55 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.1e-06 Score=87.67 Aligned_cols=143 Identities=20% Similarity=0.312 Sum_probs=93.1
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---------------------------------------hHHHHHH
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------------------------PQLQYEA 53 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---------------------------------------~~~~~E~ 53 (475)
+.||.-+.|+||+|+- .+|+.||||+-+..-.. -++..|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5789999999999995 56999999974332110 0133344
Q ss_pred HHHHHHhC--CCCC------cCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 011882 54 KLYKILQG--GSTG------IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124 (475)
Q Consensus 54 ~il~~l~~--~~~~------i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g 124 (475)
+....+.. .+.. ||.+++. .....+|+|||| |..+.++-.-....++...+..-+.++.. +.|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 43333322 1122 4444443 344578999999 66666654434556887766665555443 3344578
Q ss_pred ceecCCCCCcEEEeeC-CCCCcEEEeecCCccccccc
Q 011882 125 FLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 125 IvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~~~~~~ 160 (475)
++|+|-.|.||++..+ ..+..+.+.|||+...+...
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 9999999999999632 24678999999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.3e-05 Score=76.66 Aligned_cols=74 Identities=16% Similarity=0.182 Sum_probs=49.3
Q ss_pred eeeEeeeCce-eEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCC-CCCcCeeEEeeEeC---CEEEEEEEcC
Q 011882 12 GRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-STGIPNLRWFGVEG---DYNVLVIDLL 86 (475)
Q Consensus 12 ~~~LG~G~fG-~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~~---~~~~lvme~~ 86 (475)
++.|+.|+.. .||+.. ..+++|+.........+..|.+++..+... ...++.+...+... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777776 599752 357889865544445789999999998753 23466666655443 2457889998
Q ss_pred -CCCH
Q 011882 87 -GPSL 90 (475)
Q Consensus 87 -g~sL 90 (475)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 5454
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.7e-07 Score=94.35 Aligned_cols=185 Identities=12% Similarity=0.046 Sum_probs=134.1
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCC-cCeeEEeeEeCCEEEEEEEcCC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTG-IPNLRWFGVEGDYNVLVIDLLG 87 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~-i~~l~~~~~~~~~~~lvme~~g 87 (475)
|....-+++|+++.+++.+...+...+ .|++... ....-++++|.++++ ++ .+....-+..+++.+++|++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~--P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNN--PNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccC--CCCcccccccCCcccccchhhhhhc
Confidence 445566789999999999876555444 6665433 456678888888887 55 3333444456678899999993
Q ss_pred CC--HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 88 PS--LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 88 ~s--L~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+. -...+.-..-.|..-+...+.+.-+.+|++||+.-=+||| ||+. ..+..++.||+....+....
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc----
Confidence 32 2222221111244455666777778899999998789999 8887 45788999999988765542
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 215 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~ 215 (475)
...++.+|+.++|||+..+..+....|+|++|+--.++.-|..|-.
T Consensus 386 ----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2356789999999999999999999999999988778877777654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.6e-05 Score=85.42 Aligned_cols=78 Identities=9% Similarity=0.144 Sum_probs=54.6
Q ss_pred EeeeEeeeCceeEEEEEEccCC--eEEEEEEeccCC---CchHHHHHHHHHHHHh-CCCCCcCeeEEeeEeC---CEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKT---KHPQLQYEAKLYKILQ-GGSTGIPNLRWFGVEG---DYNVL 81 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~--~~vAvKi~~~~~---~~~~~~~E~~il~~l~-~~~~~i~~l~~~~~~~---~~~~l 81 (475)
-+++|+.|.+..+|+......+ ..+++|+..... ....+.+|.++++.+. +....++.+++++.+. ...|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3577899999999998764332 467888754322 2246889999999996 3334567777776653 45789
Q ss_pred EEEcCCC
Q 011882 82 VIDLLGP 88 (475)
Q Consensus 82 vme~~g~ 88 (475)
|||++.+
T Consensus 122 VME~v~G 128 (822)
T PLN02876 122 IMEYLEG 128 (822)
T ss_pred EEEecCC
Confidence 9999943
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.3e-05 Score=68.58 Aligned_cols=126 Identities=20% Similarity=0.327 Sum_probs=85.7
Q ss_pred CCceEEeeeEeeeCc-eeEEEEEEccCCeEEEEEEecc---C--------------------CCchHHHHHHHHHHHHhC
Q 011882 6 GNKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLENV---K--------------------TKHPQLQYEAKLYKILQG 61 (475)
Q Consensus 6 ~~~y~l~~~LG~G~f-G~Vy~a~~~~~~~~vAvKi~~~---~--------------------~~~~~~~~E~~il~~l~~ 61 (475)
+.+++.++.||.|.- |.||+++ ..|+.||||++.. . ....-+..|.+.+-+|+.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 368999999999999 9999998 5788999998321 0 011236778888888876
Q ss_pred CCC-Cc--CeeEEeeEeC------------------CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 011882 62 GST-GI--PNLRWFGVEG------------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120 (475)
Q Consensus 62 ~~~-~i--~~l~~~~~~~------------------~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yL 120 (475)
.+. ++ ++.++|..-. ....||.||....- .++. .=+.+|.+-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 433 34 3444333211 12356666652211 1222 2346778888999
Q ss_pred HhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 121 H~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
|..||+-+|+|+.|..=+ ||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HHCCeeeccCccccccCC--------EEEecccC
Confidence 999999999999998732 79999965
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00073 Score=68.28 Aligned_cols=71 Identities=14% Similarity=0.214 Sum_probs=48.3
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEe----cc-----CCCchHHHHHHHHHHHHhCCCC-CcCeeEEeeEeCCEEEEEE
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLE----NV-----KTKHPQLQYEAKLYKILQGGST-GIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~----~~-----~~~~~~~~~E~~il~~l~~~~~-~i~~l~~~~~~~~~~~lvm 83 (475)
.||.|....||++.+...++.|+||.- +. .....+...|.+.|+......| .+|.++.|. .+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 579999999999997544468999952 21 1123456788888887765434 456655544 44567899
Q ss_pred EcC
Q 011882 84 DLL 86 (475)
Q Consensus 84 e~~ 86 (475)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 988
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00099 Score=68.60 Aligned_cols=74 Identities=19% Similarity=0.273 Sum_probs=52.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccC---------CCchHHHHHHHHHHHHhCC-CCCcCeeEEeeEeCCEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLQYEAKLYKILQGG-STGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~---------~~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~~~~~~l 81 (475)
.+.||.|.+..||++.+...++.|+||.-... ........|.+.|+.+... ...+|.++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46789999999999997543368999973311 1234567888888887542 245788877754 44689
Q ss_pred EEEcCC
Q 011882 82 VIDLLG 87 (475)
Q Consensus 82 vme~~g 87 (475)
|||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999983
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00023 Score=70.67 Aligned_cols=80 Identities=15% Similarity=0.126 Sum_probs=58.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCC-CCcCeeEEeeEe---CCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGS-TGIPNLRWFGVE---GDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~-~~i~~l~~~~~~---~~~~~lvm 83 (475)
.-.-.+.||.|..+.||.... .+..+++|+.+.......+..|.+.++.|.... ..+|.++.++.. .+..+|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567899999999999863 233577888543234468999999999997642 468888877653 36689999
Q ss_pred EcC-CCC
Q 011882 84 DLL-GPS 89 (475)
Q Consensus 84 e~~-g~s 89 (475)
|++ |.+
T Consensus 93 E~i~G~~ 99 (297)
T PRK10593 93 ERLRGVS 99 (297)
T ss_pred eccCCEe
Confidence 998 443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00048 Score=68.96 Aligned_cols=72 Identities=15% Similarity=0.172 Sum_probs=47.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEE------eeEeCCEEEEEEEc
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRW------FGVEGDYNVLVIDL 85 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~------~~~~~~~~~lvme~ 85 (475)
.+.|+.|....+|+... . +..+++|+.. ......+..|..++..|......++.+.. +....+..++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45677777789999873 3 3468999876 33445677788888888653333555432 22345567899999
Q ss_pred C
Q 011882 86 L 86 (475)
Q Consensus 86 ~ 86 (475)
+
T Consensus 104 l 104 (319)
T PRK05231 104 L 104 (319)
T ss_pred c
Confidence 8
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00044 Score=65.90 Aligned_cols=74 Identities=19% Similarity=0.213 Sum_probs=48.8
Q ss_pred eeeEeeeCceeEEEEEEcc-CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++.|..|-...+|++.... .++.|++|+....... -....|..++..+... ...|.++.... ..++|||+ |.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~-gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKH-GLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhC-CCCCeEEEEeC----CcEEEEeeCCC
Confidence 4667788888999997432 3578999986543222 2345788899888654 34666654432 24799998 54
Q ss_pred CH
Q 011882 89 SL 90 (475)
Q Consensus 89 sL 90 (475)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 44
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00035 Score=69.65 Aligned_cols=141 Identities=18% Similarity=0.262 Sum_probs=82.7
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEe------eEeCCEEEEEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWF------GVEGDYNVLVI 83 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~------~~~~~~~~lvm 83 (475)
.-++.|+.|....+|++.. . +..+++|+.........+..|.+++..|......++.+... ....+..+++|
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3466777777789999863 3 44688898755434456778888888886532334444331 12345678999
Q ss_pred EcC-CCCH-----H------HHHH---HcCCCC--------CHH---HHH------------HHHHHHHHHHHHHHh---
Q 011882 84 DLL-GPSL-----E------DLFN---FCSRKL--------SLK---TVL------------MLADQMINRVEFVHS--- 122 (475)
Q Consensus 84 e~~-g~sL-----~------~ll~---~~~~~l--------s~~---~~~------------~i~~qi~~aL~yLH~--- 122 (475)
+++ |..+ . ..+. .....+ ... ... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 998 4221 1 1111 100111 000 000 001123344555542
Q ss_pred ----CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 ----~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.+++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6899999999999995 44556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00061 Score=67.33 Aligned_cols=138 Identities=15% Similarity=0.173 Sum_probs=82.3
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEE------eeEeCCEEEEEEEc
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRW------FGVEGDYNVLVIDL 85 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~------~~~~~~~~~lvme~ 85 (475)
++.|..|....+|+... .+..+++|+... .....+..|..++..|......++.+.. +...++..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 56777788789999863 445789998765 3445688899999988653333444432 22334566899999
Q ss_pred C-CCCHHH-----------HHH---HcCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------C
Q 011882 86 L-GPSLED-----------LFN---FCSRKL----------SLKTV----------LMLADQMINRVEFVHS-------K 123 (475)
Q Consensus 86 ~-g~sL~~-----------ll~---~~~~~l----------s~~~~----------~~i~~qi~~aL~yLH~-------~ 123 (475)
+ |..+.. .+. .....+ .+... ......+...+.++-. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 8 444311 111 000000 11000 0011112334444443 4
Q ss_pred CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 124 gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+++|+|+.|.|||+. +++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 799999999999994 45556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=8.4e-05 Score=72.98 Aligned_cols=132 Identities=19% Similarity=0.332 Sum_probs=92.3
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC--------CCc----------------hHHHHHHHHHHHHhCCCC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------TKH----------------PQLQYEAKLYKILQGGST 64 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~--------~~~----------------~~~~~E~~il~~l~~~~~ 64 (475)
+.++.+||-|--+.||.+.+ ..|.+.++|+-... .+. -...+|...++.|..+.-
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66889999999999999986 67888999952211 000 024568888888876434
Q ss_pred CcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
-+|... +....|+|||++ |..|..+.+ -.+.. .+...+..-+.-|-.+|+||+|..-=||+| +++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCChH---HHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 444432 345678999999 666655432 12233 344445555667779999999999999999 467
Q ss_pred CcEEEeecCCcc
Q 011882 144 NQVYIIDFGLAK 155 (475)
Q Consensus 144 ~~vkL~DFGlA~ 155 (475)
+.++++||=-..
T Consensus 239 ~~i~vIDFPQmv 250 (465)
T KOG2268|consen 239 DKIVVIDFPQMV 250 (465)
T ss_pred CCEEEeechHhh
Confidence 889999997554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00067 Score=67.83 Aligned_cols=138 Identities=23% Similarity=0.281 Sum_probs=93.8
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----------------------Cch------HHHHHHHHHHHHhCC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHP------QLQYEAKLYKILQGG 62 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----------------------~~~------~~~~E~~il~~l~~~ 62 (475)
|-..|..|--+.||.|. ..+|..+|||+.+... ..+ ....|.+-|..+..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~- 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN- 225 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh-
Confidence 44567778888999998 4788889999754211 001 13556677777765
Q ss_pred CCCcCeeEEeeEeCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeeCC
Q 011882 63 STGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 63 ~~~i~~l~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~ 141 (475)
-.||.-.-+.. ...+|||+|+|.+-+-.-....-.++...+..+-.|++.-|.-|. .+++||.||.-=|+|+
T Consensus 226 -aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---- 298 (520)
T KOG2270|consen 226 -AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---- 298 (520)
T ss_pred -cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence 33432211111 235799999975443322212345777788888888888887765 5799999999999999
Q ss_pred CCCcEEEeecCCcccc
Q 011882 142 RANQVYIIDFGLAKRY 157 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~ 157 (475)
..|.++|+|-+-+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 5789999999877543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0082 Score=61.51 Aligned_cols=73 Identities=18% Similarity=0.289 Sum_probs=50.6
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEE----eccC----CCchHHHHHHHHHHHHhCCCC-CcCeeEEeeEeCCEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVK----TKHPQLQYEAKLYKILQGGST-GIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi----~~~~----~~~~~~~~E~~il~~l~~~~~-~i~~l~~~~~~~~~~~lv 82 (475)
.+.||.|.-..||++.+...++.|+||. ++.. ....+...|.+.|+.+....| .+|.++.+.. +...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 5688999999999999744457899994 2221 123457789999988765434 5666666544 445688
Q ss_pred EEcC
Q 011882 83 IDLL 86 (475)
Q Consensus 83 me~~ 86 (475)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8877
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00041 Score=64.13 Aligned_cols=98 Identities=23% Similarity=0.287 Sum_probs=75.3
Q ss_pred HHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcCC-CCHHHH----HHHcCCCCCHHHHHHHHHHHHHHHHHHHh--
Q 011882 50 QYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLG-PSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHS-- 122 (475)
Q Consensus 50 ~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~g-~sL~~l----l~~~~~~ls~~~~~~i~~qi~~aL~yLH~-- 122 (475)
..|.-+++.+++. .+++++++++ + .+++.|+.+ +++... .+ -..-+|....+|+.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~-~~~pk~lG~C--G--~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGS-EPFPKLLGSC--G--RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCC-CCCCCeeeEC--C--CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3578888888886 5888887776 2 357888885 344321 11 1136899999999999999999997
Q ss_pred -CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 123 -KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 123 -~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
..+.-.|++|+||-+. +++.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 4588899999999994 6788999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=65.82 Aligned_cols=74 Identities=14% Similarity=0.087 Sum_probs=48.9
Q ss_pred eeeEeeeCceeEEEEEEcc------CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
++.|..|-...||++.... .++.|++|+....... .....|.+++..+... ...+.++.+... .+|++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~-g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSER-NLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhC-CCCCceEEEeCC----Cchhh
Confidence 3556667777999987432 2578999997654322 4578899999998765 345666655532 35788
Q ss_pred cC-CCCH
Q 011882 85 LL-GPSL 90 (475)
Q Consensus 85 ~~-g~sL 90 (475)
|+ |..+
T Consensus 78 ~i~G~~l 84 (302)
T cd05156 78 FIPSRTL 84 (302)
T ss_pred eeCCCcC
Confidence 87 4444
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=74.66 Aligned_cols=202 Identities=16% Similarity=0.160 Sum_probs=127.6
Q ss_pred HHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE----EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 011882 51 YEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI----DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125 (475)
Q Consensus 51 ~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm----e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gI 125 (475)
.|.++.......|.++..+..|..+.....+++ ++| ..++..++.. -..++..+++.+..++..||.|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 355554455555588888888887665554444 445 5677776663 4568999999999999999999999854
Q ss_pred eecCCCCCcEEEeeCCCCCcEEEe--ecCCcccccccccccccccccCCCCccCccccccccccCCCCC--CchhHHHHH
Q 011882 126 LHRDIKPDNFLMGLGRRANQVYII--DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDDLESLG 201 (475)
Q Consensus 126 vHrDIKP~NILl~~~~~~~~vkL~--DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s--~ksDIwSlG 201 (475)
.|.=|-..-..-...+..+.+.+. ||+..+.+.+..... ...-+..|.++|......+. +..|+|.+|
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHHH
Confidence 443333221111111344555655 888888766543211 12334557778877765554 457999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 202 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 202 ~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..+..+..|..+-.... ....-++..+..+..+.+.+|+.-+.++|+.+.++ +...|.+.
T Consensus 380 ll~~~~~~~~~i~~~~~-----------------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l---l~~~f~~~ 439 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA-----------------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALEL---LTHPFLRF 439 (1351)
T ss_pred HHHhhhhhcCccccccc-----------------chhhhhccccchhhhhhhhhhcchhhhhccchhhh---hhchhccc
Confidence 99999988755422100 00111112223378889999999999999998776 45555443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0034 Score=60.77 Aligned_cols=131 Identities=18% Similarity=0.169 Sum_probs=76.9
Q ss_pred eEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCH
Q 011882 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSL 90 (475)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL 90 (475)
.+..|-.+.+|+.. .+++.+++|+....... -....|.++++.+... ...|.++.... .++||+|+ |..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~-g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSAL-GLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhc-CCCCceEEEeC----CEEEEEeccCccc
Confidence 35567888999987 46778999975443222 2467899999998763 23566655542 36899998 4443
Q ss_pred HH-----------H---HHHc------CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceecCCCC
Q 011882 91 ED-----------L---FNFC------SRKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKP 132 (475)
Q Consensus 91 ~~-----------l---l~~~------~~~ls~~-~~~~i~~qi---------~~aL~yLH~--------~gIvHrDIKP 132 (475)
.. + +... ..+++.. .+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 21 1 1111 1112222 112222111 111222211 2589999999
Q ss_pred CcEEEeeCCCCCcEEEeecCCcc
Q 011882 133 DNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 133 ~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.|||++ +++ ++|+||..|.
T Consensus 156 ~Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred CcEEEe---CCC-CEEEeccccC
Confidence 999995 333 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0031 Score=61.97 Aligned_cols=46 Identities=7% Similarity=0.047 Sum_probs=30.2
Q ss_pred eeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCC
Q 011882 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62 (475)
Q Consensus 16 G~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~ 62 (475)
++|-...||... ...|..+++|+-........+.+|.+++..+...
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 333344555543 2457889999865433445689999999999763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.00014 Score=83.39 Aligned_cols=130 Identities=12% Similarity=-0.017 Sum_probs=98.1
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhC-----CceecCCCCCcEEEeeCCCCCc
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK-----SFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~---ls~~~~~~i~~qi~~aL~yLH~~-----gIvHrDIKP~NILl~~~~~~~~ 145 (475)
+....+.+++++ +|.+.+.+-+...+ +...-+.....+.+.+..-+|.. --+|++||+-|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 344557888888 88888877643222 44444555555547777777753 27899999999999 57788
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf 214 (475)
+|+.++|+.+....... ..+...+++.|+++++.....++.++|+|..|+.+|+...|..+|
T Consensus 1379 v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999983332211 224567899999999999999999999999999999999998887
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0032 Score=65.53 Aligned_cols=162 Identities=20% Similarity=0.194 Sum_probs=94.5
Q ss_pred CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 011882 45 KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE-GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123 (475)
Q Consensus 45 ~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~ 123 (475)
...++.-....++.+++ ++...+.++... ....++|||+++.||++++.... +-..... .+
T Consensus 25 ~s~~ilgr~~~lktl~~--~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~ 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQH--DNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AH 86 (725)
T ss_pred cHHHHhhhhHHHHhhcC--ccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------cc
Confidence 34455666677777777 677777766553 34588999999999999987432 2111111 22
Q ss_pred CceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHH
Q 011882 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYV 203 (475)
Q Consensus 124 gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~i 203 (475)
++.| -|| ++++| -++... .... .+|+||||+|.+
T Consensus 87 ~~~~-----~~~----------~~~td-~~~t~~--------------~~~~----------------~pKsdVwsl~~i 120 (725)
T KOG1093|consen 87 GVLH-----LNI----------IYITD-HFLTKY--------------PSPI----------------GPKSDVWSLGFI 120 (725)
T ss_pred ccce-----ehh----------hhccc-cccccC--------------CCCC----------------CcchhhhhHHHH
Confidence 3322 222 33444 111100 0011 249999999999
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc---ccHH-HHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 204 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---TSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 204 L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~~-~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
+.|+.-|..-|...........+.+....... ...+ .+...++..+..+...|+-..|..||...++
T Consensus 121 ~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 121 ILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 99999998888664433222222222111110 0011 1223457788999999999999999876554
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.019 Score=58.25 Aligned_cols=137 Identities=13% Similarity=0.163 Sum_probs=78.4
Q ss_pred eeeEeeeCceeEEEEEEcc----CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 12 GRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~----~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
+..|-.|-...+|++.... .++.|++|+....... -....|..+++.+... ..-+.++++...+ .|++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~-gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRH-GQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHc-CCCCceEEEECCc----eEEEee
Confidence 4455558888999987432 2468999987554321 1346788898888764 4455665554322 467777
Q ss_pred -CCCHHH-----------H---HHHc-C-----CC-CC-HHHHHHHHHHH-----------------HHHHHHH----H-
Q 011882 87 -GPSLED-----------L---FNFC-S-----RK-LS-LKTVLMLADQM-----------------INRVEFV----H- 121 (475)
Q Consensus 87 -g~sL~~-----------l---l~~~-~-----~~-ls-~~~~~~i~~qi-----------------~~aL~yL----H- 121 (475)
+.+|.. + +... . .. +. ...+..+..++ ...+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 444421 1 1100 0 01 11 22333332221 1111122 1
Q ss_pred ---hCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 122 ---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 122 ---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++|+|+++.|||++ +..+.++|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 23589999999999995 334689999998875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.023 Score=58.63 Aligned_cols=74 Identities=15% Similarity=0.273 Sum_probs=50.2
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEec-----cCC----CchHHHHHHHHHHHHhCCC-CCcCeeEEeeEeCCEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKT----KHPQLQYEAKLYKILQGGS-TGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~-----~~~----~~~~~~~E~~il~~l~~~~-~~i~~l~~~~~~~~~~~ 80 (475)
-.+.||.|....||+..+ .+..|+||.-. ... ...+...|.+.|+.+.... ..+|.++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 367889999999999986 34579999633 111 2344566777776665322 46788888777 4467
Q ss_pred EEEEcCCC
Q 011882 81 LVIDLLGP 88 (475)
Q Consensus 81 lvme~~g~ 88 (475)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999933
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.033 Score=55.26 Aligned_cols=61 Identities=11% Similarity=0.072 Sum_probs=38.2
Q ss_pred eEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEe------eEeCCEEEEEEEcC
Q 011882 22 EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWF------GVEGDYNVLVIDLL 86 (475)
Q Consensus 22 ~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~------~~~~~~~~lvme~~ 86 (475)
.||++.. ++..+++|+... ....+..|..++..|......++.+... ...++..+++++++
T Consensus 11 ~v~~v~t--~~g~~~LK~~~~--~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i 77 (313)
T TIGR02906 11 NVYKVET--DSGNKCLKKINY--PPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWI 77 (313)
T ss_pred cEEEEEe--CCCCeEEEEcCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhc
Confidence 4888873 334688998753 2345677888887776532344444321 23456789999998
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.025 Score=57.09 Aligned_cols=73 Identities=14% Similarity=0.078 Sum_probs=44.0
Q ss_pred ceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++. .|..|=...+|++..... +..|++|+....... -.-..|..+++.+... ..-+.++++.. +. ++.
T Consensus 16 ~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~-gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 16 DFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAA-GFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred ceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhc-CCCCceeEEeC-Cc---Eee
Confidence 34444 444477778999874332 347999987554321 2346788888888764 33456655543 22 467
Q ss_pred EcC
Q 011882 84 DLL 86 (475)
Q Consensus 84 e~~ 86 (475)
+|+
T Consensus 90 ~fi 92 (330)
T PLN02421 90 SFI 92 (330)
T ss_pred hhh
Confidence 776
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0092 Score=59.87 Aligned_cols=74 Identities=24% Similarity=0.292 Sum_probs=60.8
Q ss_pred EeCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 74 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 74 ~~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.++.|.|++|++-|++|.-+- ....++++.|+.+.+.-|.-+..+ .+-|||+.-.|||| + .|+|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence 566788999999998886432 246788999999988877777654 58899999999999 3 8999999999
Q ss_pred Cccc
Q 011882 153 LAKR 156 (475)
Q Consensus 153 lA~~ 156 (475)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.02 Score=57.08 Aligned_cols=143 Identities=13% Similarity=0.197 Sum_probs=76.5
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEecc-CCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--EEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--YNVLV 82 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~-~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--~~~lv 82 (475)
..+++.+-.|---.+|...+ +++.++|. ... ... .....+|.++++.+.....-++..++++.++. ..|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34455553333335555543 37788888 331 122 23456677777766553233444455555444 56899
Q ss_pred EEcCCC-------------------CHHHHHHHcC-------------CCCCHHHHHHHHHHH--------------HHH
Q 011882 83 IDLLGP-------------------SLEDLFNFCS-------------RKLSLKTVLMLADQM--------------INR 116 (475)
Q Consensus 83 me~~g~-------------------sL~~ll~~~~-------------~~ls~~~~~~i~~qi--------------~~a 116 (475)
|+++.| .|.+++.... ..+...++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999833 1222221110 001111222222222 222
Q ss_pred HHHHHhC--------CceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 117 VEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 117 L~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
..+|+.+ .++|+|+.+.||+|. ..+-+=|+||+++..-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence 4455542 489999999999995 4444889999999753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.12 Score=51.98 Aligned_cols=68 Identities=10% Similarity=0.063 Sum_probs=41.7
Q ss_pred eCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCe-e----EEeeEeCCEEEEEEEcC
Q 011882 18 GSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPN-L----RWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~-l----~~~~~~~~~~~lvme~~ 86 (475)
+.-..||+... .++..+++|+..... ...++..|.+++..|....-.++. + ..+...+++.+.+++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 34457898873 556789999876443 345677899988888652122222 1 01123345677888887
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.036 Score=54.76 Aligned_cols=75 Identities=17% Similarity=0.258 Sum_probs=52.8
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHh-CCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ-GGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~-~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
.+-.+.|+.|....+|+.. .+++.+.||+-. ......+..|.+-|+.|. .....+|.++.++...+..+|+||++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3446778889999999987 778899999876 444567899999999994 33366888999998888889999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.022 Score=58.05 Aligned_cols=60 Identities=23% Similarity=0.287 Sum_probs=44.3
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEee
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~ 139 (475)
..+|+.+|+ |-++..+++. ...+++.+..++.=.+.||.-|- -.+++|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 346777888 7788888873 33555666777776777765544 478999999999999964
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.14 Score=59.39 Aligned_cols=78 Identities=14% Similarity=0.230 Sum_probs=48.2
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCC--cCeeEE------e-eE---eC-CEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTG--IPNLRW------F-GV---EG-DYN 79 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~--i~~l~~------~-~~---~~-~~~ 79 (475)
+.|+ |..-.+|+... .+|..+++|+.+.......+..|..++..|....+. ++.+.- + .. .+ .+.
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45678898873 567789999988765555677788888877654233 333321 1 11 11 146
Q ss_pred EEEEEcC-CCCHHH
Q 011882 80 VLVIDLL-GPSLED 92 (475)
Q Consensus 80 ~lvme~~-g~sL~~ 92 (475)
+.+++|+ |..|.+
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 6788888 555544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.15 Score=50.70 Aligned_cols=29 Identities=24% Similarity=0.457 Sum_probs=25.5
Q ss_pred CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 124 gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+++|+|+.+.|||+ +.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence 79999999999999 466779999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.1 Score=52.56 Aligned_cols=135 Identities=18% Similarity=0.265 Sum_probs=78.2
Q ss_pred EeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCe----eE--EeeEeC--CEEEEEEEcC
Q 011882 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN----LR--WFGVEG--DYNVLVIDLL 86 (475)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~----l~--~~~~~~--~~~~lvme~~ 86 (475)
|.+ .-..||+... .+|+ ++||+........++..|..++..|.....-++. +. ....-. .+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 4557898874 3444 4999988775567788999999888653222211 11 111223 3778888888
Q ss_pred -CCCHHH------------HHH---HcCCC-----------CCHH----H---------HHHHHHHHHHHHHHHHh----
Q 011882 87 -GPSLED------------LFN---FCSRK-----------LSLK----T---------VLMLADQMINRVEFVHS---- 122 (475)
Q Consensus 87 -g~sL~~------------ll~---~~~~~-----------ls~~----~---------~~~i~~qi~~aL~yLH~---- 122 (475)
|..+.. ++. ...+. ..+. . -.....++...+..+.+
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 545541 110 00011 1111 0 01123444555555554
Q ss_pred ----CC--ceecCCCCCcEEEeeCCCCC-cEEEeecCCcc
Q 011882 123 ----KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 155 (475)
Q Consensus 123 ----~g--IvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~ 155 (475)
-+ +||+|+.|.||++. ... .+.++||+-|.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 23 99999999999994 333 48899999874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.58 Score=48.20 Aligned_cols=75 Identities=15% Similarity=0.159 Sum_probs=43.8
Q ss_pred EeeeEeeeCceeEEEEEEccCC-e-----EEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTN-E-----EVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~-~-----~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++.|..|-...+|++...... . .|++++..... ..-.-..|..+++.+... ..-+.+++.+. .+++.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~-glgP~l~~~f~----~g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDN-NFGPKIIGRFG----DFTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhC-CCCCeEEEecC----CEEEE
Confidence 3456656888899999743321 2 25555422111 112346688898888764 55566655553 35888
Q ss_pred EcC-CCCH
Q 011882 84 DLL-GPSL 90 (475)
Q Consensus 84 e~~-g~sL 90 (475)
||+ |..|
T Consensus 129 efIeGr~l 136 (383)
T PTZ00384 129 EWVEGNTM 136 (383)
T ss_pred EEeccccC
Confidence 888 4443
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.52 Score=54.61 Aligned_cols=71 Identities=13% Similarity=0.169 Sum_probs=43.1
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCC--CCcCeeEE-------eeE---eCCEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGS--TGIPNLRW-------FGV---EGDYNV 80 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~--~~i~~l~~-------~~~---~~~~~~ 80 (475)
..|+.+. -.+|+... ++..+++|+.+.......+..|..++..|.... ..++.+.- ... ...+.+
T Consensus 37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v 113 (972)
T PRK06149 37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV 113 (972)
T ss_pred EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence 4555333 36888764 235788999876555567888888888886642 23333311 111 124557
Q ss_pred EEEEcC
Q 011882 81 LVIDLL 86 (475)
Q Consensus 81 lvme~~ 86 (475)
.+++|+
T Consensus 114 rL~~~l 119 (972)
T PRK06149 114 RLLDYL 119 (972)
T ss_pred EEEEec
Confidence 788888
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.95 Score=47.57 Aligned_cols=71 Identities=14% Similarity=0.035 Sum_probs=44.6
Q ss_pred EeeeEeeeCceeEEEEEEcc--------CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~--------~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
-++.|..|-.-.+|++.... .++.|++++....+.. -....|..+++.+... ..-+.+++... .+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~-gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKY-RIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHC-CCCCceEEEeC----CCE
Confidence 45667667778999987532 1568999986544321 2346688888888764 33445554332 345
Q ss_pred EEEcC
Q 011882 82 VIDLL 86 (475)
Q Consensus 82 vme~~ 86 (475)
+.+|+
T Consensus 184 I~efi 188 (442)
T PTZ00296 184 IEEWL 188 (442)
T ss_pred EEEee
Confidence 67777
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.82 Score=44.70 Aligned_cols=44 Identities=23% Similarity=0.396 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHHHhC--CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 109 LADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 109 i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.+..+-.++.-+|.. -++|+|+.|+|+|++ +.+.++|+||--|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence 333444444444433 489999999999994 55899999998875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 475 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 0.0 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-136 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-135 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-135 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-95 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-95 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-94 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-94 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-94 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-93 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-93 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 7e-27 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 2e-25 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 2e-25 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-25 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 5e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 676 bits (1745), Expect = 0.0
Identities = 374/476 (78%), Positives = 417/476 (87%), Gaps = 5/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG TGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV
Sbjct: 61 GG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARY
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEA
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LCRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ
Sbjct: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
Query: 301 V-STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 359
+ S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L
Sbjct: 300 IASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTL 356
Query: 360 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 419
+KQK+P+ ND +FSK+ ++S+ N L S S R +S + ++PSR R TDAS
Sbjct: 357 AKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDAS 416
Query: 420 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475
PGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 417 PGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 571 bits (1473), Expect = 0.0
Identities = 230/295 (77%), Positives = 269/295 (91%), Gaps = 1/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 63 GG-VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 571 bits (1474), Expect = 0.0
Identities = 172/327 (52%), Positives = 224/327 (68%), Gaps = 4/327 (1%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGS 63
VG FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL E + YK L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
GIP + +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK
Sbjct: 66 -GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 124 SFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
+ ++RD+KP+NFL+G + ++IIDF LAK Y D T +HIPYRE+K+LTGTARY
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241
S+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE L
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVL 244
Query: 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 301
C +P E A+Y Y R L F +KPDY YL++LF DLF R+G+ FDY +DW +
Sbjct: 245 CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVG 303
Query: 302 STPARAIGPGAGPSSGMPPAAANVDRQ 328
+ + Q
Sbjct: 304 AVQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 565 bits (1459), Expect = 0.0
Identities = 174/296 (58%), Positives = 215/296 (72%), Gaps = 3/296 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL+ E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
G + GIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +
Sbjct: 64 GCT-GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 121 HSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
H KS ++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTA
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238
RY S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242
Query: 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 294
LC G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 83/331 (25%), Positives = 148/331 (44%), Gaps = 28/331 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKL 55
+ +++G IG G FG IYL ++ ++ +K+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 56 YKILQG-------------GSTGIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCS 98
Y+ G+P G+ Y +++D G L+ ++ +
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 99 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158
++ S KTVL L+ ++++ +E++H ++H DIK N L+ +QVY++D+GLA RY
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYC 205
Query: 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 218
H+ + GT + S++ H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 219 AGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275
K + KI ++ S+ C P E A Y + L + +KP Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 276 DLFIREGFQFDYVFDWTILKYQQSQVSTPAR 306
G + D D ++++ + T +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITK 356
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 501 bits (1293), Expect = e-178
Identities = 92/322 (28%), Positives = 144/322 (44%), Gaps = 29/322 (9%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKIL 59
++ GN++ LG+KIGSG FG IYL E+ A + V+ ++ L E K Y+ +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 60 QGGST-------------GIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLS 102
GIP G+ Y +V++ LG L+ + +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 103 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
TVL L +M++ +E++H ++H DIK N L+G +QVY+ D+GL+ RY
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGN 208
Query: 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 219
H+ K GT + S++ H G+ SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 220 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279
+ K + E S A E A + SL +D+KP+Y LK++ I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 280 REGFQFDYVFDWTILKYQQSQV 301
G D++ K Q V
Sbjct: 329 PLGP-----LDFST-KGQSINV 344
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-173
Identities = 73/317 (23%), Positives = 126/317 (39%), Gaps = 34/317 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKT------------ 44
G +++L + G +Y T ++ ++KL+
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 45 -KHPQLQYEAKLYKILQGGSTGIPNLRWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-L 101
K Q+ KLY IP FGV + Y LV+ LG SL+ + + L
Sbjct: 100 AKPLQVNKWKKLYST---PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 102 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161
S ++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A RY +
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS- 214
Query: 162 THQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 215 -GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 220 GTKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276
T+ +K C + Y +L +++KP YA L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 277 LFIREGFQFDYVFDWTI 293
L +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 55/257 (21%), Positives = 94/257 (36%), Gaps = 46/257 (17%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQMIN 115
S I +R + E + + +E DL ++ +K + M+
Sbjct: 67 HSDKI--IRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 170
Query: 176 GTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAGT 221
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--N 225
Query: 222 KKQKYEKISEKKVSTSI 238
+ K I +
Sbjct: 226 QISKLHAIIDPNHEIEF 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 54/255 (21%), Positives = 94/255 (36%), Gaps = 42/255 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQMIN 115
S I +R + E + + +E DL ++ +K + M+
Sbjct: 86 HSDKI--IRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 189
Query: 176 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKK 223
GT Y N + S + D+ SLG ++Y G P+Q + +
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--NQI 246
Query: 224 QKYEKISEKKVSTSI 238
K I +
Sbjct: 247 SKLHAIIDPNHEIEF 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/254 (21%), Positives = 93/254 (36%), Gaps = 40/254 (15%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQMIN 115
S I +R + E + + +E DL ++ +K + M+
Sbjct: 114 HSDKI--IRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 217
Query: 176 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 224
G Y N + S + D+ SLG +L Y G P+Q + +
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQIS 275
Query: 225 KYEKISEKKVSTSI 238
K I +
Sbjct: 276 KLHAIIDPNHEIEF 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 6e-25
Identities = 44/276 (15%), Positives = 76/276 (27%), Gaps = 46/276 (16%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------------------------LENV 42
G +G T+ +T E + L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 43 KTKHPQLQYEAKLYKILQGGSTGIPNL-RWFGVEGDYNVLVIDLLGPS--------LEDL 93
K + + ++ + R E D VL L P E L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 94 FNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151
+ S + L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 210
R E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 211 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 244
LP E I S K + + AL G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 37/247 (14%), Positives = 73/247 (29%), Gaps = 52/247 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQGG 62
K +L + G ++L +++ E+ A+K+ + ++ +L L G
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 63 S-------------------TGIPN-LRWFGVEGDYNV----LVIDLLGPSLEDLFNFCS 98
S P + + DY V L++ LE LF+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 99 R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152
+ + +L Q+I + SK +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 153 LAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 209
+ + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 210 GSLPWQG 216
LP+
Sbjct: 289 LFLPFGL 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 65/334 (19%), Positives = 113/334 (33%), Gaps = 66/334 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGS 63
+ + L +G G+ ++ G + +T + AIK+ + E ++ K L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 TGIPN-LRWFGVEGDYN----VLVIDLL--GPSLEDLFNFCSRK-----LSLKTVLMLAD 111
N ++ F +E + VL+++ G L+ L L++
Sbjct: 67 ---KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRE 170
++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF------- 172
Query: 171 NKNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG- 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 -VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPR 230
Query: 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--- 277
K+ KI K S +I + + D P L R + L
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTP 281
Query: 278 FIREGFQFD----YVFD------WTILKYQQSQV 301
+ + D + FD IL S
Sbjct: 282 VLANILEADQEKCWGFDQFFAETSDILHRGNSHH 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 60/319 (18%), Positives = 108/319 (33%), Gaps = 62/319 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGS 63
+ + L +G G+ ++ G + +T + AIK+ + E ++ K L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 TGIPN-LRWFGVEGDYN----VLVIDLL--GPSLEDLFNFCSRK-----LSLKTVLMLAD 111
N ++ F +E + VL+++ G L+ L L++
Sbjct: 67 ---KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRE 170
++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 171 NKNLT---GTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 218
++ GT Y + + DL S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 219 AG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
K+ KI K S +I + + D P L R + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVL 278
Query: 278 ---FIREGFQFDYVFDWTI 293
+ + D W
Sbjct: 279 LTPVLANILEADQEKCWGF 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 40/281 (14%), Positives = 74/281 (26%), Gaps = 59/281 (20%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------------------------LENVK 43
G +G T+ +T E + L +K
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 44 TKHPQLQYEAKLYKILQGGSTGIPNL-RWFGVEGDYNVLVIDLLGP----SLEDLFNFCS 98
+ + ++ + R E D VL L P +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 99 RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152
L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 153 LAKRY-RDTATHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 206
R + + + H + D +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308
Query: 207 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 244
+ LP E I S K + + AL G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 46/232 (19%), Positives = 86/232 (37%), Gaps = 37/232 (15%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ-- 60
R + F +G G+FG++ N + AIK + + + K + E L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 61 ---------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 110
+ + ++ +L DL + + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP--- 167
Q++ + ++HS+ +HRD+KP N + + V I DFGLAK + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 168 -YRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 206
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 53/239 (22%), Positives = 92/239 (38%), Gaps = 48/239 (20%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--- 58
E +RLG +G G FG ++ G + +VAIK+ + + +
Sbjct: 27 EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLE 84
Query: 59 -----LQGGSTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL-- 107
G G P L WF + + +LV++ P+ +DLF++ + K L
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSR 142
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT---- 196
Query: 168 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 216
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 -------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 46/237 (19%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLY-- 56
EP +++G +GSG FG +Y G + N VAIK K + +L ++
Sbjct: 39 EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPME 96
Query: 57 -KILQGGSTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLML 109
+L+ S+G L WF + VL+++ P +DLF+F + + L +
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
Q++ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT------ 206
Query: 170 ENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 216
GT Y+ + + G + SLG Y ++ G +P++
Sbjct: 207 -----DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 55/337 (16%), Positives = 109/337 (32%), Gaps = 80/337 (23%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKT------ 44
+ + + + ++G+G FG + + T E+VAIK E
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 45 --KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-- 100
HP + ++ G PN D +L ++ DL + ++
Sbjct: 68 KLNHPNV---VSAREVPDGLQKLAPN--------DLPLLAMEYC--EGGDLRKYLNQFEN 114
Query: 101 ---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
L + L + + + ++H +HRD+KP+N ++ G + IID G AK
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174
Query: 158 RDTATHQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL- 208
+ T GT +Y + + +EQ + D S G L +
Sbjct: 175 DQ-----------GELCTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECI 217
Query: 209 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDY 267
G P+ + ++ +K + I Y +++F P
Sbjct: 218 TGFRPFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTP 263
Query: 268 AYLKRLFRDL---FIREGFQFDYVFDWTILKYQQSQV 301
+L + +++ + T +
Sbjct: 264 NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 44/223 (19%), Positives = 80/223 (35%), Gaps = 29/223 (13%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGS 63
+ +K+G G F + L + A+K + + Q EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 TGIPN----LRWFGVEGDYNVLVIDLL----GPSLEDLFNFCSRK---LSLKTVLMLADQ 112
PN + + E LL +L + K L+ +L L
Sbjct: 86 ---PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT--HQHIPYRE 170
+ +E +H+K + HRD+KP N L+G Q ++D G + Q + ++
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 171 NKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 207
T Y + + R D+ SLG Y +M+
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 53/240 (22%), Positives = 88/240 (36%), Gaps = 38/240 (15%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
E + N + +G GS G + VA+K E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML-IDFCDIALMEIK---LLTE 64
Query: 62 GSTGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQ 112
S PN +R++ E + ++L +L+DL + + + L Q
Sbjct: 65 -SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 113 MINRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKRYRDTAT 162
+ + V +HS +HRD+KP N L G ++ I DFGL K+
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG-- 181
Query: 163 HQHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLP 213
Q N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 -QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 74/250 (29%), Positives = 110/250 (44%), Gaps = 54/250 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
F +GR +G G FG +YL Q+ +A+K LE +H QL+ E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLR 67
Query: 61 GGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLAD 111
PN LR +G V +I LE ++ + K +
Sbjct: 68 H-----PNILRLYGYFHDATRVYLI------LEYAPLGTVYRELQKLSKFDEQRTATYIT 116
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
++ N + + HSK +HRDIKP+N L+G A ++ I DFG + H P
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRR 164
Query: 172 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 225
+L GT Y M IE D DL SLG VL Y FL G P++ A T ++
Sbjct: 165 TDLCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQET 215
Query: 226 YEKISEKKVS 235
Y++IS + +
Sbjct: 216 YKRISRVEFT 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 55/253 (21%), Positives = 96/253 (37%), Gaps = 56/253 (22%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 56 YKILQGGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTV 106
++ L + + + G E + V V+ LE L R+ L+
Sbjct: 69 HRSLAH-----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEA 117
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166
Q++ +++H +HRD+K N + +V I DFGLA + +
Sbjct: 118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK---------V 165
Query: 167 PYRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 218
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 166 EYDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE--- 216
Query: 219 AGTKKQKYEKISE 231
K+ Y +I +
Sbjct: 217 TSCLKETYLRIKK 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 22/224 (9%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
VG F +G G+ G I + N +VA+K E + +L+
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-PECFSFADREVQ---LLRE- 73
Query: 63 STGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
S PN +R+F E D + I+L +L++ + L Q + +
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 120 VHSKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 177
+HS + +HRD+KP N L M + I DFGL K+ + + GT
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGT 189
Query: 178 ARYAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 216
+ + ++ + D+ S G + Y++ GS P+
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 3e-20
Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 39/239 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
F++G +G GSF +Y +I T EVAIK + ++Q E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 61 GGSTGIPN-LRWFGV-EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
P+ L + E V LV+++ + + S Q+I
Sbjct: 70 H-----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT- 175
+ ++HS LHRD+ N L+ R + I DFGLA + K+ T
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHEKHYTL 172
Query: 176 -GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 230
GT Y S + T D+ SLG + Y L G P+ T K K+
Sbjct: 173 CGTPNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 44/198 (22%), Positives = 72/198 (36%), Gaps = 29/198 (14%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
++ R G F+ IGSG FG+++ + + IK VK + + + E K L
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--VKYNNEKAEREVKALAKLD 62
Query: 61 --------------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLK 104
+ + + ++ +LE KL
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 105 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164
L L +Q+ V+++HSK ++RD+KP N + QV I DFGL ++
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRT 179
Query: 165 HIPYRENKNLTGTARYAS 182
GT RY S
Sbjct: 180 RS--------KGTLRYMS 189
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 20/172 (11%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
+ +G G+F ++Y T + + ++ +K++ + +L + L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLK 122
Query: 61 G-GSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMI 114
+ + +VLV +L +L + N + + V+ A +M+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKRYR 158
+E VH +H DIKPDNF++G G + +ID G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/253 (22%), Positives = 94/253 (37%), Gaps = 56/253 (22%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 56 YKILQGGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTV 106
++ L + + + G E + V V+ LE L R L+
Sbjct: 95 HRSLAH-----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEA 143
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166
Q++ +++H +HRD+K N L V I DFGLA + +
Sbjct: 144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------V 191
Query: 167 PYRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 218
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 192 EYDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE--- 242
Query: 219 AGTKKQKYEKISE 231
K+ Y +I +
Sbjct: 243 TSCLKETYLRIKK 255
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 58/245 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQ 50
+ +GSG+FG ++ + + N+EV +K K K ++
Sbjct: 20 GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVT 77
Query: 51 YEAKLYKILQGGSTGIPN-LRWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK--LSLK 104
E + ++ N ++ + +G + LV++ G L+ LF F R L
Sbjct: 78 LEIAILSRVEH-----ANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEP 130
Query: 105 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164
+ Q+++ V ++ K +HRDIK +N + + + +IDFG A
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER----- 182
Query: 165 HIPYRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLP 213
K GT Y N + G E ++ SLG Y L++ P
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENP 229
Query: 214 WQGLK 218
+ L+
Sbjct: 230 FCELE 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 37/172 (21%), Positives = 61/172 (35%), Gaps = 16/172 (9%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
E F+ ++G GS+GE++ + + A+K K + +L
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 56 YKILQGGSTGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 112
K+ Q P R EG L +L GPSL+ L V
Sbjct: 111 EKVGQH-----PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164
+ + +HS+ +H D+KP N +G + + DFGL +
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 34/188 (18%), Positives = 75/188 (39%), Gaps = 27/188 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG 62
+ K+ + +G G FG ++ + + K VK ++ E + I +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 63 STGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMI 114
N+ E + ++ + + D+F + L+ + ++ Q+
Sbjct: 61 ----RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVC 112
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
++F+HS + H DI+P+N + RR++ + II+FG A++ + P + L
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLL 163
Query: 175 TGTARYAS 182
Y +
Sbjct: 164 FTAPEYYA 171
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 45/251 (17%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK--HPQLQYEAKLYK 57
++++ R +G GSFGE+ L + T +E A+K VK K L E +L K
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 58 ILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLA 110
L PN ++ + E LV ++ G +LF+ SRK S +
Sbjct: 82 QLDH-----PNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARII 132
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 170
Q+++ + ++H +HRD+KP+N L+ + + IIDFGL+ + +
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM------- 185
Query: 171 NKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQ 224
K+ GTA Y + E D+ S G V++Y L G P+ G +
Sbjct: 186 -KDKIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYD 234
Query: 225 KYEKISEKKVS 235
+K+ + K +
Sbjct: 235 ILKKVEKGKYT 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 54/250 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
+ F +GR +G G FG +YL Q +A+K LE +H QL+ E ++ L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 72
Query: 61 GGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLAD 111
PN LR + + ++ LE +L+ + + + +
Sbjct: 73 H-----PNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
++ + + + H + +HRDIKP+N LMG ++ I DFG + H P
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRR 169
Query: 172 KNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 225
+ + GT Y M IE D DL G VL Y FL G P+ + + +
Sbjct: 170 RTMCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTET 220
Query: 226 YEKISEKKVS 235
+ +I +
Sbjct: 221 HRRIVNVDLK 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 61/249 (24%), Positives = 115/249 (46%), Gaps = 44/249 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKIL 59
+ ++ +K+GSG++GE+ L + T+ E AIK +V T + +L E + K+L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 60 QGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQ 112
PN ++ + E N LV++ G +LF+ R + ++ Q
Sbjct: 94 DH-----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQ 144
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
+++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + + K
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------K 196
Query: 173 NLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKY 226
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 197 ERLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEIL 246
Query: 227 EKISEKKVS 235
K+ + K +
Sbjct: 247 RKVEKGKYT 255
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 43/230 (18%), Positives = 84/230 (36%), Gaps = 30/230 (13%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQ 60
+G + R+ R + G F +Y ++ + E A+K + + E K L
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 61 G--------GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLA 110
G + I + ++ +L+ +L L + + LS TVL +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEF-LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142
Query: 111 DQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-----TATH 163
Q V+ +H + +HRD+K +N L+ + + DFG A +
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQ 199
Query: 164 QHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 207
+ E T Y + ++ + + D+ +LG Y+L +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 43/249 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQG 61
+ + F RK+GSG+FG+++L + E IK + + Q++ E ++ K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLF------NFCSRKLSLKTVLMLA 110
PN+ + F V E +N+ +V++ G +L + LS V L
Sbjct: 80 -----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELM 130
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 170
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS------- 183
Query: 171 NKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKY 226
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++
Sbjct: 184 -TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQ 234
Query: 227 EKISEKKVS 235
+K + K+ +
Sbjct: 235 QKATYKEPN 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 60/251 (23%), Positives = 108/251 (43%), Gaps = 44/251 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYK 57
+ ++ + +G GSFGE+ + T +E A+K + K K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLA 110
L PN ++ F + E + +V +L G +LF+ RK S +
Sbjct: 77 KLDH-----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARII 127
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM------- 180
Query: 171 NKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQ 224
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 -KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYD 229
Query: 225 KYEKISEKKVS 235
+++ K +
Sbjct: 230 ILKRVETGKYA 240
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 28/177 (15%)
Query: 4 RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYK 57
G ++ R K+G G F ++L ++ N VA+K + K + E KL +
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58 ILQGGSTGIPN----------LRWF---GVEGDYNVLVIDLLGPSLEDL---FNFCSRKL 101
+ + L F G G + V+V ++LG +L L + R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128
Query: 102 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLA 154
L V ++ Q++ ++++H + +H DIKP+N LM + Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 65/287 (22%), Positives = 118/287 (41%), Gaps = 40/287 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQ-- 60
+ +G++IGSGSFG +Y G + +VA+K+ NV PQ + E + + +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 61 ------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 113
G ST P L +V G SL + K +K ++ +A Q
Sbjct: 81 NILLFMGYSTA-PQL----------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
++++H+KS +HRD+K +N + N V I DFGLA + + +
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQ 181
Query: 174 LTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230
L+G+ + + + S + D+ + G VL + G LP+ + + Q E +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVG 239
Query: 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
+S + + P C + D++P + + +L
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 43/233 (18%), Positives = 85/233 (36%), Gaps = 41/233 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQ-- 60
+ +G IG G FG++Y G + EVAI+L +++ + + E Y+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 61 ------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 113
G P+L ++ L G +L + L + +A ++
Sbjct: 90 NVVLFMGACMSPPHL----------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ + ++H+K LH+D+K N G+ V I DFGL + + +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR--EDKLRI 193
Query: 174 LTGTARY---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 217
G + + + S+ D+ +LG + P++
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 55/230 (23%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEAK 54
+ ++++ K+G G +YL + N +VAIK + E
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFEREVH 63
Query: 55 LYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 113
L I ++ E D LV++ + GP+L + LS+ T + +Q+
Sbjct: 64 NSSQLS--HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQI 120
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
++ ++ H +HRDIKP N L+ + I DFG+AK +T+ Q +
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNH 171
Query: 174 LTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 216
+ GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 172 VLGTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 46/248 (18%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH---PQLQYEAKLY 56
+P +GN +RL + IG G+F ++ L +I T EVAIK ++ + +L E ++
Sbjct: 10 EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVL 107
KIL PN ++ F V E + + +I +E ++F++ ++ K
Sbjct: 69 KILNH-----PNIVKLFEVIETEKTLYLI------MEYASGGEVFDYLVAHGRMKEKEAR 117
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
Q+++ V++ H K +HRD+K +N L L N + I DFG + +
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV-------- 166
Query: 168 YRENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 223
L G YA+ G + D+ SLG +L + GSLP+ G K
Sbjct: 167 ---GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLK 220
Query: 224 QKYEKISE 231
+ E++
Sbjct: 221 ELRERVLR 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 46/248 (18%), Positives = 99/248 (39%), Gaps = 45/248 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYK 57
+G K+ +G +G GS+G++ + +T A+K L + ++ E +L +
Sbjct: 3 LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 58 ILQGGSTGIPN-LR----WFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLAD 111
L+ N ++ + E +V++ ++++ + ++ +
Sbjct: 62 RLRH-----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
Q+I+ +E++HS+ +H+DIKP N L L + I G+A+ P+ +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAAD 165
Query: 172 KNLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222
G+ + ++T G + D+ S G L G P++G
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG---DNI 218
Query: 223 KQKYEKIS 230
+ +E I
Sbjct: 219 YKLFENIG 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 22/174 (12%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNL 69
+G G++G +Y G ++ +AIK + L E L+K L+ N+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-----KNI 81
Query: 70 -RWFGVEGDYNVLVIDL---LGPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
++ G + + I + G SL L + K + +T+ Q++ ++++H
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 177
+HRDIK DN L + + + I DFG +KR + TGT
Sbjct: 142 QIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 40/189 (21%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQG 61
V + + + ++G+G+FG ++ T T A K + ++ E + +L+
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 62 GSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQM 113
P L E D + ++ + + G +LF + + +S + Q+
Sbjct: 214 -----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQV 264
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ +H +++H D+KP+N + +R+N++ +IDFGL P + K
Sbjct: 265 CKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKV 315
Query: 174 LTGTARYAS 182
TGTA +A+
Sbjct: 316 TTGTAEFAA 324
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 65/254 (25%), Positives = 99/254 (38%), Gaps = 47/254 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
P V + L + +G G++GE+ L N T E VA+K+ + + ++ E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGSTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 107
+L N ++++G EG+ L LE +LF+ +
Sbjct: 61 MLNH-----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQ 108
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL- 164
Query: 168 YRENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDS 214
Query: 223 KQKYEKISEKKVST 236
Q+Y EKK
Sbjct: 215 CQEYSDWKEKKTYL 228
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 44/200 (22%), Positives = 64/200 (32%), Gaps = 24/200 (12%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQ 60
R F + +G G FG ++ N + AIK L N + ++ E K L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 61 --------GGSTGIPNLRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL--KTVL 107
L I + +L+D N L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
+ Q+ VEF+HSK +HRD+KP N + V + DFGL Q +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 168 YRENKNLT-----GTARYAS 182
GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 17/175 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ ++G GSFGE++ + QT + A+K ++ E L
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSS----- 109
Query: 67 PNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
P + +G + + I + G SL L L L Q + +E++H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 177
+ LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 31/229 (13%)
Query: 2 EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--------- 49
E R G +F RL R +G G G++Y + VA+KL L
Sbjct: 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTR 80
Query: 50 -QYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVL 107
Q EA+ LQ + + FG + + L+ G L + L+ +
Sbjct: 81 MQREARTAGRLQ--EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAV 137
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
+ Q+ + ++ H+ HRD+KP+N L+ + Y++DFG+A D Q
Sbjct: 138 AIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ--- 191
Query: 168 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
N GT Y + + R D+ +L VL L GS P+QG
Sbjct: 192 ---LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKIL 59
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL 105
Query: 60 QGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLAD 111
P L + VL+++ L G +LF+ + + +S V+
Sbjct: 106 HH-----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMR 156
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
Q ++ +H S +H DIKP+N + ++A+ V IIDFGLA + P
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIV 207
Query: 172 KNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 208
K T TA +A+ +G D+ ++G VL Y L
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 32/189 (16%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---------EAKLYK 57
N+ ++IG G FG ++ G ++ VAIK + + + E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 58 ILQGGSTGIPN-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
L PN ++ +G+ + +V++ + L + + L L +
Sbjct: 79 NLNH-----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 116 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRDTATHQHIPYREN 171
+E++ +++ +HRD++ N + V + DFGL+++ + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--------- 184
Query: 172 KNLTGTARY 180
L G ++
Sbjct: 185 -GLLGNFQW 192
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYK 57
+ ++ + +G GSFGE+ + T +E A+K+ + K K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSR-KLSLKTVLMLA 110
L PN ++ F + E + +V +L G +LF+ R + S +
Sbjct: 77 KLDH-----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARII 127
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 38/172 (22%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKTKHPQLQYEAK 54
+ +++ + + +GSG+ GE+ L +T ++VAI+ ++ E +
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 55 LYKILQGGSTGIPN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLM 108
+ K L P ++ + +V++L+ G +LF+ +L T +
Sbjct: 193 ILKKLNH-----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKL 243
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
QM+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 52/280 (18%), Positives = 99/280 (35%), Gaps = 56/280 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVKT----- 44
+ K+ L IG GS+G + + QT AIK +E +KT
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 45 ---KHPQL--QYEA-----KLYKIL---QGG-------------STGIPNLRWFGVEGDY 78
HP + YE + ++ GG +
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138
+ + S+ K + + Q+ + + ++H++ HRDIKP+NFL
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201
Query: 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 196
++ ++ ++DFGL+K + ++ GT + + + + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 197 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 235
S G VL++ L G++P+ G ++ KK+
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 65/254 (25%), Positives = 99/254 (38%), Gaps = 47/254 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
P V + L + +G G++GE+ L N T E VA+K+ + + ++ E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGSTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 107
+L N ++++G EG+ L LE +LF+ +
Sbjct: 61 MLNH-----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQ 108
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 109 RFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL- 164
Query: 168 YRENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDS 214
Query: 223 KQKYEKISEKKVST 236
Q+Y EKK
Sbjct: 215 CQEYSDWKEKKTYL 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 1 MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQ 48
MEP +V + + +G ++GSG F + T E A K +
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 49 LQYEAKLYKILQGGSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL 103
++ E + + + N+ V E +V L+++L+ G +LF+F ++K SL
Sbjct: 62 IEREVSILRQVLH-----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESL 112
Query: 104 --KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRD 159
+ Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIED 171
Query: 160 TATHQHIPYRENKNLTGTARY 180
KN+ GT +
Sbjct: 172 GVEF--------KNIFGTPEF 184
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKTKHPQLQYEAK 54
+ +++ + + +GSG+ GE+ L +T ++VAIK ++ E +
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 55 LYKILQGGSTGIPN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLM 108
+ K L P ++ + +V++L+ G +LF+ +L T +
Sbjct: 68 ILKKLNH-----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKL 118
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
QM+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 49/259 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------LENVKTKHPQLQYE 52
E ++G + RK+GSG++GE+ L + E AIK ++
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 53 AKLY---KILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LS 102
++Y +L+ S PN ++ F V E LV + G +LF +R
Sbjct: 91 EEIYNEISLLK--SLDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFD 144
Query: 103 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
+ Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQG 216
++ GTA Y + E ++ D+ S G V+MY L G P+ G
Sbjct: 205 L--------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG 249
Query: 217 LKAGTKKQKYEKISEKKVS 235
+ +K+ + K
Sbjct: 250 ---QNDQDIIKKVEKGKYY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 24/169 (14%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKL 55
+ +G + + +G GSFG++ L T+ +T ++VA+K + + H +++ E
Sbjct: 5 KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISY 62
Query: 56 YKILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLLGPSLEDLFNFCSRK--LSLKTVLMLA 110
K+L+ P+ ++ + V ++ +VI+ G +LF++ K ++
Sbjct: 63 LKLLRH-----PHIIKLYDVITTPTDIVMVIEYAG---GELFDYIVEKKRMTEDEGRRFF 114
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
Q+I +E+ H +HRD+KP+N L L N V I DFGL+ D
Sbjct: 115 QQIICAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD 160
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 7e-17
Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 20/168 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYKI 58
+ + + + ++G G+F + + T E A K+ + + + Q L+ EA++ +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 59 LQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 111
LQ PN +R + + LV DL+ G +LF +R S
Sbjct: 62 LQH-----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 112
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
Q++ + + HS +HR++KP+N L+ + V + DFGLA D
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 46/248 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKI 58
+ + L IG GS+GE+ + T A K +E+V + + E ++ K
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKS 62
Query: 59 LQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK--LSLKTVLMLAD 111
L PN +R + E + ++ LV++L G +LF K +
Sbjct: 63 LDH-----PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMK 113
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 171
+++ V + H + HRD+KP+NFL + + +IDFGLA R++
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------- 165
Query: 172 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 227
+ GT Y S + G E D S G V+MY L G P+ T +
Sbjct: 166 RTKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVML 217
Query: 228 KISEKKVS 235
KI E +
Sbjct: 218 KIREGTFT 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 31/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKL 55
++G+ + LG +G G+FG++ +G + T +VA+K+ N + K +++ E +
Sbjct: 7 RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQN 64
Query: 56 YKILQGGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTV 106
K+ + P+ ++ + V + ++ +E +LF++ + +
Sbjct: 65 LKLFRH-----PHIIKLYQVISTPTDFFMV------MEYVSGGELFDYICKHGRVEEMEA 113
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 114 RRLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 34/183 (18%), Positives = 76/183 (41%), Gaps = 29/183 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGI 66
+++G G F + + T +E A K + + ++ +E + ++ +
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC---- 88
Query: 67 PNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRV 117
P + V +L+++ G ++F+ C + +S V+ L Q++ V
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 177
++H + +H D+KP N L+ + I+DFG++++ E + + GT
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIMGT 196
Query: 178 ARY 180
Y
Sbjct: 197 PEY 199
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 50/261 (19%), Positives = 90/261 (34%), Gaps = 47/261 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
N++ L +IG GS+G + L N N A+K+ + K K + +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS-KKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 67 PNLRWFGVEGDY-------------NVL----VIDLLGPS-----LE-----DLFNFCSR 99
++ G NV+ V+D E + +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 100 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158
LS +I +E++H + +HRDIKP N L+G + I DFG++ ++
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFK 188
Query: 159 DTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ N GT + + T + D+ ++G L F+ G P+
Sbjct: 189 GSDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPF 240
Query: 215 QGLKAGTKKQKYEKISEKKVS 235
+ KI + +
Sbjct: 241 MD---ERIMCLHSKIKSQALE 258
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 43/192 (22%), Positives = 83/192 (43%), Gaps = 33/192 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKTKHPQLQYEAKLY 56
V + + +G ++GSG F + T +E A K +++ E +
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 57 KILQGGSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLML 109
+ ++ PN+ + E +V L+++L+ G +LF+F + K SL
Sbjct: 63 REIRH-----PNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQF 113
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
Q+++ V ++HSK H D+KP+N ++ ++ +IDFG+A +
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----- 168
Query: 169 RENKNLTGTARY 180
KN+ GT +
Sbjct: 169 ---KNIFGTPEF 177
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 19/162 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ--- 60
V ++ + + IG GSFG++ + + ++ VA+K + N K H Q E ++ + L+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 61 --GGSTGIPNLRWFGVEGDYN---VLVIDLLGPSLEDLF---NFCSRKLSLKTVLMLADQ 112
I L F + + +LL +L +L F + SL V A
Sbjct: 155 KDNTMNVIHMLENF----TFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVRKFAHS 208
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
++ ++ +H +H D+KP+N L+ R + + +IDFG +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 36/175 (20%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQY 51
+ +G G + + T +E A+K E V+
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 52 EAKLYKILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLK 104
E + + + G PN ++ E + LV DL+ G +LF++ + LS K
Sbjct: 73 EVDILRKVSGH----PNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEK 124
Query: 105 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 125 ETRKIMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 42/185 (22%), Positives = 66/185 (35%), Gaps = 61/185 (32%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHP 47
++ + IGSG+FG L + T E VA+K ENV+ +HP
Sbjct: 18 DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 48 ---QLQYE-----AKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF 96
+ E L I+ GG +L+
Sbjct: 77 NIVRF-KEVILTPTHLAIIMEYASGG-----------------------------ELYER 106
Query: 97 -CSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
C+ + S Q+++ V + HS HRD+K +N L+ G A ++ I DFG +
Sbjct: 107 ICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYS 165
Query: 155 KRYRD 159
K
Sbjct: 166 KSSVL 170
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 26/181 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ + +G G+FG + ++VAIK +++ E + +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----- 60
Query: 67 PN-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS 122
PN ++ +G + LV++ G SL ++ + + + Q V ++HS
Sbjct: 61 PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 123 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
K+ +HRD+KP N L L + I DFG A + T N G+A
Sbjct: 121 MQPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAA 168
Query: 180 Y 180
+
Sbjct: 169 W 169
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 43/210 (20%), Positives = 69/210 (32%), Gaps = 44/210 (20%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
M+ R +F KIGSG FG ++ AIK L + L+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 56 YKILQGGSTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSL---KTVLM 108
+ Q + +R+F E D+ ++ + G SL D + R +S +
Sbjct: 65 AVLGQ-----HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFG 152
L Q+ + ++HS S +H DIKP N F+ D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 153 LAKRYRDTATHQHIPYRENKNLTGTARYAS 182
R G +R+ +
Sbjct: 180 HVTRISSPQV-----------EEGDSRFLA 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 45/194 (23%), Positives = 83/194 (42%), Gaps = 35/194 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKL 55
+V + + +G ++GSG F + T E A K +++ E +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 56 YKILQGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSL--KTVLM 108
+ + PN+ V VL+++L+ G +LF+F ++K SL +
Sbjct: 69 LRQVLH-----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATS 119
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDTATHQHI 166
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 167 PYRENKNLTGTARY 180
KN+ GT +
Sbjct: 176 -----KNIFGTPEF 184
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKTKHPQLQYEAKLY 56
V + + G ++GSG F + T + A K ++ E +
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 57 KILQGGSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLML 109
K +Q PN+ V E +V L+++L+ G +LF+F + K SL +
Sbjct: 69 KEIQH-----PNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEF 119
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
Q++N V ++HS H D+KP+N ++ ++ IIDFGLA +
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----- 174
Query: 169 RENKNLTGTARY 180
KN+ GT +
Sbjct: 175 ---KNIFGTPEF 183
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 54/268 (20%), Positives = 96/268 (35%), Gaps = 42/268 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLY 56
M R + + IG+GS+G + + K ++ L E L
Sbjct: 1 MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 KILQGGSTGIPNL-----RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVL 107
+ L+ PN+ R +V++ G L + +++ L + VL
Sbjct: 60 RELKH-----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 108 MLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
+ Q+ ++ H +S LHRD+KP N + V + DFGLA+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTS 171
Query: 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG----- 216
K GT Y S + + + D+ SLG L+Y L P+
Sbjct: 172 F-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKE 223
Query: 217 LKAGTKKQKYEKISEKKVSTSIEALCRG 244
L ++ K+ +I + S + +
Sbjct: 224 LAGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYK 57
+ + + + ++G G+F + + T E A K+ N K +L+ EA++ +
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 58 ILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLA 110
LQ PN +R + + LV DL+ G +LF +R S
Sbjct: 84 KLQH-----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCI 134
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
Q++ + + HS +HR++KP+N L+ + V + DFGLA D+
Sbjct: 135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN-L 69
+ +G GSF + ++N+ A+K+ + K Q E K+ +G PN +
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH----PNIV 69
Query: 70 RWFGV-EGDYNV-LVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVE 118
+ V + LV++LL G +LF +F + S + ++++ V
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVS 120
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--- 175
+H +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPC 170
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 208
T YA+ DL SLG V++Y +
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 28/185 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLR 70
L IG G FGE++ G EEVA+K+ + + + + EA++Y+ + I L
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI--LG 100
Query: 71 WFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ + N L SL D N ++++ ++ LA + + +H +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 124 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
+ HRD+K N L+ ++ I D GLA R+ I +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRV 212
Query: 176 GTARY 180
GT RY
Sbjct: 213 GTKRY 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 42/228 (18%), Positives = 79/228 (34%), Gaps = 41/228 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIK-LENVKTKHPQ--LQYEAKLYKIL 59
V ++ + I G G IYL + N V +K L + Q E + +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 60 QGGSTGIPNLRWFGVEGDYNV-----LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 113
I + F D + +V++ + G SL+ +KL + + ++
Sbjct: 137 V--HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEI 191
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ + ++HS ++ D+KP+N ++ Q+ +ID G R
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGY----------- 236
Query: 174 LTGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQG 216
L GT + + E R D+ ++G L G
Sbjct: 237 LYGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 50/238 (21%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEA 53
+ +++ LG +G G E++L +++ + +VA+K+ L + EA
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREA 63
Query: 54 KLYKILQGGSTGIPNL-------RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKT 105
+ L P + G +V++ + G +L D+ + ++ K
Sbjct: 64 QNAAALNH-----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKR 117
Query: 106 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165
+ + + F H +HRD+KP N ++ N V ++DFG+A+ D+
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN--- 171
Query: 166 IPYRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 216
+ + GTA+Y S EQ+R R D+ SLG ++Y L G P+ G
Sbjct: 172 -SVTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 24/171 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
FR+ +KIG G F E+Y + VA+K L + K + E L K L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 61 GGSTGIPN-LRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL---KTVLMLADQM 113
PN ++++ + N L I L L + ++ L +TV Q+
Sbjct: 91 H-----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 114 INRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 163
+ +E +HS+ +HRDIKP N F+ V + D GL + + T
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 49/252 (19%), Positives = 93/252 (36%), Gaps = 50/252 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQ 60
+ L IG G F + N +T ++ A+K+ +V L+ EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 61 GGSTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLAD---- 111
P++ D + +V + + DL ++ V A
Sbjct: 85 H-----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHY 135
Query: 112 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
Q++ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGL 188
Query: 170 ENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKK 223
GT + + G D+ G V+++ L G LP + GTK+
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKE 238
Query: 224 QKYEKISEKKVS 235
+ +E I + K
Sbjct: 239 RLFEGIIKGKYK 250
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 19/187 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ--LQYEAKLYKILQGGS 63
+ G +G G FG+ T+ +T E + +K L + + L+ E K+ + L+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEH-- 66
Query: 64 TGIPN-LRWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
PN L++ GV + N + + + G +L + + + A + + +
Sbjct: 67 ---PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
++HS + +HRD+ N L+ V + DFGLA R Q R K
Sbjct: 123 YLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDRKK 178
Query: 179 RYASMNT 185
RY +
Sbjct: 179 RYTVVGN 185
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 39/166 (23%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQ 60
+ F +GSG+F E++L T + A+K ++ + L+ E + K ++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 61 GGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 113
N + + E + LV+ L+ G +LF+ R + K ++ Q+
Sbjct: 65 H-----ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQV 115
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
++ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 37/169 (21%), Positives = 69/169 (40%), Gaps = 27/169 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGG 62
K+ +KIG GSFG+ L + + + IK + + +K + + E + ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 63 STGIPN-LRWFGVEGDYNVLVIDLLGPSLE-----DLFNFCSRK----LSLKTVLMLADQ 112
PN +++ + L I ++ DLF + + +L Q
Sbjct: 83 ----PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161
+ ++ VH + LHRDIK N + + V + DFG+A+ T
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKI 58
R +++L ++G G+F + + +E A + N K H +L+ EA++ ++
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 59 LQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 111
L+ PN +R + + L+ DL+ G +LF +R S
Sbjct: 67 LKH-----PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQ 117
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
Q++ V H +HR++KP+N L+ + V + DFGLA
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 46/193 (23%), Positives = 78/193 (40%), Gaps = 44/193 (22%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
+ ++IG G +GE+++G E+VA+K+ + + E ++Y+ IL
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFI 97
Query: 61 ----GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
G+ L + L+ D SL D S L K++L LA ++
Sbjct: 98 AADIKGTGSWTQL-Y---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVS 145
Query: 116 RVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
+ +H++ F HRD+K N L+ ++ I D GLA ++ IP
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 168 YRENKNLTGTARY 180
GT RY
Sbjct: 203 ---PNTRVGTKRY 212
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 48/198 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL------ENVKTKHPQLQYEAKLYKIL 59
+ L IG G FG++Y +EVA+K E++ ++ EAKL+ +L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 60 Q--------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 110
+ G PNL LV++ G L + + +++ ++ A
Sbjct: 64 KHPNIIALRGVCLKEPNL----------CLVMEFARGGPLNRVLS--GKRIPPDILVNWA 111
Query: 111 DQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKRYRDTAT 162
Q+ + ++H + +HRD+K N L+ + I DFGLA+ + T
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-- 169
Query: 163 HQHIPYRENKNLTGTARY 180
+ G +
Sbjct: 170 -------TKMSAAGAYAW 180
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 34/226 (15%)
Query: 3 PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
R + ++L +G G+ + N+ T++E A+K+ + H + + E ++
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 60 QGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLF-------NFCSRKLSLKTVL 107
QG N L E + LV + + G + +F + S
Sbjct: 68 QGH----RNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS----- 114
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
++ + + ++F+H+K HRD+KP+N L + + V I DF L + I
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 168 YRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 208
E G+A Y + + DL SLG V++Y L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 43/259 (16%), Positives = 89/259 (34%), Gaps = 48/259 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
N +R+ R + G F +I L N+ A+K E + + ++ KI
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 66 I-------------PN-LRWFGVEGD----YNVL-------VIDLLGPSLEDLFNFCSRK 100
L G+ + Y + ++ L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCF 147
Query: 101 LSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++ + + ++N ++H+ K+ HRD+KP N LM + +V + DFG ++ D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVD 204
Query: 160 TATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 216
GT + ++ + D+ SLG + +Y +P+
Sbjct: 205 KKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL 254
Query: 217 LKAGTKKQKYEKISEKKVS 235
+ + + I K +
Sbjct: 255 --KISLVELFNNIRTKNIE 271
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 47/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGS 63
+ ++L RK+G G + E++ NI NE+V +K L+ VK K +++ E K+ + L+GG
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGG- 90
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLK-TVLMLAD---------- 111
PN +I L D+ + SR +L + D
Sbjct: 91 ---PN-------------IITLA-----DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD 129
Query: 112 --------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163
+++ +++ HS +HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 130 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEY 187
Query: 164 QH 165
Sbjct: 188 NV 189
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 42/192 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
L +G G +GE++ G+ E VA+K+ + + + + E +LY IL
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFI 68
Query: 61 GGSTGIPNLR---WFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
+ W L+ SL D L + L + + +
Sbjct: 69 ASDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASG 117
Query: 117 VEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
+ +H + F HRD+K N L+ ++ Q I D GLA + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG- 173
Query: 169 RENKNLTGTARY 180
N GT RY
Sbjct: 174 --NNPRVGTKRY 183
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY-------K 57
K+ IG G + + T E A+K+ V + + ++
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGSTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLA 110
IL+ + G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 152 ILRQVA-GHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIM 206
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPG 253
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 41/249 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
+ + + + IG GS+ + TN E A+K+ + K+K + L + Q
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQH- 75
Query: 63 STGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMIN 115
PN + V + V +V +L+ G +L + + S + + +
Sbjct: 76 ----PNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITK 127
Query: 116 RVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
VE++H++ +HRD+KP N L + I DFG AK+ R EN L
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLL 177
Query: 175 T---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKY 226
TA + + D+ SLG VL+Y L G P+ T ++
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 227 EKISEKKVS 235
+I K S
Sbjct: 233 ARIGSGKFS 241
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 34/191 (17%)
Query: 4 RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK 57
V + + + + +G G FG+++ T ++A K+ +KT+ + ++ E +
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMN 141
Query: 58 ILQGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLML 109
L NL + + + VLV++ + G +LF+ + L+ ++
Sbjct: 142 QLDH-----ANLIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILF 192
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA+RY+ P
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PRE 243
Query: 170 ENKNLTGTARY 180
+ K GT +
Sbjct: 244 KLKVNFGTPEF 254
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 40/231 (17%), Positives = 76/231 (32%), Gaps = 51/231 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
+ +L IG G +G +Y G+ VA+K+ + + E +Y+ I
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNI 69
Query: 59 LQ-------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 110
+ + G LV++ SL + + LA
Sbjct: 70 ARFIVGDERVTADGRMEY-L---------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLA 117
Query: 111 DQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161
+ + ++H+ + HRD+ N L+ + I DFGL+ R
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 162 THQHIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 204
+ + GT RY ++N ++ D+ +LG +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 53/237 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQ- 60
+ KIG+GSFG ++ + +VA+K+ + H + E + K L+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 61 -------GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLF--NFCSRKLSLKTVLMLA 110
G T PNL +V + L SL L + +L + L +A
Sbjct: 94 PNIVLFMGAVTQPPNL----------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 111 DQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
+ + ++H+++ +HR++K N L+ + V + DFGL++ T +
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------F 193
Query: 169 RENKNLTGTARYASM------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219
+K+ GT + M + + + D+ S G +L PW L
Sbjct: 194 LSSKSAAGTPEW--MAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGSTG 65
F R+IG GSFG +Y +++ +E VAIK + K +++ K + LQ
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 66 IPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
PN ++ G + LV++ S DL + L + + + + ++HS
Sbjct: 114 -PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKR 156
+ +HRD+K N L+ V + DFG +A
Sbjct: 173 HNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAPA 207
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGS 63
+++ + IG GSFG++ + E VAIK ++N K Q Q E +L +++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 64 TG-----IPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 112
T + R F + LV ++L +L DL NF R +SL A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165
Query: 113 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
M + F+ + S +H D+KP+N L+ +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 42/173 (24%), Positives = 84/173 (48%), Gaps = 31/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKL 55
++G+ + LG +G G+FG++ +G + T +VA+K+ N + K +++ E +
Sbjct: 12 RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQN 69
Query: 56 YKILQGGSTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTV 106
K+ + P+ ++ + V ++ ++ +E +LF++ + L K
Sbjct: 70 LKLFRH-----PHIIKLYQVISTPSDIFMV------MEYVSGGELFDYICKNGRLDEKES 118
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 41/206 (19%), Positives = 82/206 (39%), Gaps = 13/206 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
++ + RK+G G F ++L +IQ + VA+K +++ + E +L K ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 66 IPN-------LRWF---GVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 114
PN L F GV G + +V ++LG L + L L V + Q++
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 115 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
++++H+K +H DIKP+N L+ + + + + +R
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 174 LTGTARYASMNTHLGIEQSRRDDLES 199
+ + + DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKIL 59
+ + L IGSG+ + E+VAIK LE +T +L E +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 60 QGGSTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM-- 113
PN + ++ V D LV+ LL G S+ D+ K K+ ++ +
Sbjct: 71 HH-----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 114 INR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
I R +E++H +HRD+K N L+G V I DFG++
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 169 R 169
R
Sbjct: 183 R 183
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 18/168 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
K+ KIG GS+G ++ N T + VAIK ++ E ++ K L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH- 61
Query: 63 STGIPNL-RWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
PNL V LV + ++ + R + V + Q + V F
Sbjct: 62 ----PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 164
H + +HRD+KP+N L+ + + + + DFG A+ D +
Sbjct: 118 CHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
F + K+G GS+G +Y + +T + VAIK V++ ++ E I+Q + P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKE---ISIMQQCDS--P 84
Query: 68 NL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
++ +++G + +V++ S+ D+ ++ L+ + + + +E++H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRDIK N L+ + DFG+A + DT
Sbjct: 145 RKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 42/180 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
K+ +G GS+G + N T VAIK + +K +H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
L L ++ + RW+ LV + + ++ D L + V
Sbjct: 85 NL---VNLLEVCKKKK------RWY--------LVFEFVDHTILDDLELFPNGLDYQVVQ 127
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 164
Q+IN + F HS + +HRDIKP+N L+ ++ V + DFG A+ + +
Sbjct: 128 KYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 35/151 (23%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
+ + ++G G+FG++Y N +T A K+ K++ +L+ +IL P
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDH--P 76
Query: 68 NL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ + G ++I+ G +++ + R L+ + ++ QM+ + F+HSK
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+HRD+K N LM + + DFG++
Sbjct: 137 RIIHRDLKAGNVLMT---LEGDIRLADFGVS 164
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 24/170 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGGST 64
+ +IG GSF +Y G + +T EVA + K++ + + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 GIPNL-----RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
PN+ W +V+ +L+ + + +K + Q++
Sbjct: 85 --PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKG 141
Query: 117 VEFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 163
++F+H+++ +HRD+K DN F+ G V I D GLA R +
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 49/239 (20%), Positives = 80/239 (33%), Gaps = 51/239 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
+L G FG ++ NE VA+K+ ++ K Q E ++Y I
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENI 80
Query: 59 LQ--GGSTGIPNL---RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 112
LQ G ++ W L+ SL D + +S + +A+
Sbjct: 81 LQFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129
Query: 113 MINRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
M + ++H HRDIK N L+ + I DFGLA ++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKS 186
Query: 163 HQHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ GT RY + + R D+ ++G VL G
Sbjct: 187 AG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 35/165 (21%), Positives = 68/165 (41%), Gaps = 16/165 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
+ + F + ++G G+ +Y T + A+K+ ++ E + L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107
Query: 63 STGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMIN 115
PN ++ + E + LV++L+ G +LF+ + S + Q++
Sbjct: 108 ----PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILE 159
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
V ++H +HRD+KP+N L + I DFGL+K
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 33/154 (21%), Positives = 67/154 (43%), Gaps = 16/154 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL- 69
+ +G G G++ N +T E+ A+K + P+ + E +L+ P++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC----PHIV 74
Query: 70 RWFGV-----EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
R V G + +V++ L G + + + + + + + ++++H
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
S + HRD+KP+N L R + + DFG AK
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 42/180 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G ++ N +T+E VA+K L++ + KH
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
+ +L+ +L L LV + L+ F+ C+ L + V
Sbjct: 62 NI---VRLHDVLHSDK----KL----------TLVFEFCDQDLKKYFDSCNGDLDPEIVK 104
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 164
Q++ + F HS++ LHRD+KP N L+ R ++ + +FGLA+ + + +
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 40/156 (25%), Positives = 81/156 (51%), Gaps = 11/156 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
F KIG GSFGE++ G + +T + VAIK+ +++ +++ + +L + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PY 81
Query: 69 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ +++G ++ ++++ L G S DL L + + +++ ++++HS+
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEK 139
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRDIK N L+ +V + DFG+A + DT
Sbjct: 140 KIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 33/181 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQY---------- 51
++ +G G F +Y + TN+ VAIK K K + +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK----KIKLGHRSEAKDGINRTALR 61
Query: 52 EAKLYKILQGGSTGIPN-LRWFGVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTV-- 106
E KL + L PN + G + LV D + LE + S L+ +
Sbjct: 62 EIKLLQELSH-----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA 116
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATH 163
ML + +E++H LHRD+KP+N L+ + + DFGLAK + TH
Sbjct: 117 YML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTH 171
Query: 164 Q 164
Q
Sbjct: 172 Q 172
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/194 (20%), Positives = 78/194 (40%), Gaps = 46/194 (23%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ--- 60
+ N F + RK+G G+FG + L +I + A+K + N+K + EA + K +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 61 -GGSTGIPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQM 113
+ + F Y L+ + LGPSL ++ N+ ++ + + ++
Sbjct: 93 INNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146
Query: 114 INRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYIIDF 151
+ + ++ S H D+KP+N L+ ++ + +IDF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 152 GLAKRYRDTATHQH 165
G AT +
Sbjct: 207 G-------CATFKS 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 31/166 (18%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 4 RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
V + ++L ++ +G G G++ + +T ++ A+K + P+ + E + GG
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGG 81
Query: 63 STGIPN-LRWFGV-----EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQM 113
P+ + V G + ++++ + G + + + + + +
Sbjct: 82 ----PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
++F+HS + HRD+KP+N L + + + DFG AK
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
+ K+G G++ +Y G + T+ VA I+LE+ V KH
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 49 LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 108
+ L+ I+ +L LV + L L+ + C +++ V +
Sbjct: 62 I---VTLHDIIHTEK----SL----------TLVFEYLDKDLKQYLDDCGNIINMHNVKL 104
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 164
Q++ + + H + LHRD+KP N L+ ++ + DFGLA+ T ++
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 31/174 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKIL 59
+ ++F++ R G G+FG + LG T VAIK +++ + ++ +LQ + +L
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVL 76
Query: 60 QGGSTGIPN---LRWF----GVEGD---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 109
PN L+ + G Y +V++ + + L C +
Sbjct: 77 HH-----PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPP 128
Query: 110 AD------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
Q+I + +H S HRDIKP N L + + + DFG AK
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAK 180
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 57/263 (21%), Positives = 95/263 (36%), Gaps = 75/263 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KH 46
+ F + R IG GSFG++ + T + A+K + NV +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 47 P---QLQY----EAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFC 97
P L Y E ++ +V+DLL G DL
Sbjct: 75 PFLVNLWYSFQDEEDMF------------------------MVVDLLLGG----DLRYHL 106
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ +TV + +++ ++++ ++ +HRD+KPDN L+ V+I DF +A
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAA 163
Query: 156 RYRDTATHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGS 211
+ GT Y + ++ G S D SLG V Y LRG
Sbjct: 164 MLPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGR 214
Query: 212 LPWQGLKAGTKKQKYEKISEKKV 234
P+ + + K+ V
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVV 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 33/175 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKI 58
+ + + IG+GSFG +Y + E VAIK K + ++ E ++ +
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDK-RFKNRELQIMRK 103
Query: 59 LQGGSTGIPN---LRWF------GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 109
L N LR+F + Y LV+D + E ++ K L +
Sbjct: 104 LDH-----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPV 155
Query: 110 AD------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 31/181 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHP 47
+K+ KIG G+FGE++ + +T ++VA+K +EN K KH
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
+ L +I + ++ + Y LV D L L + K +L +
Sbjct: 77 NV---VNLIEICRTKASPYNRCK----GSIY--LVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 167
+ ++N + ++H LHRD+K N L+ R + + DFGLA+ + Q
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 168 Y 168
Y
Sbjct: 185 Y 185
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 33/158 (20%), Positives = 67/158 (42%), Gaps = 16/158 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN-L 69
+ +G G G++ N +T E+ A+K + P+ + E +L+ P+ +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC----PHIV 118
Query: 70 RWFGV-----EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
R V G + +V++ L G + + + + + + + ++++H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
S + HRD+KP+N L R + + DFG AK
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 36/167 (21%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGST 64
F L +G+G++G++Y G +++T + AIK+ +V + ++ E +L+ S
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSH 79
Query: 65 GIPN--------LRWFGVEGDYNV-LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQM 113
N ++ D + LV++ S+ DL L + + + ++
Sbjct: 80 H-RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+ + +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 74/259 (28%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F+ G+ +G GSF + L + T+ E AIK + V HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
+L + + KLY L + G +L +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNG-----------------------------ELLKYIR 122
Query: 99 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
+ ++++ +E++H K +HRD+KP+N L+ + I DFG AK
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKV 179
Query: 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 215
+ + GTA+Y S + DL +LG ++Y + G P+
Sbjct: 180 LSPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF- 232
Query: 216 GLKAGTKKQKYEKISEKKV 234
+AG + ++KI + +
Sbjct: 233 --RAGNEYLIFQKIIKLEY 249
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 43/181 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
F+ KIG G++G +Y N T E VA+K L+ T HP
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTV 106
+ KL ++ + L LV + L L+ + + + L +
Sbjct: 63 NI---VKLLDVIHTEN----KL----------YLVFEFLHQDLKKFMDASALTGIPLPLI 105
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATH 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTH 162
Query: 164 Q 164
+
Sbjct: 163 E 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 42/182 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
+++R K+G G++GE+Y + TNE VAIK LE+ V +H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
+ +L ++ L L+ + L+ + +S++ +
Sbjct: 94 NI---IELKSVIHHNH----RL----------HLIFEYAENDLKKYMDKN-PDVSMRVIK 135
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRD---TAT 162
Q+IN V F HS+ LHRD+KP N L+ + + + I DFGLA+ + T
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 163 HQ 164
H+
Sbjct: 196 HE 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 23/169 (13%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY----EAKLYKILQGGSTGI 66
+IG G++G +Y + + VA +++ N L E L + L+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH-- 73
Query: 67 PN-------LRWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRV 117
PN + + V LV + + L + L +T+ L Q + +
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133
Query: 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 164
+F+H+ +HRD+KP+N L+ V + DFGLA+ Y T
Sbjct: 134 DFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
K+ KIG G+ G +Y ++ T +EVAI+ N++ + P+ + +++ P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKN--P 77
Query: 68 NL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
N+ + + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+HRDIK DN L+G V + DFG
Sbjct: 136 QVIHRDIKSDNILLG---MDGSVKLTDFGFC 163
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 35/177 (19%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKTKHPQLQYEAKLYKILQ-- 60
+ ++ + +G G+FG++ + + VA+K ++NV + E ++ + L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 61 ---GGSTGIPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 111
+ L WF +++ +V +LLG S D F L + +A
Sbjct: 72 DPNSTFRCVQMLEWF----EHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIIDFG 152
Q+ V F+HS H D+KP+N L + ++DFG
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 36/171 (21%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQ 60
+ + + IG+GSFG ++ ++++E VAIK K + ++ E ++ +I++
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK----KVLQDK-RFKNRELQIMRIVK 90
Query: 61 GGSTGIPN---LRWF-------GVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLK 104
PN L+ F E N LV++ + E + + + + +
Sbjct: 91 H-----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPML 141
Query: 105 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ + Q++ + ++HS HRDIKP N L L + + +IDFG AK
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 6e-12
Identities = 21/188 (11%), Positives = 50/188 (26%), Gaps = 37/188 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQG 61
+ K+ GE++ G ++ +K+ V+ + E +I
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 62 GSTGIPN-LRWFGV----EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMI 114
PN L G + L+ + SL + L + + + A M
Sbjct: 67 -----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 115 NRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
+ F+H+ + + ++ I + ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR---------- 168
Query: 173 NLTGTARY 180
+
Sbjct: 169 --MYAPAW 174
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 7e-12
Identities = 49/180 (27%), Positives = 71/180 (39%), Gaps = 43/180 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G +Y N E A+K LE T KH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
KLY ++ L VLV + L L+ L + C L T
Sbjct: 61 ---NIVKLYDVIHTKK----RL----------VLVFEHLDQDLKKLLDVCEGGLESVTAK 103
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 164
Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+ + TH+
Sbjct: 104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 31/151 (20%), Positives = 72/151 (47%), Gaps = 12/151 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIP 67
KIG GS G + L + +VA+K+ +++ K + + I++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH--F 102
Query: 68 NL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
N+ + + G+ ++++ L G +L D+ + +L+ + + + + ++ + ++H++
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ 160
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+HRDIK D+ L+ +V + DFG
Sbjct: 161 GVIHRDIKSDSILLT---LDGRVKLSDFGFC 188
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 43/175 (24%), Positives = 72/175 (41%), Gaps = 20/175 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGS 63
LG +IG G+FGE++ G N VA+K EA++ K
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171
Query: 64 TGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
PN+ R GV + +V++L+ G +L +KT+L + +E+
Sbjct: 172 ---PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-----IPYR 169
+ SK +HRD+ N L+ N + I DFG+++ D +P +
Sbjct: 229 LESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 35/177 (19%), Positives = 68/177 (38%), Gaps = 35/177 (19%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LENVKTKHPQLQYEAK-LYKILQG 61
+ ++ + +G G+FG++ + + +VA+K + NV + E L KI +
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 62 GSTGIPN----LRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 111
WF +++ + +LLG + + NF + L V +A
Sbjct: 77 DKENKFLCVLMSDWF----NFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHVRHMAY 130
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIIDFG 152
Q+ + + F+H H D+KP+N L + + + DFG
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 43/180 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVK-----T-----------KHP 47
K++ K+G G++G +Y + VA I+L+ T HP
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 48 QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL 107
+ L ++ L LV + + L+ + + L +
Sbjct: 80 NI---VSLIDVIHSER----CL----------TLVFEFMEKDLKKVLDENKTGLQDSQIK 122
Query: 108 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 164
+ Q++ V H LHRD+KP N L+ + + DFGLA+ + + TH+
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 38/195 (19%), Positives = 70/195 (35%), Gaps = 47/195 (24%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-----------HP- 47
K+ LG+ +G+GSFG + +I++ + A+K L++ + K H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 48 ---------------------QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86
+ K + + N ++++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN-VIMEYV 120
Query: 87 GPSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 140
+ L F R + + + + Q+ V F+HS HRDIKP N L +
Sbjct: 121 P---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VN 175
Query: 141 RRANQVYIIDFGLAK 155
+ N + + DFG AK
Sbjct: 176 SKDNTLKLCDFGSAK 190
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 46/184 (25%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
++F+ K+G+G++ +Y G N T VA +KL++ + KH
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 49 LQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL-----FNFCSRKLSL 103
+ +LY ++ + L LV + + L+ R L L
Sbjct: 65 I---VRLYDVIHTEN----KL----------TLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---T 160
V Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+ + T
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNT 164
Query: 161 ATHQ 164
+ +
Sbjct: 165 FSSE 168
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 29/182 (15%), Positives = 62/182 (34%), Gaps = 19/182 (10%)
Query: 7 NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYKILQ 60
+ L IG G + L T E V ++ LE + LQ E + K+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 61 GGSTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMIN 115
PN + + + + +V + S +DL ++ + + ++
Sbjct: 85 H-----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
++++H ++HR +K + L+ +VY+ Q + + K
Sbjct: 140 ALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 176 GT 177
Sbjct: 197 KV 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 22/172 (12%)
Query: 3 PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
RV + F G K+G G++G +Y + +++ A+K E L + L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75
Query: 60 QGGSTGIPN----LRWFGVEGDYNV-LVID--------LLGPSLEDLFNFCSRKLSLKTV 106
+ PN + F D V L+ D ++ N +L V
Sbjct: 76 KH-----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 107 LMLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 157
L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 43/197 (21%), Positives = 77/197 (39%), Gaps = 49/197 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
+ + F+L +G G++G + T+ T E VAIK K E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI------ 62
Query: 62 GSTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 111
L+ F E N++ + ++ P + FN ++ + LM D
Sbjct: 63 -------LKHFKHE---NIITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQM 108
Query: 112 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRD 159
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ +
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDE 164
Query: 160 TATHQHIPYRENKNLTG 176
+A P + +
Sbjct: 165 SAADNSEPTGQQSGMVE 181
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 21/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
+ R +G G FG++ L TN T E VA+K + +H + E + + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 60 QGGSTGIPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMI 114
++ ++ G G ++ ++ P L L ++ + L +L+ A Q+
Sbjct: 91 YH-----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 57/263 (21%), Positives = 91/263 (34%), Gaps = 78/263 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
+ + + IG G+FGE+ L + T + A+KL + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 48 --QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
QL Y + LY +++ GG DL N S
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG-----------------------------DLVNLMS 161
Query: 99 R-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157
+ K +++ ++ +HS F+HRD+KPDN L+ ++ + + DFG +
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKM 218
Query: 158 RDTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 212
+ GT Y S + R D S+G V +Y L G
Sbjct: 219 NKEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDT 271
Query: 213 PWQGLKAGTKKQKYEKISEKKVS 235
P+ A + Y KI K S
Sbjct: 272 PF---YADSLVGTYSKIMNHKNS 291
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 20/169 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
+ + +GSG++G + + ++ E+VAIK L + Y E L K
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 58 ---ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
++ P Y LV+ + DL K S + + L QM+
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQML 136
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 162
++++HS +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 33/175 (18%), Positives = 73/175 (41%), Gaps = 37/175 (21%)
Query: 14 KIGSGSFGEIYLGTNIQ-TNEEVA---IKLENVKTKHP-----------QLQYEA----- 53
+IG G++G+++ +++ VA ++++ + P L+
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 54 KLYKILQGGSTGIPNLRWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRK-LSLKTVLMLAD 111
+L+ + T + + + LV + + L + + +T+ +
Sbjct: 78 RLFDVCTVSRT----------DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 164
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y T
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV 179
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 10/85 (11%)
Query: 104 KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTAT 162
L + Q+ VEF+HSK +HRD+KP N F + V + DFGL
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 219
Query: 163 HQHIPYRENKNLT-----GTARYAS 182
Q + T GT Y S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 12/56 (21%), Positives = 21/56 (37%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
R F + +G G FG ++ N + AIK + + + + K L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
+ R +G G FG++ L T E+VA+K H L+ E ++ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 60 QGGSTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQM 113
N+ ++ G+ +G + +I P SL++ K++LK L A Q+
Sbjct: 81 YH-----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 63/299 (21%), Positives = 116/299 (38%), Gaps = 56/299 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
+ K+G G +GE+Y G + + VA+K L+ + + EA + K ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275
Query: 66 IPNL-RWFGV--EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEF 119
PNL + GV ++ + + G +L D L +++S +L +A Q+ + +E+
Sbjct: 276 -PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLT 175
+ K+F+HR++ N L+G + V + DFGL++ P +
Sbjct: 334 LEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW----- 385
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKK 233
TA + S + D+ + G VL++ G P Y I +
Sbjct: 386 -TAPESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQ 427
Query: 234 VSTSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 284
V E L + Y P + C D+P +A + + F +F
Sbjct: 428 V---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 39/180 (21%), Positives = 72/180 (40%), Gaps = 50/180 (27%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQ 60
+G+++ + +G G G ++ + ++ VAIK L + + + E K+
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKI----- 61
Query: 61 GGSTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTV-----LMLAD--- 111
+R + N++ V ++LGPS L + L +V M D
Sbjct: 62 --------IRRLDHD---NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 112 -----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
Q++ ++++HS + LHRD+KP N + + I DFGLA
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 20/161 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQ 60
+ ++G G+FG + L T VA+K L++ + Q E ++ K L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 61 GGSTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 114
+ ++ GV G ++ ++ P L D +L +L+ + Q+
Sbjct: 83 S-----DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++ S+ +HRD+ N L+ V I DFGLAK
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 39/179 (21%), Positives = 69/179 (38%), Gaps = 55/179 (30%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
+ +++ + IG+GS+G + + VAIK + V + E +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI----- 105
Query: 61 GGSTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD-------- 111
L + +V+ V+D++ P + F+ +L + + +D
Sbjct: 106 --------LNRLNHD---HVVKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTP 150
Query: 112 -------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 154
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
+ +++G G+FG + + T E VA+K + + + E ++ K LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 61 GGSTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 114
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 101 H-----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGSTG 65
+ K+G G +GE+Y G + + VA+K T + EA + K ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68
Query: 66 IPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
PNL + GV ++ + + G L+ L +++S +L +A Q+ + +E++
Sbjct: 69 -PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
K+F+HRD+ N L+G + V + DFGL++
Sbjct: 128 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
+ +++G G+FG + + T E VA+K + + + E ++ K LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 61 GGSTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 114
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 70 H-----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 54/291 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
RL K+G G FGE+++GT VAIK L+ EA++ K L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 66 IPNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 239 -EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGT 177
+++HRD++ N L+G + DFGLA+ D P + T
Sbjct: 298 RMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WT 348
Query: 178 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
A A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 349 APEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV- 390
Query: 236 TSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
++ + RGY P C +++P + YL+ D F
Sbjct: 391 --LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 62/309 (20%), Positives = 99/309 (32%), Gaps = 100/309 (32%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+F E+ + QT + A+K+ N V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 48 --QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
QL + E LY +++ GG DL S
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG-----------------------------DLLTLLS 153
Query: 99 R---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++ + +++ ++ VH ++HRDIKPDN L+ R + + DFG
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCL 210
Query: 156 RYRDTATHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-F 207
+ R T + + GT Y A D +LG V Y
Sbjct: 211 KLRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEM 263
Query: 208 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267
G P+ A + + Y KI K S+ + G P E R
Sbjct: 264 FYGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEE-------ARDF-------- 305
Query: 268 AYLKRLFRD 276
++RL
Sbjct: 306 --IQRLLCP 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 59/266 (22%), Positives = 90/266 (33%), Gaps = 81/266 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+FGE+ + ++ A+K+ N V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 48 --QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
L Y + LY ++ GG DL S
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG-----------------------------DLLTLLS 166
Query: 99 R---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ +L + +M+ ++ VH ++HRDIKPDN LM + + DFG
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCL 223
Query: 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLR 209
+ + T Q + GT Y S +E + D SLG V MY L
Sbjct: 224 KLMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLY 276
Query: 210 GSLPWQGLKAGTKKQKYEKISEKKVS 235
G P+ A + + Y KI K
Sbjct: 277 GETPFY---AESLVETYGKIMNHKER 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 34/157 (21%), Positives = 68/157 (43%), Gaps = 20/157 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGST 64
+++G+G FG + G + +VAIK+ + ++ EAK+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSH--- 78
Query: 65 GIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVE 118
L + +GV + ++ + + + L N+ + + +L + + +E
Sbjct: 79 --EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++ SK FLHRD+ N L+ V + DFGL++
Sbjct: 135 YLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 34/156 (21%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGSTG 65
++ ++IGSG FG ++LG ++VAIK + EA++ L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62
Query: 66 IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 119
P L + +GV E LV + + L ++ + +T+L + + + +
Sbjct: 63 -PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ +HRD+ N L+G + + DFG+ +
Sbjct: 120 LEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTR 152
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 64/281 (22%), Positives = 91/281 (32%), Gaps = 85/281 (30%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N F + R IG G FGE+Y T + A+K L V T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 45 -KHP---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL 93
P + Y KL IL GG DL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG-----------------------------DL 279
Query: 94 FNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151
S+ S + A ++I +E +H++ ++RD+KP N L+ V I D
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDL 336
Query: 152 GLAKRYRDTATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLR 209
GLA + H GT Y A G+ D SLG +++ LR
Sbjct: 337 GLACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLR 386
Query: 210 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 244
G P++ K K + V S + +L G
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +++ + IGSG+ G + + VAIK L H + Y E L K
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 58 ---ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
I+ + P + Y +V++L+ +L +L + + L QM+
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVY--IVMELMD---ANLCQVIQMELDHERMSYLLYQML 137
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 154
++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +R + +GSG++G + + +T +VAIK L + Y E +L K
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 58 ---ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
++ P+ Y LV+ +G L L KL + L QM+
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFY--LVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQML 138
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 162
+ ++H+ +HRD+KP N + + ++ I+DFGLA++ T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGST 64
+ L +++GSG FG + LG + +VA+K+ + Q EA+ L
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSH--- 62
Query: 65 GIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVE 118
P L +++GV + +V + + S L N+ + L +L + + +
Sbjct: 63 --PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
F+ S F+HRD+ N L+ R V + DFG+ + D
Sbjct: 119 FLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 42/212 (19%), Positives = 75/212 (35%), Gaps = 56/212 (26%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
V + + + IG GS+G +YL + T + VAIK + + + E +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI----- 78
Query: 61 GGSTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD-------- 111
L + ++ + DL+ P F+ +L + + +D
Sbjct: 79 --------LNRLKSD---YIIRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKTP 123
Query: 112 -------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAK 155
++ F+H +HRD+KP N L NQ V + DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA- 176
Query: 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHL 187
R ++ +I +N ++ L
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 49/175 (28%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
VG ++ IG G++G + + VAIK + + Q E K+
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI------ 78
Query: 62 GSTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 111
L F E N++ + D++ + + + LM D
Sbjct: 79 -------LLRFRHE---NIIGINDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQH 124
Query: 112 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 154
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 64/291 (21%), Positives = 115/291 (39%), Gaps = 54/291 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
RL K+G G FGE+++GT VAIK L+ EA++ K L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321
Query: 66 IPNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 322 -EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGT 177
+++HRD++ N L+G + DFGLA+ D P + T
Sbjct: 381 RMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WT 431
Query: 178 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
A A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 432 APEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV- 473
Query: 236 TSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
++ + RGY P C +++P + YL+ D F
Sbjct: 474 --LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 32/163 (19%), Positives = 69/163 (42%), Gaps = 18/163 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAK-LYKILQGG 62
N ++GSG+ G+++ +T +A+K K ++ ++ + + K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC- 83
Query: 63 STGIPNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
P + + FG D + ++L+G E L + + + + ++ +
Sbjct: 84 ----PYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 119 FVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
++ K +HRD+KP N L+ Q+ + DFG++ R D
Sbjct: 139 YLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +++ +GSG++G + + +T VA+K L H + Y E +L K
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 58 ---ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
++ P Y LV L+G L ++ +KL+ V L Q++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDHVQFLIYQIL 142
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 162
++++HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +++ + IGSG+ G + + + VAIK L H + Y E L K
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 58 ---ILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
I+ + P + Y LV++L+ +L +L + + L QM+
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVY--LVMELMD---ANLCQVIQMELDHERMSYLLYQML 174
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 154
++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 38/175 (21%), Positives = 66/175 (37%), Gaps = 28/175 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ +L + IG G FG++ LG +VA+K EA + L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----- 73
Query: 67 PNL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF----CSRKLSLKTVLMLADQMI 114
NL + GV E + ++ E L ++ L +L + +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
+E++ +F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 22/218 (10%), Positives = 50/218 (22%), Gaps = 48/218 (22%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKIL 59
++RL G + + + + +VA+ + + P +
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 60 QGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 118
G+ + ++V + + G SL+++ S + + +
Sbjct: 89 D--KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAAD 143
Query: 119 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 178
H P + V + A
Sbjct: 144 AAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDANP--------------- 181
Query: 179 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+DD+ +G L L P
Sbjct: 182 ---------------QDDIRGIGASLYALLVNRWPLPE 204
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 20/165 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L ++G+G FGE+++G + +VA+K + P EA L K LQ
Sbjct: 11 PR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH 67
Query: 62 GSTGIPNL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 115
L R + V E Y ++ + + SL D L KL++ +L +A Q+
Sbjct: 68 -----QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+ F+ ++++HRD++ N L+ I DFGLA+ D
Sbjct: 121 GMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDN 162
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 12/159 (7%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK 57
+ V K+ L +K+G G++G ++ + +T E VA+K + + + Q + E +
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 58 ILQGGSTGIPNLRWFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
L G + L + D +V LV D + L + + L + Q+I
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKV 121
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 154
++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 2e-08
Identities = 34/200 (17%), Positives = 60/200 (30%), Gaps = 52/200 (26%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQ----------- 48
K + KIG G FGE++ + VAIK+ + V H +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 49 LQYEAKLYKILQGGSTGIPNLR-WFGVEGDYNVLVIDL---------------------- 85
+ + L + + G L V+G Y L++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 86 ------LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMG 138
DL ++ SL T + Q+ + + F HRD+ N L+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL- 195
Query: 139 LGRRANQVYIIDFGLAKRYR 158
++ + + K
Sbjct: 196 --KKTSLKKLHYTLNGKSST 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 48/180 (26%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGST 64
+ + + + R I SGS+G + G + VAIK + + + IL
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK------RVFNTVSDGRTVNILSDSFL 72
Query: 65 G------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 111
I L F N+L + D+ E + KL L T LM D
Sbjct: 73 CKRVLREIRLLNHFHHP---NILGLRDIFVHFEEPAMH----KLYLVTELMRTDLAQVIH 125
Query: 112 ----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 154
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 43/215 (20%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTG 65
F ++G+G+ G ++ ++ + +A K LE Q+ E ++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLH--ECN 89
Query: 66 IPNL-RWFG---VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
P + ++G +G+ + ++ + G SL+ + R + + + ++ +I + ++
Sbjct: 90 SPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYL 147
Query: 121 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT
Sbjct: 148 REKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRS 195
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
Y S G S + D+ S+G L+ G P
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 18/170 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ +L + IG G FG++ LG +VA+K EA + L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----- 245
Query: 67 PNL-RWFGV---EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEF 119
NL + GV E +V + + G SL D L + L +L + + +E+
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
+ +F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 305 LEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 31/170 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LQYEAKLY 56
P R IG G FG +Y G I + AIK + + + E L
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 57 KILQGGSTGIPNL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKT 105
+ L PN+ G+ + V+ L DL F R ++K
Sbjct: 77 RGLNH-----PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKD 125
Query: 106 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++ Q+ +E++ + F+HRD+ N ++ V + DFGLA+
Sbjct: 126 LISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLAR 172
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 53/276 (19%), Positives = 96/276 (34%), Gaps = 100/276 (36%)
Query: 3 PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
P+ F++ R +G+GSFG ++L + A+K +E+
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 45 ---KHP---QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLE 91
HP ++ +++ I+ +GG
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----------------------------- 91
Query: 92 DLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 149
+LF+ + + A ++ +E++HSK ++RD+KP+N L L + + + I
Sbjct: 92 ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKIT 148
Query: 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY------- 202
DFG AK D L GT Y + E + + Y
Sbjct: 149 DFGFAKYVPDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWW 187
Query: 203 ---VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 234
+L+Y L G P+ + YEKI ++
Sbjct: 188 SFGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 61 GGSTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLAD 111
P++ + GV + V +I +E +L +F L L ++++ A
Sbjct: 75 H-----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161
Q+ + ++ SK F+HRDI N L+ + V + DFGL++ D+
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 170
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 33/182 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 61 GGSTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLAD 111
P++ + GV + V +I +E +L +F L L ++++ A
Sbjct: 450 H-----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 112 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIP 167
Q+ + ++ SK F+HRDI N L+ + V + DFGL++ D A+ +P
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 168 YR 169
+
Sbjct: 556 IK 557
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 14/154 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
+L +K+G+G FGE+++ T + +VA+K ++ EA + K LQ
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 66 IPNL-RWFGVEGDYNVLVIDLLGP--SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L + V + +I SL D L + K L ++ + Q+ + F+
Sbjct: 243 -DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++++HRD++ N L+ + I DFGLA+
Sbjct: 302 QRNYIHRDLRAANILVS---ASLVCKIADFGLAR 332
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 22/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGSTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 114
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN-----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/260 (21%), Positives = 96/260 (36%), Gaps = 81/260 (31%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G+GSFG + L + ++ A+K +E+ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-- 96
+L++ + LY ++ GG ++F+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG-----------------------------EMFSHLR 133
Query: 97 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AKR
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKR 190
Query: 157 YRD-TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 214
+ T T L GT + L ++ D +LG VL+Y G P+
Sbjct: 191 VKGRTWT-----------LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF 238
Query: 215 QGLKAGTKKQKYEKISEKKV 234
A Q YEKI KV
Sbjct: 239 ---FADQPIQIYEKIVSGKV 255
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 35/163 (21%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTG 65
++G G++G + ++ + + +A+K + +L + I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65
Query: 66 IPNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVE 118
P ++G EGD + ++L+ SL+ + K +L ++ +E
Sbjct: 66 -PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 119 FVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HSK S +HRD+KP N L+ QV + DFG++ D
Sbjct: 124 HLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 43/185 (23%), Positives = 74/185 (40%), Gaps = 40/185 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
PR ++ +LG+ +G G+FG++ I VA+K+ H + L E K
Sbjct: 25 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL----------GPSLEDLF 94
+ + N+ G + ++VI +L P
Sbjct: 83 ILIHIGHH----LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 95 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
+ L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLA 195
Query: 155 KRYRD 159
RD
Sbjct: 196 ---RD 197
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 47/187 (25%), Positives = 76/187 (40%), Gaps = 43/187 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
PR N+ G+ +G+G+FG++ T + ++ VA+K+ + + L E K
Sbjct: 21 PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL------------GPSLED 92
+ L G+ N+ G G LVI DLL +
Sbjct: 79 VLSYL--GNH--MNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 93 LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152
+ L L+ +L + Q+ + F+ SK+ +HRD+ N L+ G I DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFG 190
Query: 153 LAKRYRD 159
LA RD
Sbjct: 191 LA---RD 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 33/167 (19%), Positives = 66/167 (39%), Gaps = 25/167 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKI 58
+ + IG+G FGE+Y G + + VAIK Q L EA +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102
Query: 59 LQGGSTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 112
N+ R GV + +++ + + L F + S+ ++ +
Sbjct: 103 FSH-----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++++ + +++HRD+ N L+ + DFGL++ D
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 39/183 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLENVKTKHPQ---LQYEAK 54
PR N + G+ +G+G+FG++ T +E VA+K+ + L E K
Sbjct: 44 PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL--------GPSLEDLFNF 96
+ L N+ G G VLVI DLL + F
Sbjct: 102 IMSHLGQH----ENIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 97 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
+ S + +L + Q+ + F+ SK+ +HRD+ N L+ G + I DFGLA
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA-- 211
Query: 157 YRD 159
RD
Sbjct: 212 -RD 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
++ + + IGSG GE+ G Q + VAIK Q + EA +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 61 GGSTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 114
PN+ R GV G ++V + + L F + ++ ++ + +
Sbjct: 109 H-----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
+ ++ ++HRD+ N L+ + DFGL++ D
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 29/170 (17%), Positives = 60/170 (35%), Gaps = 29/170 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LENVKTKHPQ--LQYEAKLY 56
+G G+F +I+ G EV +K L+ + + + A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMM 66
Query: 57 KILQGGSTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLA 110
L +L +GV GD N+LV + + L + +++ L +A
Sbjct: 67 SKLSH-----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVA 119
Query: 111 DQMINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAK 155
Q+ + F+ + +H ++ N L + + D G++
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 58/285 (20%), Positives = 88/285 (30%), Gaps = 93/285 (32%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N FR R +G G FGE+ T + A K LE V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 45 KHP---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 94
L Y + L +L GG DL
Sbjct: 243 -SRFVVSLAYAYETKDALCLVLTLMNGG-----------------------------DLK 272
Query: 95 ----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVY 147
+ + A ++ +E +H + ++RD+KP+N L+ G +
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIR 326
Query: 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
I D GLA + T K GT Y + + D +LG L+Y
Sbjct: 327 ISDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYE 377
Query: 207 FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 244
+ G P+Q K K+++ + E S +A LC
Sbjct: 378 MIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 46/184 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQ-LQYEAKL 55
R N LG+ +G G FG + G Q + VA+K L+N + + EA
Sbjct: 32 DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 56 YKILQGGSTGIPN-LRWFGV------EGDYNVLVIDLLGPSLE-----DLFNF------- 96
K PN +R GV +G +VI L DL +
Sbjct: 90 MKDFSH-----PNVIRLLGVCIEMSSQGIPKPMVI------LPFMKYGDLHTYLLYSRLE 138
Query: 97 -CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ + L+T+L + +E++ +++FLHRD+ N ++ V + DFGL+
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLS- 194
Query: 156 RYRD 159
+
Sbjct: 195 --KK 196
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 41/184 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
R L R++G G+FG+++L N+ ++ VA+K T + Q EA+L
Sbjct: 13 KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 56 YKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR 99
LQ ++ +++GV +GD ++++ DL GP L + R
Sbjct: 71 LTNLQH-----EHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 100 ----KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+L L +L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS- 180
Query: 156 RYRD 159
RD
Sbjct: 181 --RD 182
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 44/159 (27%), Positives = 63/159 (39%), Gaps = 21/159 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQY-----EAKLYKILQ 60
RL K+G GSFG + G + + + VA+K E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 61 GGSTGIPNL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
NL R +GV +V +L LG SL D L T+ A Q+
Sbjct: 80 H-----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++ SK F+HRD+ N L+ + V I DFGL +
Sbjct: 134 MGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 36/184 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGS 63
IG G FG +Y GT + + + A+K N T ++ E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 TGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 112
PN L G+ + + LV+ L DL NF + ++K ++ Q
Sbjct: 86 ---PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
+ ++++ SK F+HRD+ N ++ V + DFGLA RD + Y +
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RD--MYDKEYYSVHN 188
Query: 173 NLTG 176
Sbjct: 189 KTGA 192
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 29/159 (18%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGSTGIPNL- 69
+IG G++G + + + + +A+K + + QL + ++ S+ P +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVM-RSSDCPYIV 84
Query: 70 RWFG---VEGDYNVLVIDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHS 122
+++G EGD + ++L+ S + ++ + + + + + + +
Sbjct: 85 QFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 123 K-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
+HRDIKP N L+ R+ + + DFG++ + D+
Sbjct: 144 NLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 40/181 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
R K + R++G GSFG +Y G + VAIK E + EA
Sbjct: 23 AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCS 98
+ K ++ R GV +G LVI DL P++ + N
Sbjct: 81 VMKEFNC-----HHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMAN--NPVL 132
Query: 99 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158
SL ++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ R
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---R 186
Query: 159 D 159
D
Sbjct: 187 D 187
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGST 64
+++GSG+FG + G + + VA+K+ + P L+ EA + + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 GIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFV 120
P + R G+ E + +LV+++ L L + +R + K ++ L Q+ ++++
Sbjct: 78 --PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+F+HRD+ N L+ + I DFGL+K
Sbjct: 134 EESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 51/288 (17%), Positives = 93/288 (32%), Gaps = 96/288 (33%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
+ F R +G G FGE++ T + A K L K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA--KV 242
Query: 45 KHP---QLQY----EAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLF- 94
L Y + L LV+ ++ G D+
Sbjct: 243 HSRFIVSLAYAFETKTDLC------------------------LVMTIMNGG----DIRY 274
Query: 95 -----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQV 146
+ + + Q+++ +E +H ++ ++RD+KP+N L+ G V
Sbjct: 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------NV 328
Query: 147 YIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVL 204
I D GLA + + K GT + + LG E D +LG V
Sbjct: 329 RISDLGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VT 378
Query: 205 MY-FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 244
+Y + P++ + ++ +++ E+ V S + C
Sbjct: 379 LYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/163 (20%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ + +G+G FGE+ G + + +E VAIK V Q + EA +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 61 GGSTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
PN+ R GV + ++V + + SL+ + ++ ++ + + +
Sbjct: 105 H-----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
++++ ++HRD+ N L+ + DFGL + D
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 47/185 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTK--HPQLQYEAKL 55
P +F LGR +G G FG + Q + VA+K+ ++ + EA
Sbjct: 21 PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 56 YKILQGGSTGIPN-LRWFGV-------EGDYNVLVIDLLGPSLE-----DLFNF------ 96
K P+ + GV +VI L DL F
Sbjct: 79 MKEFDH-----PHVAKLVGVSLRSRAKGRLPIPMVI------LPFMKHGDLHAFLLASRI 127
Query: 97 --CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154
L L+T++ + +E++ S++F+HRD+ N ++ V + DFGL+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLS 184
Query: 155 KRYRD 159
R
Sbjct: 185 ---RK 186
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 22/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGSTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 114
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN-----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 31/160 (19%), Positives = 59/160 (36%), Gaps = 20/160 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ--LQYEAKLYKI 58
+ R + +GSG FG ++ G V IK+ + + Q
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGS 71
Query: 59 LQGGSTGIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 115
L ++ R G+ ++ ++ P SL D L + +L Q+
Sbjct: 72 LDH-----AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++ +HR++ N L+ +QV + DFG+A
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 36/158 (22%), Positives = 66/158 (41%), Gaps = 17/158 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
L R +G G FGE+Y G + VA+K + EA + K L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 61 GGSTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 117
P++ + G+ E + ++++L L L + T+++ + Q+ +
Sbjct: 72 H-----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++ S + +HRDI N L+ V + DFGL++
Sbjct: 127 AYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 36/179 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
PR L R +G G+FGE+Y G N + +VA+K E + EA
Sbjct: 28 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRK 100
+ N+ R GV + ++++L+ G DL +F
Sbjct: 86 IISKFNH-----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSS 136
Query: 101 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
L++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 192
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 40/183 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
R L ++G G+FG+++L N+ ++ VA+K ++ + Q EA+L
Sbjct: 39 KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 56 YKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL---------GPSLEDLFNF 96
+LQ ++ R+FGV EG +L++ DL L +
Sbjct: 97 LTMLQH-----QHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150
Query: 97 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156
L L +L +A Q+ + ++ F+HRD+ N L+G G V I DFG++
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS-- 205
Query: 157 YRD 159
RD
Sbjct: 206 -RD 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 43/177 (24%), Positives = 70/177 (39%), Gaps = 34/177 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGS 63
IG G FG +Y GT + + + A+K N T ++ E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 TGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 112
PN L G+ + + LV+ L DL NF + ++K ++ Q
Sbjct: 150 ---PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 113 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
+ ++F+ SK F+HRD+ N ++ V + DFGLA RD +
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 40/236 (16%), Positives = 71/236 (30%), Gaps = 70/236 (29%)
Query: 74 VEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINR-----VEFVHSKSFLH 127
+E NVL + L F S + + ++ +I V +H S +
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 128 RDIK------PDNFLMGLGRRANQVY----IID----------FGLAKRYRDTATHQHIP 167
+ K P +L + N+ I+D L Y D + HI
Sbjct: 419 KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 168 YRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226
+ HL IE R L + ++ FL +K ++
Sbjct: 479 H-----------------HLKNIEHPERMTLFRMVFLDFRFLE------------QKIRH 509
Query: 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIR 280
+ + + + L + Y Y D+ P Y +RL + F+
Sbjct: 510 DSTAWNASGSILNTL-----QQLKFYKPYI----CDNDPKY---ERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-06
Identities = 33/352 (9%), Positives = 96/352 (27%), Gaps = 104/352 (29%)
Query: 28 NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFG--VEGDYNVLV--- 82
+I + EE+ + +K + +L + ++ + +Y L+
Sbjct: 44 SILSKEEID---HIIMSKDAVSGTLRLFWTLLSKQEEMVQ--KFVEEVLRINYKFLMSPI 98
Query: 83 -IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL--- 136
+ PS+ ++ +L + A ++R++ + L ++P +
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKNVLID 156
Query: 137 -M-GLG----------------RRANQVYIIDFGLAKRYRDTATH-QHIPYRENKNLTGT 177
+ G G + +++ ++ Q + Y+ + N T
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 178 ARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF------------- 207
+ ++S + H + RR ++++ F
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILLTTRFK 275
Query: 208 ---------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP-------- 246
+ + + + K + + L P
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 247 --TEFASYFHYCRSLRFD----------DKPDYAYLKRLFRDLFIREGFQFD 286
+ + + + + D + + A +++F L + F
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPS 384
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 36/179 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
PR L R +G G+FGE+Y G N + +VA+K E + EA
Sbjct: 69 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRK 100
+ N+ R GV + ++++L+ G DL +F
Sbjct: 127 IISKFNH-----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSS 177
Query: 101 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159
L++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGSTG 65
++G G+FG + G ++ VAIK+ K ++ EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 IPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
P + R GV + + +LV+++ G L ++ + V L Q+ ++++
Sbjct: 396 -PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
K+F+HR++ N L+ + I DFGL+K
Sbjct: 455 KNFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 7 NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIKL--ENVKTKHPQ--LQYEAKLYKIL 59
+ + ++G G+FG + G ++ + +VAIK+ + + + ++ EA++ L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQL 67
Query: 60 QGGSTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
P + R GV + + +LV+++ G L ++ + V L Q+
Sbjct: 68 DN-----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 122
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
++++ K+F+HRD+ N L+ + I DFGL+K
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 40/182 (21%), Positives = 63/182 (34%), Gaps = 36/182 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYK 57
N + IG G+FG++ + AIK E + E ++
Sbjct: 23 DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 58 ILQGGSTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDLFNFCS 98
L G PN+ G Y L I +LL + N +
Sbjct: 81 KL--GHH--PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 99 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158
LS + +L A + ++++ K F+HRD+ N L+G I DFGL+ R
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLS---R 190
Query: 159 DT 160
Sbjct: 191 GQ 192
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 35/159 (22%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGST 64
N F IG G FG++Y G ++ +VA+K ++ + + E + +
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94
Query: 65 GIPNL-RWFG--VEGDYNVLVIDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQMINR 116
P+L G E + +L+ + G +L+ L+ + + +S + L +
Sbjct: 95 --PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ ++H+++ +HRD+K N L+ I DFG++K
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISK 187
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 36/183 (19%), Positives = 67/183 (36%), Gaps = 71/183 (38%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A+K ++ V+T HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 48 ---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
L E++L+ +++ GG DL
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGG-----------------------------DLMFHM 101
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYG 155
Query: 153 LAK 155
+ K
Sbjct: 156 MCK 158
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 61/284 (21%), Positives = 96/284 (33%), Gaps = 99/284 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L + +G GSFG+++L +TN+ AIK +E +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 48 QL-------QYEAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
L Q + L+ +++ GG DL
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGG-----------------------------DLMYHI 109
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
K L A ++I ++F+HSK ++RD+K DN L+ G + I DFG
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFG 163
Query: 153 LAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
+ K T GT Y + LG + + D S G VL+Y
Sbjct: 164 MCKENMLGDAKTN------------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYE 210
Query: 207 FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 244
L G P+ G +++ + I + L
Sbjct: 211 MLIGQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 38/182 (20%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKLENVKTKHPQLQ---YE 52
PR ++ LG+ +G G+FG++ L + ++ VA+K+ L E
Sbjct: 67 PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 53 AKLYKILQGGSTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDL 93
++ K++ N+ G + +++ +L +
Sbjct: 125 MEMMKMIGKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 94 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153
+ +LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGL
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGL 237
Query: 154 AK 155
A+
Sbjct: 238 AR 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 39/186 (20%), Positives = 77/186 (41%), Gaps = 41/186 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
PR +K LG+ +G G+FG++ + I ++ VA+K+ ++ K L E
Sbjct: 33 PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 53 AKLYKILQGGSTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDL 93
++ K++ N+ G + +++ +L D+
Sbjct: 91 MEMMKMIGKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 94 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGL 203
Query: 154 AKRYRD 159
A RD
Sbjct: 204 A---RD 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 60/284 (21%), Positives = 96/284 (33%), Gaps = 99/284 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 48 ---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
QL +LY +++ GG DL
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGG-----------------------------DLMYHI 112
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFG 166
Query: 153 LAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
+ K T T GT Y + + D + G VL+Y
Sbjct: 167 MCKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYE 213
Query: 207 FLRGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 244
L G P++G + + ++ I E V S S EA +C+G
Sbjct: 214 MLAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 58/284 (20%), Positives = 94/284 (33%), Gaps = 99/284 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 48 QL-------QYEAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
L Q +LY +++ GG DL
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG-----------------------------DLMYHI 433
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFG 487
Query: 153 LAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
+ K T T GT Y + + D + G VL+Y
Sbjct: 488 MCKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYE 534
Query: 207 FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 244
L G P++G + + ++ I E V S A+C+G
Sbjct: 535 MLAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 40/193 (20%), Positives = 70/193 (36%), Gaps = 50/193 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
PR LG+ +G G FG++ T +++ VA+K+ +K L E
Sbjct: 21 PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76
Query: 53 AKLYKILQ--------GGST-GIP-----------NLRWF--GVEGDYNVLVIDLLGPSL 90
+ K + G + P +LR F + +
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 91 EDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146
L + R L++ ++ A Q M +++ +HRD+ N L+ G ++
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG---RKM 189
Query: 147 YIIDFGLAKRYRD 159
I DFGL+ RD
Sbjct: 190 KISDFGLS---RD 199
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 35/183 (19%), Positives = 67/183 (36%), Gaps = 71/183 (38%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A++ ++ V+T HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 48 ---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
L E++L+ +++ GG DL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG-----------------------------DLMFHM 144
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G
Sbjct: 145 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYG 198
Query: 153 LAK 155
+ K
Sbjct: 199 MCK 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 59/283 (20%), Positives = 102/283 (36%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------------EN---VKTKHP- 47
F + +G G+FG++ L T A+K+ E+ T+HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 48 --QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
L+Y +L +++ GG +LF S
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGG-----------------------------ELFFHLS 97
Query: 99 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 153
R + + ++++ +E++HS+ ++RDIK +N ++ G + I DFGL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGL 151
Query: 154 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 207
K T T GT Y + + R D LG V+MY
Sbjct: 152 CKEGISDGATMK------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEM 198
Query: 208 LRGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 244
+ G LP+ ++ +E I +++ + S EA L G
Sbjct: 199 MCGRLPFYN---QDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 42/189 (22%), Positives = 63/189 (33%), Gaps = 50/189 (26%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
+ R ++G FG++Y G E+ VAIK K + P ++EA
Sbjct: 7 SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 55 LYKILQGGSTGIPNL-RWFGV--EGDYNVLVI-------DLL----------GPSLEDLF 94
L LQ PN+ GV + + +I DL D
Sbjct: 65 LRARLQH-----PNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 95 NFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150
L + L Q M E++ S +H+D+ N L+ V I D
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGM----EYLSSHHVVHKDLATRNVLVYDK---LNVKISD 171
Query: 151 FGLAKRYRD 159
GL R+
Sbjct: 172 LGLF---RE 177
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 39/186 (20%), Positives = 76/186 (40%), Gaps = 41/186 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
PR +K LG+ +G G FG++ + I ++ VA+K+ ++ K L E
Sbjct: 79 PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 53 AKLYKILQGGSTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDL 93
++ K++ N+ G + +++ +L D+
Sbjct: 137 MEMMKMIGKH----KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 94 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGL 249
Query: 154 AKRYRD 159
A RD
Sbjct: 250 A---RD 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 54/284 (19%), Positives = 91/284 (32%), Gaps = 99/284 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F R +G GSFG++ L +T + A+K +E T HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 48 ---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
QL +L+ +++ GG DL
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGG-----------------------------DLMFHI 115
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
+ + A ++I+ + F+H K ++RD+K DN L+ G + DFG
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFG 169
Query: 153 LAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
+ K T T GT Y + + D ++G VL+Y
Sbjct: 170 MCKEGICNGVTTA------------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYE 216
Query: 207 FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 244
L G P++ + +E I +V + +
Sbjct: 217 MLCGHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 52/263 (19%), Positives = 94/263 (35%), Gaps = 81/263 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHPQ 48
F + +G G+FG++ L T A+K + + T +HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 49 L-------QYEAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 98
L Q +L ++ GG +LF S
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG-----------------------------ELFFHLS 240
Query: 99 R--KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
R S ++++ ++++HS K+ ++RD+K +N ++ + + I DFGL K
Sbjct: 241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK 297
Query: 156 RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 212
+ I T GT Y + + R D LG V+MY + G L
Sbjct: 298 --------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRL 347
Query: 213 PWQGLKAGTKKQKYEKISEKKVS 235
P+ ++ +E I +++
Sbjct: 348 PFYN---QDHEKLFELILMEEIR 367
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 57/284 (20%), Positives = 93/284 (32%), Gaps = 99/284 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F + IG GSFG++ L + A+K +++ + KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 48 ---QLQY----EAKLYKILQ---GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 97
L + KLY +L GG +LF
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG-----------------------------ELFYHL 130
Query: 98 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 152
R A ++ + + ++HS + ++RD+KP+N L+ G + + DFG
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFG 184
Query: 153 LAK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 206
L K + T + T GT Y + R D LG ++Y
Sbjct: 185 LCKENIEHNSTTS------------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYE 231
Query: 207 FLRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 244
L G P+ + Y+ I K + + S L G
Sbjct: 232 MLYGLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 43/193 (22%), Positives = 66/193 (34%), Gaps = 50/193 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
PR N R IG G+FG ++ + E VA+K+ +K + Q E
Sbjct: 45 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100
Query: 53 AKLYKILQ--------GGST-GIP-----------NLRWF--GVEGDYNVLVIDLLGPSL 90
A L G G P +L F + + +
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 91 EDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146
+ + LS L +A Q M ++ + F+HRD+ N L+G V
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGM----AYLSERKFVHRDLATRNCLVGENM---VV 213
Query: 147 YIIDFGLAKRYRD 159
I DFGL+ R+
Sbjct: 214 KIADFGLS---RN 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 2e-05
Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 88/267 (32%)
Query: 9 FRLGRKIGSGSFGEIYL-------GTN------------IQTNEEVAIKLEN---VKTKH 46
F L + +G GSFG+++L ++ + V K+E V+ H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 47 P---QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF 96
P +L Y E KLY IL +GG DLF
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGG-----------------------------DLFTR 116
Query: 97 CSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDF 151
S+ + + V ++ ++ +HS ++RD+KP+N L+ G + + DF
Sbjct: 117 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDF 170
Query: 152 GLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 208
GL+K + I + E K + GT Y + ++ D S G VLM+ L
Sbjct: 171 GLSK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEML 220
Query: 209 RGSLPWQGLKAGTKKQKYEKISEKKVS 235
G+LP+QG +K+ I + K+
Sbjct: 221 TGTLPFQG---KDRKETMTMILKAKLG 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 46/187 (24%), Positives = 71/187 (37%), Gaps = 38/187 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
PR G+ +GSG+FG++ T I VA+K+ E + + L E K
Sbjct: 43 PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 55 LYKILQ---------GGST-GIP-----------NLRWFGVEGDYNVLVIDLLGPSLEDL 93
+ L G T P +L + ++ + + L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 94 FNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152
L+ + +L A Q+ +EF+ KS +HRD+ N L+ G V I DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKICDFG 217
Query: 153 LAKRYRD 159
LA RD
Sbjct: 218 LA---RD 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 64/271 (23%), Positives = 96/271 (35%), Gaps = 94/271 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-------------LENVKT-------- 44
F L R +G G +G+++ T T + A+K + K
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 45 KHP---QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 94
KHP L Y KLY IL GG +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGG-----------------------------ELF 109
Query: 95 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 149
R T ++ + +H K ++RD+KP+N ++ G V +
Sbjct: 110 MQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLT 163
Query: 150 DFGLAKR--YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLM 205
DFGL K + T TH T GT Y + + +R D SLG LM
Sbjct: 164 DFGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALM 211
Query: 206 Y-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
Y L G+ P+ G +K+ +KI + K++
Sbjct: 212 YDMLTGAPPFTG---ENRKKTIDKILKCKLN 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 56/276 (20%), Positives = 103/276 (37%), Gaps = 96/276 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LENV 42
F L + +G+G++G+++L + T + A+K LE++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 43 KTKHP---QLQY----EAKLYKIL---QGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLED 92
+ + P L Y E KL+ IL GG +
Sbjct: 116 R-QSPFLVTLHYAFQTETKLHLILDYINGG-----------------------------E 145
Query: 93 LFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVY 147
LF S+ + + V + +++ +E +H ++RDIK +N L+ G V
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVV 199
Query: 148 IIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLG 201
+ DFGL+K + + + GT Y + G +++ D SLG
Sbjct: 200 LTDFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG 249
Query: 202 YVLMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 235
VLMY L G+ P+ ++ + +I + +
Sbjct: 250 -VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 88 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 148 IIDFGLAKR-YRD 159
I DFGLA+ Y+D
Sbjct: 234 ICDFGLARDIYKD 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 475 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.94 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.44 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.76 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.66 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-80 Score=652.19 Aligned_cols=470 Identities=81% Similarity=1.276 Sum_probs=277.6
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
|+++++++|+++++||+|+||.||+|++..+++.||||+++......++..|.++++.|++. ++++.+.+++...+..+
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~-~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-TGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTS-TTCCCEEEEEEETTEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCC-CCCCeEEEEEeeCCEEE
Confidence 89999999999999999999999999999999999999998888888899999999999875 88888999999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||||++++|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.++..+.+||+|||+|+.+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999999999987888999999999999999999999999999999999999965557889999999999998877
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
....+.++.......||+.|+|||++.+..++.++||||||||||||++|..||.+.......+.+.++........++.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 77667777777788999999999999999999999999999999999999999999888888889999988888888999
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCC-CCCcCCCCCCCCCCCC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST-PARAIGPGAGPSSGMP 319 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~-p~~~~~~~~~~s~~~~ 319 (475)
++.++|.++.+||.+||..||++||++.+|+++|++++.+.+++++..+||+..+.++.+... |++..++..++++..
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~- 318 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLA- 318 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC------------------------
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCC-
Confidence 999999999999999999999999999999999999999999999999999998887665544 344444444444433
Q ss_pred CCcccccccCCCCcCCCCCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCccccccccccc-ccCCccccccccCC
Q 011882 320 PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNS 398 (475)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 398 (475)
++....+++++..+.+.++|++.+ +|+.+++....|+++++++++.++...++|.+.++++++ |++++||+.++|++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (483)
T 3sv0_A 319 PPALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSS 396 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CccccccccCccccccccCCcccc--cccCCcccccccccccccCCCCCCccccccccccccccccccCCcccccccccc
Confidence 444556777778888888888765 678889999999999999999999999999999988877 99999999999999
Q ss_pred CCcccCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCcccCCCcccccccccCCccccccccccccceeccCCCccCC
Q 011882 399 REAAVVGSDTDPSRPRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 475 (475)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 475 (475)
|++.. +.+.+|+++|++++.+++..+.++.|+.+|..+.++|+++|+|++++++|||+||||||+|+|++|+|++|
T Consensus 397 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 397 RDVMP-IDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472 (483)
T ss_dssp -----------------------------------------------------------------------------
T ss_pred ccccC-CCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhhhhhhcccCCchHHHH
Confidence 99866 66778899999999988878999999999999999999999999999999999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=453.17 Aligned_cols=246 Identities=22% Similarity=0.243 Sum_probs=207.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+.+++.|+| +||+.+++++.+++..|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH--PNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC--CCCCcEEEEEEECCEEEEE
Confidence 6899999999999999999999999999999998765432 357889999999875 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 83 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||| |++|.+++...+ ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence 9999 899999997543 458999999999999999999999999999999999999 57889999999999977543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
... ....+||+.|||||++.+..|+.++||||||||||||++|+.||.+. +..+.+.++.......
T Consensus 179 ~~~-------~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~---- 244 (350)
T 4b9d_A 179 VEL-------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPP---- 244 (350)
T ss_dssp HHH-------HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCC----
T ss_pred ccc-------ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC----
Confidence 221 12458999999999999999999999999999999999999999874 4455566665554432
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+...+++++.+||.+||+.||++||++.+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 275 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 3356899999999999999999999988874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=442.83 Aligned_cols=261 Identities=21% Similarity=0.234 Sum_probs=217.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.++..|+| +||+.+++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H--pnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS--PRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC--TTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC--CCCCcEEEEEEECCEEEEEEec
Confidence 3579999999999999999999999999999999976543 2468888888765 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC-cEEEeecCCcccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~~~~~~~~ 163 (475)
| |++|.+++... +.|++.+++.|+.||+.||+|||++|||||||||+||||+ .++ .+||+|||+|+.+......
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcc
Confidence 9 89999999854 5799999999999999999999999999999999999994 555 6999999999987643321
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.. ......++||+.|||||++.+..|+.++|||||||+||||++|..||.+........ ++..... ....+..
T Consensus 208 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~~--~~~~~~~ 280 (336)
T 4g3f_A 208 KS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEPP--PIREIPP 280 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSCC--GGGGSCT
T ss_pred cc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCCC--CchhcCc
Confidence 11 112245689999999999999999999999999999999999999998765544333 3333222 2234557
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.+++++.+||.+||+.||++||++.||++.|...+.+.+
T Consensus 281 ~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 889999999999999999999999999999998887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=439.57 Aligned_cols=268 Identities=19% Similarity=0.306 Sum_probs=224.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+++++||+|+||+||+|+++.+++.||||+++.. .....+.+|+++++.|+| +||+.++.++.+.+..|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH--PFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEeCCEEE
Confidence 36799999999999999999999999999999998642 234568899999998865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||||| ||+|.+++... +.+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 109 ivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCC
Confidence 999999 88999999753 579999999999999999999999999999999999999 5788999999999998754
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
..... ...+++||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 185 ~~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~---- 252 (311)
T 4aw0_A 185 ESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYD---- 252 (311)
T ss_dssp TTTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC----
T ss_pred CCCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 32211 234679999999999999999999999999999999999999999773 455666666655543
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
+...+++++++||.+||..||++||++.++... ..+. .-+|...+||+.+..
T Consensus 253 -~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i~---~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 253 -FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLK---AHPFFESVTWENLHQ 304 (311)
T ss_dssp -CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHHH---TSGGGTTCCCTTGGG
T ss_pred -CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHHH---CCCCcCCCCHHHhcC
Confidence 235688999999999999999999998886431 1111 123344578987643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=442.66 Aligned_cols=246 Identities=18% Similarity=0.269 Sum_probs=211.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..|+++++||+|+||+||+|+++.+|+.||||+++... ....+.+|+.+++.++| +||+.+++++.+.+..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH--ENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999986543 33568899999999875 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|| |++|.+++.. ..+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC-
Confidence 99 8899999974 469999999999999999999999999999999999999 5788999999999997755432
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
...+++||+.|||||++.+..|+.++||||||||||||++|..||.+. +..+.+..+....... + ....
T Consensus 226 ------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~-~-~~~~ 294 (346)
T 4fih_A 226 ------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPR-L-KNLH 294 (346)
T ss_dssp ------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCC-C-SCGG
T ss_pred ------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC-C-Cccc
Confidence 124679999999999999999999999999999999999999999874 3344444444332111 1 1224
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+++++++||.+||..||++||++.+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 6789999999999999999999988773
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-55 Score=424.79 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=202.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||+||+|.++.+|+.||||+++... ....+.+|+.+++.++| +||+.++.++.+.+..|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH--PHIIKLYDVIKSKDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC--CCCCeEEEEEEECCEEE
Confidence 368999999999999999999999999999999986542 22458899999999875 99999999999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||||++++|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCC
Confidence 9999999999999874 4579999999999999999999999999999999999999 57889999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.. ..+.+||+.|||||++.+..+ +.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 166 ~~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~---- 230 (275)
T 3hyh_A 166 NF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT---- 230 (275)
T ss_dssp -----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC----
T ss_pred Cc--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 22 235689999999999999886 58999999999999999999999763 445555555554433
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+...+++++.+||.+||+.||++||+++++ |++-|.+.
T Consensus 231 -~p~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~ 268 (275)
T 3hyh_A 231 -LPKFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKV 268 (275)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHT
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHH---HcCccccc
Confidence 235689999999999999999999998877 55555544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=419.92 Aligned_cols=293 Identities=78% Similarity=1.358 Sum_probs=256.8
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
|+..++++|++.+.||+|+||.||+|.+..+++.||||++........+..|.++++.+.+. ++++.+..++...+..+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~-~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-VGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTS-TTCCCEEEEEEETTEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCC-CCCCeeeeecCCCCceE
Confidence 56788999999999999999999999999999999999988777778899999999999885 77888888888999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||..++..+.+||+|||+++.+...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999999999999877778999999999999999999999999999999999999954457788999999999988776
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
......++.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.........+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 66555666666778999999999999999999999999999999999999999998766665666667777677777788
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 294 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 294 (475)
++..+|+++.+++..||+.||++||++.+|++.|++++.+.+...++++||+.+
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 888999999999999999999999999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=430.65 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=216.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|.+.++||+|+||+||+|++. .++..||||+++.... ..++.+|++++..++| +||+.+++++.+.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H--pnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH--EHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC--CCCccEEEEEeeCCE
Confidence 468999999999999999999875 3578999999875432 2457889999998865 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
.||||||| +|+|.+++... ...+++.+++.|+.||+.||.|||+++||||||||+|||| +.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCc
Confidence 99999999 99999999753 2469999999999999999999999999999999999999 57889
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.. ..+
T Consensus 167 ~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~ 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNE 238 (299)
T ss_dssp EEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHH
T ss_pred EEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHH
Confidence 999999999876543321 12234579999999999999999999999999999999998 999998753 345
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+..+....... .+..+|+++.+|+..||+.||++||++.+|.+.|+++....
T Consensus 239 ~~~~i~~~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 239 VIECITQGRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 555555443322 24678999999999999999999999999999999987544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=417.48 Aligned_cols=293 Identities=78% Similarity=1.358 Sum_probs=263.0
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+..|..+++.+.+. ++++.+..++......+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~-~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-VGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTS-TTCCCEEEEEEETTEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcC-CCCCccccccCCCCceE
Confidence 67789999999999999999999999999999999999988877778899999999999885 67788888888999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++..+.+||+|||+++.+...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999999999877778999999999999999999999999999999999999965456789999999999988776
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
......++.......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+.........+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 55555555566778999999999999999999999999999999999999999998665555566666666666677778
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 294 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 294 (475)
++..+|+++.+++..||+.||++||++.+|++.|++++.+.+...++++||+..
T Consensus 242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 888999999999999999999999999999999999999999999999999854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=445.25 Aligned_cols=246 Identities=18% Similarity=0.262 Sum_probs=211.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.|+++++||+|+||.||+|+++.+|+.||||+++... ....+.+|+.+++.++| +||+.+++++...+..|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H--pnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH--ENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC--CCCCceEEEEEECCEEEEEEe
Confidence 56999999999999999999999999999999987543 33468899999999875 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|| |++|.+++.. ..+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc-
Confidence 99 8899999974 469999999999999999999999999999999999999 5788999999999997755432
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
...+++||+.|||||++.+..|+.++||||||||||||++|..||.+. ...+.+..+....... .....
T Consensus 303 ------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~--~~~~~ 371 (423)
T 4fie_A 303 ------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPR--LKNLH 371 (423)
T ss_dssp ------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCC--CSCTT
T ss_pred ------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC--Ccccc
Confidence 124679999999999999999999999999999999999999999874 3344444444332111 11235
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+++++.+||.+||..||++||++.+|+
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 6889999999999999999999988773
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=425.24 Aligned_cols=286 Identities=60% Similarity=1.056 Sum_probs=260.5
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+++++|++.++||+|+||.||+|.+..+++.||||++........+..|+.+++.+.. |++|+.++.++...+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS-GDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCS-CTTSCCEEEEEEETTEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhC-CCCCCEEEEEEecCCccEEE
Confidence 35788999999999999999999999999999999999877777789999999999943 39999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc-----EEEeecCCcccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKRY 157 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~-----vkL~DFGlA~~~ 157 (475)
|||++++|.+++......+++.+++.|+.||+.||+|||++||+||||||+||||+ ..+. +||+|||+|+.+
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEES
T ss_pred EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceee
Confidence 99999999999987777899999999999999999999999999999999999995 4444 999999999988
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.........+++......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 77666566666666788999999999999999999999999999999999999999999877777788888877777777
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 293 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 293 (475)
.+.++..+| ++.+++..||..||.+||++.+|.+.|++++.+.++..+..+||+.
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 888888888 9999999999999999999999999999999999999999999983
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=429.28 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=206.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.++|++.++||+|+||+||+|++. ..||||+++..... ..+.+|+.++..++| +||+.+++++.+ +..||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~H--pNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH--VNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEC-CeEEE
Confidence 367899999999999999999853 36999998755433 347789999988865 999999998765 45799
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||| |++|.+++......+++.+++.|+.||+.||+|||+++||||||||+||||+ +++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccC
Confidence 99999 8999999986667899999999999999999999999999999999999994 7789999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... .....+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+... .......+........
T Consensus 186 ~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 186 SGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQIIFMVGRGYASPD 258 (307)
T ss_dssp -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHTTCCCCC
T ss_pred Ccce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCC
Confidence 2211 22456899999999999754 589999999999999999999999987543 2222333333333333
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+..+...+|+++.+|+.+||+.||++||++.+|++.|+.+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4455678899999999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=431.14 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=208.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|.+.++||+|+||+||+|++. .+++.||||+++.... ..++.+|++++..++| +||+.+++++.+.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H--pnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH--QHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCE
Confidence 357999999999999999999865 3688999999875432 2458889999998865 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~--------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.||||||| +++|.+++.... .++++.+++.|+.||+.||+|||+++||||||||+||||+ .+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---CC
Confidence 99999999 999999987432 3599999999999999999999999999999999999994 78
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCH
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 222 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~ 222 (475)
+.+||+|||+|+.+...... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.. .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~ 266 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---N 266 (329)
T ss_dssp TEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---H
T ss_pred CcEEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---H
Confidence 89999999999876543221 12245689999999999999999999999999999999998 999998753 3
Q ss_pred HHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 223 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+.+..+...... ..+..+|+++.+|+..||+.||++||++.+|++.|+.+.+
T Consensus 267 ~~~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 TEAIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 4445555443321 1235789999999999999999999999999999998864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=419.66 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=203.7
Q ss_pred CCce-EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe----C
Q 011882 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE----G 76 (475)
Q Consensus 6 ~~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~ 76 (475)
.++| ++.++||+|+||+||+|.+..+++.||||++...... ..+.+|+++++.|+| |||+.+++++.. .
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--PNIVRFYDSWESTVKGK 101 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEEEEETTE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEeeccCCC
Confidence 3455 8889999999999999999999999999988654322 347889999998875 999999988764 3
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...||||||| |++|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+ +.++.+||+|||+
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGl 178 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTG
T ss_pred cEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcC
Confidence 5689999999 8999999975 457999999999999999999999998 99999999999994 3468999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
|+...... ..+.+||+.|||||++.+ .|+.++|||||||+||||++|..||.+.. ...+.+..+....
T Consensus 179 a~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~ 246 (290)
T 3fpq_A 179 ATLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGV 246 (290)
T ss_dssp GGGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTC
T ss_pred CEeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCC
Confidence 98643321 235689999999999876 69999999999999999999999997643 2344444444433
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+. .+...+++++.+||.+||..||++||++.+++
T Consensus 247 ~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 247 KPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp CCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 222 23456789999999999999999999988774
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=432.89 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=211.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
++|++++.||+|+||+||+|++. .+++.||||+++... ....+.+|++++..++| +||+.++.++.+++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC--TTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC--CCCCeEEEEEEECCEE
Confidence 67999999999999999999974 467899999986432 22357789988887765 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||| |++|.+++... +.+++.++..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999 89999999854 579999999999999999999999999999999999999 578899999999998754
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 178 ~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~--- 244 (304)
T 3ubd_A 178 DHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG--- 244 (304)
T ss_dssp ---C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC---
Confidence 4322 124578999999999999999999999999999999999999999874 445556666554433
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 298 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 298 (475)
++..+++++.+||.+||+.||++||++. .+.+++++-| -..+||+.+..++
T Consensus 245 --~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~-------f~~idw~~l~~~~ 297 (304)
T 3ubd_A 245 --MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF-------FSTIDWNKLYRRE 297 (304)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG-------GTTCCHHHHHTTC
T ss_pred --CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc-------ccCCCHHHHHhCC
Confidence 2356899999999999999999999963 1333344433 3346898765443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=423.63 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=213.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
..+++++++||+|+||+||+|.+. .+++.||||+++.... ..++.+|+.++..++| +||+.+++++.+.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H--pNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH--PNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC--TTBCCEEEEECSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC--CCCCCcceEEEECC
Confidence 357899999999999999999863 4678999999865433 2468899999998875 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..+|||||| +|+|.+++... ...+++.+++.|+.||+.||+|||+++||||||||+|||| +
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence 999999999 99999999642 1358999999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 220 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~ 220 (475)
+++.+||+|||+|+.+...... .......||+.|||||++.+..|+.++|||||||+||||++ |..||.+..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-- 252 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-- 252 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--
T ss_pred CCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--
Confidence 7889999999999876543321 12345689999999999999999999999999999999998 899998754
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
..+.+..+....... .+..+|+++.+|+..||+.||++||++.+|++.|+.
T Consensus 253 -~~~~~~~i~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 253 -NQDVVEMIRNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHHHHHcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 344455554443322 346789999999999999999999999999988874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=410.61 Aligned_cols=290 Identities=60% Similarity=1.015 Sum_probs=261.1
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+++++|++.+.||+|+||.||+|.+..+++.||||++........+.+|..+++.+.++ ++++.+..++......++|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~-~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC-TGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTC-TTCCCEEEEEEETTEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcC-CCCCeEEeecCCCceeEEE
Confidence 457899999999999999999999999999999999998777777899999999998653 8999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC--CCCCcEEEeecCCccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--~~~~~vkL~DFGlA~~~~~~ 160 (475)
|||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.+ .....+||+|||+++.+...
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999999999998777779999999999999999999999999999999999999532 12334999999999988776
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
......++.......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+...........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 55555555556778899999999999999999999999999999999999999998777777777777777777777788
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 293 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 293 (475)
++..+|+++.+++..||+.||++||++.+|++.|++++.+.+...+..+||+.
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 88899999999999999999999999999999999999999999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=424.14 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=215.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE-GD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~ 77 (475)
++|+++++||+|+||+||+|.+..+ ++.||||+++..... ..+..|++++..+.|+ +||+.+++++.+ +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hh-pnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH-LNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCC-CcEEEEEEEEEecCC
Confidence 6799999999999999999998654 368999998765443 3478899999999875 899999988765 46
Q ss_pred EEEEEEEcC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 141 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~ 141 (475)
..+|||||| +|+|.+++... ...+++.+++.|+.||+.||+|||+++||||||||+|||| +
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---C
Confidence 789999999 89999999743 2348999999999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 011882 142 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 220 (475)
Q Consensus 142 ~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~ 220 (475)
+++.+||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+....
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 7789999999999876543321 12245689999999999999999999999999999999998 99999886543
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
. .....+...... ..+..+|+++.+++..||+.||++||++.+|++.|+++++.+
T Consensus 295 ~--~~~~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 295 E--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp H--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H--HHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2 222223222211 123568999999999999999999999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=424.05 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=209.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE----- 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~----- 75 (475)
++++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+++++.|+| +||+.++++...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH--DNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC--TTBCCEEEECCCSSCTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC--CCcceEeeeeecccccc
Confidence 568899999999999999999999999999999998755432 346789999998875 999999887653
Q ss_pred -CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 -GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 -~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....|||||||+++|.+++.. .+.+++.++..|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeeccee
Confidence 357899999998899999873 5679999999999999999999999999999999999999 57899999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh--
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-- 231 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~-- 231 (475)
+.+....... .....+++||+.|||||++.+.. ++.++||||||||||||++|..||.+.......+.+.....
T Consensus 206 ~~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 8765432211 11234679999999999998864 69999999999999999999999987543322222222111
Q ss_pred ---------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 232 ---------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 232 ---------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.........+..++++++.+||.+||..||++|||+.++ |++-|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~ 347 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA---LRHPF 347 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGG
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH---hcCHh
Confidence 011223345556788999999999999999999998876 44544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=413.97 Aligned_cols=268 Identities=22% Similarity=0.271 Sum_probs=203.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----EEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----YNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----~~~ 80 (475)
|..+|.+.++||+|+||+||+|++ +|+.||||+++... ...+.+|.++.......|+||+.+++++.+.+ ..|
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 456899999999999999999986 68999999986542 34455676666555556799999999887653 579
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
|||||| +++|.++++. ..+++..++.|+.|++.||+|||++ +||||||||+|||| +.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence 999999 8999999974 4699999999999999999999987 99999999999999 57899999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCC------CCCCchhHHHHHHHHHHHHcCCCCCCC---------
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG--------- 216 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~------~~s~ksDIwSlG~iL~elltG~~Pf~~--------- 216 (475)
|+|+.......... ......+||+.|||||++.+. .++.++|||||||+||||++|..||..
T Consensus 153 Gla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99987654332111 112346899999999999865 367899999999999999999766532
Q ss_pred -CCC--CCHHHHHHHHhhccccccHHHHhcC--ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 217 -LKA--GTKKQKYEKISEKKVSTSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 217 -~~~--~~~~~~~~~i~~~~~~~~~~~l~~~--~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
... ....+....+........++..... ++..+.+|+.+||+.||++|||+.+|++.|+++..+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 211 1122333333333332222222222 346899999999999999999999999999999876654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=408.23 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=188.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-----
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----- 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----- 77 (475)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+|+.+++.|+| +||+.++.++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~H--pnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--PGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEecCccccc
Confidence 35799999999999999999999999999999998765432 357789999998865 99999988776433
Q ss_pred -------EEEEEEEcC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 78 -------YNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 78 -------~~~lvme~~-g~sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
+.||||||| |++|.+++..... ...+..++.|+.||+.||+|||++|||||||||+|||| +.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence 479999999 8999999974322 25567789999999999999999999999999999999 4778999
Q ss_pred EeecCCccccccccccccc-----ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH
Q 011882 148 IIDFGLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~ 222 (475)
|+|||+|+.+......... ......+.+||+.|||||++.+..|+.++|||||||+||||++ ||.+. ...
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHH
Confidence 9999999987654321110 1112345689999999999999999999999999999999996 88542 112
Q ss_pred HHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 223 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+..+.....+. .....++++.+||.+||+.||++||++.+|++
T Consensus 234 ~~~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22333333333322 22233567889999999999999999888743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=409.09 Aligned_cols=286 Identities=29% Similarity=0.552 Sum_probs=228.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC-----CeEEEEEEeccCCCchHHHHHHHHHHHHhC-------------CCCCc
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQLQYEAKLYKILQG-------------GSTGI 66 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAvKi~~~~~~~~~~~~E~~il~~l~~-------------~~~~i 66 (475)
..++|+++++||+|+||.||+|.+..+ ++.||||++... ...+..|.++++.+.+ .|++|
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT--CHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc--chhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456999999999999999999998764 578999998654 3456677777776654 46999
Q ss_pred CeeEEeeEeC----CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 67 PNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 67 ~~l~~~~~~~----~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
+.+++++... .+.||||||+|++|.+++......+++.+++.|+.||+.||.|||++||+||||||+||||+. +.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 9998887754 568999999999999999877678999999999999999999999999999999999999952 15
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 222 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~ 222 (475)
.+.+||+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 68899999999988765443332222233456799999999999999999999999999999999999999986433221
Q ss_pred HHHHHHHhhccccccHHHH---h---cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011882 223 KQKYEKISEKKVSTSIEAL---C---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l---~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
...... ......+..+ | ..+|.++.+++..||..||++||++.+|++.|++++.+.+...+..+||+....
T Consensus 270 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 270 YVRDSK---IRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHHHHH---HHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred HHHHHH---HHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 111111 1111122222 2 578999999999999999999999999999999999999999999999997553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=408.64 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=204.4
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
|.+.++|+++++||+|+||+||+|+++ .+++.||||.+.......++.+|+++++.+.+ |+||+.++.++...+..
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~-h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGG-QDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCS-BTTBCCCSEEEEETTEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcC-CCCCceEEEEEEECCEE
Confidence 567889999999999999999999875 46789999998776666778899999988754 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||+ |++|.++++ .+++.++..|+.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccC
Confidence 9999999 889999884 599999999999999999999999999999999999996 344799999999998765
Q ss_pred ccccccc---------------------cccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 011882 159 DTATHQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 216 (475)
Q Consensus 159 ~~~~~~~---------------------~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~ 216 (475)
+...... .........+||+.|+|||++.+.. |+.++||||+|||||||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 4321100 0001123468999999999998865 89999999999999999999999965
Q ss_pred CCCCCHHHHHHHHhhccc----------------------c---------------------------ccHHHHhcCChH
Q 011882 217 LKAGTKKQKYEKISEKKV----------------------S---------------------------TSIEALCRGYPT 247 (475)
Q Consensus 217 ~~~~~~~~~~~~i~~~~~----------------------~---------------------------~~~~~l~~~~p~ 247 (475)
... ....+..|....- . .........+++
T Consensus 250 ~~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 250 ASD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp CSS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 332 2222222211000 0 000011245788
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
++.+||.+||..||++|||+++++
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHCcCChhHCcCHHHHh
Confidence 999999999999999999988774
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=426.87 Aligned_cols=269 Identities=22% Similarity=0.284 Sum_probs=221.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGD 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~ 77 (475)
.-.++|+++++||+|+||+||+|+++.+|+.||||+++.. ........|..++..+.. .||+|+.++..+.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999999999999999998642 223345667777777654 5799999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..||||||| ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 999999999 8999999985 4579999999999999999999999999999999999999 5789999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+.... ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+....+..+.+..+......
T Consensus 342 ~~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 342 FSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412 (689)
T ss_dssp CSSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred cCCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence 65432 245799999999999974 57999999999999999999999999876555544555555444332
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 300 (475)
++..+++++++||..||..||.+|++ +++| +++. |...+||+.+..++.+
T Consensus 413 -----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei---~~Hp-------fF~~idW~~l~~~~~~ 467 (689)
T 3v5w_A 413 -----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KESP-------FFRSLDWQMVFLQKYP 467 (689)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH---TTSG-------GGTTCCHHHHHTTCSC
T ss_pred -----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH---hcCc-------cccCCCHHHHHcCCCC
Confidence 23568999999999999999999998 3444 3333 3445789987655443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=423.63 Aligned_cols=251 Identities=18% Similarity=0.275 Sum_probs=214.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+|+.+++.|+| +||+.++.++.+....||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH--PTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC--TTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC--CCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999865432 2457889999998875 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||| |++|.+++......|++.++..|+.||+.||+|||++||+||||||+||||+. +..+.+||+|||+|+.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc
Confidence 999 88999998755567999999999999999999999999999999999999952 2347899999999998754332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+........ ....
T Consensus 313 --------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 380 (573)
T 3uto_A 313 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAF 380 (573)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCC-SGGG
T ss_pred --------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCC-cccc
Confidence 12458999999999999999999999999999999999999999874 34555566655443222 2234
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+++++++||.+||..||.+||++.+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 67899999999999999999999988773
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=383.90 Aligned_cols=281 Identities=24% Similarity=0.411 Sum_probs=223.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccC--------CeEEEEEEeccCCCchHHHHHHHHHHHHhCC-------------CC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKTKHPQLQYEAKLYKILQGG-------------ST 64 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~--------~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-------------~~ 64 (475)
+++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+++.+++. ..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 68999999999999999999999874 889999998754 5688999999988751 12
Q ss_pred CcCeeEEeeEe-CCEEEEEEEcCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 65 GIPNLRWFGVE-GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 65 ~i~~l~~~~~~-~~~~~lvme~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
+++.++.++.. ....|+||||++++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+||||+ .
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence 34446677766 7899999999999999999854 35799999999999999999999999999999999999995 4
Q ss_pred CC--cEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 143 AN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 143 ~~--~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 55 8999999999877654332222222234568999999999999999999999999999999999999999875322
Q ss_pred CHHHHHHHHh--hccccccHH--HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011882 221 TKKQKYEKIS--EKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 293 (475)
Q Consensus 221 ~~~~~~~~i~--~~~~~~~~~--~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 293 (475)
. ........ ......... .....++.++.+|+..||..||++||++.+|++.|++++.+.+...+.++||..
T Consensus 275 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 275 T-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp H-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred H-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 1 11111111 111100000 001356899999999999999999999999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=369.05 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=215.5
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
...+.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+.| ++|+.++.++...
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~ 83 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH--QNIVSMIDVDEED 83 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB--TTBCCEEEEEECS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC--CCCceEEEeeeeC
Confidence 346788999999999999999999999999999999987554322 246678888777765 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+..|+||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence 9999999999 88999999754 479999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ......+.......
T Consensus 160 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~ 230 (294)
T 4eqm_A 160 ALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIAIKHIQDSVP 230 (294)
T ss_dssp TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHHHHHHHSSCCC
T ss_pred cccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhccCC
Confidence 76543221 1234579999999999999999999999999999999999999998743 23333334444444
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 280 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 280 (475)
.....+...+|+.+.+++.+||+.||.+|| +++++.+.|+.++.+
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 444556678999999999999999999999 888888888776543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=374.13 Aligned_cols=255 Identities=18% Similarity=0.231 Sum_probs=213.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| +||+.++.++...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~ 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH--PHIVELLETYSSD 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC--TTBCCEEEEEEET
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC--CCCCcEEEEEEeC
Confidence 45678999999999999999999999999999999875321 24568899999998865 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
+..|+||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999 78998877533 3358999999999999999999999999999999999999654445669999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
+++.+..... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+. ....+..+...
T Consensus 179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHT
T ss_pred ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcC
Confidence 9987654322 123458999999999999999999999999999999999999999763 23444445444
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..... ......++.++.+||.+||..||++||++.++++
T Consensus 248 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 43332 2334678999999999999999999999988753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=372.55 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=213.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.+.++|++++.||+|+||.||+|.++.+|+.||||+++.... ...+.+|+.+++.+.| ++|+.++.++..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~ 86 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH--PNIITLHDVYEN 86 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC--TTBCCEEEEEEC
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC--cCCCcEEEEEEe
Confidence 467789999999999999999999999999999999875432 2457889999988864 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-CCcEEEeecCC
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGL 153 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGl 153 (475)
....|+||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+..++. ...+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999 8999999973 457999999999999999999999999999999999999952111 12799999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++.+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+....
T Consensus 166 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 234 (361)
T 2yab_A 166 AHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVS 234 (361)
T ss_dssp CEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTC
T ss_pred ceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcC
Confidence 987654321 23568999999999999999999999999999999999999999874 3445555555544
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.... ......++.++.+||..||..||.+||++.+++
T Consensus 235 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 235 YDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 4332 344578899999999999999999999988764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=375.16 Aligned_cols=270 Identities=19% Similarity=0.263 Sum_probs=219.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+++++||+|+||.||+|+++.+++.||||+++... ....+..|..++..+.. |++|+.++.++......|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~-hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTT-CTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCC-CCCcCeeEEEEEECCEEE
Confidence 468999999999999999999999999999999987542 22457889999887743 499999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeeccc
Confidence 999999 8899999875 3579999999999999999999999999999999999999 5788999999999986433
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC------CHHHHHHHHhhcc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKK 233 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~ 233 (475)
... .....+||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+....
T Consensus 206 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 206 PGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp TTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred CCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 221 234578999999999999999999999999999999999999999754221 1223334444433
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 299 (475)
.. ++..++.++.+||..||..||.+||++. .+.+++++. +...+||+.....+.
T Consensus 279 ~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp-------ff~~i~w~~l~~~~~ 335 (396)
T 4dc2_A 279 IR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP-------FFRNVDWDMMEQKQV 335 (396)
T ss_dssp CC-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST-------TTTTCCHHHHHTTCS
T ss_pred cC-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc-------cccCCCHHHHHcCCC
Confidence 32 2356789999999999999999999963 344445443 344578987655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=368.68 Aligned_cols=260 Identities=20% Similarity=0.283 Sum_probs=215.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||.||+|+++.+++.||||+++.. .....+..|..+++.+. |++|+.++.++...+..|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC--CTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC--CCcCcceEEEEEeCCEEE
Confidence 47899999999999999999999999999999998642 23345778888888765 499999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 999999 8899999874 4579999999999999999999999999999999999999 5788999999999986433
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+. .....+..+......
T Consensus 158 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~---- 223 (337)
T 1o6l_A 158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIR---- 223 (337)
T ss_dssp TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 221 124568999999999999999999999999999999999999999763 334444455443332
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
+...+++++.++|.+||..||.+|| ++.+| +++.| -..++|.....
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei---~~h~~-------f~~~~~~~~~~ 274 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRF-------FLSINWQDVVQ 274 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSGG-------GTTCCHHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH---HcCCC-------cCCCCHHHHHh
Confidence 2356789999999999999999999 76665 33332 33467876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=368.27 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=208.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++.++| +||+.++.++......|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH--PNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEECCEEE
Confidence 457899999999999999999999999999999998654332 346789999988875 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 999999 88999998754 579999999999999999999999999999999999999 5788999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s-~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
... ....+||+.|+|||++.+..+. .++|||||||+||||++|..||.+.. ..+....+.......
T Consensus 167 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~-- 233 (328)
T 3fe3_A 167 GGK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYRI-- 233 (328)
T ss_dssp SCG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCC--
T ss_pred CCc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC--
Confidence 321 2356899999999999998875 89999999999999999999998743 344444444443322
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
+..+++++.+|+.+||..||.+||++.+++
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 245789999999999999999999988774
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=363.28 Aligned_cols=255 Identities=19% Similarity=0.260 Sum_probs=209.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.+.++|+++++||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.++| ++|+.++.++......
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH--PNIVSLIDVIHSERCL 94 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCC--TTBCCEEEEECCSSCE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC--CCEeeeeeEEccCCEE
Confidence 3678999999999999999999998 46899999998654332 357789999998865 9999999999999999
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
++||||+.++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence 9999999889999988666679999999999999999999999999999999999999 5778999999999987653
Q ss_pred cccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc----
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 234 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 234 (475)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 172 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PVR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred Ccc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 322 1234578999999999987 4589999999999999999999999988766555544443322111
Q ss_pred ------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+...+++++.+||.+||..||++||++.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1223345566889999999999999999999988774
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=367.71 Aligned_cols=259 Identities=19% Similarity=0.279 Sum_probs=217.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+.| +||+.++.++...+..++|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH--RNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC--TTBCCEEEEEEETTEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC--CCCCeEeEEEecCCEEEEE
Confidence 4678999999999999999999999999999999998754322 347789999988865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ |++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCC
Confidence 9999 78999999755567999999999999999999999999999999999999952 126889999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+........ ...
T Consensus 159 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~-~~~ 226 (321)
T 1tki_A 159 N--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEA 226 (321)
T ss_dssp E--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHH
T ss_pred c--------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHHcCCCCCC-hhh
Confidence 2 12347899999999999988999999999999999999999999874 34455555555544333 334
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+..++.++.+++.+||..||.+||++.++ |++.+.+
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~ 262 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhc
Confidence 56789999999999999999999998887 4455544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=364.62 Aligned_cols=264 Identities=17% Similarity=0.246 Sum_probs=214.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++| ++|+.++.++......++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH--PNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC--cCcccEEEEEecCCeeEEEE
Confidence 4789999999999999999999999999999998754322 2357788888888864 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccccc
Confidence 999 889999998777789999999999999999999999999999999999999 5788999999999987654332
Q ss_pred cccc-------ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHH--HHHHHhhcc
Q 011882 163 HQHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKK 233 (475)
Q Consensus 163 ~~~~-------~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~--~~~~i~~~~ 233 (475)
.... .........||+.|+|||++.+..++.++|||||||+||||++|..||.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc--
Confidence 1100 0011125689999999999999999999999999999999999999997643321110 0011000
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
......+|+++.+++.+||+.||++||++.+|++.|+++....
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 -----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1123568899999999999999999999999999999886544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=372.08 Aligned_cols=268 Identities=19% Similarity=0.248 Sum_probs=214.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|+++++||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.. |++|+.++.++...+..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~-hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccC-CCceeeEEEEEEeCCEE
Confidence 357899999999999999999999999999999998643 233456778888887753 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+...
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 88999998753 579999999999999999999999999999999999999 578899999999998643
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+..+.......
T Consensus 176 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~-- 243 (353)
T 3txo_A 176 CNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVVY-- 243 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCC--
T ss_pred cCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCC--
Confidence 3221 124568999999999999989999999999999999999999999874 3455556665544332
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCCcccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQQS 299 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 299 (475)
...++.++.++|..||..||.+||++.+ ..+++++.| -..++|......+.
T Consensus 244 ---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~-------f~~~~w~~l~~~~~ 297 (353)
T 3txo_A 244 ---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF-------FKEIDWAQLNHRQI 297 (353)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG-------GTTCCHHHHHTTCS
T ss_pred ---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc-------ccCCCHHHHhcCcC
Confidence 2457899999999999999999999721 123344433 33468887654443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=382.38 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=214.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.+.++|+++++||+|+||.||+|.+..+|+.||+|++...... ..+.+|+.+++.++| +||+.++.++.+.+..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH--PNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB--TTBCCEEEEEECSSEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC--cCCCeEEEEEEECCEE
Confidence 4567899999999999999999999999999999998765432 347789999998865 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||+|+.+.
T Consensus 86 ~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999 8899998874 4579999999999999999999999999999999999999654466889999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ......||+.|+|||++.+..++.++|||||||+||+|++|..||.+. .....+..+.........
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCT
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCc
Confidence 4322 123568999999999999999999999999999999999999999774 344555555544433222
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+ ....+++++.+||..||..||++||++.++++
T Consensus 235 ~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 P-EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2 23567899999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=361.91 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=206.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.++|++.++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++|+.++.++...+..|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN--PNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC--CCCCeEeEEEEECCEEEEEE
Confidence 468999999999999999999999999999999876443 33457788888888765 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 9999999974 369999999999999999999999999999999999999 4778999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+....... ....
T Consensus 172 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~ 239 (297)
T 3fxz_A 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNP 239 (297)
T ss_dssp -------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCG
T ss_pred -------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCc
Confidence 12356899999999999999999999999999999999999999977432 22222222211111 0112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..++..+.++|.+||+.||++||++.+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 45789999999999999999999988774
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=372.86 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=211.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| +||+.++.++.+.+..|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEeCCEEE
Confidence 456899999999999999999999999999999998765432 347789999998865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++..+.+||+|||+++.+..
T Consensus 105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999 7899998863 45699999999999999999999999999999999999996544456799999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +....+..+.........
T Consensus 184 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~- 251 (362)
T 2bdw_A 184 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDYPS- 251 (362)
T ss_dssp CCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCCT-
T ss_pred Ccc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCCCc-
Confidence 321 23468999999999999999999999999999999999999999874 334444455444332221
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+++++.+||.+||..||++||++.+++
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 12356789999999999999999999988874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=359.69 Aligned_cols=258 Identities=18% Similarity=0.233 Sum_probs=207.1
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-------CchHHHHHHHHHHHHhC-CCCCcCeeEEeeE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQG-GSTGIPNLRWFGV 74 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~ 74 (475)
..+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|..+++.+.. .|+||+.++.++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 356789999999999999999999999999999999876432 23467889999888862 3499999988887
Q ss_pred eCC-----EEEEEEEcCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 75 EGD-----YNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 75 ~~~-----~~~lvme~~g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
... ..++||||++++|.+++..... .+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl 161 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL 161 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence 654 5899999999999999985433 39999999999999999999999999999999999999 57789999
Q ss_pred eecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
+|||+|+.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..
T Consensus 162 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999987643322 2345789999999999999999999999999999999999999987543222222222
Q ss_pred Hhhc-------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 229 ISEK-------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 229 i~~~-------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.... ........+...+++++.+||.+||+.||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 1110 111233455567889999999999999999999988774
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=372.78 Aligned_cols=260 Identities=17% Similarity=0.311 Sum_probs=214.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-------cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-------~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.++|++++.||+|+||.||+|++. .++..||||+++..... ..+.+|+.+++.+.. |++|+.+++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCC-CTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEcc
Confidence 468999999999999999999975 34568999998765432 347789999988842 4999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
.+..|+||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 236 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-- 236 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--
Confidence 99999999999 889999998543 348999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
+.++.+||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+..
T Consensus 237 -~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 237 -TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp -CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 57789999999999876543221 12234567899999999999999999999999999999999 999998754
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
... .+..+...... .....++.++.++|..||..||++||++.+|++.|+.++...
T Consensus 311 ~~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 311 VEE---LFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGG---HHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 432 22233222211 123567899999999999999999999999999999988643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=373.48 Aligned_cols=270 Identities=31% Similarity=0.540 Sum_probs=201.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEcc---CCeEEEEEEeccCCCchHHHHHHHHHHHH-------------hCCCCCcC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLQYEAKLYKIL-------------QGGSTGIP 67 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAvKi~~~~~~~~~~~~E~~il~~l-------------~~~~~~i~ 67 (475)
..+++|+++++||+|+||.||+|.+.. ++..||||++..... ....|..+++.+ ...|++|+
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG--PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C--HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc--chHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 456899999999999999999999987 788999999875432 233333333322 12459999
Q ss_pred eeEEeeEe----CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 68 NLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 68 ~l~~~~~~----~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.+++++.. ....|+||||++++|.+++.... .+++.+++.|+.||+.||.|||++||+||||||+||||+.+ ..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~ 189 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NP 189 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-ST
T ss_pred eeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CC
Confidence 99998887 78899999999999999987443 79999999999999999999999999999999999999622 22
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK- 222 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~- 222 (475)
+.+||+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 3899999999988765432221111122456899999999999999999999999999999999999999965322111
Q ss_pred HHHHHHHhhccccccHHHHhc--CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 223 KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 223 ~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
...............+..... .+|.++.+++..||..||++||++.+|++.|+++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111112222222333333 7899999999999999999999999999888764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=368.26 Aligned_cols=273 Identities=19% Similarity=0.268 Sum_probs=219.2
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
|++.-.++|++++.||+|+||.||+|+++.+++.||||+++..... ..+..|..++..+.. |++|+.++.++..
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~-hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-HPFLVGLHSCFQT 81 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEEC
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCC-CCccCeEEEEEEe
Confidence 5667778999999999999999999999999999999998754322 236678888877633 4999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....|+||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMC 157 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEecccc
Confidence 99999999999 88999998743 579999999999999999999999999999999999999 57889999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC------CCHHHHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEK 228 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~------~~~~~~~~~ 228 (475)
+....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||..... ......+..
T Consensus 158 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 158 KEGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp BCSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred ccccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 86433221 12456899999999999999999999999999999999999999975322 122233334
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
+...... ++..++.++.++|.+||..||.+||++. .+.+++++.| ...++|+.....
T Consensus 231 i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~-------f~~~~w~~~~~~ 290 (345)
T 3a8x_A 231 ILEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF-------FRNVDWDMMEQK 290 (345)
T ss_dssp HHHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG-------GTTCCHHHHHTT
T ss_pred HHcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc-------cCCCCHHHHHhC
Confidence 4433322 2356789999999999999999999962 2334444433 345788876443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=362.80 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=204.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..++|++.++||+|+||.||+|++ +++.||||++...... ..+.+|+++++.++| ++|+.++.++......+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH--PNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC--TTBCCEEEEECSTTCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEECCceE
Confidence 357899999999999999999985 6889999998765433 246789999998875 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 81 LVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+||||+ +++|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+|||+++
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC---
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCc
Confidence 999999 8899999974322 3999999999999999999999999 9999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+......
T Consensus 188 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~ 257 (309)
T 3p86_A 188 LKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKR 257 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCC
T ss_pred ccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC
Confidence 5443221 12345799999999999999999999999999999999999999987432 3333333222111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
. .+...+++++.++|..||..||.+||++.+|++.|+.++.
T Consensus 258 ~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 258 L---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 2335789999999999999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=368.76 Aligned_cols=261 Identities=17% Similarity=0.251 Sum_probs=213.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
+..++|++.++||+|+||.||+|.+..+++ .||||+++..... ..+.+|+.++..++| ++|+.++.++....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH--PNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEeCC
Confidence 345789999999999999999999986554 5999998765332 347788888888864 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..++||||+ +++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence 999999999 889999997666789999999999999999999999999999999999999 5788999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+........ ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+......
T Consensus 201 ~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~ 273 (325)
T 3kul_A 201 LEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRL 273 (325)
T ss_dssp CC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC
T ss_pred cccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCC
Confidence 755322111 1223456889999999999899999999999999999999 9999977433 3333333332211
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
. ....++.++.+++..||..||++||++.+|++.|+.++..
T Consensus 274 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 P----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1 2356899999999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=369.51 Aligned_cols=268 Identities=19% Similarity=0.242 Sum_probs=217.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-.++|++++.||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+. .|++|+.++.++...+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT-CCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC-CCCEEeeEEEEEEcCCEE
Confidence 457899999999999999999999999999999998643 23345667777776654 359999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+...
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 9999999 88999999753 469999999999999999999999999999999999999 578899999999998643
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 173 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~--- 239 (353)
T 2i0e_A 173 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA--- 239 (353)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred cCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC---
Confidence 3221 124568999999999999999999999999999999999999999874 344555555554432
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 299 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 299 (475)
++..++.++.+||..||..||.+||++. .+.+++++.| -..++|......+.
T Consensus 240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~-------f~~~~w~~l~~~~~ 293 (353)
T 2i0e_A 240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF-------FRYIDWEKLERKEI 293 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG-------GTTCCHHHHHTTCS
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc-------ccCCCHHHHHhCCC
Confidence 2356889999999999999999999752 2333344332 33578987654433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=366.75 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=208.8
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
|...+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++|+.++.++...+
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~ 78 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--ENVVKFYGHRREGN 78 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC--TTBCCEEEEEECSS
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC--CCCCeEEEEEecCC
Confidence 666788999999999999999999999999999999999865432 2457889999998865 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..|+||||+ +++|.+++. ....+++.+++.|+.||+.||.|||++||+||||||+|||| +..+.+||+|||+++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (323)
T ss_dssp EEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccce
Confidence 999999999 789999886 34469999999999999999999999999999999999999 5778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+....... ......||+.|+|||++.+..+ +.++|||||||+||||++|..||.+...... .+.........
T Consensus 155 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~ 227 (323)
T 3tki_A 155 FRYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTY 227 (323)
T ss_dssp CEETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTCTT
T ss_pred eccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhccccc
Confidence 65432211 1235689999999999998775 7899999999999999999999987544322 22222222111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .....++.++.+||.+||..||++||++.+++
T Consensus 228 ~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 228 L---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp S---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred C---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1 11245789999999999999999999988773
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=357.91 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=205.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++......++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH--KNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC--TTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC--CCEeeEEeEEEeCCEEEEE
Confidence 6899999999999999999999999999999998755432 346778888887764 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||++++|.+.+......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc
Confidence 9999889988888777889999999999999999999999999999999999999 5778999999999987643322
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||.... .....+..+.....
T Consensus 157 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTC
T ss_pred -------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhh
Confidence 223457899999999998876 7999999999999999999888864422 22333333322100
Q ss_pred -----------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+...++.++.+||.+||+.||++||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 0011112235789999999999999999999988774
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.05 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=212.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++|+.++.++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~ 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH--PNVITLHEVYEN 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC--TTBCCEEEEEEC
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC--CCCCcEEEEEEe
Confidence 355789999999999999999999999999999998865432 2458899999998875 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC-CCCcEEEeecCC
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGL 153 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGl 153 (475)
....++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+..+. ....+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999 8899999973 45799999999999999999999999999999999999995221 123799999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++.+..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+....
T Consensus 165 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~ 233 (326)
T 2y0a_A 165 AHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVN 233 (326)
T ss_dssp CEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTC
T ss_pred CeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcC
Confidence 987653321 234579999999999999999999999999999999999999997743 334444444433
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... .......++.++.+||..||..||++||++.++++
T Consensus 234 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 322 23445678999999999999999999999887743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=369.01 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=207.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhC---CCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQG---GSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~---~~~~i~~l~~~~~~~~~~ 79 (475)
.+.++|+++++||+|+||.||+|++..+++.||||+++.... ......|..+++.+.. .|++|+.++.++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 467899999999999999999999999999999999864322 2456779999998873 258999999999999999
Q ss_pred EEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC------------------
Q 011882 80 VLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 140 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------ 140 (475)
|+||||++++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+..
T Consensus 112 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999999999998654 359999999999999999999999999999999999999521
Q ss_pred ----CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 011882 141 ----RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216 (475)
Q Consensus 141 ----~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~ 216 (475)
...+.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 126789999999998644321 345899999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHhhccccccHH--------------------------------------HHhcCChHHHHHHHHHHhc
Q 011882 217 LKAGTKKQKYEKISEKKVSTSIE--------------------------------------ALCRGYPTEFASYFHYCRS 258 (475)
Q Consensus 217 ~~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~l~~~~p~~l~~li~~cl~ 258 (475)
.........+..+.......... .+....++.+.+||..||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 54332222222221111100000 0111224778899999999
Q ss_pred CCCCCCCCHHHHH
Q 011882 259 LRFDDKPDYAYLK 271 (475)
Q Consensus 259 ~dp~~RPt~~~l~ 271 (475)
.||.+||++.+++
T Consensus 342 ~dP~~Rpta~elL 354 (360)
T 3llt_A 342 IDPTLRPSPAELL 354 (360)
T ss_dssp SSGGGSCCHHHHT
T ss_pred CChhhCCCHHHHh
Confidence 9999999998875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=367.44 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=216.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.. |++|+.++.++...+..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-HPFLTHMFCTFQTKENL 93 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTT-CTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCC-CCCCCcEEEEEEeCCEE
Confidence 457899999999999999999999999999999998653 233457788888887633 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 88999999753 479999999999999999999999999999999999999 577899999999998643
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~--- 236 (345)
T 1xjd_A 170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPF--- 236 (345)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhCCCC---
Confidence 3221 124568999999999999999999999999999999999999999874 334445555443322
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 298 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 298 (475)
+...++.++.+||.+||..||.+||++. +| +++ ++-..++|+.....+
T Consensus 237 --~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i---~~h-------p~f~~~~w~~l~~~~ 285 (345)
T 1xjd_A 237 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI---RQH-------PLFREINWEELERKE 285 (345)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG---GGS-------GGGTTCCHHHHHTTC
T ss_pred --CCcccCHHHHHHHHHHhcCCHhHcCCChHHH---HcC-------ccccCCCHHHHhhCC
Confidence 2346789999999999999999999976 33 222 233456888765443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=369.89 Aligned_cols=254 Identities=19% Similarity=0.219 Sum_probs=197.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||+++.......+..|+.++..+.| ++|+.++.++......++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH--PNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC--TTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC--CCCcceeeeEecCCeEEEEE
Confidence 3557799999999999999999999999999999999876666678889999998875 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+..+..+.+||+|||+++.......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 999 8899999873 45699999999999999999999999999999999999996444578999999999986643221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+... ....+..+....... .....
T Consensus 207 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~-~~~~~ 275 (349)
T 2w4o_A 207 --------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYF-ISPWW 275 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCC-CTTTT
T ss_pred --------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCcc-CCchh
Confidence 2345799999999999999999999999999999999999999976432 222344444333221 12234
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..++.++.+||.+||..||++||++.+++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 56889999999999999999999988774
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=359.61 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=208.3
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----C
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----G 76 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~ 76 (475)
|...+.++|++.++||+|+||.||+|++ +++.||||++... ....+..|.+++..+...|+||+.++.++.. .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 5678899999999999999999999986 7999999998654 3455677888888865667999999877543 3
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH--------~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
...++||||+ +++|.++++ ...+++..++.|+.||+.||.||| ++||+||||||+|||| +.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence 5689999999 789999996 457999999999999999999999 9999999999999999 4778999
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccCC------CCCCchhHHHHHHHHHHHHcC----------C
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------S 211 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~------~~s~ksDIwSlG~iL~elltG----------~ 211 (475)
|+|||+|+........... ......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 9999999876554332111 12345899999999999887 445799999999999999999 8
Q ss_pred CCCCCCCCCC-HHHHHHHHh-hccccc--cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 212 LPWQGLKAGT-KKQKYEKIS-EKKVST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 212 ~Pf~~~~~~~-~~~~~~~i~-~~~~~~--~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.||....... ....+.... ...... +.......++.++.+++..||+.||++||++.+|++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8987643322 122222221 111111 11112233568899999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=357.66 Aligned_cols=245 Identities=18% Similarity=0.214 Sum_probs=199.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.++|++.++||+|+||+||+|.+..+++.||||++....... ....|...+..+. .|++++.++.++.+....|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~-~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-QHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc-CCCcEEEEEEEEEeCCEEEE
Confidence 367999999999999999999999999999999876543322 2333444443332 45999999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC---
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCC
Confidence 99999999999998777789999999999999999999999999999999999999 577899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||++.+ .++.++|||||||+||||++|..||.+. .....+..... ...+
T Consensus 212 ~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~ 273 (311)
T 3p1a_A 212 A--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEF 273 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHH
T ss_pred C--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Cccc
Confidence 2 234579999999999987 7999999999999999999997666441 22233333222 2345
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+++++.++|..||+.||++||++.+|++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 5778999999999999999999999988853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=379.55 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=217.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+++++||+|+||+||+|+++.+++.||||+++.. .....+..|..++..+.+ ++|+.++.++.+.+..|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h--p~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS--KWITTLHYAFQDDNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT--TTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEeeCCEEE
Confidence 47899999999999999999999999999999998642 233447889999887754 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhccc
Confidence 999999 999999998656789999999999999999999999999999999999999 5788999999999987654
Q ss_pred cccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.... .....+||+.|+|||++. +..++.++|||||||+||||++|..||.+. +..+.+.++.....
T Consensus 228 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 228 DGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKE 298 (437)
T ss_dssp TSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHH
T ss_pred CCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhccc
Confidence 3321 123468999999999997 456899999999999999999999999874 34455555543322
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
....+.....+++++.+||.+||..+|++ ||+++++ +++. +-..+||+...
T Consensus 299 ~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei---l~Hp-------ff~~i~w~~l~ 351 (437)
T 4aw2_A 299 RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF---KKHP-------FFSGIDWDNIR 351 (437)
T ss_dssp HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH---HTSG-------GGTTCCTTTGG
T ss_pred cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHH---hCCC-------ccCCCCHHHHh
Confidence 11222223458899999999999988887 8997766 3333 33456888763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=357.77 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=202.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||.||+|.+ .+++.||||++..... ...+.+|+.+++.++| ++|+.++.++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH--SNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC--TTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC--CCEeeeeeEEccCCeEEEE
Confidence 6899999999999999999998 7899999998865432 3467789999888864 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc
Confidence 9999889999998766789999999999999999999999999999999999999 5778999999999987643221
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 234 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 234 (475)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 156 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 -------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence 12345789999999999875 489999999999999999999999987543222222222111000
Q ss_pred --------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+...+++++.+||.+||..||++||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111223356889999999999999999999988874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.89 Aligned_cols=260 Identities=19% Similarity=0.288 Sum_probs=217.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++++.||+|+||.||+|++..+++.||||+++.. .....+..|..+++.+.| ++|+.++.++.....
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF--PFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEcCCE
Confidence 3457899999999999999999999999999999997543 233457778888887754 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceec
Confidence 99999999 89999999754 469999999999999999999999999999999999999 57889999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... ...+||+.|+|||++.+..++.++|||||||+||||++|..||.+. ...+.+..+......
T Consensus 192 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~-- 256 (350)
T 1rdq_E 192 KGRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR-- 256 (350)
T ss_dssp SSCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC--
T ss_pred cCCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC--
Confidence 4321 3468999999999999999999999999999999999999999864 345555566554432
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
+...++.++.++|.+||..||.+||+ +.+| +++. +....||......
T Consensus 257 ---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei---~~h~-------~f~~~~w~~~~~~ 308 (350)
T 1rdq_E 257 ---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI---KNHK-------WFATTDWIAIYQR 308 (350)
T ss_dssp ---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH---HTSG-------GGTTCCHHHHHTT
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH---HhCc-------CcCCCCHHHHhhc
Confidence 23568899999999999999999998 5554 3332 3345788866443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.31 Aligned_cols=258 Identities=20% Similarity=0.283 Sum_probs=215.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||.||+|++..+|+.||||+++.. .....+..|..++..+.| ++|+.++.++.+....|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH--PFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB--TTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC--CCCceEeEEEEeCCEEE
Confidence 47899999999999999999999999999999998643 233456778888887754 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence 999999 8899999974 4579999999999999999999999999999999999999 5788999999999986543
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. .....+..+......
T Consensus 159 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~---- 221 (318)
T 1fot_A 159 V----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR---- 221 (318)
T ss_dssp C----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC----
T ss_pred c----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 2 13468999999999999999999999999999999999999999763 344555555544332
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
+...++.++.++|.+||..||.+|| ++.+| +++. +-..++|.....+
T Consensus 222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i---~~hp-------~f~~~~~~~~~~~ 273 (318)
T 1fot_A 222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNHP-------WFKEVVWEKLLSR 273 (318)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTSG-------GGSSCCHHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHH---hcCc-------cccCCCHHHHHhC
Confidence 2356789999999999999999999 65555 3332 3345678866543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=368.32 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=215.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.+.++|++.+.||+|+||.||+|.++.+++.||||+++.... ....|++++..+.. |++|+.++.++.+....|+||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~-hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQ-HPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTT-STTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcC-CCCcCeEEEEEEcCCEEEEEE
Confidence 356789999999999999999999999999999999875533 34578888877743 499999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ |++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.+....
T Consensus 96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999 8899999873 4579999999999999999999999999999999999998532 122469999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+........ ...
T Consensus 175 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~ 246 (342)
T 2qr7_A 175 G-------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGY 246 (342)
T ss_dssp C-------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STT
T ss_pred C-------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-ccc
Confidence 2 12346899999999999988899999999999999999999999987655556666666665544321 122
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
+..+++++.+||.+||..||++||++.++ |++.|.
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 35688999999999999999999998876 445444
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=373.25 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=213.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEE-----EccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~-----~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
+..++|+++++||+|+||.||+|. +..+++.||||+++..... ..+.+|+.++..++| ++|+.++.++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH--QNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC--CCCCeEEEEEec
Confidence 345789999999999999999999 4457789999998654332 246778888888864 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
....++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.+.....+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 98999999999 889999998653 35999999999999999999999999999999999999964445567999
Q ss_pred eecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~ 227 (475)
+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.. ..+.+.
T Consensus 226 ~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~ 297 (367)
T 3l9p_A 226 GDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE 297 (367)
T ss_dssp CCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH
T ss_pred CCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH
Confidence 999999865433221 12234578999999999999999999999999999999998 999998743 333444
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+....... ....++.++.+|+..||+.||++||++.+|++.|+.+...
T Consensus 298 ~i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 298 FVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 443332211 2356889999999999999999999999999999887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=375.43 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=214.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++.++||+|+||.||+|.+..+++.||||+++..... ..+..|+.+++.++| ++|+.+++++...+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH--PNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC--TTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEecCCCcEEE
Confidence 46899999999999999999999889999999998754322 246789999888865 9999999999988999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence 9999 889999998766679999999999999999999999999999999999999 477899999999998654322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
... ......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... .
T Consensus 268 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~ 335 (377)
T 3cbl_A 268 YAA-----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL----P 335 (377)
T ss_dssp EEC-----CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC----C
T ss_pred eee-----cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----C
Confidence 110 1122346788999999998889999999999999999998 9999987543 2222222222111 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
....+|+++.+|+..||+.||++||++.+|++.|+++..+
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2356889999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=352.26 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=214.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+|+++++.++| ++|+.++.++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH--PKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC--TTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCceEEEEE
Confidence 468999999999999999999975 67889999987654 34568899999998875 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHH
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccccccc
Confidence 99 889999998666679999999999999999999999999999999999999 46788999999999876543211
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+....+....... ..
T Consensus 163 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~ 229 (269)
T 4hcu_A 163 ------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLY----KP 229 (269)
T ss_dssp ------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCC----CC
T ss_pred ------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhcCccCC----CC
Confidence 1234567889999999999999999999999999999999 999998743 333344433321111 12
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
..+++++.+++..||..||++||++.++++.|+++..
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 4568999999999999999999999999999998864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=357.00 Aligned_cols=267 Identities=21% Similarity=0.255 Sum_probs=205.9
Q ss_pred CccCCceEEe-eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 3 PRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 3 ~~i~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
-++.+.|++. +.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.. |++|+.++.++...+..
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~-h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG-HRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEE
Confidence 3567889995 789999999999999999999999999865533 3467888888877543 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+++.+.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999 78999999753 579999999999999999999999999999999999999643334459999999998764
Q ss_pred ccccccccccccCCCCccCccccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------------
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------ 221 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------------ 221 (475)
.................||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 332211111112234579999999999975 457899999999999999999999998754322
Q ss_pred HHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 222 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 222 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+..+.......+. .....++.++.+||.+||..||.+||++.++++
T Consensus 246 ~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 12233444444333222 234568899999999999999999999887743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=367.43 Aligned_cols=265 Identities=21% Similarity=0.303 Sum_probs=218.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+.| ++|+.++.++.....
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH--PFLVNLWYSFQDEED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEeCCE
Confidence 3457899999999999999999999999999999987542 233467789999988754 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 99999999 8899999873 5579999999999999999999999999999999999999 57889999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
..... ....+||+.|+|||++.+ ..++.++|||||||+||||++|..||.........+.+..+.....
T Consensus 166 ~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 166 PRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp CTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred cCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 54321 245689999999999974 4589999999999999999999999987655555555555444332
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
. +...++.++.+||..||..||.+||+ +.+|+ + ..+...++|......
T Consensus 238 ~-----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~---~-------hp~f~~~~w~~~~~~ 286 (384)
T 4fr4_A 238 T-----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ---N-------FPYMNDINWDAVFQK 286 (384)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH---T-------SGGGTTCCHHHHHTT
T ss_pred C-----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH---c-------ChhhhcCCHHHHHhC
Confidence 2 23567899999999999999999998 44432 1 234455788876443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=366.20 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=212.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEE-----EccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~-----~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|+++++||+|+||.||+|. +..+++.||||+++..... ..+.+|++++..+.+ |+||+.++.++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcC-CcceeeeeeeeecC
Confidence 45789999999999999999998 4456789999998765443 347889999999964 39999999887765
Q ss_pred -CEEEEEEEcC-CCCHHHHHHHcCC-------------------------------------------------------
Q 011882 77 -DYNVLVIDLL-GPSLEDLFNFCSR------------------------------------------------------- 99 (475)
Q Consensus 77 -~~~~lvme~~-g~sL~~ll~~~~~------------------------------------------------------- 99 (475)
...++||||+ +++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4589999999 8899999975432
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccc
Q 011882 100 ----------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169 (475)
Q Consensus 100 ----------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~ 169 (475)
.+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...... .
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~ 250 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----V 250 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----E
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----h
Confidence 18999999999999999999999999999999999999 47789999999999866443221 1
Q ss_pred cCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHH
Q 011882 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 248 (475)
Q Consensus 170 ~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 248 (475)
......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...... ....+...... .....++++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~ 324 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRM----RAPDYTTPE 324 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCCC----CCCTTCCHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCCC----CCCCCCCHH
Confidence 2234578999999999999999999999999999999998 9999987543322 12222221111 123557899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 249 FASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 249 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+.+++..||..||.+||++.+|++.|+.++...
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=360.28 Aligned_cols=264 Identities=19% Similarity=0.237 Sum_probs=206.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEE----EccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEe--
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVE-- 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~-- 75 (475)
+..++|+++++||+|+||.||+|+ +..+++.||||++...... ..+.+|+.++..++| ++|+.++.++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH--DNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEecCC
Confidence 456889999999999999999998 5678999999998754332 357789999888864 999999887653
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCccc
Confidence 35689999999 8899999987666799999999999999999999999999999999999995 6789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------CHH--
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKK-- 223 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~---------~~~-- 223 (475)
+.+....... .......||..|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 162 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp C-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred ccccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 8765432211 1123456788899999999999999999999999999999999998642110 000
Q ss_pred --HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 224 --QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 224 --~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.....+..... ......+|+++.+++..||..||++||++.+|++.|+++..+
T Consensus 238 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 238 VFHLIELLKNNGR----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHTTCC----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCc----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 01111111111 112356889999999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=366.69 Aligned_cols=265 Identities=20% Similarity=0.296 Sum_probs=218.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC-------CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~-------~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
..++|++.++||+|+||.||+|.+..+ +..||||+++..... ..+.+|+++++.+.. |++|+.++.++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcC-Cchhhhheeeec
Confidence 457899999999999999999997643 358999998765443 347789999999843 399999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 138 (475)
..+..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll- 224 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 224 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE-
Confidence 999999999999 789999998643 359999999999999999999999999999999999999
Q ss_pred eCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 011882 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 217 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~ 217 (475)
+.++.+||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 225 --~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 225 --TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp --CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 47789999999999876543221 12234578899999999999999999999999999999999 99999874
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 285 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 285 (475)
. ..+....+....... ....+++++.+|+..||+.||++||++.+|++.|+.++.....+.
T Consensus 298 ~---~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 298 P---VEELFKLLKEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp C---HHHHHHHHHTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred C---HHHHHHHHHcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 3 233333333322211 235688999999999999999999999999999999987765433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.20 Aligned_cols=258 Identities=20% Similarity=0.305 Sum_probs=205.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+.+++|+++++||+|+||.||+|.+ .+++.||||++...... ..+.+|+.++..+++++++|+.++.++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3577899999999999999999997 57899999998765433 347789999999998779999999999999999
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
++|||+.+++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||. ++.+||+|||+++.+..
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence 99999889999999985 45799999999999999999999999999999999999994 57899999999987654
Q ss_pred cccccccccccCCCCccCccccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..
T Consensus 160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 32211 1234579999999999975 6689999999999999999999999976432 2233333
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+....... .+....+.++.+|+..||..||.+||++.++ |++.+.+
T Consensus 233 ~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~---l~hp~~~ 278 (343)
T 3dbq_A 233 IIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 278 (343)
T ss_dssp HHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHH---HhCcccc
Confidence 32222111 1224457899999999999999999998887 4455543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=369.40 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=205.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.+|+++++||+|+||.||+|.+. +++.||||++...... ..+.+|+.++..+++.|++|+.++.++...+..|+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 456999999999999999999975 4899999998765433 35788999999999877999999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+.+++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||. ++.+||+|||+++.+....
T Consensus 134 v~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC----
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCC
Confidence 999889999999985 45799999999999999999999999999999999999993 4789999999998765432
Q ss_pred cccccccccCCCCccCccccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g-----------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
... .....+||+.|+|||++.+ ..++.++|||||||+||||++|..||.+... ....+..+.
T Consensus 209 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII 281 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred ccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence 211 1234689999999999976 3689999999999999999999999976432 223333333
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
....... +....+.++.+||..||..||.+||++.+| |++.+..
T Consensus 282 ~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~el---l~hp~~~ 325 (390)
T 2zmd_A 282 DPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 325 (390)
T ss_dssp CTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHH---hhCcCcc
Confidence 3222111 223457899999999999999999998877 4454443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=349.80 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=214.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++......
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH--PNIVRLHDSIQEESFH 80 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC--CCcCeEEEEEEcCCEE
Confidence 5789999999999999999999999999999999998765432 346789999988865 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 78998888743 569999999999999999999999999999999999999654455669999999998665
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT
T ss_pred cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc
Confidence 4322 234679999999999999999999999999999999999999997743 33444444433332222
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+ ....+++++.+++..||+.||++||++.+++ ++.+.+
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l---~h~~~~ 266 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQAL---KVPWIC 266 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT---TSHHHH
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHHh---cCcccc
Confidence 1 2356789999999999999999999988884 444443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=367.44 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=211.3
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.....++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.++.++...
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~ 81 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH--PHIIKLYDVITTP 81 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC--TTBCCEEEEEECS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC--CCCCeEEEEEEeC
Confidence 456678999999999999999999999999999999987532 334568899999988875 9999999999999
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...++||||++++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNI 157 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBT
T ss_pred CEEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEecccee
Confidence 99999999999999998874 3579999999999999999999999999999999999999 5778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
...... ....+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+....... ..+....
T Consensus 158 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~i~~~~-- 224 (336)
T 3h4j_B 158 MTDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---KKVNSCV-- 224 (336)
T ss_dssp TTTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---CCCCSSC--
T ss_pred ccCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---HHHHcCC--
Confidence 654321 235689999999999998876 78999999999999999999999764332111 1111111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..+...+++++.+||.+||..||.+||++.+| +++.+.+.
T Consensus 225 ---~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 264 (336)
T 3h4j_B 225 ---YVMPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNV 264 (336)
T ss_dssp ---CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHT
T ss_pred ---CCCcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhcc
Confidence 11234578999999999999999999998877 44555443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=372.84 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=195.1
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
+..+.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+.. |++|+.++.++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG-HENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccC-CCCCCeeeeEEecCC
Confidence 445678999999999999999999999999999999987543222 346678888888763 399999988876543
Q ss_pred --EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 78 --YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 78 --~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..|+||||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 7899999999999999974 479999999999999999999999999999999999999 578899999999998
Q ss_pred ccccccccc-c-------------cccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 156 RYRDTATHQ-H-------------IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 156 ~~~~~~~~~-~-------------~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
.+....... . .........+||+.|+|||++.+ ..++.++|||||||+||||++|..||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 764321100 0 00112244689999999999987 56899999999999999999999999875432
Q ss_pred CHHHHHHHHhhccccccHHHH------------------------------------------hcCChHHHHHHHHHHhc
Q 011882 221 TKKQKYEKISEKKVSTSIEAL------------------------------------------CRGYPTEFASYFHYCRS 258 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l------------------------------------------~~~~p~~l~~li~~cl~ 258 (475)
..+..+......+..+.+ ...+++++.+||.+||.
T Consensus 238 ---~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 ---NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp ---HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred ---HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 222222211100000000 12678899999999999
Q ss_pred CCCCCCCCHHHHH
Q 011882 259 LRFDDKPDYAYLK 271 (475)
Q Consensus 259 ~dp~~RPt~~~l~ 271 (475)
.||++||++.+++
T Consensus 315 ~dP~~R~t~~e~l 327 (388)
T 3oz6_A 315 FNPNKRISANDAL 327 (388)
T ss_dssp SSGGGSCCHHHHT
T ss_pred cCcccCCCHHHHh
Confidence 9999999987763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=373.58 Aligned_cols=260 Identities=17% Similarity=0.183 Sum_probs=200.2
Q ss_pred cCCceEEe-eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCEE
Q 011882 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDYN 79 (475)
Q Consensus 5 i~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~~ 79 (475)
+.++|.+. +.||+|+||.||+|.+..+++.||||++. ....+.+|+.++..+.. |+||+.++.++.. ....
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~E~~~~~~~~~-hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC---cchhHHHHHHHHHHhcC-CCCcceEeEEEeecccCCcEE
Confidence 44667776 78999999999999999999999999986 34567888888766543 4999999887764 5678
Q ss_pred EEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
||||||+ |++|.+++.... ..+++.+++.|+.||+.||.|||++|||||||||+||||+..+.++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999 789999997533 35999999999999999999999999999999999999964333789999999999865
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 236 (475)
..... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+.......
T Consensus 215 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 215 TSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp C-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred CCCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 43221 2346899999999999999999999999999999999999999987543221 11122222222221
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.. .....++.++.+||..||..||++||++.+| |++.|..
T Consensus 287 ~~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~ 326 (400)
T 1nxk_A 287 PN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 326 (400)
T ss_dssp CT-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred CC-cccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 11 1224688999999999999999999998877 4455543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=354.19 Aligned_cols=257 Identities=18% Similarity=0.276 Sum_probs=213.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|+++++||+|+||.||+|.+. ++..||||++.... ....+.+|++++..++| ++|+.++.++......++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH--EKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC--TTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC--CCEeeEEEEEecCCCeEEEEe
Confidence 468999999999999999999874 77889999987654 33568889999988874 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccccccccc
Confidence 99 889999998656679999999999999999999999999999999999999 47789999999999876543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+....... ..
T Consensus 177 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~----~~ 243 (283)
T 3gen_A 177 ------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RP 243 (283)
T ss_dssp ------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CC
T ss_pred ------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCC----CC
Confidence 1234467889999999999899999999999999999998 9999987443 33333333322111 12
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..+++++.+++..||+.||++||++.+|++.|++++.++
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 456899999999999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=367.24 Aligned_cols=259 Identities=17% Similarity=0.225 Sum_probs=206.4
Q ss_pred cCCceEEeeeEeee--CceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G--~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
-+++|+++++||+| +||.||+|++..+++.||||+++..... ..+.+|+.+++.++| +||+.++.++...+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH--PNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC--CCCCcEeEEEEECCE
Confidence 46789999999999 9999999999999999999998765432 346679999998875 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.|+||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEccccccee
Confidence 99999999 89999999754 3569999999999999999999999999999999999999 5788999999999876
Q ss_pred ccccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
...................||+.|+|||++.+ ..++.++|||||||+||||++|..||.+......... +.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~ 254 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE---KLNGTV 254 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH---C-----
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HhcCCC
Confidence 64433222222222344589999999999988 5789999999999999999999999987544332211 110000
Q ss_pred c-----------------------------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 S-----------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ~-----------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .....+...+++++.+||.+||..||.+||++.+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0 001123355788999999999999999999988874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=361.73 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=191.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|+++++||+|+||.||+|.+..+++.||||+++.... ...+.+|+.+++.++| ++|+.++.++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH--ENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB--TTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC--CCcceEEEEEEECCeEEEE
Confidence 4789999999999999999999999999999999865432 3567889999988865 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 83 IDLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 83 me~~g~sL~~ll~~~~-----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
|||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEET
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceec
Confidence 9999889999987542 359999999999999999999999999999999999999 57789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 234 (475)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 159 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 159 GIPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp TSCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred CCCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 43321 12345789999999999874 589999999999999999999999987543222222222111000
Q ss_pred -------------------cccHH-----HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 -------------------STSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 -------------------~~~~~-----~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+. .....++.++.+||..||..||++||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 00000 11135788999999999999999999988774
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=374.95 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=214.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|+++++||+|+||.||+|+++.+++.||||+++... ....+..|..++..+.| ++|+.++.++.+.+..
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h--p~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR--RWITQLHFAFQDENYL 136 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT--TTBCCEEEEEECSSEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC--CCeeeEEEEEeeCCEE
Confidence 3578999999999999999999999999999999986421 22347788888877654 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+++...+..+++..++.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999 999999998766689999999999999999999999999999999999999 578899999999998765
Q ss_pred ccccccccccccCCCCccCcccccccccc-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
..... .....+||+.|+|||++. +..++.++|||||||+||||++|..||.+. +..+.+.++..
T Consensus 214 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~ 284 (412)
T 2vd5_A 214 ADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIVH 284 (412)
T ss_dssp TTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHT
T ss_pred CCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHHHHh
Confidence 43221 123468999999999998 356899999999999999999999999874 34455555544
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
.......+.+...+++++++||.+||. +|.+|+ ++++| +++.| -..+||+...
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei---~~Hpf-------f~~i~w~~l~ 340 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF---RTHPF-------FFGLDWDGLR 340 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH---HTSGG-------GTTCCSTTST
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH---hcCCC-------cCCCCHHHHh
Confidence 322222223346789999999999999 999985 66655 33333 3456888653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.15 Aligned_cols=255 Identities=18% Similarity=0.277 Sum_probs=206.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---------hHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---------~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~ 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH--PNIVKLYGLMH 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC--TTBCCEEEEET
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC--CCchhhheeec
Confidence 4578999999999999999999999999999999987654322 457789988888864 99999988876
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCC--CCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGR--RANQVYII 149 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~--~~~~vkL~ 149 (475)
... ++||||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++ ....+||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 555 6999999 78999988766667999999999999999999999999 99999999999995321 11239999
Q ss_pred ecCCcccccccccccccccccCCCCccCcccccccccc--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
|||+++...... ....||+.|+|||++. +..++.++|||||||++|||++|..||....... .....
T Consensus 172 Dfg~~~~~~~~~----------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~ 240 (287)
T 4f0f_A 172 DFGLSQQSVHSV----------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFIN 240 (287)
T ss_dssp CCTTCBCCSSCE----------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHH
T ss_pred CCCccccccccc----------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHH
Confidence 999997543321 2457999999999994 4457899999999999999999999998755432 22223
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.+....... .+...+|+++.+++..||+.||.+||++.+|++.|++
T Consensus 241 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 332222221 2335789999999999999999999999999998875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=355.35 Aligned_cols=248 Identities=20% Similarity=0.279 Sum_probs=200.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----------------------------chHHHHHHHH
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLQYEAKL 55 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----------------------------~~~~~~E~~i 55 (475)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456889999999999999999999999999999999865431 2457889999
Q ss_pred HHHHhCCCCCcCeeEEeeEe--CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 011882 56 YKILQGGSTGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 132 (475)
Q Consensus 56 l~~l~~~~~~i~~l~~~~~~--~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP 132 (475)
++.++| ++|+.++.++.. ....|+||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 90 l~~l~h--~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 165 (298)
T 2zv2_A 90 LKKLDH--PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP 165 (298)
T ss_dssp HHTCCC--TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhCCC--CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 998865 999999988876 67899999999 778877653 45799999999999999999999999999999999
Q ss_pred CcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCC---CCCchhHHHHHHHHHHHHc
Q 011882 133 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLR 209 (475)
Q Consensus 133 ~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~---~s~ksDIwSlG~iL~ellt 209 (475)
+|||+ +.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 166 ~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 166 SNLLV---GEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp GGEEE---CTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred HHEEE---CCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999 4778999999999987654322 113457999999999998765 3788999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 210 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 210 G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
|..||.+.. .......+........ ....+++++.++|.+||..||++||++.+|+
T Consensus 236 g~~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 236 GQCPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp SSCSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 999997643 2333333333222111 1246789999999999999999999988874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.37 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=214.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++++.||+|+||.||+|.+. .+++.||||+++..... ..+.+|+.+++.++| ++|+.+++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN--PNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEccC
Confidence 3578999999999999999999987 35589999998765432 347789999888854 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 132 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP 132 (475)
+..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999 789999997642 5699999999999999999999999999999999
Q ss_pred CcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CC
Q 011882 133 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GS 211 (475)
Q Consensus 133 ~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~ 211 (475)
+|||| +.++.+||+|||+++.+..... +.......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 203 ~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 203 RNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp GGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999 4778999999999987644321 112234578999999999999999999999999999999999 99
Q ss_pred CCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 212 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 212 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.||.+.. ..+....+...... .+...+|.++.+++..||..||++||++.+|++.|+++..+
T Consensus 275 ~p~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 275 QPYYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CTTTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CcCCCCC---hHHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9998743 33334444333322 12357899999999999999999999999999999988643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=358.95 Aligned_cols=264 Identities=21% Similarity=0.246 Sum_probs=209.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--E
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--Y 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--~ 78 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||+++... ....+.+|+++++.+++ ++|+.++.++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH--KNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC--TTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC--CCcceEEEEeecCCCce
Confidence 46789999999999999999999999999999999986532 23457789999998875 99999988877654 7
Q ss_pred EEEEEEcC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.+++..... .+++.+++.|+.||+.||.|||++||+||||||+||||..+ +..+.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 89999999 8999999975432 39999999999999999999999999999999999998432 35567999999999
Q ss_pred ccccccccccccccccCCCCccCcccccccccc--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQK 225 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~-~~~~~ 225 (475)
+.+..... .....||+.|+|||++. +..++.++|||||||+||||++|..||...... ...+.
T Consensus 164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred eecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 87654332 13457999999999987 567899999999999999999999999764432 22333
Q ss_pred HHHHhhcccccc--------------------HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 226 YEKISEKKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 226 ~~~i~~~~~~~~--------------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+.++........ ...+...++..+.+++.+||+.||++||+++++++-..+.
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 333333221100 0011123467899999999999999999999987666544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=370.05 Aligned_cols=266 Identities=20% Similarity=0.256 Sum_probs=210.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHH-HHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLY-KILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il-~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..++|++++.||+|+||.||+|+++.+++.||||+++..... ..+..|..++ +. ..|++|+.++.++...+.
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~--~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN--VKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCC--CCCTTBCCEEEEEECSSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHh--CCCCCCCCEEEEEEeCCE
Confidence 346899999999999999999999999999999998654321 2234444432 22 345999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccc
Confidence 99999999 8899999875 3579999999999999999999999999999999999999 57889999999999864
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 190 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~-- 257 (373)
T 2r5t_A 190 IEHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ-- 257 (373)
T ss_dssp BCCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC--
T ss_pred ccCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC--
Confidence 33221 234568999999999999999999999999999999999999999763 345555555554332
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCCccccccccccc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILKYQQ 298 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 298 (475)
+...++.++.+||.+||..||.+||++.+ +.+++++ .+...++|+.+...+
T Consensus 258 ---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h-------~~f~~~~w~~l~~~~ 309 (373)
T 2r5t_A 258 ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH-------VFFSLINWDDLINKK 309 (373)
T ss_dssp ---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS-------GGGTTCCHHHHHTTC
T ss_pred ---CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC-------ccccCCCHHHHHhCC
Confidence 23568899999999999999999999753 2233333 333457898765443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=373.33 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=211.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-EEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD-YNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~-~~~lvme 84 (475)
.++|++.++||+|+||.||+|.+ .++.||||+++.......+..|+.+++.++| ++|+.+++++.... ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH--SNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCC--TTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccC--CCEEEEEEEEEcCCCceEEEEE
Confidence 46799999999999999999986 4789999999887777789999999998865 99999998877654 7899999
Q ss_pred cC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~-ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++...... +++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc-
Confidence 99 88999999865543 7999999999999999999999999999999999999 477899999999998543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
....++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+ ...... ..
T Consensus 344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~~~----~~ 407 (450)
T 1k9a_A 344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKM----DA 407 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HTTCCC----CC
T ss_pred ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCC----CC
Confidence 12367889999999999999999999999999999998 99999886554433332 222111 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
+..+|+++.+||..||..||++||++.+|++.|+++...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 357899999999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.49 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=201.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
+..++|++.+.||+|+||.||+|.+..+ +..||||++...... ..+.+|..+++.++| ++|+.++.+.. .+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH--PHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CccceEEEEEc-cC
Confidence 3567899999999999999999998654 457999987654332 346778888887754 99999988864 45
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccccc
Confidence 678999999 7799999987666799999999999999999999999999999999999995 678999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...... +..+......
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~~ 236 (281)
T 1mp8_A 166 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERL 236 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCC
T ss_pred cCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCCC
Confidence 6543221 1223467889999999999999999999999999999996 9999987654332 2333322211
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+...+|+++.+++..||..||++||++.+|++.|++++.+.
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 123578999999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.22 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=192.4
Q ss_pred CCceEEe---eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~---~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.++|++. ++||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.. |+||+.++.++.+....|+|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~-h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEG-HPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcC-CCCeeEEEEEEEcCCEEEEE
Confidence 4678886 8899999999999999999999999998653 34567789999988874 49999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ |++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999 8899999975 4679999999999999999999999999999999999999744444589999999998654432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CCHHHHHHHHhhcccccc
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~ 237 (475)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ....+.+..+........
T Consensus 164 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 164 Q-------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred C-------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 2 12345789999999999999999999999999999999999999986432 223444555554443322
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+++++.+||..||..||.+||++.+++
T Consensus 237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 223356899999999999999999999988773
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=349.48 Aligned_cols=255 Identities=17% Similarity=0.226 Sum_probs=213.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+|+.++..++| ++|+.++.++......++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH--PKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhCCC--CCEeeEEEEEccCCceEEEE
Confidence 457899999999999999999987 467789999987654 34568889999998875 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhh
Confidence 999 889999998766679999999999999999999999999999999999999 5778999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......+....... .
T Consensus 160 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~ 226 (268)
T 3sxs_A 160 V------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLY----R 226 (268)
T ss_dssp E------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----C
T ss_pred h------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCC----C
Confidence 1 1234467889999999999899999999999999999999 9999976432 33333333322111 1
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
...+++++.+++..||+.||++||++.+|++.|+.+.
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2446899999999999999999999999999988764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=346.47 Aligned_cols=251 Identities=21% Similarity=0.242 Sum_probs=212.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC--CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~--~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.++|++.++||+|+||.||+|.+..++..||+|++... .....+..|+++++.++| ++|+.++.++......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH--PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCeEEEE
Confidence 457899999999999999999999999999999987653 234568889999988854 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+..++..+.+||+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 8899998874 4569999999999999999999999999999999999999655577899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||++.+. ++.++|||||||++|||++|..||.... ..+.+..+......... ..
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~~ 230 (277)
T 3f3z_A 164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFPE-KD 230 (277)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCH-HH
T ss_pred c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-hh
Confidence 2 2345799999999998765 8999999999999999999999998743 34444555544443332 23
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+++++.+++..||+.||++||++.+++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 357899999999999999999999988874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=370.51 Aligned_cols=255 Identities=19% Similarity=0.247 Sum_probs=206.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhC----CCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQG----GSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~----~~~~i~~l~~~~~~~~~ 78 (475)
.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.+ .+++++.++.++.....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356789999999999999999999999999999999865432 2457789999999875 45789999999999999
Q ss_pred EEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc--EEEeecCCcc
Q 011882 79 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 155 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGlA~ 155 (475)
.++||||++++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+ ..+. +||+|||+|+
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccce
Confidence 99999999999999998654 3499999999999999999999999999999999999994 4444 9999999997
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
..... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+.........
T Consensus 251 ~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 251 YEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 54332 13458999999999999999999999999999999999999999875433222222221110000
Q ss_pred ---------------------------------------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCC
Q 011882 236 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK 264 (475)
Q Consensus 236 ---------------------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~R 264 (475)
.....+....++++.+||.+||.+||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00111222347889999999999999999
Q ss_pred CCHHHHH
Q 011882 265 PDYAYLK 271 (475)
Q Consensus 265 Pt~~~l~ 271 (475)
||+.+++
T Consensus 401 pta~e~L 407 (429)
T 3kvw_A 401 MTPGQAL 407 (429)
T ss_dssp CCHHHHH
T ss_pred CCHHHHh
Confidence 9988874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=363.69 Aligned_cols=253 Identities=19% Similarity=0.263 Sum_probs=200.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++......++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--ANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC--TTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC--CCCCeeeeEEeeCCEEEEEe
Confidence 6899999999999999999999999999999988654322 234568888887764 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc-
Confidence 999999999998777789999999999999999999999999999999999999 5778999999999986543322
Q ss_pred cccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 234 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 234 (475)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 156 ------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 1234578999999999987 5689999999999999999999999987543332222222211110
Q ss_pred --------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........+++++.+||.+||+.||.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 1112233456789999999999999999999988774
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=370.20 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=208.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEecc-----CCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~-----~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|+++++||+|+||.||+|+++.+++.||||+++. ......+..|..++..+.| ++|+.++.++.+....
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS--PWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC--TTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC--CCCCeEEEEEEECCEE
Confidence 34789999999999999999999999999999998754 2234457889999988765 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 8999999874 469999999999999999999999999999999999999 578899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~----~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
..... .....+||+.|+|||++.+.. ++.++|||||||+||||++|..||.+. +....+.++.....
T Consensus 220 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKN 290 (410)
T ss_dssp TTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHH
T ss_pred cCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccc
Confidence 43211 123568999999999998766 789999999999999999999999874 34455555544321
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 271 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~ 271 (475)
....+ ....++.++++||..||..+|.+ ||++.+|+
T Consensus 291 ~~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 291 SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp HCCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred cccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 11111 12467899999999999988888 99987763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=359.28 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=204.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeE----EEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~----vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
...++|+++++||+|+||.||+|.+..+++. ||+|.+.... ....+.+|+.++..++| +||+.+++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN--PHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB--TTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC--CCEeEEEEEEecC
Confidence 4567899999999999999999999888765 5777764332 23468889999998875 9999999998877
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
. .+++|+++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence 6 45667776 9999999987777899999999999999999999999999999999999994 67899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. ....
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~ 237 (327)
T 3poz_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGER 237 (327)
T ss_dssp HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCC
T ss_pred EccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCC
Confidence 765433211 1233467889999999999999999999999999999999 999998765433322222 1111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.. ....++.++.+++..||+.||++||++.+|++.|+.+..
T Consensus 238 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC----CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC----CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 124578899999999999999999999999999988763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=352.21 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=216.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEE-----ccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.+.||+|+||.||+|.+ ..+++.||||++...... ..+.+|+.++..+.. |++|+.++.++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-HMNIVNLLGACTIG 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhccc-CCCeeeEEEEEecC
Confidence 357899999999999999999985 356789999998765432 457889999999843 39999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~-----------------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 138 (475)
+..++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 9999999999 7799999976533 489999999999999999999999999999999999994
Q ss_pred eCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 011882 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 217 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~ 217 (475)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 180 ---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 180 ---HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp ---TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ---CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 6789999999999876543321 11234568899999999999999999999999999999998 99999875
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
...... ........... ....++.++.+++..||..||.+||++.+|++.|++++.+..
T Consensus 252 ~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 252 PVDSKF---YKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CSSHHH---HHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred cchhHH---HHHhccCCCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 543222 12111111111 124678999999999999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.22 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=211.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.| ++|+.++.++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH--HNVITLHDVYENR 87 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC--TTBCCEEEEEECS
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC--CCcceEEEEEecC
Confidence 45689999999999999999999999999999998865432 2458889999998875 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC----cEEEeec
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 151 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~----~vkL~DF 151 (475)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ..+ .+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence 9999999999 8899999973 45799999999999999999999999999999999999995 334 7999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+..
T Consensus 164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~ 232 (321)
T 2a2a_A 164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITS 232 (321)
T ss_dssp TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHT
T ss_pred ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh
Confidence 99987654321 23457999999999999999999999999999999999999999774 33444444444
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..... ...+...++.++.++|..||..||++||++.++++
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYDF-DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCCC-CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccc-ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33322 23455778999999999999999999999888753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.57 Aligned_cols=260 Identities=19% Similarity=0.325 Sum_probs=219.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++......++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH--PNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEccCCCEEEEE
Confidence 467899999999999999999999999999999998765433 467889999998875 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCCc
Confidence 999 789999998643 459999999999999999999999999999999999999 467889999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......+. +...... .
T Consensus 166 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~~~~~----~ 232 (288)
T 3kfa_A 166 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRM----E 232 (288)
T ss_dssp SE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCCC----C
T ss_pred cc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhccCCC----C
Confidence 21 1233467889999999999999999999999999999999 9999987554333222 2221111 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
....+|+++.+++..||..||.+||++.+|++.|+.++.+..
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 225678999999999999999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=357.39 Aligned_cols=253 Identities=21% Similarity=0.350 Sum_probs=197.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch-----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQGGSTGIPNLRWFGVEGD- 77 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~-----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~- 77 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++....... .+.+|+.++..++ |++|+.++.++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--HPAIVAVYDTGEAETP 86 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC--CTTBCCEEEEEEEEET
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC--CCCcceEEEeeeccCC
Confidence 46789999999999999999999999999999999987653322 3566777776665 499999988776543
Q ss_pred ---EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 78 ---YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 78 ---~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
..|+||||+ |++|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~ 162 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI 162 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSC
T ss_pred CCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccC
Confidence 459999999 88999999753 5799999999999999999999999999999999999995 678899999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++.+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...........
T Consensus 163 a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~ 235 (311)
T 3ork_A 163 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVRED 235 (311)
T ss_dssp C----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCC
T ss_pred ccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCC
Confidence 98765432211 122345799999999999999999999999999999999999999987432 22222332222
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 270 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 270 (475)
. .........++.++.++|.+||+.||++||+..++
T Consensus 236 ~-~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 236 P-IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp C-CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred C-CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 2 23344557789999999999999999999976554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=354.91 Aligned_cols=259 Identities=17% Similarity=0.284 Sum_probs=213.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.++ |++|+.++.++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN--HPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC--CTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC--CCceeeEEEEEecC
Confidence 3578999999999999999999984 45589999998755432 34677888888775 49999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 132 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP 132 (475)
+..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 9999999999 799999997543 2389999999999999999999999999999999
Q ss_pred CcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CC
Q 011882 133 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GS 211 (475)
Q Consensus 133 ~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~ 211 (475)
+||||+ .++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 179 ~NIli~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 179 RNILVA---EGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp GGEEEE---TTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred heEEEc---CCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999994 6789999999999876543221 11234567899999999999889999999999999999999 99
Q ss_pred CCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 212 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 212 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.||.+....... ..+...... .....+++++.+++..||+.||++||++.+|++.|++++.+
T Consensus 251 ~p~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 251 NPYPGIPPERLF---NLLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CSSTTCCGGGHH---HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHH---HHhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 999875543322 222222111 12356889999999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=369.06 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=209.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.++|+++++||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| ++|+.++.++......++|
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH--PKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS--TTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC--cCCCeEEEEEEeCCEEEEE
Confidence 45789999999999999999999999999999999875432 2357788888887765 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ |++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++. +..+.+||+|||+|+.+....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCc
Confidence 9999 88999998755557999999999999999999999999999999999999942 235679999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+........ ...
T Consensus 206 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~ 273 (387)
T 1kob_A 206 I--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFD-EDA 273 (387)
T ss_dssp C--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCC-SST
T ss_pred c--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-ccc
Confidence 2 123479999999999999999999999999999999999999998743 3344444443332211 122
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+++++.+||..||..||++||++.+++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 356889999999999999999999988774
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=374.05 Aligned_cols=262 Identities=18% Similarity=0.221 Sum_probs=188.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe----
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE---- 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~---- 75 (475)
.+.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++| +||+.++.++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH--DHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC--TTBCCEEEECCCSCTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC--CCCCceEEEEecCCcc
Confidence 4678999999999999999999999999999999988654322 357789999998865 999999888743
Q ss_pred -CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 -GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 -~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....|+||||++++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|
T Consensus 128 ~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence 35689999999999999997 34579999999999999999999999999999999999999 57889999999999
Q ss_pred cccccccccccc--------------------ccccCCCCccCcccccccccc-CCCCCCchhHHHHHHHHHHHHc----
Q 011882 155 KRYRDTATHQHI--------------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR---- 209 (475)
Q Consensus 155 ~~~~~~~~~~~~--------------------~~~~~~~~~GT~~Y~APE~~~-g~~~s~ksDIwSlG~iL~ellt---- 209 (475)
+.+......... ........+||+.|+|||++. +..++.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 876543211100 001234568899999999874 5669999999999999999998
Q ss_pred -------CCCCCCCCCCCC-----------------HHHHHHHHhh--------------------------ccccccHH
Q 011882 210 -------GSLPWQGLKAGT-----------------KKQKYEKISE--------------------------KKVSTSIE 239 (475)
Q Consensus 210 -------G~~Pf~~~~~~~-----------------~~~~~~~i~~--------------------------~~~~~~~~ 239 (475)
|..+|.+..... ....+..+.. ........
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 666665532100 0111111111 00011112
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+++++.+||.+||..||++||++.+++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L 395 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECL 395 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 22345689999999999999999999987763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=354.88 Aligned_cols=259 Identities=23% Similarity=0.397 Sum_probs=200.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+..++|++.++||+|+||.||+|.+ ...||||+++..... ..+.+|+.+++.++| ++++.++.+.. ....
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~-~~~~ 94 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH--VNILLFMGYST-APQL 94 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEC-SSSC
T ss_pred cCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCC--CcEEEEEeecc-CCcc
Confidence 5678999999999999999999984 335999998766543 346778888887765 89999888654 4557
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccccc
Confidence 8999999 7899999976667799999999999999999999999999999999999995 67899999999998654
Q ss_pred ccccccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
...... ......||+.|+|||++. +..++.++|||||||++|||++|..||.+... .......+......
T Consensus 172 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS 244 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCC
T ss_pred cccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccC
Confidence 322111 123457999999999997 56788999999999999999999999987543 23334444444444
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.....+...+|+++.+++.+||..||++||++.+|++.|+++.
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 4444555678999999999999999999999999999998864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.10 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=206.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
+..++|++++.||+|+||.||+|++. .+++.||||+++... ....+..|..+++.++| ++|+.++.++.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~ 91 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH--PFIVDLIYAFQ 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC--TTBCCEEEEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC--CCccceeEEEE
Confidence 45678999999999999999999985 689999999986542 22346779999988865 99999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
..+..|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL 167 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence 999999999999 8899999874 3469999999999999999999999999999999999999 5778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++....... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+....
T Consensus 168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCK 237 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC
T ss_pred ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCC
Confidence 986543221 1234689999999999999999999999999999999999999998743 344444444433
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
.. +...++.++.++|.+||..||.+||++. .+.+++++.|. ..++|....
T Consensus 238 ~~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f-------~~~~~~~~~ 289 (327)
T 3a62_A 238 LN-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-------RHINWEELL 289 (327)
T ss_dssp CC-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG-------SSCCHHHHH
T ss_pred CC-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc-------cCCCHHHHh
Confidence 32 2346789999999999999999999433 33344554442 245676543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=361.33 Aligned_cols=260 Identities=20% Similarity=0.226 Sum_probs=201.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|+.++.++......++||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC--CCCCcEEEEEeeCCEEEEEE
Confidence 3578999999999999999999999999999999987644 34668899999998875 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+||||+. +..+.+||+|||+|+.......
T Consensus 96 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 96 EYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC--------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccCC
Confidence 999 8899999874 346999999999999999999999999999999999999941 1233599999999975332211
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCCC-HHHHHHHHhhccccccHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~k-sDIwSlG~iL~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~ 240 (475)
.....||+.|+|||++.+..++.+ +|||||||+||+|++|..||.+..... ....+..+.......+.
T Consensus 174 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (361)
T 3uc3_A 174 --------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD-- 243 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--
T ss_pred --------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--
Confidence 234579999999999998887655 899999999999999999998754432 23333333333222111
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
...+++++.+||.+||..||.+||++.+| +++.+....
T Consensus 244 -~~~~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~~~ 281 (361)
T 3uc3_A 244 -DIRISPECCHLISRIFVADPATRISIPEI---KTHSWFLKN 281 (361)
T ss_dssp -TSCCCHHHHHHHHHHSCSCTTTSCCHHHH---HTSHHHHTT
T ss_pred -cCCCCHHHHHHHHHHccCChhHCcCHHHH---HhCcchhcC
Confidence 13578999999999999999999998877 555555443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=348.93 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=203.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+++++.+++ ++|+.++.++......+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH--PNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC--chHHhHHHheecCCeEE
Confidence 356789999999999999999999999999999998865432 3568889999988865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 81 LVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
+||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+||||..++..+.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999 78999988533 46799999999999999999999999999999999999996545567899999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
+..... .....||+.|+|||++. ..++.++|||||||++|||++|..||.+... .+....+.......
T Consensus 177 ~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 177 FKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY 244 (285)
T ss_dssp ------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC
T ss_pred cCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc
Confidence 654322 23457999999999986 4689999999999999999999999987432 22223322222211
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. ..+..+++++.+++.+||..||++||++.+|+
T Consensus 245 ~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 245 A--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp C--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred c--cccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1 12345789999999999999999999998875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=356.28 Aligned_cols=269 Identities=20% Similarity=0.320 Sum_probs=209.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----CEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG----DYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----~~~ 79 (475)
.+.++|++.++||+|+||.||+|++ +++.||||++... .......|.+++..+...|++|+.++.++... ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3567899999999999999999986 4899999998543 33456667777777655679999999888877 789
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||| +.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEe
Confidence 9999999 7899999974 4699999999999999999999999 99999999999999 4778999999
Q ss_pred cCCcccccccccccccccccCCCCccCccccccccccCCCCCCc------hhHHHHHHHHHHHHcC----------CCCC
Q 011882 151 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPW 214 (475)
Q Consensus 151 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~k------sDIwSlG~iL~elltG----------~~Pf 214 (475)
||+|+.+......... ......||+.|+|||++.+..++.. +|||||||+||||++| ..||
T Consensus 186 fg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999876554332111 1234589999999999998776665 9999999999999999 7788
Q ss_pred CCCCCCC-HHHHHHH-HhhccccccHH--HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 215 QGLKAGT-KKQKYEK-ISEKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 215 ~~~~~~~-~~~~~~~-i~~~~~~~~~~--~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
....... ....... +.........+ .....+++++.+++..||+.||.+||++.+|++.|+.+......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 6643322 1122222 21111111111 11124678899999999999999999999999999999876644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.00 Aligned_cols=246 Identities=17% Similarity=0.286 Sum_probs=205.8
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.|+..++||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++|+.++.++...+..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH--FNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC--TTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEECCEEEEEEec
Confidence 488999999999999999999889999999998755432 457789888887765 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 124 ~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~-- 196 (321)
T 2c30_A 124 LQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-- 196 (321)
T ss_dssp CCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc--
Confidence 9 889999986 4569999999999999999999999999999999999999 4778999999999987654322
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+........ .....
T Consensus 197 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~--~~~~~ 266 (321)
T 2c30_A 197 -----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKL--KNSHK 266 (321)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCC--TTGGG
T ss_pred -----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCc--Ccccc
Confidence 1235689999999999999999999999999999999999999997643 3333333333222111 11245
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+++++.+++.+||..||++||++.+|++
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7899999999999999999999888743
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=359.02 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=205.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++| ++|+.+++++...+..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH--PNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEECCeEEE
Confidence 4599999999999999999999999999999998755332 346789999988865 999999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||||+.++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+...
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB-
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC-
Confidence 999998899999876777899999999999999999999999999999999999994 7789999999999865432
Q ss_pred cccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
....||+.|+|||++. +..++.++|||||||+||||++|..||.+... ...+..+........
T Consensus 208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL- 273 (348)
T ss_dssp ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC-
T ss_pred ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC-
Confidence 2457999999999985 45689999999999999999999999976432 233333333222111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....++..+.++|..||+.||++||++.+|++
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 12457899999999999999999999988743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=356.91 Aligned_cols=255 Identities=24% Similarity=0.250 Sum_probs=199.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
...++|+++++||+|+||.||+|.+..+++.||||+++..... ..+.+|+.+++.++| ++|+.++.++......
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH--RNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC--TTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC--CCcceEEEEEecCCEE
Confidence 3567899999999999999999999999999999998655432 246688888888864 9999999999999999
Q ss_pred EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC--CCCCcEEEeecCCcccc
Q 011882 80 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--~~~~~vkL~DFGlA~~~ 157 (475)
++||||++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||..+ +..+.+||+|||+|+.+
T Consensus 109 ~lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999998899999974 4569999999999999999999999999999999999999643 23456999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc--
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 234 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 234 (475)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 188 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 188 GIPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLP 257 (329)
T ss_dssp C------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred CCccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCC
Confidence 53322 123457899999999998754 89999999999999999999999987433 222222221100
Q ss_pred -----------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 -----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 -----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+...+++++.+||.+||..||++||++.+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0011122234789999999999999999999988774
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.79 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=199.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH--PNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC--CCccchhheeecCCeEEE
Confidence 57899999999999999999999999999999988665443 236678888888875 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++. ....+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 80 v~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 80 VFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCc
Confidence 99999 566777665 45679999999999999999999999999999999999999 57789999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 233 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 233 (475)
.. ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+.....
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 156 SD-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred cc-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 22 1234578999999999987 568999999999999999999999998754332222222211110
Q ss_pred -----------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 -----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 -----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...........++.++.+|+..||..||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 01122333457889999999999999999999988774
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=356.79 Aligned_cols=260 Identities=17% Similarity=0.294 Sum_probs=194.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
..++|++++.||+|+||.||+|.+..++. .||||+++.... ...+.+|+.+++.++| ++|+.++.++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH--PHVAKLVGVSLRSR 98 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC--TTBCCCCEEEECC-
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC--Cceehhhceeeccc
Confidence 46789999999999999999999877765 899999865432 2357788888888754 99999998887766
Q ss_pred EE------EEEEEcC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 78 YN------VLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 78 ~~------~lvme~~-g~sL~~ll~~~~-----~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
.. ++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence 55 9999999 889999986432 259999999999999999999999999999999999999 47789
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
+||+|||+|+.+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-- 248 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-- 248 (323)
T ss_dssp EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred EEEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence 999999999876543221 11234467889999999999999999999999999999999 9999987554332
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+..+....... ....++.++.+++.+||..||++||++.+|++.|++++...
T Consensus 249 -~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 -YNYLIGGNRLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHHhcCCCCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 23332222111 23567899999999999999999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=366.57 Aligned_cols=262 Identities=18% Similarity=0.248 Sum_probs=199.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG--- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--- 76 (475)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS--DYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCC--TTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCC--CCcceEEEEEecCCCC
Confidence 4789999999999999999999999999999999998654332 357789999998875 9999998887765
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+||||++++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCCeEEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCc
Confidence 5689999999999999997 34569999999999999999999999999999999999999 57789999999999
Q ss_pred cccccccccccc---------------ccccCCCCccCccccccccc-cCCCCCCchhHHHHHHHHHHHHcCCCCCC---
Q 011882 155 KRYRDTATHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQ--- 215 (475)
Q Consensus 155 ~~~~~~~~~~~~---------------~~~~~~~~~GT~~Y~APE~~-~g~~~s~ksDIwSlG~iL~elltG~~Pf~--- 215 (475)
+........... ........+||+.|+|||++ .+..++.++|||||||+||||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 976543221000 00112457899999999986 45569999999999999999998655543
Q ss_pred --------CCCCC--------------CHHHHHHHHh--------------------------hccccccHHHHhcCChH
Q 011882 216 --------GLKAG--------------TKKQKYEKIS--------------------------EKKVSTSIEALCRGYPT 247 (475)
Q Consensus 216 --------~~~~~--------------~~~~~~~~i~--------------------------~~~~~~~~~~l~~~~p~ 247 (475)
+.... .....+..+. ..............+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 22100 0011111111 11112223344467899
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 248 EFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 248 ~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
++.+||.+||..||.+||++.+++
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L 360 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQAL 360 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHh
Confidence 999999999999999999988774
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=359.35 Aligned_cols=257 Identities=18% Similarity=0.213 Sum_probs=206.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeE----EEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~----vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
...++|+++++||+|+||.||+|.+..+++. ||+|++..... ...+..|..++..+.| +||+.+++++..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~- 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH--AHIVRLLGLCPG- 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC--TTBCCEEEEECB-
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC--CCcCeEEEEEcC-
Confidence 3467899999999999999999999888775 77887654332 2356778888877754 999999988764
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +..+.+||+|||+|+
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccc
Confidence 4578999999 899999997555679999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+......... +.....
T Consensus 164 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~ 235 (325)
T 3kex_A 164 LLPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGER 235 (325)
T ss_dssp GSCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHTTCB
T ss_pred ccCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHcCCC
Confidence 775433211 1234578889999999999999999999999999999999 9999987654332222 222111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.. ....++.++.+++.+||..||.+||++.+|++.|+.+.
T Consensus 236 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LA----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CC----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CC----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 12346788999999999999999999999999998874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=357.25 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=210.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ....+.+|+.++..+.. |++|+.+++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-HENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEeeCC
Confidence 468999999999999999999973 356789999986542 33568899999999943 399999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 134 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~----------------------~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 134 (475)
..++||||+ +++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 999999999 8899999975432 37999999999999999999999999999999999
Q ss_pred EEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 011882 135 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLP 213 (475)
Q Consensus 135 ILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~P 213 (475)
|||+ .++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..|
T Consensus 203 Ill~---~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 203 VLVT---HGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp EEEE---TTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred EEEc---CCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9994 6789999999999876543221 11234567899999999999999999999999999999998 9999
Q ss_pred CCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 214 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 214 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
|.+...... +..+....... .....+++++.+|+..||..||.+||++.+|++.|+.++..
T Consensus 275 ~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 275 YPGIPVDAN---FYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp STTCCCSHH---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cccCCcHHH---HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 987644322 22222221111 12245789999999999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=358.57 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=201.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----EEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----YNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----~~~ 80 (475)
.++|++.++||+|+||.||+|++. ++.||||++...... .....|+.++..++ |+||+.++.++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK--HENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCC--CTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCC--CCCchhhcceeccCCCCCceEE
Confidence 468999999999999999999864 899999998654321 22344555555554 599999988887643 479
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEeeCCCCCcEEEe
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYII 149 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~----------gIvHrDIKP~NILl~~~~~~~~vkL~ 149 (475)
+||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||| +..+.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence 999999 8899999974 4599999999999999999999999 99999999999999 577899999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC---
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--- 221 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-----~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~--- 221 (475)
|||+|+.+...... .......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.....
T Consensus 174 DFg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 99999876543321 122346899999999999874 45678899999999999999999997643221
Q ss_pred ----------HHHHHHHHhhccccccHHHHh--cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 222 ----------KKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 222 ----------~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.......+........+.... ...+.++.+|+.+||+.||++||++.+|++.|+++....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111112222222211111111 123567999999999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=357.95 Aligned_cols=258 Identities=21% Similarity=0.228 Sum_probs=203.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEe------
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVE------ 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------ 75 (475)
.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+++ ++|+.++.++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH--ENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCC--TTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccC--CCcccHhheeeccccccc
Confidence 4789999999999999999999999999999998755433 2357789999998875 999999888776
Q ss_pred --CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 --GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 --~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.+..|+||||++++|.+.+......+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 170 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTT
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchh
Confidence 45689999999889999887666779999999999999999999999999999999999999 5778999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
|+.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+......
T Consensus 171 a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 171 ARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CEECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 987654322111 122346789999999999874 5899999999999999999999999875433222222222111
Q ss_pred cccccHHHH------------------------hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 KVSTSIEAL------------------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~~~~~~~~l------------------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......+.. ....++++.+||.+||..||++||++.+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 111000000 001267899999999999999999988774
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=344.14 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=198.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
-.++|++.++||+|+||.||+|.+ +++.||||++..... ...+..|.++++.++| ++|+.++.++...+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH--PNIIALRGVCLKEPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC--TTBCCEEEEECCC--
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC--CCEeeEEEEEecCCc
Confidence 357899999999999999999996 489999998765422 2457789999988875 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEeeCC-----CCCcEEEe
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYII 149 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~-----~~~~vkL~ 149 (475)
.++||||+ +++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... ..+.+||+
T Consensus 81 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred eEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999 889999986 567999999999999999999999999 99999999999995321 26789999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i 229 (475)
|||+++.+..... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+
T Consensus 159 Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~ 226 (271)
T 3dtc_A 159 DFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGV 226 (271)
T ss_dssp CCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH
T ss_pred cCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhh
Confidence 9999986654322 235799999999999999999999999999999999999999987432 2333333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
........ +...+++++.+++.+||..||++||++.++++.|+++
T Consensus 227 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 32222211 2356789999999999999999999999999988753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.85 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=205.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|+++++||+|+||.||+|.+..+++.||||++... .....+..|+.+++.+.| ++|+.++.++...+..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH--PFLTALKYSFQTHDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC--TTSCCEEEEEEETTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC--CeEeeEEEEEeeCCEE
Confidence 347899999999999999999999999999999988642 122345667777776654 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
|+||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+ +|||||||||+|||| +.++.+||+|||+|+..
T Consensus 224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 9999999 8899998875 3579999999999999999999998 999999999999999 57789999999999864
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+......
T Consensus 300 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~-- 367 (446)
T 4ejn_A 300 IKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR-- 367 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC--
T ss_pred cCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC--
Confidence 43222 1245689999999999999999999999999999999999999997743 34444444443332
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
+...+++++.+||..||..||.+|| ++.++ |++.| -..++|....
T Consensus 368 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~el---l~hp~-------f~~~~~~~~~ 417 (446)
T 4ejn_A 368 ---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI---MQHRF-------FAGIVWQHVY 417 (446)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSGG-------GTTCCHHHHH
T ss_pred ---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHH---HhCcc-------ccCCCHHHHh
Confidence 2356789999999999999999999 87766 33333 2335777543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=352.77 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=208.1
Q ss_pred CCceEEeeeEeeeCceeEEEEE----EccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG-- 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-- 76 (475)
.++|+++++||+|+||.||+|+ +..+++.||||++..... ...+.+|+.+++.++| ++++.++.++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH--ENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC--TTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC--CCeeeeeeEEecCCC
Confidence 4569999999999999999999 567899999999865432 2467889999988865 9999998888766
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccccc
Confidence 6689999999 7899999977777899999999999999999999999999999999999995 67899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----------CCCHH-
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----------AGTKK- 223 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~-----------~~~~~- 223 (475)
.+...... ........||..|+|||++.+..++.++|||||||++|||++|..||.... .....
T Consensus 175 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred cccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 76543321 112344578999999999999999999999999999999999999874310 00011
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.....+..... ......+++++.+++.+||+.||.+||++.+|++.|++++
T Consensus 251 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKR----LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCC----CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111111 1123567899999999999999999999999999999876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.76 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=211.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEecc----CCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~----~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+.++|+++++||+|+||.||+|.+..+++.||||++.. ......+.+|+.+++.+.| +||+.++.++......|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH--PNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC--CCcCeEEEEEEcCCEEE
Confidence 45789999999999999999999999999999999753 2234568899999999865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+.+... ..+++..++.|+.||+.||.|||++||+||||||+||||...+..+.+||+|||+|+.+..
T Consensus 98 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999 88999988643 5799999999999999999999999999999999999996555567899999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ...+.+..+.........+
T Consensus 177 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp C------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSCSG
T ss_pred CCc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCc
Confidence 321 234579999999999987 5999999999999999999999999874 3344555555544333222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+++++.+||.+||..||.+||++.++++
T Consensus 245 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23567899999999999999999999888743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.16 Aligned_cols=256 Identities=20% Similarity=0.221 Sum_probs=207.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG----- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----- 76 (475)
++++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|++++..++| ++|+.++.++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH--ENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC--TTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCC--CCCccceeEEecCCcccc
Confidence 568999999999999999999999999999999998754332 357789999988865 9999998877544
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...|+||||++++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 103 ~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 103 KDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARV 177 (364)
T ss_dssp CCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEe
Confidence 46899999999999999874 469999999999999999999999999999999999999 5778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 232 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 232 (475)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+......
T Consensus 178 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 178 ADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp CCGGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred cCCCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 65433211 112346899999999987654 4899999999999999999999999886554433333222111
Q ss_pred --------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+...++.++.+||.+||..||++||++.+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111223445567889999999999999999999988773
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=356.68 Aligned_cols=258 Identities=20% Similarity=0.268 Sum_probs=203.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEE----EEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~v----AvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
...++|+++++||+|+||.||+|.+..+++.| |+|.+.... ....+..|+.++..+.| ++|+.++.++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN--PHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB--TTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC--CCeeEEEEEEecC
Confidence 45688999999999999999999998888754 666654332 33467889999888865 9999999988877
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
. .+++|+++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||+++
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence 6 56666766 8999999987777899999999999999999999999999999999999994 67889999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... ......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+ .....
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~~ 237 (327)
T 3lzb_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGER 237 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCC
T ss_pred EccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCC
Confidence 765433211 1223467889999999999999999999999999999999 99999886544332222 22111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.. ....++.++.+++..||..||.+||++.+|++.|+.+..
T Consensus 238 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LP----QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 134578999999999999999999999999999998863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.88 Aligned_cols=255 Identities=20% Similarity=0.267 Sum_probs=214.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+|.++++.++| ++++.++.++...+..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH--PKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC--TTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC--CCEeeEEEEEccCCCeEEEEe
Confidence 468999999999999999999985 678999999876543 3568889999988864 999999999998899999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc-
Confidence 99 789999998766779999999999999999999999999999999999999 4678899999999987644221
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
.......||..|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+....+...... ...
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~ 227 (267)
T 3t9t_A 160 -----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRL----YKP 227 (267)
T ss_dssp -----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----CCC
T ss_pred -----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcC----CCC
Confidence 11234467889999999999899999999999999999999 899998643 33333343332211 112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
..++.++.+++..||..||++||++.++++.|+++..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4578999999999999999999999999999998864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=388.71 Aligned_cols=269 Identities=19% Similarity=0.245 Sum_probs=220.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
..++|+++++||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.+ |++|+.++.++...+..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~-~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-PPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTC-CTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEEEeCCEE
Confidence 357899999999999999999999999999999997642 234556778888776654 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||+ |++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence 9999999 88999999854 579999999999999999999999999999999999999 578899999999998644
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... ....++||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 494 ~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~--- 560 (674)
T 3pfq_A 494 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA--- 560 (674)
T ss_dssp CTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC---
T ss_pred cCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC---
Confidence 3222 124578999999999999999999999999999999999999999873 445666666655443
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 300 (475)
+...++.++.+||..||..||.+||++ ....+++++ .+...+||+.+...+.+
T Consensus 561 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h-------~ff~~i~w~~l~~~~~~ 615 (674)
T 3pfq_A 561 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH-------AFFRYIDWEKLERKEIQ 615 (674)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS-------GGGSSCCHHHHTTTCSC
T ss_pred --CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC-------ccccCCCHHHHHhCCCC
Confidence 235689999999999999999999997 222233333 33345789877655433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=367.01 Aligned_cols=259 Identities=16% Similarity=0.263 Sum_probs=201.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.+.||+|+||.||+|++. .++..||||+++..... ..+.+|+.++..++| ++|+.+++++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH--PNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEeeCCce
Confidence 468999999999999999999976 46778999998765332 347788888887754 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccccc
Confidence 9999999 899999998666679999999999999999999999999999999999999 577899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
....... ......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.......
T Consensus 199 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~- 270 (373)
T 2qol_A 199 DDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP- 270 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC-
T ss_pred cCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC-
Confidence 4322110 1122346788999999999999999999999999999998 9999977432 33333333322111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
....+|.++.+++..||+.||.+||++.+|++.|+.++..
T Consensus 271 ---~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 271 ---PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1246789999999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=349.06 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=208.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
...++|++.+.||+|+||.||+|.+..+|+.||||++........+..|+.++..+.| ++++.++.++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS--PHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC--TTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC--CCCccEEEEEEeCCEEEEEe
Confidence 3567899999999999999999999999999999999887777889999999988865 99999999999999999999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 999 679999998667789999999999999999999999999999999999999 4778999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+........ ...
T Consensus 181 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~ 248 (314)
T 3com_A 181 -------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPTF--RKP 248 (314)
T ss_dssp -------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC--SSG
T ss_pred -------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCccc--CCc
Confidence 12345799999999999999999999999999999999999999976432 222222222111110 112
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
..++.++.++|..||..||.+||++.+++ ++.+.+.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll---~~~~~~~ 284 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLL---QHPFVRS 284 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHT---TSHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHH---hCHHHhc
Confidence 44689999999999999999999988874 4444443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=342.80 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=209.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.+.++|++++.||+|+||.||+|.+..+++.||||+++.... ...+.+|+.+++.++| ++|+.++.++..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~ 79 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH--PNIITLHDIFEN 79 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC--TTBCCEEEEEEC
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC--CCeeehhheecC
Confidence 356789999999999999999999999999999998765432 3458889999998875 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC-CCCcEEEeecCC
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGL 153 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGl 153 (475)
....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+. ....+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999 8999999974 45799999999999999999999999999999999999995321 123799999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+....
T Consensus 159 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~ 227 (283)
T 3bhy_A 159 AHKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVN 227 (283)
T ss_dssp CEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTC
T ss_pred ceeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcc
Confidence 987654322 124579999999999999999999999999999999999999998743 334444444333
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... .......++.++.+++.+||..||++||++.++++
T Consensus 228 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 322 23445778999999999999999999999998865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.62 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=212.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---------------CchHHHHHHHHHHHHhCCCCCcCe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLQYEAKLYKILQGGSTGIPN 68 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---------------~~~~~~~E~~il~~l~~~~~~i~~ 68 (475)
.+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| ++|+.
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~ 110 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH--PNIIK 110 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC--TTBCC
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC--CCCCe
Confidence 46789999999999999999999999999999999986542 23457889999988865 99999
Q ss_pred eEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 69 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 69 l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
++.++......|+||||+ |++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||..++....+|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999 88999988743 5799999999999999999999999999999999999996433334799
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
|+|||+|+.+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ...+.+.
T Consensus 190 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~ 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIK 257 (504)
T ss_dssp ECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH
T ss_pred EEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHH
Confidence 999999987654321 234579999999999875 6899999999999999999999999874 3445555
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+.........+ .+..+++++.+||..||..||.+||++.++ |++.+.+
T Consensus 258 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~ 306 (504)
T 3q5i_A 258 KVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA---LNSRWIK 306 (504)
T ss_dssp HHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHH---hcCHhhh
Confidence 565555443333 346789999999999999999999998887 4444443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.75 Aligned_cols=248 Identities=19% Similarity=0.279 Sum_probs=197.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| +||+.++.++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH--ENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB--TTBCCCSEEECSCSSTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC--cCCCCceeeEecCCccc
Confidence 568899999999999999999999999999999998654332 346789999998875 9999998877654
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred cCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecc
Confidence 34599999999999999974 579999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+..... .....||..|+|||++.+ ..++.++|||||||++|||++|..||.+.... ..+..+....
T Consensus 176 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~ 242 (367)
T 1cm8_A 176 RQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVT 242 (367)
T ss_dssp EECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred cccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc
Confidence 875432 234588999999999988 67999999999999999999999999875432 2222222111
Q ss_pred c--------------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 V--------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 ~--------------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ......+...+++++.+|+.+||..||.+||++.++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 11122233567899999999999999999999887743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=372.79 Aligned_cols=248 Identities=20% Similarity=0.242 Sum_probs=193.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| +||+.++.++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH--KNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCC--CCCCcEEEEEccCCccc
Confidence 45789999999999999999999999999999999865422 2356788999888865 9999998877543
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+||||++++|.+.+. ..+++..+..|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+|
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 211 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC
T ss_pred cCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEee
Confidence 4679999999888887774 459999999999999999999999999999999999999 57889999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+....... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.... ..+.++.....
T Consensus 212 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg 280 (464)
T 3ttj_A 212 RTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLG 280 (464)
T ss_dssp -----CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC
T ss_pred eecCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 87644221 23468999999999999999999999999999999999999999875432 22222222110
Q ss_pred cc-------------------------cHHHHhcC------------ChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ST-------------------------SIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ~~-------------------------~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. ..+.+... .++++.+||.+||..||++||++++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00 01111111 156799999999999999999988763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.16 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=197.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD---- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~---- 77 (475)
+.++|+++++||+|+||.||+|++..+++.||||+++..... ..+.+|+.+++.++| +||+.++.++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--PGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCC--TTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCC--CCEeeEEEEEEEeccchh
Confidence 457899999999999999999999999999999998754432 457889999988864 99999988765432
Q ss_pred -----------------------------------------------------EEEEEEEcC-CCCHHHHHHHcCC--CC
Q 011882 78 -----------------------------------------------------YNVLVIDLL-GPSLEDLFNFCSR--KL 101 (475)
Q Consensus 78 -----------------------------------------------------~~~lvme~~-g~sL~~ll~~~~~--~l 101 (475)
+.++||||+ +++|.+++..... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 489999999 8899999985332 25
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc-----ccccCCCCcc
Q 011882 102 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTG 176 (475)
Q Consensus 102 s~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~-----~~~~~~~~~G 176 (475)
.+..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+......... .+.......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 677899999999999999999999999999999999 47789999999999887654321110 0122345689
Q ss_pred CccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHH
Q 011882 177 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYC 256 (475)
Q Consensus 177 T~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~c 256 (475)
|+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+...... .....+++++.++|..|
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP----LLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC----cccccCChhHHHHHHHH
Confidence 9999999999999999999999999999999998776522 12222333232222 22233467889999999
Q ss_pred hcCCCCCCCCHHHHHH
Q 011882 257 RSLRFDDKPDYAYLKR 272 (475)
Q Consensus 257 l~~dp~~RPt~~~l~~ 272 (475)
|+.||++||++.++++
T Consensus 310 l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 310 LSPSPTERPEATDIIE 325 (332)
T ss_dssp HCSSGGGSCCHHHHHH
T ss_pred ccCCCCcCCCHHHHhh
Confidence 9999999999888753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=361.17 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=200.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE----------
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV---------- 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~---------- 74 (475)
..++|+++++||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++| +||+.++.++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDH--VNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCC--TTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCC--CCccchhheeeecCccccccc
Confidence 46789999999999999999999999999999998765432 33478999888865 99999987763
Q ss_pred ----------------------------eCCEEEEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 011882 75 ----------------------------EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK 123 (475)
Q Consensus 75 ----------------------------~~~~~~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~ 123 (475)
...+.++||||++++|.+.+.. ....+++..++.|+.||+.||.|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3446899999998898888763 356799999999999999999999999
Q ss_pred CceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHH
Q 011882 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGY 202 (475)
Q Consensus 124 gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~ 202 (475)
||+||||||+||||+ ...+.+||+|||+|+.+..... .....||..|+|||++.+.. ++.++|||||||
T Consensus 161 gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 161 GICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999999999995 3578999999999987654332 23457899999999998755 899999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc---------------------ccccHHHHhcCChHHHHHHHHHHhcCCC
Q 011882 203 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRF 261 (475)
Q Consensus 203 iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp 261 (475)
++|||++|..||.+.........+.+..... .......+...+++++.+||.+||..||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999998754322222222111110 0111122334578999999999999999
Q ss_pred CCCCCHHHHH
Q 011882 262 DDKPDYAYLK 271 (475)
Q Consensus 262 ~~RPt~~~l~ 271 (475)
.+||++.+++
T Consensus 311 ~~R~t~~e~l 320 (383)
T 3eb0_A 311 DLRINPYEAM 320 (383)
T ss_dssp GGSCCHHHHH
T ss_pred hhCCCHHHHh
Confidence 9999998885
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.20 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=201.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCC------CCCcCeeEEeeE--
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG------STGIPNLRWFGV-- 74 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~------~~~i~~l~~~~~-- 74 (475)
.+.++|+++++||+|+||.||+|++..+++.||||+++.... ...+.+|+.+++.+.+. |++|+.++.++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 457899999999999999999999999999999999864322 24578899999999752 466888877766
Q ss_pred --eCCEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCC---------
Q 011882 75 --EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR--------- 141 (475)
Q Consensus 75 --~~~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~--------- 141 (475)
.....|+||||++++|.+.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 456889999999888888776543 5699999999999999999999998 999999999999995221
Q ss_pred -------------------------------------CCCcEEEeecCCcccccccccccccccccCCCCccCccccccc
Q 011882 142 -------------------------------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184 (475)
Q Consensus 142 -------------------------------------~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 184 (475)
....+||+|||+|+...... ....||+.|+|||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~aPE 263 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRSLE 263 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCCHH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccCCh
Confidence 11379999999998764321 2457999999999
Q ss_pred cccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC---HHHHHHHHhhccccccH-----------------------
Q 011882 185 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSI----------------------- 238 (475)
Q Consensus 185 ~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~----------------------- 238 (475)
++.+..++.++|||||||+||||++|..||.+..... ....+..+....-..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9999999999999999999999999999998654322 11112221110000000
Q ss_pred --------HHH------hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 --------EAL------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 --------~~l------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..+ ...++.++.+||.+||..||++||++.+|++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 1123567899999999999999999988753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=377.78 Aligned_cols=256 Identities=19% Similarity=0.326 Sum_probs=215.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
..+|++.++||+|+||.||+|.+..++..||||+++.... ...+.+|+.+++.++| +||+.+++++......+||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH--PNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC--CCEeeEEEEEecCCcEEEEEE
Confidence 3579999999999999999999999999999999876543 3568899999998865 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+.....
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce
Confidence 99 789999998643 459999999999999999999999999999999999999 4778999999999987654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+.......+ .+..... . ..
T Consensus 374 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~~-~---~~ 440 (495)
T 1opk_A 374 ------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LLEKDYR-M---ER 440 (495)
T ss_dssp ------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HHHTTCC-C---CC
T ss_pred ------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCC-C---CC
Confidence 12234467889999999999899999999999999999999 999998865433222 2222111 1 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...+|+++.+||..||..||++||++.+|++.|+.++.
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 35689999999999999999999999999999987753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=346.07 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=203.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+++ ++|+.++.++...+.
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH--PNVIKYYASFIEDNE 106 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEEETTE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEcCCc
Confidence 345789999999999999999999999999999999875322 1346778888887764 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccce
Confidence 99999999 7799999864 24569999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ........+.....
T Consensus 184 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~ 255 (310)
T 2wqm_A 184 RFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDY 255 (310)
T ss_dssp ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCS
T ss_pred eeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccC
Confidence 86654322 12345789999999999999999999999999999999999999976432 22233333333222
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
... ....++.++.+++..||..||++||++.+|++.|+++....
T Consensus 256 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 256 PPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 211 12467899999999999999999999999999999987544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.29 Aligned_cols=252 Identities=19% Similarity=0.205 Sum_probs=203.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+.| ++|+.++.++....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH--PNIIGLLDAFGHKS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC--TTBCCEEEEECCTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC--CCCCeEEEEEeeCC
Confidence 45789999999999999999999999999999998864321 2457789999998865 99999999999999
Q ss_pred EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 78 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
..++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF 162 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence 999999999889999987666679999999999999999999999999999999999999 57789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc---
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--- 233 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--- 233 (475)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+....
T Consensus 163 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 163 GSPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTP 232 (346)
T ss_dssp TSCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred cCCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCC
Confidence 54322 12345789999999999765 489999999999999999999999987533 33333332210
Q ss_pred --------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 --------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......+...++.++.+||..||..||++||++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 01123344567789999999999999999999988773
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=343.43 Aligned_cols=257 Identities=20% Similarity=0.230 Sum_probs=208.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..++|++.+.||+|+||.||+|.+... +..||||++..... ...+.+|+.+++.++| ++++.++.+...+ .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH--PHIVKLIGIIEEE-P 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC--TTBCCEEEEECSS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC--CCcceEEEEEcCC-C
Confidence 457899999999999999999997543 45699999876532 2457789999999965 9999998887644 4
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCccc
Confidence 68999999 7899999987777799999999999999999999999999999999999995 6789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.. .....
T Consensus 164 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~~ 234 (281)
T 3cc6_A 164 EDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLP 234 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCCC
T ss_pred cccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCCC
Confidence 543221 1233467889999999999999999999999999999998 9999987554333322222 11111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
....+++.+.+++..||..||++||++.+|++.|++++..
T Consensus 235 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 ----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1245789999999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.41 Aligned_cols=261 Identities=17% Similarity=0.311 Sum_probs=213.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-------cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-------~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
..++|++++.||+|+||.||+|.+. .+++.||||+++..... ..+..|+.+++.+.. |++|+.++.++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK-HKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhc-CCCEeeEEEEEc
Confidence 3578999999999999999999976 45678999998765432 347789999998843 399999999999
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEe
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 138 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 138 (475)
..+..++||||+ +++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll- 190 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 190 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE-
Confidence 999999999999 789999997543 248999999999999999999999999999999999999
Q ss_pred eCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 011882 139 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGL 217 (475)
Q Consensus 139 ~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~ 217 (475)
+.++.+||+|||+++.+...... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 191 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 191 --TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp --CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 57789999999999876543221 11234567899999999999889999999999999999999 99999874
Q ss_pred CCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 218 KAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
. ..+.+..+...... .....++.++.+++..||..||.+||++.+|++.|+.++...
T Consensus 264 ~---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 264 P---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp C---HHHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---HHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 3 23333333332211 123568899999999999999999999999999999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=350.68 Aligned_cols=259 Identities=17% Similarity=0.213 Sum_probs=204.8
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEE-ccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCC----CCCcCeeEEeeEeC
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG----STGIPNLRWFGVEG 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~-~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~----~~~i~~l~~~~~~~ 76 (475)
.++.++|+++++||+|+||.||+|.+ ..+++.||||+++.... ...+..|..+++.+.+. +.+++.+..++...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 35678999999999999999999998 56889999999864322 24578899999998763 23578888999999
Q ss_pred CEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-------------
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR------------- 142 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~------------- 142 (475)
+..++||||++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||...+.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 9999999999999999997544 36899999999999999999999999999999999999953211
Q ss_pred ---CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 011882 143 ---ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219 (475)
Q Consensus 143 ---~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~ 219 (475)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 567999999999864332 1345899999999999999999999999999999999999999987543
Q ss_pred CCHHHHHHHHhhccccccH--------------------------HHH----------hcCChHHHHHHHHHHhcCCCCC
Q 011882 220 GTKKQKYEKISEKKVSTSI--------------------------EAL----------CRGYPTEFASYFHYCRSLRFDD 263 (475)
Q Consensus 220 ~~~~~~~~~i~~~~~~~~~--------------------------~~l----------~~~~p~~l~~li~~cl~~dp~~ 263 (475)
......+..+......... ... ...+++++.+||..||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 3222222222211100000 000 0123578999999999999999
Q ss_pred CCCHHHHH
Q 011882 264 KPDYAYLK 271 (475)
Q Consensus 264 RPt~~~l~ 271 (475)
||++.+++
T Consensus 320 Rpt~~ell 327 (339)
T 1z57_A 320 RITLREAL 327 (339)
T ss_dssp SCCHHHHT
T ss_pred ccCHHHHh
Confidence 99988874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=351.79 Aligned_cols=262 Identities=19% Similarity=0.292 Sum_probs=213.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCe-----EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.+.||+|+||.||+|.+..+++ .||||++...... ..+..|+.++..+.. |++|+.+++++...
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ-HENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEecC
Confidence 35789999999999999999999877664 7999998765432 357789999999842 39999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 142 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~-------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~ 142 (475)
+..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+ .
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence 9999999999 77999998743 34589999999999999999999999999999999999994 6
Q ss_pred CCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 011882 143 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 221 (475)
Q Consensus 143 ~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~ 221 (475)
++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 789999999999866543221 11234567899999999999999999999999999999998 999998754432
Q ss_pred HHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 222 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 222 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.. ..+........ ....+|.++.+++..||+.||.+||++.+|++.|+++..+.
T Consensus 275 ~~---~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 KF---YKLVKDGYQMA---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HH---HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---HHHHhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 22 22221111111 12457899999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=362.39 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=204.4
Q ss_pred CCceEE--eeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l--~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.+.|.+ .+.||+|+||.||+|.+..+|+.||||+++... ....+.+|+.++..++| ++|+.++.++...+..+|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH--ANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC--CCCCeEEEEEEECCEEEE
Confidence 344555 678999999999999999999999999987653 23457889999888864 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||.. +..+.+||+|||+++.+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCc
Confidence 99999 88999988765567999999999999999999999999999999999999953 24578999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+........ ..
T Consensus 243 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~ 310 (373)
T 2x4f_A 243 EK--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE-DE 310 (373)
T ss_dssp CB--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SG
T ss_pred cc--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hh
Confidence 22 234579999999999999899999999999999999999999998743 3444445544333221 12
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+++++.+||.+||..||.+||++.++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 33578999999999999999999999988854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=355.68 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=212.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
+..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+.| ++|+.+++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC--HHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC--TTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC--CCEeeeEEEEcc
Confidence 34678999999999999999999876 35789999998754432 246678888887764 899999999998
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
....++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence 99999999999 789999987432 457999999999999999999999999999999999999 47789
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~ 224 (475)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.. ..+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~ 248 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQ 248 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHH
T ss_pred EEECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHH
Confidence 999999999866543221 11234567899999999999999999999999999999999 899998743 333
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
....+....... ....++.++.+++..||..||.+||++.++++.|++++.
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 344443332221 235688999999999999999999999999998887643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.36 Aligned_cols=263 Identities=19% Similarity=0.288 Sum_probs=213.0
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.++..+.+ |++|+.+++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-HLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhccc-CCCeeeEEEEEecC
Confidence 4578999999999999999999853 46789999998765433 347789999998864 39999998887654
Q ss_pred -CEEEEEEEcC-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 77 -DYNVLVIDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 77 -~~~~lvme~~-g~sL~~ll~~~~~~---------------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
...++||||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+||||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-- 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence 4589999999 78999999754322 8999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
+..+.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 182 -~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 182 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 467899999999998764432211 1234568899999999999999999999999999999998 999998754
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
... .....+...... .....+++++.+++..||..||.+||++.+|++.|+.++....
T Consensus 256 ~~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhH--HHHHHhccCccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 332 222222222111 1234578999999999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=350.76 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=205.2
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCC-------eEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~-------~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+|+.+++.++| ++|+.++.++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH--KHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC--TTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC--CCEeEEEEEE
Confidence 345688999999999999999999998877 5799999865432 2457788888888864 9999999999
Q ss_pred EeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCC-----CCcEE
Q 011882 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVY 147 (475)
Q Consensus 74 ~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~-----~~~vk 147 (475)
...+..++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.+.. .+.+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999 78999999876556999999999999999999999999999999999999963321 11299
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 225 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~-~Pf~~~~~~~~~~~ 225 (475)
|+|||++....... ...||..|+|||++.+ ..++.++|||||||++|||++|. .||.... ....
T Consensus 162 l~Dfg~~~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~ 227 (289)
T 4fvq_A 162 LSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD---SQRK 227 (289)
T ss_dssp ECCCCSCTTTSCHH-----------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHH
T ss_pred eccCcccccccCcc-----------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---hHHH
Confidence 99999997654322 2367899999999998 67899999999999999999954 5554422 1222
Q ss_pred HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 226 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...... .. .+...++.++.+++..||+.||++||++.+|++.|++++.
T Consensus 228 ~~~~~~-~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 228 LQFYED-RH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHT-TC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHhhc-cC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 211111 11 1224567889999999999999999999999999988764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=352.01 Aligned_cols=262 Identities=16% Similarity=0.222 Sum_probs=207.6
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCC----eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+..++|++.+.||+|+||.||+|.+..++ ..||||++...... ..+.+|+.++..++| ++|+.+++++...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH--HNIIRLEGVISKY 118 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEecC
Confidence 34678999999999999999999986553 46999998755432 246778888887764 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+..++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 9999999999 779999998766789999999999999999999999999999999999999 477899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... .......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.....
T Consensus 196 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~ 268 (333)
T 1mqb_A 196 VLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFR 268 (333)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCC
T ss_pred hhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCc
Confidence 765432211 01123356889999999999999999999999999999999 9999976432 333333333221
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.. ....++.++.+++.+||..||++||++.+|++.|++++...
T Consensus 269 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 13468899999999999999999999999999999987643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.57 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=211.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++......++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH--ENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC--TTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC--CCeeehhhhcccCCEEEEE
Confidence 5678999999999999999999999999999999987543 23457889999998865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp ECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999 78999988743 469999999999999999999999999999999999999544567889999999997543321
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+....... ...+
T Consensus 164 ~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~ 230 (304)
T 2jam_A 164 M---------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPF 230 (304)
T ss_dssp T---------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTT
T ss_pred c---------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Cccc
Confidence 1 22468999999999999999999999999999999999999997643 334444444433221 1123
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
...++.++.++|..||..||++||++.++ |++.+..
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~ 266 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKA---LSHPWID 266 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCcccc
Confidence 45688999999999999999999998877 4454444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=342.02 Aligned_cols=249 Identities=18% Similarity=0.178 Sum_probs=202.2
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
|..++.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|..++..+. .|++|+.++.++...
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG-QHSHVVRYFSAWAED 83 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC-SCTTBCCEEEEEEET
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeecC
Confidence 4556778999999999999999999999999999999998754322 34566766666663 349999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC-----------
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----------- 141 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~----------- 141 (475)
+..++||||+ +++|.+++... ...+++.+++.|+.||+.||.|||++||+||||||+|||++.+.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999 78999999754 25699999999999999999999999999999999999995332
Q ss_pred -----CCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 011882 142 -----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQ 215 (475)
Q Consensus 142 -----~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~ 215 (475)
....+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+.
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 44579999999998765422 24699999999999876 56789999999999999999987764
Q ss_pred CCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 216 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 216 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. .....+...... .+...+++++.+++..||..||++||++.+++
T Consensus 233 ~~------~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 233 NG------DQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp SS------HHHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ch------hHHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 42 122333332221 23457889999999999999999999988874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.03 Aligned_cols=249 Identities=22% Similarity=0.242 Sum_probs=197.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe------CCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------GDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~~~~ 79 (475)
..+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++++.++| +||+.++.++.. ..+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~h--pniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDH--CNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCC--TTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCC--CCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999999999999999876543 234578999988865 899998776642 2356
Q ss_pred EEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 80 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
++||||+.++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+|+.
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEE
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhh
Confidence 79999998888877653 356799999999999999999999999999999999999995 3456789999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+.++....-.
T Consensus 207 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~ 275 (420)
T 1j1b_A 207 LVRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGT 275 (420)
T ss_dssp CCTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCS
T ss_pred cccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 654322 2345789999999999875 6899999999999999999999999875432 222222211000
Q ss_pred ------------------------ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 236 ------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 236 ------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+...+++++.+||.+||..||.+||++.+++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 001112345689999999999999999999988774
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=355.44 Aligned_cols=254 Identities=18% Similarity=0.278 Sum_probs=206.5
Q ss_pred cCCceEEe-eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 5 i~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+.++|.+. ++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.++ ++|+.++.++......
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC-PRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTC-TTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCC-CCEEEEEEEEEeCCeE
Confidence 45678888 899999999999999999999999998865432 34678899999888764 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
++||||+ +++|.+++... ...+++.+++.|+.||+.||+|||++||+||||||+||||+.....+.+||+|||+++.+
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999 77999887532 356999999999999999999999999999999999999963334689999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+........
T Consensus 185 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 185 GHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDYS 253 (327)
T ss_dssp -----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCC
T ss_pred CCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhcccccC
Confidence 54322 134579999999999999999999999999999999999999997743 3344444433332221
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
......++..+.++|..||..||++||++.+++
T Consensus 254 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 254 -EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp -TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred -chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 223356889999999999999999999988773
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=346.83 Aligned_cols=258 Identities=20% Similarity=0.331 Sum_probs=207.7
Q ss_pred CCceEEee-eEeeeCceeEEEEEE--ccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~-~LG~G~fG~Vy~a~~--~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++|++.+ .||+|+||.||+|.+ ..+++.||||+++..... ..+..|+.+++.+.| ++|+.+++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--PYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC--TTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC--CCEEEEEEEE-CCCC
Confidence 46799998 999999999999954 466789999998765332 357788888888864 9999999888 5667
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceee
Confidence 78999999 7899999975 45699999999999999999999999999999999999995 6789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+......
T Consensus 168 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~- 239 (291)
T 1xbb_A 168 RADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM- 239 (291)
T ss_dssp CTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC-
T ss_pred ccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC-
Confidence 5433211 11223457899999999998889999999999999999999 9999987443 2333333322211
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+...+|+++.+++..||..||++||++.+|++.|++++...
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 ---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 123568999999999999999999999999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=371.79 Aligned_cols=252 Identities=22% Similarity=0.324 Sum_probs=207.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| +||+.++.++......|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH--PNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC--TTBCCEEEEEECSSEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC--CCCCeEEEEEEeCCEEE
Confidence 3457999999999999999999999999999999986542 34568889999988865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||...+..+.+||+|||+|+.+..
T Consensus 113 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999 88999888643 5699999999999999999999999999999999999996544567799999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........+
T Consensus 192 ~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~ 259 (494)
T 3lij_A 192 QKK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDSP 259 (494)
T ss_dssp TBC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCSG
T ss_pred Ccc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCch
Confidence 322 234579999999999874 69999999999999999999999998743 344455554444332222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+++++.+||.+||..||.+||++.++++
T Consensus 260 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 -EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 23578999999999999999999999998853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=372.73 Aligned_cols=255 Identities=20% Similarity=0.366 Sum_probs=210.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.++||+|+||.||+|.+. ++..||||+++... ....+..|+.+++.++| ++|+.++.++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH--DKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCC--TTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCC--CCEeeEEEEEe-CCccEEEEe
Confidence 467999999999999999999974 57889999987644 33568899999998865 99999988875 566899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCce
Confidence 99 88999999743 2368999999999999999999999999999999999999 4778999999999987654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+....... .
T Consensus 340 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~~----~ 406 (454)
T 1qcf_A 340 ------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRMP----R 406 (454)
T ss_dssp ------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCCC----C
T ss_pred ------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC----C
Confidence 11233457889999999998899999999999999999999 9999987543 33333333322111 1
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
...+|+++.+||.+||..||++||++.+|++.|++++..
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 356899999999999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=341.80 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=204.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.++.++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH--PNILRLYGYFHDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC--CCCcchhheEecCCE
Confidence 3457899999999999999999999999999999987532 223457788888887764 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence 99999999 78999998754 569999999999999999999999999999999999999 57889999999998654
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus 160 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 225 (279)
T 3fdn_A 160 PSSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT-- 225 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred Cccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC--
Confidence 3322 134579999999999999999999999999999999999999998643 33344444333322
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...++.++.+||..||..||.+||++.+|++
T Consensus 226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 23457899999999999999999999888743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.58 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=212.8
Q ss_pred CCceEEee-eEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~-~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++..... ..+.+|+.++..+++ ++|+.++.++ ..+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN--PYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEE-ESSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC--CCEeEEEEEe-cCCCc
Confidence 46688877 9999999999999864 46789999998765432 347789999998864 9999998888 55668
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeeec
Confidence 9999999 7799999975566799999999999999999999999999999999999995 67899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+......
T Consensus 162 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~-- 232 (287)
T 1u59_A 162 ADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM-- 232 (287)
T ss_dssp TCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC--
T ss_pred cCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcC--
Confidence 432211 11234467899999999998889999999999999999998 9999987543 2333333332211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
.+...+|+++.++|..||..||++||++.+|++.|+.++...+
T Consensus 233 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1235789999999999999999999999999999999987664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.07 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=212.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.| +||+.++.++.....
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH--PNIMKLYEFFEDKGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC--CCCCcEEEEEEeCCE
Confidence 35578999999999999999999999999999999986432 23458889999988864 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||...+..+.+||+|||+|+.+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999 8899998873 457999999999999999999999999999999999999965456789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ...+.+..+........
T Consensus 180 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC
T ss_pred ccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence 54322 123479999999999987 6999999999999999999999999874 33445555555443332
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+ .+..+++++.+||.+||..||.+||++.+++
T Consensus 248 ~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 248 LP-QWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp SG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 22 2356789999999999999999999988874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.60 Aligned_cols=205 Identities=26% Similarity=0.353 Sum_probs=175.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCC----CcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGST----GIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~----~i~~l~~~~~~~~~ 78 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||+++.... ..++..|..+++.+.+... +++.+..++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 356889999999999999999999999999999999864322 2456778889988875311 37888888899999
Q ss_pred EEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 79 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.|+||||++++|.+++.... ..+++..++.|+.||+.||.||| +.|||||||||+||||+. +..+.+||+|||+|+
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence 99999999889999998654 46999999999999999999999 579999999999999952 246789999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~ 219 (475)
...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+...
T Consensus 210 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764321 345899999999999999999999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=350.92 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=213.3
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
++...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| ++|+.++.++...
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~ 113 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH--QHVVGFHGFFEDN 113 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEECS
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEecC
Confidence 34567899999999999999999999999999999999865432 2346778888887754 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+..|+||||+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 189 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCce
Confidence 9999999999 7899998874 3579999999999999999999999999999999999999 477899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.+..... ......||..|+|||++.+..++.++|||||||+||||++|..||.... ..+.+..+......
T Consensus 190 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~ 259 (335)
T 2owb_A 190 KVEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS 259 (335)
T ss_dssp ECCSTTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC
T ss_pred ecccCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCC
Confidence 7653322 1234579999999999999999999999999999999999999997643 33333443333222
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
+...++.++.+||.+||..||++||++.+| |++.|...+
T Consensus 260 -----~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~ 298 (335)
T 2owb_A 260 -----IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 298 (335)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCC
Confidence 234678999999999999999999998877 445555544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=348.97 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=202.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+++ ++|+.++.++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--p~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE--PHVVPIHDFGEIDGQ 108 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEETTE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC--CCeeEEEEEEeeCCe
Confidence 3467899999999999999999999999999999998654322 346778888887755 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccc
Confidence 99999999 67999999753 579999999999999999999999999999999999999 46789999999999866
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... . .+........ ..
T Consensus 185 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~~-~~ 253 (309)
T 2h34_A 185 TDEKLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQAI-PR 253 (309)
T ss_dssp ------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSCC-CC
T ss_pred cccccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccCC-CC
Confidence 543211 12345799999999999999999999999999999999999999976432 1 2222222211 11
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~ 279 (475)
...+...+|.++.++|.+||..||++|| +++++++.|+.++.
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 2234567899999999999999999999 99999998887753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=366.50 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=199.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
+.++|++.++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|+.++.++.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH--PCIIKIKNFFD 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC--TTBCCCCEEEE
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC--CCEeeEEEEEe
Confidence 3578999999999999999999999999999999976432 11247889999998865 99999988865
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.+..|+||||+ +++|.+++. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.++....+||+|||+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred -cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 45579999999 889988876 345799999999999999999999999999999999999996544566799999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g---~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|+.+..... .....||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....... ...+.
T Consensus 289 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~ 358 (419)
T 3i6u_A 289 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT 358 (419)
T ss_dssp TTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHH
T ss_pred ceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHh
Confidence 987654321 234689999999999864 56789999999999999999999999875432221 22222
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.... ...+.....+++++.+||.+||..||++||++.++++
T Consensus 359 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222 2234455778999999999999999999999887743
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.33 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=208.9
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe------
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------ 75 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------ 75 (475)
+..++++|++++.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++| ++++.+..++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDH--VNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCC--TTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCC--CCEEEEeeeEeccccCcc
Confidence 445678999999999999999999999989999999998654 3567889999998865 899998777643
Q ss_pred ----------CCEEEEEEEcC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 76 ----------GDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 76 ----------~~~~~lvme~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
....++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~ 158 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DT 158 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ET
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CC
Confidence 45579999999 67999999754 35699999999999999999999999999999999999995 67
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 223 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~ 223 (475)
+.+||+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.. ..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~ 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS 225 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH
T ss_pred CCEEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH
Confidence 8999999999987654322 2345799999999999999999999999999999999999998843 12
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.....+.... +...++.++.+++.+||..||.+||++.++++.|..+.
T Consensus 226 ~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 226 KFFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 2222222221 12457899999999999999999999999999887663
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=351.22 Aligned_cols=259 Identities=17% Similarity=0.222 Sum_probs=203.3
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCC-eEEEEEEeccCCC-chHHHHHHHHHHHHhCCC----CCcCeeEEeeEeC
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTK-HPQLQYEAKLYKILQGGS----TGIPNLRWFGVEG 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~----~~i~~l~~~~~~~ 76 (475)
..+.++|++++.||+|+||.||+|.+..++ +.||||+++.... ...+..|+.+++.+.+.+ .+++.+..++...
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 357789999999999999999999998777 7999999864322 345778999999987632 2367778888889
Q ss_pred CEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC---------------
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--------------- 140 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~--------------- 140 (475)
...++||||++++|.+.+.... ..+++..++.|+.||+.||.|||++||+||||||+||||...
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 9999999999988888877543 469999999999999999999999999999999999999432
Q ss_pred -CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 011882 141 -RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 219 (475)
Q Consensus 141 -~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~ 219 (475)
+..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+...
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 256789999999998643321 345899999999999999999999999999999999999999987543
Q ss_pred CCHHHHHHHHhhcccccc--------------------------HHHHh----------cCChHHHHHHHHHHhcCCCCC
Q 011882 220 GTKKQKYEKISEKKVSTS--------------------------IEALC----------RGYPTEFASYFHYCRSLRFDD 263 (475)
Q Consensus 220 ~~~~~~~~~i~~~~~~~~--------------------------~~~l~----------~~~p~~l~~li~~cl~~dp~~ 263 (475)
......+.++........ ....+ ...+.++.+||..||..||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 322222222221110000 00000 012458999999999999999
Q ss_pred CCCHHHHH
Q 011882 264 KPDYAYLK 271 (475)
Q Consensus 264 RPt~~~l~ 271 (475)
||++.+++
T Consensus 325 Rpt~~e~l 332 (355)
T 2eu9_A 325 RITLAEAL 332 (355)
T ss_dssp SCCHHHHT
T ss_pred CcCHHHHh
Confidence 99988773
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=367.92 Aligned_cols=268 Identities=21% Similarity=0.251 Sum_probs=214.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC--E
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--Y 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--~ 78 (475)
.++++|++.++||+|+||.||+|.+..+++.||||+++... ....+.+|+++++.++| ++|+.++.++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH--KNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC--TTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC--CCCCeEEEeeccCCCCe
Confidence 46789999999999999999999999999999999986532 23457789999998875 99999998887654 7
Q ss_pred EEEEEEcC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~--~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||..+ +..+.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 89999999 889999987432 239999999999999999999999999999999999998432 34567999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CCHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQK 225 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~-~~~~~~ 225 (475)
+.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+.
T Consensus 164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred eEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 87654322 234579999999999875 4578899999999999999999999976433 223334
Q ss_pred HHHHhhccccccH--------------------HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 226 YEKISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 226 ~~~i~~~~~~~~~--------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+.++........+ ..+...++..+.+++..||+.||++||++.++++.+++++.+.
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 4444333221100 0111234678999999999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=369.56 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=209.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+..++|++++.||+|+||.||+|.+..+|+.||||+++.. .....+.+|+.+++.++| ++|+.++.++.....
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH--PHIIKLYQVISTPSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCE
Confidence 4568899999999999999999999999999999998643 223467889999887765 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhc
Confidence 99999999 8899999863 4579999999999999999999999999999999999999 57789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
..... ....+||+.|+|||++.+..+ +.++|||||||+||||++|..||.+... ...+.++......
T Consensus 167 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~- 234 (476)
T 2y94_A 167 SDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY- 234 (476)
T ss_dssp CTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC-
T ss_pred ccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC-
Confidence 54321 234689999999999998875 7899999999999999999999987433 3444444443322
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....+++++.+||..||..||.+||++.+|++
T Consensus 235 ----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 12457899999999999999999999888743
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.93 Aligned_cols=269 Identities=19% Similarity=0.235 Sum_probs=218.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++.+.||+|+||.||+|+++.+|+.||||++... .....+..|..++..+.+ ++|+.++.++.....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS--RFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC--TTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC--CCEeeEEEEEeeCCE
Confidence 4457899999999999999999999999999999998543 223457789999988865 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.|+||||+ |++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeeccee
Confidence 99999999 89999998754 2359999999999999999999999999999999999999 57889999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-CHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~ 233 (475)
+.+..... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.... ...+....+....
T Consensus 337 ~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 337 VELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409 (543)
T ss_dssp EECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred eeccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence 87654322 123468999999999999999999999999999999999999999875432 2333444444333
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccccc
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
.. +...++.++.+||.+||..||.+||++.+ +.+++++.| -..++|.....
T Consensus 410 ~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf-------f~~i~w~~l~~ 462 (543)
T 3c4z_A 410 VT-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL-------FRDISWRQLEA 462 (543)
T ss_dssp CC-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG-------GTTCCHHHHHT
T ss_pred cC-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc-------ccCCCHHHHHc
Confidence 22 23568899999999999999999998642 233343332 33467876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=380.82 Aligned_cols=268 Identities=20% Similarity=0.284 Sum_probs=212.7
Q ss_pred CceEEee-eEeeeCceeEEEEEEcc--CCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 7 NKFRLGR-KIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 7 ~~y~l~~-~LG~G~fG~Vy~a~~~~--~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
++|.+.+ +||+|+||.||+|.+.. ++..||||+++... ....+.+|+.+++.++| ++|+.+++++.. +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN--PYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC--TTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC--CCEeeEEEEecc-CCeE
Confidence 4566666 89999999999998763 56689999987643 23568889999988865 999999998876 5589
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+..
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccccC
Confidence 999999 8899999976666799999999999999999999999999999999999995 678999999999987644
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 489 ~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~--- 558 (613)
T 2ozo_A 489 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM--- 558 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC---
T ss_pred CCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC---
Confidence 3211 111123356789999999999999999999999999999998 99999886543 333333332211
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 291 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw 291 (475)
.+...+|+++.+||..||..||++||++.+|++.|++++...+...+...++
T Consensus 559 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~l 610 (613)
T 2ozo_A 559 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSAL 610 (613)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSC
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccce
Confidence 1235689999999999999999999999999999999998876655543333
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.76 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=209.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----------chHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+..|..+++.+.. |++|+.++.++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG-HPHIITLIDSYES 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTT-CTTBCCEEEEEEB
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcC-CCCEeEEEEEEee
Confidence 3579999999999999999999988999999999876542 2346778888888843 3999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....|+||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 99999999999 7899999874 3579999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 228 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~ 228 (475)
..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|..||.+. .....+..
T Consensus 248 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~ 316 (365)
T 2y7j_A 248 CHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILMLRM 316 (365)
T ss_dssp EECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHH
T ss_pred cccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHHHHHH
Confidence 87654322 234689999999999874 35789999999999999999999999763 33444445
Q ss_pred HhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 229 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 229 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+.........+ ....++.++.++|.+||..||++||++.++++
T Consensus 317 i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 54444433333 23678899999999999999999999888854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.32 Aligned_cols=258 Identities=16% Similarity=0.207 Sum_probs=206.3
Q ss_pred CCceEEeeeEeeeCceeEEEE-----EEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a-----~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.++||+|+||.||+| .+..+++.||||+++.. ...++..|..++..+.. .|++++.++.++...+..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 577999999999999999999 46778999999998654 44567888888888763 258899999999999999
Q ss_pred EEEEEcC-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee--------CCCCCcE
Q 011882 80 VLVIDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQV 146 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~----~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~--------~~~~~~v 146 (475)
|+||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+. ++..+.+
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999 8999999975 2456999999999999999999999999999999999999952 1127899
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~ 226 (475)
||+|||+|+.+....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||........
T Consensus 223 kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp EECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred EEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 999999997654322111 12456899999999999999999999999999999999999999965322110
Q ss_pred HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHc
Q 011882 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 227 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R-Pt~~~l~~~L~~l~~~~ 281 (475)
........ ...++.+.+++..|++.+|.+| |++.++.+.|++++.+.
T Consensus 294 ------~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 ------KPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------EECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------eechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000000 1236789999999999999998 67899999999988764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=344.27 Aligned_cols=261 Identities=17% Similarity=0.257 Sum_probs=206.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEee-EeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFG-VEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~-~~~~~ 78 (475)
..+|++.++||+|+||.||+|.+..++ ..||||.++..... ..+.+|..+++.++| ++|+.++.++ .....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH--PNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC--TTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCC--CCEeeeeeEEEcCCCc
Confidence 356999999999999999999975443 46899988764433 346788888888764 9999998874 45667
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccc
Confidence 89999999 779999998666679999999999999999999999999999999999999 57789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......... +.......
T Consensus 179 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 252 (298)
T 3f66_A 179 YDKEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLL 252 (298)
T ss_dssp SCGGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HHTTCCCC
T ss_pred cccchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhcCCCCC
Confidence 5433211 112344578899999999999999999999999999999999 6667766544333222 22221111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
....+|.++.+++..||..||++||++.+|++.|++++...
T Consensus 253 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 ----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12457899999999999999999999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.73 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=187.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
+.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| +||+.++.++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH--ENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCSSGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEecCCccc
Confidence 568999999999999999999999999999999998654322 356789999988875 8999988776543
Q ss_pred --CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 --DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 --~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
...|+|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 105 ~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a 179 (367)
T 2fst_X 105 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA 179 (367)
T ss_dssp GCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC----
T ss_pred cCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccc
Confidence 56799999999999999873 579999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh--
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-- 231 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~-- 231 (475)
+..... .....||..|+|||++.+ ..++.++|||||||+||||++|..||.+.........+.+...
T Consensus 180 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 180 RHTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp ---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 865432 134589999999999987 6789999999999999999999999987543222222221110
Q ss_pred ---------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ---------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ---------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.........+..++++++.+||.+||..||.+||++.+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 0111233445567789999999999999999999988773
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.43 Aligned_cols=257 Identities=22% Similarity=0.386 Sum_probs=211.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
..++|++++.||+|+||.||+|.+ .+++.||||++.... ....+..|+++++.++| ++++.++.+... +..++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH--QRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECS-SSCEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCC--cCcceEEEEEcC-CCcEEEE
Confidence 457899999999999999999996 467889999887554 33568889999998865 899999888764 4578999
Q ss_pred EcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCcc
Confidence 999 889999986332 269999999999999999999999999999999999999 477899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+...... .
T Consensus 164 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 230 (279)
T 1qpc_A 164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM----V 230 (279)
T ss_dssp EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----C
T ss_pred cc------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC----C
Confidence 21 1234467889999999998889999999999999999999 9999987433 3333333322111 1
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
....++.++.+++..||..||++||++.+|++.|++++...
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 23568899999999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.60 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=206.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-------CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-------~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
+.++|++.++||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++| ++|+.++.++.+.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~ 101 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH--PNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC--TTBCCEEEEEECSS
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC--CCcceeehhhccCC
Confidence 457899999999999999999999999999999987543 122467889999998864 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 011882 78 YNVLVIDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRV 117 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~---------------------------------------~~~ls~~~~~~i~~qi~~aL 117 (475)
..++||||+ |++|.+++... ...+++..++.|+.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999 99999988411 11246788999999999999
Q ss_pred HHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccC--CCCCCch
Q 011882 118 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRD 195 (475)
Q Consensus 118 ~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ks 195 (475)
.|||++||+||||||+||||+. +....+||+|||+++.+........ .......||+.|+|||++.+ ..++.++
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEY---YGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCcccc---ccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999952 1233899999999987654322111 11235579999999999976 6789999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 196 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 196 DIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
|||||||+||||++|..||.+.. ..+.+..+.........+ ....+++++.+||..||+.||.+||++.++ |+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~ 330 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVN---DADTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRA---LQ 330 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---HH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHH---hc
Confidence 99999999999999999998743 334444444433322111 224578999999999999999999998877 44
Q ss_pred HHHHH
Q 011882 276 DLFIR 280 (475)
Q Consensus 276 ~l~~~ 280 (475)
+.|.+
T Consensus 331 hp~~~ 335 (345)
T 3hko_A 331 HPWIS 335 (345)
T ss_dssp SHHHH
T ss_pred Chhhc
Confidence 55543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=357.94 Aligned_cols=263 Identities=21% Similarity=0.243 Sum_probs=209.5
Q ss_pred CCceEEeeeEeeeCceeEEEEE----EccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeE--eCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGV--EGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~~ 77 (475)
.++|+++++||+|+||.||+|+ +..+++.||||++...... ..+.+|+++++.+.+ ++|+.++.++. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS--DFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC--CceeEEEEEEecCCCc
Confidence 4789999999999999999999 4678999999998755332 347889999888854 89999987765 567
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEE
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEccccccee
Confidence 789999999 8999999987666799999999999999999999999999999999999994 678999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----------CH-HH
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------TK-KQ 224 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~-----------~~-~~ 224 (475)
+....... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... .. ..
T Consensus 177 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 177 LPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CCTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 65432211 1223457899999999999988999999999999999999999999652110 00 11
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
....+..... ......+++++.+++..||..||++||++.+|++.|+.++...
T Consensus 253 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQR----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111111111 1123467899999999999999999999999999999886543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=350.17 Aligned_cols=265 Identities=18% Similarity=0.223 Sum_probs=193.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeE--------e
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGV--------E 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~--------~ 75 (475)
..+|++.++||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.. |++|+.++.++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-HPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTT-STTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhcc-CCChhhccccccccccccccC
Confidence 4589999999999999999999999999999998754432 2357788999988863 399999988773 3
Q ss_pred CCEEEEEEEcCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 76 GDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~--~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
....++||||++++|.+++.. ....+++.+++.|+.||+.||.|||++| |+||||||+|||| +.++.+||+||
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecC
Confidence 456899999999999998865 3456999999999999999999999999 9999999999999 47789999999
Q ss_pred CCccccccccccccc-----ccccCCCCccCccccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH
Q 011882 152 GLAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 223 (475)
Q Consensus 152 GlA~~~~~~~~~~~~-----~~~~~~~~~GT~~Y~APE~~---~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~ 223 (475)
|+++.+......... .........||+.|+|||++ .+..++.++|||||||+||||++|..||.+....
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876543221100 00112245699999999998 5667899999999999999999999999763221
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 284 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 284 (475)
. +........ ....++..+.+|+..||+.||++||++.++++.|+++.......
T Consensus 260 ~----~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 260 R----IVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ----------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred H----hhcCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 1 111111111 12456788999999999999999999999999999998766543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.00 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=207.1
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEc-cCCeEEEEEEeccCC----CchHHHHHHHHHHHHhC-CCCCcCeeEEeeE---
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQG-GSTGIPNLRWFGV--- 74 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~--- 74 (475)
...++|++++.||+|+||.||+|.+. .+++.||||++.... ....+.+|..+++.+.. .|++|+.++.++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999985 678999999876432 23467889999888842 4599999988876
Q ss_pred --eCCEEEEEEEcCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 75 --EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 75 --~~~~~~lvme~~g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
.....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence 556789999999889999998654 349999999999999999999999999999999999999 57789999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
|+++.+..... .....||..|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+..
T Consensus 165 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD 233 (326)
T ss_dssp CSCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cccccccCCCC--------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence 99986643221 2345789999999999999999999999999999999999999987543 222333221
Q ss_pred cc----------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~~----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. ....+..+...++.++.+||.+||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 01122334467899999999999999999999988774
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.66 Aligned_cols=259 Identities=17% Similarity=0.250 Sum_probs=207.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE-EE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY-NV 80 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~-~~ 80 (475)
.|++.++||+|+||.||+|.+..+++ .||||++...... ..+.+|+.+++.++| ++|+.++.++...+. .+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH--PNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCC--TTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEecCCCCcE
Confidence 47778999999999999999766554 7999998754433 346778888888764 999999888775554 48
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
++|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccC
Confidence 999999 899999998666779999999999999999999999999999999999999 5778999999999986654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.... .........+|..|+|||.+.+..++.++|||||||++|+|++|..| |....... ....+.......
T Consensus 177 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~-- 248 (298)
T 3pls_A 177 REYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRLP-- 248 (298)
T ss_dssp GGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCCC--
T ss_pred Cccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCCC--
Confidence 3211 11223456789999999999999999999999999999999995555 44433222 222222222111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
....+++++.+++..||..||.+||++.++++.|++++...
T Consensus 249 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 249 --QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 13467899999999999999999999999999999998765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=343.83 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=212.8
Q ss_pred CCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 2 ~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
++...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.| ++|+.+++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~ 87 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH--QHVVGFHGFFEDN 87 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEECS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC--CCEeeeeeeeccC
Confidence 46678899999999999999999999999999999999865432 2346678888887754 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+..++||||+ +++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLAT 163 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCce
Confidence 9999999999 7899998874 3579999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+......
T Consensus 164 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 233 (294)
T 2rku_A 164 KVEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS 233 (294)
T ss_dssp ECCSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC
T ss_pred ecccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCC
Confidence 7643222 1234579999999999999999999999999999999999999997643 33334444333222
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+...++.++.+++.+||..||++||++.+++ ++.+...
T Consensus 234 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll---~~~~~~~ 271 (294)
T 2rku_A 234 -----IPKHINPVAASLIQKMLQTDPTARPTINELL---NDEFFTS 271 (294)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG---GSHHHHT
T ss_pred -----CccccCHHHHHHHHHHcccChhhCcCHHHHh---hChheec
Confidence 2346789999999999999999999988774 4555444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.76 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=209.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEE-----EccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~-----~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
+..++|++++.||+|+||.||+|. +..+++.||||++...... ..+.+|+.+++.+.| ++|+.+++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH--QNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC--CCCCeEEEEEcC
Confidence 467899999999999999999999 5567889999998644322 346778888888854 999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
....|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++....+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 88999999999 889999998653 34899999999999999999999999999999999999964445667999
Q ss_pred eecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~ 227 (475)
+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |..||.... ..+.+.
T Consensus 185 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH
T ss_pred Ccccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHH
Confidence 999999865433221 11233468999999999999999999999999999999998 999997643 233333
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+....... ....++.++.++|..||..||.+||++.+|++.|+.+...
T Consensus 257 ~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FVTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 333322211 2356889999999999999999999999999999887643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.72 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=202.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CCEEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE-GDYNVLVI 83 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~~~~lvm 83 (475)
..++|++.+.||+|+||.||+|.+ +++.||||+++.......+.+|+.+++.++| ++++.++.+... ....++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH--SNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC--TTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCC--CCEeeEEEEEEcCCCceEEEE
Confidence 357899999999999999999986 5899999999877666778899999988865 899999887554 45789999
Q ss_pred EcC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 84 DLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc
Confidence 999 6799999975432 38999999999999999999999999999999999999 477899999999998654322
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
....++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+..... ..
T Consensus 172 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----~~ 234 (278)
T 1byg_A 172 ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK----MD 234 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCC----CC
T ss_pred ----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----CC
Confidence 23367889999999999999999999999999999998 999998754322 2233322211 11
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
....+|+++.+++..||..||++||++.+|++.|+++...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 2356899999999999999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.16 Aligned_cols=249 Identities=18% Similarity=0.299 Sum_probs=200.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~~~~lvm 83 (475)
.++|+++++||+|+||.||+|.+..+++.||||+++.. ....+.+|+.+++.+.++ ++|+.+..++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~-~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGG-PNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTS-TTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCC-CCEEEeeeeeccCCCCceEEEE
Confidence 57899999999999999999999999999999998643 456789999999999843 999999988887 67789999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||+ +++|.+++. .+++.+++.|+.||+.||.|||++||+||||||+||||+ .+...+||+|||+|+.+.....
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc
Confidence 999 789988875 489999999999999999999999999999999999995 3344899999999987654322
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc----
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS---- 237 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---- 237 (475)
.....||..|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..+........
T Consensus 187 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 187 --------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp --------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHH
T ss_pred --------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhH
Confidence 234578999999999987 5689999999999999999999999965322 1222222111100000
Q ss_pred -----------HHH-----------------HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 -----------IEA-----------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 -----------~~~-----------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... ....+++++.+||.+||..||++||++.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 01126899999999999999999999888743
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=349.24 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=211.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEE--EEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~v--AvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++.+.||+|+||.||+|.+..++..+ |||.+.... ....+..|++++..+.. |++|+.++.++...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~-hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC-CTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccC-CCchhhhceeeeeCCceE
Confidence 378999999999999999999999898865 999876432 33457889988888733 499999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCC
Q 011882 81 LVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 144 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~ 144 (475)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 999999 889999997432 369999999999999999999999999999999999999 4678
Q ss_pred cEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHH
Q 011882 145 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 223 (475)
Q Consensus 145 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~ 223 (475)
.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.. ..
T Consensus 180 ~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~ 248 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CA 248 (327)
T ss_dssp CEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH
T ss_pred eEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HH
Confidence 99999999997433221 1223467889999999999889999999999999999998 999998743 33
Q ss_pred HHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 224 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 224 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
+.+..+...... .....+++++.+++.+||..||.+||++.++++.|+.++.+..
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 ELYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 334444332211 1234678999999999999999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=353.60 Aligned_cols=265 Identities=18% Similarity=0.279 Sum_probs=210.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccC------CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~------~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
.++|+++++||+|+||.||+|++. .+++.||||+++.. .....+..|+.++..+.++ ++|+.++.++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS-PFLVTLHYAFQTE 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTC-TTBCCEEEEEEET
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCC-CceeEEEEEEeeC
Confidence 378999999999999999999984 48999999987643 2334577899999998643 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSK 207 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEE
T ss_pred ceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCe
Confidence 9999999999 78999999753 479999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHH-HHHHHHhhc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEK 232 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~--~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~-~~~~~i~~~ 232 (475)
.+....... .....||+.|+|||++.+. .++.++|||||||+||||++|..||......... .....+...
T Consensus 208 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 208 EFVADETER------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281 (355)
T ss_dssp ECCGGGGGG------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred ecccCCCCc------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc
Confidence 765432211 2345799999999999864 4789999999999999999999999865433322 222222222
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 296 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 296 (475)
.. .+...++..+.+||.+||..||.+|| ++.+| +++.+. ..++|.....
T Consensus 282 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el---l~h~~f-------~~~~~~~l~~ 335 (355)
T 1vzo_A 282 EP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---KEHLFF-------QKINWDDLAA 335 (355)
T ss_dssp CC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---HTSGGG-------TTCCHHHHHT
T ss_pred CC-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH---HcCcch-------hcCChhHhhh
Confidence 21 12356789999999999999999999 76665 444432 2356765543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=373.79 Aligned_cols=270 Identities=20% Similarity=0.216 Sum_probs=217.1
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
++..++|++++.||+|+||.||+|.+..+|+.||||++... .....+..|..++..+.| ++|+.++.++...+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS--RFVVSLAYAYETKD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC--TTBCCEEEEEECSS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC--CCEeeEEEEEeeCC
Confidence 35567899999999999999999999999999999987542 233457789999998865 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..|+||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~ 334 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccce
Confidence 999999999 899999987443 349999999999999999999999999999999999999 578899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~ 234 (475)
.+..... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+.....
T Consensus 335 ~~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~ 406 (576)
T 2acx_A 335 HVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406 (576)
T ss_dssp ECCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC
T ss_pred ecccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc
Confidence 7654322 1245899999999999998999999999999999999999999987544322 223333332222
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
. +...+++++.+||.+||..||.+||++. .+.+++++.| -..++|......
T Consensus 407 ~-----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf-------F~~i~w~~l~~~ 459 (576)
T 2acx_A 407 E-----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL-------FKKLNFKRLGAG 459 (576)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG-------GTTCCHHHHHTT
T ss_pred c-----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh-------hccCCHHHHhcC
Confidence 1 2356789999999999999999999431 2233344433 234678766443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.93 Aligned_cols=261 Identities=19% Similarity=0.218 Sum_probs=204.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC----
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG---- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---- 76 (475)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++|+.++.++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH--ENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCC--TTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcC--CCcCCeeeeecccccCc
Confidence 4678999999999999999999999999999999998654332 346689999988865 9999998877653
Q ss_pred -CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 -~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccc
Confidence 67899999999999999874 579999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccc---cccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 156 RYRDTATHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 156 ~~~~~~~~~~~~---~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
.+.........+ ........||+.|+|||++.+ ..++.++|||||||+||||++|..||.+.........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 765432211100 011234579999999998875 6789999999999999999999999987542211111111110
Q ss_pred ------------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ------------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ------------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.........+...+++++.+||.+||..||++||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0112234455567899999999999999999999988774
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.37 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=194.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC---
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--- 77 (475)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|+.++.++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH--KNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCC--TTBCCEEEEECSCCSTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCC--CCccceEEeeccccccc
Confidence 457899999999999999999999999999999998754332 346788888888865 99999988876554
Q ss_pred ---EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 ---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ---~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..|+||||++++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC-
T ss_pred cccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecc
Confidence 789999999889998886 469999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 175 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~ 243 (371)
T 2xrw_A 175 RTAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLG 243 (371)
T ss_dssp -----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CC
T ss_pred cccccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhC
Confidence 86543221 2345899999999999999999999999999999999999999987432 233333322111
Q ss_pred cc-------------------------cHHHHh------------cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 235 ST-------------------------SIEALC------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 235 ~~-------------------------~~~~l~------------~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
.. ....+. ...+.++.+||.+||..||.+||++.++ |++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp 320 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA---LQHP 320 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH---HHSH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH---hCCc
Confidence 00 000000 1125789999999999999999998877 5565
Q ss_pred HHH
Q 011882 278 FIR 280 (475)
Q Consensus 278 ~~~ 280 (475)
|.+
T Consensus 321 ~~~ 323 (371)
T 2xrw_A 321 YIN 323 (371)
T ss_dssp HHH
T ss_pred chh
Confidence 554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.28 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=184.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++| ++++.++.++...+..+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH--PSILELYNYFEDSNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC--TTBCCEEEEEECSSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC--CCeEeEEEEEccCCeEE
Confidence 467999999999999999999999999999999975432 22457788888887764 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccC
Confidence 999999 789999998655679999999999999999999999999999999999999 5778999999999987653
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+..+.....
T Consensus 165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~----- 229 (278)
T 3cok_A 165 PHE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADY----- 229 (278)
T ss_dssp ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----
T ss_pred CCC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhccc-----
Confidence 322 1124578999999999999899999999999999999999999998754321 2222222111
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+...++.++.++|.+||..||++||++.+++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 12345789999999999999999999988774
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=363.61 Aligned_cols=252 Identities=15% Similarity=0.127 Sum_probs=188.8
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeE-------EeeE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLR-------WFGV 74 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~-------~~~~ 74 (475)
.+|++.++||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.|...|++++.++ .+..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999998875432 346778888888875568876633 2222
Q ss_pred eC-----------------CEEEEEEEcCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCC
Q 011882 75 EG-----------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK 131 (475)
Q Consensus 75 ~~-----------------~~~~lvme~~g~sL~~ll~~~~~~ls~~~~------~~i~~qi~~aL~yLH~~gIvHrDIK 131 (475)
.. ...||||||++++|.+++...+..+....+ +.++.||+.||+|||++||||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 21 347999999999999999865555665566 7888999999999999999999999
Q ss_pred CCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHc
Q 011882 132 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 209 (475)
Q Consensus 132 P~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~ellt 209 (475)
|+|||| +.++.+||+|||+|+....... ...||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEEE----------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCcc----------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 5778999999999986643221 2357799999999988 679999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHh--hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 210 GSLPWQGLKAGTKKQKYEKIS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 210 G~~Pf~~~~~~~~~~~~~~i~--~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
|..||.+....... .+.... ...........+..+++++.+||.+||..||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999875322110 000000 000001111123578999999999999999999999988853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.32 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=199.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
.++|++.+.||+|+||.||+|.+ .++.||||++........+..|+.++..++| +||+.+++++. +..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH--PNIVKLYGACL--NPVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC--TTBCCEEEBCT--TTTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC--CCcCeEEEEEc--CCcEEEEEc
Confidence 46899999999999999999986 4789999998766555678889999988865 99999987765 347899999
Q ss_pred C-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEeeCCCCC-cEEEeecCCccccc
Q 011882 86 L-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYR 158 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGlA~~~~ 158 (475)
+ +++|.+++..... .++...++.++.||+.||.|||+ +||+||||||+||||+ .++ .+||+|||++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccccc
Confidence 9 8899999974332 37899999999999999999999 8999999999999995 444 48999999997654
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
... ....||+.|+|||++.+..++.++|||||||++|||++|..||...... .......+......
T Consensus 158 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--- 223 (307)
T 2eva_A 158 THM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMWAVHNGTRP--- 223 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHHHHHTTCCC---
T ss_pred ccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHHHHhcCCCC---
Confidence 321 2346999999999999999999999999999999999999999865432 22222222222211
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+...+|.++.+++.+||..||++||++.+|++.|+.+..
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2335789999999999999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.91 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=203.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----------chHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|+.++.++.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~ 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH--PCIIKIKNFFD 85 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC--TTBCCEEEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC--CCCceEeeEEc
Confidence 56789999999999999999999999999999999864321 2347789999998865 99999988887
Q ss_pred eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 75 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 75 ~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
... .|+||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++....+||+|||+
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred CCc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 665 79999999 779999886 345799999999999999999999999999999999999996444455699999999
Q ss_pred cccccccccccccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
++.+..... .....||+.|+|||++. +..++.++|||||||++|+|++|..||......... ...+.
T Consensus 164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT 233 (322)
T ss_dssp CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH
T ss_pred ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH
Confidence 987644221 11246899999999974 456899999999999999999999999875433221 12222
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.... ...+..+..++.++.+++.+||..||++||++.+++
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 234 SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 2222 223445577899999999999999999999998875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.50 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=207.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+.|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+ ++++.++.++......++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC--CCEeEEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999876543 2567888888888755 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 779999986 4579999999999999999999999999999999999999 477899999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...... .+
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNPP----TL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC----CC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCCC----CC
Confidence 2 12345799999999999999999999999999999999999999976432 2333333222211 23
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...++.++.+++..||..||.+||++.+|++
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3568899999999999999999999988854
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=345.03 Aligned_cols=260 Identities=19% Similarity=0.311 Sum_probs=200.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEcc---CCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
..++|++.+.||+|+||.||+|.+.. +++.||||+++..... ..+..|+.++..++| ++|+.++.++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH--PNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCC--TTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCC--CCeeeeeEEEeecc
Confidence 35789999999999999999998765 5568999998765433 346778888888764 99999988877554
Q ss_pred -----EEEEEEEcC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcE
Q 011882 78 -----YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146 (475)
Q Consensus 78 -----~~~lvme~~-g~sL~~ll~~~-----~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 146 (475)
..++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcE
Confidence 359999999 78999998532 3469999999999999999999999999999999999999 477899
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHH
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 225 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~ 225 (475)
||+|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 187 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--- 258 (313)
T ss_dssp EECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---
T ss_pred EEeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---
Confidence 99999999876543211 11234467889999999999999999999999999999999 9999987544332
Q ss_pred HHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 226 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+..+...... .....+++++.+++..||..||.+||++.+|++.|++++...
T Consensus 259 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 YDYLLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2222222211 123568899999999999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=340.65 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=207.1
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
|...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++++.++.++...+
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--ENVVKFYGHRREGN 78 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC--TTBCCEEEEEEETT
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC--CCceeeeeEEEcCC
Confidence 334456789999999999999999999999999999999865432 2457788888887754 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccc
Confidence 999999999 7799988863 4569999999999999999999999999999999999999 4778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
+....... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||........ .+..+......
T Consensus 155 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~ 227 (276)
T 2yex_A 155 FRYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTY 227 (276)
T ss_dssp CEETTEEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTT
T ss_pred cCCCcchh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhcccc
Confidence 65432111 1234679999999999988775 7899999999999999999999987543322 22222222111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. .....++.++.+++..||..||.+||++.+|++
T Consensus 228 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 L---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp S---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 112457899999999999999999999887743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=355.07 Aligned_cols=258 Identities=18% Similarity=0.246 Sum_probs=209.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV 74 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~ 74 (475)
+.++|+++++||+|+||.||+|.+..+++.||||+++... ....+..|+.+++.++| ++|+.++.++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~Iv~~~~~~~ 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH--ANIIKVLDIFE 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC--TTBCCEEEEEE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC--CCEeeEEEEEe
Confidence 4568999999999999999999999999999999987653 22356789999988864 99999999999
Q ss_pred eCCEEEEEEEcC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 75 EGDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 75 ~~~~~~lvme~~-g~-sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.....++||||+ ++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg 175 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG 175 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence 999999999998 33 99999873 4579999999999999999999999999999999999999 477899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+++.+..... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||..... ...
T Consensus 176 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~ 238 (335)
T 3dls_A 176 SAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVE 238 (335)
T ss_dssp TCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTT
T ss_pred cceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHh
Confidence 9987654322 123579999999999998886 8899999999999999999999976321 111
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 294 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 294 (475)
.... ....+++++.+||..||..||++||++.+| |++.|.+.... ...++|+..
T Consensus 239 ~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~el---l~hp~~~~~~~-~~~~~~~~~ 292 (335)
T 3dls_A 239 AAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKL---VTDPWVTQPVN-LADYTWEEV 292 (335)
T ss_dssp TCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHH---HHCTTTTCCCC-GGGCCHHHH
T ss_pred hccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHH---hcCccccCCcc-ccccCHHHH
Confidence 1111 123478999999999999999999998877 44544333221 123455543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.43 Aligned_cols=246 Identities=18% Similarity=0.268 Sum_probs=207.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|++++..++| ++++.++.++...+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH--PNILRMYNYFHDRKR 88 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC--CCEeeEEEEEEcCCE
Confidence 3457899999999999999999999999999999987532 233567889999888865 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence 99999999 77999998754 469999999999999999999999999999999999999 47789999999999765
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+......
T Consensus 165 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~-- 230 (284)
T 2vgo_A 165 PSLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDLK-- 230 (284)
T ss_dssp SSSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC--
T ss_pred cccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccccC--
Confidence 4321 134579999999999999999999999999999999999999997643 33333344333221
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...++.++.++|..||..||.+||++.++++
T Consensus 231 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 ---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 23567899999999999999999999888743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.57 Aligned_cols=264 Identities=19% Similarity=0.254 Sum_probs=208.6
Q ss_pred ccCCce-EEeeeEeeeCceeEEEEEE----ccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y-~l~~~LG~G~fG~Vy~a~~----~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.+.++| +++++||+|+||.||++.+ ..+++.||||+++..... ..+.+|+++++.+++ ++|+.++.++..
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~ 104 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH--EHIIKYKGCCED 104 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC--cchhhEEEEEec
Confidence 456666 9999999999999988864 347899999998765432 347889999998875 999999988887
Q ss_pred --CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 76 --GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 76 --~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
....++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 46889999999 7899999973 459999999999999999999999999999999999999 577899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------CHHH
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQ 224 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~--------~~~~ 224 (475)
+++.+...... ........||..|+|||++.+..++.++|||||||++|||++|..||...... ....
T Consensus 180 ~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 180 LAKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GCEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred ccccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 99877543221 11223457899999999999989999999999999999999999999652110 0000
Q ss_pred ---HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 225 ---KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 225 ---~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+........ .......++.++.+||..||+.||.+||++.+|++.|+.+..+.
T Consensus 256 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 256 TVLRLTELLERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0111111111 01123567899999999999999999999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=345.13 Aligned_cols=255 Identities=19% Similarity=0.246 Sum_probs=198.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEee--------
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFG-------- 73 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~-------- 73 (475)
.++++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++| ++++.++.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH--DNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCC--CCeeEEEEeccccccccc
Confidence 468899999999999999999999999999999998865432 2356788888888765 8999987765
Q ss_pred ------EeCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 74 ------VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 74 ------~~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
......++||||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEE
T ss_pred cccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEE
Confidence 3457889999999889999986 45799999999999999999999999999999999999995 3467899
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~ 226 (475)
|+|||+++......... .......||..|+|||++.+ ..++.++|||||||++|||++|..||.+... ...+
T Consensus 162 l~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~ 234 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQM 234 (320)
T ss_dssp ECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred EccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 99999998764322111 11223467999999999876 6789999999999999999999999987543 2222
Q ss_pred HHHhhcc-------------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 227 EKISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 227 ~~i~~~~-------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+.... .......+...++.++.++|.+||+.||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 2222111 11233445567899999999999999999999988874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=368.00 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=205.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.++||+|+||.||+|.+. .+..||||+++.... ...+.+|+.+++.++| ++|+.++.++.. +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH--EKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhCCC--CCEeeEEEEEcC-CceEEEeh
Confidence 467999999999999999999985 456799999876543 3568899999999875 999999888765 66899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+.....
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCce
Confidence 99 88999999743 3469999999999999999999999999999999999999 4678999999999987654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ..
T Consensus 336 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~ 402 (452)
T 1fmk_A 336 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PC 402 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred ------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 11233467889999999999999999999999999999999 9999987543 3333333332211 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...+|+++.++|.+||..||++||++.+|++.|++++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 35689999999999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=348.50 Aligned_cols=255 Identities=23% Similarity=0.247 Sum_probs=200.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..++|++++.||+|+||.||+|.+..+++.||||++....... .+.+|+.+++.++| ++|+.++.++......+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH--ENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC--CCEeeEEEEeecCCEEE
Confidence 4578999999999999999999999999999999886554332 35678888888875 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+..
T Consensus 101 lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 101 LVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-----
T ss_pred EEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecC
Confidence 999999 555555544 45679999999999999999999999999999999999999 5778999999999986654
Q ss_pred cccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------ 232 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 232 (475)
... ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 177 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 177 PGE-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred Ccc-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 322 12345789999999999876 6899999999999999999999999875432222111111100
Q ss_pred -----------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 -----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 -----------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
............+++++.+||.+||..||++||++.+|++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1112233444578999999999999999999999888743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=354.62 Aligned_cols=265 Identities=18% Similarity=0.231 Sum_probs=210.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
..++|++.+.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.++| ++|+.+++++...+..++|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--PHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC--TTBCCEEEECCCTTCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC--CCEeeEEEEEcCCCeEEEE
Confidence 468899999999999999999995 57899999987655433 457788888877764 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 83 IDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGT 190 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence 9999 789999886432 248999999999999999999999999999999999999 578899999999998654
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHH----Hhhccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----ISEKKV 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~ 234 (475)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+............ ......
T Consensus 191 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 191 ELDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp SSSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 32211 112345799999999999998999999999999999999999999986543322111111 111100
Q ss_pred cc-----cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 235 ST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 235 ~~-----~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.. ....+...++.++.+++.+||+.||++||++.+|++.|+.++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 00 00111223467899999999999999999999999999988753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=352.15 Aligned_cols=255 Identities=16% Similarity=0.199 Sum_probs=176.9
Q ss_pred ccCCceEEee-eEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCE
Q 011882 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDY 78 (475)
Q Consensus 4 ~i~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~ 78 (475)
.+.++|++.+ .||+|+||.||+|.+..+++.||||++... .....|...+..+. .|++++.+..++.. ...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQAS-GGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHT-TSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhc-CCCChHHHHHHHhhccCCCce
Confidence 4678999965 599999999999999999999999998642 33444444433333 34999999887765 556
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.++||||+ |++|.+++.... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++..+.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999 779999998543 3699999999999999999999999999999999999997544567799999999986
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHH-HHHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~ 235 (475)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...+......
T Consensus 181 ~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 181 TTQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp C-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred ccccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 54322 1345789999999999988899999999999999999999999976543221111 1111111111
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. ......++.++.+||..||..||.+||++.++++
T Consensus 252 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 FP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 1122467899999999999999999999888743
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=356.14 Aligned_cols=261 Identities=18% Similarity=0.257 Sum_probs=200.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeE-eCCEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGV-EGDYN 79 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~-~~~~~ 79 (475)
..|++.++||+|+||.||+|.+..++ ..||||.++..... ..+.+|+.+++.++| ++|+.++.++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH--PNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCC--TTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEcCCCCe
Confidence 35889999999999999999976443 46899988654333 346778888887764 99999988754 45678
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccc
Confidence 9999999 789999998666679999999999999999999999999999999999999 577899999999998764
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... ........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+ .......
T Consensus 244 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~~- 316 (373)
T 3c1x_A 244 DKEFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLL- 316 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCCC-
T ss_pred cccccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCCC-
Confidence 432111 011234467889999999999999999999999999999999 78888776554433322 2221111
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 282 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 282 (475)
....+|.++.+++.+||..||++||++.+|++.|++++....
T Consensus 317 ---~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 124678999999999999999999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.59 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=199.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE-
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN- 79 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~- 79 (475)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++|+.++.++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH--ENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCSSST
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCC--CCchhhhhheeccCCcc
Confidence 568999999999999999999999999999999998764433 346788888888875 9999998888766544
Q ss_pred -----EEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 80 -----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 80 -----~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
|+||||++++|.+++. ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC
T ss_pred cceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcc
Confidence 9999999989888764 469999999999999999999999999999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh--
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-- 231 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~-- 231 (475)
+...... ....||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+.........+.....
T Consensus 192 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 192 RHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp ------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 8654322 34578999999999987 6789999999999999999999999987443222211111110
Q ss_pred ---------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ---------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ---------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.........+...+++++.+||.+||+.||++||++.+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 0111223344456789999999999999999999988773
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=350.75 Aligned_cols=268 Identities=23% Similarity=0.305 Sum_probs=212.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----EEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----YNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----~~~ 80 (475)
+.++|++.+.||+|+||.||+|++ +++.||||+++.. ....+..|.+++..+...|++|+.++.++.... ..+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 457899999999999999999996 6899999998644 345677899998886556799999998888765 789
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH--------~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
+||||+ +++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||| +.++.+||+||
T Consensus 117 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 191 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 191 (342)
T ss_dssp EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCC
T ss_pred EEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEEC
Confidence 999999 7799999974 46999999999999999999999 8999999999999999 57789999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCC------CCCchhHHHHHHHHHHHHcC----------CCCCC
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPWQ 215 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~------~s~ksDIwSlG~iL~elltG----------~~Pf~ 215 (475)
|+++........... ......||+.|+|||++.+.. ++.++|||||||+||||++| ..||.
T Consensus 192 g~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 192 GLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp TTCEEEETTTTEEEE---CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCceecccccccccc---ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999876543321110 123457999999999998763 34789999999999999999 88997
Q ss_pred CCCCC--CHHHHHHHHhhccccccHHHH--hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011882 216 GLKAG--TKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 283 (475)
Q Consensus 216 ~~~~~--~~~~~~~~i~~~~~~~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 283 (475)
..... ........+........++.. ...++..+.+|+..||..||++||++.+|++.|+++..+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 65432 222333333332222221111 123457899999999999999999999999999999887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=343.30 Aligned_cols=251 Identities=20% Similarity=0.349 Sum_probs=199.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe------CC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------GD 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~~ 77 (475)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.. |++|+.+++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH-HRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCC-STTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccC-CCCeeeeeeEEeeccCccccc
Confidence 5688999999999999999999999999999999986543 34578899999998853 3999999888876 56
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 889999999 679999998543 469999999999999999999999999999999999999 477899999999998
Q ss_pred cccccccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
.+..... ......||+.|+|||++. +..++.++|||||||+||+|++|..||.+... ...+..+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 7643221 123457999999999997 55689999999999999999999999976432 22233332
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....... ....++.++.++|..||..||.+||++.+|++
T Consensus 248 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 2221111 12467899999999999999999999888754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=337.61 Aligned_cols=249 Identities=10% Similarity=0.159 Sum_probs=204.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--CE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG--DY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~--~~ 78 (475)
..++|++.++||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++ |++|+.+++++... ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--HPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS--CTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcC--CCchhheEEEEccCCCCC
Confidence 357899999999999999999997 4889999998765433 24667777777775 49999999988776 78
Q ss_pred EEEEEEcC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~-~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVK 160 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSC
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccce
Confidence 89999999 7899999985433 4899999999999999999999999 9999999999999 47788999999887
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~---ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
..... ....||+.|+|||++.+..++. ++|||||||++|||++|..||.+... ......+..
T Consensus 161 ~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~ 225 (271)
T 3kmu_A 161 FSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVAL 225 (271)
T ss_dssp CTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHH
T ss_pred eeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHh
Confidence 64322 2347899999999999876554 89999999999999999999987433 333333332
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
..... .+...+++++.+++..||+.||++||++.++++.|+++.
T Consensus 226 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22221 233568999999999999999999999999999998873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.34 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.++..+++.+++++.++.++......+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 467899999999999999999997 46899999998765433 4578899999999986799999999999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+|||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+. ++.+||+|||+++.+...
T Consensus 105 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC----
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCc
Confidence 9999889999999984 45799999999999999999999999999999999999994 478999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g-----------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i 229 (475)
.... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..+
T Consensus 180 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 252 (313)
T 3cek_A 180 TTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 252 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHH
T ss_pred cccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHH
Confidence 2211 1234579999999999976 4688899999999999999999999976432 22223333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
....... .+...++.++.+++..||..||.+||++.+|+
T Consensus 253 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 253 IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred Hhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 2222111 12245678999999999999999999988774
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.77 Aligned_cols=251 Identities=18% Similarity=0.278 Sum_probs=188.7
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH---HHHHHHH-HHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LQYEAKL-YKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~---~~~E~~i-l~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+..++|+++++||+|+||.||+|.+..+++.||||++........ ...|... ++ ...|++++.++.++...+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~--~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR--TVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHT--TCCCTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHH--hCCCCeEEEEeeeeeccCCE
Confidence 345789999999999999999999999999999999876543322 1122222 22 23569999999999999999
Q ss_pred EEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 80 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 80 ~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
++||||++++|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||+ +..+.+||+|||+++
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC----
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 99999998899888764 356799999999999999999999998 99999999999999 477899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccc----cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
.+..... .....||+.|+|||++ .+..++.++|||||||++|||++|..||..... ....+.....
T Consensus 159 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~ 228 (290)
T 3fme_A 159 YLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVE 228 (290)
T ss_dssp -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHH
T ss_pred ccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhc
Confidence 7654322 1234799999999996 556789999999999999999999999976432 2233333322
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...... ....+++++.+++..||..||++||++.++++
T Consensus 229 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 222111 12457899999999999999999999998855
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=337.31 Aligned_cols=250 Identities=18% Similarity=0.204 Sum_probs=207.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----------chHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----------~~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.. |++|+.++.++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~i~~~~~~~ 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG-HPNIIQLKDTY 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTT-CTTBCCEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcC-CCCEeeeeeee
Confidence 56899999999999999999999999999999999875431 1346788899988863 39999999999
Q ss_pred EeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 74 ~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
......++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence 9999999999999 7899999975 3579999999999999999999999999999999999999 577899999999
Q ss_pred CcccccccccccccccccCCCCccCcccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~ 226 (475)
++..+..... .....||+.|+|||++. ...++.++|||||||++|||++|..||.+.. .....
T Consensus 170 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML 238 (298)
T ss_dssp TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred chhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH
Confidence 9987654321 23457999999999985 4568899999999999999999999997643 33334
Q ss_pred HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 227 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+......... .....++.++.+++..||..||.+||++.+++
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 239 RMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 444433332221 12246789999999999999999999988874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=347.00 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=206.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.+.+++++.+..++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 46789999999999999999999999999999999886543 2245778999999998877999999999999
Q ss_pred CCEEEEEEEcCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 GDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 ~~~~~lvme~~g--~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.+..++|||++. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGS 196 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTT
T ss_pred CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCcc
Confidence 999999999993 799999875 45799999999999999999999999999999999999995 3568999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
++.+..... ....||+.|+|||++.+..+ +.++|||||||+||||++|..||.... .+...
T Consensus 197 ~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~~ 258 (320)
T 3a99_A 197 GALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRG 258 (320)
T ss_dssp CEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHHC
T ss_pred ccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhcc
Confidence 987654321 34579999999999987775 788999999999999999999996521 11111
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... +...+++++.++|.+||..||++||++.+|++
T Consensus 259 ~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 QVF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 23568899999999999999999999888743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=354.06 Aligned_cols=251 Identities=19% Similarity=0.277 Sum_probs=203.0
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
....++|+++++||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++ |++|+.++.++...+..
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--SPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC--CTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC--CCCEEEEeEEEEECCEE
Confidence 34568899999999999999999999999999999998765432 34677888888775 49999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
++||||+ +++|.+++... ..+++..+..|+.||+.||.|||++ ||+||||||+|||| +.++.+||+|||+++.+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 9999999 78999999754 4699999999999999999999996 99999999999999 47789999999999766
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-----------
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY----------- 226 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~----------- 226 (475)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+
T Consensus 183 ~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 183 IDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp HHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred cccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 4322 13458999999999999999999999999999999999999999764321111110
Q ss_pred ----------------------------HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 227 ----------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 227 ----------------------------~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+....... .....++.++.+||..||..||++||++.+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 323 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 0111100000 00123688999999999999999999988884
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=349.99 Aligned_cols=268 Identities=16% Similarity=0.218 Sum_probs=197.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeE-----eCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGV-----EGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~-----~~~~ 78 (475)
+-.++|+++++||+|+||.||+|++ +++.||||++... ....+..|.+++......|++|+.++..+. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 3468899999999999999999975 7899999998654 234455666666554456699999876433 2346
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEeeCCCCCcEEE
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~---------gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
.++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||| +.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence 78999999 8899999974 3468999999999999999999999 99999999999999 47789999
Q ss_pred eecCCcccccccccccc-cccccCCCCccCccccccccccC-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 149 IDFGLAKRYRDTATHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~g-------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
+|||+|+.+........ ..........||+.|+|||++.+ ..++.++|||||||+||||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654321110 01112234579999999999987 35677999999999999999997776432211
Q ss_pred CH---------------HHHHHHHhhccccccHHHHhc---CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 221 TK---------------KQKYEKISEKKVSTSIEALCR---GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 221 ~~---------------~~~~~~i~~~~~~~~~~~l~~---~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.. ......+........++..+. .+++++.+||..||..||++||++.+|++.|++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10 000011111111111111111 135689999999999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.30 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=208.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+++ ++|+.++.++......+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH--PNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC--CCccEEEEEEeCCCeEE
Confidence 4578999999999999999999999999999999975432 23467889999988854 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++..+..
T Consensus 98 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999 88999888643 4799999999999999999999999999999999999996444456899999999986644
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.. .......+.........+
T Consensus 177 ~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NTK--------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CSS--------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSG
T ss_pred CCc--------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCch
Confidence 321 1234689999999998874 8999999999999999999999998743 333444444433322222
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
....++.++.++|..||..||++||++.++++
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23568899999999999999999999988854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.70 Aligned_cols=240 Identities=14% Similarity=0.127 Sum_probs=189.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhC-CCCCcCeeE-------Ee
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQG-GSTGIPNLR-------WF 72 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~-~~~~i~~l~-------~~ 72 (475)
.++|++.++||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+.. .|++|+.++ .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5789999999999999999999989999999999864321 2457788877666653 458887765 44
Q ss_pred eEeCC-----------------EEEEEEEcCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceec
Q 011882 73 GVEGD-----------------YNVLVIDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR 128 (475)
Q Consensus 73 ~~~~~-----------------~~~lvme~~g~sL~~ll~~~~~~ls-------~~~~~~i~~qi~~aL~yLH~~gIvHr 128 (475)
....+ ..|+||||++++|.+++.... .++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 44332 278999999999999997542 233 48888999999999999999999999
Q ss_pred CCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCC-----------CCCCchhH
Q 011882 129 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL 197 (475)
Q Consensus 129 DIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-----------~~s~ksDI 197 (475)
||||+|||| +.++.+||+|||+|+..... .....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 47789999999999854331 124577 999999999988 79999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 198 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 198 wSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
|||||+||||++|..||.+....... .. +...+..+|+++.+||.+||..||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~---~~---------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGS---EW---------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCS---GG---------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccch---hh---------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999999999764321111 01 11123578999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.70 Aligned_cols=254 Identities=17% Similarity=0.192 Sum_probs=195.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-------------hHHHHHHHHHHHHhCCCCCcCeeE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLQYEAKLYKILQGGSTGIPNLR 70 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-------------~~~~~E~~il~~l~~~~~~i~~l~ 70 (475)
.+.++|++.++||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.++| ++|+.++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~ 95 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH--PNILGLR 95 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC--TTBCCCS
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC--cCcccee
Confidence 35789999999999999999999974 5999999987543221 457889999998875 9999987
Q ss_pred EeeEe-----CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 71 WFGVE-----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 71 ~~~~~-----~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
.++.. ....|+||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~ 172 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNND 172 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred eeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCC
Confidence 77643 34789999999999999988656679999999999999999999999999999999999999 47789
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~ 224 (475)
+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 173 ~kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 173 ITICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999975443322 234578999999999987 668999999999999999999999998754322222
Q ss_pred HHHHHhhc------------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 225 KYEKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 225 ~~~~i~~~------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+...... ........+...+++.+.+||..||..||.+||++.+++
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 22111110 011122344566789999999999999999999988774
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=350.73 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=200.2
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCC---------CCCcCeeEEe
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGG---------STGIPNLRWF 72 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~---------~~~i~~l~~~ 72 (475)
+...++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.+. |++|+.++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345689999999999999999999999999999999986432 224577899999988743 4789888777
Q ss_pred eEeCC----EEEEEEEcCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeC---CCC
Q 011882 73 GVEGD----YNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRA 143 (475)
Q Consensus 73 ~~~~~----~~~lvme~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~---~~~ 143 (475)
+.... ..++|||+++++|.+++... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+.+ +..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 66543 78999999999999999864 34599999999999999999999998 99999999999999643 233
Q ss_pred CcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC--
Q 011882 144 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 221 (475)
Q Consensus 144 ~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~-- 221 (475)
+.+||+|||+++.+.... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.....
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 479999999998765422 23478999999999999999999999999999999999999998643211
Q ss_pred -HHHHHHHHhhcccccc------------------------------HHH-------HhcCChHHHHHHHHHHhcCCCCC
Q 011882 222 -KKQKYEKISEKKVSTS------------------------------IEA-------LCRGYPTEFASYFHYCRSLRFDD 263 (475)
Q Consensus 222 -~~~~~~~i~~~~~~~~------------------------------~~~-------l~~~~p~~l~~li~~cl~~dp~~ 263 (475)
....+..+.......+ ... +...++.++.+||..||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1112222211000000 000 01234678999999999999999
Q ss_pred CCCHHHHH
Q 011882 264 KPDYAYLK 271 (475)
Q Consensus 264 RPt~~~l~ 271 (475)
||++.+|+
T Consensus 325 Rpt~~ell 332 (373)
T 1q8y_A 325 RADAGGLV 332 (373)
T ss_dssp CBCHHHHH
T ss_pred cCCHHHHh
Confidence 99988773
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.55 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=202.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..+.| ++|+.+++++...+..++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH--PYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC--TTBCCEEEEEECC-CEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC--CCEeeeeeeeeeCCeEEE
Confidence 356789999999999999999999999999999999865432 3567789999888764 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCcccccc
Confidence 99999 889999988767789999999999999999999999999999999999999 47789999999998654322
Q ss_pred ccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.. ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+......
T Consensus 171 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~ 240 (302)
T 2j7t_A 171 LQ-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPP 240 (302)
T ss_dssp HH-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC
T ss_pred cc-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCc
Confidence 11 123457999999999984 66789999999999999999999999987432 2333333322211
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. .....++.++.+++..||..||++||++.+|++
T Consensus 241 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 112457899999999999999999999887743
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=347.30 Aligned_cols=254 Identities=18% Similarity=0.202 Sum_probs=186.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC-------
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD------- 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~------- 77 (475)
.++|++.++||+|+||.||+|.+..+++.||||++..... ......|...+..++| +||+.++.++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH--PNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCC--TTBCCEEEEEEEECSSCTTCE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCC--CCcccHHHhhhccccccccce
Confidence 4689999999999999999999999999999998755432 3456666777777765 99999988775422
Q ss_pred EEEEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 78 YNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 78 ~~~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
+.++||||+.++|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+||||+ ..++.+||+|||
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg 177 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCC
Confidence 4789999998888776543 3456899999999999999999999 99999999999999995 337899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
+++.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.........+.....
T Consensus 178 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 178 SAKKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp TCBCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CceecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 9987654332 23457899999999997765 89999999999999999999999987543222222221111
Q ss_pred ccccc--------------------cHHHHh----cCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 KKVST--------------------SIEALC----RGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~~~~~--------------------~~~~l~----~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..... ....+. ..++.++.+||.+||+.||.+||++.+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 11000 011111 12578999999999999999999988774
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=340.01 Aligned_cols=251 Identities=22% Similarity=0.269 Sum_probs=203.6
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeE--eC
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGV--EG 76 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~--~~ 76 (475)
|...++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++| ++|+.++.++. ..
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH--PNIVRYYDRIIDRTN 79 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEEEGGG
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC--CCCCeEEEEEecCCC
Confidence 34568999999999999999999999999999999998765432 347788999988864 99999988664 46
Q ss_pred CEEEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeeCCCCCcEE
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vk 147 (475)
...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++| |+||||||+|||+ +.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~k 156 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVK 156 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEE
Confidence 7899999999 77999998753 234999999999999999999999999 9999999999999 5778999
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~ 227 (475)
|+|||+++.+...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.... ......
T Consensus 157 l~dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~ 226 (279)
T 2w5a_A 157 LGDFGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG 226 (279)
T ss_dssp ECCCCHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred EecCchheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHH
Confidence 9999999876543211 112468999999999999999999999999999999999999998743 233334
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.+...... .+...++.++.+++.+||..||++||++.+|++
T Consensus 227 ~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 227 KIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 44333322 233568899999999999999999999888854
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=335.01 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=201.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE----GD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~ 77 (475)
+..|++.++||+|+||.||+|.+..++..||+|++...... ..+..|..+++.++| ++|+.++.++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--PNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCC--CCeeeeeeeeccccCCCc
Confidence 56699999999999999999999999999999988654332 346778888887764 999999877654 46
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..++||||+ +++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+ ...+.+||+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred eEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCc
Confidence 789999999 88999999753 56999999999999999999999999 99999999999994 36789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
........ ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ....+..+.....
T Consensus 180 ~~~~~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 180 TLKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK 247 (290)
T ss_dssp GGCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC
T ss_pred cccccccc---------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCC
Confidence 75443221 23579999999998875 589999999999999999999999976432 3333444333322
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
. ..+...+++++.++|..||..||.+||++.+|++
T Consensus 248 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2 1234567789999999999999999999888753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=374.00 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=210.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|++.++||+|+||.||+|.+. .+..||||+++.... ...+.+|+.+++.++| ++|+.++.++.. +..|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH--EKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhCCC--CCEeeEEEEEee-ccceEeee
Confidence 467999999999999999999985 456799999876543 3568899999999875 899999888765 66899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ...+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.....
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCce
Confidence 99 78999999743 3469999999999999999999999999999999999999 4678999999999987654221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ..
T Consensus 419 ------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~ 485 (535)
T 2h8h_A 419 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PC 485 (535)
T ss_dssp ------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred ------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 11233467889999999999999999999999999999999 9999987543 3333333332211 12
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...++.++.+||.+||..||++||++.+|++.|++++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 35689999999999999999999999999999988764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=334.08 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=199.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
+..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.++.++...+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH--PHIIKLYQVISTPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC--CCEeEEEEEEecCCe
Confidence 4568899999999999999999999999999999987543 223467788888887764 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCC
T ss_pred EEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeeccccccc
Confidence 99999999 78999999754 469999999999999999999999999999999999999 47789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....+..+......
T Consensus 162 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~- 229 (276)
T 2h6d_A 162 SDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY- 229 (276)
T ss_dssp CC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-
T ss_pred CCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc-
Confidence 54321 123478999999999998775 689999999999999999999997632 33334444332221
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...++.++.+++..||..||++||++.+|++
T Consensus 230 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 ----IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 23457899999999999999999999988754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=354.08 Aligned_cols=252 Identities=18% Similarity=0.247 Sum_probs=194.8
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC------CE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG------DY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~------~~ 78 (475)
...+|+++++||+|+||.||+|++..+++ ||+|.+..... ...+|..+++.++| +||+.++.++... .+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKH--PNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCC--TTBCCEEEEEEEESSSSSCEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCC--CCcceEEEEEEecCCCCCceE
Confidence 45679999999999999999999876666 88886643322 23478999988865 9999998777432 34
Q ss_pred EEEEEEcCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 79 NVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.++||||+.++|...+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ ...+.+||+|||+|+
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcc
Confidence 889999998777665542 356799999999999999999999999999999999999994 367899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc-
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 233 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 233 (475)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+.........+.+.....
T Consensus 191 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 191 ILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 7644322 2345789999999999875 48999999999999999999999998754322222222111000
Q ss_pred -------------------ccccH-HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 -------------------VSTSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 -------------------~~~~~-~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..... ..+...+++++.+||.+||..||.+||++.+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 00111 122235789999999999999999999988774
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.25 Aligned_cols=264 Identities=19% Similarity=0.235 Sum_probs=208.6
Q ss_pred cCCceEEeeeEeeeCceeEEEEEE----ccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEG-- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-- 76 (475)
..++|+++++||+|+||.||+|.+ ..+++.||||++...... ..+.+|+.+++.+++ ++|+.+..++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH--DNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCC--TTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEEecCC
Confidence 456799999999999999999984 568999999998765432 357789999888864 8999998876544
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
...++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcchh
Confidence 3679999999 7899999987667799999999999999999999999999999999999995 67899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---------CCHHH--
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA---------GTKKQ-- 224 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~---------~~~~~-- 224 (475)
.+....... .......++..|+|||++.+..++.++|||||||+||||++|..||..... .....
T Consensus 194 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred hcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 765432211 112344678899999999998899999999999999999999999864210 00000
Q ss_pred -HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 225 -KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 225 -~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+......... ......+|.++.++|..||..||++||++.+|++.|+++..+
T Consensus 270 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGR---LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00111110000 012356889999999999999999999999999999988654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.10 Aligned_cols=250 Identities=17% Similarity=0.280 Sum_probs=201.2
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC------CchHHHHHHHHHHHHhCCCCCcCeeEEeeE--e
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGSTGIPNLRWFGV--E 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~--~ 75 (475)
++.++|++++.||+|+||.||+|.+..+++.||||+++... ....+.+|+.+++.++| ++|+.++.++. .
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH--KNVIQLVDVLYNEE 79 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC--TTBCCEEEEEECC-
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC--CCeeEEEEEEEcCC
Confidence 46689999999999999999999999999999999986432 23457889998888864 99999988774 4
Q ss_pred CCEEEEEEEcCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
....++||||+.++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVA 156 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccc
Confidence 5678999999977788888754 4569999999999999999999999999999999999999 47789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~--s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
.......... ......||+.|+|||++.+... +.++|||||||++|||++|..||.+. ...+.+..+...
T Consensus 157 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~~ 228 (305)
T 2wtk_C 157 EALHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENIGKG 228 (305)
T ss_dssp EECCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHC
T ss_pred cccCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHHHhcC
Confidence 8765322111 1234579999999999987543 78999999999999999999999864 333444444433
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
... +...+++++.+++.+||..||.+||++.+++
T Consensus 229 ~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 262 (305)
T 2wtk_C 229 SYA-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR 262 (305)
T ss_dssp CCC-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCC-----CCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 322 2356889999999999999999999988874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=359.73 Aligned_cols=262 Identities=18% Similarity=0.246 Sum_probs=189.7
Q ss_pred ccCCceEE-eeeEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CCE
Q 011882 4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GDY 78 (475)
Q Consensus 4 ~i~~~y~l-~~~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~~ 78 (475)
.+.+.|++ +++||+|+||.||+|.+. .+++.||||++........+.+|+.+++.++| ++|+.++.++.. ...
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH--PNVISLQKVFLSHADRK 94 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCC--TTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCC--CCeeeEeeEEecCCCCe
Confidence 45567888 558999999999999976 56889999999877777789999999999975 999999888754 678
Q ss_pred EEEEEEcCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC-CCCCcEEEe
Q 011882 79 NVLVIDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYII 149 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~--------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~ 149 (475)
.|+||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||... +..+.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999999999998886321 249999999999999999999999999999999999999543 356799999
Q ss_pred ecCCcccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------H
Q 011882 150 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------K 222 (475)
Q Consensus 150 DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------~ 222 (475)
|||+|+.+..... +........||+.|+|||++.+. .++.++|||||||+||||++|..||.+..... .
T Consensus 175 Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 175 DMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred ECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999987654321 11122456899999999999885 48999999999999999999999997643210 0
Q ss_pred HHHHHHHhhc---cccc--------------------------c----HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHH
Q 011882 223 KQKYEKISEK---KVST--------------------------S----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 269 (475)
Q Consensus 223 ~~~~~~i~~~---~~~~--------------------------~----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~ 269 (475)
...+..+... .... . ........+.++.+||..||..||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111110 0000 0 00001123678999999999999999999877
Q ss_pred HH
Q 011882 270 LK 271 (475)
Q Consensus 270 l~ 271 (475)
++
T Consensus 331 ~L 332 (405)
T 3rgf_A 331 AM 332 (405)
T ss_dssp HH
T ss_pred Hh
Confidence 73
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.44 Aligned_cols=254 Identities=20% Similarity=0.350 Sum_probs=203.5
Q ss_pred eEEe-eeEeeeCceeEEEEEE--ccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 9 FRLG-RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 9 y~l~-~~LG~G~fG~Vy~a~~--~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.+. ++||+|+||.||+|.+ ..+++.||||+++.... ...+..|+.++..++| ++|+.+++++.. +..++
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--PYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC--TTBCCEEEEEES-SSEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEec-CCEEE
Confidence 3443 4899999999999965 35678999999875433 2468889999999875 999999998865 45789
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccC
Confidence 99999 8899999974 56799999999999999999999999999999999999995 6789999999999877543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... +.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+......
T Consensus 523 ~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~---- 591 (635)
T 4fl3_A 523 ENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM---- 591 (635)
T ss_dssp ----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----
T ss_pred ccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence 321 112233467889999999999999999999999999999998 9999987543 3333333332221
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
.+...+|.++.+||..||..||++||++.+|++.|++++.+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12356899999999999999999999999999999998864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=346.62 Aligned_cols=261 Identities=17% Similarity=0.226 Sum_probs=201.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeE----eCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGV----EGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~----~~~~ 78 (475)
..++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.| ++|+.++.++. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH--PNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCC--TTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCC--CCeeeEEEEEEeccCCCce
Confidence 35789999999999999999999999999999998765432 2457788888888754 89999987775 2347
Q ss_pred EEEEEEcC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~---~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcc
Confidence 89999999 77999998753 4669999999999999999999999999999999999999 57789999999998
Q ss_pred ccccccccccc--cccccCCCCccCccccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCC--CCHHHHHH
Q 011882 155 KRYRDTATHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYE 227 (475)
Q Consensus 155 ~~~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~~~g~~---~s~ksDIwSlG~iL~elltG~~Pf~~~~~--~~~~~~~~ 227 (475)
+.......... ..........||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-- 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH--
Confidence 76543211000 0000011235799999999998664 68999999999999999999999954211 111111
Q ss_pred HHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 228 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 228 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
+.. .... .....++.++.++|..||+.||.+||++.+|++.|+.+
T Consensus 260 -~~~-~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 -VQN-QLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -HHC-C--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -hhc-cCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 111 1110 11246789999999999999999999999999988765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.88 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=200.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEcc-CC--eEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~-~~--~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
..++|+++++||+|+||.||+|.+.. ++ ..||||+++.... ...+.+|+.+++.++| ++++.++.++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~ 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH--RNLIRLYGVVLTP 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC--TTBCCEEEEECSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC--CCcccEEEEEccC
Confidence 35689999999999999999998653 33 3699998765421 2357788899888864 9999999888766
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
. .++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEccccccc
Confidence 5 78999999 7899999987666799999999999999999999999999999999999995 67899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
.+....... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+.+..+.....
T Consensus 170 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~ 242 (291)
T 1u46_A 170 ALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGE 242 (291)
T ss_dssp ECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCC
T ss_pred cccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHccCC
Confidence 765433211 11234467889999999999889999999999999999999 999998743 3334444433222
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
... ....+|.++.+++..||..||++||++.+|++.|+++.
T Consensus 243 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 RLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111 23568899999999999999999999999999998774
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=348.39 Aligned_cols=260 Identities=18% Similarity=0.232 Sum_probs=203.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+..|++++..+.| ++|+.++.++......++
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH--RNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC--TTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC--CCccceEEEEecCCceEE
Confidence 568899999999999999999984 5789999999865432 2367889988887764 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 82 VIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~---~~ls~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 181 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence 99999 889999997532 2499999999999999999999999 99999999999999 57789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CCCCHHHHHHHH
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKI 229 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~-----~~~~~~~~~~~i 229 (475)
+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||... ........+...
T Consensus 182 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 182 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp EECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 876543321 123456999999999999888999999999999999999999999521 111111111111
Q ss_pred hhcc-cccc-----HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 230 SEKK-VSTS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 230 ~~~~-~~~~-----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.... .... ........+.++.+++..||+.||.+||++.+|++.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 0000 000111234789999999999999999999999888875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.43 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=202.8
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
|...++||+|+||.||+|.+ +++.||||++..... ...+.+|+.+++.++| ++|+.+++++...+..++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH--ENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC--CCeEEEEEEEecCCceEEE
Confidence 34458999999999999984 688999998764321 2457789999988865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 83 IDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 83 me~~-g~sL~~ll~~~--~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccc
Confidence 9999 89999998743 3459999999999999999999999999999999999999 5778999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+........ ..+.
T Consensus 186 ~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 258 (307)
T 2nru_A 186 FAQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIE 258 (307)
T ss_dssp CSSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHH
T ss_pred ccccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhh
Confidence 32211 1234579999999999876 589999999999999999999999987554332222221111110 1111
Q ss_pred HH--------hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 240 AL--------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 240 ~l--------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
.. ...++..+.+++..||..||.+||++.+|++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 259 DYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11 1123578999999999999999999999999998863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.07 Aligned_cols=259 Identities=21% Similarity=0.260 Sum_probs=186.9
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..++ |++|+.++.++...+..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH--HPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC--CTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC--CCCEeeEEEEEeecCCcE
Confidence 34678999999999999999999988899999999876542 2345667777777665 499999999999999999
Q ss_pred EEEEcC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 81 LVIDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~-------~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
+||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEecc
Confidence 999999 8899999874 23459999999999999999999999999999999999999 477899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
++..+....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||......... .....
T Consensus 167 ~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~ 241 (303)
T 2vwi_A 167 VSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQ 241 (303)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHT
T ss_pred chheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhc
Confidence 998765432111 0111234579999999999976 56899999999999999999999999875433221 11111
Q ss_pred ccccc-----cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~-----~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
..... ........++.++.+++.+||..||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111 111223567899999999999999999999988854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=338.00 Aligned_cols=250 Identities=19% Similarity=0.298 Sum_probs=186.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchH---HHHHH-HHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LQYEA-KLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~---~~~E~-~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.++|++++.||+|+||.||+|.+..+++.||||++........ ...|. .+++.+ .|++|+.++.++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~--~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH--DCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT--TCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc--CCCceeeEEEEEecCCcEEE
Confidence 4689999999999999999999999999999999876544322 22222 233333 45999999999999999999
Q ss_pred EEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+++.+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCC
Confidence 999998888888876677899999999999999999999995 99999999999999 57789999999999866543
Q ss_pred ccccccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 235 (475)
.. .....||+.|+|||++. +..++.++|||||||+||||++|..||..... ..+.+..+......
T Consensus 179 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 179 KA--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPP 248 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCC
T ss_pred cc--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCC
Confidence 22 12347999999999995 45689999999999999999999999976432 23333333332221
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.. .....++.++.++|..||..||.+||++.+|++
T Consensus 249 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11 011357899999999999999999999998864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=345.44 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=196.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE--
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY-- 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~-- 78 (475)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++| ++|+.++.++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH--ENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCSSGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCC--CCcccHhheEecccccc
Confidence 457899999999999999999999999999999998654432 346778888888865 999999888776543
Q ss_pred ----EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 79 ----NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 79 ----~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
.|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCT
T ss_pred cceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccc
Confidence 49999999888887764 469999999999999999999999999999999999999 47789999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... ...+..+....
T Consensus 174 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~ 240 (353)
T 3coi_A 174 RHADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVT 240 (353)
T ss_dssp TC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHH
T ss_pred cCCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 8654321 24578999999999987 6789999999999999999999999987433 22222221100
Q ss_pred --------------------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 --------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 --------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.......+...+++++.+||.+||..||++||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00111223346789999999999999999999988774
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=345.94 Aligned_cols=272 Identities=18% Similarity=0.254 Sum_probs=202.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
+..++|++.+.||+|+||.||+|.+.. .||||+++.... ...+.+|+.+++.++| ++|+.+++++......
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH--ENVVLFMGACMSPPHL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC--TTBCCCCEEEECSSCE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC--CCEeEEEEEEecCCce
Confidence 345789999999999999999998743 499998865432 2346778888887765 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccc
Confidence 9999999 7899999986555799999999999999999999999999999999999993 5789999999987653
Q ss_pred ccccccccccccCCCCccCccccccccccC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g---------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i 229 (475)
...... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ......+
T Consensus 181 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~ 255 (319)
T 2y4i_B 181 VLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHH
T ss_pred cccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHh
Confidence 221111 0112234569999999999975 3578999999999999999999999976432 3333333
Q ss_pred hhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011882 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 292 (475)
Q Consensus 230 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 292 (475)
........ ....++.++.+++..||..||++||++.+|++.|+++..+..........|.
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 33222111 1235788999999999999999999999999999998776655444444453
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.85 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=196.4
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
...||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|+.+++++...+..++||||+ ++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH--KNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC--TTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC--CCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 3489999999999999999999999998875533 3557888888888765 99999999999999999999999 88
Q ss_pred CHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 89 SLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 89 sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
+|.+++..... .+++..+..++.||+.||.|||++||+||||||+|||++ ...+.+||+|||+++.+.....
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~---- 178 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP---- 178 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC----
Confidence 99999986533 467899999999999999999999999999999999995 3378999999999987654221
Q ss_pred ccccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 167 PYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ............. ..+...
T Consensus 179 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---~~~~~~ 250 (295)
T 2clq_A 179 ---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVH---PEIPES 250 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCCC---CCCCTT
T ss_pred ---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccccc---cccccc
Confidence 123457999999999998654 789999999999999999999999754321 1111111111111 123356
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
++.++.+++.+||..||++||++.+++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 789999999999999999999988774
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.92 Aligned_cols=242 Identities=21% Similarity=0.321 Sum_probs=193.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhC--CCCCcCeeEEee
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQG--GSTGIPNLRWFG 73 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~--~~~~i~~l~~~~ 73 (475)
.+.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.. .|++|+.++.++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 457889999999999999999999999999999999865432 2345678899888853 459999999999
Q ss_pred EeCCEEEEEEEc-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 74 VEGDYNVLVIDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 74 ~~~~~~~lvme~-~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
...+..++|||+ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence 888899999998 4 8899999975 34699999999999999999999999999999999999995 36789999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
|+++.+..... ....||..|+|||++.+..+ +.++|||||||++|||++|..||... . .+.
T Consensus 185 g~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----~~~ 246 (312)
T 2iwi_A 185 GSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----EIL 246 (312)
T ss_dssp SSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HHH
T ss_pred chhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H----HHh
Confidence 99987654321 34579999999999987766 45899999999999999999999652 1 111
Q ss_pred hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 231 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 231 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..... +...++.++.++|.+||..||++||++.+++
T Consensus 247 ~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 247 EAELH-----FPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp HTCCC-----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhccC-----CcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11111 2356789999999999999999999988874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=334.71 Aligned_cols=258 Identities=19% Similarity=0.219 Sum_probs=194.3
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-------
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------- 75 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------- 75 (475)
++.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.| ++++.++.++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH--QYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEECCCCCC-
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCc--hHHHHHHHHHHhhcchhhh
Confidence 45678999999999999999999999999999999885432 12456778888887764 999998877654
Q ss_pred ------CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 76 ------GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 76 ------~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
....|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl 157 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKI 157 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEE
Confidence 45789999999 789999998766678999999999999999999999999999999999999 57789999
Q ss_pred eecCCcccccccccccc-----c--ccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 011882 149 IDFGLAKRYRDTATHQH-----I--PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 220 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~-----~--~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~ 220 (475)
+|||+++.+........ . .........||+.|+|||++.+. .++.++|||||||++|||++ ||... .
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~ 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--M 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--H
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--h
Confidence 99999987653211000 0 01112345799999999999875 68999999999999999998 66431 1
Q ss_pred CHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 221 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 221 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.....+..+..... .....+...++..+.+++..||..||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ERVNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 12222233322211 1112234567788999999999999999999888753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.65 Aligned_cols=253 Identities=16% Similarity=0.290 Sum_probs=179.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch---HHHHHHH-HHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAK-LYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~---~~~~E~~-il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..++|++++.||+|+||.||+|.+..+++.||||++....... ++..|.. +++. ..|++|+.+++++...+..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~--~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS--SDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSS--CCCTTBCCEEEEEECSSEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHc--CCCCcEeeeeeEEEeCCceE
Confidence 3578999999999999999999999999999999987654332 2333333 2222 24599999999999999999
Q ss_pred EEEEcCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 81 LVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 81 lvme~~g~sL~~ll~~----~~~~ls~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
+||||+.++|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+||||+ .++.+||+|||+++
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSC
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCce
Confidence 9999998899988864 256799999999999999999999998 999999999999994 77899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccc----cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
.+..... .....||+.|+|||++ .+..++.++|||||||++|||++|..||.+.... ...+..+..
T Consensus 175 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 244 (327)
T 3aln_A 175 QLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVK 244 (327)
T ss_dssp C--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC
T ss_pred ecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhc
Confidence 7654322 1234799999999998 4567899999999999999999999999764321 111111111
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.............+++++.+|+..||..||++||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111112457899999999999999999999998854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=368.26 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=209.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccC---CeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..++|++.+.||+|+||.||+|.+..+ +..||||++...... ..+..|+.++..+.| +||+.+++++. .+.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH--PHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEe-cCc
Confidence 346799999999999999999998653 467999987654332 457788888888865 99999988875 456
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCeec
Confidence 79999999 7899999986666799999999999999999999999999999999999995 6789999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
...... ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.......
T Consensus 542 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~ 612 (656)
T 2j0j_A 542 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLP 612 (656)
T ss_dssp CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCC
T ss_pred CCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence 543221 1223467889999999999999999999999999999997 9999987543 33333433322211
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
+...+|+++.+++.+||..||++||++.+|++.|++++.+.
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 23578899999999999999999999999999999998764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.91 Aligned_cols=251 Identities=16% Similarity=0.220 Sum_probs=203.8
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-------------------hHHHHHHHHHHHHhCCCC
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------------PQLQYEAKLYKILQGGST 64 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-------------------~~~~~E~~il~~l~~~~~ 64 (475)
...++|++++.||+|+||.||+|.+ +++.||||++...... ..+.+|+.++..++| +
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ 103 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN--E 103 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC--T
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC--C
Confidence 3457999999999999999999997 8999999987543211 678889999988864 9
Q ss_pred CcCeeEEeeEeCCEEEEEEEcC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcE
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNF 135 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~-g~sL~~l------l~~~-~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NI 135 (475)
+++.+++++...+..++||||+ +++|.++ +... ...+++..++.|+.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 9999999999999999999999 6799988 5422 4569999999999999999999999 9999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCC-CCCC-chhHHHHHHHHHHHHcCCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLP 213 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~-ksDIwSlG~iL~elltG~~P 213 (475)
|+ +.++.+||+|||++....... .....||..|+|||++.+. .++. ++|||||||++|||++|..|
T Consensus 184 l~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 184 LM---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp EE---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EE---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99 577899999999998764431 1345799999999999987 5666 99999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhcccccc--------------HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 214 WQGLKAGTKKQKYEKISEKKVSTS--------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 214 f~~~~~~~~~~~~~~i~~~~~~~~--------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
|...... .+.+..+.......+ .......++.++.+|+..||..||.+||++.++++
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9875431 333444433322111 01112567899999999999999999999888754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.66 Aligned_cols=240 Identities=15% Similarity=0.145 Sum_probs=185.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-----chHHHHHHHHHHHHhCCC-C--------Cc------
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGS-T--------GI------ 66 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~-~--------~i------ 66 (475)
..|++.++||+|+||+||+|.+..+|+.||||++..... ...+.+|..++..+.+.. + .+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999874332 346788888888776520 0 00
Q ss_pred -----CeeEEeeEe-----CCEEEEEEEcCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 011882 67 -----PNLRWFGVE-----GDYNVLVIDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 130 (475)
Q Consensus 67 -----~~l~~~~~~-----~~~~~lvme~~g~sL~~ll~~~------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDI 130 (475)
+.+..+... ....+++|++++++|.++++.. ...+++..++.|+.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111111111 2346889999999999999633 334788899999999999999999999999999
Q ss_pred CCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccc----------cCCCCCCchhHHHH
Q 011882 131 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL 200 (475)
Q Consensus 131 KP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----------~g~~~s~ksDIwSl 200 (475)
||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 57788999999999865443 134577 999999999 55568899999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 201 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 201 G~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
||+||||++|+.||.+...... +.. +...+..+|+++.+||..||..||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---~~~---------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---SEW---------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---SGG---------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---HHH---------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999976432111 011 11123468999999999999999999999887743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.45 Aligned_cols=258 Identities=20% Similarity=0.227 Sum_probs=190.3
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ....+..|+.++..+.. |+||+.++.++......|+|
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~-HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDD-HPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTT-STTBCCEEEEEECSSEEEEE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccC-CCCcCeEEEEEecCCeEEEE
Confidence 4567788889999999999998754 578999999987653 23457789999887743 49999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC----------CCCCcE
Q 011882 83 IDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQV 146 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~------ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----------~~~~~v 146 (475)
|||++++|.+++...... .++..++.|+.||+.||+|||++||+||||||+||||+.+ +....+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999988999999743211 1333567899999999999999999999999999999632 234689
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-------~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
||+|||+|+.+........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999987754322110 01234579999999999976 568999999999999999999 999997643
Q ss_pred CCCHHHHHHHHhhccccc-cHHHH-hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 219 AGTKKQKYEKISEKKVST-SIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~-~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. .. .+....... ....+ ...++.++.++|.+||+.||.+||++.+|+
T Consensus 245 ~~--~~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 245 SR--ES---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp TH--HH---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hh--HH---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 21 11 111111110 00000 112468899999999999999999998875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=323.53 Aligned_cols=231 Identities=11% Similarity=0.074 Sum_probs=189.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.++++|++.++||+|+||.||+|.+..+++.||||++...... ..+..|..++..+. |+||+.++.++...+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID--KPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC--CTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC--CCCcceeeEEEEECCc
Confidence 5678999999999999999999999999999999998765443 45777888777665 4999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.|+||||+ |++|.+++.. .....+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+++|.
T Consensus 106 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~~---- 175 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPAT---- 175 (286)
T ss_dssp EEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCCC----
T ss_pred EEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEeccc----
Confidence 99999999 7899999852 346678999999999999999999999999999999995 678888875432
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
++ .++.++|||||||+||||++|+.||.+...........+... .....
T Consensus 176 -----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~ 224 (286)
T 3uqc_A 176 -----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIE 224 (286)
T ss_dssp -----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCC
T ss_pred -----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCC
Confidence 22 368899999999999999999999987544221100001111 11233
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
...+...+|+++.++|.+||+.||++| ++.++++.|+++.
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 445667899999999999999999999 9999999998875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=322.71 Aligned_cols=234 Identities=17% Similarity=0.205 Sum_probs=183.2
Q ss_pred cCCceEEe-eeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCEE
Q 011882 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDYN 79 (475)
Q Consensus 5 i~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~~ 79 (475)
+.++|.+. +.||+|+||.||+|.+..+++.||||+++. .....+|+.++..+.. |++|+.++.++.. ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhcc-CCCchhHHhhhhhhcCCCceE
Confidence 45678887 789999999999999999999999999863 4567888888855543 4999999888776 6788
Q ss_pred EEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+..+..+.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999 779999998653 36999999999999999999999999999999999999964333788999999998643
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 236 (475)
.. ..++.++|||||||+||||++|..||.+.......... ..+.......
T Consensus 171 ~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 171 TG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221 (299)
T ss_dssp TT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS
T ss_pred cc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC
Confidence 21 24678999999999999999999999764321100000 0011111111
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.......+++++.+++..||..||.+||++.++++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 222 -PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12233578999999999999999999999888743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.15 Aligned_cols=253 Identities=17% Similarity=0.200 Sum_probs=189.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
.+|++.++||+|+||+||.. ...+++.||||++... ......+|+.+++.+. .|+||+.++.++......||||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~-~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESD-EHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhcc-CCCCcCeEEEEEecCCEEEEEEECC
Confidence 35999999999999997643 3478999999988653 3345678999988874 2499999999999999999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC--CCCcEEEeecCCccccccccccc
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+++|.+++......+.+..++.|+.||+.||.|||++||+||||||+||||+.++ ....+||+|||+|+.+......
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~- 179 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS- 179 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc-
Confidence 9999999986555667777889999999999999999999999999999996432 2336889999999876543211
Q ss_pred ccccccCCCCccCcccccccccc---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 165 HIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~---g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
+.......||+.|+|||++. +..++.++|||||||+||||++ |..||..... .+....+....... ..
T Consensus 180 ---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~~--~~ 251 (432)
T 3p23_A 180 ---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQANILLGACSLDC--LH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHHHHHTTCCCCTT--SC
T ss_pred ---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHHHHHhccCCccc--cC
Confidence 11224467999999999998 4567889999999999999999 9999965322 11111111111100 00
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+..+.+||.+||+.||.+||++.+|+
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 0112356689999999999999999998875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=351.66 Aligned_cols=241 Identities=15% Similarity=0.195 Sum_probs=192.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEcc-CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE-
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY- 78 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~- 78 (475)
++.++|++.++||+|+||.||+|.+.. +++.||||++...... ..+..|+.++..++| ++|+.++.++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH--PSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC--TTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC--CCcCeEeeeEeecCCC
Confidence 467899999999999999999999976 7899999987654332 246678888887764 999999988876554
Q ss_pred ----EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 79 ----NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 79 ----~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
.||||||+ |++|.+++. ..+++.+++.|+.||+.||.|||++|||||||||+||||+ . +.+||+|||+
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~ 227 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGA 227 (681)
T ss_dssp SCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTT
T ss_pred CCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEeccc
Confidence 79999999 789988765 3799999999999999999999999999999999999994 3 4899999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++..... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||.+.......
T Consensus 228 a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------- 285 (681)
T 2pzi_A 228 VSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------- 285 (681)
T ss_dssp CEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------
T ss_pred chhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------
Confidence 9876432 2457999999999998754 89999999999999999999998753211100
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFI 279 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~l~~ 279 (475)
..... ..+++.+.++|.+||..||++||+ ++++.+.|..++.
T Consensus 286 ~~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 EDDPV----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp TTCHH----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccc----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00001 113578999999999999999995 6667777766653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=352.93 Aligned_cols=265 Identities=18% Similarity=0.240 Sum_probs=199.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe------
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE------ 75 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~------ 75 (475)
..++|++.++||+|+||.||+|.+..+|+.||||++...... ..+.+|++++..+.| +||+.++.+...
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H--pnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH--PNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB--TTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC--CCCCceeeeecccccccC
Confidence 458899999999999999999999999999999988654332 347789999998865 999999887654
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~--~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.+..++||||+ |++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 67789999999 8999999985432 58999999999999999999999999999999999999754445569999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC------HHHHH
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY 226 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~------~~~~~ 226 (475)
+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .....
T Consensus 170 ~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred cccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9987654322 234689999999999999999999999999999999999999996531100 00000
Q ss_pred HHHh-----hc-----cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHH-----HHHHHHHHHH
Q 011882 227 EKIS-----EK-----KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-----LKRLFRDLFI 279 (475)
Q Consensus 227 ~~i~-----~~-----~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-----l~~~L~~l~~ 279 (475)
..+. .. ........+...++..+.++|..||..||++||++.+ ..+.+++++.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 00 0000011122346789999999999999999999977 4455555553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=320.81 Aligned_cols=242 Identities=19% Similarity=0.174 Sum_probs=182.4
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------hHHHHHHHHHHHHhC-------CCCCcCe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQG-------GSTGIPN 68 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~-------~~~~i~~ 68 (475)
.++|+++++||+|+||+||+|++ +|+.||||++...... ..+.+|+.+++.++. .|++++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999997 7899999998765322 568899999999972 3478877
Q ss_pred eEEeeE------------------------------eCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 011882 69 LRWFGV------------------------------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 117 (475)
Q Consensus 69 l~~~~~------------------------------~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL 117 (475)
+..... .....||||||+ ++++.+.+. ...+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 765532 267899999998 665444443 35689999999999999999
Q ss_pred HHHH-hCCceecCCCCCcEEEeeCC-----------------CCCcEEEeecCCcccccccccccccccccCCCCccCcc
Q 011882 118 EFVH-SKSFLHRDIKPDNFLMGLGR-----------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179 (475)
Q Consensus 118 ~yLH-~~gIvHrDIKP~NILl~~~~-----------------~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~ 179 (475)
.||| ++|||||||||+||||+.++ ....+||+|||+|+.+... ...||+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~ 242 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCDV 242 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEeec
Confidence 9999 99999999999999996332 1128999999999876542 2379999
Q ss_pred ccccccccCCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCCCCHHHHHHHHhhc-cc-cccHHHHhcCChHHHHHHHHHH
Q 011882 180 YASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEK-KV-STSIEALCRGYPTEFASYFHYC 256 (475)
Q Consensus 180 Y~APE~~~g~~~s~ksDIwSlG~i-L~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~-~~~~~~l~~~~p~~l~~li~~c 256 (475)
|+|||++.+.. +.++||||||++ .++++.|..||.+... .......+... .. ......+...+++++.+||.+|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999999876 899999998777 7778889999843100 01111122110 00 1111223345688999999999
Q ss_pred hcCCCCCCCCHHHHH
Q 011882 257 RSLRFDDKPDYAYLK 271 (475)
Q Consensus 257 l~~dp~~RPt~~~l~ 271 (475)
|+.| ++.+++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 776664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=290.85 Aligned_cols=185 Identities=15% Similarity=0.116 Sum_probs=130.3
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccCCC------------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~------------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
..++.|++|.+..++....|+.||||++..... ..++.+|+++|+.+.. |++|+.++.+++++...|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~-~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPA-GFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCT-TCCCCCEEEEEECSSEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEEECCEEE
Confidence 346778888888888788999999999865421 1347889999998865 399999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||||+ |++|.+++.. .+.++.. .|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 319 LVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC-
T ss_pred EEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCC
Confidence 999999 8999999984 4567765 578999999999999999999999999999 5788999999999987655
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCC
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 213 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~P 213 (475)
... ...+.+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 392 ~~~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 432 12346899999999999874 67789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=257.46 Aligned_cols=188 Identities=21% Similarity=0.202 Sum_probs=143.3
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----------hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
...++||+|+||.||+|. ..++.+++|....+... ..+.+|+++++.++| ++|+.+..++...+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD--FGIPAPYIFDVDLDNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG--GTCCCCCEEEEETTTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC--CCcCceEEEEEeCCcc
Confidence 345789999999999995 56889999976543321 236889999999976 8888666666677778
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||+ |++|.+++.. ++.|+.||+.||.|||++||+||||||+|||++ . .+||+|||+|+.+.
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECC
Confidence 9999999 7999999863 678999999999999999999999999999994 3 99999999999876
Q ss_pred ccccccccccccCCCCccCccccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 215 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g--~~~s~ksDIwSlG~iL~elltG~~Pf~ 215 (475)
.........+.....+.||+.|||||++.+ ..|+..+|+|+..+-.++-+.++-+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532211000111234689999999999987 557888999999999998888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.4e-25 Score=214.10 Aligned_cols=141 Identities=17% Similarity=0.265 Sum_probs=111.3
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------------------chHHHHHHHHHHHHhCCCCCcC
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLQYEAKLYKILQGGSTGIP 67 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------------------~~~~~~E~~il~~l~~~~~~i~ 67 (475)
.|++++.||+|+||.||+|.+ .+|+.||||+++.... ...+.+|..++..+. + ..++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C-CCcC
Confidence 455669999999999999999 8899999999864321 134778999999988 2 5454
Q ss_pred eeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcE
Q 011882 68 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 146 (475)
Q Consensus 68 ~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~v 146 (475)
.+. .. +..|+||||+ |++|.+ +. ......++.||+.||.|||++||+||||||+||||+ ++.+
T Consensus 168 ~~~---~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~v 231 (282)
T 1zar_A 168 KVY---AW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGI 231 (282)
T ss_dssp CEE---EE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEE
T ss_pred eEE---ec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcE
Confidence 432 22 4459999999 779987 32 134567999999999999999999999999999994 7899
Q ss_pred EEeecCCcccccccccccccccccCCCCccCcccccccccc
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 187 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~ 187 (475)
||+|||+|+. +..|+|||.+.
T Consensus 232 kl~DFG~a~~--------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE--------------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE--------------------TTSTTHHHHHH
T ss_pred EEEECCCCeE--------------------CCCCCHHHHHH
Confidence 9999999963 34578898875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3e-22 Score=193.30 Aligned_cols=137 Identities=19% Similarity=0.296 Sum_probs=108.7
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeE--EEEEEeccCCCc--------------------------hHHHHHHHHHHHH
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--------------------------PQLQYEAKLYKIL 59 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~--vAvKi~~~~~~~--------------------------~~~~~E~~il~~l 59 (475)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ..+.+|..++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998788999 999986543111 1477899999999
Q ss_pred hCCCCCcCeeEEeeEeCCEEEEEEEcCCC------CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCC
Q 011882 60 QGGSTGIPNLRWFGVEGDYNVLVIDLLGP------SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP 132 (475)
Q Consensus 60 ~~~~~~i~~l~~~~~~~~~~~lvme~~g~------sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP 132 (475)
.+....++.++.+ ...+|||||+|+ +|.++... +++..+..++.||+.||.||| ++|||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8743345555443 246899999952 77766431 335578899999999999999 99999999999
Q ss_pred CcEEEeeCCCCCcEEEeecCCcccc
Q 011882 133 DNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 133 ~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-18 Score=171.10 Aligned_cols=136 Identities=17% Similarity=0.245 Sum_probs=97.2
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC----------------chH--------HHHHHHHHHHHhCCCC
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------HPQ--------LQYEAKLYKILQGGST 64 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~----------------~~~--------~~~E~~il~~l~~~~~ 64 (475)
|+|+++||.|+||.||+|.+ .+|+.||||+++.... ... ...|...+..+.....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 5799999998653210 000 1346667777755222
Q ss_pred CcCeeEEeeEeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCC
Q 011882 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 143 (475)
Q Consensus 65 ~i~~l~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~ 143 (475)
.++..+ .... .+|||||+ |..|..+. .......++.||+.+|.|||++|||||||||.||||+.+.+.
T Consensus 176 ~vp~p~--~~~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPI--AQSR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEE--EEET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeee--eccC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 233332 2222 37999999 65665432 123456788999999999999999999999999999743211
Q ss_pred -------CcEEEeecCCccc
Q 011882 144 -------NQVYIIDFGLAKR 156 (475)
Q Consensus 144 -------~~vkL~DFGlA~~ 156 (475)
..+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 1489999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-12 Score=124.39 Aligned_cols=137 Identities=17% Similarity=0.278 Sum_probs=110.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC--CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~--~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.|++...++.|+++.||++.. .++.++||+.... .....+..|..+++.+.. +..++.++.++...+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CCCCCeEEEEEecCCceEEEEE
Confidence 5699999999999999999973 4789999997642 233468999999999976 3778899999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS----------------------------------------- 122 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~----------------------------------------- 122 (475)
++ |.+|.+.+. +......++.+++.+|..||+
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99 778876531 122345788999999999998
Q ss_pred ------------------CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 ------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 ------------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
..++|+|++|.|||+. +...+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999994 34456799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=117.64 Aligned_cols=135 Identities=16% Similarity=0.084 Sum_probs=100.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
..|.+....+.|..+.||++. ..+|..|+||+.... ....+..|..+++.+......++.++.++...+..++|||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 457776555566679999996 356778999987654 345688999999999875334777888888777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----------------------------------------- 124 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g----------------------------------------- 124 (475)
|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 66663 21 122 2356777778888888643
Q ss_pred -----------------ceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 125 -----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 125 -----------------IvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
++|+|++|.|||+. +.+.+.|+|||.|.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999994 34456799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=1.1e-10 Score=117.12 Aligned_cols=140 Identities=13% Similarity=0.211 Sum_probs=104.4
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEec--cCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC---CEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG---DYNVLV 82 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~--~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~---~~~~lv 82 (475)
-++.|+.|.++.||++.. .+..+++|+.. ... ....+.+|..+++.|......++.++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 467889999999999874 35688899765 322 23468899999999987556688888887766 447899
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------------------------------------- 122 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~--------------------------------------- 122 (475)
||++ |..+.+. .-..++..+...++.+++..|..||.
T Consensus 120 me~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999 5555331 12347888889999999999999997
Q ss_pred -------------------CCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 123 -------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 123 -------------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+||+|++|.|||+..+ ....+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 368999999999999521 113468999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=2.5e-11 Score=119.12 Aligned_cols=190 Identities=16% Similarity=0.190 Sum_probs=122.2
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCC-CCCcCeeEEeeEeCC---EEEEEEEcC-
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-STGIPNLRWFGVEGD---YNVLVIDLL- 86 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~~~---~~~lvme~~- 86 (475)
++.|+.|.+..||++. ..++||+.........+..|.++++.+... ...++.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 458999865332335688999999988542 233566666654433 458899999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 011882 87 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------- 122 (475)
Q Consensus 87 g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-------------------------------------------- 122 (475)
|.+|.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 667765332 247888888899999999999986
Q ss_pred --------------CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccC---------cc
Q 011882 123 --------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT---------AR 179 (475)
Q Consensus 123 --------------~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT---------~~ 179 (475)
..++|+|++|.|||++.+ ....+.|+||+.+........-..... .. ...+. ..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~-~~-~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLME-DD-EEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCC-TT-TSCCHHHHHHHHHHHT
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHh-hc-cccCHHHHHHHHHHcC
Confidence 137999999999999511 145678999999875322111000000 00 00000 00
Q ss_pred ccc-cccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 011882 180 YAS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214 (475)
Q Consensus 180 Y~A-PE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf 214 (475)
+.. |+.... .....+.|++++++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 121111 122368999999999999998877
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=9.6e-08 Score=93.74 Aligned_cols=137 Identities=23% Similarity=0.273 Sum_probs=93.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCC-CCCcCeeEEeeE-eCCEEEEEEEcC-CC
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-STGIPNLRWFGV-EGDYNVLVIDLL-GP 88 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~-~~~~~~lvme~~-g~ 88 (475)
++.++.|....||+. +..++||+-........+..|.++++.+... ...++.+..++. ..+..+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888999987 5678899853222235688999999999863 234677777764 455678999999 66
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 011882 89 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------------------------------- 123 (475)
Q Consensus 89 sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~--------------------------------------------- 123 (475)
.|.+..- ..++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 6655321 1345555555666666666655542
Q ss_pred ---------------CceecCCCCCcEEEeeCCCCCc-EEEeecCCccc
Q 011882 124 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKR 156 (475)
Q Consensus 124 ---------------gIvHrDIKP~NILl~~~~~~~~-vkL~DFGlA~~ 156 (475)
.++|+|++|.|||+..++..+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999952111344 58999998863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.5e-07 Score=88.54 Aligned_cols=132 Identities=17% Similarity=0.162 Sum_probs=95.8
Q ss_pred eEeeeCce-eEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCHH
Q 011882 14 KIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLE 91 (475)
Q Consensus 14 ~LG~G~fG-~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL~ 91 (475)
.+..|..| .||+......+..++||+-... ....+..|..+++.|... .-+|.++.++.+.+..++||+++ |.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~-vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAF-MPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTT-SCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccC-CCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445555 6999887667788999986533 234688899999999765 55888999999999999999999 66777
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 011882 92 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSK------------------------------------------------ 123 (475)
Q Consensus 92 ~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~------------------------------------------------ 123 (475)
+..... ......+..++...|..||..
T Consensus 109 ~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 665421 122334555666666666631
Q ss_pred ----------CceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 124 ----------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 124 ----------gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.++|+|+.+.|||+. ..+.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 268999999999994 44556799999885
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3.8e-07 Score=91.08 Aligned_cols=81 Identities=14% Similarity=0.299 Sum_probs=57.1
Q ss_pred eEEeeeE-eeeCceeEEEEEEc--c----CCeEEEEEEeccCC-----CchHHHHHHHHHHHHhCC-CCCcCeeEEeeEe
Q 011882 9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGG-STGIPNLRWFGVE 75 (475)
Q Consensus 9 y~l~~~L-G~G~fG~Vy~a~~~--~----~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~ 75 (475)
....+.| +.|....+|+.... . +++.+++|+..... ....+..|..+++.|... ...++.++.++..
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88889999998742 1 26789999865432 135688999999998763 3557778777655
Q ss_pred C---CEEEEEEEcC-CCC
Q 011882 76 G---DYNVLVIDLL-GPS 89 (475)
Q Consensus 76 ~---~~~~lvme~~-g~s 89 (475)
. ...++|||++ |..
T Consensus 102 ~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp STTTSSCEEEEECCCCBC
T ss_pred CCccCCceEEEEecCCCC
Confidence 4 3568999999 434
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2e-06 Score=87.15 Aligned_cols=76 Identities=13% Similarity=0.142 Sum_probs=51.0
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---------CchHHHHHHHHHHHHhCCC-CCcCeeEEeeEeCCEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLQYEAKLYKILQGGS-TGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---------~~~~~~~E~~il~~l~~~~-~~i~~l~~~~~~~~~~~ 80 (475)
-.+.||.|.++.||++....+++.|+||...... .......|.++++.+.... ..+|.++.+. .+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 3568999999999999755567889999754221 2245688999999886532 3455666543 44568
Q ss_pred EEEEcCCC
Q 011882 81 LVIDLLGP 88 (475)
Q Consensus 81 lvme~~g~ 88 (475)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999944
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=6.5e-06 Score=81.02 Aligned_cols=72 Identities=11% Similarity=0.148 Sum_probs=44.8
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEE------eeEeCCEEEEEEEc
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRW------FGVEGDYNVLVIDL 85 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~------~~~~~~~~~lvme~ 85 (475)
++.|+.|..+.||++.. .+..+++|+... ....+..|..+++.|......++.++. +....+..+++|++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 44566677899999874 344599998765 234566788888877642234454443 22356778999999
Q ss_pred CC
Q 011882 86 LG 87 (475)
Q Consensus 86 ~g 87 (475)
+.
T Consensus 113 i~ 114 (346)
T 2q83_A 113 IE 114 (346)
T ss_dssp CC
T ss_pred ec
Confidence 93
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.4e-05 Score=77.99 Aligned_cols=74 Identities=14% Similarity=0.288 Sum_probs=48.3
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEecc-----CC----CchHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KT----KHPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~-----~~----~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~~ 80 (475)
-++.||.|..+.||++. .+++.++||.... .. .......|.+++..+.. ....+|.++.++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 35678999999999996 3567899993211 11 11344556666655532 124567777665 56678
Q ss_pred EEEEcC-CC
Q 011882 81 LVIDLL-GP 88 (475)
Q Consensus 81 lvme~~-g~ 88 (475)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00013 Score=71.52 Aligned_cols=73 Identities=22% Similarity=0.299 Sum_probs=58.7
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCC-CCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-STGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
-.+.|+.|.+..+|+... ++..++||+.... ....+..|...++.|... ...+|.++.++...+..++|||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 457789999999999873 5778999986543 245688899999998753 366888888888888899999999
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00015 Score=70.43 Aligned_cols=68 Identities=12% Similarity=0.091 Sum_probs=46.5
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CC
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GP 88 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~ 88 (475)
++.|+.|....+|++ +.+++|+...... .-....|..+++.+... ...+.++.+. .+..+++++|+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~-g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKA-GVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHT-TSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHc-CCCCceEEEE--CCCCEEEEeecCCC
Confidence 788999999999998 4588998654321 12356799999888764 2236666543 33457889998 44
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00035 Score=68.16 Aligned_cols=141 Identities=18% Similarity=0.219 Sum_probs=80.7
Q ss_pred EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEe------eEeCCEEEEEE
Q 011882 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWF------GVEGDYNVLVI 83 (475)
Q Consensus 10 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~------~~~~~~~~lvm 83 (475)
.-++.|+.|....+|++.. .++ .+++|+.........+..|..+++.|......++.+... ....+..+++|
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3456778888899999874 333 688998775434567888999999887532334544322 22346678999
Q ss_pred EcC-CCCH-----HH------H---HHHcCCCC--------C---HHHHHH------------HHHHHHHHHHHHHh---
Q 011882 84 DLL-GPSL-----ED------L---FNFCSRKL--------S---LKTVLM------------LADQMINRVEFVHS--- 122 (475)
Q Consensus 84 e~~-g~sL-----~~------l---l~~~~~~l--------s---~~~~~~------------i~~qi~~aL~yLH~--- 122 (475)
+++ |..+ .. . ++.....+ . +...+. +...+...++++..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 998 4332 11 1 11111111 1 111000 01123445556653
Q ss_pred ----CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 ----~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.+++|+|+.+.|||+. .++.+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3699999999999994 33445799999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00017 Score=70.99 Aligned_cols=141 Identities=18% Similarity=0.154 Sum_probs=75.3
Q ss_pred eeeEeeeCcee-EEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcCC-CC
Q 011882 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLLG-PS 89 (475)
Q Consensus 12 ~~~LG~G~fG~-Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~g-~s 89 (475)
++.|+.|+... +|+... .+++.+++|...... ...+..|..+++.+......++.++.+..... +++||+++ ..
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 34565555444 667652 236778888654331 14567788998888764344677776644433 68999984 45
Q ss_pred HHHHHHHc-------------------C------CCCCHHHHHH-------HH-------------HHHHHHHHHH----
Q 011882 90 LEDLFNFC-------------------S------RKLSLKTVLM-------LA-------------DQMINRVEFV---- 120 (475)
Q Consensus 90 L~~ll~~~-------------------~------~~ls~~~~~~-------i~-------------~qi~~aL~yL---- 120 (475)
+.+.+... . ..++...... +. ..+...+..|
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54333210 0 0122211110 00 0111222333
Q ss_pred --HhCCceecCCCCCcEEEeeCCC-CCcEEEeecCCccc
Q 011882 121 --HSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKR 156 (475)
Q Consensus 121 --H~~gIvHrDIKP~NILl~~~~~-~~~vkL~DFGlA~~ 156 (475)
+...++|+|+.+.|||+..+.. .+.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1347999999999999952100 25789999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00096 Score=64.16 Aligned_cols=77 Identities=12% Similarity=0.141 Sum_probs=56.5
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCC-CCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGG-STGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~-~~~i~~l~~~~~~~~~~~l 81 (475)
.+.+..-++.+|.|..+.||+.+ ..+|+.|+||+...... ...+..|.+.|+.|... ...+|.++.. .. .++
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 45677788999999999999998 46889999998654332 24578899999999653 2335555544 33 368
Q ss_pred EEEcC
Q 011882 82 VIDLL 86 (475)
Q Consensus 82 vme~~ 86 (475)
|||++
T Consensus 88 v~e~l 92 (288)
T 3f7w_A 88 AMEWV 92 (288)
T ss_dssp EEECC
T ss_pred EEEee
Confidence 89988
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0022 Score=58.97 Aligned_cols=140 Identities=13% Similarity=0.124 Sum_probs=90.2
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccccc
Q 011882 88 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 166 (475)
Q Consensus 88 ~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~ 166 (475)
.+|.+++...+.+|++++++.++.|.+.+|.-+-. +.-..+=+-|..|+|. .+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 48999999889999999999999999999877621 1111222346788883 667666553 2111
Q ss_pred ccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcCCh
Q 011882 167 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 246 (475)
Q Consensus 167 ~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 246 (475)
.....+.+||... ...+.+.=|||||++||..+-=.+|=.. ...++
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-------------------------E~eLS 143 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-------------------------ERELS 143 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-------------------------EECCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-------------------------chhhC
Confidence 1122456777653 2346788999999999998873333111 14567
Q ss_pred HHHHHHHHHHhcC-------------------------CCCCCCCHHHHHHHHHH
Q 011882 247 TEFASYFHYCRSL-------------------------RFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 247 ~~l~~li~~cl~~-------------------------dp~~RPt~~~l~~~L~~ 276 (475)
+.|..||..|..- .+..|+++++|+++...
T Consensus 144 ~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 144 PPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp HHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 8888888888755 24577888888766553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0013 Score=64.32 Aligned_cols=74 Identities=11% Similarity=0.077 Sum_probs=49.0
Q ss_pred eeEeeeCceeEEEEEEccCCeEEEEEEeccC-CCchHHHHHHHHHHHHhCCCCCcCeeEEe-----eEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGSTGIPNLRWF-----GVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~~i~~l~~~-----~~~~~~~~lvme~~ 86 (475)
..|+ |....||++.. .+|+.+++|+.... .....+..|..++..|......++.+... ...++..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889998763 45667999998643 23456788999999887532334444332 12356678899999
Q ss_pred CC
Q 011882 87 GP 88 (475)
Q Consensus 87 g~ 88 (475)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0016 Score=64.91 Aligned_cols=71 Identities=14% Similarity=0.037 Sum_probs=43.8
Q ss_pred eeeEeeeCceeEEEEEEcc--------CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~--------~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+.|+.|....+|++.... .++.|++|+....... .....|..+++.+... ...+.++... . .+++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~-g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKY-KIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHT-TSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhc-CCCCceEEec--C--CcEE
Confidence 5567888888999998543 1368999986543211 1347899999988764 2256665433 2 3689
Q ss_pred EEcCC
Q 011882 83 IDLLG 87 (475)
Q Consensus 83 me~~g 87 (475)
|+++.
T Consensus 113 ~e~i~ 117 (369)
T 3c5i_A 113 EEWLY 117 (369)
T ss_dssp EECCC
T ss_pred EEEec
Confidence 99983
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.005 Score=62.94 Aligned_cols=70 Identities=13% Similarity=0.092 Sum_probs=49.1
Q ss_pred EeeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
-++.|+.|-...||++.... .++.|+||+.... .. ..+..|..+++.|... ...+.+++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~-g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSER-HLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHT-TSSSCEEEEET--T--EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhC-CCCCcEEEEeC--C--CEE
Confidence 35678888889999998642 2578999987432 23 5677899999998764 33466655432 2 388
Q ss_pred EEcC
Q 011882 83 IDLL 86 (475)
Q Consensus 83 me~~ 86 (475)
|+|+
T Consensus 151 ~e~l 154 (429)
T 1nw1_A 151 EEYI 154 (429)
T ss_dssp ECCC
T ss_pred EEEe
Confidence 9988
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0043 Score=62.38 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=80.2
Q ss_pred eeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
++.|..|-...+|++.... +++.|+||+..... ......+|..+++.|... ...+.+++++.. .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~-gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAER-SLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHT-TSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhc-CCCCeEEEEcCC----ccEE
Confidence 3567778888999998532 35789999853322 234567899999998764 335777655432 3899
Q ss_pred EcC-CCCHH--------------HHHHH---cC----CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 011882 84 DLL-GPSLE--------------DLFNF---CS----RKLS--LKTVLMLADQMIN-------------------RVEFV 120 (475)
Q Consensus 84 e~~-g~sL~--------------~ll~~---~~----~~ls--~~~~~~i~~qi~~-------------------aL~yL 120 (475)
||+ |..|. +.+.. .. +... +.++..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 998 33321 11111 11 1122 3455656554422 23333
Q ss_pred Hh--------CCceecCCCCCcEEEeeC-CCCCcEEEeecCCcc
Q 011882 121 HS--------KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 155 (475)
Q Consensus 121 H~--------~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGlA~ 155 (475)
.+ ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 258999999999999632 123689999999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.024 Score=58.36 Aligned_cols=71 Identities=15% Similarity=0.066 Sum_probs=46.9
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
-++.|+.|-...+|++.....+..|++|+...... .-....|..++..|... ...+.+++++ .+ .+||+|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~-gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNK-NIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTS-SSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhc-CCCCCEEEEe--CC--eEEEEee
Confidence 35678888889999998644358899998744321 11236899999999864 3456666655 22 3599998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0089 Score=58.94 Aligned_cols=66 Identities=11% Similarity=0.155 Sum_probs=41.7
Q ss_pred eCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCC-cCeeEEe------eEeCCEEEEEEEcC-CCC
Q 011882 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTG-IPNLRWF------GVEGDYNVLVIDLL-GPS 89 (475)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~-i~~l~~~------~~~~~~~~lvme~~-g~s 89 (475)
|....||++.. .+| .+++|+...... ..|..+++.|...... ++.+... ....+..+++|+++ |..
T Consensus 34 g~~N~vy~v~~-~~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 34 DTNAFAYQADS-ESK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp CSSCEEEEEEC-SSC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred ccccceEEEEe-CCC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 33679999873 345 899998765432 4677788777643222 4444322 23457789999999 443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.24 E-value=0.078 Score=53.95 Aligned_cols=71 Identities=10% Similarity=0.105 Sum_probs=47.9
Q ss_pred EeeeEeeeCceeEEEEEEccC-------CeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~-------~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
-++.|..|-...+|++..... ++.|+||+...... .-...+|..+++.+... ...+.++.. .. .++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~-gi~P~l~~~--~~--~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNI-NIAPNIIAD--FP--EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHT-TSSCCEEEE--ET--TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhc-CCCCCEEEE--cC--CCEE
Confidence 345677788889999986421 57899998644321 22457899999998764 345666642 33 3788
Q ss_pred EEcC
Q 011882 83 IDLL 86 (475)
Q Consensus 83 me~~ 86 (475)
|+|+
T Consensus 149 ~efI 152 (424)
T 3mes_A 149 EEFI 152 (424)
T ss_dssp EECC
T ss_pred EEEe
Confidence 9999
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.66 E-value=0.16 Score=51.10 Aligned_cols=32 Identities=28% Similarity=0.503 Sum_probs=25.9
Q ss_pred ceecCCCCCcEEEeeC---CCCCcEEEeecCCccc
Q 011882 125 FLHRDIKPDNFLMGLG---RRANQVYIIDFGLAKR 156 (475)
Q Consensus 125 IvHrDIKP~NILl~~~---~~~~~vkL~DFGlA~~ 156 (475)
++|+|+.+.|||+..+ ++...++|+||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999532 3467799999998863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 475 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-96 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-93 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-19 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-19 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 290 bits (743), Expect = 3e-96
Identities = 231/300 (77%), Positives = 272/300 (90%), Gaps = 1/300 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++
Sbjct: 61 GGV-GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
HSK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240
AS+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 300
LC+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 282 bits (723), Expect = 2e-93
Identities = 175/292 (59%), Positives = 215/292 (73%), Gaps = 3/292 (1%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGST 64
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL+ E + YK+L G T
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG-CT 61
Query: 65 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
GIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 125 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242
+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 294
G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-31
Identities = 48/272 (17%), Positives = 101/272 (37%), Gaps = 28/272 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGS 63
+ F ++G+G+ G ++ ++ + +A K LE Q+ E ++ S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--S 63
Query: 64 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
I + ++ + G SL+ + + ++ + + ++ +I + ++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 123 K-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT Y
Sbjct: 123 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 170
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241
S G S + D+ S+G L+ G P A + + +E
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VEGD 222
Query: 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 273
P + S D +P A + L
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 5e-31
Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 32/285 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGG 62
+ +G++IGSGSFG +Y G + + +VA+K+ NV PQ + E + + +
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 63 STGIPNL-RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
N+ + G + +V G SL + K + ++ +A Q +++
Sbjct: 64 ----VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+H+KS +HRD+K +N + V I DFGLA + + L+G+
Sbjct: 120 LHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSIL 171
Query: 180 YASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 236
+ + ++ S + D+ + G VL + G LP+ + + Q + +S
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSP 229
Query: 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 277
+ + P C + D++P + A ++ L R L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (302), Expect = 5e-31
Identities = 44/213 (20%), Positives = 93/213 (43%), Gaps = 14/213 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGST 64
+ + + ++G+G+FG ++ T T A K + ++ ++ E + +L+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--HP 83
Query: 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ NL + + V++ + + G L + K+S + Q+ + +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
+++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 144 NYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAP 194
Query: 184 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
G D+ S+G + L G P+ G
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-31
Identities = 45/230 (19%), Positives = 97/230 (42%), Gaps = 16/230 (6%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTGI 66
K+ + +G G FG ++ + + K ++ T ++ E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--HRNI 63
Query: 67 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
+L + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 185
H DI+P+N + RR++ + II+FG A++ + + + Y +
Sbjct: 124 GHFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEV 174
Query: 186 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
H S D+ SLG ++ L G P+ T +Q E I + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYT 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 7e-31
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 26/248 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLYKI 58
+++++G +GSG FG +Y G + N VAIK ++ E L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59 LQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 116
+ G +G+ L + D VL+++ P DLF+F + + L + Q++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
V H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171
Query: 177 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
T Y+ R + SLG +L + G +P++ + + + ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228
Query: 236 TSIEALCR 243
+ + L R
Sbjct: 229 SECQHLIR 236
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 20/234 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
F+ G+ +G GSF + L + T+ E AIK + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 63 STGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
L + + + + L ++++ +E++H
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH 125
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
K +HRD+KP+N L+ + I DFG AK + + GTA+Y
Sbjct: 126 GKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYV 177
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
S + DL +LG ++ + G P++ G + ++KI + +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 22/234 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
F +GR +G G FG +YL Q+ +A+K QL+ E ++ L+
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
I L + + L+++ K + ++ N + + H
Sbjct: 65 -HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
SK +HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 124 SKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYL 171
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 41/233 (17%), Positives = 90/233 (38%), Gaps = 23/233 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGI 66
+ + ++G G+FG++Y N +T+ A K+ + K++ E + I
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD--HPNI 71
Query: 67 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
L + ++I+ G +++ + R L+ + ++ Q ++ + ++H
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 185
+HRD+K N L + + DFG++ + T + + GT + +
Sbjct: 132 IHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEV 181
Query: 186 HLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233
+ R D+ SLG L+ P L + KI++ +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (295), Expect = 5e-30
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 21/236 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
+ NL + VL+++ L G L D K+S V+ Q ++
Sbjct: 85 --HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+H S +H DIKP+N + ++A+ V IIDFGLA + + T TA
Sbjct: 143 MHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAE 193
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
+A+ D+ ++G + L G P+ G + + +
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-29
Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 20/248 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGS 63
+ L + +G G++GE+ L N T E VA+K ++ ++ E + K+L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--H 62
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ EG+ L ++ + Q++ V ++H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
HRDIKP+N L+ + + I DFGLA +R + + + GT Y +
Sbjct: 123 GITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAP 174
Query: 184 NTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVST 236
E + D+ S G VL L G LPW + K++K KK+ +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 237 SIEALCRG 244
+ AL
Sbjct: 235 APLALLHK 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (278), Expect = 2e-28
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 20/223 (8%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
+ +++ LG +G G E++L +++ + +VA+K L + + + + EA+
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 59 LQGGSTGIPNLRWFGVE----GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM 113
L I + G G +V++ + G +L D+ + ++ K + +
Sbjct: 64 LN--HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADA 120
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAA 173
Query: 174 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 24/235 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
N F + +G G+FG++ L T A+K + K + E+++ + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 119
+ L++ D L + + +LF SR+ + + ++++ +E+
Sbjct: 64 -HPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+HS+ ++RDIK +N ++ + + I DFGL K GT
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234
Y + + R D LG V+ + G LP+ ++ +E I +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 2e-27
Identities = 48/249 (19%), Positives = 88/249 (35%), Gaps = 29/249 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
F R+IG GSFG +Y +++ +E VAIK + K + E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-- 73
Query: 63 STGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
R + LV++ S DL + L + + + + ++HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
+ +HRD+K N L+ V + DFG A + GT + +
Sbjct: 134 HNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMA 179
Query: 183 MNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKV 234
L +++ + D D+ SLG + P + A + + + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW 239
Query: 235 STSIEALCR 243
S
Sbjct: 240 SEYFRNFVD 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 2e-27
Identities = 50/236 (21%), Positives = 100/236 (42%), Gaps = 20/236 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
+ + + +G+G+F E+ L + +T + VAIK + ++ K ++ E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 119
I L G + L++ L+ S +LF+ K + + L Q+++ V++
Sbjct: 66 -HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+H +HRD+KP+N L +++ I DFGL+K + GT
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPG 174
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
Y + S+ D S+G + L G P+ + +E+I + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 3e-27
Identities = 53/246 (21%), Positives = 97/246 (39%), Gaps = 23/246 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGST 64
K+ KIG G+ G +Y ++ T +EVAI+ N++ K + E + + + +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK--NP 77
Query: 65 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
I N + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 136 QVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAP 185
Query: 184 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTS 237
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 238 IEALCR 243
Sbjct: 246 FRDFLN 251
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-27
Identities = 58/275 (21%), Positives = 110/275 (40%), Gaps = 22/275 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
+L ++G+G FGE+++G + +VA+K L+ EA L K LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ--HQR 69
Query: 66 IPNLRWFGVEGDYNVLVIDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ L + ++ + SL D L KL++ +L +A Q+ + F+ ++
Sbjct: 70 LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAPE 180
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD---- 233
Query: 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
P E C R +D+P + YL+ + D F
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 8e-27
Identities = 68/295 (23%), Positives = 109/295 (36%), Gaps = 27/295 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQGG 62
+K+ KIG G+FGE++ + +T ++VA+K +EN K P E K+ ++L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-- 67
Query: 63 STGIPNLRWFGVEGDYNV--------LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
+ NL LV D L L + K +L + + ++
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
N + ++H LHRD+K N L+ R + + DFGLA+ + Q Y N
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNR 181
Query: 175 TGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233
T Y LG DL G ++ S QG T++ + IS+
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLC 238
Query: 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--LFRDLFIREGFQFD 286
S + E E + + K R DL I + D
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 41/212 (19%), Positives = 82/212 (38%), Gaps = 18/212 (8%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL- 69
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQ-CPHIVRIV 71
Query: 70 ---RWFGVEGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
++V++ L G L + + + + + + + ++++HS +
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
HRD+KP+N L R + + DFG AK + Y T Y +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPE 183
Query: 185 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ + D+ SLG ++ L G P+
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (266), Expect = 2e-26
Identities = 50/288 (17%), Positives = 109/288 (37%), Gaps = 24/288 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ ++L RK+G G + E++ NI NE+V +K+ K +++ E K+ + L+ G I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLR-GGPNI 92
Query: 67 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 126
L + + + D + L+ + +++ +++ HS +
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 127 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 186
HRD+KP N + + ++ +ID+GLA+ Y + + +
Sbjct: 152 HRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELL 201
Query: 187 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 245
+ + D+ SLG +L + P+ + +I++ + + Y
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 246 PTEFASYFH-------YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
E F+ R RF + + D + + ++D
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-26
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 16/215 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI----LQGG 62
F L + +G GSFG+++L +TN+ AIK E + + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 63 STGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
+ ++ + V++ L G L C K L A ++I ++F+H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 120
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
SK ++RD+K DN L+ + + I DFG+ K + GT Y
Sbjct: 121 SKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYI 170
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ LG + + D S G +L L G P+ G
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 105 bits (262), Expect = 4e-26
Identities = 42/239 (17%), Positives = 80/239 (33%), Gaps = 22/239 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQYEAKLY 56
+ +G G + + T +E A+K E V+ E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 KILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
+ + G I L+ + LV DL+ L D LS K + ++
Sbjct: 64 RKVSGHPNII-QLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLE 121
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
+ +H + +HRD+KP+N L+ + + DFG + + + + +
Sbjct: 122 VICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 179 EIIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 9e-26
Identities = 56/278 (20%), Positives = 92/278 (33%), Gaps = 24/278 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK-----LENVKTKHPQLQYEAKLYKILQ 60
RL K+G GSFG + G + VA+K + + E L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
+ L + ++ SL D L T+ A Q+ + ++
Sbjct: 70 --HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
SK F+HRD+ N L+ + V I DFGL + H Y ++ +
Sbjct: 128 ESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAW 180
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
+ + S D G L G PW GL Q KI ++
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRP 237
Query: 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
C P + + C + + +D+P + L+ +
Sbjct: 238 EDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 104 bits (260), Expect = 1e-25
Identities = 48/234 (20%), Positives = 94/234 (40%), Gaps = 23/234 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQY---EAKLYKILQG 61
F++ R +G+GSFG ++L + A+K+ + + + Q+++ E + I+
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
I + + +++D + S++ A ++ +E++H
Sbjct: 63 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
SK ++RD+KP+N L+ + + I DFG AK D L GT Y
Sbjct: 122 SKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYI 168
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
+ ++ D S G ++ L G P+ + YEKI ++
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 1e-25
Identities = 54/235 (22%), Positives = 86/235 (36%), Gaps = 19/235 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQ- 60
N F + R IG G FGE+Y T + A+K +K E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
G I + + D ++DL+ S + A ++I +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
H++ ++RD+KP N L+ V I D GLA + H + GT Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171
Query: 181 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234
+ G+ D SLG +L LRG P++ K K + V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-25
Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 22/275 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
RL K+G G FGE+++GT T VAIK L+ EA++ K L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR--HEK 73
Query: 66 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 124
+ L E ++ + SL D + K L ++ +A Q+ + + +V +
Sbjct: 74 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
++HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 134 YVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPE 184
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP---- 237
Query: 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
P C +++P + YL+ D F
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 4e-25
Identities = 57/292 (19%), Positives = 98/292 (33%), Gaps = 25/292 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
VG ++ IG G++G + + VAIK +T + E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64
Query: 62 GSTGIPNLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
I + LV L+G L L ++ LS + Q++
Sbjct: 65 -HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRG 121
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----YVA 174
Query: 177 TARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
T Y + ++ D+ S+G +L L + G + I S
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILGS 231
Query: 236 TSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
S E L + +Y + + DL + + F+
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 9e-25
Identities = 49/242 (20%), Positives = 88/242 (36%), Gaps = 30/242 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGS 63
+ + IG+GS+G + + K + + L E L + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK--H 62
Query: 64 TGIPNLRWFGVE--GDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 117
I ++ +V++ G L + +++ L + VL + Q+ +
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 118 EFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
+ H +S LHRD+KP N + V + DFGLA+ + K
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------K 172
Query: 173 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
GT Y S + + + D+ SLG +L P+ ++K+ KI E
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREG 229
Query: 233 KV 234
K
Sbjct: 230 KF 231
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-24
Identities = 61/291 (20%), Positives = 102/291 (35%), Gaps = 35/291 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPN 68
+ + IG+GSFG +Y + E VAIK V E ++ + L I
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKNRELQIMRKLD--HCNIVR 77
Query: 69 LRWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 119
LR+F Y LV+D + ++ + SR L + V + Q+ + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYRENKNLT 175
+HS HRDIKP N L + + DFG AK+ + YR + +
Sbjct: 138 IHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
G Y + D+ S G VL L G + G + + +I + +
Sbjct: 196 GATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGT 241
Query: 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
+ E + P F ++ + K L ++
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 54/276 (19%), Positives = 108/276 (39%), Gaps = 28/276 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQGGSTGIP 67
++G G+FG + G + +VAIK K ++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-----P 69
Query: 68 NL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ R GV + + +LV+++ G L ++ + V L Q+ ++++ K+
Sbjct: 70 YIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
F+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 130 FVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPE 182
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPP 235
Query: 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279
P E + C +++D+PD+ +++ R +
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (250), Expect = 2e-24
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 26/219 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGG 62
K+ KIG G++G +Y N E A+K ++ + E + K L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-- 58
Query: 63 STGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
+ I L VLV + L L+ L + C L T Q++N + + H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH-----QHIPYRENKNLTGT 177
+ LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+
Sbjct: 119 RRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 178 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+Y S D+ S+G + + G+ + G
Sbjct: 176 KKY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 2e-24
Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 18/230 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
+++G+G FG + G + +VAIK ++ + EAK+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS--HEK 60
Query: 66 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ L + ++ + + L + + + +L + + +E++ SK
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
FLHRD+ N L+ V + DFGL++ D + R++
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPE 171
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 233
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 3e-24
Identities = 56/297 (18%), Positives = 109/297 (36%), Gaps = 34/297 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHP----QLQYEAKLYKI 58
R ++ +IG G++G+++ +++ VA+K V+T E + +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 59 LQGGSTGIPNL-RWFGV--------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 109
L+ PN+ R F V E ++ + L + +T+ +
Sbjct: 64 LETFEH--PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 110 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 169
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--- 175
Query: 170 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 229
T Y + L + DL S+G + R ++G + + KI
Sbjct: 176 -----VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKI 227
Query: 230 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
+ E R ++ D + L +DL + + F+
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-24
Identities = 52/278 (18%), Positives = 96/278 (34%), Gaps = 25/278 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK + + EA +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 120
I L E +++ L L L ++++ A Q+ + ++
Sbjct: 67 --HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 121 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 180
SK F+HRDI N L+ + V + DFGL++ D+ ++ ++
Sbjct: 125 ESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKW 175
Query: 181 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239
+ + + D+ G + L G P+QG+ +I +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE----RL 228
Query: 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
+ P S C + +P + LK +
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 3e-24
Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 32/250 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQG 61
G + +IG GSF +Y G + +T EVA + K++ + + EA++ K LQ
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 62 GSTGIPN-LRWFGV------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
PN +R++ VLV +L+ + + + +K + Q++
Sbjct: 68 -----PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 115 NRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 172
++F+H+++ +HRD+K DN + V I D GLA R + K
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------K 171
Query: 173 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
+ GT + + + + D+ + G ++ P+ Q Y +++
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSG 228
Query: 233 KVSTSIEALC 242
S + +
Sbjct: 229 VKPASFDKVA 238
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-24
Identities = 58/284 (20%), Positives = 97/284 (34%), Gaps = 21/284 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGS 63
F+ KIG G++G +Y N T E VA+K + E L K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN--H 60
Query: 64 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS 122
I L + LV + L L+ + + L + Q++ + F HS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 121 HRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAP 171
Query: 183 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242
S D+ SLG + + + G ++ + +I + + T E +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVW 227
Query: 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
G + + + R D L R L + + +D
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 4e-24
Identities = 56/276 (20%), Positives = 113/276 (40%), Gaps = 22/276 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
+ K+G G +GE+Y G + + VA+K L+ + + EA + K ++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK--HPN 74
Query: 66 IPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
+ L ++ + + G L+ L +++S +L +A Q+ + +E++ K
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
+F+HRD+ N L+G + V + DFGL++ H + ++ +
Sbjct: 135 NFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAP 185
Query: 184 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE--- 239
Query: 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278
G P + C D+P +A + + F +F
Sbjct: 240 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 5e-24
Identities = 48/244 (19%), Positives = 89/244 (36%), Gaps = 22/244 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLY 56
V + + G ++GSG F + T + A K ++ E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57 KILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
K +Q + L +L+++L+ F L+ + Q++N
Sbjct: 68 KEIQ--HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 117 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
V ++HS H D+KP+N ++ ++ IIDFGLA + ++I
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------F 177
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
GT + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 234
Query: 236 TSIE 239
E
Sbjct: 235 FEDE 238
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 1e-23
Identities = 54/282 (19%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 13 RKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGI 66
+++GSG+FG + G + + VA+K+ + P +L EA + + L
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----- 67
Query: 67 PNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
P + R G+ E + +LV+++ + + +R + K ++ L Q+ ++++ +
Sbjct: 68 PYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
F+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 128 FVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPE 180
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243
+ S + D+ S G ++ G P++G+ + + + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA---- 233
Query: 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF---IREG 282
G P E + C + +++P +A ++ R+ + + EG
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 44/228 (19%), Positives = 85/228 (37%), Gaps = 18/228 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
F+ + +GSG+FG +Y G I E+V I + ++ EA + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 121
+ + L + ++ + L D + + +L Q+ + ++
Sbjct: 70 -NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
+ +HRD+ N L+ V I DFGLAK H + ++
Sbjct: 129 DRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWM 180
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 228
++ + L + + D+ S G + + GS P+ G+ A EK
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.1 bits (246), Expect = 2e-23
Identities = 46/215 (21%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGST 64
++F + +G+GSFG + L + ++ A+K+ + K Q+++ +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ--AV 98
Query: 65 GIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH 121
P L + D + L + + + ++F+ R + S A Q++ E++H
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 122 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 181
S ++RD+KP+N L+ + + + DFG AKR + GT
Sbjct: 159 SLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEAL 205
Query: 182 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 216
+ L ++ D +LG ++ G P+
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 5e-23
Identities = 52/275 (18%), Positives = 98/275 (35%), Gaps = 28/275 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGI 66
+ +L + IG G FG++ LG +VA+K EA + L+ + +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR--HSNL 62
Query: 67 PNLRWFGVEGDYNV-LVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSK 123
L VE + +V + + SL D L + L +L + + +E++
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 124 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 183
+F+HRD+ N L+ N + DFGL K T ++ +
Sbjct: 123 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTAP 169
Query: 184 NTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242
+ S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD--- 223
Query: 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
G P C L +P + L+ +
Sbjct: 224 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 5e-23
Identities = 57/292 (19%), Positives = 112/292 (38%), Gaps = 29/292 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
V +++ +GSG++G + + +T VA+K + + + E +L K ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 61 G----GSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 116
G + E + LV L+G L ++ +KL+ V L Q++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133
Query: 117 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 176
++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA---------- 180
Query: 177 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 235
T Y + L ++ D+ S+G ++ L G + G + + I +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGT 237
Query: 236 TSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRLFRDLFIREGFQFD 286
E L + +Y + + + + L DL + + D
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 7e-23
Identities = 53/288 (18%), Positives = 107/288 (37%), Gaps = 30/288 (10%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ 60
EP ++ L RK+G G F ++L ++ N VA+K + K + E KL + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ---------GGSTGIPNLRWFGVEGDYNVLVIDLLG-----PSLEDLFNFCSRKLSLKTV 106
G+ I L N + + ++ L + + R + L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 107 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165
++ Q++ ++++H + +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 225
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 226 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 273
+ I++ I L P+ Y R+ F+ + + +L
Sbjct: 241 DDHIAQ------IIELLGELPSYLLRNGKYTRTF-FNSRGLLRNISKL 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.5 bits (237), Expect = 8e-23
Identities = 51/274 (18%), Positives = 102/274 (37%), Gaps = 22/274 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGSTG 65
++ ++IGSG FG ++LG + ++VAIK + EA++ L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS--HPK 61
Query: 66 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 124
+ L +E LV + + L D + +T+L + + + ++
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 125 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 184
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172
Query: 185 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243
S + D+ S G ++ G +P++ + + E IS R
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPR 225
Query: 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277
T ++C R +D+P ++ L R ++
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.1 bits (238), Expect = 8e-23
Identities = 58/310 (18%), Positives = 102/310 (32%), Gaps = 56/310 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK---LENVKTKHPQLQYEAK 54
PR N R IG G+FG ++ + VA+K E Q EA
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 55 LYKILQGGSTGIPNLRWFGV--EGDYNVLVIDLL-GPSLEDL------------------ 93
L ++ GV G L+ + + L +
Sbjct: 69 LMAEFD----NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 94 -----FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKI 181
Query: 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 208
DFGL++ Y+ + N R+ + + D+ + G VL
Sbjct: 182 ADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 209 -RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 267
G P+ G+ ++ + + + E P E + C S D+P +
Sbjct: 237 SYGLQPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSF 289
Query: 268 AYLKRLFRDL 277
+ R+ + +
Sbjct: 290 CSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.0 bits (238), Expect = 1e-22
Identities = 36/235 (15%), Positives = 86/235 (36%), Gaps = 18/235 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
+ ++ + IG+G FGE+ G + VAIK + + EA +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 61 GGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
+ +L + +++ + + SL+ + ++ ++ + + +++
Sbjct: 86 --HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+ +++HRD+ N L+ + DFGL++ D + Y R
Sbjct: 144 LADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIR 198
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 233
+ + + + D+ S G V+ + G P+ + T + I +
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 2e-22
Identities = 62/284 (21%), Positives = 97/284 (34%), Gaps = 30/284 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGSTG 65
+G G F +Y + TN+ VAIK E + E KL + L
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS--HPN 61
Query: 66 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 125
I L LV D + LE + S L+ + + +E++H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 126 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 185
LHRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 122 LHRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPEL 171
Query: 186 HLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244
G D+ ++G +L L G + + +I E + + E
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW--- 225
Query: 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIREGFQFD 286
+ S Y F P + DL I+ F F+
Sbjct: 226 --PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 2e-22
Identities = 52/254 (20%), Positives = 103/254 (40%), Gaps = 29/254 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKIL 59
V +++ + IGSG+ G + + + VAIK + ++ + E L K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 60 QGGSTGIPNLRWFGV------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 113
I +L E LV++L+ +L + +L + + L QM
Sbjct: 74 N--HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQM 128
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ ++ +HS +HRD+KP N ++ + + I+DFGLA+ +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY------- 178
Query: 174 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233
T Y + LG+ D+ S+G ++ +R + + G ++ K+ E+
Sbjct: 179 -VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQL 234
Query: 234 VSTSIEALCRGYPT 247
+ E + + PT
Sbjct: 235 GTPCPEFMKKLQPT 248
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 5e-22
Identities = 51/268 (19%), Positives = 92/268 (34%), Gaps = 44/268 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKL---ENVKTKHPQLQYEAKLYKI 58
G+ +GSG+FG++ T ++ +VA+K+ + ++ L E K+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 59 LQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK----------------- 100
L G I NL L+ + L + K
Sbjct: 97 L-GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 101 -----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 212
Query: 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPW 214
+ Y N ++ + + + + D+ S G +L G P+
Sbjct: 213 DIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 215 QGLKAGTKKQKYEKISEKKVSTSIEALC 242
G+ + K+ +
Sbjct: 268 PGI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 5e-22
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 17/213 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGG 62
K+ KIG G++G ++ N +T+E VA+K ++ + E L K L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-- 59
Query: 63 STGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 122
I L LV + L+ F+ C+ L + V Q++ + F HS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 123 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 182
++ LHRD+KP N L+ R ++ + +FGLA+ + IP R T Y
Sbjct: 120 RNVLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRP 169
Query: 183 MNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 214
+ G + S D+ S G + P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 6e-22
Identities = 55/294 (18%), Positives = 110/294 (37%), Gaps = 33/294 (11%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQ 60
V +R + +GSG++G + + +T +VAIK + + E +L K ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 61 GGSTGIPNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
+ L + LV+ +G L L KL + L QM+
Sbjct: 76 --HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQML 131
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ--HIPYRENK 172
+ ++H+ +HRD+KP N + ++ I+DFGLA++ T YR +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPE 188
Query: 173 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232
+ RY ++ D+ S+G ++ + G ++G + ++ K++
Sbjct: 189 VILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 286
+ ++ L + F A L +L + + D
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 1e-20
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 37/247 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQG 61
N + IG G+FG++ + + AIK K H E ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG- 68
Query: 62 GSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLSLKT 105
I NL Y L I+ +L D N + LS +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 106 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165
+L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTM 185
Query: 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQ 224
R+ ++ + + D+ S G +L + G P+ G+ T +
Sbjct: 186 G--------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE 234
Query: 225 KYEKISE 231
YEK+ +
Sbjct: 235 LYEKLPQ 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 2e-20
Identities = 44/234 (18%), Positives = 81/234 (34%), Gaps = 35/234 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKI 58
N+ G+ +G+G+FG++ T VA+K+ T+ L E K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 59 LQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL-----------------FNFCSRK 100
L G I NL G +++ + L +
Sbjct: 83 L-GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 101 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+ ++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKND 198
Query: 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ + N ++ + + + D+ S G L
Sbjct: 199 SNYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 45/224 (20%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 4 RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIK---LENVKTKHPQLQYEAKLY 56
+VG F L + +G+G++G+++L I T + A+K + K ++
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 57 KILQ--GGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 114
++L+ S + L + L++D + + + V + +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 115 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 174
+E +H ++RDIK +N L+ V + DFGL+K + T + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191
Query: 175 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 216
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 4e-19
Identities = 38/238 (15%), Positives = 85/238 (35%), Gaps = 25/238 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK---LENVKTKHPQLQYEAKLYKIL 59
+ + IG+G FGE+Y G ++ + VAIK + + EA +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 60 QGGSTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMIN 115
N+ R GV Y ++I +L+ + S+ ++ + +
Sbjct: 67 SH-----HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 116 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 175
++++ + +++HRD+ N L+ + DFGL++ D +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGK 174
Query: 176 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233
R+ + + + D+ S G V+ + + + + I++
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 9e-19
Identities = 46/254 (18%), Positives = 98/254 (38%), Gaps = 39/254 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIK---LENVKTKHPQLQYEAKLY 56
++ LG+ +G G+FG++ L I +++ VA+K + + L E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 57 KILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRK 100
K++ I L + ++++ +L + +
Sbjct: 73 KMIGKHKNIINLLGAC-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 101 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160
LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHI 188
Query: 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKA 219
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 189 DYYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-- 241
Query: 220 GTKKQKYEKISEKK 233
++ ++ + E
Sbjct: 242 -PVEELFKLLKEGH 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 42/219 (19%), Positives = 86/219 (39%), Gaps = 17/219 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKHPQLQY---EAKLYKILQG 61
IG G FG +Y GT + + A+K N T ++ E + K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS- 86
Query: 62 GSTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 119
+ +L + + + LV+ + L + + ++K ++ Q+ ++F
Sbjct: 87 -HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 120 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 179
+ SK F+HRD+ N ++ V + DFGLA+ D +
Sbjct: 146 LASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVK 199
Query: 180 YASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 217
+ ++ + + + + D+ S G +L + RG+ P+ +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 2e-18
Identities = 49/247 (19%), Positives = 94/247 (38%), Gaps = 32/247 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIK---LENVKTKHPQLQYEAKLYKI 58
K + R++G GSFG +Y G + VAIK + + EA + K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 59 LQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR---------KLSLKTVLM 108
+ L +G +++++L+ L+ SL ++
Sbjct: 80 FN--CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 109 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 168
+A ++ + + ++++ F+HRD+ N ++ V I DFG+ + +T Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----Y 189
Query: 169 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYE 227
R+ R+ S + + D+ S G VL P+QGL + +Q
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLR 246
Query: 228 KISEKKV 234
+ E +
Sbjct: 247 FVMEGGL 253
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 5e-18
Identities = 58/274 (21%), Positives = 96/274 (35%), Gaps = 27/274 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGST 64
+ L IG G FGE++ G EEVA+K+ + + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHE 57
Query: 65 GIPNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSR---------KLSLKTVLMLADQM 113
I + + + L+ E LF++ +R KL+L T LA
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 173
+ V + HRD+K N L+ + I D GLA R+ I +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NH 171
Query: 174 LTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 227
GT RY E +R D+ ++G V R +
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 228 KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 260
S+ V + +C + + + C +LR
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 8e-18
Identities = 43/232 (18%), Positives = 82/232 (35%), Gaps = 32/232 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
++ +LG+ +G G+FG++ T VA+K+ H + + KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 62 GSTGIPNLRWFGV----EGDYNVLVIDLLGPSLEDL---------------FNFCSRKLS 102
+ + G G V+V +L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 103 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162
L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189
Query: 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 214
+ + ++ + T + + D+ S G +L
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 5e-17
Identities = 23/162 (14%), Positives = 55/162 (33%), Gaps = 32/162 (19%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------KHPQLQYEAKL--- 55
+G+ +G G ++ + + E +K V A
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 56 --YKILQGGSTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 113
++ LQ G+ + + EG+ ++ E + ++ ++ + D +
Sbjct: 63 NEFRALQKLQ-GLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMI 112
Query: 114 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155
+ V + + +H D+ N L+ ++IIDF +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 475 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.05 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-61 Score=472.65 Aligned_cols=296 Identities=78% Similarity=1.353 Sum_probs=265.7
Q ss_pred CCCccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 1 m~~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
||-+++++|+++++||+|+||+||+|++..+|+.||||++.......++..|.++++.+++. ++++.+..++.+.+..+
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~-~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-VGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTS-TTCCCEEEEEEETTEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCC-CcccEEEEEEecCCEEE
Confidence 89999999999999999999999999999999999999998887778899999999999874 77888889999999999
Q ss_pred EEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 81 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 81 lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
+||||++++|.+.+....+.+++.+++.++.||+.||+|||++|||||||||+|||++..+....+||+|||+|+.+...
T Consensus 80 ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 99999999999988877888999999999999999999999999999999999999976666778999999999998876
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
......+++......||+.|||||++.+..++.++|||||||++|||++|..||...........+.+........+.+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 66666666667788999999999999999999999999999999999999999998776666666666666666677788
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
++.++|+++.+++.+||..+|++||++.+|.++|++++.+.++..+.+|||+..+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 889999999999999999999999999999999999999999999999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-59 Score=459.39 Aligned_cols=289 Identities=60% Similarity=1.016 Sum_probs=266.0
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
+++++|+++++||+|+||+||+|++..+|+.||||+++.......+..|.+++..+++. ++++.++.++......++||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~-~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC-TGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTC-TTCCCEEEEEEETTEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCC-CCCCEEEEEeecCCccEEEE
Confidence 57899999999999999999999999999999999988777778899999999999875 89999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC--CCCcEEEeecCCcccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~--~~~~vkL~DFGlA~~~~~~~ 161 (475)
||++++|.+++......++..+++.|+.|++.||+|||++|||||||||+||||+... ..+.+||+|||+|+.+....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9999999999987777899999999999999999999999999999999999996432 35689999999999988766
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
.....+.+....+.||+.|||||++.+..++.++|||||||++|||++|..||.+.......+.+.++...+.....+.+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 66666666677889999999999999999999999999999999999999999988877777888888777777788889
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 293 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 293 (475)
+.++|+++.+++..||..+|++||+++.|.++|++++.+.++..+++|||+.
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 9999999999999999999999999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=414.13 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=211.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEecc-----CCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~-----~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||+||+|+++.+++.||||++.. ......+.+|+.+++.++| +||+.+++++.+++..|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH--PNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC--TTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC--CCCCeEEEEEEECCEEE
Confidence 3689999999999999999999999999999998753 2234567889999988865 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||| +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 83 ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCC
T ss_pred EEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCC
Confidence 999999 8899999974 3579999999999999999999999999999999999999 5778999999999986654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ....||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 159 ~~~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 222 (263)
T d2j4za1 159 SRR---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT---- 222 (263)
T ss_dssp CCC---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC----
T ss_pred Ccc---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 322 3458999999999999999999999999999999999999999763 345555555554432
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
+...+++++.+||.+||+.||++|||++++++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 23568899999999999999999999988843
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=414.87 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=207.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC---chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.++|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+++++.++| +||+.++.++.+++..||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--ENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC--TTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC--CCEeeEeeeeccCceeEE
Confidence 35789999999999999999999999999999999865432 3457899999988875 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++. ....+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 81 vmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 81 FLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred EEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence 99999 789999886 34579999999999999999999999999999999999999 46789999999999976543
Q ss_pred ccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... ..+..+.......
T Consensus 157 ~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~--- 226 (271)
T d1nvra_ 157 NRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL--- 226 (271)
T ss_dssp TEE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTS---
T ss_pred Ccc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCC---
Confidence 321 12345689999999999998886 678999999999999999999997654332 2222222222111
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+++++.+||.+||+.||++||++++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 12356789999999999999999999988773
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=416.98 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=208.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
++|+++++||+|+||+||+|.++.+|+.||||+++... ....+.+|+.+++.++| +||+.+++++.+.+..|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN--PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC--CCEeeEeEEEEECCEEEEEEE
Confidence 57999999999999999999999999999999986543 33468899999998876 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|| |++|.+++.. +.+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 99 8899998863 469999999999999999999999999999999999999 4678999999999987754332
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
.....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+........ ....
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHHCSCCC--SSGG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCC--CCcc
Confidence 1245689999999999999999999999999999999999999997643 2333333332221111 1235
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+++++++||.+||..||++||++.+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6789999999999999999999988873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=414.58 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=209.4
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
+.|+++++||+|+||+||+|+++.+++.||||+++..... ..+.+|+++++.++| +||+.++.++.+.+..|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH--PNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC--TTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC--CCCCeEEEEEeeCCeEEEEEe
Confidence 4699999999999999999999999999999998765333 468899999998875 999999999999999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 85 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 85 ~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
|| |++|.+++....+.+++.++..|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.......
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~- 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ- 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc-
Confidence 99 889999987667789999999999999999999999999999999999999 4778999999999986644322
Q ss_pred cccccccCCCCccCcccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 164 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~-----g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
.....+||+.|+|||++. +..|+.++|||||||+||||++|..||.+.... +.+.++........
T Consensus 166 ------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~~~~- 235 (288)
T d2jfla1 166 ------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEPPTL- 235 (288)
T ss_dssp ------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCCCCC-
T ss_pred ------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 123568999999999984 455899999999999999999999999875443 33344443322111
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.....+++++.+||.+||+.||++|||+.+|+
T Consensus 236 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp -SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred -CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12246789999999999999999999988874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=415.39 Aligned_cols=266 Identities=20% Similarity=0.311 Sum_probs=218.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++++.||+|+||+||+|.++.+++.||||+++.. .....+.+|+++++.++| +||+.++.++.+.+..|+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH--PFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS--TTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC--CCeeEEEEEEEECCEEEE
Confidence 5799999999999999999999999999999997532 233568899999998876 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| ++++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 8899998874 4579999999999999999999999999999999999999 57789999999999977543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.... .....+||+.|||||++.+..++.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 162 ~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 162 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred Cccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 2211 123568999999999999999999999999999999999999999873 445555666554432
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
+...+++++.+||.+||+.||++|||++++.+. ..+. + -++-..++|..+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i~-~--Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLK-A--HPFFESVTWENLH 279 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHHH-T--SGGGTTCCCTTGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HHHH-c--CCccCCCCHHHhh
Confidence 235689999999999999999999999987542 1111 1 2334457898654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-53 Score=418.72 Aligned_cols=252 Identities=20% Similarity=0.251 Sum_probs=200.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
+.+.|++++.||+|+||+||+|+++.+++.||||++.... ....+.+|+.++..++| +||+.+++++.+++..||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH--PNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC--TTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCEEEE
Confidence 4567999999999999999999999999999999986543 22456789999988865 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||| |++|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||+...++++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999 8999999974 567999999999999999999999999999999999999975556789999999999866543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+......... .
T Consensus 164 ~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~-~ 231 (307)
T d1a06a_ 164 SV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFDS-P 231 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCCCT-T
T ss_pred Ce--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhccCCCCCC-c
Confidence 22 23468999999999999999999999999999999999999999874 334445555554433222 2
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
....+|+++.+||.+||..||++||++++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 3457899999999999999999999988774
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=410.89 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=208.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
.++|+++++||+|+||+||+|++ +..||||+++..... ..+.+|+.++..++| +||+.+++++.+ +..+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH--VNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC--TTBCCEEEEECS-SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC--CCEeeeeEEEec-cEEEE
Confidence 47899999999999999999974 346999998754332 357789999888865 999999988755 45789
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ +++|.+++...+..+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeecccc
Confidence 99999 7899999986667899999999999999999999999999999999999994 7789999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... ......||+.|||||++.+. .|+.++|||||||+||||++|+.||.+... ..+....+........
T Consensus 158 ~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 158 SGSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPD 230 (276)
T ss_dssp -------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCC
T ss_pred CCcc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCc
Confidence 2211 22456899999999999754 479999999999999999999999987543 2233333444444444
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
...+...+|+++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 555667899999999999999999999999999999987754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=409.03 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=197.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CCEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE--GDYNV 80 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~~~~ 80 (475)
++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+|+++++.++| +||++++.++.+ ....|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH--PNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCC--TTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCC--CCEeeEEEEEEeCCCCEEE
Confidence 6899999999999999999999999999999998765433 236778888887765 999999887754 45679
Q ss_pred EEEEcC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 81 LVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~---~~~~ls~~~~~~i~~qi~~aL~yLH~~g-----IvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
|||||| |++|.+++.. ....+++..++.|+.||+.||.|||++| ||||||||+|||| +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 999999 8899999864 3467999999999999999999999976 9999999999999 57789999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 231 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~ 231 (475)
|+|+.+..... ......||+.|||||++.+..++.++|||||||+||||++|..||.+. +..+.+.++..
T Consensus 159 G~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIRE 228 (269)
T ss_dssp HHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH
T ss_pred cceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHHHHHc
Confidence 99998754332 123568999999999999999999999999999999999999999874 34455555555
Q ss_pred ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..... +...+++++.+||.+||+.||++||++++|+
T Consensus 229 ~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 229 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 44322 3457899999999999999999999998874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=418.54 Aligned_cols=253 Identities=18% Similarity=0.267 Sum_probs=204.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
..++|+++++||+|+||+||+|+++.+|+.||||+++..... .++.+|+.+++.++| +||+++++++.+.+..||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS--PYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC--TTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCEEEE
Confidence 467899999999999999999999999999999998765332 457889999988865 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
||||+ |++|.+++... +.+++..+..++.||+.||.|||+ +|||||||||+|||| +.++.+||+|||+|+.+.+
T Consensus 82 VmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence 99999 78999999754 469999999999999999999997 599999999999999 5788999999999997654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc------
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 233 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 233 (475)
.. ..+++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.................
T Consensus 158 ~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 158 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred Cc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 32 235689999999999999999999999999999999999999997744321111000000000
Q ss_pred -----------------ccc----cHHHHh---------cCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 234 -----------------VST----SIEALC---------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 234 -----------------~~~----~~~~l~---------~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
... ....+. ..++.++.+||.+||..||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 000000 124689999999999999999999998854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=410.39 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=214.6
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
++|++.++||+|+||+||+|.+..+++.||||+++..... .++.+|+.++..++| +||+.+++++.+++..+|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH--PNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC--CCEecCCccEeeCCeeEEEeec
Confidence 4799999999999999999999999999999998765443 568899999999875 9999999999999999999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 86 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 86 ~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCce
Confidence 9 88999998753 4569999999999999999999999999999999999999 57789999999999876553321
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.... +..+.+..+... ... .+..
T Consensus 172 ~------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~-~~~---~~~~ 239 (287)
T d1opja_ 172 A------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKD-YRM---ERPE 239 (287)
T ss_dssp E------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT-CCC---CCCT
T ss_pred e------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcC-CCC---CCCc
Confidence 1 233468999999999999999999999999999999999777664422 233333333322 211 2335
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+|+++.+|+..||+.||++||++++|++.|+.+++
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 789999999999999999999999999998887754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-52 Score=418.27 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=213.9
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.++|+++++||+|+||.||+|+++.+|+.||||++..... ...+.+|+.++..++| +||+.++.++.+.+..|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH--PTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC--TTBCCEEEEEEETTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCEEEEE
Confidence 34689999999999999999999999999999999865432 2357789999999875 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||| |++|.+++....+.+++.+++.|+.||+.||.|||++|||||||||+||||.. +.++.+||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheeccccc
Confidence 9999 89999998655667999999999999999999999999999999999999952 235789999999998765433
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|||||++.+..++.++|||||||+||||++|..||.+. +..+.+..+........ ...
T Consensus 181 ~--------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~ 248 (350)
T d1koaa2 181 S--------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSA 248 (350)
T ss_dssp C--------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGG
T ss_pred c--------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-ccc
Confidence 2 12458999999999999999999999999999999999999999864 34455555554443222 223
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+++++.+||.+||..||++|||+++++
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 456889999999999999999999988773
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=400.78 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=204.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
++|+++++||+|+||+||+|.+. +++.||||+++.... ..++.+|++++..++| +||+.+++++...+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH--PKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC--CCcccccceeccCCceEEEEEe
Confidence 68999999999999999999974 678899999876543 3568899999998875 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||| +.++.+||+|||+|+.+......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce-
Confidence 9 899999988666779999999999999999999999999999999999999 57889999999999876543321
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......||+.|+|||++.+..++.++|||||||+||||+++ ..||.. ....+.+..+....... .+.
T Consensus 158 -----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~~~----~p~ 225 (263)
T d1sm2a_ 158 -----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFRLY----KPR 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHHTCCCC----CCT
T ss_pred -----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHhcCCCC----Ccc
Confidence 12345789999999999999999999999999999999995 555544 23344444444432211 235
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.+++++.+|+..||+.||++||++++|++.|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999999998854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-52 Score=409.94 Aligned_cols=260 Identities=15% Similarity=0.245 Sum_probs=204.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe---EEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++.++||+|+||+||+|.++.+++ .||||.+...... ..+.+|++++..++| +||+.+++++...+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH--PNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC--CCCccEEEEEeeCCEE
Confidence 4679999999999999999999877664 5889987654433 357789999988865 9999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
++||||| +++|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEcc
Confidence 9999999 889999988666779999999999999999999999999999999999999 578899999999998775
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
....... ........||+.|||||++.+..++.++|||||||+||||++ |..||.+.. ..+.+..+.......
T Consensus 180 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~~- 253 (299)
T d1jpaa_ 180 DDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQDYRLP- 253 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCC-
T ss_pred CCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCC-
Confidence 5332111 111223468999999999999999999999999999999998 899998753 334444444332211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
....+|.++.+|+.+||+.||++||++.+|++.|+++++
T Consensus 254 ---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 ---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 235689999999999999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=400.12 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=204.2
Q ss_pred cCCce-EEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEe----
Q 011882 5 VGNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVE---- 75 (475)
Q Consensus 5 i~~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~---- 75 (475)
..++| ++.++||+|+||+||+|.+..+++.||||++...... ..+.+|+++++.++| +||+++++++..
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--PNIVRFYDSWESTVKG 83 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEEESSS
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEeecccc
Confidence 34555 8889999999999999999999999999987654322 347789999988875 999999888754
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
....|+||||+ +++|.+++... ..+++.+++.|+.||+.||+|||+++ ||||||||+||||. ++++.+||+|||
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLG 160 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecC
Confidence 45689999999 88999999753 57999999999999999999999998 99999999999994 346789999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
+|+....... ...+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.. ...+.+..+...
T Consensus 161 la~~~~~~~~---------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 161 LATLKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSG 228 (270)
T ss_dssp GGGGCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTT
T ss_pred cceeccCCcc---------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcC
Confidence 9986443221 34689999999999876 59999999999999999999999997643 334444455443
Q ss_pred cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
.... .+...+++++.+||.+||+.||++|||+++|++
T Consensus 229 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 3322 234567899999999999999999999988853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=403.20 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=214.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC--------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+.++|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+++.++| +||+.+++++.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~ 85 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH--PNVITLHEVYENK 85 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC--TTBCCEEEEEECS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC--CCCCcEEEEEEEC
Confidence 56789999999999999999999999999999998864321 2457899999999875 9999999999999
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCC-CCCcEEEeecCCc
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 154 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~DFGlA 154 (475)
+..||||||| |++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||+..++ ....+||+|||+|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999 88999999754 4799999999999999999999999999999999999995322 2236999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+....... .....||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+..+.....
T Consensus 165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY 233 (293)
T ss_dssp EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCC
T ss_pred hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCC
Confidence 87654322 23568999999999999999999999999999999999999999874 34555555555544
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
... ......+++++.+||.+||+.||++||++++++
T Consensus 234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 332 344577899999999999999999999988874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.5e-52 Score=416.85 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=212.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
+.++|+++++||+|+||.||+|.+..+|+.||||+++..... ..+.+|+.+++.++| +||+.++.++.+++..|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H--pnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH--PKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS--TTBCCEEEEEECSSEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC--CCCCcEEEEEEECCEEEEE
Confidence 446799999999999999999999999999999998754322 346789999888865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||| |++|.+++.....++++.+++.|+.||+.||.|||++|||||||||+||||.. ...+.+||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCC
Confidence 9999 89999887755667999999999999999999999999999999999999942 246789999999999876533
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+....... ....
T Consensus 184 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~ 251 (352)
T d1koba_ 184 I--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDA 251 (352)
T ss_dssp C--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSST
T ss_pred c--------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Cccc
Confidence 2 123579999999999999999999999999999999999999998743 344455555443322 1223
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+++++.+||.+||+.||.+||++.+++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 457899999999999999999999988774
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=402.82 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=213.5
Q ss_pred CceEEeee-EeeeCceeEEEEEEcc--CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 7 NKFRLGRK-IGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 7 ~~y~l~~~-LG~G~fG~Vy~a~~~~--~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++..... ..+.+|++++..++| +||+.+++++..+ ..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN--PYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC--TTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC--CCEeeEeeeeccC-eEE
Confidence 56888884 9999999999998754 4558999998765433 357889999998865 9999999988654 578
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
|||||+ +++|.+++...+..+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+..
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcccc
Confidence 999999 7899999876667799999999999999999999999999999999999995 678999999999997754
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
..... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+......
T Consensus 162 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~--- 231 (285)
T d1u59a_ 162 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM--- 231 (285)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC---
T ss_pred ccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 33211 12234579999999999999999999999999999999998 9999987543 3334444433322
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.++..+|+++.+|+..||+.||++||++.+|.+.|++.+...
T Consensus 232 -~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234678999999999999999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-51 Score=406.06 Aligned_cols=242 Identities=21% Similarity=0.318 Sum_probs=203.4
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.|+++++||+|+||+||+|++..+++.||||+++..... ..+.+|+++++.++| +||+.+++++.+.+..|+|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH--PNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC--TTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC--CCEeeEEEEEEECCEEEEE
Confidence 499999999999999999999999999999998765433 246789999988865 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||| +++|..++. ....+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 94 ~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB-
T ss_pred EEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC-
Confidence 9999 556654444 567899999999999999999999999999999999999994 7789999999999865432
Q ss_pred cccccccccCCCCccCccccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 238 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~---~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 238 (475)
....||+.|||||++.+. .|+.++|||||||+||||++|..||.+.. ..+.+..+.........
T Consensus 169 ----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~ 235 (309)
T d1u5ra_ 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPALQ 235 (309)
T ss_dssp ----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCS
T ss_pred ----------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCC
Confidence 345899999999999753 58999999999999999999999998743 34444444444332221
Q ss_pred HHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 239 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 239 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
...+++++.+||..||+.||++|||+++|++
T Consensus 236 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2457899999999999999999999998743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=407.57 Aligned_cols=240 Identities=20% Similarity=0.284 Sum_probs=208.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+|+.+++.++| ++|+.++.++.+.+..|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH--PFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC--TTBCCEEEEEECSSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC--CCEEEEEeeeccccccc
Confidence 36899999999999999999999999999999998642 234567889999988765 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||| |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeeccccccccc
Confidence 999999 8999999875 4579999999999999999999999999999999999999 5778999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 158 ~~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~~~~~---- 223 (337)
T d1o6la_ 158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEEIR---- 223 (337)
T ss_dssp TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhcCCCC----
Confidence 322 124578999999999999999999999999999999999999999874 344455555554432
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
++..+++++.+||.+||+.||.+|++
T Consensus 224 -~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 224 -FPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred -CCccCCHHHHHHHHhhccCCchhhcc
Confidence 24678999999999999999999995
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=399.72 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=210.5
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|+++++||+|+||+||+|.+ .+++.||||+++.... ...+.+|++++..++| +||+.+++++.++ ..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~g~~~~~-~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH--QRLVRLYAVVTQE-PIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECSS-SCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC--CCEeEEEeeeccC-CeEEEEE
Confidence 36899999999999999999997 4678999999876543 3568899999998865 9999999887554 5689999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|.+++... ..++++..++.|+.||+.||.|||+++|+||||||+|||| ++++.+||+|||+|+.+.....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCcc
Confidence 99 89999876532 2359999999999999999999999999999999999999 5788999999999997754332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
. ......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+....... ..
T Consensus 165 ~------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~~----~p 232 (272)
T d1qpca_ 165 T------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRMV----RP 232 (272)
T ss_dssp E------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CC
T ss_pred c------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----Cc
Confidence 1 123457999999999999989999999999999999999965554432 23344444444332211 23
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
..+|+++.+|+.+||+.||++|||+++|++.|+++|..
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 56899999999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=396.14 Aligned_cols=251 Identities=18% Similarity=0.284 Sum_probs=214.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~ 85 (475)
++|+++++||+|+||+||+|++ .+++.||||+++.... ..++.+|+.++..++| +||+++++++.+.+..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H--pnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH--EKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC--TTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC--CceeeEEEEEeeCCceEEEEEc
Confidence 6899999999999999999997 5888999999876543 4578899999998865 9999999999999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccccc
Q 011882 86 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 164 (475)
Q Consensus 86 ~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~ 164 (475)
+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.+......
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC-
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce-
Confidence 9 789999987666789999999999999999999999999999999999999 57889999999999876543321
Q ss_pred ccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhc
Q 011882 165 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 243 (475)
Q Consensus 165 ~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 243 (475)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.. ..+....+....... .+.
T Consensus 157 -----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~~~~~~----~p~ 224 (258)
T d1k2pa_ 157 -----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLRLY----RPH 224 (258)
T ss_dssp -----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCCCC----CCT
T ss_pred -----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHHHHHhCCCCC----Ccc
Confidence 2234679999999999999999999999999999999998 899998754 344444554432211 235
Q ss_pred CChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011882 244 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 276 (475)
Q Consensus 244 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 276 (475)
.+|+++.+|+.+||+.||++||++++|++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 678999999999999999999999999887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=410.33 Aligned_cols=255 Identities=16% Similarity=0.179 Sum_probs=204.8
Q ss_pred ccCCceEEee-eEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe----CCE
Q 011882 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE----GDY 78 (475)
Q Consensus 4 ~i~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~----~~~ 78 (475)
.+.++|++++ .||+|+||.||+|++..+++.||||+++ ....+.+|++++..+.+ |+||+.++.++.. ...
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~---~~~~~~~E~~~~~~~~~-hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQ-CPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTT-STTBCCEEEEEEEEETTEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC---CcHHHHHHHHHHHHhcC-CCCCCeEEEEEeecccCCCE
Confidence 3557899875 5999999999999999999999999986 34678889988766643 4999999887754 467
Q ss_pred EEEEEEcC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
.||||||| |++|.+++...+ ..|++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 89999999 789999997543 4699999999999999999999999999999999999997555567899999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH-HHHhhcccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVS 235 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 235 (475)
...... ....+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.........+ ..+......
T Consensus 164 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 164 TTSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ccCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 655332 23568999999999999999999999999999999999999999875443222221 222222221
Q ss_pred ccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 236 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 236 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.+. .....+++++.+||.+||..||++||++.+++
T Consensus 236 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 236 FPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp CCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 111 12235789999999999999999999988874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=404.07 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=216.4
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
.+-++|++++.||+|+||+||+|.++.+++.||||+++..... ..+.+|+++++.++| +||+.++.++.+.+..|||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H--pnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH--RNILHLHESFESMEELVMI 79 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC--TTBCCEEEEEEETTEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC--CCCCeEEEEEEECCEEEEE
Confidence 3568999999999999999999999999999999998765433 346789999988875 9999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||| |++|.+++...+..+++.+++.|+.||+.||+|||++||+||||||+||||+. +....+||+|||+++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCC
Confidence 9999 78999999765557999999999999999999999999999999999999952 245689999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHH
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 241 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 241 (475)
. .....||+.|+|||.+.+..++.++|||||||+||+|++|..||.+. +..+.+..+........ ...
T Consensus 159 ~--------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~ 226 (321)
T d1tkia_ 159 N--------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEA 226 (321)
T ss_dssp E--------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHH
T ss_pred c--------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhh
Confidence 2 12347899999999999999999999999999999999999999874 34555666665554433 334
Q ss_pred hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 242 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 242 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...+++++.+||.+||..||++||++.+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 567899999999999999999999988874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-50 Score=401.44 Aligned_cols=255 Identities=20% Similarity=0.293 Sum_probs=215.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||+||+|+++.+|+.||||+++.. .....+.+|+.+++.++| +||+.++.++.+.+..|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH--PFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB--TTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC--cChhheeeeEeeCCeeee
Confidence 6899999999999999999999999999999997532 234567889999988865 999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||| |++|..++. ....+++..+..++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc
Confidence 99999 889988887 45678999999999999999999999999999999999999 57889999999999876543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
. ...+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 158 ~----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~----- 219 (316)
T d1fota_ 158 T----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR----- 219 (316)
T ss_dssp B----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----
T ss_pred c----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 2 3568999999999999999999999999999999999999999874 344555555554432
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 295 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 295 (475)
+...+++++.+++.+||..||.+|+ ++++| |++-| -..++|..+.
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i---l~Hp~-------f~~i~~~~l~ 269 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNHPW-------FKEVVWEKLL 269 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTSGG-------GSSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH---HcCcc-------cccCCHHHHH
Confidence 2356789999999999999999996 66665 33332 2345787543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.8e-51 Score=395.91 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=205.5
Q ss_pred ccCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC--
Q 011882 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGSTGIPNLRWFGVEG-- 76 (475)
Q Consensus 4 ~i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~-- 76 (475)
.+.++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+|+.+++.++| +||+.++.++...
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~h--pniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH--PAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEEEECS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCC--CCCCcccceeeeccC
Confidence 5778999999999999999999999999999999998754332 246788888877665 9999998777643
Q ss_pred --CEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 77 --DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 77 --~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
...||||||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+||||+ ..+.++|+|||+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI 157 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTT
T ss_pred CCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhh
Confidence 3579999999 7899988874 45799999999999999999999999999999999999994 778899999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
++......... ......+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ..+.+.++....
T Consensus 158 ~~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 158 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVRED 230 (277)
T ss_dssp CEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCC
T ss_pred hhhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcC
Confidence 98664433211 12345689999999999999999999999999999999999999998743 334444444333
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL 277 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l 277 (475)
... .......+|+++.++|.+||+.||++|| ++++|++.|..+
T Consensus 231 ~~~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 PIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCC-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCC-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 221 2233467899999999999999999999 889887777665
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=398.27 Aligned_cols=249 Identities=20% Similarity=0.333 Sum_probs=202.2
Q ss_pred eeEeeeCceeEEEEEEc--cCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC
Q 011882 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL 86 (475)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~ 86 (475)
++||+|+||+||+|.+. .+++.||||+++..... ..+.+|+++++.++| +||+.+++++..+ ..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--PYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC--TTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC--CCCceEEEEeccC-CEEEEEEcC
Confidence 47999999999999864 35678999998654332 357889999988865 9999999988654 468999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccccc
Q 011882 87 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 165 (475)
Q Consensus 87 -g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~ 165 (475)
+++|.+++.. ...+++.+++.|+.||+.||+|||+++||||||||+||||+ ..+.+||+|||+|+.+.......
T Consensus 90 ~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~- 164 (277)
T d1xbba_ 90 ELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY- 164 (277)
T ss_dssp TTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE-
T ss_pred CCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc-
Confidence 8899999874 56799999999999999999999999999999999999994 77899999999998765433211
Q ss_pred cccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHhcC
Q 011882 166 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 244 (475)
Q Consensus 166 ~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 244 (475)
.......||+.|||||++.+..++.++|||||||++|||++ |..||.+... .+....+...... .++..
T Consensus 165 ---~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~ 234 (277)
T d1xbba_ 165 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAG 234 (277)
T ss_dssp ---EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTT
T ss_pred ---ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCcc
Confidence 12234579999999999999999999999999999999998 8999987543 3444444433221 12357
Q ss_pred ChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 245 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 245 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
+|+++.+|+.+||+.||++||++++|.+.|++.+.
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 89999999999999999999999999999998874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=406.23 Aligned_cols=258 Identities=19% Similarity=0.300 Sum_probs=216.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNV 80 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~ 80 (475)
.++|+++++||+|+||.||+|+++.+|+.||||+++.. .....+.+|+.+++.+.| ++|+.++.++......+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF--PFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC--CcEeecccccccccccc
Confidence 37899999999999999999999999999999987532 233457889999888765 99999999999999999
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccc
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 159 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~ 159 (475)
+||||+ |++|.+++... +.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred cccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccc
Confidence 999999 88999988744 479999999999999999999999999999999999999 5778999999999987654
Q ss_pred cccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHH
Q 011882 160 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 239 (475)
Q Consensus 160 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (475)
.. ....||+.|||||++.+..++.++|||||||+||||++|..||.+. +....+..+.......
T Consensus 194 ~~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~--- 257 (350)
T d1rdqe_ 194 RT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRF--- 257 (350)
T ss_dssp CB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCC---
T ss_pred cc----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCCC---
Confidence 22 3468999999999999999999999999999999999999999874 3455556665544332
Q ss_pred HHhcCChHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 240 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 240 ~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
...+++++.+||..||..||.+|+ ++++|+ ++ ++....+|.....+
T Consensus 258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell---~H-------p~f~~~~~~~~~~~ 308 (350)
T d1rdqe_ 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---NH-------KWFATTDWIAIYQR 308 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---TS-------GGGTTCCHHHHHTT
T ss_pred --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHH---cC-------ccccCCCHHHHHhc
Confidence 356899999999999999999995 766663 22 22334578765443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=404.34 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=208.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCe-----EEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|+++++||+|+||+||+|++..+++ .||||++.... ....+.+|..++..+.. |+||+.+++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~-HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-HENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcC-CCcEeEEEEEEeeCCe
Confidence 679999999999999999999876553 79999875433 23457889999988843 4999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 011882 79 NVLVIDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 135 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NI 135 (475)
.|+||||| +++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 99999999 999999997432 2489999999999999999999999999999999999
Q ss_pred EEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 011882 136 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 214 (475)
Q Consensus 136 Ll~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf 214 (475)
|++ .++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||+||||++ |..||
T Consensus 196 ll~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 196 LVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp EEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 994 77899999999998765543211 1234578999999999999999999999999999999997 89999
Q ss_pred CCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011882 215 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 275 (475)
Q Consensus 215 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 275 (475)
.+..... .+.++........ .+..+|+++.+||..||+.||++|||+++|++.|.
T Consensus 268 ~~~~~~~---~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDA---NFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSH---HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHH---HHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8754432 2333333222211 23568999999999999999999999999988875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=393.35 Aligned_cols=259 Identities=15% Similarity=0.181 Sum_probs=205.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC----eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
.+.|++.++||+|+||+||+|.+..++ ..||||+++..... .++.+|+.++..++| +||+.+++++.+.+.
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H--~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH--HNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC--CCEeeeeEEEecCCc
Confidence 357999999999999999999987654 47999998655433 246789999988865 999999999999999
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++.+++.|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+.+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence 99999999 888988887777789999999999999999999999999999999999999 57889999999999876
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
........ ......||+.|||||++.+..++.++|||||||+||||++|..||... ....+.+..+.......
T Consensus 161 ~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~~- 233 (283)
T d1mqba_ 161 EDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRLP- 233 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCCC-
T ss_pred cCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCCCC-
Confidence 55332111 123457899999999999999999999999999999999976665442 23344444444432221
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
....+|.++.+|+..||+.||++||++.+|++.|+.++.
T Consensus 234 ---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 ---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 235689999999999999999999999999999998875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-50 Score=406.52 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=214.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhC-CCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQG-GSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~~~~~~ 79 (475)
.++|+++++||+|+||.||+|+++.+|+.||||++... .....+..|..++..+.. .|++|+.++.++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999999999999999987532 223346677777777764 469999999999999999
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
||||||| |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence 9999999 8999999975 4579999999999999999999999999999999999999 578899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
.... ....||+.|+|||++.+ ..|+.++|||||||+||||++|..||.+............+.....
T Consensus 159 ~~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 226 (364)
T d1omwa3 159 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226 (364)
T ss_dssp SSCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC---
T ss_pred CCcc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence 4322 34589999999999975 5689999999999999999999999987655444443333322222
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 297 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 297 (475)
.+...+++++.+||.+||..||++||+ +++| +++-| -..++|.....+
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei---l~Hp~-------f~~i~~~~~~~~ 279 (364)
T d1omwa3 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KESPF-------FRSLDWQMVFLQ 279 (364)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH---HTSGG-------GTTCCHHHHHTT
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH---HcCcc-------ccCCCHHHHhcC
Confidence 123578999999999999999999999 4444 33333 234678765444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=394.97 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=204.1
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--------CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeC
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEG 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~ 76 (475)
+.++|+++++||+|+||+||+|+++.+|+.||||+++... ...++.+|+.+++.+.+.|+||+.++.++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4688999999999999999999999999999999876432 12346789999999998789999999999999
Q ss_pred CEEEEEEEcC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 77 DYNVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 77 ~~~~lvme~~-g-~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
+..++||||+ + +++.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 9999999999 3 578888764 45799999999999999999999999999999999999995 34578999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 233 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~-s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 233 (475)
+...... .....||+.|+|||++.+..+ +.++|||||||+||||++|..||.+. ..+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence 8654432 245689999999999988775 67899999999999999999999752 1122222
Q ss_pred ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.. +...+|+++.+||.+||..||++|||+++++
T Consensus 221 ~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 VF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp CC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cC-----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 21 2356899999999999999999999988874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-50 Score=390.44 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=210.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc-----------hHHHHHHHHHHHHhCCCCCcCeeEEee
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGSTGIPNLRWFG 73 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~-----------~~~~~E~~il~~l~~~~~~i~~l~~~~ 73 (475)
+.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+.+++.+..+ +||+.++.++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-pnIv~~~~~~ 79 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH-PNIIQLKDTY 79 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTC-TTBCCEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCC-CCeEEEEeec
Confidence 358999999999999999999999999999999998765322 2467899999999743 9999999999
Q ss_pred EeCCEEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecC
Q 011882 74 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 152 (475)
Q Consensus 74 ~~~~~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 152 (475)
.+++..||||||+ |++|.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||
T Consensus 80 ~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG 155 (277)
T d1phka_ 80 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG 155 (277)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred ccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccch
Confidence 9999999999999 8899999975 4579999999999999999999999999999999999999 578899999999
Q ss_pred CcccccccccccccccccCCCCccCccccccccccC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 011882 153 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 226 (475)
Q Consensus 153 lA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g------~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~ 226 (475)
+|+.+..... .....||+.|+|||.+.+ ..++.++|||||||+||||++|+.||.+.. ....+
T Consensus 156 ~a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~ 224 (277)
T d1phka_ 156 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML 224 (277)
T ss_dssp TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred heeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHH
Confidence 9987654322 234689999999999863 346889999999999999999999998743 34444
Q ss_pred HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 227 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..+.........+ ...++++++.+|+.+||+.||++||++++|+
T Consensus 225 ~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 225 RMIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 4555444332222 2356899999999999999999999988774
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=392.28 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=202.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYN 79 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~ 79 (475)
.++|++++.||+|+||+||+|++..++ ..||||.++..... ..+.+|+.+++.++| +||+.+++++. .+..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH--PHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC--TTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEe-cCeE
Confidence 368999999999999999999986543 56889987654433 347789999888765 99999999885 4567
Q ss_pred EEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 80 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 80 ~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|+||||+ +++|.+++......+++..++.++.||+.||.|||+++||||||||+|||++ ..+.+||+|||+|+.+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheecc
Confidence 9999999 8899998876677899999999999999999999999999999999999994 67899999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
..... ......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 160 ~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~~~~~-- 228 (273)
T d1mp8a_ 160 DSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERL-- 228 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCC--
T ss_pred CCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCC--
Confidence 43221 1234578999999999999999999999999999999998 89999876543 333444433322
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+..++|+++.+||.+||+.||++||++.+|++.|+.++.+.
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 134678999999999999999999999999999999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=396.42 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=204.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCe----EEEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
..+|+++++||+|+||+||+|.+..+|+ .||||.++... ....+.+|++++..++| +||+.+++++.++..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN--PHVCRLLGICLTSTV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC--TTBCCEEEEEESSSE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEecCCe
Confidence 3579999999999999999999988876 58888775432 23468899999998865 999999999988776
Q ss_pred EEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 79 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 79 ~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
.++++++++++|.+.+......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceecc
Confidence 555544559999998887777899999999999999999999999999999999999994 67899999999999765
Q ss_pred ccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhcccccc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 237 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 237 (475)
...... ......||+.|+|||++.+..++.++|||||||+||||++ |..||.+......... +......
T Consensus 163 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i~~~~~~-- 232 (317)
T d1xkka_ 163 AEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERL-- 232 (317)
T ss_dssp TTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---HHHTCCC--
T ss_pred cccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCCCC--
Confidence 433211 1234578999999999999999999999999999999998 8999987654433332 2222211
Q ss_pred HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 238 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 238 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
.....+|+++.+|+.+||..||++||++.+|++.|..+..
T Consensus 233 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1225678999999999999999999999999988887653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=396.66 Aligned_cols=244 Identities=22% Similarity=0.291 Sum_probs=206.1
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccC-----CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|+++++||+|+||+||+|+++.+++.||||+++.. .....+..|..++... ..|++|+.++.++.+++..||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-TTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh-CCCCcEEEEEEEEccCCceeE
Confidence 6799999999999999999999999999999998632 2334466676665533 234999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccc
Q 011882 82 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 160 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~ 160 (475)
||||+ |++|.+++.. ...+++.+++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccc
Confidence 99999 8899999974 4579999999999999999999999999999999999999 57889999999999865543
Q ss_pred ccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHH
Q 011882 161 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 240 (475)
Q Consensus 161 ~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (475)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 157 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~----- 221 (320)
T d1xjda_ 157 DA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPF----- 221 (320)
T ss_dssp TC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----
T ss_pred cc-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 22 124468999999999999999999999999999999999999999874 344555555444332
Q ss_pred HhcCChHHHHHHHHHHhcCCCCCCCCHH-HH
Q 011882 241 LCRGYPTEFASYFHYCRSLRFDDKPDYA-YL 270 (475)
Q Consensus 241 l~~~~p~~l~~li~~cl~~dp~~RPt~~-~l 270 (475)
+...+++++.+||.+||..||++||++. +|
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 2356899999999999999999999974 55
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=391.29 Aligned_cols=261 Identities=20% Similarity=0.279 Sum_probs=200.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-C
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE-G 76 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~ 76 (475)
.++|+++++||+|+||.||+|.+.. +++.||||+++..... ..+..|..++..+.++ ++|+.+..+... +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h-~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH-LNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCC-CeEEEeeeeeccCC
Confidence 3689999999999999999999754 3478999998754433 2466677777777654 788888776654 4
Q ss_pred CEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeC
Q 011882 77 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 140 (475)
Q Consensus 77 ~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~ 140 (475)
...++||||| +++|.+++.... ..+++.+++.|+.||+.||.|||++|||||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--- 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---
Confidence 5689999999 899999987432 348999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCC
Q 011882 141 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKA 219 (475)
Q Consensus 141 ~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~ 219 (475)
+.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 577899999999998765433211 23456899999999999999999999999999999999986 567876543
Q ss_pred CCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 220 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 220 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.. .....+...... .+...+++++.+++.+||+.||++||++.+|++.|+++++.+
T Consensus 243 ~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 243 DE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp SH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH--HHHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 22 222222222211 123568899999999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=386.71 Aligned_cols=250 Identities=22% Similarity=0.260 Sum_probs=205.7
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||+||+|++..+|+.||||+++... ...++.+|+.+++.++| ++|+.++.++.+.+..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H--p~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH--PNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC--TTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC--CcEEEeccccccccceeEE
Confidence 58999999999999999999999999999999986543 24568889999998765 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~g~sL~~ll~~~-~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+++++.+++... ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCc
Confidence 999988877776543 4569999999999999999999999999999999999999 577899999999998765433
Q ss_pred cccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhh---------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--------- 231 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~--------- 231 (475)
. ......||+.|+|||++.... ++.++|||||||+||+|++|+.||.+... ...+.++..
T Consensus 157 ~-------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 157 R-------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp B-------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTT
T ss_pred c-------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhh
Confidence 2 224558999999999988766 48999999999999999999999987432 222222211
Q ss_pred ---------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 232 ---------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 232 ---------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.............++.++.+|+.+||..||++|||+.+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0112223344556789999999999999999999988874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=391.18 Aligned_cols=249 Identities=19% Similarity=0.173 Sum_probs=200.6
Q ss_pred EeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-------chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.+++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+++.++| +||+.++.++...+..||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH--PNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC--TTBCCEEEEECCTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC--CCEeEEEeeeccCCceeehh
Confidence 57899999999999999999999999999865432 2357889999998875 99999999999999999999
Q ss_pred EcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 84 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 84 e~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
||+.+.+...+...+..+++.++..|+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.+.....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc-
Confidence 999665555555456679999999999999999999999999999999999999 5789999999999987655332
Q ss_pred cccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc----------
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 232 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 232 (475)
.....+||+.|+|||++.+. .|+.++|||||||+||||++|..||.+....+....+.+....
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 ------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp ------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 12346899999999998755 5799999999999999999999999875432222222221100
Q ss_pred ----------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
........+...+++++.+||.+||..||++|||+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 011233455567789999999999999999999988873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=389.87 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=212.2
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|+++++||+|+||+||+|+++ .+++.||||+++..... .++.+|+.+++.++| +|++.+++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN--PNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC--TTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC--CCcccceeeeccCC
Confidence 367999999999999999999975 35678999998765433 357889999988865 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 133 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~ 133 (475)
..+++|||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999 889999986432 24899999999999999999999999999999999
Q ss_pred cEEEeeCCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCC-C
Q 011882 134 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-L 212 (475)
Q Consensus 134 NILl~~~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~-~ 212 (475)
|||| +.++.+||+|||+|+.+....... ......||+.|+|||.+.+..++.++|||||||+||||++|. .
T Consensus 170 NILl---d~~~~~Kl~DFGls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 170 NCLV---GENMVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp GEEE---CGGGCEEECCCSCHHHHTGGGCBC---------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEE---CCCCcEEEccchhheeccCCcccc-----ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999 577899999999998765433211 223567899999999999999999999999999999999985 5
Q ss_pred CCCCCCCCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 213 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 213 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
||.+. ...+.+..+...... .+...+|+++.+|+..||+.||++|||+.+|++.|+++
T Consensus 242 p~~~~---~~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGM---AHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC---CHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 77664 344555555544432 23467899999999999999999999999999999876
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=388.38 Aligned_cols=258 Identities=19% Similarity=0.255 Sum_probs=203.4
Q ss_pred CccCCceEEeeeEeeeCceeEEEEEEccC-CeEEEEEEeccCC----CchHHHHHHHHHHHHhC-CCCCcCeeEEeeE--
Q 011882 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKT----KHPQLQYEAKLYKILQG-GSTGIPNLRWFGV-- 74 (475)
Q Consensus 3 ~~i~~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~-~~~~i~~l~~~~~-- 74 (475)
.+..++|+++++||+|+||+||+|++..+ ++.||||+++... ....+.+|+.+++.|.. .|+||+.+++++.
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 35568999999999999999999999766 6789999876432 23457789999988853 4699999987764
Q ss_pred ---eCCEEEEEEEcCCCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEee
Q 011882 75 ---EGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 150 (475)
Q Consensus 75 ---~~~~~~lvme~~g~sL~~ll-~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 150 (475)
.....+++||++.+.+..+. ......+++..++.|+.||+.||+|||++|||||||||+|||+ +..+.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecc
Confidence 23578999999966555444 3345569999999999999999999999999999999999999 5788999999
Q ss_pred cCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh
Q 011882 151 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 230 (475)
Q Consensus 151 FGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~ 230 (475)
||+++....... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+....
T Consensus 160 fg~~~~~~~~~~--------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 160 FGLARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CCSCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred hhhhhhhccccc--------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 999986544322 245689999999999999999999999999999999999999998754322222222111
Q ss_pred h-------------------ccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 231 E-------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 231 ~-------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
. .......+.+...+++++.+||.+||..||++|||+.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0 0111222334456789999999999999999999988773
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=383.23 Aligned_cols=249 Identities=20% Similarity=0.312 Sum_probs=203.3
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CCEEEEEEEc
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE-GDYNVLVIDL 85 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~~~~lvme~ 85 (475)
++|+++++||+|+||.||+|.+ .|..||||+++.....+.+.+|++++..++| +||+.+++++.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H--pnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH--SNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC--TTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC--CCEeeEEEEEEecCCcEEEEEec
Confidence 5799999999999999999996 5789999999877777889999999998864 999999998764 4557999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccccc
Q 011882 86 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 163 (475)
Q Consensus 86 ~-g~sL~~ll~~~~-~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~~ 163 (475)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||+ +.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC--
Confidence 9 999999986432 359999999999999999999999999999999999999 578899999999998654432
Q ss_pred cccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 164 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 164 ~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
....+|..|+|||++.+..++.++|||||||++|||++ |..||..... .+.+..+....... +.
T Consensus 158 --------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~~~~~~----~~ 222 (262)
T d1byga_ 158 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYKMD----AP 222 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTCCCC----CC
T ss_pred --------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCC----CC
Confidence 23478999999999999999999999999999999998 7888877543 33444444432222 33
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
..+++++.+||.+||..||.+||++.+|++.|+++-.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=386.02 Aligned_cols=255 Identities=22% Similarity=0.278 Sum_probs=200.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEccC-C--eEEEEEEeccCCC-----chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLENVKTK-----HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDY 78 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~-~--~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~ 78 (475)
++|++++.||+|+||+||+|++..+ + ..||||+++.... ...+.+|+.++..++| +||+.+++++.++ .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH--RNLIRLYGVVLTP-P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC--TTBCCEEEEECSS-S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC--CCEEEEEEEEeec-c
Confidence 5699999999999999999986533 2 4789998765421 2357889999998865 9999999988654 5
Q ss_pred EEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccc
Q 011882 79 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 157 (475)
Q Consensus 79 ~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~ 157 (475)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhc
Confidence 68999999 8899998876667799999999999999999999999999999999999995 6789999999999987
Q ss_pred cccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHhhccccc
Q 011882 158 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 236 (475)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 236 (475)
........ ......||..|+|||++.+..++.++|||||||++|||++ |..||.+. +..+.+.++.......
T Consensus 162 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTSCCCC
T ss_pred ccCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHHHHHHhCCCCC
Confidence 55433221 1234568899999999999999999999999999999998 89999874 3344455554433322
Q ss_pred cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 237 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 237 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
. ....+|+++.+|+.+||..||++||++.+|.+.|+++
T Consensus 235 ~---~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 P---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2 2357899999999999999999999999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=384.52 Aligned_cols=258 Identities=20% Similarity=0.321 Sum_probs=209.1
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCC-------eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-------~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~ 75 (475)
.++|+++++||+|+||.||+|++..++ ..||||+++.+... .++..|...+..+.. |+||+.+++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~-HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcC-CCeEEeccccccc
Confidence 478999999999999999999976554 47999998765543 346667777777743 4999999999999
Q ss_pred CCEEEEEEEcC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 76 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 76 ~~~~~lvme~~-g~sL~~ll~~~~---------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
++..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-- 168 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 168 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence 99999999999 899999996432 358999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
+.++.+||+|||+++......... ......||+.|+|||.+.+..|+.++|||||||+||||++ |..||.+..
T Consensus 169 -~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 -TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp -CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 578899999999999776543321 2345689999999999999999999999999999999998 789997643
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 279 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 279 (475)
. .+.+..+...... .....+++++.+||.+||+.||.+||++.+|++.|+.++.
T Consensus 243 ~---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 V---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3 3444444333222 1235789999999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=385.40 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=201.9
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
.++|+++++||+|+||+||+|.+.. ++.||||+++.... .+.+.+|+.++..++| +||+.+++++.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH--EKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCC--TTBCCEEEEECS-SSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhccc--CCEeEEEEEEec-CCeEEEEE
Confidence 3689999999999999999999854 46799999875543 3568899999998876 899999998855 45689999
Q ss_pred cC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 85 LL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 85 ~~-g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+ +++|..++.. ....+++.+++.|+.||+.||.|||++||+||||||+|||| ++++.+||+|||+|+.+.....
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCc
Confidence 99 8889888753 34569999999999999999999999999999999999999 5778999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
. ......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+....... +.
T Consensus 169 ~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~~----~~ 236 (285)
T d1fmka3 169 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRMP----CP 236 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CC
T ss_pred e------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----CC
Confidence 1 123457899999999999999999999999999999999966555432 23344444444332211 33
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
..+|+++.+|+.+||+.||++||++++|++.|++.+
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 578999999999999999999999999998888765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=383.97 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=211.2
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeE--EEEEEeccCC---CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~l 81 (475)
++|++.++||+|+||+||+|+++.++.. ||||.++... ....+.+|++++..+.. |+||+++++++.+.+..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~-HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH-HPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCC-CTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccC-CCCEeeEEEEEecCCeeEE
Confidence 5899999999999999999999888874 6777664332 23468889999888742 4999999999999999999
Q ss_pred EEEcC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCc
Q 011882 82 VIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 145 (475)
Q Consensus 82 vme~~-g~sL~~ll~~~---------------~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 145 (475)
||||+ +++|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+ +..+.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCc
Confidence 99999 89999998632 3569999999999999999999999999999999999999 57789
Q ss_pred EEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCHHH
Q 011882 146 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQ 224 (475)
Q Consensus 146 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~-~Pf~~~~~~~~~~ 224 (475)
+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. .||.+. +..+
T Consensus 166 ~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~ 234 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE 234 (309)
T ss_dssp EEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHH
T ss_pred eEEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHH
Confidence 99999999986554322 23457899999999999999999999999999999999965 567653 4455
Q ss_pred HHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 225 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 225 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.+..+...... .....+|+++.+||.+||+.||++||++.+|++.|++++.+.
T Consensus 235 ~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 235 LYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 55555543222 123568899999999999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=380.40 Aligned_cols=261 Identities=20% Similarity=0.308 Sum_probs=213.6
Q ss_pred CCceEEeeeEeeeCceeEEEEEEc-----cCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|+++++||+|+||.||+|++. .+++.||||+++..... ..+.+|+.++..+.+ |+||+.+++++...+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~-HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN-HMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccC-CCCEEEEEEEEeeCC
Confidence 378999999999999999999863 46679999998765443 246789999988853 499999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEee
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 139 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~-----------------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 139 (475)
..++||||| +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|||++
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~- 179 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT- 179 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-
Confidence 999999999 889999987432 2589999999999999999999999999999999999994
Q ss_pred CCCCCcEEEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 011882 140 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 218 (475)
Q Consensus 140 ~~~~~~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~ellt-G~~Pf~~~~ 218 (475)
..+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+..
T Consensus 180 --~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 180 --HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp --TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred --ccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 7789999999999876543321 12345689999999999999999999999999999999998 566665544
Q ss_pred CCCHHHHHHHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011882 219 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 281 (475)
Q Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 281 (475)
.. ..+.++........ ....+|+++.+||..||+.||++||++.+|++.|++.+.+.
T Consensus 253 ~~---~~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 253 VD---SKFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SS---HHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH---HHHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 32 22223322222221 22457899999999999999999999999999999887653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-48 Score=377.44 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=201.9
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||+||+|++ .+|+.||||+++... ....+.+|+.+++.++| +||+.++.++...+..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH--SNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC--TTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC--CcEEeeeeecccCCceeEE
Confidence 6899999999999999999998 488999999986543 23568899999998865 9999999999999999999
Q ss_pred EEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 83 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 83 me~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
|+++++.+...+....+.+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence 9999777777776667789999999999999999999999999999999999999 5788999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhcc--------
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------- 233 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------- 233 (475)
. .....|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+....+....+.......
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 K-------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c-------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence 1 23457899999999998654 6999999999999999999999998754322222221111100
Q ss_pred -------------ccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 -------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...........+++++.+||.+||..||++|||+.+|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111223356788999999999999999999998874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=383.99 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=202.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEeC-----
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVEG----- 76 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~~----- 76 (475)
++.+|+++++||+|+||+||+|.+..+|+.||||+++..... ..+.+|+.+++.++| ++++.++.++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~h--p~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH--ENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCC--TTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCC--CCCCcEEEEEeecccccc
Confidence 578999999999999999999999999999999998754432 356789999999876 8999888776543
Q ss_pred CEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 77 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 77 ~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
...|++|+++|++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||| +..+.+||+|||+|+.
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARV 158 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceee
Confidence 34678888889999999974 469999999999999999999999999999999999999 5788999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHh-----
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS----- 230 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g-~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~----- 230 (475)
........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+............+.
T Consensus 159 ~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 159 ADPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp CCGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 65543321 12345689999999999854 557999999999999999999999997743322211111110
Q ss_pred ------------------hccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 231 ------------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 231 ------------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........+...+++++.+|+.+||..||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01112233445567788999999999999999999988884
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=384.65 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=198.4
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC---
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGD--- 77 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~--- 77 (475)
+.++|+++++||+|+||+||+|.++.+|+.||||+++..... ..+.+|+++++.++| ++++.++.++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH--ENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCB--TTBCCCSEEECSCSSTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCC--CCeeEEEEEeccCcccc
Confidence 678999999999999999999999999999999998754433 347789999998875 89999988776544
Q ss_pred ---EEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCc
Q 011882 78 ---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 154 (475)
Q Consensus 78 ---~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA 154 (475)
..|+||||++.+|..+++. ..+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|
T Consensus 94 ~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred ccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccce
Confidence 4699999999999998863 479999999999999999999999999999999999999 57899999999999
Q ss_pred ccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc-
Q 011882 155 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 232 (475)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~- 232 (475)
+...... ....||+.|+|||++.+. .++.++|||||||+||||++|..||.+.........+......
T Consensus 169 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 169 RQADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238 (346)
T ss_dssp EECCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eccCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence 8765432 346899999999999875 4689999999999999999999999875432222222111110
Q ss_pred ----------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011882 233 ----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 272 (475)
Q Consensus 233 ----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 272 (475)
........+...+++++.+||.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111122233567889999999999999999999888843
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=378.34 Aligned_cols=269 Identities=22% Similarity=0.261 Sum_probs=207.7
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC----EEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD----YNV 80 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~----~~~ 80 (475)
|..+|.+.++||+|+||+||+|++ +|+.||||+++.. ......+|.+++...+..|+||+.+++++.+.+ ..|
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 356899999999999999999984 7899999998654 234456677777665666799999998887543 679
Q ss_pred EEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEeeCCCCCcEEEeec
Q 011882 81 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDF 151 (475)
Q Consensus 81 lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~--------~gIvHrDIKP~NILl~~~~~~~~vkL~DF 151 (475)
+||||+ +++|.++++. ..+++..++.++.|++.||.|||+ +|||||||||+|||| +.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence 999999 8899999974 469999999999999999999996 599999999999999 57889999999
Q ss_pred CCcccccccccccccccccCCCCccCccccccccccCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCC------
Q 011882 152 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA------ 219 (475)
Q Consensus 152 GlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~------~s~ksDIwSlG~iL~elltG~~Pf~~~~~------ 219 (475)
|+++.+......... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||.....
T Consensus 153 Gl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 153 GLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 999987654332211 223568999999999988653 56789999999999999999888743211
Q ss_pred ------CCHHHHHHHHhhccccccHHHHh--cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011882 220 ------GTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 284 (475)
Q Consensus 220 ------~~~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 284 (475)
.........+........++... ...+.++.+|+.+||..||++||++.+|++.|+++..++|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 11122222222222222111111 123467999999999999999999999999999999888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=382.28 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=195.2
Q ss_pred ceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe------CCEEEE
Q 011882 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------GDYNVL 81 (475)
Q Consensus 8 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------~~~~~l 81 (475)
+|+.+++||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++| +||+.++.++.. ..+.||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h--~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDH--CNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCC--TTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCC--CCCCcEEEEEEecCccCCceEEEE
Confidence 6999999999999999999999999999999986543 234579999998865 899998777643 346799
Q ss_pred EEEcCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccc
Q 011882 82 VIDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 158 (475)
Q Consensus 82 vme~~g~sL~~ll~---~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~ 158 (475)
|||||++++.+.+. .....+++.++..|+.||+.||+|||++|||||||||+||||. .+...+||+|||+|+.+.
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhcc
Confidence 99999777665553 2355799999999999999999999999999999999999994 234589999999998765
Q ss_pred ccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc---cc
Q 011882 159 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---KV 234 (475)
Q Consensus 159 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~---~~ 234 (475)
.... .....||..|+|||.+.+. .++.++|||||||++|||++|..||..... ...+..+... ..
T Consensus 175 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 175 RGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPT 243 (350)
T ss_dssp TTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCCh
Confidence 4322 2346899999999998764 689999999999999999999999987443 2222222210 00
Q ss_pred ccc---------------------HHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 STS---------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ~~~---------------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
... .......+++++.+||.+||..||++|||+.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 0111234688999999999999999999988874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=376.79 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=211.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEcc-----CCeEEEEEEeccCCCch---HHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAvKi~~~~~~~~---~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
.++|+++++||+|+||.||+|.+.. ++..||||+++...... .+.+|+.++..++| +||+.+++++...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC--HHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC--TTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC--CCEeeeeeEEecCC
Confidence 3789999999999999999998753 35789999987544332 36788888887765 99999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEE
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 147 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~---------~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vk 147 (475)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||| +.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEE
Confidence 999999999 899999886431 347899999999999999999999999999999999999 5888999
Q ss_pred EeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCHHHHH
Q 011882 148 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKY 226 (475)
Q Consensus 148 L~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG-~~Pf~~~~~~~~~~~~ 226 (475)
|+|||+|+.+....... ......||+.|+|||.+.+..++.++|||||||+||||++| ..||.+. ...+.+
T Consensus 174 l~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~ 245 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVL 245 (308)
T ss_dssp ECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHH
T ss_pred EeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHH
Confidence 99999998765543211 12345789999999999999999999999999999999998 5788763 445555
Q ss_pred HHHhhccccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011882 227 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 277 (475)
Q Consensus 227 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 277 (475)
..+....... ....+|+++.++|..||+.||++||++.+|++.|++.
T Consensus 246 ~~i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 RFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5555444322 2356889999999999999999999999999888765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=372.70 Aligned_cols=256 Identities=18% Similarity=0.245 Sum_probs=205.9
Q ss_pred EeeeEeeeCceeEEEEEEccCC---eEEEEEEeccCCCc---hHHHHHHHHHHHHhCCCCCcCeeEEeeEe-CCEEEEEE
Q 011882 11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGSTGIPNLRWFGVE-GDYNVLVI 83 (475)
Q Consensus 11 l~~~LG~G~fG~Vy~a~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~~i~~l~~~~~~-~~~~~lvm 83 (475)
+.++||+|+||+||+|.+..++ ..||||.++..... .++.+|++++..++| +||+.+++++.. +...++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH--PNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCC--TTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC--CCEeEEeEEEEecCCceEEEE
Confidence 3679999999999999986654 36999988654332 357889999998865 999999988775 46889999
Q ss_pred EcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccccccccc
Q 011882 84 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 162 (475)
Q Consensus 84 e~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~~ 162 (475)
||| +++|.+++......+++..++.++.|++.||.|||+++|+||||||+|||| ++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccc
Confidence 999 899999988666678899999999999999999999999999999999999 5788999999999987655432
Q ss_pred ccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccccccHHHHh
Q 011882 163 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 242 (475)
Q Consensus 163 ~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 242 (475)
... .......||+.|+|||.+.+..++.++|||||||+||||++|..||..... ..+....+....... ..
T Consensus 186 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~----~p 256 (311)
T d1r0pa_ 186 DSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL----QP 256 (311)
T ss_dssp CCT---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC----CC
T ss_pred ccc---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCC----Cc
Confidence 221 123446799999999999999999999999999999999998888765322 222233333322221 23
Q ss_pred cCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011882 243 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 280 (475)
Q Consensus 243 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 280 (475)
..+++++.+|+..||..||++||++.+|++.|+.++..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 56789999999999999999999999999999999754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=374.33 Aligned_cols=258 Identities=21% Similarity=0.233 Sum_probs=198.0
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC----CchHHHHHHHHHHHHhCCCCCcCeeEEeeEe------
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGSTGIPNLRWFGVE------ 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~------ 75 (475)
.++|+++++||+|+||+||+|++..+|+.||||++.... ...++.+|+++++.++| ++++.++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h--~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH--ENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCC--TTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcC--CCccceEeeeeccccccc
Confidence 489999999999999999999999999999999875442 23468899999999875 889888776543
Q ss_pred --CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCC
Q 011882 76 --GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 153 (475)
Q Consensus 76 --~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 153 (475)
....|+||||+++.+...+......+++..+..|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence 34579999999877777776566789999999999999999999999999999999999999 5788999999999
Q ss_pred cccccccccccccccccCCCCccCccccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc
Q 011882 154 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 232 (475)
Q Consensus 154 A~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~-~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 232 (475)
|+.+....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+..+...
T Consensus 164 ~~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp CEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 98765433211 1123456899999999999876 5899999999999999999999999875433222222222211
Q ss_pred cccc----------------------cHHH-H-hcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 KVST----------------------SIEA-L-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ~~~~----------------------~~~~-l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
.... .... + ....++++.+||.+||..||++|||+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 1000 0000 0 011256788999999999999999988773
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=373.06 Aligned_cols=245 Identities=18% Similarity=0.273 Sum_probs=203.5
Q ss_pred CceEEeeeEeeeCceeEEEEEEc---cCCeEEEEEEeccC------CCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCC
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGD 77 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAvKi~~~~------~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~ 77 (475)
++|+++++||+|+||+||+|.+. .+|+.||||+++.. .....+.+|+++++.++|+ ++|+.++.+..+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~-pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS-PFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTC-TTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCC-CeEEEeeeeeccCC
Confidence 77999999999999999999874 46899999987543 2335678899999999885 89999999999999
Q ss_pred EEEEEEEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCccc
Q 011882 78 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 156 (475)
Q Consensus 78 ~~~lvme~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~ 156 (475)
..+++|||+ +++|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 999999999 89999998754 468899999999999999999999999999999999999 5778999999999987
Q ss_pred ccccccccccccccCCCCccCccccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc
Q 011882 157 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 234 (475)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~--~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 234 (475)
+....... .....|++.|++||.+.+.. ++.++|||||||+||||++|..||.+.........+.+......
T Consensus 179 ~~~~~~~~------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 179 FVADETER------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp CCGGGGGG------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hccccccc------ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 65433221 23457999999999998754 68899999999999999999999988665554444433322111
Q ss_pred cccHHHHhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 235 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 235 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
. .+...+++++.+||.+||..||++||+
T Consensus 253 ~----~~~~~~s~~~~~li~~~l~~dP~~R~s 280 (322)
T d1vzoa_ 253 P----PYPQEMSALAKDLIQRLLMKDPKKRLG 280 (322)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred C----CCcccCCHHHHHHHHHHcccCHHHcCC
Confidence 1 123568999999999999999999995
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-46 Score=371.79 Aligned_cols=251 Identities=18% Similarity=0.288 Sum_probs=198.2
Q ss_pred cCCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEe--CCEEEEE
Q 011882 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVE--GDYNVLV 82 (475)
Q Consensus 5 i~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~--~~~~~lv 82 (475)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+++.+.+ |++|+.++.++.. ....++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~-hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRG-GPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTT-STTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccC-CCCCcEEEEEEEecCCCceeEE
Confidence 346799999999999999999999999999999998654 45678899999999974 3999999888763 4568999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|||+ +++|..+. +.+++.++..++.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+.+....
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTC
T ss_pred EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCC
Confidence 9999 67776543 4699999999999999999999999999999999999996 345579999999998765432
Q ss_pred cccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCH-HHHHHHHhhcc------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKK------ 233 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~------ 233 (475)
. .....||+.|+|||.+.+.. ++.++|||||||++|||++|..||........ ...+..+....
T Consensus 185 ~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 185 E--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp C--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred c--------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 2 24568999999999988765 79999999999999999999999976433211 11111111000
Q ss_pred ------ccc-----------------cHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 234 ------VST-----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 234 ------~~~-----------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
... ........+++++.+||.+||..||++|||+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 00001123578999999999999999999988874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=362.45 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=202.0
Q ss_pred CceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEE
Q 011882 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLV 82 (475)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lv 82 (475)
++|+++++||+|+||+||+|+++.+++.||||+++..... .++.+|+.+++.++| +||+.++.++......++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH--KNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC--TTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc--CCEEeeccccccccceeEE
Confidence 5899999999999999999999999999999998655432 357789999887765 8999999999999999999
Q ss_pred EEcC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcccccccc
Q 011882 83 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 161 (475)
Q Consensus 83 me~~-g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~~~~~~~ 161 (475)
|+++ +++|..++ ...+.+++..+..++.|++.||+|||++|||||||||+|||| +..+.+||+|||.|+......
T Consensus 80 ~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 80 FEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCC
T ss_pred eeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCC
Confidence 9999 55555554 466789999999999999999999999999999999999999 567899999999998776543
Q ss_pred cccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc------
Q 011882 162 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------ 234 (475)
Q Consensus 162 ~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------ 234 (475)
. ......++..|+|||.+.+.. ++.++|||||||++|||++|..||.... +..+.+.++.....
T Consensus 156 ~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 156 R-------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp S-------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTT
T ss_pred c-------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhh
Confidence 2 123346788999999998765 6999999999999999999999975432 22333333221100
Q ss_pred ------------------cccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 235 ------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 235 ------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
..........+++++.+||.+||+.||.+|||+++|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1111223345678999999999999999999998873
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=374.05 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=196.8
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc----hHHHHHHHHHHHHhCCCCCcCeeEEeeE------e
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGSTGIPNLRWFGV------E 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~~i~~l~~~~~------~ 75 (475)
.++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+.+++.++| ++++.++.++. +
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h--~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH--ENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCC--CCeeeEEEEEeecccccc
Confidence 57899999999999999999999999999999998755433 246789999998875 89998877664 2
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
....+++|+++|++|.+++. .+++++.++..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|.
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 169 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----
T ss_pred CceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhc
Confidence 33466777777999999985 4579999999999999999999999999999999999999 578899999999997
Q ss_pred cccccccccccccccCCCCccCccccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhc--
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 232 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~-~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 232 (475)
...... ....||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......
T Consensus 170 ~~~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 170 HTDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp CCTGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccCccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 654322 3468999999999988765 689999999999999999999999875432222222111110
Q ss_pred ---------------------cccccHHHHhcCChHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011882 233 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 271 (475)
Q Consensus 233 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 271 (475)
...........++++++.+||.+||..||.+|||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 011223334457889999999999999999999988774
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=371.23 Aligned_cols=254 Identities=19% Similarity=0.210 Sum_probs=190.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCch----HHHHHHHHHHHHhCCCCCcCeeEEeeE------e
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGSTGIPNLRWFGV------E 75 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~~i~~l~~~~~------~ 75 (475)
.++|+++++||+|+||+||+|.++.+|+.||||+++...... .+.+|+.+++.++| ++|+.++.++. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH--KNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC--TTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC--CCeeEEEEEEeccccccc
Confidence 478999999999999999999999999999999987654332 46789999988864 99999877764 3
Q ss_pred CCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 76 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 76 ~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
....|+||||+.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhh
Confidence 46889999999877776663 569999999999999999999999999999999999999 577899999999998
Q ss_pred cccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCHHHHHHHHhhccc-
Q 011882 156 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 234 (475)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 234 (475)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+........
T Consensus 168 ~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 168 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp ---------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 6654322 2455899999999999999999999999999999999999999987543222222111110000
Q ss_pred ---------------------cccHHH------------HhcCChHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011882 235 ---------------------STSIEA------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 278 (475)
Q Consensus 235 ---------------------~~~~~~------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 278 (475)
...... .....++++.+||.+||..||++|||+++| |++-|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el---L~Hpw 313 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA---LQHPY 313 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH---HTSTT
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH---hcCcc
Confidence 000000 011235688999999999999999999887 44444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-41 Score=341.51 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=187.3
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCC-chHHHHHHHHHHHHhCC---------CCCcCeeEEeeE-
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG---------STGIPNLRWFGV- 74 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~---------~~~i~~l~~~~~- 74 (475)
+++|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+++.+.+. +++++.++.++.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4579999999999999999999999999999999875432 24567899999888752 367887766554
Q ss_pred -eCCEEEEEEEcC--CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeeCCCC---CcE
Q 011882 75 -EGDYNVLVIDLL--GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA---NQV 146 (475)
Q Consensus 75 -~~~~~~lvme~~--g~sL~~ll~~-~~~~ls~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~---~~v 146 (475)
.....+++|+++ +.+....... ....+++..+..++.||+.||+|||+ +||+||||||+||||..++.. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 445667777666 4444444332 34569999999999999999999998 899999999999999643221 258
Q ss_pred EEeecCCcccccccccccccccccCCCCccCccccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCC---HH
Q 011882 147 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KK 223 (475)
Q Consensus 147 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~g~~~s~ksDIwSlG~iL~elltG~~Pf~~~~~~~---~~ 223 (475)
+|+|||.|....... ....||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 172 kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998654322 34589999999999999999999999999999999999999997543211 11
Q ss_pred HHHHHHhhccc------------------------------cccHHH-------HhcCChHHHHHHHHHHhcCCCCCCCC
Q 011882 224 QKYEKISEKKV------------------------------STSIEA-------LCRGYPTEFASYFHYCRSLRFDDKPD 266 (475)
Q Consensus 224 ~~~~~i~~~~~------------------------------~~~~~~-------l~~~~p~~l~~li~~cl~~dp~~RPt 266 (475)
..+.......- ...... +....++++.+||.+||.+||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111100000 000000 01123578999999999999999999
Q ss_pred HHHH
Q 011882 267 YAYL 270 (475)
Q Consensus 267 ~~~l 270 (475)
++++
T Consensus 322 a~e~ 325 (362)
T d1q8ya_ 322 AGGL 325 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8877
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.9e-25 Score=203.76 Aligned_cols=164 Identities=17% Similarity=0.278 Sum_probs=114.0
Q ss_pred eEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCc--------------------hHHHHHHHHHHHHhCCCCCcCe
Q 011882 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--------------------PQLQYEAKLYKILQGGSTGIPN 68 (475)
Q Consensus 9 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~--------------------~~~~~E~~il~~l~~~~~~i~~ 68 (475)
+.++++||+|+||+||+|.+ .+|+.||||+++..... .....|...+..+.+ .+++.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~v~~ 78 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--LAVPK 78 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--SSSCC
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccC--CCcce
Confidence 56899999999999999997 57999999986532110 112345555655544 56666
Q ss_pred eEEeeEeCCEEEEEEEcCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeeCCCCCcEEE
Q 011882 69 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 148 (475)
Q Consensus 69 l~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~ls~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL 148 (475)
.+.+ .. .+++|||+++... ..++...+..++.||+.+|.|||++||+||||||+|||++ ++.++|
T Consensus 79 ~~~~--~~--~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~l 143 (191)
T d1zara2 79 VYAW--EG--NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 143 (191)
T ss_dssp EEEE--ET--TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred EEEe--cC--CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEE
Confidence 5443 22 3799999955321 1255566788999999999999999999999999999995 356999
Q ss_pred eecCCcccccccccccccccccCCCCccCcccccc--c---cccCCCCCCchhHHHHHHHHH
Q 011882 149 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM--N---THLGIEQSRRDDLESLGYVLM 205 (475)
Q Consensus 149 ~DFGlA~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP--E---~~~g~~~s~ksDIwSlG~iL~ 205 (475)
+|||+|+....+.. ..|... + .+....|+.++||||+.--+.
T Consensus 144 iDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 99999976543221 011111 0 122356788999999875543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.52 E-value=4.3e-07 Score=84.08 Aligned_cols=85 Identities=16% Similarity=0.234 Sum_probs=63.7
Q ss_pred CCceEEeeeEeeeCceeEEEEEEccCCeEEEEEEeccCC--CchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEE
Q 011882 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVI 83 (475)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvm 83 (475)
.+.|++.+..+.++.+.||+.. ..++.++||+..... ....+..|..++..+... .-+|.+..++..++..++||
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~-vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGK-LPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTT-SCCCCEEEEEEETTEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhcc-CCCCcEEEEEecCCceEEEE
Confidence 4578888876666667999986 566778889765432 234578899999988754 55788888888899999999
Q ss_pred EcC-CCCHHHH
Q 011882 84 DLL-GPSLEDL 93 (475)
Q Consensus 84 e~~-g~sL~~l 93 (475)
+++ |.++.+.
T Consensus 90 ~~l~G~~~~~~ 100 (263)
T d1j7la_ 90 SEADGVLCSEE 100 (263)
T ss_dssp ECCSSEEHHHH
T ss_pred Eeccccccccc
Confidence 999 6566543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=4.6e-06 Score=76.45 Aligned_cols=74 Identities=16% Similarity=0.081 Sum_probs=55.7
Q ss_pred EeeeC-ceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEEcC-CCCH
Q 011882 15 IGSGS-FGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVIDLL-GPSL 90 (475)
Q Consensus 15 LG~G~-fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme~~-g~sL 90 (475)
+..|. .+.||+... ..+..+++|+.... ....+..|..+++.+......+|.++.++.+++..++||+++ |.++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 368999873 56777899976544 445689999999999876566888888888888899999999 4443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.96 E-value=1.5e-05 Score=78.50 Aligned_cols=75 Identities=13% Similarity=0.168 Sum_probs=49.3
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEecc------C---CCchHHHHHHHHHHHHhCCC-CCcCeeEEeeEeCCEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV------K---TKHPQLQYEAKLYKILQGGS-TGIPNLRWFGVEGDYNVL 81 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~------~---~~~~~~~~E~~il~~l~~~~-~~i~~l~~~~~~~~~~~l 81 (475)
.+.||.|....||++.+..+++.|+||.-.. . ....+..+|.++++.+.... ..+|.++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998777788999995321 1 12235677999998886532 335666555 4455679
Q ss_pred EEEcCCC
Q 011882 82 VIDLLGP 88 (475)
Q Consensus 82 vme~~g~ 88 (475)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999943
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.23 E-value=0.00045 Score=64.98 Aligned_cols=139 Identities=18% Similarity=0.171 Sum_probs=74.0
Q ss_pred eeeEeeeCceeEEEEEEccCCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCee------EEeeEeCCEEEEEEEc
Q 011882 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNL------RWFGVEGDYNVLVIDL 85 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l------~~~~~~~~~~~lvme~ 85 (475)
.+.|..|---+.|+.+. .. ..+++|+........++..|.+++..|......++.. ..+.......+.++.+
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~-g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~ 100 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TK-DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 100 (316)
T ss_dssp EEEECC---EEEEEEEE-SS-CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eecCCCCcccCeEEEEE-CC-CcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence 44555666678899874 33 4589999866556677888999999887643333332 1222334455556655
Q ss_pred C-CCC-----HHHHH---------HHcCC--------CCC------------------HHHHHHHHHHHHHHHHHHHh--
Q 011882 86 L-GPS-----LEDLF---------NFCSR--------KLS------------------LKTVLMLADQMINRVEFVHS-- 122 (475)
Q Consensus 86 ~-g~s-----L~~ll---------~~~~~--------~ls------------------~~~~~~i~~qi~~aL~yLH~-- 122 (475)
. |.. ..... ..... ... .......+..+...+.-.+.
T Consensus 101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (316)
T d2ppqa1 101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 180 (316)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence 5 221 11111 00000 000 11111122222222333222
Q ss_pred --CCceecCCCCCcEEEeeCCCCCcEEEeecCCcc
Q 011882 123 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 155 (475)
Q Consensus 123 --~gIvHrDIKP~NILl~~~~~~~~vkL~DFGlA~ 155 (475)
.|+||+|+.++||++. .+...-|+||+.|.
T Consensus 181 L~~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcc---cccceeEecccccc
Confidence 4799999999999994 44555799999884
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.18 E-value=0.00064 Score=66.27 Aligned_cols=70 Identities=13% Similarity=0.102 Sum_probs=49.9
Q ss_pred eeeEeeeCceeEEEEEEcc-------CCeEEEEEEeccCCCchHHHHHHHHHHHHhCCCCCcCeeEEeeEeCCEEEEEEE
Q 011882 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGSTGIPNLRWFGVEGDYNVLVID 84 (475)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~~i~~l~~~~~~~~~~~lvme 84 (475)
++.|+.|-.-.+|++.... ..+.|++++.......-...+|..+++.+... ...|.+++++. .++||+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~-gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSER-HLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHT-TSSSCEEEEET----TEEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhC-CCCCeEEEEcC----CceEEE
Confidence 4678888888999998643 24678888876333334567899999988764 55677777654 268888
Q ss_pred cC
Q 011882 85 LL 86 (475)
Q Consensus 85 ~~ 86 (475)
|+
T Consensus 122 fi 123 (395)
T d1nw1a_ 122 YI 123 (395)
T ss_dssp CC
T ss_pred Ee
Confidence 88
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.05 E-value=0.0023 Score=60.47 Aligned_cols=66 Identities=11% Similarity=0.118 Sum_probs=44.4
Q ss_pred eeEEEEEEccCCeEEEEEEeccCC-CchHHHHHHHHHHHHhCCCCCcCee-----EEeeEeCCEEEEEEEcCC
Q 011882 21 GEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGSTGIPNL-----RWFGVEGDYNVLVIDLLG 87 (475)
Q Consensus 21 G~Vy~a~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~~i~~l-----~~~~~~~~~~~lvme~~g 87 (475)
-.||++.. .+|+.|++|+..... ...++..|..++..|......++.. ........+.+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 48999984 678899999976553 3456888999998887531212211 122245677888999884
|